U.S. patent application number 11/255139 was filed with the patent office on 2006-07-13 for enzymatic nucleic acid treatment of diseases or conditions related to levels of ikk-gamma and pkr.
This patent application is currently assigned to Sirna Therapeutics, Inc.. Invention is credited to James McSwiggen.
Application Number | 20060154271 11/255139 |
Document ID | / |
Family ID | 40293860 |
Filed Date | 2006-07-13 |
United States Patent
Application |
20060154271 |
Kind Code |
A1 |
McSwiggen; James |
July 13, 2006 |
Enzymatic nucleic acid treatment of diseases or conditions related
to levels of IKK-gamma and PKR
Abstract
The present invention relates to nucleic acid molecules,
including antisense and enzymatic nucleic acid molecules, such as
hammerhead ribozymes, DNAzymes, allozymes, aptamers, decoys and
siRNA (RNAi), which modulate the expression or function of IKK
genes, such as IKK-gamma, IKK-alpha, or IKK-beta, and PKR
genes.
Inventors: |
McSwiggen; James; (Boulder,
CO) |
Correspondence
Address: |
MCDONNELL BOEHNEN HULBERT & BERGHOFF LLP
300 S. WACKER DRIVE
32ND FLOOR
CHICAGO
IL
60606
US
|
Assignee: |
Sirna Therapeutics, Inc.
Boulder
CO
|
Family ID: |
40293860 |
Appl. No.: |
11/255139 |
Filed: |
October 20, 2005 |
Related U.S. Patent Documents
|
|
|
|
|
|
Application
Number |
Filing Date |
Patent Number |
|
|
10156306 |
May 28, 2002 |
7022828 |
|
|
11255139 |
Oct 20, 2005 |
|
|
|
PCT/US02/10512 |
Apr 3, 2002 |
|
|
|
10156306 |
May 28, 2002 |
|
|
|
60294412 |
May 29, 2001 |
|
|
|
PCT/US02/10512 |
Apr 3, 2002 |
|
|
|
Current U.S.
Class: |
435/6.18 ;
514/44A; 536/23.1 |
Current CPC
Class: |
C12N 2310/14 20130101;
C12N 15/1137 20130101; C12N 2310/346 20130101; C12N 2310/18
20130101; C12N 2310/317 20130101; C12N 2310/3521 20130101; C12N
2310/332 20130101; C12N 2310/321 20130101; A61K 38/00 20130101;
C12N 2310/321 20130101; C12N 15/1138 20130101; C12N 15/113
20130101; C12N 2310/121 20130101; C12N 2310/315 20130101; C12N
2310/12 20130101; C12N 2310/13 20130101 |
Class at
Publication: |
435/006 ;
536/023.1; 514/044 |
International
Class: |
A61K 48/00 20060101
A61K048/00; C12Q 1/68 20060101 C12Q001/68; C07H 21/02 20060101
C07H021/02 |
Claims
1. A chemically modified double stranded siRNA molecule that down
regulates expression of a protein kinase PKR gene via RNA
interference (RNAi), wherein: a) each strand of said siRNA molecule
is independently about 18 to about 28 nucleotides in length; and b)
one strand of said siRNA molecule comprises nucleotide sequence
having sufficient complementarity to an RNA of said protein kinase
PKR gene for the siRNA molecule to direct cleavage of said RNA via
RNA interference.
2. The siRNA molecule of claim 1, wherein each strand of the siRNA
molecule comprises about 18 to about 28 nucleotides, and wherein
each strand comprises at least about 14 to 24 nucleotides that are
complementary to the nucleotides of the other strand.
3. The siRNA molecule of claim 1, wherein said siNA molecule is
assembled from two separate oligonucleotide fragments wherein a
first fragment comprises the sense strand and a second fragment
comprises the antisense strand of said siNA molecule.
4. The siRNA molecule of claim 3, wherein said sense strand is
connected to the antisense strand via a linker molecule.
5. The siRNA molecule of claim 4, wherein said linker molecule is a
polynucleotide linker.
6. The siRNA molecule of claim 4, wherein said linker molecule is a
non-nucleotide linker.
7. The siRNA molecule of claim 1, wherein said siRNA molecule
comprises at least one 2'-sugar modification.
8. The siRNA molecule of claim 1, wherein said siRNA molecule
comprises at least one nucleic acid base modification.
9. The siRNA molecule of claim 1, wherein said siRNA molecule
comprises at least one phosphate backbone modification.
10. The siRNA molecule of claim 7, wherein said 2'-sugar
modification is a 2'-deoxy-2'-fluoro modification.
11. The siRNA molecule of claim 7, wherein said 2'-sugar
modification is a 2'-O-methyl modification.
12. The siRNA molecule of claim 7, wherein said 2'-sugar
modification is a 2'-deoxy modification.
13. The siRNA molecule of claim 3, wherein said second fragment
comprises a terminal cap moiety at a 5'-end, a 3'-end, or both of
the 5' and 3' ends of said second strand.
14. The siRNA molecule of claim 13, wherein said terminal cap
moiety is an inverted deoxy abasic moiety.
15. The siRNA molecule of claim 3, wherein said first fragment
comprises a phosphorothioate internucleotide linkage at the 3' end
of said first strand.
16. A composition comprising the siRNA molecule of claim 1 in a
pharmaceutically acceptable carrier or diluent.
Description
[0001] This patent application is a continuation of U.S. Ser. No.
10/156,306, filed May 28, 2002, now allowed, which is a
continuation in part of PCT/US02/10512, filed Apr. 3, 2002, and
which claims the benefit of U.S. Ser. No. 60/294,412, filed May 29,
2001. These applications are hereby incorporated by reference
herein in their entirety including the drawings.
FIELD OF THE INVENTION
[0002] The present invention relates to therapeutic compositions
and methods for the treatment or diagnosis of diseases or
conditions related to IKK gamma (IKKG) and PKR levels, such as
cancer, inflammatory, and autoimmune diseases and/or disorders.
BACKGROUND OF THE INVENTION
[0003] The following is a brief description of the physiological
role of nuclear factor kappa B (NFKB), IKK kinases, and protein
kinase PKR. The discussion is provided only for understanding the
invention that follows. This summary is not an admission that any
of the work described below is prior art to the claimed
invention.
[0004] Nuclear factor kappa B (NFKB) is a multiunit transcription
factor which regulates the expression of genes involved in a number
of physiologic and pathologic processes. NFKB is a key component of
the TNF signaling pathway. These processes include, but are not
limited to: apoptosis, immune, inflammatory and acute phase
responses. The REL-A gene product (a.k.a. RelA or p65), and p50
subunits of NFKB, have been implicated in the induction of
inflammatory responses and cellular transformation. NFKB exists in
the cytoplasm as an inactive heterodimer of the p50 and p65
subunits. NFKB is complexed with an inhibitory protein complex,
IkappaB (IKK complex), until activated by the appropriate stimuli.
NFKB activation can occur following stimulation of a variety of
cell types by inflammatory mediators, for example TNF and IL-1, and
reactive oxygen intermediates. In response to induction, NFKB can
stimulate production of pro-inflammatory cytokines such as
TNF-alpha, IL-1-beta, IL-6 and iNOS, thereby perpetuating a
positive feedback loop. NFKB appears to play a role in a number of
disease processes including: ischemia/reperfusion injury (CNS and
myocardial), glomerulonephritis, sepsis, allergic airway
inflammation, inflammatory bowel disease, infection, arthritis, and
cancer.
[0005] The nuclear DNA-binding protein, NFKB, was first identified
as a factor that binds and activates the immunoglobulin kappa light
chain enhancer in B cells. NFKB now is known to activate
transcription of a variety of other cellular genes (e.g.,
cytokines, adhesion proteins, oncogenes and viral proteins) in
response to a variety of stimuli (e.g., phorbol esters, mitogens,
cytokines and oxidative stress). In addition, molecular and
biochemical characterization of NFKB has shown that the activity is
due to a homodimer or heterodimer of a family of DNA binding
subunits. Each subunit bears a stretch of 300 amino acids that is
homologous to the oncogene, v-rel. The activity first described as
NFKB is a heterodimer of p49 or p50 with p65. The p49 and p50
subunits of NFKB (encoded by the NF-kappa B2 or NF kappa B1 genes,
respectively) are generated from the precursors NFKB1 (p105) or
NFKB2 (p100). The p65 subunit of NFKB (now termed REL-A) is encoded
by the rel-A locus.
[0006] The roles of each specific transcription-activating complex
now are being elucidated in cells (Perkins, et al., 1992, Proc.
Natl. Acad. Sci USA, 89, 1529-1533). For instance, the heterodimer
of NFKB1 and Rel A (p50/p65) activates transcription of the
promoter for the adhesion molecule, VCAM-1, while NFKB2/RelA
heterodimers (p49/p65) actually inhibit transcription (Shu, et al.,
1993, Mol. Cell. Biol., 13, 6283-6289). Conversely, heterodimers of
NFKB2/RelA (p49/p65) act with Tat-I to activate transcription of
the HIV genome, while NFKB1/RelA (p50/p65) heterodimers have little
effect (Liu et al., 1992, J. Virol., 3883-3887). Similarly,
blocking rel A gene expression with antisense oligonucleotides
specifically blocks embryonic stem cell adhesion; blocking NFKB1
gene expression with antisense oligonucleotides had no effect on
cellular adhesion (Narayanan et al., 1993, Mol. Cell. Biol., 13,
3802-3810). Thus, the promiscuous role initially assigned to NFKB
in transcriptional activation (Lenardo, and Baltimore, 1989, Cell,
58, 227-229) represents the sum of the activities of the rel family
of DNA-binding proteins. This conclusion is supported by recent
transgenic "knock-out" mice of individual members of the rel
family. Such "knock-outs" show few developmental defects,
suggesting that essential transcriptional activation functions can
be performed by more than one member of the rel family.
[0007] A number of specific inhibitors of NFKB function in cells
exist, including treatment with phosphorothioate antisense
oliogonucleotide, treatment with double-stranded NFKB binding
sites, and over expression of the natural inhibitor MAD-3 (an
Ikappa-B family member). These agents have been used to show that
NFKB is required for induction of a number of molecules involved in
cancer and/or inflammation, as described below.
[0008] NFkB is required for phorbol ester-mediated induction of
IL-6 (Kitajima, et al., 1992, Science, 258, 1792-5) and IL-8
(Kunsch and Rosen, 1993, Mol. Cell. Biol., 13, 6137-46).
[0009] NFkB is required for induction of the adhesion molecules
ICAM-1 (Eck, et al., 1993, Mol. Cell. Biol., 13, 6530-6536), VCAM-1
(Shu et al., supra), and E-selectin (Read, et al., 1994, J. Exp.
Med., 179, 503-512) on endothelial cells.
[0010] NFkB is involved in the induction of the integrin subunit,
CD18, and other adhesive properties of leukocytes (Eck et al., 1993
supra).
[0011] HER2/Neu overexpression induces NFKB via a PI3-kinase/Akt
pathway involving calpain-mediated degradation of IKB-alpha. Breast
cancer has been shown to typify the aberrant expression of NFKB/REL
factors (Pianetti et al., 2001, Oncogene, 20, 1287-1299; Sovak et
al., 1999, J. Clin. Invest., 100, 2952-2960).
[0012] Inhibition of NFKB activity has been shown to induce
apoptosis in murine hepatocytes (Bellas et al., 1997, Am. J.
Pathol., 151, 891-896).
[0013] NFKB has been shown to regulate cyclooxygenase-2 expression
and cell proliferation in human gastric cancer cells (Joo Weon et
al., 2001, Laboratory Investigation, 81, 349-360).
[0014] The above studies suggest that NFKB is integrally involved
in the induction of cytokines and adhesion molecules by
inflammatory mediators and is involved in the transformation of
cancerous cells. Two reported studies point to another connection
between NFKB and inflammation: glucocorticoids can exert their
anti-inflammatory effects by inhibiting NFKB. The glucocorticoid
receptor and p65 both act at NFKB binding sites in the ICAM-1
promoter (van de Stolpe, et al., 1994, J. Biol. Chem., 269,
6185-6192). Glucocorticoid receptor inhibits NFKB-mediated
induction of IL-6 (Ray and Prefontaine, 1994 Proc. Natl. Acad. Sci
USA, 91, 752-756). Conversely, overexpression of p65 inhibits
glucocorticoid induction of the mouse mammary tumor virus promoter.
Finally, protein cross-linking and co-immunoprecipitation
experiments demonstrated direct physical interaction between p65
and the glucocorticoid receptor.
[0015] The IKK complex that sequesters NFKB in the cytoplasm
comprises IkappaB (I.kappa.B) proteins (I.kappa.B-alpha,
I.kappa.B-beta, I.kappa.B-epsilon, p105, and p100). The
phosphorylation of I.kappa.B proteins results in the release of
NFKB from the I.kappa.B complex which is transported to the nucleus
via the unmasking of nuclear translocation signals. Phosphorylation
marks IkB proteins for ubiquitination and degradation via the
proteosome pathway. Most NFKB inducing stimuli initiate activation
of an I.kappa.B kinase (IKK) complex that contains two catalytic
subunits, IKK -alpha (IKK1) and IKK-beta (IKK2), that phosphorylate
I.kappa.B-alpha and I.kappa.B-beta, with IKK-beta playing a
predominant role in pro-inflammatory signaling. In addition to the
two kinases, the IKK complex contains regulatory subunits,
including IKK-gamma (NEMO/IKKAP1). IKK-gamma is a protein that is
critical for the assembly of the IKK complex. IKK-gamma directly
binds to IKK-beta and is required for activation of NFKB, for
example by TNF-alpha, IL-1-beta, lipopolysaccharide, phorbol
12-myristate 13-acetate, the human T-cell lymphotrophic virus
(HTLV-1), or double stranded RNA. Genomic rearrangements in
IKK-gamma have been shown to impair NFKB activation and result in
incontinentia pigmenti. Additional proteins that associate with the
IKK complex include, MEK kinase (MEKK1), NFKB inducing kinase
(NIK), receptor interacting protein (RIP), protein kinase CK2, and
IKK-associated protein (IKAP), which appears to be associated with
the I.kappa.B Kinase (IKK) complex, but does not appear to be an
integral component of the tripartate IKK complex as does IKK-gamma
(Krappmann et al., 2001, J. Biol. Chem., 275, 29779-87).
[0016] The RNA-dependent protein kinase PKR is a signal transducer
for NFKB and IFN regulatory factor-1. PKR is required for
activation of NFKB by IFN-gamma via a STAT-1 independent pathway
(Amitabha et al., 2001, J. Immunol., 166, 6170-6180). The induction
of NFKB by PKR takes place though phosphorylation of
I.kappa.B-alpha, and appears not to require the catalytic activity
of PKR, thereby proceeding independently of the dsRNA-binding
properties of PKR (Ishii et al., 2001, Oncogene, 20, 1900-1912).
PKR also plays an important role in the regulation of protein
synthesis by modulating the activity of eukaryotic initiation
factor 2 (eIF-2-alpha) through interferon induction.
[0017] Kamiya, JP 2000253884, describes specific antisense
oligonucleotides for inhibiting I.kappa.B-kinase subunit
expression. Krappmann et al., 2001, J. Biol. Chem., describe
specific antisense oligonucleotides to IKK-gamma.
SUMMARY OF THE INVENTION
[0018] The present invention features a nucleic acid molecule, such
as decoy RNA, dsRNA, siRNA, aptamers, antisense nucleic acid
molecules, and enzymatic nucleic acid molecule which down regulates
expression of a sequence encoding an IkappaB kinase (IKK) subunit.
The invention also features an enzymatic nucleic acid molecule
which down regulates expression of a sequence encoding protein
kinase PKR.
[0019] In one embodiment, an enzymatic nucleic acid molecule of the
invention comprises a sequence selected from the group consisting
of SEQ ID NOs. 632-1261, 1762-2260, 2480-2698, 2904-3485,
3814-4360, 4555-4748, 5253-5756, 6034-6310, 6380-6789, 7142-7770,
and 7884-8001.
[0020] In another embodiment, an enzymatic nucleic acid molecule of
the invention comprises at least one binding arm wherein one or
more of said binding arms comprises a sequence complementary to a
sequence selected from the group consisting of SEQ ID NOs. 1-631,
1263-1761, 2261-2479, 2699-2903, 3486-3813, 4361-4554, 4749-5252,
5757-6033, 6311-6379, 6790-7141, and 7771-7883.
[0021] In another embodiment, an antisense nucleic acid molecule of
the invention comprises a sequence complementary to a sequence
selected from the group consisting of SEQ ID NOs. 1-631, 1263-1761,
2261-2479, 2699-2903, 3486-3813, 4361-4554, 4749-5252, 5757-6033,
6311-6379, 6790-7141, and 7771-7883.
[0022] In another embodiment, an nucleic acid molecule of the
invention is adapted to treat cancer. In yet another embodiment, an
enzymatic nucleic acid molecule of the invention has an
endonuclease activity to cleave RNA having IKK-gamma or PKR nucleic
acid sequence.
[0023] In one embodiment, an enzymatic nucleic acid molecule of the
invention is in an Inozyme, Zinzyme, G-cleaver, Amberzyme, DNAzyme,
or Hammerhead configuration.
[0024] In another embodiment, an Inozyme of the invention comprises
a sequence complementary to a sequence selected from the group
consisting of SEQ ID NOs. 1263-1761, 4749-5252, 7781-7787,
7796-7800, 7822-7846, and 7866-7870.
[0025] In another embodiment, an Inozyme of the invention comprises
a sequence selected from the group consisting of SEQ ID NOs.
1762-2260, 5253-5756, 7894-7900, 7909-7913, 7938-7962, and
7982-7986.
[0026] In another embodiment, a Zinzyme of the invention comprises
a sequence complementary to a sequence selected from the group
consisting of SEQ ID NOs. 2261-2479, 5757-6033, 7788-7790,
7847-7860, and 7871-7895.
[0027] In another embodiment, a Zinzyme of the invention comprises
a sequence selected from the group consisting of SEQ ID NOs
2480-2698, 6034-6310, 7901-7903, 7963-7976, and 7987-7991.
[0028] In another embodiment, an Amberzyme of the invention
comprises a sequence selected from the group consisting of SEQ ID
NOs 3814-4360, 7142-7770, 7924-7928, and 7997-8001.
[0029] In another embodiment, a DNAzyme of the invention comprises
a sequence selected from the group consisting of SEQ ID NOs
2904-3485, 6380-6789, 7919-7923, and 7992-7996.
[0030] In another embodiment, a Hammerhead of the invention
comprises a sequence complementary to a sequence selected from the
group consisting of SEQ ID NOs. 1-631, 4361-4554, 7771-7780,
7791-7795, 7813-7821, and 7861-7865.
[0031] In another embodiment, a Hammerhead of the invention
comprises a sequence selected from the group consisting of SEQ ID
NOs 632-1262, 4555-4748, 7884-7894, 7904-7908, 7929-7937,
7977-7981.
[0032] In one embodiment, a nucleic acid molecule of the invention
comprises between 12 and 100 bases complementary to RNA having an
IKK-gamma or PKR nucleic acid sequence. In another embodiment, a
nucleic acid molecule of the invention comprises between 14 and 24
bases complementary to RNA having an IKK-gamma or PKR nucleic acid
sequence.
[0033] In yet another embodiment, a nucleic acid molecule of the
invention is chemically synthesized.
[0034] In another embodiment, a nucleic acid molecule or antisense
nucleic acid molecule of the invention comprises at least one
2'-sugar modification, at least one nucleic acid base modification,
or at least one phosphate backbone modification.
[0035] In one embodiment, a siRNA molecule of the invention
comprises a double stranded RNA wherein one strand of the RNA is
complimentary to the RNA of IKK-gamma or PKR gene.
[0036] In another embodiment, a siRNA molecule of the invention
comprises a double stranded RNA wherein one strand of the RNA
comprises a portion of a sequence of RNA having IKK-gamma or PKR
gene sequence. In yet another embodiment, a siRNA molecule of the
invention comprises a double stranded RNA wherein both strands of
RNA are connected by a non-nucleotide linker. Alternately, a siRNA
molecule of the invention comprises a double stranded RNA wherein
both strands of RNA are connected by a nucleotide linker, such as a
loop or stem loop structure.
[0037] In one embodiment, a single strand component of a siRNA
molecule of the invention is from about 14 to about 50 nucleotides
in length. In another embodiment, a single strand component of a
siRNA molecule of the invention is about 14, 15, 16, 17, 18, 19,
20, 21, 22, 23, 24, 25, 26, 27, or 28 nucleotides in length. In yet
another embodiment, a single strand component of a siRNA molecule
of the invention is about 23 nucleotides in length. In one
embodiment, a siRNA molecule of the invention is from about 28 to
about 56 nucleotides in length. In another embodiment, a siRNA
molecule of the invention is about 40, 41, 42, 43, 44, 45, 46, 47,
48, 49, 50, 51, or 52 nucleotides in length. In yet another
embodiment, a siRNA molecule of the invention is about 46
nucleotides in length.
[0038] In another embodiment, an enzymatic nucleic acid molecule,
antisense nucleic acid molecule, decoy RNA, dsRNA, siRNA, or
aptamer molecules of the invention comprises at least one 2'-sugar
modification.
[0039] In another embodiment, an enzymatic nucleic acid molecule,
antisense nucleic acid molecule, decoy RNA, dsRNA, siRNA, or
aptamer, nucleic acids of the invention comprises at least one
nucleic acid base modification.
[0040] In another embodiment, an enzymatic nucleic acid molecule,
antisense nucleic acid molecule, decoy RNA, dsRNA, siRNA, or
aptamer, nucleic acids of the invention comprises at least one
phosphate backbone modification.
[0041] In one embodiment, the invention features a mammalian cell,
for example a human cell, including an nucleic acid molecule of the
invention.
[0042] The present invention features method of down-regulating PKR
activity in a cell, comprising contacting the cell with an
enzymatic nucleic acid molecule or antisense nucleic acid molecule,
or other nucleic acid molecule of the invention, under conditions
suitable for down-regulating of PKR activity.
[0043] The present invention also features method of treatment of a
subject having a condition associated with the level of PKR,
comprising contacting cells of the subject with an enzymatic
nucleic acid molecule or antisense nucleic acid molecule or other
nucleic acid molecule of the invention under conditions suitable
for the treatment.
[0044] The present invention features method of down-regulating
IKK-gamma activity in a cell, comprising contacting the cell with
an enzymatic nucleic acid molecule or antisense nucleic acid
molecule or other nucleic acid molecule of the invention, under
conditions suitable for down-regulating of IKK-gamma activity.
[0045] The present invention also features method of treatment of a
subject having a condition associated with the level of IKK-gamma,
comprising contacting cells of the subject with the enzymatic
nucleic acid molecule or antisense nucleic acid molecule or other
nucleic acid molecule of the invention, under conditions suitable
for the treatment.
[0046] In one embodiment, a method of treatment of the invention
comprises the use of one or more drug therapies under conditions
suitable for said treatment.
[0047] The present invention features methods of cleaving RNA
comprising a PKR nucleic acid sequence comprising contacting an
enzymatic nucleic acid molecule of the invention with the RNA under
conditions suitable for the cleavage.
[0048] The present invention also features methods of cleaving RNA
comprising a IKK-gamma nucleic acid sequence comprising contacting
an enzymatic nucleic acid molecule of the invention with the RNA
under conditions suitable for the cleavage.
[0049] In one embodiment, a method of cleavage of the invention is
carried out in the presence of a divalent cation, for example
Mg2+.
[0050] In another embodiment, an enzymatic nucleic acid or
antisense nucleic acid molecule or other nucleic acid molecule of
the invention comprises a cap structure, wherein the cap structure
is at the 5'-end, or 3'-end, or both the 5'-end and the 3'-end, for
example a 3',3'-linked or 5',5'-linked deoxyabasic derivative.
[0051] The present invention also features an expression vector
comprising a nucleic acid sequence encoding at least one enzymatic
nucleic acid molecule, antisense, or other nucleic acid molecule of
the invention in a manner which allows expression of the nucleic
acid molecule.
[0052] In one embodiment, the invention features a mammalian cell,
for example a human cell, including an expression vector
contemplated by the invention.
[0053] In another embodiment, an expression vector of the invention
further comprises an antisense nucleic acid molecule complementary
to RNA of a subunit of IKK-gamma or PKR.
[0054] In yet another embodiment, an expression vector of the
invention comprises a nucleic acid sequence encoding two or more
enzymatic nucleic acid molecules, which can be the same or
different.
[0055] The present invention also features a method for treatment
of cancer, for example breast cancer, lung cancer, prostate cancer,
colorectal cancer, brain cancer, esophageal cancer, stomach cancer,
bladder cancer, pancreatic cancer, cervical cancer, head and neck
cancer, ovarian cancer, melanoma, lymphoma, glioma, or multidrug
resistant cancer, comprising administering to a subject an
enzymatic nucleic acid molecule or antisense nucleic acid molecule
or other nucleic acid molecule of the invention under conditions
suitable for said treatment.
[0056] In one embodiment, a nucleic acid molecule of the invention
comprises at least five ribose residues, at least ten 2'-O-methyl
modifications, and a 3'-end modification such as a 3'-3' inverted
abasic moiety, and/or phosphorothioate linkages on at least three
of the 5' terminal nucleotides.
[0057] In another embodiment, other drug therapies contemplated by
the invention include monoclonal antibodies, IKK-gamma or
PKR-specific inhibitors, chemotherapy, or radiation therapy.
[0058] Specific chemotherapy contemplated by the invention include
paclitaxel, docetaxel, cisplatin, methotrexate, cyclophosphamide,
5-fluoro uridine, Leucovorin, Irinotecan (CAMPTOSAR.RTM. or CPT-11
or Camptothecin-11 or Campto), Paclitaxel, Carboplatin doxorubin,
fluorouracil carboplatin, edatrexate, gemcitabine, or vinorelbine
or a combination thereof.
[0059] The invention also features a method for treatment of an
inflammatory disease, for example rheumatoid arthritis, restenosis,
asthma, Crohn's disease, diabetes, obesity, autoimmune disease,
lupus, multiple sclerosis, transplant/graft rejection, gene therapy
applications, ischemia/reperfusion injury, glomerulonephritis,
sepsis, allergic airway inflammation, inflammatory bowel disease,
or infection, comprising the step of administering to a subject an
enzymatic nucleic acid or antisense nucleic acid molecule of the
invention under conditions suitable for the treatment.
[0060] The present invention features compositions comprising the
enzymatic nucleic acid and/or antisense nucleic acid molecules of
the invention in a pharmaceutically acceptable carrier.
[0061] The invention also features a method of administering to a
cell, such as mammalian cell (e.g. human cell), where the cell can
be in culture or in a mammal, such as a human, an enzymatic nucleic
acid molecule or antisense molecule of the instant invention,
comprising contacting the cell with the enzymatic nucleic acid
molecule or antisense molecule or other nucleic acid molecule of
the invention under conditions suitable for such administration.
The method of administration can be in the presence of a delivery
reagent, for example a lipid, cationic lipid, phospholipid, or
liposome.
DETAILED DESCRIPTION OF THE INVENTION
[0062] First the drawings will be described briefly.
DRAWINGS
[0063] FIG. 1 shows examples of chemically stabilized ribozyme
motifs. HH Rz, represents hammerhead ribozyme motif (Usman et al.,
1996, Curr. Op. Struct. Bio., 1, 527); NCH Rz represents the NCH
ribozyme motif (Ludwig & Sproat, International PCT Publication
No. WO 98/58058); G-Cleaver, represents G-cleaver ribozyme motif
(Kore et al., 1998, Nucleic Acids Research 26, 4116-4120, Eckstein
et al., International PCT publication No. WO 99/16871). N or n,
represent independently a nucleotide which can be same or different
and have complementarity to each other; rI, represents ribo-Inosine
nucleotide; arrow indicates the site of cleavage within the target.
Position 4 of the HH Rz and the NCH Rz is shown as having
2'-C-allyl modification, but those skilled in the art will
recognize that this position can be modified with other
modifications well known in the art, so long as such modifications
do not significantly inhibit the activity of the ribozyme.
[0064] FIG. 2 shows an example of the Amberzyme ribozyme motif that
is chemically stabilized (see for example Beigelman et al.,
International PCT publication No. WO 99/55857).
[0065] FIG. 3 shows an example of the Zinzyme A ribozyme motif that
is chemically stabilized (see for example Beigelman et al.,
Beigelman et al, International PCT publication No. WO
99/55857).
[0066] FIG. 4 shows an example of a DNAzyme motif described by
Santoro et al., 1997, PNAS, 94, 4262.
[0067] The invention features nucleic acid molecules, for example
enzymatic nucleic acid molecules, antisense nucleic acid molecules,
2,5-A chimeras, decoys, double stranded RNA, triplex
oligonucleotides, and/or aptamers, and methods to modulate gene
expression, for example, genes encoding a member of the I.kappa.B
kinase IKK complex, such as IKK-alpha (IKK1), IKK-beta (IKK2), or
IKK-gamma (IKK.gamma.) and/or a protein kinase PKR protein. In
particular, the instant invention features nucleic-acid based
molecules and methods to modulate the expression of IKK-gamma
(IKK.gamma.) and protein kinase PKR.
[0068] The invention features one or more enzymatic nucleic
acid-based molecules and methods that independently or in
combination modulate the expression of gene(s) encoding a member of
the I.kappa.B kinase IKK complex or PKR. In particular embodiments,
the invention features nucleic acid-based molecules and methods
that modulate the expression of a member of the I.kappa.B kinase
IKK complex, for example IKK-alpha (IKK1), IKK-beta (IKK2), or
IKK-gamma (IKK.gamma.) and/or a protein kinase PKR protein, such as
IKK-alpha (IKK1) gene (Genbank Accession No. NM.sub.--001278);
IKK-beta (IKK2) gene, for example (Genbank Accession No.AF080158),
IKK-gamma (IKK.gamma.) gene, for example (Genbank Accession No.
NM.sub.--003639), and protein kinase PKR gene, for example (Genbank
Accession No. NM.sub.--002759).
[0069] The description below of the various aspects and embodiments
is provided with reference to the exemplary IKK-gamma and PKR
genes. IKK-gamma is also known as NEMO/IKKAP1. However, the various
aspects and embodiments are also directed to other genes which
encode other subunits of the IKK complex, such as IKK-alpha (IKK1)
or IKK-beta (IKK2). Those additional genes can be analyzed for
target sites using the methods described for IKK-gamma or PKR.
Thus, the inhibition and the effects of such inhibition of the
other genes can be performed as described herein.
[0070] In one embodiment, the invention features the use of an
enzymatic nucleic acid molecule, preferably in the hammerhead, NCH,
G-cleaver, amberzyme, zinzyme and/or DNAzyme motif, to
down-regulate the expression of IKK-gamma or PKR genes.
[0071] By "inhibit" or "down-regulate" it is meant that the
expression of the gene, or level of RNAs or equivalent RNAs
encoding one or more protein subunits, or activity of one or more
protein subunits, such as IKK-gamma or PKR subunit(s), is reduced
below that observed in the absence of the nucleic acid molecules of
the invention. In one embodiment, inhibition or down-regulation
with enzymatic nucleic acid molecule preferably is below that level
observed in the presence of an enzymatically inactive or attenuated
molecule that is able to bind to the same site on the target RNA,
but is unable to cleave that RNA. In another embodiment, inhibition
or down-regulation with antisense oligonucleotides is preferably
below that level observed in the presence of, for example, an
oligonucleotide with scrambled sequence or with mismatches. In
another embodiment, inhibition or down-regulation of IKK-gamma or
PKR with the nucleic acid molecule of the instant invention is
greater in the presence of the nucleic acid molecule than in its
absence.
[0072] By "up-regulate" is meant that the expression of the gene,
or level of RNAs or equivalent RNAs encoding one or more protein
subunits, or activity of one or more protein subunits, such as
IKK-gamma or PKR subunit(s), is greater than that observed in the
absence of the nucleic acid molecules of the invention. For
example, the expression of a gene, such as IKK-gamma or PKR gene,
can be increased in order to treat, prevent, ameliorate, or
modulate a pathological condition caused or exacerbated by an
absence or low level of gene expression.
[0073] By "modulate" is meant that the expression of the gene, or
level of RNAs or equivalent RNAs encoding one or more protein
subunits, or activity of one or more protein subunit(s) is
up-regulated or down-regulated, such that the expression, level, or
activity is greater than or less than that observed in the absence
of the nucleic acid molecules of the invention.
[0074] By "enzymatic nucleic acid molecule" it is meant a nucleic
acid molecule which has complementarity in a substrate binding
region to a specified gene target, and also has an enzymatic
activity which is active to specifically cleave target RNA. That
is, the enzymatic nucleic acid molecule is able to intermolecularly
cleave RNA and thereby inactivate a target RNA molecule. These
complementary regions allow sufficient hybridization of the
enzymatic nucleic acid molecule to the target RNA and thus permit
cleavage. One hundred percent complementarity is preferred, but
complementarity as low as 50-75% can also be useful in this
invention (see for example Werner and Uhlenbeck, 1995, Nucleic
Acids Research, 23, 2092-2096; Hammann et al., 1999, Antisense and
Nucleic Acid Drug Dev., 9, 25-31). The nucleic acids can be
modified at the base, sugar, and/or phosphate groups. The term
enzymatic nucleic acid is used interchangeably with phrases such as
ribozymes, catalytic RNA, enzymatic RNA, catalytic DNA, aptazyme or
aptamer-binding ribozyme, regulatable ribozyme, catalytic
oligonucleotides, nucleozyme, DNAzyme, RNA enzyme,
endoribonuclease, endonuclease, minizyme, leadzyme, oligozyme or
DNA enzyme. All of these terminologies describe nucleic acid
molecules with enzymatic activity. The specific enzymatic nucleic
acid molecules described in the instant application are not
limiting in the invention and those skilled in the art will
recognize that all that is important in an enzymatic nucleic acid
molecule of this invention is that it has a specific substrate
binding site which is complementary to one or more of the target
nucleic acid regions, and that it have nucleotide sequences within
or surrounding that substrate binding site which impart a nucleic
acid cleaving and/or ligation activity to the molecule (Cech et
al., U.S. Pat. No. 4,987,071; Cech et al., 1988, 260 JAMA
3030).
[0075] Several varieties of enzymatic RNAs are known presently.
Each can catalyze the hydrolysis of RNA phosphodiester bonds in
trans (and thus can cleave other RNA molecules) under physiological
conditions. Table I summarizes some of the characteristics of these
ribozymes. In general, enzymatic nucleic acids act by first binding
to a target RNA. Such binding occurs through the target binding
portion of a enzymatic nucleic acid which is held in close
proximity to an enzymatic portion of the molecule that acts to
cleave the target RNA. Thus, the enzymatic nucleic acid first
recognizes and then binds a target RNA through complementary
base-pairing, and once bound to the correct site, acts
enzymatically to cut the target RNA. Strategic cleavage of such a
target RNA will destroy its ability to direct synthesis of an
encoded protein. After an enzymatic nucleic acid has bound and
cleaved its RNA target, it is released from that RNA to search for
another target and can repeatedly bind and cleave new targets.
Thus, a single ribozyme molecule is able to cleave many molecules
of target RNA. In addition, the ribozyme is a highly specific
inhibitor of gene expression, with the specificity of inhibition
depending not only on the base-pairing mechanism of binding to the
target RNA, but also on the mechanism of target RNA cleavage.
Single mismatches, or base-substitutions, near the site of cleavage
can completely eliminate catalytic activity of a ribozyme.
[0076] By "nucleic acid molecule" as used herein is meant a
molecule having nucleotides. The nucleic acid can be single,
double, or multiple stranded and can comprise modified or
unmodified nucleotides or non-nucleotides or various mixtures and
combinations thereof.
[0077] By "enzymatic portion" or "catalytic domain" is meant that
portion/region of the enzymatic nucleic acid molecule essential for
cleavage of a nucleic acid substrate (for example see FIGS.
1-4).
[0078] By "substrate binding arm" or "substrate binding domain" is
meant that portion/region of a enzymatic nucleic acid which is able
to interact, for example via complementarity (i.e., able to
base-pair with), with a portion of its substrate. Preferably, such
complementarity is 100%, but can be less if desired. For example,
as few as 10 bases out of 14 can be base-paired (see for example
Werner and Uhlenbeck, 1995, Nucleic Acids Research, 23, 2092-2096;
Hammann et al., 1999, Antisense and Nucleic Acid Drug Dev., 9,
25-31). Examples of such arms are shown generally in FIGS. 1-4.
That is, these arms contain sequences within a enzymatic nucleic
acid which are intended to bring enzymatic nucleic acid and target
RNA together through complementary base-pairing interactions. The
enzymatic nucleic acid of the invention can have binding arms that
are contiguous or non-contiguous and can be of varying lengths. The
length of the binding arm(s) are preferably greater than or equal
to three nucleotides and of sufficient length to stably interact
with the target RNA; preferably 12-100 nucleotides; more preferably
14-24 nucleotides long (see for example Werner and Uhlenbeck,
supra; Hamman et al., supra; Hampel et al., EP0360257;
Berzal-Herranz et al., 1993, EMBO J., 12, 2567-73). If two binding
arms are chosen, the design is such that the length of the binding
arms are symmetrical (i.e., each of the binding arms is of the same
length; e.g., five and five nucleotides, or six and six
nucleotides, or seven and seven nucleotides long) or asymmetrical
(i.e., the binding arms are of different length; e.g., six and
three nucleotides; three and six nucleotides long; four and five
nucleotides long; four and six nucleotides long; four and seven
nucleotides long; and the like).
[0079] By "Inozyme" or "NCH" motif or configuration is meant, an
enzymatic nucleic acid molecule comprising a motif as is generally
described as NCH Rz in FIG. 1. Inozymes possess endonuclease
activity to cleave RNA substrates having a cleavage triplet NCH/,
where N is a nucleotide, C is cytidine and H is adenosine, uridine
or cytidine, and/represents the cleavage site. H is used
interchangeably with X. Inozymes can also possess endonuclease
activity to cleave RNA substrates having a cleavage triplet NCN/,
where N is a nucleotide, C is cytidine, and/represents the cleavage
site. "I" in FIG. 1 represents an Inosine nucleotide, preferably a
ribo-Inosine or xylo-Inosine nucleoside.
[0080] By "G-cleaver" motif or configuration is meant, an enzymatic
nucleic acid molecule comprising a motif as is generally described
as G-cleaver Rz in FIG. 1. G-cleavers possess endonuclease activity
to cleave RNA substrates having a cleavage triplet NYN/, where N is
a nucleotide, Y is uridine or cytidine and/represents the cleavage
site. G-cleavers can be chemically modified as is generally shown
in FIG. 1.
[0081] By "amberzyme" motif or configuration is meant, an enzymatic
nucleic acid molecule comprising a motif as is generally described
in FIG. 2. Amberzymes possess endonuclease activity to cleave RNA
substrates having a cleavage triplet NG/N, where N is a nucleotide,
G is guanosine, and/represents the cleavage site. Amberzymes can be
chemically modified to increase nuclease stability through
substitutions as are generally shown in FIG. 2. In addition,
differing nucleoside and/or non-nucleoside linkers can be used to
substitute the 5'-gaaa-3' loops shown in the figure. Amberzymes
represent a non-limiting example of an enzymatic nucleic acid
molecule that does not require a ribonucleotide (2'-OH) group
within its own nucleic acid sequence for activity.
[0082] By "zinzyme" motif or configuration is meant, an enzymatic
nucleic acid molecule comprising a motif as is generally described
in FIG. 3. Zinzymes possess endonuclease activity to cleave RNA
substrates having a cleavage triplet including but not limited to
YG/Y, where Y is uridine or cytidine, and G is guanosine
and/represents the cleavage site. Zinzymes can be chemically
modified to increase nuclease stability through substitutions as
are generally shown in FIG. 3, including substituting 2'-O-methyl
guanosine nucleotides for guanosine nucleotides. In addition,
differing nucleotide and/or non-nucleotide linkers can be used to
substitute the 5'-gaaa-2' loop shown in the figure. Zinzymes
represent a non-limiting example of an enzymatic nucleic acid
molecule that does not require a ribonucleotide (2'-OH) group
within its own nucleic acid sequence for activity.
[0083] By `DNAzyme` is meant, an enzymatic nucleic acid molecule
that does not require the presence of a 2'-OH group within its own
nucleic acid sequence for activity. In particular embodiments the
enzymatic nucleic acid molecule can have an attached linker(s) or
other attached or associated groups, moieties, or chains containing
one or more nucleotides with 2'-OH groups. DNAzymes can be
synthesized chemically or expressed endogenously in vivo, by means
of a single stranded DNA vector or equivalent thereof. An example
of a DNAzyme is shown in FIG. 4 and is generally reviewed in Usman
et al., U.S. Pat. No. 6,159,714; Chartrand et al., 1995, NAR 23,
4092; Breaker et al., 1995, Chem. Bio. 2, 655; Santoro et al.,
1997, PNAS 94, 4262; Breaker, 1999, Nature Biotechnology, 17,
422-423; and Santoro et. al., 2000, J. Am. Chem. Soc., 122,
2433-39. Additional DNAzyme motifs can be selected for using
techniques similar to those described in these references, and
hence, are within the scope of the present invention.
[0084] By "sufficient length" is meant an oligonucleotide of
greater than or equal to 3 nucleotides that is of a length great
enough to provide the intended function under the expected
condition. For example, for binding arms of enzymatic nucleic acid
"sufficient length" means that the binding arm sequence is long
enough to provide stable binding to a target site under the
expected binding conditions. Preferably, the binding arms are not
so long as to prevent useful turnover of the nucleic acid
molecule.
[0085] By "stably interact" is meant interaction of the
oligonucleotides with target nucleic acid (e.g., by forming
hydrogen bonds with complementary nucleotides in the target under
physiological conditions) that is sufficient to the intended
purpose (e.g., cleavage of target RNA by an enzyme).
[0086] By "equivalent" or "related" RNA to IKK-gamma is meant to
include those naturally occurring RNA molecules having homology
(partial or complete) to IKK-gamma proteins or encoding for
proteins with similar function as IKK-gamma proteins in various
organisms, including human, rodent, primate, rabbit, pig,
protozoans, fungi, plants, and other microorganisms and parasites.
The equivalent RNA sequence also includes in addition to the coding
region, regions such as 5'-untranslated region, 3'-untranslated
region, introns, intron-exon junction and the like.
[0087] By "equivalent" or "related" RNA to PKR is meant to include
those naturally occurring RNA molecules having homology (partial or
complete) to PKR proteins or encoding for proteins with similar
function as PKR proteins in various organisms, including human,
rodent, primate, rabbit, pig, protozoans, fungi, plants, and other
microorganisms and parasites. The equivalent RNA sequence also
includes in addition to the coding region, regions such as
5'-untranslated region, 3'-untranslated region, introns,
intron-exon junction and the like.
[0088] By "homology" is meant the nucleotide sequence of two or
more nucleic acid molecules is partially or completely
identical.
[0089] By "antisense nucleic acid", it is meant a non-enzymatic
nucleic acid molecule that binds to target RNA by means of RNA-RNA
or RNA-DNA or RNA-PNA (protein nucleic acid; Egholm et al., 1993
Nature 365, 566) interactions and alters the activity of the target
RNA (for a review, see Stein and Cheng, 1993 Science 261, 1004 and
Woolf et al., U.S. Pat. No. 5,849,902). Typically, antisense
molecules are complementary to a target sequence along a single
contiguous sequence of the antisense molecule. However, in certain
embodiments, an antisense molecule can bind to substrate such that
the substrate molecule forms a loop, and/or an antisense molecule
can bind such that the antisense molecule forms a loop. Thus, the
antisense molecule can be complementary to two (or even more)
non-contiguous substrate sequences or two (or even more)
non-contiguous sequence portions of an antisense molecule can be
complementary to a target sequence or both. For a review of current
antisense strategies, see Schmajuk et al., 1999, J. Biol. Chem.,
274, 21783-21789, Delihas et al., 1997, Nature, 15, 751-753, Stein
et al., 1997, Antisense N. A. Drug Dev., 7, 151, Crooke, 2000,
Methods Enzymol., 313, 3-45; Crooke, 1998, Biotech. Genet. Eng.
Rev., 15, 121-157, Crooke, 1997, Ad. Pharmacol., 40, 1-49. In
addition, antisense DNA can be used to target RNA by means of
DNA-RNA interactions, thereby activating RNase H, which digests the
target RNA in the duplex. The antisense oligonucleotides can
comprise one or more RNAse H activating region, which is capable of
activating RNAse H cleavage of a target RNA. Antisense DNA can be
synthesized chemically or expressed via the use of a single
stranded DNA expression vector or equivalent thereof.
[0090] By "RNase H activating region" is meant a region (generally
greater than or equal to 4-25 nucleotides in length, preferably
from 5-11 nucleotides in length) of a nucleic acid molecule capable
of binding to a target RNA to form a non-covalent complex that is
recognized by cellular RNase H enzyme (see for example Arrow et
al., U.S. Pat. No. 5,849,902; Arrow et al., U.S. Pat. No.
5,989,912). The RNase H enzyme binds to the nucleic acid
molecule-target RNA complex and cleaves the target RNA sequence.
The RNase H activating region comprises, for example,
phosphodiester, phosphorothioate (preferably at least four of the
nucleotides are phosphorothiote substitutions; more specifically,
4-11 of the nucleotides are phosphorothiote substitutions);
phosphorodithioate, 5'-thiophosphate, or methylphosphonate backbone
chemistry or a combination thereof. In addition to one or more
backbone chemistries described above, the RNase H activating region
can also comprise a variety of sugar chemistries. For example, the
RNase H activating region can comprise deoxyribose, arabino,
fluoroarabino or a combination thereof, nucleotide sugar chemistry.
Those skilled in the art will recognize that the foregoing are
non-limiting examples and that any combination of phosphate, sugar
and base chemistry of a nucleic acid that supports the activity of
RNase H enzyme is within the scope of the definition of the RNase H
activating region and the instant invention.
[0091] By "2-5A chimera" is meant an oligonucleotide, for example
an antisense nucleic acid molecule or enzymatic nucleic acid
molecule, containing a 5'-phosphorylated 2'-5'-linked adenylate
residue. These chimeras bind to target RNA in a sequence-specific
manner and activate a cellular 2-5A-dependent ribonuclease which,
in turn, cleaves the target RNA (Torrence et al., 1993 Proc. Natl.
Acad. Sci. USA 90, 1300; Silverman et al., 2000, Methods Enzymol.,
313, 522-533; Player and Torrence, 1998, Pharmacol. Ther., 78,
55-113).
[0092] By "triplex forming oligonucleotides" or "triplex
oligonucleotide" is meant an oligonucleotide that can bind to a
double-stranded DNA in a sequence-specific manner to form a
triple-strand helix. Formation of such triple helix structure has
been shown to inhibit transcription of the targeted gene
(Duval-Valentin et al., 1992 Proc. Natl. Acad. Sci. USA 89, 504;
Fox, 2000, Curr. Med. Chem., 7, 17-37; Praseuth et. al., 2000,
Biochim. Biophys. Acta, 1489, 181-206).
[0093] By "double stranded RNA" or "dsRNA" is meant a double
stranded RNA that matches a predetermined gene sequence that is
capable of activating cellular enzymes that degrade the
corresponding messenger RNA transcripts of the gene. These dsRNAs
are referred to as short intervening RNA (siRNA) and can be used to
inhibit gene expression (see for example Elbashir et al., 2001,
Nature, 411, 494-498; and Bass, 2001, Nature, 411, 428-429). The
term "double stranded RNA" or "dsRNA" as used herein refers to a
double stranded RNA molecule capable of RNA interference "RNAi",
including short interfering RNA "siRNA" see for example Bass, 2001,
Nature, 411, 428-429; Elbashir et al., 2001, Nature, 411, 494-498;
and Kreutzer et al., International PCT Publication No. WO 00/44895;
Zernicka-Goetz et al., International PCT Publication No. WO
01/36646; Fire, International PCT Publication No. WO 99/32619;
Plaetinck et al., International PCT Publication No. WO 00/01846;
Mello and Fire, International PCT Publication No. WO 01/29058;
Deschamps-Depaillette, International PCT Publication No. WO
99/07409; and Li et al., International PCT Publication No. WO
00/44914.
[0094] By "gene" it is meant a nucleic acid that encodes an RNA,
for example, nucleic acid sequences including but not limited to
structural genes encoding a polypeptide.
[0095] "Complementarity" refers to the ability of a nucleic acid to
form hydrogen bond(s) with another RNA sequence by either
traditional Watson-Crick or other non-traditional types. In
reference to the nucleic molecules of the present invention, the
binding free energy for a nucleic acid molecule with its target or
complementary sequence is sufficient to allow the relevant function
of the nucleic acid to proceed, e.g., enzymatic nucleic acid
cleavage, antisense or triple helix inhibition. Determination of
binding free energies for nucleic acid molecules is well known in
the art (see, e.g., Turner et al., 1987, CSH Symp. Quant. Biol. LII
pp. 123-133; Frier et al., 1986, Proc. Nat. Acad. Sci. USA
83:9373-9377; Turner et al., 1987, J. Am. Chem. Soc.
109:3783-3785). A percent complementarity indicates the percentage
of contiguous residues in a nucleic acid molecule which can form
hydrogen bonds (e.g., Watson-Crick base pairing) with a second
nucleic acid sequence (e.g., 5, 6, 7, 8, 9, 10 out of 10 being 50%,
60%, 70%, 80%, 90%, and 100% complementary). "Perfectly
complementary" means that all the contiguous residues of a nucleic
acid sequence will hydrogen bond with the same number of contiguous
residues in a second nucleic acid sequence.
[0096] By "RNA" is meant a molecule comprising at least one
ribonucleotide residue. By "ribonucleotide" or "2'-OH" is meant a
nucleotide with a hydroxyl group at the 2' position of a
.beta.-D-ribo-furanose moiety.
[0097] By "decoy" is meant a nucleic acid molecule, for example RNA
or DNA, or aptamer that is designed to preferentially bind to a
predetermined ligand. Such binding can result in the inhibition or
activation of a target molecule. The decoy or aptamer can compete
with a naturally occurring binding target for the binding of a
specific ligand. For example, it has been shown that
over-expression of HIV trans-activation response (TAR) RNA can act
as a "decoy" and efficiently binds HIV tat protein, thereby
preventing it from binding to TAR sequences encoded in the HIV RNA
(Sullenger et al., 1990, Cell, 63, 601-608). This is but a specific
example and those in the art will recognize that other embodiments
can be readily generated using techniques generally known in the
art, see for example Gold et al., 1995, Annu. Rev. Biochem., 64,
763; Brody and Gold, 2000, J. Biotechnol., 74, 5; Sun, 2000, Curr.
Opin. Mol. Ther., 2, 100; Kusser, 2000, J. Biotechnol., 74, 27;
Hermann and Patel, 2000, Science, 287, 820; and Jayasena, 1999,
Clinical Chemistry, 45, 1628. Similarly, a decoys can be designed
to bind to IKK-gamma or PKR and block the binding of IKK-gamma or
PKR or a decoy can be designed to bind to IKK-gamma or PKR and
prevent interaction with the IKK-gamma or PKR protein.
[0098] By "aptamer" or "nucleic acid aptamer" as used herein is
meant a nucleic acid molecule that binds specifically to a target
molecule wherein the nucleic acid molecule has sequence that is
distinct from sequence recognized by the target molecule in its
natural setting. Alternately, an aptamer can be a nucleic acid
molecule that binds to a target molecule where the target molecule
does not naturally bind to a nucleic acid. The target molecule can
be any molecule of interest. For example, the aptamer can be used
to bind to a ligand binding domain of a protein, thereby preventing
interaction of the naturally occurring ligand with the protein.
Similarly, the nucleic acid molecules of the instant invention can
bind to IKK-gamma or PKR to block activity of the respective
proteins. This is a non-limiting example and those in the art will
recognize that other embodiments can be readily generated using
techniques generally known in the art, see for example Gold et al.,
U.S. Pat. Nos. 5,475,096 and 5,270,163; Gold et al., 1995, Annu.
Rev. Biochem., 64, 763; Brody and Gold, 2000, J. Biotechnol., 74,
5; Sun, 2000, Curr. Opin. Mol. Ther., 2, 100; Kusser, 2000, J.
Biotechnol., 74, 27; Hermann and Patel, 2000, Science, 287, 820;
and Jayasena, 1999, Clinical Chemistry, 45, 1628.
[0099] The enzymatic nucleic acid molecule, antisense nucleic acid
or other nucleic acid molecules of the invention that down regulate
IKK-gamma or PKR gene expression represent a therapeutic approach
to treat a variety of inflammatory-related diseases and conditions,
including but not limited to rheumatoid arthritis, restenosis,
asthma, Crohn's disease, incontinentia pigmenti, diabetes, obesity,
autoimmune disease, lupus, multiple sclerosis, transplant/graft
rejection, gene therapy applications, ischemia/reperfusion injury
(CNS and myocardial), glomerulonephritis, sepsis, allergic airway
inflammation, inflammatory bowel disease, infection, and any other
inflammatory disease or condition which respond to the modulation
of IKK-gamma or PKR function.
[0100] The enzymatic nucleic acid molecule, antisense nucleic acid
or other nucleic acid molecules of the invention that down regulate
IKK-gamma or PKR gene expression also represent a therapeutic
approach to treat a variety of cancers, including but not limited
to breast, lung, prostate, colorectal, brain, esophageal, bladder,
pancreatic, cervical, head and neck, and ovarian cancer, melanoma,
lymphoma, glioma, multidrug resistant cancers, and/or other cancers
which respond to the modulation of IKK-gamma or PKR function.
[0101] In one embodiment of the inventions described herein, the
enzymatic nucleic acid molecule is formed in a hammerhead or
hairpin motif, but can also be formed in the motif of a hepatitis
delta virus, group I intron, group II intron or RNase P RNA (in
association with an RNA guide sequence), Neurospora VS RNA,
DNAzymes, NCH cleaving motifs, or G-cleavers. Examples of such
hammerhead motifs are described by Dreyfus, supra, Rossi et al.,
1992, AIDS Research and Human Retroviruses 8, 183; of hairpin
motifs by Hampel et al., EP0360257, Hampel and Tritz, 1989
Biochemistry 28, 4929, Feldstein et al., 1989, Gene 82, 53,
Haseloff and Gerlach, 1989, Gene, 82, 43, and Hampel et al., 1990
Nucleic Acids Res. 18, 299; Chowrira & McSwiggen, U.S. Pat. No.
5,631,359; of the hepatitis delta virus motif is described by
Perrotta and Been, 1992 Biochemistry 31, 16; of the RNase P motif
by Guerrier-Takada et al., 1983 Cell 35, 849; Forster and Altman,
1990, Science 249, 783; Li and Altman, 1996, Nucleic Acids Res. 24,
835; Neurospora VS RNA ribozyme motif is described by Collins
(Saville and Collins, 1990 Cell 61, 685-696; Saville and Collins,
1991 Proc. Natl. Acad. Sci. USA 88, 8826-8830; Collins and Olive,
1993 Biochemistry 32, 2795-2799; Guo and Collins, 1995, EMBO. J.
14, 363); Group II introns are described by Griffin et al., 1995,
Chem. Biol. 2, 761; Michels and Pyle, 1995, Biochemistry 34, 2965;
Pyle et al., International PCT Publication No. WO 96/22689; of the
Group I intron by Cech et al., U.S. Pat. No. 4,987,071 and of
DNAzymes by Usman et al., International PCT Publication No. WO
95/11304; Chartrand et al., 1995, NAR 23, 4092; Breaker et al.,
1995, Chem. Bio. 2, 655; Santoro et al., 1997, PNAS 94, 4262, and
Beigelman et al., International PCT publication No. WO 99/55857.
NCH cleaving motifs are described in Ludwig & Sproat,
International PCT Publication No. WO 98/58058; and G-cleavers are
described in Kore et al., 1998, Nucleic Acids Research 26,
4116-4120 and Eckstein et al., International PCT Publication No. WO
99/16871. Additional motifs such as the Aptazyme (Breaker et al.,
WO 98/43993), Amberzyme (Class I motif; FIG. 2; Beigelman et al.,
U.S. Ser. No. 09/301,511) and Zinzyme (FIG. 3) (Beigelman et al.,
U.S. Ser. No. 09/301,511), all included by reference herein
including drawings, can also be used in the present invention.
These specific motifs or configurations are not limiting in the
invention and those skilled in the art will recognize that all that
is important in an enzymatic nucleic acid molecule of this
invention is that it has a specific substrate binding site which is
complementary to one or more of the target gene RNA regions, and
that it have nucleotide sequences within or surrounding that
substrate binding site which impart an RNA cleaving activity to the
molecule (Cech et al., U.S. Pat. No. 4,987,071).
[0102] In one embodiment of the present invention, a nucleic acid
molecule of the instant invention can be between about 10 and 100
nucleotides in length. Exemplary enzymatic nucleic acid molecules
of the invention are shown in Tables III to VII. For example,
enzymatic nucleic acid molecules of the invention are preferably
between about 15 and 50 nucleotides in length, more preferably
between about 25 and 40 nucleotides in length, e.g., 34, 36, or 38
nucleotides in length (for example see Jarvis et al., 1996, J.
Biol. Chem., 271, 29107-29112). Exemplary DNAzymes of the invention
are preferably between about 15 and 40 nucleotides in length, more
preferably between about 25 and 35 nucleotides in length, e.g., 29,
30, 31, or 32 nucleotides in length (see for example Santoro et
al., 1998, Biochemistry, 37, 13330-13342; Chartrand et al., 1995,
Nucleic Acids Research, 23, 4092-4096). Exemplary antisense
molecules of the invention are preferably between about 15 and 75
nucleotides in length, more preferably between about 20 and 35
nucleotides in length, e.g., 25, 26, 27, or 28 nucleotides in
length (see for example Woolf et al., 1992, PNAS, 89, 7305-7309;
Milner et al., 1997, Nature Biotechnology, 15, 537-541). Exemplary
triplex forming oligonucleotide molecules of the invention are
preferably between about 10 and 40 nucleotides in length, more
preferably between about 12 and 25 nucleotides in length, e.g., 18,
19, 20, or 21 nucleotides in length (see for example Maher et al.,
1990, Biochemistry, 29, 8820-8826; Strobel and Dervan, 1990,
Science, 249, 73-75). Those skilled in the art will recognize that
all that is required is that the nucleic acid molecule be of
sufficient length and suitable conformation for the nucleic acid
molecule to interact with its target and/or catalyze a reaction
contemplated herein. The length of the nucleic acid molecules of
the instant invention are not limiting within the general limits
stated.
[0103] Preferably, a nucleic acid molecule that modulates, for
example, down-regulates IKK-gamma or PKR expression comprises
between 12 and 100 bases complementary to a RNA molecule of
IKK-gamma or PKR. Even more preferably, a nucleic acid molecule
that modulates, for example IKK-gamma or PKR expression comprises
between 14 and 24 bases complementary to a RNA molecule of
IKK-gamma or PKR.
[0104] The invention provides a method for producing a class of
nucleic acid-based gene modulating agents which exhibit a high
degree of specificity for the RNA of a desired target. For example,
the enzymatic nucleic acid molecule is preferably targeted to a
highly conserved sequence region of target RNAs encoding IKK-gamma
or PKR (specifically IKK-gamma or PKR genes) such that specific
treatment of a disease or condition can be provided with either one
or several nucleic acid molecules of the invention. Such nucleic
acid molecules can be delivered exogenously to specific tissue or
cellular targets as required. Alternatively, the nucleic acid
molecules (e.g., ribozymes and antisense) can be expressed from DNA
and/or RNA vectors that are delivered to specific cells.
[0105] As used in herein "cell" is used in its usual biological
sense, and does not refer to an entire multicellular organism. The
cell can, for example, be in vitro, e.g., in cell culture, or
present in a multicellular organism, including, e.g., birds, plants
and mammals such as humans, cows, sheep, apes, monkeys, swine,
dogs, and cats. The cell can be prokaryotic (e.g., bacterial cell)
or eukaryotic (e.g., mammalian or plant cell).
[0106] By "IKK-gamma proteins" is meant, a peptide or protein
comprising a IKK-gamma or NEMO/IKKAP1 component of the IKK complex,
for example a regulatory IKK subunit involved in the assembly of
the high molecular weight IKK complex and/or induction of NFKB.
[0107] By "PKR proteins" is meant, a peptide or protein comprising
a protein kinase PKR activity, for example the activation of
NFKB.
[0108] By "highly conserved sequence region" is meant, a nucleotide
sequence of one or more regions in a target gene does not vary
significantly from one generation to the other or from one
biological system to the other.
[0109] Nucleic acid-based inhibitors of IKK-gamma or PKR function
are useful for the prevention and/or treatment of cancers and
cancerous conditions such as breast, lung, prostate, colorectal,
brain, esophageal, bladder, pancreatic, cervical, head and neck,
and ovarian cancer, melanoma, lymphoma, glioma, multidrug resistant
cancers, and any other diseases or conditions that are related to
or will respond to the levels of IKK-gamma or PKR in a cell or
tissue, alone or in combination with other therapies.
[0110] Nucleic acid-based inhibitors of IKK-gamma or PKR function
are also useful for the prevention and/or treatment of inflammatory
related diseases and conditions, including but not limited to
rheumatoid arthritis, restenosis, asthma, Crohn's disease,
incontinentia pigmenti, diabetes, obesity, autoimmune disease,
lupus, multiple sclerosis, transplant/graft rejection, gene therapy
applications, ischemia/reperfusion injury (CNS and myocardial),
glomerulonephritis, sepsis, allergic airway inflammation,
inflammatory bowel disease, infection, and any other inflammatory
disease or condition which respond to the modulation of IKK-gamma
or PKR function.
[0111] The nucleic acid-based inhibitors of the invention are added
directly, or can be complexed with cationic lipids, packaged within
liposomes, or otherwise delivered to target cells or tissues. The
nucleic acid or nucleic acid complexes can be locally administered
to relevant tissues ex vivo, or in vivo through injection or
infusion pump, with or without their incorporation in biopolymers.
In preferred embodiments, the enzymatic nucleic acid inhibitors
comprise sequences, which are complementary to the substrate
sequences in Tables III to XIII. Examples of such enzymatic nucleic
acid molecules also are shown in Tables III to XIII. Examples of
such enzymatic nucleic acid molecules consist essentially of
sequences defined in these tables.
[0112] In another embodiment, the invention features antisense
nucleic acid molecules and 2-5A chimera including sequences
complementary to the substrate sequences shown in Tables III to
XIII. Such nucleic acid molecules can include sequences as shown
for the binding arms of the enzymatic nucleic acid molecules in
Tables III to XIII. Similarly, triplex molecules can be provided
targeted to the corresponding DNA target regions, and containing
the DNA equivalent of a target sequence or a sequence complementary
to the specified target (substrate) sequence. Typically, antisense
molecules are complementary to a target sequence along a single
contiguous sequence of the antisense molecule. However, in certain
embodiments, an antisense molecule can bind to substrate such that
the substrate molecule forms a loop, and/or an antisense molecule
can bind such that the antisense molecule forms a loop. Thus, the
antisense molecule can be complementary to two (or even more)
non-contiguous substrate sequences or two (or even more)
non-contiguous sequence portions of an antisense molecule can be
complementary to a target sequence or both.
[0113] By "consists essentially of" is meant that the active
nucleic acid molecule of the invention, for example, an enzymatic
nucleic acid molecule, contains an enzymatic center or core
equivalent to those in the examples, and binding arms able to bind
RNA such that cleavage at the target site occurs. Other sequences
can be present which do not interfere with such cleavage. Thus, a
core region can, for example, include one or more loop, stem-loop
structure, or linker which does not prevent enzymatic activity.
Thus, the underlined regions in the sequences in Tables III, IV,
VIII, and IX can be such a loop, stem-loop, nucleotide linker,
and/or non-nucleotide linker and can be represented generally as
sequence "X". For example, a core sequence for a hammerhead
enzymatic nucleic acid can comprise a conserved sequence, such as
5'-CUGAUGAG-3' and 5'-CGAA-3' connected by "X", where X is
5'-GCCGUUAGGC-3' (SEQ ID NO 8002), or any other Stem II region
known in the art, or a nucleotide and/or non-nucleotide linker.
Similarly, for other nucleic acid molecules of the instant
invention, such as Inozyme, G-cleaver, amberzyme, zinzyme, DNAzyme,
antisense, 2-5A antisense, triplex forming nucleic acid, and decoy
nucleic acids, other sequences or non-nucleotide linkers can be
present that do not interfere with the function of the nucleic acid
molecule.
[0114] Sequence X can be a linker of .gtoreq.2 nucleotides in
length, preferably 3, 4, 5, 6, 7, 8, 9, 10, 15, 20, 26, 30, where
the nucleotides can preferably be internally base-paired to form a
stem of preferably .gtoreq.2 base pairs. In yet another embodiment,
the nucleotide linker X can be a nucleic acid aptamer, such as an
ATP aptamer, HIV Rev aptamer (RRE), HIV Tat aptamer (TAR) and
others (for a review see Gold et al., 1995, Annu. Rev. Biochem.,
64, 763; and Szostak & Ellington, 1993, in The RNA World, ed.
Gesteland and Atkins, pp. 511, CSH Laboratory Press). A "nucleic
acid aptamer" as used herein is meant to indicate a nucleic acid
sequence capable of interacting with a ligand. The ligand can be
any natural or a synthetic molecule, including but not limited to a
resin, metabolites, nucleosides, nucleotides, drugs, toxins,
transition state analogs, peptides, lipids, proteins, amino acids,
nucleic acid molecules, hormones, carbohydrates, receptors, cells,
viruses, bacteria and others.
[0115] In yet another embodiment, alternatively or in addition,
sequence X can be a non-nucleotide linker. Non-nucleotides as can
include abasic nucleotide, polyether, polyamine, polyamide,
peptide, carbohydrate, lipid, or polyhydrocarbon compounds.
Specific examples include those described by Seela and Kaiser,
Nucleic Acids Res. 1990, 18:6353 and Nucleic Acids Res. 1987,
15:3113; Cload and Schepartz, J. Am. Chem. Soc. 1991, 113:6324;
Richardson and Schepartz, J. Am. Chem. Soc. 1991, 113:5109; Ma et
al., Nucleic Acids Res. 1993, 21:2585 and Biochemistry 1993,
32:1751; Durand et al., Nucleic Acids Res. 1990, 18:6353; McCurdy
et al., Nucleosides & Nucleotides 1991, 10:287; Jschke et al.,
Tetrahedron Lett. 1993, 34:301; Ono et al., Biochemistry 1991,
30:9914; Arnold et al., International Publication No. WO 89/02439;
Usman et al., International Publication No. WO 95/06731; Dudycz et
al., International Publication No. WO 95/11910 and Ferentz and
Verdine, J. Am. Chem. Soc. 1991, 113:4000, all hereby incorporated
by reference herein. A "non-nucleotide" further means any group or
compound which can be incorporated into a nucleic acid chain in the
place of one or more nucleotide units, including either sugar
and/or phosphate substitutions, and allows the remaining bases to
exhibit their enzymatic activity. The group or compound can be
abasic in that it does not contain a commonly recognized nucleotide
base, such as adenosine, guanine, cytosine, uracil or thymine.
Thus, in a preferred embodiment, the invention features an
enzymatic nucleic acid molecule having one or more non-nucleotide
moieties, and having enzymatic activity to cleave an RNA or DNA
molecule.
[0116] In another aspect of the invention, enzymatic nucleic acid
molecules or antisense molecules that interact with target RNA
molecules and down-regulate IKK-gamma or PKR (specifically
IKK-gamma or PKR gene) activity are expressed from transcription
units inserted into DNA or RNA vectors. The recombinant vectors are
preferably DNA plasmids or viral vectors. Enzymatic nucleic acid
molecule or antisense expressing viral vectors can be constructed
based on, but not limited to, adeno-associated virus, retrovirus,
adenovirus, or alphavirus. Preferably, the recombinant vectors
capable of expressing the enzymatic nucleic acid molecules or
antisense are delivered as described above, and persist in target
cells. Alternatively, viral vectors can be used that provide for
transient expression of enzymatic nucleic acid molecules or
antisense. Such vectors can be repeatedly administered as
necessary. Once expressed, the enzymatic nucleic acid molecules or
antisense bind to the target RNA and down-regulate its function or
expression. Delivery of enzymatic nucleic acid molecule or
antisense expressing vectors can be systemic, such as by
intravenous or intramuscular administration, by administration to
target cells ex-planted from the patient or subject followed by
reintroduction into the patient or subject, or by any other means
that would allow for introduction into the desired target cell.
Antisense DNA can be expressed via the use of a single stranded DNA
intracellular expression vector.
[0117] By "vectors" is meant any nucleic acid- and/or viral-based
technique used to deliver a desired nucleic acid.
[0118] By "subject" is meant an organism, which is a donor or
recipient of explanted cells or the cells themselves. "subject"
also refers to an organism to which the nucleic acid molecules of
the invention can be administered. Preferably, a subject is a
mammal or mammalian cells. More preferably, a subject is a human or
human cells.
[0119] By "enhanced enzymatic activity" is meant to include
activity measured in cells and/or in vivo where the activity is a
reflection of both the catalytic activity and the stability of the
nucleic acid molecules of the invention. In this invention, the
product of these properties can be increased in vivo compared to an
all RNA enzymatic nucleic acid or all DNA enzyme. In some cases,
the activity or stability of the nucleic acid molecule can be
decreased (i.e., less than ten-fold), but the overall activity of
the nucleic acid molecule is enhanced, in vivo.
[0120] The nucleic acid molecules of the instant invention,
individually, or in combination or in conjunction with other drugs,
can be used to treat diseases or conditions discussed above. For
example, to treat a disease or condition associated with the levels
of IKK-gamma or PKR, the subject can be treated, or other
appropriate cells can be treated, as is evident to those skilled in
the art, individually or in combination with one or more drugs
under conditions suitable for the treatment.
[0121] In a further embodiment, the described nucleic acid
molecules, such as antisense or ribozymes, can be used in
combination with other known treatments to treat conditions or
diseases discussed above. For example, the described molecules can
be used in combination with one or more known therapeutic agents to
treat breast, lung, prostate, colorectal, brain, esophageal,
bladder, pancreatic, cervical, head and neck, and ovarian cancer,
melanoma, lymphoma, glioma, multidrug resistant cancers, rheumatoid
arthritis, restenosis, asthma, Crohn's disease, diabetes,
incontinentia pigmenti, obesity, autoimmune disease, lupus,
multiple sclerosis, transplant/graft rejection, gene therapy
applications, ischemia/reperfusion injury (CNS and myocardial),
glomerulonephritis, sepsis, allergic airway inflammation,
inflammatory bowel disease, infection, and any other cancerous
disease or inflammatory disease or condition which respond to the
modulation of IKK-gamma or PKR expression.
[0122] In another embodiment, the invention features nucleic
acid-based inhibitors (e.g., enzymatic nucleic acid molecules (eg;
ribozymes), antisense nucleic acids, 2-5A antisense chimeras,
triplex DNA, dsRNA, antisense nucleic acids containing RNA cleaving
chemical groups) and methods for their use to down regulate or
inhibit the expression of genes (e.g., IKK-gamma or PKR) capable of
progression and/or maintenance of cancer, inflammatory diseases,
and/or other disease states which respond to the modulation of
IKK-gamma or PKR expression.
[0123] By "comprising" is meant including, but not limited to,
whatever follows the word "comprising". Thus, use of the term
"comprising" indicates that the listed elements are required or
mandatory, but that other elements are optional and can or can not
be present. By "consisting of" is meant including, and limited to,
whatever follows the phrase "consisting of". Thus, the phrase
"consisting of" indicates that the listed elements are required or
mandatory, and that no other elements can be present.
[0124] Other features and advantages of the invention will be
apparent from the following description of the preferred
embodiments thereof, and from the claims.
Mechanism of Action of Nucleic Acid Molecules of the Invention as
Proposed in the Art
[0125] Antisense: Antisense molecules can be modified or unmodified
RNA, DNA, or mixed polymer oligonucleotides and primarily function
by specifically binding to matching sequences resulting in
inhibition of peptide synthesis (Wu-Pong, November 1994, BioPharm,
20-33). The antisense oligonucleotide binds to target RNA by Watson
Crick base-pairing and blocks gene expression by preventing
ribosomal translation of the bound sequences either by steric
blocking or by activating RNase H enzyme. Antisense molecules can
also alter protein synthesis by interfering with RNA processing or
transport from the nucleus into the cytoplasm (Mukhopadhyay &
Roth, 1996, Crit. Rev. in Oncogenesis 7, 151-190).
[0126] In addition, binding of single stranded DNA to RNA can
result in nuclease degradation of the heteroduplex (Wu-Pong, supra;
Crooke, supra). To date, the only backbone modified DNA chemistry
which act as substrates for RNase H are phosphorothioates,
phosphorodithioates, and borontrifluoridates. Recently it has been
reported that 2'-arabino and 2'-fluoro arabino-containing oligos
can also activate RNase H activity.
[0127] A number of antisense molecules have been described that
utilize novel configurations of chemically modified nucleotides,
secondary structure, and/or RNase H substrate domains (Woolf et
al., International PCT Publication No. WO 98/13526; Thompson et
al., International PCT Publication No. WO 99/54459; Hartmann et
al., U.S. Ser. No. 60/101,174 which was filed on Sep. 21, 1998) all
of these are incorporated by reference herein in their
entirety.
[0128] In addition, antisense deoxyoligoribonucleotides can be used
to target RNA by means of DNA-RNA interactions, thereby activating
RNase H, which digests the target RNA in the duplex. Antisense DNA
can be expressed via the use of a single stranded DNA intracellular
expression vector or equivalents and variations thereof.
[0129] Enzymatic Nucleic Acid: Several varieties of enzymatic RNAs
are presently known. In addition, several in vitro selection
(evolution) strategies (Orgel, 1979, Proc. R. Soc. London, B 205,
435) have been used to evolve new nucleic acid catalysts capable of
catalyzing cleavage and ligation of phosphodiester linkages (Joyce,
1989, Gene, 82, 83-87; Beaudry et al., 1992, Science 257, 635-641;
Joyce, 1992, Scientific American 267, 90-97; Breaker et al., 1994,
TIBTECH 12, 268; Bartel et al., 1993, Science 261:1411-1418;
Szostak, 1993, TIBS 17, 89-93; Kumar et al, 1995, FASEB J., 9,
1183; Breaker, 1996, Curr. Op. Biotech., 7, 442; Santoro et al.,
1997, Proc. Natl. Acad. Sci., 94, 4262; Tang et al., 1997, RNA 3,
914; Nakacane & Eckstein, 1994, supra; Long & Uhlenbeck,
1994, supra; Ishizaka et al., 1995, supra; Vaish et al., 1997,
Biochemistry 36, 6495; all of these are incorporated by reference
herein). Each can catalyze a series of reactions including the
hydrolysis of phosphodiester bonds in trans (and thus can cleave
other RNA molecules) under physiological conditions.
[0130] Nucleic acid molecules of this invention will block to some
extent IKK-gamma or PKR and/or IKK-gamma or PKR protein expression
and can be used to treat disease or diagnose disease associated
with the levels of IKK-gamma or PKR and/or IKK-gamma or PKR.
Enzymatic nucleic acid sequences targeting IKK-gamma or PKR RNA and
sequences that can be targeted with nucleic acid molecules of the
invention to down-regulate IKK-gamma or PKR expression are shown in
Tables III to XIII.
[0131] The enzymatic nature of an enzymatic nucleic acid molecule
can allow the concentration of enzymatic nucleic acid molecule
necessary to affect a therapeutic treatment to be lower. This
reflects the ability of the enzymatic nucleic acid molecule to act
enzymatically. Thus, a single enzymatic nucleic acid molecule is
able to cleave many molecules of target RNA. In addition, the
enzymatic nucleic acid molecule is a highly specific inhibitor,
with the specificity of inhibition depending not only on the
base-pairing mechanism of binding to the target RNA, but also on
the mechanism of target RNA cleavage. Single mismatches, or
base-substitutions, near the site of cleavage can be chosen to
greatly attenuate the catalytic activity of a enzymatic nucleic
acid molecule.
[0132] Nucleic acid molecules having an endonuclease enzymatic
activity are able to repeatedly cleave other separate RNA molecules
in a nucleotide base sequence-specific manner. Such enzymatic
nucleic acid molecules can be targeted to virtually any RNA
transcript, and achieve efficient cleavage in vitro (Zaug et al.,
324, Nature 429 1986; Uhlenbeck, 1987 Nature 328, 596; Kim et al.,
84 Proc. Natl. Acad. Sci. USA 8788, 1987; Dreyfus, 1988, Einstein
Quart. J. Bio. Med., 6, 92; Haseloff and Gerlach, 334 Nature 585,
1988; Cech, 260 JAMA 3030, 1988; and Jefferies et al., 17 Nucleic
Acids Research 1371, 1989; Santoro et al., 1997 supra).
[0133] Because of their sequence specificity, trans-cleaving
enzymatic nucleic acid molecules can be used as therapeutic agents
for human disease (Usman & McSwiggen, 1995 Ann. Rep. Med. Chem.
30, 285-294; Christoffersen and Marr, 1995 J. Med. Chem. 38,
2023-2037). Enzymatic nucleic acid molecules can be designed to
cleave specific RNA targets within the background of cellular RNA.
Such a cleavage event renders the RNA non-functional and abrogates
protein expression from that RNA. In this manner, synthesis of a
protein associated with a disease state can be selectively
inhibited (Warashina et al., 1999, Chemistry and Biology, 6,
237-250).
[0134] Enzymatic nucleic acid molecules of the invention that are
allosterically regulated ("allozymes") can be used to modulate
IKK-gamma or PKR expression. These allosteric enzymatic nucleic
acids or allozymes (see for example George et al., U.S. Pat. Nos.
5,834,186 and 5,741,679, Shih et al., U.S. Pat. No. 5,589,332,
Nathan et al., U.S. Pat. No. 5,871,914, Nathan and Ellington,
International PCT publication No. WO 00/24931, Breaker et al.,
International PCT Publication Nos. WO 00/26226 and 98/27104, and
Sullenger et al., International PCT publication No. WO 99/29842)
are designed to respond to a signaling agent, for example, mutant
IKK-gamma protein, wild-type IKK-gamma protein, mutant IKK-gamma
RNA, wild-type IKK-gamma RNA, other proteins and/or RNAs involved
in IKK-gamma activity, compounds, metals, polymers, molecules
and/or drugs that are targeted to IKK-gamma or an IKK subunit, such
as IKK-alpha or IKK-beta, expressing cells etc., which in turn
modulates the activity of the enzymatic nucleic acid molecule. In
response to interaction with a predetermined signaling agent, the
allosteric enzymatic nucleic acid molecule's activity is activated
or inhibited such that the expression of a particular target is
selectively down-regulated. The target can comprise wild-type
IKK-gamma, mutant IKK-gamma, a component of IKK-gamma, and/or a
predetermined cellular component that modulates IKK-gamma activity.
In a specific example, allosteric enzymatic nucleic acid molecules
that are activated by interaction with a RNA encoding a mutant
IKK-gamma protein are used as therapeutic agents in vivo. The
presence of RNA encoding the mutant IKK-gamma activates the
allosteric enzymatic nucleic acid molecule that subsequently
cleaves the RNA encoding a mutant IKK-gamma protein resulting in
the inhibition of mutant IKK-gamma protein expression. In this
manner, cells that express the mutant form of the IKK-gamma protein
are selectively targeted. Such an approach, can be used to treat,
for example, incontinentia pigmenti.
[0135] In another non-limiting example, an allozyme can be
activated by a IKK-gamma or PKR protein, peptide, or mutant
polypeptide that caused the allozyme to inhibit the expression of
IKK-gamma or PKR gene, by, for example, cleaving RNA encoded by
IKK-gamma or PKR gene. In this non-limiting example, the allozyme
acts as a decoy to inhibit the function of IKK-gamma or PKR and
also inhibit the expression of IKK-gamma or PKR once activated by
the IKK-gamma or PKR protein.
[0136] The nucleic acid molecules of the instant invention are also
referred to as GeneBloc reagents, which are essentially nucleic
acid molecules (eg; ribozymes, antisense) capable of
down-regulating gene expression.
Target Sites
[0137] Targets for useful enzymatic nucleic acid molecules and
antisense nucleic acids can be determined as disclosed in Draper et
al., WO 93/23569; Sullivan et al., WO 93/23057; Thompson et al., WO
94/02595; Draper et al., WO 95/04818; McSwiggen et al., U.S. Pat.
No. 5,525,468, and hereby incorporated by reference herein in
totality. Other examples include the following PCT applications,
which concern inactivation of expression of disease-related genes:
WO 95/23225, WO 95/13380, WO 94/02595, incorporated by reference
herein. Rather than repeat the guidance provided in those documents
here, below are provided specific examples of such methods, not
limiting to those in the art. Enzymatic nucleic acid molecules and
antisense to such targets are designed as described in those
applications and synthesized to be tested in vitro and in vivo, as
also described. The sequences of human IKK-gamma or PKR RNAs were
screened for optimal enzymatic nucleic acid and antisense target
sites using a computer-folding algorithm. Antisense, hammerhead,
DNAzyme, NCH, amberzyme, zinzyme, or G-Cleaver enzymatic nucleic
acid molecule binding/cleavage sites were identified. These sites
are shown in Tables III to XIII (all sequences are 5' to 3' in the
tables; underlined regions can be any sequence "X" or linker X, the
actual sequence is not relevant here). The nucleotide base position
is noted in the Tables as that site to be cleaved by the designated
type of enzymatic nucleic acid molecule. While human sequences can
be screened and enzymatic nucleic acid molecule and/or antisense
thereafter designed, as discussed in Stinchcomb et al., WO
95/23225, mouse targeted enzymatic nucleic acid molecules can be
useful to test efficacy of action of the enzymatic nucleic acid
molecule and/or antisense prior to testing in humans.
[0138] Antisense, hammerhead, DNAzyme, NCH, amberzyme, zinzyme or
G-Cleaver enzymatic nucleic acid molecule binding/cleavage sites
were identified. The nucleic acid molecules are individually
analyzed by computer folding (Jaeger et al., 1989 Proc. Natl. Acad.
Sci. USA, 86, 7706) to assess whether the sequences fold into the
appropriate secondary structure. Those nucleic acid molecules with
unfavorable intramolecular interactions such as between the binding
arms and the catalytic core are eliminated from consideration.
Varying binding arm lengths can be chosen to optimize activity.
[0139] Antisense, hammerhead, DNAzyme, NCH, amberzyme, zinzyme or
G-Cleaver enzymatic nucleic acid molecule binding/cleavage sites
were identified and were designed to anneal to various sites in the
RNA target. The binding arms are complementary to the target site
sequences described above. The nucleic acid molecules were
chemically synthesized. The method of synthesis used follows the
procedure for normal DNA/RNA synthesis as described below and in
Usman et al., 1987 J. Am. Chem. Soc., 109, 7845; Scaringe et al.,
1990 Nucleic Acids Res., 18, 5433; and Wincott et al., 1995 Nucleic
Acids Res. 23, 2677-2684; Caruthers et al., 1992, Methods in
Enzymology 211,3-19.
Synthesis of Nucleic Acid Molecules
[0140] Synthesis of nucleic acids greater than 100 nucleotides in
length can be difficult using automated methods, and the
therapeutic cost of such molecules can be prohibitive. In this
invention, small nucleic acid motifs ("small refers to nucleic acid
motifs less than about 100 nucleotides in length, preferably less
than about 80 nucleotides in length, and more preferably less than
about 50 nucleotides in length; e.g., antisense oligonucleotides,
hammerhead or the NCH ribozymes) are preferably used for exogenous
delivery. The simple structure of these molecules increases the
ability of the nucleic acid to invade targeted regions of RNA
structure. Exemplary molecules of the instant invention are
chemically synthesized, and others can similarly be
synthesized.
[0141] Oligonucleotides (eg; antisense, GeneBlocs) are synthesized
using protocols known in the art as described in Caruthers et al.,
1992, Methods in Enzymology 211, 3-19, Thompson et al.,
International PCT Publication No. WO 99/54459, Wincott et al.,
1995, Nucleic Acids Res. 23, 2677-2684, Wincott et al., 1997,
Methods Mol. Bio., 74, 59, Brennan et al., 1998, Biotechnol
Bioeng., 61, 33-45, and Brennan, U.S. Pat. No. 6,001,311. All of
these references are incorporated herein by reference. The
synthesis of oligonucleotides makes use of common nucleic acid
protecting and coupling groups, such as dimethoxytrityl at the
5'-end, and phosphoramidites at the 3'-end. In a non-limiting
example, small scale syntheses are conducted on a 394 Applied
Biosystems, Inc. synthesizer using a 0.2 .mu.mol scale protocol
with a 2.5 min coupling step for 2'-O-methylated nucleotides and a
45 sec coupling step for 2'-deoxy nucleotides. Table II outlines
the amounts and the contact times of the reagents used in the
synthesis cycle. Alternatively, syntheses at the 0.2 .mu.mol scale
can be performed on a 96-well plate synthesizer, such as the
instrument produced by Protogene (Palo Alto, Calif.) with minimal
modification to the cycle. A 33-fold excess (60 .mu.L of 0.11 M=6.6
.mu.mol) of 2'-O-methyl phosphoramidite and a 105-fold excess of
S-ethyl tetrazole (60 .mu.L of 0.25 M=15 .mu.mol) can be used in
each coupling cycle of 2'-O-methyl residues relative to
polymer-bound 5'-hydroxyl. A 22-fold excess (40 .mu.L of 0.11 M=4.4
.mu.mol) of deoxy phosphoramidite and a 70-fold excess of S-ethyl
tetrazole (40 .mu.L of 0.25 M=10 .mu.mol) can be used in each
coupling cycle of deoxy residues relative to polymer-bound
5'-hydroxyl. Average coupling yields on the 394 Applied Biosystems,
Inc. synthesizer, determined by colorimetric quantitation of the
trityl fractions, are typically 97.5-99%. Other oligonucleotide
synthesis reagents for the 394 Applied Biosystems, Inc. synthesizer
include; detritylation solution is 3% TCA in methylene chloride
(ABI); capping is performed with 16% N-methyl imidazole in THF
(ABI) and 10% acetic anhydride/10% 2,6-lutidine in THF (ABI); and
oxidation solution is 16.9 mM I.sub.2, 49 mM pyridine, 9% water in
THF (PERSEPTIVE.TM.). Burdick & Jackson Synthesis Grade
acetonitrile is used directly from the reagent bottle.
S-Ethyltetrazole solution (0.25 M in acetonitrile) is made up from
the solid obtained from American International Chemical, Inc.
Alternately, for the introduction of phosphorothioate linkages,
Beaucage reagent (3H-1,2-Benzodithiol-3-one 1,1-dioxide, 0.05 M in
acetonitrile) is used.
[0142] Deprotection of the antisense oligonucleotides is performed
as follows: the polymer-bound trityl-on oligoribonucleotide is
transferred to a 4 mL glass screw top vial and suspended in a
solution of 40% aq. methylamine (1 mL) at 65.degree. C. for 10 min.
After cooling to -20.degree. C., the supernatant is removed from
the polymer support. The support is washed three times with 1.0 mL
of EtOH:MeCN:H2O/3:1:1, vortexed and the supernatant is then added
to the first supernatant. The combined supernatants, containing the
oligoribonucleotide, are dried to a white powder.
[0143] The method of synthesis used for RNA and chemically modified
RNA including certain enzymatic nucleic acid molecules follows the
procedure as described in Usman et al., 1987, J. Am. Chem. Soc.,
109, 7845; Scaringe et al., 1990, Nucleic Acids Res., 18, 5433; and
Wincott et al., 1995, Nucleic Acids Res. 23, 2677-2684 Wincott et
al., 1997, Methods Mol. Bio., 74, 59, and makes use of common
nucleic acid protecting and coupling groups, such as
dimethoxytrityl at the 5'-end, and phosphoramidites at the 3'-end.
In a non-limiting example, small scale syntheses are conducted on a
394 Applied Biosystems, Inc. synthesizer using a 0.2 .mu.mol scale
protocol with a 7.5 min coupling step for alkylsilyl protected
nucleotides and a 2.5 min coupling step for 2'-O-methylated
nucleotides. Table II outlines the amounts and the contact times of
the reagents used in the synthesis cycle. Alternatively, syntheses
at the 0.2 .mu.mol scale can be done on a 96-well plate
synthesizer, such as the instrument produced by Protogene (Palo
Alto, Calif.) with minimal modification to the cycle. A 33-fold
excess (60 .mu.L of 0.11 M=6.6 .mu.mol) of 2'-O-methyl
phosphoramidite and a 75-fold excess of S-ethyl tetrazole (60 .mu.L
of 0.25 M=15 .mu.mol) can be used in each coupling cycle of
2'-O-methyl residues relative to polymer-bound 5'-hydroxyl. A
66-fold excess (120 .mu.L of 0.11 M=13.2 .mu.mol) of alkylsilyl
(ribo) protected phosphoramidite and a 150-fold excess of S-ethyl
tetrazole (120 .mu.L of 0.25 M=30 .mu.mol) can be used in each
coupling cycle of ribo residues relative to polymer-bound
5'-hydroxyl. Average coupling yields on the 394 Applied Biosystems,
Inc. synthesizer, determined by colorimetric quantitation of the
trityl fractions, are typically 97.5-99%. Other oligonucleotide
synthesis reagents for the 394 Applied Biosystems, Inc. synthesizer
include; detritylation solution is 3% TCA in methylene chloride
(ABI); capping is performed with 16% N-methyl imidazole in THF
(ABI) and 10% acetic anhydride/10% 2,6-lutidine in THF (ABI);
oxidation solution is 16.9 mM I.sub.2, 49 mM pyridine, 9% water in
THF (PERSEPTIVE.TM.). Burdick & Jackson Synthesis Grade
acetonitrile is used directly from the reagent bottle.
S-Ethyltetrazole solution (0.25 M in acetonitrile) is made up from
the solid obtained from American International Chemical, Inc.
Alternately, for the introduction of phosphorothioate linkages,
Beaucage reagent (3H-1,2-Benzodithiol-3-one 1,1-dioxide 0.05 M in
acetonitrile) is used.
[0144] Deprotection of the RNA is performed using either a two-pot
or one-pot protocol. For the two-pot protocol, the polymer-bound
trityl-on oligoribonucleotide is transferred to a 4 mL glass screw
top vial and suspended in a solution of 40% aq. methylamine (1 mL)
at 65.degree. C. for 10 min. After cooling to -20.degree. C., the
supernatant is removed from the polymer support. The support is
washed three times with 1.0 mL of EtOH:MeCN:H2O/3:1:1, vortexed and
the supernatant is then added to the first supernatant. The
combined supernatants, containing the oligoribonucleotide, are
dried to a white powder. The base deprotected oligoribonucleotide
is resuspended in anhydrous TEA/HF/NMP solution (300 .mu.l of a
solution of 1.5 mL N-methylpyrrolidinone, 750 .mu.L TEA and 1 mL
TEA.3HF to provide a 1.4 M HF concentration) and heated to
65.degree. C. After 1.5 h, the oligomer is quenched with 1.5 M
NH.sub.4HCO.sub.3.
[0145] Alternatively, for the one-pot protocol, the polymer-bound
trityl-on oligoribonucleotide is transferred to a 4 mL glass screw
top vial and suspended in a solution of 33% ethanolic
methylamine/DMSO: 1/1 (0.8 mL) at 65.degree. C. for 15 min. The
vial is brought to r.t. TEA.3HF (0.1 mL) is added and the vial is
heated at 65.degree. C. for 15 min. The sample is cooled at
-20.degree. C. and then quenched with 1.5 M NH.sub.4HCO.sub.3.
[0146] For purification of the trityl-on oligomers, the quenched
NH.sub.4HCO.sub.3 solution is loaded onto a C-18 containing
cartridge that had been prewashed with acetonitrile followed by 50
mM TEAA. After washing the loaded cartridge with water, the RNA is
detritylated with 0.5% TFA for 13 min. The cartridge is then washed
again with water, salt exchanged with 1 M NaCl and washed with
water again. The oligonucleotide is then eluted with 30%
acetonitrile.
[0147] Inactive hammerhead ribozymes or binding attenuated control
(BAC) oligonucleotides can be synthesized by substituting a U for
G.sub.5 and a U for A.sub.14 (numbering from Hertel, K. J., et al.,
1992, Nucleic Acids Res., 20, 3252). Similarly, one or more
nucleotide substitutions can be introduced in other enzymatic
nucleic acid molecules to inactivate the molecule and such
molecules can serve as a negative control.
[0148] The average stepwise coupling yields are typically >98%
(Wincott et al., 1995 Nucleic Acids Res. 23, 2677-2684). Those of
ordinary skill in the art will recognize that the scale of
synthesis can be adapted to be larger or smaller than the example
described above including but not limited to 96 well format, with
the ratio of chemicals being used in the reaction adjusted
accordingly.
[0149] Alternatively, the nucleic acid molecules of the present
invention can be synthesized separately and joined together
post-synthetically, for example by ligation (Moore et al., 1992,
Science 256, 9923; Draper et al., International PCT publication No.
WO 93/23569; Shabarova et al., 1991, Nucleic Acids Research 19,
4247; Bellon et al., 1997, Nucleosides & Nucleotides, 16, 951;
Bellon et al., 1997, Bioconjugate Chem. 8, 204).
[0150] The nucleic acid molecules of the present invention are
modified extensively to enhance stability by modification with
nuclease resistant groups, for example, 2'-amino, 2'-C-allyl,
2'-flouro, 2'-O-methyl, 2'-H (for a review see Usman and Cedergren,
1992, TIBS 17, 34; Usman et al., 1994, Nucleic Acids Symp. Ser. 31,
163). Ribozymes are purified by gel electrophoresis using general
methods or are purified by high pressure liquid chromatography
(HPLC; See Wincott et al., Supra, the totality of which is hereby
incorporated herein by reference) and are re-suspended in
water.
[0151] The sequences of the nucleic acid molecules, including
enzymatic nucleic acid molecules and antisense, that are chemically
synthesized, are shown in Table XIII. The sequences of the
enzymatic nucleic acid and antisense constructs that are chemically
synthesized, are complementary to the Substrate sequences shown in
Table XIII. Those in the art will recognize that these sequences
are representative only of many more such sequences where the
enzymatic portion of the ribozyme (all but the binding arms) is
altered to affect activity. The enzymatic nucleic acid and
antisense construct sequences listed in Tables III to XIII can be
formed of ribonucleotides or other nucleotides or non-nucleotides.
Such enzymatic nucleic acid molecules with enzymatic activity are
equivalent to the enzymatic nucleic acid molecules described
specifically in the Tables.
Optimizing Activity of the Nucleic Acid Molecule of the
Invention.
[0152] Chemically synthesizing nucleic acid molecules with
modifications (base, sugar and/or phosphate) that prevent their
degradation by serum ribonucleases can increase their potency (see
e.g., Eckstein et al., International Publication No. WO 92/07065;
Perrault et al., 1990 Nature 344, 565; Pieken et al., 1991, Science
253, 314; Usman and Cedergren, 1992, Trends in Biochem. Sci. 17,
334; Usman et al., International Publication No. WO 93/15187; and
Rossi et al., International Publication No. WO 91/03162; Sproat,
U.S. Pat. No. 5,334,711; and Burgin et al., supra; all of these
describe various chemical modifications that can be made to the
base, phosphate and/or sugar moieties of the nucleic acid molecules
herein). Modifications which enhance their efficacy in cells, and
removal of bases from nucleic acid molecules to shorten
oligonucleotide synthesis times and reduce chemical requirements
are desired. (All these publications are hereby incorporated by
reference herein).
[0153] There are several examples in the art describing sugar, base
and phosphate modifications that can be introduced into nucleic
acid molecules with significant enhancement in their nuclease
stability and efficacy. For example, oligonucleotides are modified
to enhance stability and/or enhance biological activity by
modification with nuclease resistant groups, for example, 2'-amino,
2'-C-allyl, 2'-flouro, 2'-O-methyl, 2'-H, nucleotide base
modifications (for a review see Usman and Cedergren, 1992, TIBS.
17, 34; Usman et al., 1994, Nucleic Acids Symp. Ser. 31, 163;
Burgin et al., 1996, Biochemistry, 35, 14090). Sugar modification
of nucleic acid molecules have been extensively described in the
art (see Eckstein et al., International Publication PCT No. WO
92/07065; Perrault et al. Nature, 1990, 344, 565-568; Pieken et al.
Science, 1991, 253, 314-317; Usman and Cedergren, Trends in
Biochem. Sci., 1992, 17, 334-339; Usman et al. International
Publication PCT No. WO 93/15187; Sproat, U.S. Pat. No. 5,334,711
and Beigelman et al, 1995, J. Biol. Chem., 270, 25702; Beigelman et
al., International PCT publication No. WO 97/26270; Beigelman et
al., U.S. Pat. No. 5,716,824; Usman et al., U.S. Pat. No.
5,627,053; Woolf et al., International PCT Publication No. WO
98/13526; Thompson et al., U.S. Ser. No. 60/082,404 which was filed
on Apr. 20, 1998; Karpeisky et al., 1998, Tetrahedron Lett., 39,
1131; Earnshaw and Gait, 1998, Biopolymers (Nucleic acid Sciences),
48, 39-55; Verma and Eckstein, 1998, Annu. Rev. Biochem., 67,
99-134; and Burlina et al., 1997, Bioorg. Med. Chem., 5, 1999-2010;
all of the references are hereby incorporated in their totality by
reference herein). Such publications describe general methods and
strategies to determine the location of incorporation of sugar,
base and/or phosphate modifications and the like into ribozymes
without inhibiting catalysis, and are incorporated by reference
herein. In view of such teachings, similar modifications can be
used as described herein to modify the nucleic acid molecules of
the instant invention.
[0154] While chemical modification of oligonucleotide
internucleotide linkages with phosphorothioate, phosphorothioate,
and/or 5'-methylphosphonate linkages improves stability, too many
of these modifications can cause some toxicity. Therefore when
designing nucleic acid molecules the amount of these
internucleotide linkages should be minimized. The reduction in the
concentration of these linkages should lower toxicity resulting in
increased efficacy and higher specificity of these molecules.
[0155] Nucleic acid molecules having chemical modifications that
maintain or enhance activity are provided. Such nucleic acid is
also generally more resistant to nucleases than unmodified nucleic
acid. Thus, in a cell and/or in vivo the activity can not be
significantly lowered. Therapeutic nucleic acid molecules delivered
exogenously are optimally stable within cells until translation of
the target RNA has been inhibited long enough to reduce the levels
of the undesirable protein. This period of time varies between
hours to days depending upon the disease state. Nucleic acid
molecules are preferably resistant to nucleases in order to
function as effective intracellular therapeutic agents.
Improvements in the chemical synthesis of RNA and DNA (Wincott et
al., 1995 Nucleic Acids Res. 23, 2677; Caruthers et al., 1992,
Methods in Enzymology 211,3-19 (incorporated by reference herein)
have expanded the ability to modify nucleic acid molecules by
introducing nucleotide modifications to enhance their nuclease
stability as described above.
[0156] Use of the nucleic acid-based molecules of the invention can
lead to better treatment of the disease progression by affording
the possibility of combination therapies (e.g., multiple antisense
or enzymatic nucleic acid molecules targeted to different genes,
nucleic acid molecules coupled with known small molecule
inhibitors, or intermittent treatment with combinations of
molecules (including different motifs) and/or other chemical or
biological molecules). The treatment of subjects with nucleic acid
molecules can also include combinations of different types of
nucleic acid molecules.
[0157] Therapeutic nucleic acid molecules (e.g., enzymatic nucleic
acid molecules and antisense nucleic acid molecules) delivered
exogenously are optimally stable within cells until translation of
the target RNA has been inhibited long enough to reduce the levels
of the undesirable protein. This period of time varies between
hours to days depending upon the disease state. These nucleic acid
molecules should be resistant to nucleases in order to function as
effective intracellular therapeutic agents. Improvements in the
chemical synthesis of nucleic acid molecules described in the
instant invention and in the art have expanded the ability to
modify nucleic acid molecules by introducing nucleotide
modifications to enhance their nuclease stability as described
above.
[0158] In one embodiment, nucleic acid catalysts having chemical
modifications that maintain or enhance enzymatic activity are
provided. Such nucleic acids are also generally more resistant to
nucleases than unmodified nucleic acid. Thus, in a cell and/or in
vivo the activity of the nucleic acid can not be significantly
lowered. As exemplified herein such enzymatic nucleic acids are
useful in a cell and/or in vivo even if activity over all is
reduced about 10 fold (Burgin et al., 1996, Biochemistry, 35,
14090). Such enzymatic nucleic acids herein are said to "maintain"
the enzymatic activity of an all RNA ribozyme or all DNA
DNAzyme.
[0159] In another aspect the nucleic acid molecules comprise a 5'
and/or a 3'-cap structure.
[0160] By "cap structure" is meant chemical modifications, which
have been incorporated at either terminus of the oligonucleotide
(see for example Wincott et al., WO 97/26270, incorporated by
reference herein). These terminal modifications protect the nucleic
acid molecule from exonuclease degradation, and can help in
delivery and/or localization within a cell. The cap can be present
at the 5'-terminus (5'-cap) or at the 3'-terminus (3'-cap) or can
be present on both terminus. In non-limiting examples, the 5'-cap
includes inverted abasic residue (moiety), 4',5'-methylene
nucleotide; 1-(beta-D-erythrofuranosyl) nucleotide, 4'-thio
nucleotide, carbocyclic nucleotide; 1,5-anhydrohexitol nucleotide;
L-nucleotides; alpha-nucleotides; modified base nucleotide;
phosphorodithioate linkage; threo-pentofuranosyl nucleotide;
acyclic 3',4'-seco nucleotide; acyclic 3,4-dihydroxybutyl
nucleotide; acyclic 3,5-dihydroxypentyl nucleotide, 3'-3'-inverted
nucleotide moiety; 3'-3'-inverted abasic moiety; 3'-2'-inverted
nucleotide moiety; 3'-2'-inverted abasic moiety; 1,4-butanediol
phosphate; 3'-phosphoramidate; hexylphosphate; aminohexyl
phosphate; 3'-phosphate; 3'-phosphorothioate; phosphorodithioate;
or bridging or non-bridging methylphosphonate moiety (for more
details see Wincott et al., International PCT publication No. WO
97/26270, incorporated by reference herein).
[0161] In another embodiment the 3'-cap includes, for example
4',5'-methylene nucleotide; 1-(beta-D-erythrofuranosyl) nucleotide;
4'-thio nucleotide, carbocyclic nucleotide; 5'-amino-alkyl
phosphate; 1,3-diamino-2-propyl phosphate, 3-aminopropyl phosphate;
6-aminohexyl phosphate; 1,2-aminododecyl phosphate; hydroxypropyl
phosphate; 1,5-anhydrohexitol nucleotide; L-nucleotide;
alpha-nucleotide; modified base nucleotide; phosphorodithioate;
threo-pentofuranosyl nucleotide; acyclic 3',4'-seco nucleotide;
3,4-dihydroxybutyl nucleotide; 3,5-dihydroxypentyl nucleotide,
5'-5'-inverted nucleotide moiety; 5'-5'-inverted abasic moiety;
5'-phosphoramidate; 5'-phosphorothioate; 1,4-butanediol phosphate;
5'-amino; bridging and/or non-bridging 5'-phosphoramidate,
phosphorothioate and/or phosphorodithioate, bridging or non
bridging methylphosphonate and 5'-mercapto moieties (for more
details see Beaucage and Iyer, 1993, Tetrahedron 49, 1925;
incorporated by reference herein).
[0162] By the term "non-nucleotide" is meant any group or compound
which can be incorporated into a nucleic acid chain in the place of
one or more nucleotide units, including either sugar and/or
phosphate substitutions, and allows the remaining bases to exhibit
their enzymatic activity. The group or compound is abasic in that
it does not contain a commonly recognized nucleotide base, such as
adenosine, guanine, cytosine, uracil or thymine.
[0163] The term "alkyl" as used herein refers to a saturated
aliphatic hydrocarbon, including straight-chain, branched-chain
"isoalkyl", and cyclic alkyl groups. The term "alkyl" also
comprises alkoxy, alkyl-thio, alkyl-thio-alkyl, alkoxyalkyl,
alkylamino, alkenyl, alkynyl, alkoxy, cycloalkenyl, cycloalkyl,
cycloalkylalkyl, heterocycloalkyl, heteroaryl, C.sub.1-C.sub.6
hydrocarbyl, aryl or substituted aryl groups. Preferably, the alkyl
group has 1 to 12 carbons. More preferably it is a lower alkyl of
from about 1 to 7 carbons, more preferably about 1 to 4 carbons.
The alkyl group can be substituted or unsubstituted. When
substituted the substituted group(s) preferably comprise hydroxy,
oxy, thio, amino, nitro, cyano, alkoxy, alkyl-thio,
alkyl-thio-alkyl, alkoxyalkyl, alkylamino, silyl, alkenyl, alkynyl,
alkoxy, cycloalkenyl, cycloalkyl, cycloalkylalkyl,
heterocycloalkyl, heteroaryl, C.sub.1-C.sub.6 hydrocarbyl, aryl or
substituted aryl groups. The term "alkyl" also includes alkenyl
groups containing at least one carbon-carbon double bond, including
straight-chain, branched-chain, and cyclic groups. Preferably, the
alkenyl group has about 2 to 12 carbons. More preferably it is a
lower alkenyl of from about 2 to 7 carbons, more preferably about 2
to 4 carbons. The alkenyl group can be substituted or
unsubstituted. When substituted the substituted group(s) preferably
comprise hydroxy, oxy, thio, amino, nitro, cyano, alkoxy,
alkyl-thio, alkyl-thio-alkyl, alkoxyalkyl, alkylamino, silyl,
alkenyl, alkynyl, alkoxy, cycloalkenyl, cycloalkyl,
cycloalkylalkyl, heterocycloalkyl, heteroaryl, C.sub.1-C.sub.6
hydrocarbyl, aryl or substituted aryl groups. The term "alkyl" also
includes alkynyl groups containing at least one carbon-carbon
triple bond, including straight-chain, branched-chain, and cyclic
groups. Preferably, the alkynyl group has about 2 to 12 carbons.
More preferably it is a lower alkynyl of from about 2 to 7 carbons,
more preferably about 2 to 4 carbons. The alkynyl group can be
substituted or unsubstituted. When substituted the substituted
group(s) preferably comprise hydroxy, oxy, thio, amino, nitro,
cyano, alkoxy, alkyl-thio, alkyl-thio-alkyl, alkoxyalkyl,
alkylamino, silyl, alkenyl, alkynyl, alkoxy, cycloalkenyl,
cycloalkyl, cycloalkylalkyl, heterocycloalkyl, heteroaryl,
C.sub.1-C.sub.6 hydrocarbyl, aryl or substituted aryl groups. Alkyl
groups or moieties of the invention can also include aryl,
alkylaryl, carbocyclic aryl, heterocyclic aryl, amide and ester
groups. The preferred substituent(s) of aryl groups are halogen,
trihalomethyl, hydroxyl, SH, OH, cyano, alkoxy, alkyl, alkenyl,
alkynyl, and amino groups. An "alkylaryl" group refers to an alkyl
group (as described above) covalently joined to an aryl group (as
described above). Carbocyclic aryl groups are groups wherein the
ring atoms on the aromatic ring are all carbon atoms. The carbon
atoms are optionally substituted. Heterocyclic aryl groups are
groups having from about 1 to 3 heteroatoms as ring atoms in the
aromatic ring and the remainder of the ring atoms are carbon atoms.
Suitable heteroatoms include oxygen, sulfur, and nitrogen, and
include furanyl, thienyl, pyridyl, pyrrolyl, N-lower alkyl pyrrolo,
pyrimidyl, pyrazinyl, imidazolyl and the like, all optionally
substituted. An "amide" refers to an --C(O)--NH--R, where R is
either alkyl, aryl, alkylaryl or hydrogen. An "ester" refers to an
--C(O)--OR', where R is either alkyl, aryl, alkylaryl or
hydrogen.
[0164] The term "alkoxyalkyl" as used herein refers to an
alkyl-O-alkyl ether, for example methoxyethyl or ethoxymethyl.
[0165] The term "alkyl-thio-alkyl" as used herein refers to an
alkyl-S-alkyl thioether, for example methylthiomethyl or
methylthioethyl.
[0166] The term "amino" as used herein refers to a nitrogen
containing group as is known in the art derived from ammonia by the
replacement of one or more hydrogen radicals by organic radicals.
For example, the terms "aminoacyl" and "aminoalkyl" refer to
specific N-substituted organic radicals with acyl and alkyl
substituent groups respectively.
[0167] The term "amination" as used herein refers to a process in
which an amino group or substituted amine is introduced into an
organic molecule.
[0168] The term "exocyclic amine protecting moiety" as used herein
refers to a nucleobase amino protecting group compatible with
oligonucleotide synthesis, for example an acyl or amide group.
[0169] The term "alkenyl" as used herein refers to a straight or
branched hydrocarbon of a designed number of carbon atoms
containing at least one carbon-carbon double bond. Examples of
"alkenyl" include vinyl, allyl, and 2-methyl-3-heptene.
[0170] The term "alkoxy" as used herein refers to an alkyl group of
indicated number of carbon atoms attached to the parent molecular
moiety through an oxygen bridge. Examples of alkoxy groups include,
for example, methoxy, ethoxy, propoxy and isopropoxy.
[0171] The term "alkynyl" as used herein refers to a straight or
branched hydrocarbon of a designed number of carbon atoms
containing at least one carbon-carbon triple bond. Examples of
"alkynyl" include propargyl, propyne, and 3-hexyne.
[0172] The term "aryl" as used herein refers to an aromatic
hydrocarbon ring system containing at least one aromatic ring. The
aromatic ring can optionally be fused or otherwise attached to
other aromatic hydrocarbon rings or non-aromatic hydrocarbon rings.
Examples of aryl groups include, for example, phenyl, naphthyl,
1,2,3,4-tetrahydronaphthalene and biphenyl. Preferred examples of
aryl groups include phenyl and naphthyl.
[0173] The term "cycloalkenyl" as used herein refers to a
C.sub.3-C.sub.8 cyclic hydrocarbon containing at least one
carbon-carbon double bond. Examples of cycloalkenyl include
cyclopropenyl, cyclobutenyl, cyclopentenyl, cyclopentadiene,
cyclohexenyl, 1,3-cyclohexadiene, cycloheptenyl, cycloheptatrienyl,
and cyclooctenyl.
[0174] The term "cycloalkyl" as used herein refers to a
C.sub.3-C.sub.8 cyclic hydrocarbon. Examples of cycloalkyl include
cyclopropyl, cyclobutyl, cyclopentyl, cyclohexyl, cycloheptyl and
cyclooctyl.
[0175] The term "cycloalkylalkyl," as used herein, refers to a
C.sub.3-C.sub.7 cycloalkyl group attached to the parent molecular
moiety through an alkyl group, as defined above. Examples of
cycloalkylalkyl groups include cyclopropylmethyl and
cyclopentylethyl.
[0176] The terms "halogen" or "halo" as used herein refers to
indicate fluorine, chlorine, bromine, and iodine.
[0177] The term "heterocycloalkyl," as used herein refers to a
non-aromatic ring system containing at least one heteroatom
selected from nitrogen, oxygen, and sulfur. The heterocycloalkyl
ring can be optionally fused to or otherwise attached to other
heterocycloalkyl rings and/or non-aromatic hydrocarbon rings.
Preferred heterocycloalkyl groups have from 3 to 7 members.
Examples of heterocycloalkyl groups include, for example,
piperazine, morpholine, piperidine, tetrahydrofuran, pyrrolidine,
and pyrazole. Preferred heterocycloalkyl groups include
piperidinyl, piperazinyl, morpholinyl, and pyrolidinyl.
[0178] The term "heteroaryl" as used herein refers to an aromatic
ring system containing at least one heteroatom selected from
nitrogen, oxygen, and sulfur. The heteroaryl ring can be fused or
otherwise attached to one or more heteroaryl rings, aromatic or
non-aromatic hydrocarbon rings or heterocycloalkyl rings. Examples
of heteroaryl groups include, for example, pyridine, furan,
thiophene, 5,6,7,8-tetrahydroisoquinoline and pyrimidine. Preferred
examples of heteroaryl groups include thienyl, benzothienyl,
pyridyl, quinolyl, pyrazinyl, pyrimidyl, imidazolyl,
benzimidazolyl, furanyl, benzofuranyl, thiazolyl, benzothiazolyl,
isoxazolyl, oxadiazolyl, isothiazolyl, benzisothiazolyl, triazolyl,
tetrazolyl, pyrrolyl, indolyl, pyrazolyl, and benzopyrazolyl.
[0179] The term "C1-C6 hydrocarbyl" as used herein refers to
straight, branched, or cyclic alkyl groups having 1-6 carbon atoms,
optionally containing one or more carbon-carbon double or triple
bonds. Examples of hydrocarbyl groups include, for example, methyl,
ethyl, propyl, isopropyl, n-butyl, sec-butyl, tert-butyl, pentyl,
2-pentyl, isopentyl, neopentyl, hexyl, 2-hexyl, 3-hexyl,
3-methylpentyl, vinyl, 2-pentene, cyclopropylmethyl, cyclopropyl,
cyclohexylmethyl, cyclohexyl and propargyl. When reference is made
herein to C1-C6 hydrocarbyl containing one or two double or triple
bonds it is understood that at least two carbons are present in the
alkyl for one double or triple bond, and at least four carbons for
two double or triple bonds.
[0180] By "nucleotide" is meant a heterocyclic nitrogenous base in
N-glycosidic linkage with a phosphorylated sugar. Nucleotides are
recognized in the art to include natural bases (standard), and
modified bases well known in the art. Such bases are generally
located at the 1' position of a nucleotide sugar moiety.
Nucleotides generally comprise a base, sugar and a phosphate group.
The nucleotides can be unmodified or modified at the sugar,
phosphate and/or base moiety, (also referred to interchangeably as
nucleotide analogs, modified nucleotides, non-natural nucleotides,
non-standard nucleotides and other; see for example, Usman and
McSwiggen, supra; Eckstein et al., International PCT Publication
No. WO 92/07065; Usman et al., International PCT Publication No. WO
93/15187; Uhlman & Peyman, supra all are hereby incorporated by
reference herein). There are several examples of modified nucleic
acid bases known in the art as summarized by Limbach et al., 1994,
Nucleic Acids Res. 22, 2183. Some of the non-limiting examples of
chemically modified and other natural nucleic acid bases that can
be introduced into nucleic acids include, for example, inosine,
purine, pyridin-4-one, pyridin-2-one, phenyl, pseudouracil,
2,4,6-trimethoxy benzene, 3-methyl uracil, dihydrouridine,
naphthyl, aminophenyl, 5-alkylcytidines (e.g., 5-methylcytidine),
5-alkyluridines (e.g., ribothymidine), 5-halouridine (e.g.,
5-bromouridine) or 6-azapyrimidines or 6-alkylpyrimidines (e.g.
6-methyluridine), propyne, quesosine, 2-thiouridine, 4-thiouridine,
wybutosine, wybutoxosine, 4-acetylcytidine,
5-(carboxyhydroxymethyl)uridine,
5'-carboxymethylaminomethyl-2-thiouridine,
5-carboxymethylaminomethyluridine, beta-D-galactosylqueosine,
1-methyladenosine, 1-methylinosine, 2,2-dimethylguanosine,
3-methylcytidine, 2-methyladenosine, 2-methylguanosine,
N6-methyladenosine, 7-methylguanosine,
5-methoxyaminomethyl-2-thiouridine, 5-methylaminomethyluridine,
5-methylcarbonylmethyluridine, 5-methyloxyuridine,
5-methyl-2-thiouridine, 2-methylthio-N-6-isopentenyladenosine,
beta-D-mannosylqueosine, uridine-5-oxyacetic acid, 2-thiocytidine,
threonine derivatives and others (Burgin et al., 1996,
Biochemistry, 35, 14090; Uhlman & Peyman, supra). By "modified
bases" in this aspect is meant nucleotide bases other than adenine,
guanine, cytosine and uracil at 1' position or their equivalents;
such bases can be used at any position, for example, within the
catalytic core of an enzymatic nucleic acid molecule and/or in the
substrate-binding regions of the nucleic acid molecule.
[0181] By "nucleoside" is meant a heterocyclic nitrogenous base in
N-glycosidic linkage with a sugar. Nucleosides are recognized in
the art to include natural bases (standard), and modified bases
well known in the art. Such bases are generally located at the 1'
position of a nucleoside sugar moiety. Nucleosides generally
comprise a base and sugar group. The nucleosides can be unmodified
or modified at the sugar, and/or base moiety, (also referred to
interchangeably as nucleoside analogs, modified nucleosides,
non-natural nucleosides, non-standard nucleosides and other; see
for example, Usman and McSwiggen, supra; Eckstein et al.,
International PCT Publication No. WO 92/07065; Usman et al.,
International PCT Publication No. WO 93/15187; Uhlman & Peyman,
supra all are hereby incorporated by reference herein). There are
several examples of modified nucleic acid bases known in the art as
summarized by Limbach et al., 1994, Nucleic Acids Res. 22, 2183.
Some of the non-limiting examples of chemically modified and other
natural nucleic acid bases that can be introduced into nucleic
acids include, inosine, purine, pyridin-4-one, pyridin-2-one,
phenyl, pseudouracil, 2,4,6-trimethoxy benzene, 3-methyl uracil,
dihydrouridine, naphthyl, aminophenyl, 5-alkylcytidines (e.g.,
5-methylcytidine), 5-alkyluridines (e.g., ribothymidine),
5-halouridine (e.g., 5-bromouridine) or 6-azapyrimidines or
6-alkylpyrimidines (e.g. 6-methyluridine), propyne, quesosine,
2-thiouridine, 4-thiouridine, wybutosine, wybutoxosine,
4-acetylcytidine, 5-(carboxyhydroxymethyl)uridine,
5'-carboxymethylaminomethyl-2-thiouridine,
5-carboxymethylaminomethyluridine, beta-D-galactosylqueosine,
1-methyladenosine, 1-methylinosine, 2,2-dimethylguanosine,
3-methylcytidine, 2-methyladenosine, 2-methylguanosine,
N6-methyladenosine, 7-methylguanosine,
5-methoxyaminomethyl-2-thiouridine, 5-methylaminomethyluridine,
5-methylcarbonylmethyluridine, 5-methyloxyuridine,
5-methyl-2-thiouridine, 2-methylthio-N6-isopentenyladenosine,
beta-D-mannosylqueosine, uridine-5-oxyacetic acid, 2-thiocytidine,
threonine derivatives and others (Burgin et al., 1996,
Biochemistry, 35, 14090; Uhlman & Peyman, supra). By "modified
bases" in this aspect is meant nucleoside bases other than adenine,
guanine, cytosine and uracil at 1' position or their equivalents;
such bases can be used at any position, for example, within the
catalytic core of an enzymatic nucleic acid molecule and/or in the
substrate-binding regions of the nucleic acid molecule.
[0182] In one embodiment, the invention features modified enzymatic
nucleic acid molecules with phosphate backbone modifications
comprising one or more phosphorothioate, phosphorodithioate,
methylphosphonate, morpholino, amidate carbamate, carboxymethyl,
acetamidate, polyamide, sulfonate, sulfonamide, sulfamate,
formacetal, thioformacetal, and/or alkylsilyl, substitutions. For a
review of oligonucleotide backbone modifications see Hunziker and
Leumann, 1995, Nucleic Acid Analogues: Synthesis and Properties, in
Modern Synthetic Methods, VCH, 331-417, and Mesmaeker et al., 1994,
Novel Backbone Replacements for Oligonucleotides, in Carbohydrate
Modifications in Antisense Research, ACS, 24-39. These references
are hereby incorporated by reference herein.
[0183] By "abasic" is meant sugar moieties lacking a base or having
other chemical groups in place of a base at the 1' position, for
example a 3',3'-linked or 5',5'-linked deoxyabasic ribose
derivative (for more details see Wincott et al., International PCT
publication No. WO 97/26270).
[0184] By "unmodified nucleoside" is meant one of the bases
adenine, cytosine, guanine, thymine, uracil joined to the 1' carbon
of .beta.-D-ribo-furanose.
[0185] By "modified nucleoside" is meant any nucleotide base which
contains a modification in the chemical structure of an unmodified
nucleotide base, sugar and/or phosphate.
[0186] In connection with 2'-modified nucleotides as described for
the present invention, by "amino" is meant 2'-NH.sub.2 or
2'-O--NH.sub.2, which can be modified or unmodified. Such modified
groups are described, for example, in Eckstein et al., U.S. Pat.
No. 5,672,695 and Matulic-Adamic et al., WO 98/28317, respectively,
which are both incorporated by reference in their entireties.
[0187] Various modifications to nucleic acid (e.g., antisense and
ribozyme) structure can be made to enhance the utility of these
molecules. For example, such modifications can enhance shelf-life,
half-life in vitro, stability, and ease of introduction of such
oligonucleotides to the target site, including e.g., enhancing
penetration of cellular membranes and conferring the ability to
recognize and bind to targeted cells.
[0188] Use of these molecules can lead to better treatment of the
disease progression by affording the possibility of combination
therapies (e.g., multiple enzymatic nucleic acid molecules targeted
to different genes, enzymatic nucleic acid molecules coupled with
known small molecule inhibitors, or intermittent treatment with
combinations of enzymatic nucleic acid molecules (including
different enzymatic nucleic acid molecule motifs) and/or other
chemical or biological molecules). The treatment of subjects with
nucleic acid molecules can also include combinations of different
types of nucleic acid molecules. Therapies can be devised which
include a mixture of enzymatic nucleic acid molecules (including
different enzymatic nucleic acid molecule motifs), antisense and/or
2-5A chimera molecules to one or more targets to alleviate symptoms
of a disease.
Administration of Nucleic Acid Molecules
[0189] Methods for the delivery of nucleic acid molecules are
described in Akhtar et al., 1992, Trends Cell Bio., 2, 139; and
Delivery Strategies for Antisense Oligonucleotide Therapeutics, ed.
Akhtar, 1995 which are both incorporated herein by reference.
Sullivan et al., PCT WO 94/02595, further describes the general
methods for delivery of enzymatic RNA molecules. These protocols
can be utilized for the delivery of virtually any nucleic acid
molecule. Nucleic acid molecules can be administered to cells by a
variety of methods known to those familiar to the art, including,
but not restricted to, encapsulation in liposomes, by
iontophoresis, or by incorporation into other vehicles, such as
hydrogels, cyclodextrins, biodegradable nanocapsules, and
bioadhesive microspheres. Alternatively, the nucleic acid/vehicle
combination is locally delivered by direct injection or by use of
an infusion pump. Other routes of delivery include, but are not
limited to oral (tablet or pill form) and/or intrathecal delivery
(Gold, 1997, Neuroscience, 76, 1153-1158). Other approaches include
the use of various transport and carrier systems, for example,
through the use of conjugates and biodegradable polymers. For a
comprehensive review on drug delivery strategies including CNS
delivery, see Ho et al., 1999, Curr. Opin. Mol. Ther., 1, 336-343
and Jain, Drug Delivery Systems: Technologies and Commercial
Opportunities, Decision Resources, 1998 and Groothuis et al., 1997,
J. NeuroVirol., 3, 387-400. More detailed descriptions of nucleic
acid delivery and administration are provided in Sullivan et al.,
supra, Draper et al., PCT WO93/23569, Beigelman et al., PCT
WO99/05094, and Klimuk et al., PCT WO99/04819 all of which have
been incorporated by reference herein.
[0190] The molecules of the instant invention can be used as
pharmaceutical agents. Pharmaceutical agents prevent, inhibit the
occurrence, or treat (alleviate a symptom to some extent,
preferably all of the symptoms) of a disease state in a
subject.
[0191] The negatively charged polynucleotides of the invention can
be administered (e.g., RNA, DNA or protein) and introduced into a
subject by any standard means, with or without stabilizers,
buffers, and the like, to form a pharmaceutical composition. When
it is desired to use a liposome delivery mechanism, standard
protocols for formation of liposomes can be followed. The
compositions of the present invention can also be formulated and
used as tablets, capsules or elixirs for oral administration;
suppositories for rectal administration; sterile solutions;
suspensions for injectable administration; and the other
compositions known in the art.
[0192] The present invention also includes pharmaceutically
acceptable formulations of the compounds described. These
formulations include salts of the above compounds, e.g., acid
addition salts, for example, salts of hydrochloric, hydrobromic,
acetic acid, and benzene sulfonic acid.
[0193] A pharmacological composition or formulation refers to a
composition or formulation in a form suitable for administration,
e.g., systemic administration, into a cell or subject, preferably a
human. Suitable forms, in part, depend upon the use or the route of
entry, for example oral, transdermal, or by injection. Such forms
should not prevent the composition or formulation from reaching a
target cell (i.e., a cell to which the negatively charged polymer
is desired to be delivered to). For example, pharmacological
compositions injected into the blood stream should be soluble.
Other factors are known in the art, and include considerations such
as toxicity and forms which prevent the composition or formulation
from exerting its effect.
[0194] By "systemic administration" is meant in vivo systemic
absorption or accumulation of drugs in the blood stream followed by
distribution throughout the entire body. Administration routes
which lead to systemic absorption include, without limitations:
intravenous, subcutaneous, intraperitoneal, inhalation, oral,
intrapulmonary and intramuscular. Each of these administration
routes expose the desired negatively charged polymers, e.g.,
nucleic acids, to an accessible diseased tissue. The rate of entry
of a drug into the circulation has been shown to be a function of
molecular weight or size. The use of a liposome or other drug
carrier comprising the compounds of the instant invention can
potentially localize the drug, for example, in certain tissue
types, such as the tissues of the reticular endothelial system
(RES). A liposome formulation which can facilitate the association
of drug with the surface of cells, such as, lymphocytes and
macrophages is also useful. This approach can provide enhanced
delivery of the drug to target cells by taking advantage of the
specificity of macrophage and lymphocyte immune recognition of
abnormal cells, such as cancer cells.
[0195] By pharmaceutically acceptable formulation is meant, a
composition or formulation that allows for the effective
distribution of the nucleic acid molecules of the instant invention
in the physical location most suitable for their desired activity.
Non-limiting examples of agents suitable for formulation with the
nucleic acid molecules of the instant invention include: PEG
conjugated nucleic acids, phospholipid conjugated nucleic acids,
nucleic acids containing lipophilic moieties, phosphorothioates,
P-glycoprotein inhibitors (such as Pluronic P85) which can enhance
entry of drugs into various tissues, for example the CNS
(Jolliet-Riant and Tillement, 1999, Fundam. Clin. Pharmacol., 13,
16-26); biodegradable polymers, such as poly
(DL-lactide-coglycolide) microspheres for sustained release
delivery after implantation (Emerich, D F et al, 1999, Cell
Transplant, 8, 47-58) Alkermes, Inc. Cambridge, Mass.; and loaded
nanoparticles, such as those made of polybutylcyanoacrylate, which
can deliver drugs across the blood brain barrier and can alter
neuronal uptake mechanisms (Prog Neuropsychopharmacol Biol
Psychiatry, 23, 941-949, 1999). Other non-limiting examples of
delivery strategies, including CNS delivery of the nucleic acid
molecules of the instant invention include material described in
Boado et al., 1998, J. Pharm. Sci., 87, 1308-1315; Tyler et al.,
1999, FEBS Lett., 421, 280-284; Pardridge et al., 1995, PNAS USA.,
92, 5592-5596; Boado, 1995, Adv. Drug Delivery Rev., 15, 73-107;
Aldrian-Herrada et al., 1998, Nucleic Acids Res., 26, 4910-4916;
and Tyler et al., 1999, PNAS USA., 96, 7053-7058. All these
references are hereby incorporated herein by reference.
[0196] The invention also features the use of the composition
comprising surface-modified liposomes containing poly (ethylene
glycol) lipids (PEG-modified, or long-circulating liposomes or
stealth liposomes). Nucleic acid molecules of the invention can
also comprise covalently attached PEG molecules of various
molecular weights. These formulations offer a method for increasing
the accumulation of drugs in target tissues. This class of drug
carriers resists opsonization and elimination by the mononuclear
phagocytic system (MPS or RES), thereby enabling longer blood
circulation times and enhanced tissue exposure for the encapsulated
drug (Lasic et al. Chem. Rev. 1995, 95, 2601-2627; Ishiwata et al.,
Chem. Pharm. Bull. 1995, 43, 1005-1011). Such liposomes have been
shown to accumulate selectively in tumors, presumably by
extravasation and capture in the neovascularized target tissues
(Lasic et al., Science 1995, 267, 1275-1276; Oku et al., 1995,
Biochim. Biophys. Acta, 1238, 86-90). The long-circulating
liposomes enhance the pharmacokinetics and pharmacodynamics of DNA
and RNA, particularly compared to conventional cationic liposomes
which are known to accumulate in tissues of the MPS (Liu et al., J.
Biol. Chem. 1995, 42, 24864-24870; Choi et al., International PCT
Publication No. WO 96/10391; Ansell et al., International PCT
Publication No. WO 96/10390; Holland et al., International PCT
Publication No. WO 96/10392; all of which are incorporated by
reference herein). Long-circulating liposomes are also likely to
protect drugs from nuclease degradation to a greater extent
compared to cationic liposomes, based on their ability to avoid
accumulation in metabolically aggressive MPS tissues such as the
liver and spleen. All of these references are incorporated by
reference herein.
[0197] The present invention also includes compositions prepared
for storage or administration which include a pharmaceutically
effective amount of the desired compounds in a pharmaceutically
acceptable carrier or diluent. Acceptable carriers or diluents for
therapeutic use are well known in the pharmaceutical art, and are
described, for example, in Remington's Pharmaceutical Sciences,
Mack Publishing Co. (A. R. Gennaro edit. 1985) hereby incorporated
by reference herein. For example, preservatives, stabilizers, dyes
and flavoring agents can be provided. These include sodium
benzoate, sorbic acid and esters of p-hydroxybenzoic acid. In
addition, antioxidants and suspending agents can be used.
[0198] A pharmaceutically effective dose is that dose required to
prevent, inhibit the occurrence, or treat (alleviate a symptom to
some extent, preferably all of the symptoms) of a disease state.
The pharmaceutically effective dose depends on the type of disease,
the composition used, the route of administration, the type of
mammal being treated, the physical characteristics of the specific
mammal under consideration, concurrent medication, and other
factors which those skilled in the medical arts will recognize.
Generally, an amount between 0.1 mg/kg and 100 mg/kg body
weight/day of active ingredients is administered dependent upon
potency of the negatively charged polymer.
[0199] The nucleic acid molecules of the invention and formulations
thereof can be administered orally, topically, parenterally, by
inhalation or spray or rectally in dosage unit formulations
containing conventional non-toxic pharmaceutically acceptable
carriers, adjuvants and vehicles. The term parenteral as used
herein includes percutaneous, subcutaneous, intravascular (e.g.,
intravenous), intramuscular, or intrathecal injection or infusion
techniques and the like. In addition, there is provided a
pharmaceutical formulation comprising a nucleic acid molecule of
the invention and a pharmaceutically acceptable carrier. One or
more nucleic acid molecules of the invention can be present in
association with one or more non-toxic pharmaceutically acceptable
carriers and/or diluents and/or adjuvants, and if desired other
active ingredients. The pharmaceutical compositions containing
nucleic acid molecules of the invention can be in a form suitable
for oral use, for example, as tablets, troches, lozenges, aqueous
or oily suspensions, dispersible powders or granules, emulsion,
hard or soft capsules, or syrups or elixirs.
[0200] Compositions intended for oral use can be prepared according
to any method known to the art for the manufacture of
pharmaceutical compositions and such compositions can contain one
or more such sweetening agents, flavoring agents, coloring agents
or preservative agents in order to provide pharmaceutically elegant
and palatable preparations. Tablets contain the active ingredient
in admixture with non-toxic pharmaceutically acceptable excipients
that are suitable for the manufacture of tablets. These excipients
can be for example, inert diluents, such as calcium carbonate,
sodium carbonate, lactose, calcium phosphate or sodium phosphate;
granulating and disintegrating agents, for example, corn starch, or
alginic acid; binding agents, for example starch, gelatin or
acacia, and lubricating agents, for example magnesium stearate,
stearic acid or talc. The tablets can be uncoated or they can be
coated by known techniques. In some cases such coatings can be
prepared by known techniques to delay disintegration and absorption
in the gastrointestinal tract and thereby provide a sustained
action over a longer period. For example, a time delay material
such as glyceryl monosterate or glyceryl distearate can be
employed.
[0201] Formulations for oral use can also be presented as hard
gelatin capsules wherein the active ingredient is mixed with an
inert solid diluent, for example, calcium carbonate, calcium
phosphate or kaolin, or as soft gelatin capsules wherein the active
ingredient is mixed with water or an oil medium, for example peanut
oil, liquid paraffin or olive oil.
[0202] Aqueous suspensions contain the active materials in
admixture with excipients suitable for the manufacture of aqueous
suspensions. Such excipients are suspending agents, for example
sodium carboxymethylcellulose, methylcellulose,
hydropropyl-methylcellulose, sodium alginate, polyvinylpyrrolidone,
gum tragacanth and gum acacia; dispersing or wetting agents can be
a naturally-occurring phosphatide, for example, lecithin, or
condensation products of an alkylene oxide with fatty acids, for
example polyoxyethylene stearate, or condensation products of
ethylene oxide with long chain aliphatic alcohols, for example
heptadecaethyleneoxycetanol, or condensation products of ethylene
oxide with partial esters derived from fatty acids and a hexitol
such as polyoxyethylene sorbitol monooleate, or condensation
products of ethylene oxide with partial esters derived from fatty
acids and hexitol anhydrides, for example polyethylene sorbitan
monooleate. The aqueous suspensions can also contain one or more
preservatives, for example ethyl, or n-propyl p-hydroxybenzoate,
one or more coloring agents, one or more flavoring agents, and one
or more sweetening agents, such as sucrose or saccharin.
[0203] Oily suspensions can be formulated by suspending the active
ingredients in a vegetable oil, for example arachis oil, olive oil,
sesame oil or coconut oil, or in a mineral oil such as liquid
paraffin. The oily suspensions can contain a thickening agent, for
example beeswax, hard paraffin or cetyl alcohol. Sweetening agents
and flavoring agents can be added to provide palatable oral
preparations. These compositions can be preserved by the addition
of an anti-oxidant such as ascorbic acid.
[0204] Dispersible powders and granules suitable for preparation of
an aqueous suspension by the addition of water provide the active
ingredient in admixture with a dispersing or wetting agent,
suspending agent and one or more preservatives. Suitable dispersing
or wetting agents or suspending agents are exemplified by those
already mentioned above. Additional excipients, for example
sweetening, flavoring and coloring agents, can also be present.
[0205] Pharmaceutical compositions of the invention can also be in
the form of oil-in-water emulsions. The oily phase can be a
vegetable oil or a mineral oil or mixtures of these. Suitable
emulsifying agents can be naturally-occurring gums, for example gum
acacia or gum tragacanth, naturally-occurring phosphatides, for
example soy bean, lecithin, and esters or partial esters derived
from fatty acids and hexitol, anhydrides, for example sorbitan
monooleate, and condensation products of the said partial esters
with ethylene oxide, for example polyoxyethylene sorbitan
monooleate. The emulsions can also contain sweetening and flavoring
agents.
[0206] Syrups and elixirs can be formulated with sweetening agents,
for example glycerol, propylene glycol, sorbitol, glucose or
sucrose. Such formulations can also contain a demulcent, a
preservative and flavoring and coloring agents. The pharmaceutical
compositions can be in the form of a sterile injectable aqueous or
oleaginous suspension. This suspension can be formulated according
to the known art using those suitable dispersing or wetting agents
and suspending agents that have been mentioned above. The sterile
injectable preparation can also be a sterile injectable solution or
suspension in a non-toxic parentally acceptable diluent or solvent,
for example as a solution in 1,3-butanediol. Among the acceptable
vehicles and solvents that can be employed are water, Ringer's
solution and isotonic sodium chloride solution. In addition,
sterile, fixed oils are conventionally employed as a solvent or
suspending medium. For this purpose any bland fixed oil can be
employed including synthetic mono- or diglycerides. In addition,
fatty acids such as oleic acid find use in the preparation of
injectables.
[0207] The nucleic acid molecules of the invention can also be
administered in the form of suppositories, e.g., for rectal
administration of the drug. These compositions can be prepared by
mixing the drug with a suitable non-irritating excipient that is
solid at ordinary temperatures but liquid at the rectal temperature
and will therefore melt in the rectum to release the drug. Such
materials include cocoa butter and polyethylene glycols.
[0208] Nucleic acid molecules of the invention can be administered
parenterally in a sterile medium. The drug, depending on the
vehicle and concentration used, can either be suspended or
dissolved in the vehicle. Advantageously, adjuvants such as local
anesthetics, preservatives and buffering agents can be dissolved in
the vehicle.
[0209] Dosage levels of the order of from about 0.1 mg to about 140
mg per kilogram of body weight per day are useful in the treatment
of the above-indicated conditions (about 0.5 mg to about 7 g per
patient or subject per day). The amount of active ingredient that
can be combined with the carrier materials to produce a single
dosage form varies depending upon the host treated and the
particular mode of administration. Dosage unit forms generally
contain between from about 1 mg to about 500 mg of an active
ingredient.
[0210] It is understood that the specific dose level for any
particular patient or subject depends upon a variety of factors
including the activity of the specific compound employed, the age,
body weight, general health, sex, diet, time of administration,
route of administration, and rate of excretion, drug combination
and the severity of the particular disease undergoing therapy.
[0211] For administration to non-human animals, the composition can
also be added to the animal feed or drinking water. It can be
convenient to formulate the animal feed and drinking water
compositions so that the animal takes in a therapeutically
appropriate quantity of the composition along with its diet. It can
also be convenient to present the composition as a premix for
addition to the feed or drinking water.
[0212] The nucleic acid molecules of the present invention can also
be administered to a subject in combination with other therapeutic
compounds to increase the overall therapeutic effect. The use of
multiple compounds to treat an indication can increase the
beneficial effects while reducing the presence of side effects.
[0213] Alternatively, certain of the nucleic acid molecules of the
instant invention can be expressed within cells from eukaryotic
promoters (e.g., Izant and Weintraub, 1985, Science, 229, 345;
McGarry and Lindquist, 1986, Proc. Natl. Acad. Sci., USA 83, 399;
Scanlon et al., 1991, Proc. Natl. Acad. Sci. USA, 88, 10591-5;
Kashani-Sabet et al., 1992, Antisense Res. Dev., 2, 3-15; Dropulic
et al., 1992, J. Virol., 66, 1432-41; Weerasinghe et al., 1991, J.
Virol., 65, 5531-4; Ojwang et al., 1992, Proc. Natl. Acad. Sci.
USA, 89, 10802-6; Chen et al., 1992, Nucleic Acids Res., 20,
4581-9; Sarver et al., 1990 Science, 247, 1222-1225; Thompson et
al., 1995, Nucleic Acids Res., 23, 2259; Good et al., 1997, Gene
Therapy, 4, 45; all of these references are hereby incorporated in
their totalities by reference herein). Those skilled in the art
realize that any nucleic acid can be expressed in eukaryotic cells
from the appropriate DNA/RNA vector. The activity of such nucleic
acids can be augmented by their release from the primary transcript
by a enzymatic nucleic acid (Draper et al., PCT WO 93/23569, and
Sullivan et al., PCT WO 94/02595; Ohkawa et al., 1992, Nucleic
Acids Symp. Ser., 27, 15-6; Taira et al., 1991, Nucleic Acids Res.,
19, 5125-30; Ventura et al., 1993, Nucleic Acids Res., 21, 3249-55;
Chowrira et al., 1994, J. Biol. Chem., 269, 25856; all of these
references are hereby incorporated in their totalities by reference
herein). Gene therapy approaches specific to the CNS are described
by Blesch et al., 2000, Drug News Perspect., 13, 269-280; Peterson
et al., 2000, Cent. Nerv. Syst. Dis., 485-508; Peel and Klein,
2000, J. Neurosci. Methods, 98, 95-104; Hagihara et al., 2000, Gene
Ther., 7, 759-763; and Herrlinger et al., 2000, Methods Mol. Med.,
35, 287-312. AAV-mediated delivery of nucleic acid to cells of the
nervous system is further described by Kaplitt et al., U.S. Pat.
No. 6,180,613.
[0214] In another aspect of the invention, RNA molecules of the
present invention are preferably expressed from transcription units
(see for example Couture et al., 1996, TIG., 12, 510) inserted into
DNA or RNA vectors. The recombinant vectors are preferably DNA
plasmids or viral vectors. Ribozyme expressing viral vectors can be
constructed based on, but not limited to, adeno-associated virus,
retrovirus, adenovirus, or alphavirus. Preferably, the recombinant
vectors capable of expressing the nucleic acid molecules are
delivered as described above, and persist in target cells.
Alternatively, viral vectors can be used that provide for transient
expression of nucleic acid molecules. Such vectors can be
repeatedly administered as necessary. Once expressed, the nucleic
acid molecule binds to the target mRNA. Delivery of nucleic acid
molecule expressing vectors can be systemic, such as by intravenous
or intra-muscular administration, by administration to target cells
ex-planted from the patient or subject followed by reintroduction
into the patient or subject, or by any other means that would allow
for introduction into the desired target cell (for a review see
Couture et al., 1996, TIG., 12, 510).
[0215] In one aspect the invention features an expression vector
comprising a nucleic acid sequence encoding at least one of the
nucleic acid molecules of the instant invention is disclosed. The
nucleic acid sequence encoding the nucleic acid molecule of the
instant invention is operably linked in a manner which allows
expression of that nucleic acid molecule.
[0216] In another aspect the invention features an expression
vector comprising: a) a transcription initiation region (e.g.,
eukaryotic pol I, II or III initiation region); b) a transcription
termination region (e.g., eukaryotic pol I, II or III termination
region); c) a nucleic acid sequence encoding at least one of the
nucleic acid catalyst of the instant invention; and wherein said
sequence is operably linked to said initiation region and said
termination region, in a manner which allows expression and/or
delivery of said nucleic acid molecule. The vector can optionally
include an open reading frame (ORF) for a protein operably linked
on the 5' side or the 3'-side of the sequence encoding the nucleic
acid catalyst of the invention; and/or an intron (intervening
sequences).
[0217] Transcription of the nucleic acid molecule sequences are
driven from a promoter for eukaryotic RNA polymerase I (pol I), RNA
polymerase II (pol II), or RNA polymerase III (pol III).
Transcripts from pol II or pol III promoters are expressed at high
levels in all cells; the levels of a given pol II promoter in a
given cell type depends on the nature of the gene regulatory
sequences (enhancers, silencers, etc.) present nearby. Prokaryotic
RNA polymerase promoters are also used, providing that the
prokaryotic RNA polymerase enzyme is expressed in the appropriate
cells (Elroy-Stein and Moss, 1990, Proc. Natl. Acad. Sci. USA, 87,
6743-7; Gao and Huang 1993, Nucleic Acids Res., 21, 2867-72; Lieber
et al., 1993, Methods Enzymol., 217, 47-66; Zhou et al., 1990, Mol.
Cell. Biol., 10, 4529-37). All of these references are incorporated
by reference herein. Several investigators have demonstrated that
nucleic acid molecules, such as ribozymes expressed from such
promoters can function in mammalian cells (e.g. Kashani-Sabet et
al., 1992, Antisense Res. Dev., 2, 3-15; Ojwang et al., 1992, Proc.
Natl. Acad. Sci. USA, 89, 10802-6; Chen et al., 1992, Nucleic Acids
Res., 20, 4581-9; Yu et al., 1993, Proc. Natl. Acad. Sci. USA, 90,
6340-4; L'Huillier et al., 1992, EMBO J, 11, 4411-8; Lisziewicz et
al., 1993, Proc. Natl. Acad. Sci. U.S.A, 90, 8000-4; Thompson et
al., 1995, Nucleic Acids Res., 23, 2259; Sullenger & Cech,
1993, Science, 262, 1566). More specifically, transcription units
such as the ones derived from genes encoding U6 small nuclear
(snRNA), transfer RNA (tRNA) and adenovirus VA RNA are useful in
generating high concentrations of desired RNA molecules such as
ribozymes in cells (Thompson et al., supra; Couture and Stinchcomb,
1996, supra; Noonberg et al., 1994, Nucleic Acid Res., 22, 2830;
Noonberg et al., U.S. Pat. No. 5,624,803; Good et al., 1997, Gene
Ther., 4, 45; Beigelman et al., International PCT Publication No.
WO 96/18736; all of these publications are incorporated by
reference herein. The above ribozyme transcription units can be
incorporated into a variety of vectors for introduction into
mammalian cells, including but not restricted to, plasmid DNA
vectors, viral DNA vectors (such as adenovirus or adeno-associated
virus vectors), or viral RNA vectors (such as retroviral or
alphavirus vectors) (for a review see Couture and Stinchcomb, 1996,
supra).
[0218] In another aspect the invention features an expression
vector comprising nucleic acid sequence encoding at least one of
the nucleic acid molecules of the invention, in a manner which
allows expression of that nucleic acid molecule. The expression
vector comprises in one embodiment; a) a transcription initiation
region; b) a transcription termination region; c) a nucleic acid
sequence encoding at least one said nucleic acid molecule; and
wherein said sequence is operably linked to said initiation region
and said termination region, in a manner which allows expression
and/or delivery of said nucleic acid molecule.
[0219] In another embodiment the expression vector comprises: a) a
transcription initiation region; b) a transcription termination
region; c) an open reading frame; d) a nucleic acid sequence
encoding at least one said nucleic acid molecule, wherein said
sequence is operably linked to the 3'-end of said open reading
frame; and wherein said sequence is operably linked to said
initiation region, said open reading frame and said termination
region, in a manner which allows expression and/or delivery of said
nucleic acid molecule. In yet another embodiment the expression
vector comprises: a) a transcription initiation region; b) a
transcription termination region; c) an intron; d) a nucleic acid
sequence encoding at least one said nucleic acid molecule; and
wherein said sequence is operably linked to said initiation region,
said intron and said termination region, in a manner which allows
expression and/or delivery of said nucleic acid molecule.
[0220] In another embodiment, the expression vector comprises: a) a
transcription initiation region; b) a transcription termination
region; c) an intron; d) an open reading frame; e) a nucleic acid
sequence encoding at least one said nucleic acid molecule, wherein
said sequence is operably linked to the 3'-end of said open reading
frame; and wherein said sequence is operably linked to said
initiation region, said intron, said open reading frame and said
termination region, in a manner which allows expression and/or
delivery of said nucleic acid molecule.
EXAMPLES
[0221] The following are non-limiting examples showing the
selection, isolation, synthesis and activity of nucleic acids of
the instant invention.
[0222] The following examples demonstrate the selection and design
of Antisense, hammerhead, DNAzyme, NCH, Amberzyme, Zinzyme, or
G-Cleaver ribozyme molecules and binding/cleavage sites within
IKK-gamma or PKR RNA.
Example 1
Identification of Potential Target Sites in Human IKK-Gamma and PKR
RNA
[0223] The sequence of human IKK-gamma or PKR genes are screened
for accessible sites using a computer-folding algorithm. Regions of
the RNA that do not form secondary folding structures and contained
potential enzymatic nucleic acid molecule and/or antisense
binding/cleavage sites are identified. The sequences of these
binding/cleavage sites are shown in Tables III-XIII.
Example 2
Selection of Enzymatic Nucleic Acid Cleavage Sites in Human
IKK-Gamma and PKR RNA
[0224] Enzymatic nucleic acid molecule target sites are chosen by
analyzing sequences of Human IKK-gamma (Genbank accession No:
NM.sub.--003639) and PKR (Genbank accession No: NM.sub.--002759)
and prioritizing the sites on the basis of folding. Enzymatic
nucleic acid molecules are designed that can bind each target and
are individually analyzed by computer folding (Christoffersen et
al., 1994 J. Mol. Struc. Theochem, 311, 273; Jaeger et al., 1989,
Proc. Natl. Acad. Sci. USA, 86, 7706) to assess whether the
enzymatic nucleic acid molecule sequences fold into the appropriate
secondary structure. Those enzymatic nucleic acid molecules with
unfavorable intramolecular interactions between the binding arms
and the catalytic core were eliminated from consideration. As noted
below, varying binding arm lengths can be chosen to optimize
activity. Generally, at least 5 bases on each arm are able to bind
to, or otherwise interact with, the target RNA.
Example 3
Chemical Synthesis and Purification of Ribozymes and Antisense for
Efficient Cleavage and/or Blocking of IKK-Gamma and PKR RNA
[0225] Enzymatic nucleic acid molecules and antisense constructs
are designed to anneal to various sites in the RNA message. The
binding arms of the enzymatic nucleic acid molecules are
complementary to the target site sequences described above, while
the antisense constructs are fully complementary to the target site
sequences described above. The enzymatic nucleic acid molecules and
antisense constructs were chemically synthesized. The method of
synthesis used followed the procedure for normal RNA synthesis as
described above and in Usman et al., (1987 J. Am. Chem. Soc., 109,
7845), Scaringe et al., (1990 Nucleic Acids Res., 18, 5433) and
Wincott et al., supra, and made use of common nucleic acid
protecting and coupling groups, such as dimethoxytrityl at the
5'-end, and phosphoramidites at the 3'-end. The average stepwise
coupling yields were typically >98%.
[0226] Enzymatic nucleic acid molecules and antisense constructs
are also synthesized from DNA templates using bacteriophage T7 RNA
polymerase (Milligan and Uhlenbeck, 1989, Methods Enzymol. 180,
51). Enzymatic nucleic acid molecules and antisense constructs are
purified by gel electrophoresis using general methods or are
purified by high pressure liquid chromatography (HPLC; See Wincott
et al., supra; the totality of which is hereby incorporated herein
by reference) and are resuspended in water. The sequences of the
chemically synthesized enzymatic nucleic acid molecules used in
this study are shown below in Table XIII. The sequences of the
chemically synthesized antisense constructs used in this study are
complementary sequences to the Substrate sequences shown below as
in Tables III to XIII.
Example 4
Enzymatic Nucleic Acid Molecule Cleavage of IKK-Gamma and PKR RNA
Target In Vitro
[0227] Enzymatic nucleic acid molecules targeted to the human
IKK-gamma or PKR RNA are designed and synthesized as described
above. These enzymatic nucleic acid molecules can be tested for
cleavage activity in vitro, for example, using the following
procedure. The target sequences and the nucleotide location within
the IKK-gamma or PKR RNA are given in Tables III-XIII.
[0228] Cleavage Reactions: Full-length or partially full-length,
internally-labeled target RNA for enzymatic nucleic acid molecule
cleavage assay is prepared by in vitro transcription in the
presence of [a-.sup.32P] CTP, passed over a G 50 Sephadex column by
spin chromatography and used as substrate RNA without further
purification. Alternately, substrates are 5'-.sup.32P-end labeled
using T4 polynucleotide kinase enzyme. Assays are performed by
pre-warming a 2.times. concentration of purified enzymatic nucleic
acid molecule in enzymatic nucleic acid molecule cleavage buffer
(50 mM Tris-HCl, pH 7.5 at 37.degree. C., 10 mM MgCl.sub.2) and the
cleavage reaction was initiated by adding the 2.times. enzymatic
nucleic acid molecule mix to an equal volume of substrate RNA
(maximum of 1-5 nM) that was also pre-warmed in cleavage buffer. As
an initial screen, assays are carried out for 1 hour at 37.degree.
C. using a final concentration of either 40 nM or 1 mM enzymatic
nucleic acid molecule, i.e., enzymatic nucleic acid molecule
excess. The reaction is quenched by the addition of an equal volume
of 95% formamide, 20 mM EDTA, 0.05% bromophenol blue and 0.05%
xylene cyanol after which the sample is heated to 95.degree. C. for
2 minutes, quick chilled and loaded onto a denaturing
polyacrylamide gel. Substrate RNA and the specific RNA cleavage
products generated by enzymatic nucleic acid molecule cleavage are
visualized on an autoradiograph of the gel. The percentage of
cleavage is determined by Phosphor Imager.RTM. quantitation of
bands representing the intact substrate and the cleavage
products.
Example 5
Nucleic Acid Down-Regulation of IKK-Gamma and PKR Target RNA In
Vivo
[0229] Nucleic acid molecules targeted to the human IKK-gamma or
PKR RNA are designed and synthesized as described above. These
nucleic acid molecules can be tested for cleavage activity in vivo,
for example using the procedures described below. The target
sequences and the nucleotide location within the IKK-gamma or PKR
RNA are given in Tables III-XIII.
Example 6
In Vivo Models Used to Evaluate the Down-Regulation of IKK-Gamma or
PKR Gene Expression
[0230] A variety of endpoints have been used in cell culture models
to evaluate IKK-gamma or PKR-mediated effects after treatment with
anti-IKK-gamma or PKR agents. Phenotypic endpoints include
inhibition of cell proliferation, apoptosis assays and reduction of
IKK-gamma or PKR protein expression, or a decrease in NFKB
expression. Since IKK-gamma and PKR are both involved in the
induction of NFKB, NFKB can be used as a surrogate marker in cell
culture, animal, and clinical studies. Because overexpression of
NFKB is directly associated with increased proliferation of tumor
cells, a proliferation endpoint for cell culture assays is
preferably used as a primary screen. There are several methods by
which this endpoint can be measured. Following treatment of cells
with nucleic acid molecules, cells are allowed to grow (typically 5
days) after which either the cell viability, the incorporation of
[.sup.3H] thymidine into cellular DNA and/or the cell density can
be measured. The assay of cell density is very straightforward and
can be performed in a 96-well format using commercially available
fluorescent nucleic acid stains (such as Syto.RTM. 13 or
CyQuant.RTM.). An assay using CyQuant.RTM. is described herein.
[0231] As a secondary, confirmatory endpoint a nucleic
acid-mediated decrease in the level of IKK-gamma or PKR RNA and/or
IKK-gamma or PKR protein expression can be evaluated. Alternately,
a decrease in the level of NFKB RNA can be evaluated.
Cell Culture
[0232] Cell types that express/over-express NFKB include HeLa,
macrophages, peripheral blood lymphocytes, hepatocytes,
fibroblasts, endothelial cells and epithelial cells. In culture,
these cells can be stimulated to express/over-express NFKB by
addition of TNF-alpha PMA or IL-1-beta to the culture medium. Some
of these cell types also can respond with a similar activation of
NFKB following LPS treatment. Activation of NFKB in cultured cells
can be evaluated by electrophoretic mobility shift assay (EMSA).
Delineation of alterations in the subunits can be determined by
Western blot.
Primary Screen
[0233] A useful cell culture system in evaluating NFKB modulation
is human colonic epithelial cells. One suitable cell line is SW620
colon carcinoma cells (CCL227). These cells respond to stimulation
with TNF-alpha, LPS and/or IL-1-beta with an increase in NFKB
activation. SW620 cells are grown in MEM supplemented with 10%
heat-inactivated FBS and glutamine (2 mmol/L).
[0234] TNF-alpha dose-response curves in these cells are determined
by incubating cells with various concentrations of recombinant
human TNF-alpha (Sigma Chemical Co.). Maximal DNA binding activity
induction can occur with 150 U/ml TNF-alpha in the culture medium.
Induction is typically evident within 10 minutes of treatment with
TNF-alpha reaches a peak at one hour post-treatment and persists
for up to 4 hours post-treatment. The primary readout can be NFKB
DNA activity in nuclear extracts of SW620 cells as determined by
electrophoretic mobility shift assays (EMSA). Once the appropriate
TNF-alpha dose/response profile has been determined, inhibition of
IKK-gamma, PKR, or NFKB activation is evaluated using specific and
non-specific inhibitors of activation, sulfasalazine and steroids,
respectively. Cells are incubated with inhibitors or control media
for 30 minutes prior to stimulation with TNF-alpha Nuclear extracts
are prepared and evaluated for DNA binding activity by EMSA. Once
the activity of positive controls has been established, enzymatic
nucleic acids targeting the IKK-gamma or PKR are evaluated in this
system. Supershift assays using polyclonal antibodies against the
NFKB or PKR protein subunits can be performed to confirm
down-regulation of NFKB.
Secondary Screens
[0235] SW620 cells can be transfected with the
3.times.Ig-kappa-B-Luc reporter construct 18 hours before challenge
with TNF-alpha, LPS or PMA. The readout for this assay is
luciferase activity. Test compounds are applied 17.5 hours after
transfection (30 minutes before challenge). Cells are harvested 24
hours after challenge and relative changes in luciferase activity
is used as the endpoint. Lastly, the activation of NFKB can be
visualized fluorescently. Inactive NFKB heterodimers are held in
the cytoplasm by inhibitory proteins. Once activated, the free
heterodimers translocate to the nucleus. Thus, the relative change
in cytoplasmic versus nuclear fluorescence can indicate the degree
of NFKB activation. Cells can be grown on chamber slides, treated
with TNF-alpha with and without test compounds), and the location
of the NFKB subunit can be determined by immunofluorescence using a
FITC-labeled antibody to NFKB.
Animal Models
[0236] Evaluating the efficacy of anti-IKK-gamma or PKR agents in
animal models is an important prerequisite to human clinical
trials. Studies have shown that human breast carcinoma cell lines
express high levels of NFKB (Sovak et al., 1997, J. Clin. Invest.,
100, 2952-2960). High levels of NFKB have also been observed in
carcinogen-induced primary rat mammary tumors and in human breast
cancer specimins. Additionally, HER2/neu overexpression has been
shown to activate NFKB (Pianetti et al., 2001, Oncogene, 20,
1287-1299). As such, xenografts of cell lines that over-express
NFKB can be used in animal models of tumorigenesis and/or
inflammation to study the inhibition of NFKB.
Oncology Animal Model Development
[0237] Tumor cell lines are characterized to establish their growth
curves in mice. These cell lines are implanted into both nude and
SCID mice and primary tumor volumes are measured 3 times per week.
Growth characteristics of these tumor lines using a Matrigel
implantation format can also be established. The use of other cell
lines that have been engineered to express high levels of NFKB can
also be used in the described studies. The tumor cell line(s) and
implantation method that supports the most consistent and reliable
tumor growth is used in animal studies testing the lead IKK-gamma
or PKR nucleic acid(s). Nucleic acids are administered by daily
subcutaneous injection or by continuous subcutaneous infusion from
Alzet mini osmotic pumps beginning 3 days after tumor implantation
and continuing for the duration of the study. Group sizes of at
least 10 animals are employed. Efficacy is determined by
statistical comparison of tumor volume of nucleic acid-treated
animals to a control group of animals treated with saline alone.
Because the growth of these tumors is generally slow (45-60 days),
an initial endpoint is the time in days it takes to establish an
easily measurable primary tumor (i.e. 50-100 mm.sup.3) in the
presence or absence of nucleic acid treatment.
Inflammation Animal Model Development
[0238] Chronic, sublethal administration of indomethacin to outbred
rats produces an enteropathy characterized by thickening of the
small intestine and mesentery, ulcerations, granulomatous
inflammation, crypt abcesses and adhesions. These lesions are
similar to those that are characteristic findings in human patients
with Crohn's disease (CD). Thus, any beneficial therapeutic effects
revealed using this model can be extrapolated to potential benefit
for patients with CD.
[0239] Male Sprague-Dawley rats (200-275 g) are utilized for these
studies. Chronic intestinal inflammation is induced by two
subcutaneous injections of indomethacin (7.5 mg/kg in 5% NaHCO3)
administered on subsequent days (Day-0 and Day-1). Animals are
followed for four days following the first indomethacin injection.
The mortality rate associated with this model is typically less
than 10%. On the last day of the study, animals are euthanized by
CO2 asphyxiation, small intestines excised and gross pathologic
findings ranked according to the following criteria: 0, normal; 1,
minimal abnormalities, slight thickening of the small intestine, no
adhesions; 2, obvious thickening of small intestine with 1
adhesion; 3, obvious thickening of small intestine with 2 or 3
adhesions; 4, massive adhesions to the extent that the intestine
cannot be separated, contents primarily fluid; 5, severe
peritonitis resulting in death. A 10-cm portion of the most
affected region of the small intestine is weighed, placed in 10%
neutral buffered formalin and submitted for histopathologic
evaluation.
[0240] The 10 cm portion of gut from each animal is cut into five
equal sections. Transverse and longitudinal sections of each
portion are cut and stained with hematoxylin and eosin. All slides
are read in a blinded fashion and each section is scored for
necrosis (% area of involvement) and inflammatory response
according to the following scale: [0241] Necrosis--1, 10%; 2,
10-25%; 3, 25-50%; 4, 50-75%; 5, 75-100%; [0242] Inflammation--
[0243] 1=minimal in mesentery and muscle or lesion [0244] 2=mild in
mesentery and muscle or lesion [0245] 3=moderate in mesentery and
muscle or lesion [0246] 4=marked in lesion [0247] 5=severe in
lesion
[0248] The scores for each of the five sections are averaged for
necrosis and for inflammation.
NFKB Levels for Patient Screening and as a Potential Endpoint
[0249] Because elevated NFKB levels can be detected in cancers,
cancer patients can be pre-screened for elevated NFKB prior to
admission to initial clinical trials testing an anti-IKK-gamma or
PKR nucleic acid. Initial NFKB levels can be determined (by ELISA)
from tumor biopsies or resected tumor samples. During clinical
trials, it can be possible to monitor circulating NFKB protein by
ELISA. Evaluation of serial blood/serum samples over the course of
the anti-IKK-gamma or PKR nucleic acid treatment period could be
useful in determining early indications of efficacy.
Example 7
Activity of Nucleic Acid Molecules Used to Down-Regulate IKK-Gamma
and PKR Gene Expression
[0250] Several nucleic acid molecules targeted against IKK-gamma or
PKR RNA have been designed and synthesized. These nucleic acid
molecules can be tested in cell proliferation and RNA reduction
assays described herein.
Proliferation Assay
[0251] The model proliferation assay used in the study requires a
cell-plating density of 2,000-10,000 cells/well in 96-well plates
and at least 2 cell doublings over a 5-day treatment period. Cells
used in proliferation studies were either lung or ovarian cancer
cells (A549 and SKOV-3 cells respectively). To calculate cell
density for proliferation assays, the FIPS (fluoro-imaging
processing system) method known in the art was used. This method
allows for cell density measurements after nucleic acids are
stained with CyQuant.RTM. dye, and has the advantage of accurately
measuring cell densities over a very wide range 1,000-100,000
cells/well in 96-well format. Enzymatic nucleic acid molecules
(50-200 nM) are delivered in the presence of cationic lipid at
2.5-5.0 .mu.g/mL and inhibition of proliferation was determined on
day 5 post-treatment.
RNA Assay
[0252] RNA is harvested 24 hours post-treatment using the Qiagen
RNeasy.RTM. 96 procedure. Real time RT-PCR (TaqMan.RTM. assay) is
performed on purified RNA samples using separate primer/probe sets
specific for target IKK-gamma or PKR RNA.
Indications
[0253] Particular degenerative and disease states that can be
associated with IKK-gamma or PKR expression modulation include but
are not limited to cancerous and/or inflammatory diseases and
conditions such as breast, lung, prostate, colorectal, brain,
esophageal, bladder, pancreatic, cervical, head and neck, and
ovarian cancer, melanoma, lymphoma, glioma, multidrug resistant
cancers, rheumatoid arthritis, restenosis, asthma, Crohn's disease,
diabetes, obesity, autoimmune disease, lupus, multiple sclerosis,
transplant/graft rejection, gene therapy applications,
ischemia/reperfusion injury (CNS and myocardial),
glomerulonephritis, sepsis, allergic airway inflammation,
inflammatory bowel disease, infection, incontinentia pigmenti and
any other diseases or conditions that are related to or respond to
the levels of IKK-gamma or PKR in a cell or tissue. The present
body of knowledge in IKK-gamma and PKR research indicates the need
for methods to assay IKK-gamma and PKR activity and for compounds
that can regulate IKK-gamma and PKR expression for research,
diagnostic, and therapeutic use.
[0254] The use of monoclonal antibodies, chemotherapy, radiation
therapy, analgesics, and/or anti-inflammatory compounds, are all
non-limiting examples of a methods that can be combined with or
used in conjunction with the nucleic acid molecules (e.g. ribozymes
and antisense molecules) of the instant invention. Common
chemotherapies that can be combined with nucleic acid molecules of
the instant invention include various combinations of cytotoxic
drugs to kill cancer cells. These drugs include but are not limited
to paclitaxel (Taxol), docetaxel, cisplatin, methotrexate,
cyclophosphamide, doxorubin, fluorouracil carboplatin, edatrexate,
gemcitabine, vinorelbine etc. Those skilled in the art will
recognize that other drug compounds and therapies can be similarly
be readily combined with the nucleic acid molecules of the instant
invention (e.g. ribozymes and antisense molecules) are hence within
the scope of the instant invention.
Diagnostic Uses
[0255] The nucleic acid molecules of this invention (e.g.,
enzymatic nucleic acid molecules) can be used as diagnostic tools
to examine genetic drift and mutations within diseased cells or to
detect the presence of IKK-gamma or PKR RNA in a cell. The close
relationship between enzymatic nucleic acid molecule activity and
the structure of the target RNA allows the detection of mutations
in any region of the molecule which alters the base-pairing and
three-dimensional structure of the target RNA. By using multiple
enzymatic nucleic acid molecules described in this invention, one
can map nucleotide changes which are important to RNA structure and
function in vitro, as well as in cells and tissues. Cleavage of
target RNAs with enzymatic nucleic acid molecules can be used to
inhibit gene expression and define the role (essentially) of
specified gene products in the progression of disease. In this
manner, other genetic targets can be defined as important mediators
of the disease. These experiments can lead to better treatment of
the disease progression by affording the possibility of
combinational therapies (e.g., multiple enzymatic nucleic acid
molecules targeted to different genes, enzymatic nucleic acid
molecules coupled with known small molecule inhibitors, or
intermittent treatment with combinations of enzymatic nucleic acid
molecules and/or other chemical or biological molecules). Other in
vitro uses of enzymatic nucleic acid molecules of this invention
are well known in the art, and include detection of the presence of
mRNAs associated with IKK-gamma or PKR-related condition. Such RNA
is detected by determining the presence of a cleavage product after
treatment with an enzymatic nucleic acid molecule using standard
methodology.
[0256] In a specific example, enzymatic nucleic acid molecules
which cleave only wild-type or mutant forms of the target RNA are
used for the assay. The first enzymatic nucleic acid molecule is
used to identify wild-type RNA present in the sample and the second
enzymatic nucleic acid molecule is used to identify mutant RNA in
the sample. As reaction controls, synthetic substrates of both
wild-type and mutant RNA are cleaved by both enzymatic nucleic acid
molecules to demonstrate the relative enzymatic nucleic acid
molecule efficiencies in the reactions and the absence of cleavage
of the "non-targeted" RNA species. The cleavage products from the
synthetic substrates also serve to generate size markers for the
analysis of wild-type and mutant RNAs in the sample population.
Thus each analysis requires two enzymatic nucleic acid molecules,
two substrates and one unknown sample which is combined into six
reactions. The presence of cleavage products is determined using an
RNAse protection assay so that full-length and cleavage fragments
of each RNA can be analyzed in one lane of a polyacrylamide gel. It
is not absolutely required to quantify the results to gain insight
into the expression of mutant RNAs and putative risk of the desired
phenotypic changes in target cells. The expression of mRNA whose
protein product is implicated in the development of the phenotype
(i.e., IKK-gamma or PKR) is adequate to establish risk. If probes
of comparable specific activity are used for both transcripts, then
a qualitative comparison of RNA levels will be adequate and will
decrease the cost of the initial diagnosis. Higher mutant form to
wild-type ratios are correlated with higher risk whether RNA levels
are compared qualitatively or quantitatively. The use of enzymatic
nucleic acid molecules in diagnostic applications contemplated by
the instant invention is more fully described in George et al.,
U.S. Pat. Nos. 5,834,186 and 5,741,679, Shih et al., U.S. Pat. No.
5,589,332, Nathan et al., U.S. Pat. No. 5,871,914, Nathan and
Ellington, International PCT publication No. WO 00/24931, Breaker
et al., International PCT Publication Nos. WO 00/26226 and
98/27104, and Sullenger et al., International PCT publication No.
WO 99/29842.
Additional Uses
[0257] Potential uses of sequence-specific enzymatic nucleic acid
molecules of the instant invention can have many of the same
applications for the study of RNA that DNA restriction
endonucleases have for the study of DNA (Nathans et al., 1975 Ann.
Rev. Biochem. 44:273). For example, the pattern of restriction
fragments can be used to establish sequence relationships between
two related RNAs, and large RNAs can be specifically cleaved to
fragments of a size more useful for study. The ability to engineer
sequence specificity of the enzymatic nucleic acid molecule is
ideal for cleavage of RNAs of unknown sequence. Applicant has
described the use of nucleic acid molecules to down-regulate gene
expression of target genes in bacterial, microbial, fungal, viral,
and eukaryotic systems including plant, or mammalian cells.
[0258] All patents and publications mentioned in the specification
are indicative of the levels of skill of those skilled in the art
to which the invention pertains. All references cited in this
disclosure are incorporated by reference to the same extent as if
each reference had been incorporated by reference in its entirety
individually.
[0259] One skilled in the art would readily appreciate that the
present invention is well adapted to carry out the objects and
obtain the ends and advantages mentioned, as well as those inherent
therein. The methods and compositions described herein as presently
representative of preferred embodiments are exemplary and are not
intended as limitations on the scope of the invention. Changes
therein and other uses will occur to those skilled in the art,
which are encompassed within the spirit of the invention, are
defined by the scope of the claims.
[0260] It will be readily apparent to one skilled in the art that
varying substitutions and modifications can be made to the
invention disclosed herein without departing from the scope and
spirit of the invention. Thus, such additional embodiments are
within the scope of the present invention and the following
claims.
[0261] The invention illustratively described herein suitably can
be practiced in the absence of any element or elements, limitation
or limitations which is not specifically disclosed herein. Thus,
for example, in each instance herein any of the terms "comprising",
"consisting essentially of" and "consisting of" can be replaced
with either of the other two terms. The terms and expressions which
have been employed are used as terms of description and not of
limitation, and there is no intention that in the use of such terms
and expressions of excluding any equivalents of the features shown
and described or portions thereof, but it is recognized that
various modifications are possible within the scope of the
invention claimed. Thus, it should be understood that although the
present invention has been specifically disclosed by preferred
embodiments, optional features, modification and variation of the
concepts herein disclosed can be resorted to by those skilled in
the art, and that such modifications and variations are considered
to be within the scope of this invention as defined by the
description and the appended claims.
[0262] In addition, where features or aspects of the invention are
described in terms of Markush groups or other grouping of
alternatives, those skilled in the art will recognize that the
invention is also thereby described in terms of any individual
member or subgroup of members of the Markush group or other
group.
[0263] Other embodiments are within the claims that follow.
TABLE-US-00001 TABLE I Characteristics of naturally occurring
ribozymes Group I Introns Size: .about.150 to >1000 nucleotides.
Requires a U in the target sequence immediately 5' of the cleavage
site. Binds 4-6 nucleotides at the 5'-side of the cleavage site.
Reaction mechanism: attack by the 3'-OH of guanosine to generate
cleavage products with 3'-OH and 5'-guanosine. Additional protein
cofactors required in some cases to help folding and maintenance of
the active structure. Over 300 known members of this class. Found
as an intervening sequence in Tetrahymena thermophila rRNA, fungal
mitochondria, chloroplasts, phage T4, blue- green algae, and
others. Major structural features largely established through
phylogenetic comparisons, mutagenesis, and biochemical
studies[.sup.i,.sup.ii]. Complete kinetic framework established for
one ribozyme[.sup.iii,.sup.iv,.sup.v,.sup.vi]. Studies of ribozyme
folding and substrate docking underway[.sup.vii,.sup.viii,.sup.ix].
Chemical modification investigation of important residues well
established[.sup.x,.sup.xi]. The small (4-6 nt) binding site can
make this ribozyme too non-specific for targeted RNA cleavage,
however, the Tetrahymena group I intron has been used to repair a
"defective" .beta.-galactosidase message by the ligation of new
.beta.- galactosidase sequences onto the defective
message[.sup.xii]. RNAse P RNA (M1 RNA) Size: .about.290 to 400
nucleotides. RNA portion of a ubiquitous ribonucleoprotein enzyme.
Cleaves tRNA precursors to form mature tRNA[.sup.xiii]. Reaction
mechanism: possible attack by M.sup.2+-OH to generate cleavage
products with 3'-OH and 5'-phosphate. RNAse P is found throughout
the prokaryotes and eukaryotes. The RNA subunit has been sequenced
from bacteria, yeast, rodents, and primates. Recruitment of
endogenous RNAse P for therapeutic applications is possible through
hybridization of an External Guide Sequence (EGS) to the target
RNA[.sup.xiv,.sup.xv] Important phosphate and 2' OH contacts
recently identified[.sup.xvi,.sup.xvii] Group II Introns Size:
>1000 nucleotides. Trans cleavage of target RNAs recently
demonstrated[.sup.xviii,.sup.xix]. Sequence requirements not fully
determined. Reaction mechanism: 2'-OH of an internal adenosine
generates cleavage products with 3'-OH and a "lariat" RNA
containing a 3'-5' and a 2'-5' branch point. Only natural ribozyme
with demonstrated participation in DNA cleavage[.sup.xx,.sup.xxi]
in addition to RNA cleavage and ligation. Major structural features
largely established through phylogenetic comparisons[.sup.xxii].
Important 2' OH contacts beginning to be identified[.sup.xxiii]
Kinetic framework under development[.sup.xxiv] Neurospora VS RNA
Size: .about.144 nucleotides. Trans cleavage of hairpin target RNAs
recently demonstrated[.sup.xxv]. Sequence requirements not fully
determined. Reaction mechanism: attack by 2'-OH 5' to the scissile
bond to generate cleavage products with 2',3'-cyclic phosphate and
5'-OH ends. Binding sites and structural requirements not fully
determined. Only 1 known member of this class. Found in Neurospora
VS RNA. Hammerhead Ribozyme (see text for references) Size:
.about.13 to 40 nucleotides. Requires the target sequence UH
immediately 5' of the cleavage site. Binds a variable number
nucleotides on both sides of the cleavage site. Reaction mechanism:
attack by 2'-OH 5' to the scissile bond to generate cleavage
products with 2',3'-cyclic phosphate and 5'-OH ends. 14 known
members of this class. Found in a number of plant pathogens
(virusoids) that use RNA as the infectious agent. Essential
structural features largely defined, including 2 crystal
structures[.sup.xxvi,.sup.xxvii] Minimal ligation activity
demonstrated (for engineering through in vitro
selection)[.sup.xxviii] Complete kinetic framework established for
two or more ribozymes[.sup.xxix]. Chemical modification
investigation of important residues well established[.sup.xxx].
Hairpin Ribozyme Size: .about.50 nucleotides. Requires the target
sequence GUC immediately 3' of the cleavage site. Binds 4-6
nucleotides at the 5'-side of the cleavage site and a variable
number to the 3'-side of the cleavage site. Reaction mechanism:
attack by 2'-OH 5' to the scissile bond to generate cleavage
products with 2',3'-cyclic phosphate and 5'-OH ends. 3 known
members of this class. Found in three plant pathogen (satellite
RNAs of the tobacco ringspot virus, arabis mosaic virus and chicory
yellow mottle virus) which uses RNA as the infectious agent.
Essential structural features largely
defined[.sup.xxxi,.sup.xxxii,.sup.xxxiii,.sup.xxxiv] Ligation
activity (in addition to cleavage activity) makes ribozyme amenable
to engineering through in vitro selection[.sup.xxxv] Complete
kinetic framework established for one ribozyme[.sup.xxxvi].
Chemical modification investigation of important residues
begun[.sup.xxxvii,.sup.xxxviii]. Hepatitis Delta Virus (HDV)
Ribozyme Size: .about.60 nucleotides. Trans cleavage of target RNAs
demonstrated[.sup.xxxix]. Binding sites and structural requirements
not fully determined, although no sequences 5' of cleavage site are
required. Folded ribozyme contains a pseudoknot structure[.sup.xl].
Reaction mechanism: attack by 2'-OH 5' to the scissile bond to
generate cleavage products with 2',3'-cyclic phosphate and 5'-OH
ends. Only 2 known members of this class. Found in human HDV.
Circular form of HDV is active and shows increased nuclease
stability[.sup.xli] .sup.iMichel, Francois; Westhof, Eric. Slippery
substrates. Nat. Struct. Biol. (1994), 1(1), 5-7. .sup.iiLisacek,
Frederique; Diaz, Yolande; Michel, Francois. Automatic
identification of group I intron cores in genomic DNA sequences. J.
Mol. Biol. (1994), 235(4), 1206-17. .sup.iiiHerschlag, Daniel;
Cech, Thomas R.. Catalysis of RNA cleavage by the Tetrahymena
thermophila ribozyme. 1. Kinetic description of the reaction of an
RNA substrate complementary to the active site. Biochemistry
(1990), 29(44), 10159-71. .sup.ivHerschlag, Daniel; Cech, Thomas
R.. Catalysis of RNA cleavage by the Tetrahymena thermophila
ribozyme. 2. Kinetic description of the reaction of an RNA
substrate that forms a mismatch at the active site. Biochemistry
(1990), 29(44), 10172-80. .sup.vKnitt, Deborah S.; Herschlag,
Daniel. pH Dependencies of the Tetrahymena Ribozyme Reveal an
Unconventional Origin of an Apparent pKa. Biochemistry (1996),
35(5), 1560-70. .sup.viBevilacqua, Philip C.; Sugimoto, Naoki;
Turner, Douglas H.. A mechanistic framework for the second step of
splicing catalyzed by the Tetrahymena ribozyme. Biochemistry
(1996), 35(2), 648-58. .sup.viiLi, Yi; Bevilacqua, Philip C.;
Mathews, David; Turner, Douglas H.. Thermodynamic and activation
parameters for binding of a pyrene-labeled substrate by the
Tetrahymena ribozyme: docking is not diffusion-controlled and is
driven by a favorable entropy change. Biochemistry (1995), 34(44),
14394-9. .sup.viiiBanerjee, Aloke Raj; Turner, Douglas H.. The time
dependence of chemical modification reveals slow steps in the
folding of a group I ribozyme. Biochemistry (1995), 34(19),
6504-12. .sup.ixZarrinkar, Patrick P.; Williamson, James R.. The
P9.1-P9.2 peripheral extension helps guide folding of the
Tetrahymena ribozyme. Nucleic Acids Res. (1996), 24(5), 854-8.
.sup.xStrobel, Scott A.; Cech, Thomas R.. Minor groove recognition
of the conserved G.cntdot.U pair at the Tetrahymena ribozyme
reaction site. Science (Washington, D. C.) (1995), 267(5198),
675-9. .sup.xiStrobel, Scott A.; Cech, Thomas R.. Exocyclic Amine
of the Conserved G.cntdot.U Pair at the Cleavage Site of the
Tetrahymena Ribozyme Contributes to 5'-Splice Site Selection and
Transition State Stabilization. Biochemistry (1996), 35(4),
1201-11. .sup.xiiSullenger, Bruce A.; Cech, Thomas R..
Ribozyme-mediated repair of defective mRNA by targeted
trans-splicing. Nature (London) (1994), 371(6498), 619-22.
.sup.xiiiRobertson, H. D.; Altman, S.; Smith, J. D. J. Biol. Chem.,
247, 5243-5251 (1972) .sup.xivForster, Anthony C.; Altman, Sidney.
External guide sequences for an RNA enzyme. Science (Washington, D.
C., 1883-) (1990), 249(4970), 783-6. .sup.xvYuan, Y.; Hwang, E. S.;
Altman, S. Targeted cleavage of mRNA by human RNase P. Proc. Natl.
Acad. Sci. USA (1992) 89, 8006-10. .sup.xviHarris, Michael E.;
Pace, Norman R.. Identification of phosphates involved in catalysis
by the ribozyme RNase P RNA. RNA (1995), 1(2), 210-18.
.sup.xviiPan, Tao; Loria, Andrew; Zhong, Kun. Probing of tertiary
interactions in RNA: 2'-hydroxyl-base contacts between the RNase P
RNA and pre-tRNA. Proc. Natl. Acad. Sci. U.S.A. (1995), 92(26),
12510-14. .sup.xviiiPyle, Anna Marie; Green, Justin B.. Building a
Kinetic Framework for Group II Intron Ribozyme Activity:
Quantitation of Interdomain Binding and Reaction Rate. Biochemistry
(1994), 33(9), 2716-25. .sup.xixMichels, William J. Jr.; Pyle, Anna
Marie. Conversion of a Group II Intron into a New Multiple-Turnover
Ribozyme that Selectively Cleaves Oligonucleotides: Elucidation of
Reaction Mechanism and Structure/Function Relationships.
Biochemistry (1995), 34(9), 2965-77. .sup.xxZimmerly, Steven; Guo,
Huatao; Eskes, Robert; Yang, Jian; Perlman, Philip S.; Lambowitz,
Alan M.. A group II intron RNA is a catalytic component of a DNA
endonuclease involved in intron mobility. Cell (Cambridge, Mass.)
(1995), 83(4), 529-38. .sup.xxiGriffin, Edmund A., Jr.; Qin,
Zhifeng; Michels, Williams J., Jr.; Pyle, Anna Marie. Group II
intron ribozymes that cleave DNA and RNA linkages with similar
efficiency, and lack contacts with substrate 2'-hydroxyl groups.
Chem. Biol. (1995), 2(11), 761-70. .sup.xxiiMichel, Francois;
Ferat, Jean Luc. Structure and activities of group II introns.
Annu. Rev. Biochem. (1995), 64, 435-61. .sup.xxiiiAbramovitz, Dana
L.; Friedman, Richard A.; Pyle, Anna Marie. Catalytic role of
2'-hydroxyl groups within a group II intron active site. Science
(Washington, D. C.) (1996), 271(5254), 1410-13. .sup.xxivDaniels,
Danette L.; Michels, William J., Jr.; Pyle, Anna Marie. Two
competing pathways for self-splicing by group II introns: a
quantitative analysis of in vitro reaction rates and products. J.
Mol. Biol. (1996), 256(1), 31-49. .sup.xxvGuo, Hans C. T.; Collins,
Richard A.. Efficient trans-cleavage of a stem-loop RNA substrate
by a ribozyme derived from Neurospora VS RNA. EMBO J. (1995),
14(2), 368-76. .sup.xxviScott, W. G., Finch, J. T., Aaron, K. The
crystal structure of an all RNA hammerhead ribozyme:Aproposed
mechanism for RNA catalytic cleavage. Cell, (1995), 81, 991-1002.
.sup.xxviiMcKay, Structure and function of the hammerhead ribozyme:
an unfinished story. RNA, (1996), 2, 395-403. .sup.xxviiiLong, D.,
UhIenbeck, O., Hertel, K. Ligation with hammerhead ribozymes. U.S.
Pat. No. 5,633,133. .sup.xxixHertel, K. J., Herschlag, D.,
Uhlenbeck, O. A kinetic and thermodynamic framework for the
hammerhead ribozyme reaction. Biochemistry, (1994) 33, 3374-3385.
Beigelman, L., et al., Chemical modifications of hammerhead
ribozymes. J. Biol. Chem., (1995) 270, 25702-25708.
.sup.xxxBeigelman, L., et al., Chemical modifications of hammerhead
ribozymes. J. Biol. Chem., (1995) 270, 25702-25708.
.sup.xxxiHampel, Arnold; Tritz, Richard; Hicks, Margaret; Cruz,
Philip. `Hairpin` catalytic RNA model: evidence for helixes and
sequence requirement for substrate RNA. Nucleic Acids Res. (1990),
18(2), 299-304. .sup.xxxiiChowrira, Bharat M.; Berzal-Herranz,
Alfredo; Burke, John M.. Novel guanosine requirement for catalysis
by the hairpin ribozyme. Nature (London) (1991), 354(6351), 320-2.
.sup.xxxiiiBerzal-Herranz, Alfredo; Joseph, Simpson; Chowrira,
Bharat M.; Butcher, Samuel E.; Burke, John M.. Essential nucleotide
sequences and secondary structure elements of the hairpin ribozyme.
EMBO J. (1993), 12(6), 2567-73. .sup.xxxivJoseph, Simpson;
Berzal-Herranz, Alfredo; Chowrira, Bharat M.; Butcher, Samuel E..
Substrate selection rules for the hairpin ribozyme determined by in
vitro selection, mutation, and analysis of mismatched substrates.
Genes Dev. (1993), 7(1), 130-8. .sup.xxxvBerzal-Herranz, Alfredo;
Joseph, Simpson; Burke, John M.. In vitro selection of active
hairpin ribozymes by sequential RNA-catalyzed cleavage and ligation
reactions. Genes Dev. (1992), 6(1), 129-34. .sup.xxxviHegg, Lisa
A.; Fedor, Martha J.. Kinetics and Thermodynamics of Intermolecular
Catalysis by Hairpin Ribozymes. Biochemistry (1995), 34(48),
15813-28. .sup.xxxviiGrasby, Jane A.; Mersmann, Karin; Singh,
Mohinder; Gait, Michael J.. Purine Functional Groups in Essential
Residues of the Hairpin Ribozyme Required for Catalytic Cleavage of
RNA. Biochemistry (1995), 34(12), 4068-76.
.sup.xxxviiiSchmidt, Sabine; Beigelman, Leonid; Karpeisky,
Alexander; Usman, Nassim; Sorensen, Ulrik S.; Gait, Michael J..
Base and sugar requirements for RNA cleavage of essential
nucleoside residues in internal loop B of the hairpin ribozyme:
implications for secondary structure. Nucleic Acids Res. (1996),
24(4), 573-81. .sup.xxxixPerrotta, Anne T.; Been, Michael D..
Cleavage of oligoribonucleotides by a ribozyme derived from the
hepatitis delta. virus RNA sequence. Biochemistry (1992), 31(1),
16-21. .sup.xlPerrotta, Anne T.; Been, Michael D.. A
pseudoknot-like structure required for efficient self-cleavage of
hepatitis delta virus RNA. Nature (London) (1991), 350(6317),
434-6. .sup.xliPuttaraju, M.; Perrotta, Anne T.; Been, Michael D..
A circular trans-acting hepatitis delta virus ribozyme. Nucleic
Acids Res. (1993), 21(18), 4253-8.
[0264] TABLE-US-00002 TABLE II Reagent Equivalents Amount Wait
Time* DNA Wait Time* 2'-O-methyl Wait Time*RNA A. 2.5 .mu.mol
Synthesis Cycle ABI 394 Instrument Phosphoramidites 6.5 163 .mu.L
45 sec 2.5 min 7.5 min S-Ethyl Tetrazole 23.8 238 .mu.L 45 sec 2.5
min 7.5 min Acetic Anhydride 100 233 .mu.L 5 sec 5 sec 5 sec
N-Methyl 186 233 .mu.L 5 sec 5 sec 5 sec Imidazole TCA 176 2.3 mL
21 sec 21 sec 21 sec Iodine 11.2 1.7 mL 45 sec 45 sec 45 sec
Beaucage 12.9 645 .mu.L 100 sec 300 sec 300 sec Acetonitrile NA
6.67 mL NA NA NA B. 0.2 .mu.mol Synthesis Cycle ABI 394 Instrument
Phosphoramidites 15 31 .mu.L 45 sec 233 sec 465 sec S-Ethyl
Tetrazole 38.7 31 .mu.L 45 sec 233 min 465 sec Acetic Anhydride 655
124 .mu.L 5 sec 5 sec 5 sec N-Methyl 1245 124 .mu.L 5 sec 5 sec 5
sec Imidazole TCA 700 732 .mu.L 10 sec 10 sec 10 sec Iodine 20.6
244 .mu.L 15 sec 15 sec 15 sec Beaucage 7.7 232 .mu.L 100 sec 300
sec 300 sec Acetonitrile NA 2.64 mL NA NA NA C. 0.2 .mu.mol
Synthesis Cycle 96 well Instrument Equivalents: DNA/ Amount:
DNA/2'-O- Wait Time* 2'-O- Reagent 2'-O-methyl/Ribo methyl/Ribo
Wait Time* DNA methyl Wait Time* Ribo Phosphoramidites 22/33/66
40/60/120 .mu.L 60 sec 180 sec 360 sec S-Ethyl Tetrazole 70/105/210
40/60/120 .mu.L 60 sec 180 min 360 sec Acetic Anhydride 265/265/265
50/50/50 .mu.L 10 sec 10 sec 10 sec N-Methyl 502/502/502 50/50/50
.mu.L 10 sec 10 sec 10 sec Imidazole TCA 238/475/475 250/500/500
.mu.L 15 sec 15 sec 15 sec Iodine 6.8/6.8/6.8 80/80/80 .mu.L 30 sec
30 sec 30 sec Beaucage 34/51/51 80/120/120 100 sec 200 sec 200 sec
Acetonitrile NA 1150/1150/1150 .mu.L NA NA NA *Wait time does not
include contact time during delivery.
[0265] TABLE-US-00003 TABLE III Human IKK-gamma Hammerhead and
Substrate Sequence Seq Seq Pos Substrate ID Hammerhead ID 18
AUGGCCCU U GUGAUCCA 4361 UGGAUCAC CUGAUGAGGCCGUUAGGCCGAA AGGGCCAU
4555 24 CUUGUGAU C CAGGUGGG 4362 CCCACCUG CUGAUGAGGCCGUUAGGCCGAA
AUCACAAG 4556 39 GGGAAACU A AGGCCCAG 4363 CUGGGCCU
CUGAUGAGGCCGUUAGGCCGAA AGUUUCCC 4557 70 CGCAGACU A UCAAUCCC 4364
GGGAUUGA CUGAUGAGGCCGUUAGGCCGAA AGUCUGCG 4558 72 CAGACUAU C
AAUCCCAG 4365 CUGGGAUU CUGAUGAGGCCGUUAGGCCGAA AUAGUCUG 4559 76
CUAUCAAU C CCAGUCUC 4366 GAGACUGG CUGAUGAGGCCGUUAGGCCGAA AUUGAUAG
4560 82 AUCCCAGU C UCUUCCCC 4367 GGGGAAGA CUGAUGAGGCCGUUAGGCCGAA
ACUGGGAU 4561 84 CCCAGUCU C UUCCCCUC 4368 GAGGGGAA
CUGAUGAGGCCGUUAGGCCGAA AGACUGGG 4562 86 CAGUCUCU U CCCCUCAC 4369
GUGAGGGG CUGAUGAGGCCGUUAGGCCGAA AGAGACUG 4563 87 AGUCUCUU C
CCCUCACU 4370 AGUGAGGG CUGAUGAGGCCGUUAGGCCGAA AAGAGACU 4564 92
CUUCCCCU C ACUCCCUG 4371 CAGGGAGU CUGAUGAGGCCGUUAGGCCGAA AGGGGAAG
4565 96 CCCUCACU C CCUGUGAA 4372 UUCACAGG CUGAUGAGGCCGUUAGGCCGAA
AGUGAGGG 4566 108 GUGAAGCU C UCCAGCAU 4373 AUGCUGGA
CUGAUGAGGCCGUUAGGCCGAA AGCUUCAC 4567 110 GAAGCUCU C CAGCAUCA 4374
UGAUGCUG CUGAUGAGGCCGUUAGGCCGAA AGAGCUUC 4568 117 UCCAGCAU C
AUCGAGGU 4375 ACCUCGAU CUGAUGAGGCCGUUAGGCCGAA AUGCUGGA 4569 120
AGCAUCAU C GAGGUCCC 4376 GGGACCUC CUGAUGAGGCCGUUAGGCCGAA AUGAUGCU
4570 126 AUCGAGGU C CCAUCAGC 4377 GCUGAUGG CUGAUGAGGCCGUUAGGCCGAA
ACCUCGAU 4571 131 GGUCCCAU C AGCCCUUG 4378 CAAGGGCU
CUGAUGAGGCCGUUAGGCCGAA AUGGGACC 4572 138 UCAGCCCU U GCCCUGUU 4379
AACAGGGC CUGAUGAGGCCGUUAGGCCGAA AGGGCUGA 4573 146 UGCCCUGU U
GGAUGAAU 4380 AUUCAUCC CUGAUGAGGCCGUUAGGCCGAA ACAGGGCA 4574 155
GGAUGAAU A GGCACCUC 4381 GAGGUGCC CUGAUGAGGCCGUUAGGCCGAA AUUCAUCC
4575 163 AGGCACCU C UGGAAGAG 4382 CUCUUCCA CUGAUGAGGCCGUUAGGCCGAA
AGCUGCCU 4576 218 CAGCAGAU C AGGACGUA 4383 UACGUCCU
CUGAUGAGGCCGUUAGGCCGAA AUCUGCUG 4577 226 CAGGACGU A CUGGGCGA 4384
UCGCCCAG CUGAUGAGGCCGUUAGGCCGAA ACGUCCUG 4578 240 CGAAGAGU C
UCCUCUGG 4385 CCAGAGGA CUGAUGAGGCCGUUAGGCCGAA ACUCUUCG 4579 242
AAGAGUCU C CUCUGGGG 4386 CCCCAGAG CUGAUGAGGCCGUUAGGCCGAA AGACUCUU
4580 245 AGUCUCCU C UGGGGAAG 4387 CUUCCCCA CUGAUGAGGCCGUUAGGCCGAA
AGGAGACU 4581 275 ACCUGCCU U CAGAACAG 4388 CUGUUCUG
CUGAUGAGGCCGUUAGGCCGAA AGGCAGGU 4582 276 CCUGCCUU C AGAACAGG 4389
CCUGUUCU CUGAUGAGGCCGUUAGGCCGAA AAGGCAGG 4583 290 AGGGCGCU C
CUGAGACC 4390 GGUCUCAG CUGAUGAGGCCGUUAGGCCGAA AGCGCCCU 4584 301
GAGACCCU C CAGCGCUG 4391 CAGCGCUG CUGAUGAGGCCGUUAGGCCGAA AGGGUCUC
4585 323 AGGAGAAU C AAGAGCUC 4392 GAGCUCUU CUGAUGAGGCCGUUAGGCCGAA
AUUCUCCU 4586 331 CAAGAGCU C CGAGAUGC 4393 GCAUCUCG
CUGAUGAGGCCGUUAGGCCGAA AGCUCUUG 4587 343 GAUGCCAU C CGGCAGAG 4394
CUCUGCCG CUGAUGAGGCCGUUAGGCCGAA AUGGCAUC 4588 361 AACCAGAU U
CUGCGGGA 4395 UCCCGCAG CUGAUGAGGCCGUUAGGCCGAA AUCUGGUU 4589 362
ACCAGAUU C UGCGGGAG 4396 CUCCCGCA CUGAUGAGGCCGUUAGGCCGAA AAUCUGGU
4590 385 GAGGAGCU U CUGCAUUU 4397 AAAUGCAG CUGAUGAGGCCGUUAGGCCGAA
AGCUCCUC 4591 386 AGGAGCUU C UGCAUUUC 4398 GAAAUGCA
CUGAUGAGGCCGUUAGGCCGAA AAGCUCCU 4592 392 UUCUGCAU U UCCAAGCC 4399
GGCUUGGA CUGAUGAGGCCGUUAGGCCGAA AUGCAGAA 4593 393 UCUGCAUU U
CCAAGCCA 4400 UGGCUUGG CUGAUGAGGCCGUUAGGCCGAA AAUGCAGA 4594 394
CUGCAUUU C CAAGCCAG 4401 CUGGCUUG CUGAUGAGGCCGUUAGGCCGAA AAAUGCAG
4595 423 GAAGGAGU U CCUCAUGU 4402 ACAUGAGG CUGAUGAGGCCGUUAGGCCGAA
ACUCCUUC 4596 424 AAGGAGUU C CUCAUGUG 4403 CACAUGAG
CUGAUGAGGCCGUUAGGCCGAA AACUCCUU 4597 427 GAGUUCCU C AUGUGCAA 4404
UUGCACAU CUGAUGAGGCCGUUAGGCCGAA AGGAACUC 4598 438 GUGCAAGU U
CCAGGAGG 4405 CCUCCUGG CUGAUGAGGCCGUUAGGCCGAA ACUUGCAC 4599 439
UGCAAGUU C CAGGAGGC 4406 GCCUCCUG CUGAUGAGGCCGUUAGGCCGAA AACUUGCA
4600 469 GAGAGACU C GGCCUGGA 4407 UCCAGGCC CUGAUGAGGCCGUUAGGCCGAA
AGUCUCUC 4601 484 GAGAAGCU C GAUCUGAA 4408 UUCAGAUC
CUGAUGAGGCCGUUAGGCCGAA AGCUUCUC 4602 488 AGCUCGAU C UGAAGAGG 4409
CCUCUUCA CUGAUGAGGCCGUUAGGCCGAA AUCGAGCU 4603 512 AGCAGGCU C
UGCGGGAG 4410 CUCCCGCA CUGAUGAGGCCGUUAGGCCGAA AGCCUGCU 4604 570
CAAGGCCU C UGUGAAAG 4411 CUUUCACA CUGAUGAGGCCGUUAGGCCGAA AGGCCUUG
4605 591 GGUGACGU C CUUGCUCG 4412 CGAGCAAG CUGAUGAGGCCGUUAGGCCGAA
ACGUCACC 4606 594 GACGUCCU U GCUCGGGG 4413 CCCCGAGC
CUGAUGAGGCCGUUAGGCCGAA AGGACGUC 4607 598 UCCUUGCU C GGGGAGCU 4414
AGCUCCCC CUGAUGAGGCCGUUAGGCCGAA AGCAAGGA 4608 623 GCCAGAGU C
GCUUGGAG 4415 CUCCAAGC CUGAUGAGGCCGUUAGGCCGAA ACUCUGGC 4609 627
GAGUCGCU U GGAGGCUG 4416 CAGCCUCC CUGAUGAGGCCGUUAGGCCGAA AGCGACUC
4610 641 CUGCCACU A AGGAAUGC 4417 GCAUUCCU CUGAUGAGGCCGUUAGGCCGAA
AGUGGCAG 4611 656 GCCAGGCU C UGGAGGGU 4418 ACCCUCCA
CUGAUGAGGCCGUUAGGCCGAA AGCCUGGC 4612 665 UGGAGGGU C GGGCCCGG 4419
CCGGGCCC CUGAUGAGGCCGUUAGGCCGAA ACCCUCCA 4613 787 GCCGCGCU C
CGCAUGGA 4420 UCCAUGCG CUGAUGAGGCCGUUAGGCCGAA AGCGCGGC 4614 810
GGCCGCCU C GGAGGAGA 4421 UCUCCUCC CUGAUGAGGCCGUUAGGCCGAA AGGCGGCC
4615 837 GGCCCAGU U GCAGGUGG 4422 CCACCUGC CUGAUGAGGCCGUUAGGCCGAA
ACUGGGCC 4616 849 GGUGGCCU A UCACCAGC 4423 GCUGGUGA
CUGAUGAGGCCGUUAGGCCGAA AGGCCACC 4617 851 UGGCCUAU C ACCAGCUC 4424
GAGCUGGU CUGAUGAGGCCGUUAGGCCGAA AUAGGCCA 4618 859 CACCAGCU C
UUCCAAGA 4425 UCUUGGAA CUGAUGAGGCCGUUAGGCCGAA AGCUGGUG 4619 861
CCAGCUCU U CCAAGAAU 4426 AUUCUUGG CUGAUGAGGCCGUUAGGCCGAA AGAGCUGG
4620 862 CAGCUCUU C CAAGAAUA 4427 UAUUCUUG CUGAUGAGGCCGUUAGGCCGAA
AAGAGCUG 4621 870 CCAAGAAU A CGACAACC 4428 GGUUGUCG
CUGAUGAGGCCGUUAGGCCGAA AUUCUUGG 4622 883 AACCACAU C AAGAGCAG 4429
CUGCUCUU CUGAUGAGGCCGUUAGGCCGAA AUGUGGUU 4623 935 UGGAAGAU C
UCAAACAG 4430 CUGUUUGA CUGAUGAGGCCGUUAGGCCGAA AUCUUCCA 4624 937
GAAGAUCU C AAACAGCA 4431 UGCUGUUU CUGAUGAGGCCGUUAGGCCGAA AGAUCUUC
4625 949 CAGCAGCU C CAGCAGGC 4432 GCCUGCUG CUGAUGAGGCCGUUAGGCCGAA
AGCUGCUG 4626 991 GAGGUGAU C GAUAAGCU 4433 AGCUUAUC
CUGAUGAGGCCGUUAGGCCGAA AUCACCUC 4627 995 UGAUCGAU A AGCUGAAG 4434
CUUCAGCU CUGAUGAGGCCGUUAGGCCGAA AUCGAUCA 4628 1027 CACAAGAU U
GUGAUGGA 4435 UCCAUCAC CUGAUGAGGCCGUUAGGCCGAA AUCUUGUG 4629 1042
GAGACCGU U CCGGUGCU 4436 AGCACCGG CUGAUGAGGCCGUUAGGCCGAA ACGGUCUC
4630 1043 AGACCGUU C CGGUGCUG 4437 CAGCACCG CUGAUGAGGCCGUUAGGCCGAA
AACGGUCU 4631 1067 AGGCGGAU A UCUACAAG 4438 CUUGUAGA
CUGAUGAGGCCGUUAGGCCGAA AUCCGCCU 4632 1069 GCGGAUAU C UACAAGGC 4439
GCCUUGUA CUGAUGAGGCCGUUAGGCCGAA AUAUCCGC 4633 1071 GGAUAUCU A
CAAGGCGG 4440 CCGCCUUG CUGAUGAGGCCGUUAGGCCGAA AGAUAUCC 4634 1083
GGCGGACU U CCAGGCUG 4441 CAGCCUGG CUGAUGAGGCCGUUAGGCCGAA AGUCCGCC
4635 1084 GCGGACUU C CAGGCUGA 4442 UCAGCCUG CUGAUGAGGCCGUUAGGCCGAA
AAGUCCGC 4636 1132 AAGGAGCU C CUGCAGGA 4443 UCCUGCAG
CUGAUGAGGCCGUUAGGCCGAA AGCUCCUU 4637 1167 GAGGGAGU A CAGCAAAC 4444
GUUUGCUG CUGAUGAGGCCGUUAGGCCGAA ACUCCCUC 4638 1190 CCAGCUGU C
AGGAGUCG 4445 CGACUCCU CUGAUGAGGCCGUUAGGCCGAA ACAGCUGG 4639
1197 UCAGGAGU C GGCCAGGA 4446 UCCUGGCC CUGAUGAGGCCGUUAGGCCGAA
ACUCCUGA 4640 1207 GCCAGGAU C GAGGACAU 4447 AUGUCCUC
CUGAUGAGGCCGUUAGGCCGAA AUCCUGGC 4641 1231 CGGCAUGU C GAGGUCUC 4448
GAGACCUC CUGAUGAGGCCGUUAGGCCGAA ACAUGCCG 4642 1237 GUCGAGGU C
UCCCAGGC 4449 GCCUGGGA CUGAUGAGGCCGUUAGGCCGAA ACCUCGAC 4643 1239
CGAGGUCU C CCAGGCCC 4450 GGGCCUGG CUGAUGAGGCCGUUAGGCCGAA AGACCUCG
4644 1251 GGCCCCCU U GCCCCCCG 4451 CGGGGGGC CUGAUGAGGCCGUUAGGCCGAA
AGGGGGCC 4645 1269 CCCUGCCU A CCUCUCCU 4452 AGGAGAGG
CUGAUGAGGCCGUUAGGCCGAA AGGCAGGG 4646 1273 GCCUACCU C UCCUCUCC 4453
GGAGAGGA CUGAUGAGGCCGUUAGGCCGAA AGGUAGGC 4647 1275 CUACCUCU C
CUCUCCCC 4454 GGGGAGAG CUGAUGAGGCCGUUAGGCCGAA AGAGGUAG 4648 1278
CCUCUCCU C UCCCCUGG 4455 CCAGGGGA CUGAUGAGGCCGUUAGGCCGAA AGGAGAGG
4649 1280 UCUCCUCU C CCCUGGCC 4456 GGCCAGGG CUGAUGAGGCCGUUAGGCCGAA
AGAGGAGA 4650 1332 ACCUGACU U CUGCUGUC 4457 GACAGCAG
CUGAUGAGGCCGUUAGGCCGAA AGUCAGGU 4651 1333 CCUGACUU C UGCUGUCC 4458
GGACAGCA CUGAUGAGGCCGUUAGGCCGAA AAGUCAGG 4652 1340 UCUGCUGU C
CCAAGUGC 4459 GCACUUGG CUGAUGAGGCCGUUAGGCCGAA ACAGCAGA 4653 1353
GUGCCAGU A UCAGGCCC 4460 GGGCCUGA CUGAUGAGGCCGUUAGGCCGAA ACUGGCAC
4654 1355 GCCAGUAU C AGGCCCCU 4461 AGGGGCCU CUGAUGAGGCCGUUAGGCCGAA
AUACUGGC 4655 1367 CCCCUGAU A UGGACACC 4462 GGUGUCCA
CUGAUGAGGCCGUUAGGCCGAA AUCAGGGG 4656 1384 CUGCAGAU A CAUGUCAU 4463
AUGACAUG CUGAUGAGGCCGUUAGGCCGAA AUCUGCAG 4657 1390 AUACAUGU C
AUGGAGUG 4464 CACUCCAU CUGAUGAGGCCGUUAGGCCGAA ACAUGUAU 4658 1402
GAGUGCAU U GAGUAGGG 4465 CCCUACUC CUGAUGAGGCCGUUAGGCCGAA AUGCACUC
4659 1407 CAUUGAGU A GGGCCGGC 4466 GCCGGCCC CUGAUGAGGCCGUUAGGCCGAA
ACUCAAUG 4660 1464 CGUGCAGU C UGCGCUUU 4467 AAAGCGCA
CUGAUGAGGCCGUUAGGCCGAA ACUGCACG 4661 1471 UCUGCGCU U UCCUCUCC 4468
GGAGAGGA CUGAUGAGGCCGUUAGGCCGAA AGCGCAGA 4662 1472 CUGCGCUU U
CCUCUCCC 4469 GGGAGAGG CUGAUGAGGCCGUUAGGCCGAA AAGCGCAG 4663 1473
UGCGCUUU C CUCUCCCG 4470 CGGGAGAG CUGAUGAGGCCGUUAGGCCGAA AAAGCGCA
4664 1476 GCUUUCCU C UCCCGCCU 4471 AGGCGGGA CUGAUGAGGCCGUUAGGCCGAA
AGGAAAGC 4665 1478 UUUCCUCU C CCGCCUGC 4472 GCAGGCGG
CUGAUGAGGCCGUUAGGCCGAA AGAGGAAA 4666 1489 GCCUGCCU A GCCCAGGA 4473
UCCUGGGC CUGAUGAGGCCGUUAGGCCGAA AGGCAGGC 4667 1565 CGGCACCU U
ACGCUUCA 4474 UGAAGCGU CUGAUGAGGCCGUUAGGCCGAA AGGUGCCG 4668 1566
GGCACCUU A CGCUUCAG 4475 CUGAAGCG CUGAUGAGGCCGUUAGGCCGAA AAGGUGCC
4669 1571 CUUACGCU U CAGCUGUU 4476 AACAGCUG CUGAUGAGGCCGUUAGGCCGAA
AGCGUAAG 4670 1572 UUACGCUU C AGCUGUUG 4477 CAACAGCU
CUGAUGAGGCCGUUAGGCCGAA AAGCGUAA 4671 1579 UCAGCUGU U GAUCCGCU 4478
AGCGGAUC CUGAUGAGGCCGUUAGGCCGAA ACAGCUGA 4672 1583 CUGUUGAU C
CGCUGGUC 4479 GACCAGCG CUGAUGAGGCCGUUAGGCCGAA AUCAACAG 4673 1591
CCGCUGGU C CCCUCUUU 4480 AAAGAGGG CUGAUGAGGCCGUUAGGCCGAA ACCAGCGG
4674 1596 GGUCCCCU C UUUUGGGG 4481 CCCCAAAA CUGAUGAGGCCGUUAGGCCGAA
AGGGGACC 4675 1598 UCCCCUCU U UUGGGGUA 4482 UACCCCAA
CUGAUGAGGCCGUUAGGCCGAA AGAGGGGA 4676 1599 CCCCUCUU U UGGGGUAG 4483
CUACCCCA CUGAUGAGGCCGUUAGGCCGAA AAGAGGGG 4677 1600 CCCUCUUU U
GGGGUAGA 4484 UCUACCCC CUGAUGAGGCCGUUAGGCCGAA AAAGAGGG 4678 1606
UUUGGGGU A GAUGCGGC 4485 GCCGCAUC CUGAUGAGGCCGUUAGGCCGAA ACCCCAAA
4679 1621 GCCCCGAU C AGGCCUGA 4486 UCAGGCCU CUGAUGAGGCCGUUAGGCCGAA
AUCGGGGC 4680 1632 GCCUGACU C GCUGCUCU 4487 AGAGCAGC
CUGAUGAGGCCGUUAGGCCGAA AGUCAGGC 4681 1639 UCGCUGCU C UUUUUGUU 4488
AACAAAAA CUGAUGAGGCCGUUAGGCCGAA AGCAGCGA 4682 1641 GCUGCUCU U
UUUGUUCC 4489 GGAACAAA CUGAUGAGGCCGUUAGGCCGAA AGAGCAGC 4683 1642
CUGCUCUU U UUGUUCCC 4490 GGGAACAA CUGAUGAGGCCGUUAGGCCGAA AAGAGCAG
4684 1643 UGCUCUUU U UGUUCCCU 4491 AGGGAACA CUGAUGAGGCCGUUAGGCCGAA
AAAGAGCA 4685 1644 GCUCUUUU U GUUCCCUU 4492 AAGGGAAC
CUGAUGAGGCCGUUAGGCCGAA AAAAGAGC 4686 1647 CUUUUUGU U CCCUUCUG 4493
CAGAAGGG CUGAUGAGGCCGUUAGGCCGAA ACAAAAAG 4687 1648 UUUUUGUU C
CCUUCUGU 4494 ACAGAAGG CUGAUGAGGCCGUUAGGCCGAA AACAAAAA 4688 1652
UGUUCCCU U CUGUCUGC 4495 GCAGACAG CUGAUGAGGCCGUUAGGCCGAA AGGGAACA
4689 1653 GUUCCCUU C UGUCUGCU 4496 AGCAGACA CUGAUGAGGCCGUUAGGCCGAA
AAGGGAAC 4690 1657 CCUUCUGU C UGCUCGAA 4497 UUCGAGCA
CUGAUGAGGCCGUUAGGCCGAA ACAGAAGG 4691 1662 UGUCUGCU C GAACCACU 4498
AGUGGUUC CUGAUGAGGCCGUUAGGCCGAA AGCAGACA 4692 1671 GAACCACU U
GCCUCGGG 4499 CCCGAGGC CUGAUGAGGCCGUUAGGCCGAA AGUGGUUC 4693 1676
ACUUGCCU C GGGCUAAU 4500 AUUAGCCC CUGAUGAGGCCGUUAGGCCGAA AGGCAAGU
4694 1682 CUCGGGCU A AUCCCUCC 4501 GGAGGGAU CUGAUGAGGCCGUUAGGCCGAA
AGCCCGAG 4695 1685 GGGCUAAU C CCUCCCUC 4502 GAGGGAGG
CUGAUGAGGCCGUUAGGCCGAA AUUAGCCC 4696 1689 UAAUCCCU C CCUCUUCC 4503
GGAAGAGG CUGAUGAGGCCGUUAGGCCGAA AGGGAUUA 4697 1693 CCCUCCCU C
UUCCUCCA 4504 UGGAGGAA CUGAUGAGGCCGUUAGGCCGAA AGGGAGGG 4698 1695
CUCCCUCU U CCUCCACC 4505 GGUGGAGG CUGAUGAGGCCGUUAGGCCGAA AGAGGGAG
4699 1696 UCCCUCUU C CUCCACCC 4506 GGGUGGAG CUGAUGAGGCCGUUAGGCCGAA
AAGAGGGA 4700 1699 CUCUUCCU C CACCCGGC 4507 GCCGGGUG
CUGAUGAGGCCGUUAGGCCGAA AGGAAGAG 4701 1719 GGGGAAGU C AAGAAUGG 4508
CCAUUCUU CUGAUGAGGCCGUUAGGCCGAA ACUUCCCC 4702 1739 CUGGGGCU C
UCAGGGAG 4509 CUCCCUGA CUGAUGAGGCCGUUAGGCCGAA AGCCCCAG 4703 1741
GGGGCUCU C AGGGAGAA 4510 UUCUCCCU CUGAUGAGGCCGUUAGGCCGAA AGAGCCCC
4704 1755 GAACUGCU U CCCCUGGC 4511 GCCAGGGG CUGAUGAGGCCGUUAGGCCGAA
AGCAGUUC 4705 1756 AACUGCUU C CCCUGGCA 4512 UGCCAGGG
CUGAUGAGGCCGUUAGGCCGAA AAGCAGUU 4706 1781 UGGCAGCU C UUCCUCCC 4513
GGGAGGAA CUGAUGAGGCCGUUAGGCCGAA AGCUGCCA 4707 1783 GCAGCUCU U
CCUCCCAC 4514 GUGGGAGG CUGAUGAGGCCGUUAGGCCGAA AGAGCUGC 4708 1784
CAGCUCUU C CUCCCACC 4515 GGUGGGAG CUGAUGAGGCCGUUAGGCCGAA AAGAGCUG
4709 1787 CUCUUCCU C CCACCGGA 4516 UCCGGUGG CUGAUGAGGCCGUUAGGCCGAA
AGGAAGAG 4710 1836 GCUGCCCU C UUACCAUG 4517 CAUGGUAA
CUGAUGAGGCCGUUAGGCCGAA AGGGCAGC 4711 1838 UGCCCUCU U ACCAUGCA 4518
UGCAUGGU CUGAUGAGGCCGUUAGGCCGAA AGAGGGCA 4712 1839 GCCCUCUU A
CCAUGCAC 4519 GUGCAUGG CUGAUGAGGCCGUUAGGCCGAA AAGAGGGC 4713 1857
CGGGUGCU C UCCUUUUG 4520 CAAAAGGA CUGAUGAGGCCGUUAGGCCGAA AGCACCCG
4714 1859 GGUGCUCU C CUUUUGGG 4521 CCCAAAAG CUGAUGAGGCCGUUAGGCCGAA
AGAGCACC 4715 1862 GCUCUCCU U UUGGGCUG 4522 CAGCCCAA
CUGAUGAGGCCGUUAGGCCGAA AGGAGAGC 4716 1863 CUCUCCUU U UGGGCUGC 4523
GCAGCCCA CUGAUGAGGCCGUUAGGCCGAA AAGGAGAG 4717 1864 UCUCCUUU U
GGGCUGCA 4524 UGCAGCCC CUGAUGAGGCCGUUAGGCCGAA AAAGGAGA 4718 1877
UGCAUGCU A UUCCAUUU 4525 AAAUGGAA CUGAUGAGGCCGUUAGGCCGAA AGCAUGCA
4719 1879 CAUGCUAU U CCAUUUUG 4526 CAAAAUGG CUGAUGAGGCCGUUAGGCCGAA
AUAGCAUG 4720 1880 AUGCUAUU C CAUUUUGC 4527 GCAAAAUG
CUGAUGAGGCCGUUAGGCCGAA AAUAGCAU 4721 1884 UAUUCCAU U UUGCAGCC 4528
GGCUGCAA CUGAUGAGGCCGUUAGGCCGAA AUGGAAUA 4722 1885 AUUCCAUU U
UGCAGCCA 4529 UGGCUGCA CUGAUGAGGCCGUUAGGCCGAA AAUGGAAU
4723 1886 UUCCAUUU U GCAGCCAG 4530 CUGGCUGC CUGAUGAGGCCGUUAGGCCGAA
AAAUGGAA 4724 1905 CGAUGUGU A UUUAACCA 4531 UGGUUAAA
CUGAUGAGGCCGUUAGGCCGAA ACACAUCG 4725 1907 AUGUGUAU U UAACCAGU 4532
ACUGGUUA CUGAUGAGGCCGUUAGGCCGAA AUACACAU 4726 1908 UGUGUAUU U
AACCAGUC 4533 GACUGGUU CUGAUGAGGCCGUUAGGCCGAA AAUACACA 4727 1909
GUGUAUUU A ACCAGUCA 4534 UGACUGGU CUGAUGAGGCCGUUAGGCCGAA AAAUACAC
4728 1916 UAACCAGU C ACUAUUGA 4535 UCAAUAGU CUGAUGAGGCCGUUAGGCCGAA
ACUGGUUA 4729 1920 CAGUCACU A UUGAUGGA 4536 UCCAUCAA
CUGAUGAGGCCGUUAGGCCGAA AGUGACUG 4730 1922 GUCACUAU U GAUGGACA 4537
UGUCCAUC CUGAUGAGGCCGUUAGGCCGAA AUAGUGAC 4731 1932 AUGGACAU U
UGGGUUGU 4538 ACAACCCA CUGAUGAGGCCGUUAGGCCGAA AUGUCCAU 4732 1933
UGGACAUU U GGGUUGUU 4539 AACAACCC CUGAUGAGGCCGUUAGGCCGAA AAUGUCCA
4733 1938 AUUUGGGU U GUUUCCCA 4540 UGGGAAAC CUGAUGAGGCCGUUAGGCCGAA
ACCCAAAU 4734 1941 UGGGUUGU U UCCCAUCU 4541 AGAUGGGA
CUGAUGAGGCCGUUAGGCCGAA ACAACCCA 4735 1942 GGGUUGUU U CCCAUCUU 4542
AAGAUGGG CUGAUGAGGCCGUUAGGCCGAA AACAACCC 4736 1943 GGUUGUUU C
CCAUCUUU 4543 AAAGAUGG CUGAUGAGGCCGUUAGGCCGAA AAACAACC 4737 1948
UUUCCCAU C UUUUUGUU 4544 AACAAAAA CUGAUGAGGCCGUUAGGCCGAA AUGGGAAA
4738 1950 UCCCAUCU U UUUGUUAC 4545 GUAACAAA CUGAUGAGGCCGUUAGGCCGAA
AGAUGGGA 4739 1951 CCCAUCUU U UUGUUACC 4546 GGUAACAA
CUGAUGAGGCCGUUAGGCCGAA AAGAUGGG 4740 1952 CCAUCUUU U UGUUACCA 4547
UGGUAACA CUGAUGAGGCCGUUAGGCCGAA AAAGAUGG 4741 1953 CAUCUUUU U
GUUACCAU 4548 AUGGUAAC CUGAUGAGGCCGUUAGGCCGAA AAAAGAUG 4742 1956
CUUUUUGU U ACCAUAAA 4549 UUUAUGGU CUGAUGAGGCCGUUAGGCCGAA ACAAAAAG
4743 1957 UUUUUGUU A CCAUAAAU 4550 AUUUAUGG CUGAUGAGGCCGUUAGGCCGAA
AACAAAAA 4744 1962 GUUACCAU A AAUAAUGG 4551 CCAUUAUU
CUGAUGAGGCCGUUAGGCCGAA AUGGUAAC 4745 1966 CCAUAAAU A AUGGCAUA 4552
UAUGCCAU CUGAUGAGGCCGUUAGGCCGAA AUUUAUGG 4746 1974 AAUGGCAU A
GUAAAAAA 4553 UUUUUUAC CUGAUGAGGCCGUUAGGCCGAA AUGCCAUU 4747 1977
GGCAUAGU A AAAAAAAA 4554 UUUUUUUU CUGAUGAGGCCGUUAGGCCGAA ACUAUGCC
4748 Input Sequence = NM_003639. Cut Site = UH/. Arm Length = 8.
Core Sequence = CUGAUGAG GCCGUUAGGC CGAA NM_003639 (Homo sapiens
inhibitor of kappa light polypeptide gene enhancer in B-cells,
kinase gamma (IKBKG), mRNA.; 1994 bp) Underlined region can be any
X sequence or linker, as described herein.
[0266] TABLE-US-00004 TABLE IV Human IKK-gamma Inozyme and
Substrate Sequence Seq Seq Pos Substrate ID Inozyme ID 10 GCACGAGC
A UGGCCCUU 4749 AAGGGCCA CUGAUGAGGCCGUUAGGCCGAA ICUCGUGC 5253 15
AGCAUGGC C CUUGUGAU 4750 AUCACAAG CUGAUGAGGCCGUUAGGCCGAA ICCAUGCU
5254 16 GCAUGGCC C UUGUGAUC 4751 GAUCACAA CUGAUGAGGCCGUUAGGCCGAA
IGCCAUGC 5255 17 CAUGGCCC U UGUGAUCC 4752 GGAUCACA
CUGAUGAGGCCGUUAGGCCGAA IGGCCAUG 5256 25 UUGUGAUC C AGGUGGGG 4753
CCCCACCU CUGAUGAGGCCGUUAGGCCGAA IAUCACAA 5257 26 UGUGAUCC A
GGUGGGGA 4754 UCCCCACC CUGAUGAGGCCGUUAGGCCGAA IGAUCACA 5258 38
GGGGAAAC U AAGGCCCA 4755 UGGGCCUU CUGAUGAGGCCGUUAGGCCGAA IUUUCCCC
5259 44 ACUAAGGC C CAGAGAAG 4756 CUUCUCUG CUGAUGAGGCCGUUAGGCCGAA
ICCUUAGU 5260 45 CUAAGGCC C AGAGAAGU 4757 ACUUCUCU
CUGAUGAGGCCGUUAGGCCGAA IGCCUUAG 5261 46 UAAGGCCC A GAGAAGUG 4758
CACUUCUC CUGAUGAGGCCGUUAGGCCGAA IGGCCUUA 5262 60 GUGAGGAC C
CCGCAGAC 4759 GUCUGCGG CUGAUGAGGCCGUUAGGCCGAA IUCCUCAC 5263 61
UGAGGACC C CGCAGACU 4760 AGUCUGCG CUGAUGAGGCCGUUAGGCCGAA IGUCCUCA
5264 62 GAGGACCC C GCAGACUA 4761 UAGUCUGC CUGAUGAGGCCGUUAGGCCGAA
IGGUCCUC 5265 65 GACCCCGC A GACUAUCA 4762 UGAUAGUC
CUGAUGAGGCCGUUAGGCCGAA ICGGGGUC 5266 69 CCGCAGAC U AUCAAUCC 4763
GGAUUGAU CUGAUGAGGCCGUUAGGCCGAA IUCUGCGG 5267 73 AGACUAUC A
AUCCCAGU 4764 ACUGGGAU CUGAUGAGGCCGUUAGGCCGAA IAUAGUCU 5268 77
UAUCAAUC C CAGUCUCU 4765 AGAGACUG CUGAUGAGGCCGUUAGGCCGAA IAUUGAUA
5269 78 AUCAAUCC C AGUCUCUU 4766 AAGAGACU CUGAUGAGGCCGUUAGGCCGAA
IGAUUGAU 5270 79 UCAAUCCC A GUCUCUUC 4767 GAAGAGAC
CUGAUGAGGCCGUUAGGCCGAA IGGAUUGA 5271 83 UCCCAGUC U CUUCCCCU 4768
AGGGGAAG CUGAUGAGGCCGUUAGGCCGAA IACUGGGA 5272 85 CCAGUCUC U
UCCCCUCA 4769 UGAGGGGA CUGAUGAGGCCGUUAGGCCGAA IAGACUGG 5273 88
GUCUCUUC C CCUCACUC 4770 GAGUGAGG CUGAUGAGGCCGUUAGGCCGAA IAAGAGAC
5274 89 UCUCUUCC C CUCACUCC 4771 GGAGUGAG CUGAUGAGGCCGUUAGGCCGAA
IGAAGAGA 5275 90 CUCUUCCC C UCACUCCC 4772 GGGAGUGA
CUGAUGAGGCCGUUAGGCCGAA IGGAAGAG 5276 91 UCUUCCCC U CACUCCCU 4773
AGGGAGUG CUGAUGAGGCCGUUAGGCCGAA IGGGAAGA 5277 93 UUCCCCUC A
CUCCCUGU 4774 ACAGGGAG CUGAUGAGGCCGUUAGGCCGAA IAGGGGAA 5278 95
CCCCUCAC U CCCUGUGA 4775 UCACAGGG CUGAUGAGGCCGUUAGGCCGAA IUGAGGGG
5279 97 CCUCACUC C CUGUGAAG 4776 CUUCACAG CUGAUGAGGCCGUUAGGCCGAA
IAGUGAGG 5280 98 CUCACUCC C UGUGAAGC 4777 GCUUCACA
CUGAUGAGGCCGUUAGGCCGAA IGAGUGAG 5281 99 UCACUCCC U GUGAAGCU 4778
AGCUUCAC CUGAUGAGGCCGUUAGGCCGAA IGGAGUGA 5282 107 UGUGAAGC U
CUCCAGCA 4779 UGCUGGAG CUGAUGAGGCCGUUAGGCCGAA ICUUCACA 5283 109
UGAAGCUC U CCAGCAUC 4780 GAUGCUGG CUGAUGAGGCCGUUAGGCCGAA IAGCUUCA
5284 111 AAGCUCUC C AGCAUCAU 4781 AUGAUGCU CUGAUGAGGCCGUUAGGCCGAA
IAGAGCUU 5285 112 AGCUCUCC A GCAUCAUC 4782 GAUGAUGC
CUGAUGAGGCCGUUAGGCCGAA IGAGAGCU 5286 115 UCUCCAGC A UCAUCGAG 4783
CUCGAUGA CUGAUGAGGCCGUUAGGCCGAA ICUGGAGA 5287 118 CCAGCAUC A
UCGAGGUC 4784 GACCUCGA CUGAUGAGGCCGUUAGGCCGAA IAUGCUGG 5288 127
UCGAGGUC C CAUCAGCC 4785 GGCUGAUG CUGAUGAGGCCGUUAGGCCGAA IACCUCGA
5289 128 CGAGGUCC C AUCAGCCC 4786 GGGCUGAU CUGAUGAGGCCGUUAGGCCGAA
IGACCUCG 5290 129 GAGGUCCC A UCAGCCCU 4787 AGGGCUGA
CUGAUGAGGCCGUUAGGCCGAA IGGACCUC 5291 132 GUCCCAUC A GCCCUUGC 4788
GCAAGGGC CUGAUGAGGCCGUUAGGCCGAA IAUGGGAC 5292 135 CCAUCAGC C
CUUGCCCU 4789 AGGGCAAG CUGAUGAGGCCGUUAGGCCGAA ICUGAUGG 5293 136
CAUCAGCC C UUGCCCUG 4790 CAGGGCAA CUGAUGAGGCCGUUAGGCCGAA IGCUGAUG
5294 137 AUCAGCCC U UGCCCUGU 4791 ACAGGGCA CUGAUGAGGCCGUUAGGCCGAA
IGGCUGAU 5295 141 GCCCUUGC C CUGUUGGA 4792 UCCAACAG
CUGAUGAGGCCGUUAGGCCGAA ICAAGGGC 5296 142 CCCUUGCC C UGUUGGAU 4793
AUCCAACA CUGAUGAGGCCGUUAGGCCGAA IGCAAGGG 5297 143 CCUUGCCC U
GUUGGAUG 4794 CAUCCAAC CUGAUGAGGCCGUUAGGCCGAA IGGCAAGG 5298 159
GAAUAGGC A CCUCUGGA 4795 UCCAGAGG CUGAUGAGGCCGUUAGGCCGAA ICCUAUUC
5299 161 AUAGGCAC C UCUGGAAG 4796 CUUCCAGA CUGAUGAGGCCGUUAGGCCGAA
IUGCCUAU 5300 162 UAGGCACC U CUGGAAGA 4797 UCUUCCAG
CUGAUGAGGCCGUUAGGCCGAA IGUGCCUA 5301 164 GGCACCUC U GGAAGAGC 4798
GCUCUUCC CUGAUGAGGCCGUUAGGCCGAA IAGGUGCC 5302 173 GGAAGAGC C
AACUGUGU 4799 ACACAGUU CUGAUGAGGCCGUUAGGCCGAA ICUCUUCC 5303 174
GAAGAGCC A ACUGUGUG 4800 CACACAGU CUGAUGAGGCCGUUAGGCCGAA IGCUCUUC
5304 177 GAGCCAAC U GUGUGAGA 4801 UCUCACAC CUGAUGAGGCCGUUAGGCCGAA
IUUGGCUC 5305 192 GAUGGUGC A GCCCAGUG 4802 CACUGGGC
CUGAUGAGGCCGUUAGGCCGAA ICACCAUC 5306 195 GGUGCAGC C CAGUGGUG 4803
CACCACUG CUGAUGAGGCCGUUAGGCCGAA ICUGCACC 5307 196 GUGCAGCC C
AGUGGUGG 4804 CCACCACU CUGAUGAGGCCGUUAGGCCGAA IGCUGCAC 5308 197
UGCAGCCC A GUGGUGGC 4805 GCCACCAC CUGAUGAGGCCGUUAGGCCGAA IGGCUGCA
5309 206 GUGGUGGC C CGGCAGCA 4806 UGCUGCCG CUGAUGAGGCCGUUAGGCCGAA
ICCACCAC 5310 207 UGGUGGCC C GGCAGCAG 4807 CUGCUGCC
CUGAUGAGGCCGUUAGGCCGAA IGCCACCA 5311 211 GGCCCGGC A GCAGAUCA 4808
UGAUCUGC CUGAUGAGGCCGUUAGGCCGAA ICCGGGCC 5312 214 CCGGCAGC A
GAUCAGGA 4809 UCCUGAUC CUGAUGAGGCCGUUAGGCCGAA ICUGCCGG 5313 219
AGCAGAUC A GGACGUAC 4810 GUACGUCC CUGAUGAGGCCGUUAGGCCGAA IAUCUGCU
5314 228 GGACGUAC U GGGCGAAG 4811 CUUCGCCC CUGAUGAGGCCGUUAGGCCGAA
IUACGUCC 5315 241 GAAGAGUC U CCUCUGGG 4812 CCCAGAGG
CUGAUGAGGCCGUUAGGCCGAA IACUCUUC 5316 243 AGAGUCUC C UCUGGGGA 4813
UCCCCAGA CUGAUGAGGCCGUUAGGCCGAA IAGACUCU 5317 244 GAGUCUCC U
CUGGGGAA 4814 UUCCCCAG CUGAUGAGGCCGUUAGGCCGAA IGAGACUC 5318 246
GUCUCCUC U GGGGAAGC 4815 GCUUCCCC CUGAUGAGGCCGUUAGGCCGAA IAGGAGAC
5319 255 GGGGAAGC C AGCCAUGC 4816 GCAUGGCU CUGAUGAGGCCGUUAGGCCGAA
ICUUCCCC 5320 256 GGGAAGCC A GCCAUGCU 4817 AGCAUGGC
CUGAUGAGGCCGUUAGGCCGAA IGCUUCCC 5321 259 AAGCCAGC C AUGCUGCA 4818
UGCAGCAU CUGAUGAGGCCGUUAGGCCGAA ICUGGCUU 5322 260 AGCCAGCC A
UGCUGCAC 4819 GUGCAGCA CUGAUGAGGCCGUUAGGCCGAA IGCUGGCU 5323 264
AGCCAUGC U GCACCUGC 4820 GCAGGUGC CUGAUGAGGCCGUUAGGCCGAA ICAUGGCU
5324 267 CAUGCUGC A CCUGCCUU 4821 AAGGCAGG CUGAUGAGGCCGUUAGGCCGAA
ICAGCAUG 5325 269 UGCUGCAC C UGCCUUCA 4822 UGAAGGCA
CUGAUGAGGCCGUUAGGCCGAA IUGCAGCA 5326 270 GCUGCACC U GCCUUCAG 4823
CUGAAGGC CUGAUGAGGCCGUUAGGCCGAA IGUGCAGC 5327 273 GCACCUGC C
UUCAGAAC 4824 GUUCUGAA CUGAUGAGGCCGUUAGGCCGAA ICAGGUGC 5328 274
CACCUGCC U UCAGAACA 4825 UGUUCUGA CUGAUGAGGCCGUUAGGCCGAA IGCAGGUG
5329 277 CUGCCUUC A GAACAGGG 4826 CCCUGUUC CUGAUGAGGCCGUUAGGCCGAA
IAAGGCAG 5330 282 UUCAGAAC A GGGCGCUC 4827 GAGCGCCC
CUGAUGAGGCCGUUAGGCCGAA IUUCUGAA 5331 289 CAGGGCGC U CCUGAGAC 4828
GUCUCAGG CUGAUGAGGCCGUUAGGCCGAA ICGCCCUG 5332 291 GGGCGCUC C
UGAGACCC 4829 GGGUCUCA CUGAUGAGGCCGUUAGGCCGAA IAGCGCCC 5333 292
GGCGCUCC U GAGACCCU 4830 AGGGUCUC CUGAUGAGGCCGUUAGGCCGAA IGAGCGCC
5334 298 CCUGAGAC C CUCCAGCG 4831 CGCUGGAG CUGAUGAGGCCGUUAGGCCGAA
IUCUCAGG 5335 299 CUGAGACC C UCCAGCGC 4832 GCGCUGGA
CUGAUGAGGCCGUUAGGCCGAA IGUCUCAG 5336 300 UGAGACCC U CCAGCGCU 4833
AGCGCUGG CUGAUGAGGCCGUUAGGCCGAA IGGUCUCA 5337 302 AGACCCUC C
AGCGCUGC 4834 GCAGCGCU CUGAUGAGGCCGUUAGGCCGAA IAGGGUCU 5338 303
GACCCUCC A GCGCUGCC 4835 GGCAGCGC CUGAUGAGGCCGUUAGGCCGAA IGAGGGUC
5339 308 UCCAGCGC U GCCUGGAG 4836 CUCCAGGC CUGAUGAGGCCGUUAGGCCGAA
ICGCUGGA 5340 311 AGCGCUGC C UGGAGGAG 4837 CUCCUCCA
CUGAUGAGGCCGUUAGGCCGAA ICAGCGCU 5341 312 GCGCUGCC U GGAGGAGA 4838
UCUCCUCC CUGAUGAGGCCGUUAGGCCGAA IGCAGCGC 5342 324 GGAGAAUC A
AGAGCUCC 4839 GGAGCUCU CUGAUGAGGCCGUUAGGCCGAA IAUUCUCC 5343
330 UCAAGAGC U CCGAGAUG 4840 CAUCUCGG CUGAUGAGGCCGUUAGGCCGAA
ICUCUUGA 5344 332 AAGAGCUC C GAGAUGCC 4841 GGCAUCUC
CUGAUGAGGCCGUUAGGCCGAA IAGCUCUU 5345 340 CGAGAUGC C AUCCGGCA 4842
UGCCGGAU CUGAUGAGGCCGUUAGGCCGAA ICAUCUCG 5346 341 GAGAUGCC A
UCCGGCAG 4843 CUGCCGGA CUGAUGAGGCCGUUAGGCCGAA IGCAUCUC 5347 344
AUGCCAUC C GGCAGAGC 4844 GCUCUGCC CUGAUGAGGCCGUUAGGCCGAA IAUGGCAU
5348 348 CAUCCGGC A GAGCAACC 4845 GGUUGCUC CUGAUGAGGCCGUUAGGCCGAA
ICCGGAUG 5349 353 GGCAGAGC A ACCAGAUU 4846 AAUCUGGU
CUGAUGAGGCCGUUAGGCCGAA ICUCUGCC 5350 356 AGAGCAAC C AGAUUCUG 4847
CAGAAUCU CUGAUGAGGCCGUUAGGCCGAA IUUGCUCU 5351 357 GAGCAACC A
GAUUCUGC 4848 GCAGAAUC CUGAUGAGGCCGUUAGGCCGAA IGUUGCUC 5352 363
CCAGAUUC U GCGGGAGC 4849 GCUCCCGC CUGAUGAGGCCGUUAGGCCGAA IAAUCUGG
5353 374 GGGAGCGC U GCGAGGAG 4850 CUCCUCGC CUGAUGAGGCCGUUAGGCCGAA
ICGCUCCC 5354 384 CGAGGAGC U UCUGCAUU 4851 AAUGCAGA
CUGAUGAGGCCGUUAGGCCGAA ICUCCUCG 5355 387 GGAGCUUC U GCAUUUCC 4852
GGAAAUGC CUGAUGAGGCCGUUAGGCCGAA IAAGCUCC 5356 390 GCUUCUGC A
UUUCCAAG 4853 CUUGGAAA CUGAUGAGGCCGUUAGGCCGAA ICAGAAGC 5357 395
UGCAUUUC C AAGCCAGC 4854 GCUGGCUU CUGAUGAGGCCGUUAGGCCGAA IAAAUGCA
5358 396 GCAUUUCC A AGCCAGCC 4855 GGCUGGCU CUGAUGAGGCCGUUAGGCCGAA
IGAAAUGC 5359 400 UUCCAAGC C AGCCAGAG 4856 CUCUGGCU
CUGAUGAGGCCGUUAGGCCGAA ICUUGGAA 5360 401 UCCAAGCC A GCCAGAGG 4857
CCUCUGGC CUGAUGAGGCCGUUAGGCCGAA IGCUUGGA 5361 404 AAGCCAGC C
AGAGGGAG 4858 CUCCCUCU CUGAUGAGGCCGUUAGGCCGAA ICUGGCUU 5362 405
AGCCAGCC A GAGGGAGG 4859 CCUCCCUC CUGAUGAGGCCGUUAGGCCGAA IGCUGGCU
5363 425 AGGAGUUC C UCAUGUGC 4860 UCACAUGA CUGAUGAGGCCGUUAGGCCGAA
IAACUCCU 5364 426 GGAGUUCC U CAUGUGCA 4861 UGCACAUG
CUGAUGAGGCCGUUAGGCCGAA IGAACUCC 5365 428 AGUUCCUC A UGUGCAAG 4862
CUUGCACA CUGAUGAGGCCGUUAGGCCGAA IAGGAACU 5366 434 UCAUGUGC A
AGUUCCAG 4863 CUGGAACU CUGAUGAGGCCGUUAGGCCGAA ICACAUGA 5367 440
GCAAGUUC C AGGAGGCC 4864 GGCCUCCU CUGAUGAGGCCGUUAGGCCGAA IAACUUGC
5368 441 CAAGUUCC A GGAGGCCA 4865 UGGCCUCC CUGAUGAGGCCGUUAGGCCGAA
IGAACUUG 5369 448 CAGGAGGC C AGGAAACU 4866 AGUUUCCU
CUGAUGAGGCCGUUAGGCCGAA ICCUCCUG 5370 449 AGGAGGCC A GGAAACUG 4867
CAGUUUCC CUGAUGAGGCCGUUAGGCCGAA IGCCUCCU 5371 456 CAGGAAAC U
GGUGGAGA 4868 UCUCCACC CUGAUGAGGCCGUUAGGCCGAA IUUUCCUG 5372 468
GGAGAGAC U CGGCCUGG 4869 CCAGGCCG CUGAUGAGGCCGUUAGGCCGAA IUCUCUCC
5373 473 GACUCGGC C UGGAGAAG 4870 CUUCUCCA CUGAUGAGGCCGUUAGGCCGAA
ICCGAGUC 5374 474 ACUCGGCC U GGAGAAGC 4871 GCUUCUCC
CUGAUGAGGCCGUUAGGCCGAA IGCCGAGU 5375 483 GGAGAAGC U CGAUCUGA 4872
UCAGAUCG CUGAUGAGGCCGUUAGGCCGAA ICUUCUCC 5376 489 GCUCGAUC U
GAAGAGGC 4873 GCCUCUUC CUGAUGAGGCCGUUAGGCCGAA IAUCGAGC 5377 498
GAAGAGGC A GAAGGAGC 4874 GCUCCUUC CUGAUGAGGCCGUUAGGCCGAA ICCUCUUC
5378 507 GAAGGAGC A GGCUCUGC 4875 GCAGAGCC CUGAUGAGGCCGUUAGGCCGAA
ICUCCUUC 5379 511 GAGCAGGC U CUGCGGGA 4876 UCCCGCAG
CUGAUGAGGCCGUUAGGCCGAA ICCUGCUC 5380 513 GCAGGCUC U GCGGGAGG 4877
CCUCCCGC CUGAUGAGGCCGUUAGGCCGAA IAGCCUGC 5381 528 GGUGGAGC A
CCUGAAGA 4878 UCUUCAGG CUGAUGAGGCCGUUAGGCCGAA ICUCCACC 5382 530
UGGAGCAC C UGAAGAGA 4879 UCUCUUCA CUGAUGAGGCCGUUAGGCCGAA IUGCUCCA
5383 531 GGAGCACC U GAAGAGAU 4880 AUCUCUUC CUGAUGAGGCCGUUAGGCCGAA
IGUGCUCC 5384 542 AGAGAUGC C AGCAGCAG 4881 CUGCUGCU
CUGAUGAGGCCGUUAGGCCGAA ICAUCUCU 5385 543 GAGAUGCC A GCAGCAGA 4882
UCUGCUGC CUGAUGAGGCCGUUAGGCCGAA IGCAUCUC 5386 546 AUGCCAGC A
GCAGAUGG 4883 CCAUCUGC CUGAUGAGGCCGUUAGGCCGAA ICUGGCAU 5387 549
CCAGCAGC A GAUGGCUG 4884 CAGCCAUC CUGAUGAGGCCGUUAGGCCGAA ICUGCUGG
5388 556 CAGAUGGC U GAGGACAA 4885 UUGUCCUC CUGAUGAGGCCGUUAGGCCGAA
ICCAUCUG 5389 563 CUGAGGAC A AGGCCUCU 4886 AGAGGCCU
CUGAUGAGGCCGUUAGGCCGAA IUCCUCAG 5390 568 GACAAGGC C UCUGUGAA 4887
UUCACAGA CUGAUGAGGCCGUUAGGCCGAA ICCUUGUC 5391 569 ACAAGGCC U
CUGUGAAA 4888 UUUCACAG CUGAUGAGGCCGUUAGGCCGAA IGCCUUGU 5392 571
AAGGCCUC U GUGAAAGC 4889 GCUUUCAC CUGAUGAGGCCGUUAGGCCGAA IAGGCCUU
5393 580 GUGAAAGC C CAGGUGAC 4890 GUCACCUG CUGAUGAGGCCGUUAGGCCGAA
ICUUUCAC 5394 581 UGAAAGCC C AGGUGACG 4891 CGUCACCU
CUGAUGAGGCCGUUAGGCCGAA IGCUUUCA 5395 582 GAAAGCCC A GGUGACGU 4892
ACGUCACC CUGAUGAGGCCGUUAGGCCGAA IGGCUUUC 5396 592 GUGACGUC C
UUGCUCGG 4893 CCGAGCAA CUGAUGAGGCCGUUAGGCCGAA IACGUCAC 5397 593
UGACGUCC U UGCUCGGG 4894 CCCGAGCA CUGAUGAGGCCGUUAGGCCGAA IGACGUCA
5398 597 GUCCUUGC U CGGGGAGC 4895 GCUCCCCG CUGAUGAGGCCGUUAGGCCGAA
ICAAGGAC 5399 606 CGGGGAGC U GCAGGAGA 4896 UCUCCUGC
CUGAUGAGGCCGUUAGGCCGAA ICUCCCCG 5400 609 GGAGCUGC A GGAGAGCC 4897
GGCUCUCC CUGAUGAGGCCGUUAGGCCGAA ICAGCUCC 5401 617 AGGAGAGC C
AGAGUCGC 4898 GCGACUCU CUGAUGAGGCCGUUAGGCCGAA ICUCUCCU 5402 618
GGAGAGCC A GAGUCGCU 4899 AGCGACUC CUGAUGAGGCCGUUAGGCCGAA IGCUCUCC
5403 626 AGAGUCGC U UGGAGGCU 4900 AGCCUCCA CUGAUGAGGCCGUUAGGCCGAA
ICGACUCU 5404 634 UUGGAGGC U GCCACUAA 4901 UUAGUGGC
CUGAUGAGGCCGUUAGGCCGAA ICCUCCAA 5405 637 GAGGCUGC C ACUAAGGA 4902
UCCUUAGU CUGAUGAGGCCGUUAGGCCGAA ICAGCCUC 5406 638 AGGCUGCC A
CUAAGGAA 4903 UUCCUUAG CUGAUGAGGCCGUUAGGCCGAA IGCAGCCU 5407 640
GCUGCCAC U AAGGAAUG 4904 CAUUCCUU CUGAUGAGGCCGUUAGGCCGAA IUGGCAGC
5408 650 AGGAAUGC C AGGCUCUG 4905 CAGAGCCU CUGAUGAGGCCGUUAGGCCGAA
ICAUUCCU 5409 651 GGAAUGCC A GGCUCUGG 4906 CCAGAGCC
CUGAUGAGGCCGUUAGGCCGAA IGCAUUCC 5410 655 UGCCAGGC U CUGGAGGG 4907
CCCUCCAG CUGAUGAGGCCGUUAGGCCGAA ICCUGGCA 5411 657 CCAGGCUC U
GGAGGGUC 4908 GACCCUCC CUGAUGAGGCCGUUAGGCCGAA IAGCCUGG 5412 670
GGUCGGGC C CGGGCGGC 4909 GCCGCCCG CUGAUGAGGCCGUUAGGCCGAA ICCCGACC
5413 671 GUCGGGCC C GGGCGGCC 4910 GGCCGCCC CUGAUGAGGCCGUUAGGCCGAA
IGCCCGAC 5414 679 CGGGCGGC C AGCGAGCA 4911 UGCUCGCU
CUGAUGAGGCCGUUAGGCCGAA ICCGCCCG 5415 680 GGGCGGCC A GCGAGCAG 4912
CUGCUCGC CUGAUGAGGCCGUUAGGCCGAA IGCCGCCC 5416 687 CAGCGAGC A
GGCGCGGC 4913 GCCGCGCC CUGAUGAGGCCGUUAGGCCGAA ICUCGCUG 5417 696
GGCGCGGC A GCUGGAGA 4914 UCUCCAGC CUGAUGAGGCCGUUAGGCCGAA ICCGCGCC
5418 699 GCGGCAGC U GGAGAGUG 4915 CACUCUCC CUGAUGAGGCCGUUAGGCCGAA
ICUGCCGC 5419 720 CGAGGCGC U GCAGCAGC 4916 GCUGCUGC
CUGAUGAGGCCGUUAGGCCGAA ICGCCUCG 5420 723 GGCGCUGC A GCAGCAGC 4917
GCUGCUGC CUGAUGAGGCCGUUAGGCCGAA ICAGCGCC 5421 726 GCUGCAGC A
GCAGCACA 4918 UGUGCUGC CUGAUGAGGCCGUUAGGCCGAA ICUGCAGC 5422 729
GCAGCAGC A GCACAGCG 4919 CGCUGUGC CUGAUGAGGCCGUUAGGCCGAA ICUGCUGC
5423 732 GCAGCAGC A CAGCGUGC 4920 GCACGCUG CUGAUGAGGCCGUUAGGCCGAA
ICUGCUGC 5424 734 AGCAGCAC A GCGUGCAG 4921 CUGCACGC
CUGAUGAGGCCGUUAGGCCGAA IUGCUGCU 5425 741 CAGCGUGC A GGUGGACC 4922
GGUCCACC CUGAUGAGGCCGUUAGGCCGAA ICACGCUG 5426 749 AGGUGGAC C
AGCUGCGC 4923 GCGCAGCU CUGAUGAGGCCGUUAGGCCGAA IUCCACCU 5427
750 GGUGGACC A GCUGCGCA 4924 UGCGCAGC CUGAUGAGGCCGUUAGGCCGAA
IGUCCACC 5428 753 GGACCAGC U GCGCAUGC 4925 GCAUGCGC
CUGAUGAGGCCGUUAGGCCGAA ICUGGUCC 5429 758 AGCUGCGC A UGCAGGGC 4926
GCCCUGCA CUGAUGAGGCCGUUAGGCCGAA ICGCAGCU 5430 762 GCGCAUGC A
GGGCCAGA 4927 UCUGGCCC CUGAUGAGGCCGUUAGGCCGAA ICAUGCGC 5431 767
UGCAGGGC C AGAGCGUG 4928 CACGCUCU CUGAUGAGGCCGUUAGGCCGAA ICCCUGCA
5432 768 GCAGGGCC A GAGCGUGG 4929 CCACGCUC CUGAUGAGGCCGUUAGGCCGAA
IGCCCUGC 5433 781 GUGGAGGC C GCGCUCCG 4930 CGGAGCGC
CUGAUGAGGCCGUUAGGCCGAA ICCUCCAC 5434 786 GGCCGCGC U CCGCAUGG 4931
CCAUGCGG CUGAUGAGGCCGUUAGGCCGAA ICGCGGCC 5435 788 CCGCGCUC C
GCAUGGAG 4932 CUCCAUGC CUGAUGAGGCCGUUAGGCCGAA IAGCGCGG 5436 791
CGCUCCGC A UGGAGCGC 4933 GCGCUCCA CUGAUGAGGCCGUUAGGCCGAA ICGGAGCG
5437 800 UGGAGCGC C AGGCCGCC 4934 GGCGGCCU CUGAUGAGGCCGUUAGGCCGAA
ICGCUCCA 5438 801 GGAGCGCC A GGCCGCCU 4935 AGGCGGCC
CUGAUGAGGCCGUUAGGCCGAA IGCGCUCC 5439 805 CGCCAGGC C GCCUCGGA 4936
UCCGAGGC CUGAUGAGGCCGUUAGGCCGAA ICCUGGCG 5440 808 CAGGCCGC C
UCGGAGGA 4937 UCCUCCGA CUGAUGAGGCCGUUAGGCCGAA ICGGCCUG 5441 809
AGGCCGCC U CGGAGGAG 4938 CUCCUCCG CUGAUGAGGCCGUUAGGCCGAA IGCGGCCU
5442 828 GAGGAAGC U GGCCCAGU 4939 ACUGGGCC CUGAUGAGGCCGUUAGGCCGAA
ICUUCCUC 5443 832 AAGCUGGC C CAGUUGCA 4940 UGCAACUG
CUGAUGAGGCCGUUAGGCCGAA ICCAGCUU 5444 833 AGCUGGCC C AGUUGCAG 4941
CUGCAACU CUGAUGAGGCCGUUAGGCCGAA IGCCAGCU 5445 834 GCUGGCCC A
GUUGCAGG 4942 CCUGCAAC CUGAUGAGGCCGUUAGGCCGAA IGGCCAGC 5446 840
CCAGUUGC A GGUGGCCU 4943 AGGCCACC CUGAUGAGGCCGUUAGGCCGAA ICAACUGG
5447 847 CAGGUGGC C UAUCACCA 4944 UGGUGAUA CUGAUGAGGCCGUUAGGCCGAA
ICCACCUG 5448 848 AGGUGGCC U AUCACCAG 4945 CUGGUGAU
CUGAUGAGGCCGUUAGGCCGAA IGCCACCU 5449 852 GGCCUAUC A CCAGCUCU 4946
AGAGCUGG CUGAUGAGGCCGUUAGGCCGAA IAUAGGCC 5450 854 CCUAUCAC C
AGCUCUUC 4947 GAAGAGCU CUGAUGAGGCCGUUAGGCCGAA IUGAUAGG 5451 855
CUAUCACC A GCUCUUCC 4948 GGAAGAGC CUGAUGAGGCCGUUAGGCCGAA IGUGAUAG
5452 858 UCACCAGC U CUUCCAAG 4949 CUUGGAAG CUGAUGAGGCCGUUAGGCCGAA
ICUGGUGA 5453 860 ACCAGCUC U UCCAAGAA 4950 UUCUUGGA
CUGAUGAGGCCGUUAGGCCGAA IAGCUGGU 5454 863 AGCUCUUC C AAGAAUAC 4951
GUAUUCUU CUGAUGAGGCCGUUAGGCCGAA IAAGAGCU 5455 864 GCUCUUCC A
AGAAUACG 4952 CGUAUUCU CUGAUGAGGCCGUUAGGCCGAA IGAAGAGC 5456 875
AAUACGAC A ACCACAUC 4953 GAUGUGGU CUGAUGAGGCCGUUAGGCCGAA IUCGUAUU
5457 878 ACGACAAC C ACAUCAAG 4954 CUUGAUGU CUGAUGAGGCCGUUAGGCCGAA
IUUGUCGU 5458 879 CGACAACC A CAUCAAGA 4955 UCUUGAUG
CUGAUGAGGCCGUUAGGCCGAA IGUUGUCG 5459 881 ACAACCAC A UCAAGAGC 4956
GCUCUUGA CUGAUGAGGCCGUUAGGCCGAA IUGGUUGU 5460 884 ACCACAUC A
AGAGCAGC 4957 GCUGCUCU CUGAUGAGGCCGUUAGGCCGAA IAUGUGGU 5461 890
UCAAGAGC A GCGUGGUG 4958 CACCACGC CUGAUGAGGCCGUUAGGCCGAA ICUCUUGA
5462 902 UGGUGGGC A GUGAGCGG 4959 CCGCUCAC CUGAUGAGGCCGUUAGGCCGAA
ICCCACCA 5463 924 AGGAAUGC A GCUGGAAG 4960 CUUCCAGC
CUGAUGAGGCCGUUAGGCCGAA ICAUUCCU 5464 927 AAUGCAGC U GGAAGAUC 4961
GAUCUUCC CUGAUGAGGCCGUUAGGCCGAA ICUGCAUU 5465 936 GGAAGAUC U
CAAACAGC 4962 GCUGUUUG CUGAUGAGGCCGUUAGGCCGAA IAUCUUCC 5466 938
AAGAUCUC A AACAGCAG 4963 CUGCUGUU CUGAUGAGGCCGUUAGGCCGAA IAGAUCUU
5467 942 UCUCAAAC A GCAGCUCC 4964 GGAGCUGC CUGAUGAGGCCGUUAGGCCGAA
IUUUGAGA 5468 945 CAAACAGC A GCUCCAGC 4965 GCUGGAGC
CUGAUGAGGCCGUUAGGCCGAA ICUGUUUG 5469 948 ACAGCAGC U CCAGCAGG 4966
CCUGCUGG CUGAUGAGGCCGUUAGGCCGAA ICUGCUGU 5470 950 AGCAGCUC C
AGCAGGCC 4967 GGCCUGCU CUGAUGAGGCCGUUAGGCCGAA IAGCUGCU 5471 951
GCAGCUCC A GCAGGCCG 4968 CGGCCUGC CUGAUGAGGCCGUUAGGCCGAA IGAGCUGC
5472 954 GCUCCAGC A GGCCGAGG 4969 CCUCGGCC CUGAUGAGGCCGUUAGGCCGAA
ICUGGAGC 5473 958 CAGCAGGC C GAGGAGGC 4970 GCCUCCUC
CUGAUGAGGCCGUUAGGCCGAA ICCUGCUG 5474 967 GAGGAGGC C CUGGUGGC 4971
GCCACCAG CUGAUGAGGCCGUUAGGCCGAA ICCUCCUC 5475 968 AGGAGGCC C
UGGUGGCC 4972 GGCCACCA CUGAUGAGGCCGUUAGGCCGAA IGCCUCCU 5476 969
GGAGGCCC U GGUGGCCA 4973 UGGCCACC CUGAUGAGGCCGUUAGGCCGAA IGGCCUCC
5477 976 CUGGUGGC C AAACAGGA 4974 UCCUGUUU CUGAUGAGGCCGUUAGGCCGAA
ICCACCAG 5478 977 UGGUGGCC A AACAGGAG 4975 CUCCUGUU
CUGAUGAGGCCGUUAGGCCGAA IGCCACCA 5479 981 GGCCAAAC A GGAGGUGA 4976
UCACCUCC CUGAUGAGGCCGUUAGGCCGAA IUUUGGCC 5480 999 CGAUAAGC U
GAAGGAGG 4977 CCUCCUUC CUGAUGAGGCCGUUAGGCCGAA ICUUAUCG 5481 1012
GAGGAGGC C GAGCAGCA 4978 UGCUGCUC CUGAUGAGGCCGUUAGGCCGAA ICCUCCUC
5482 1017 GGCCGAGC A GCACAAGA 4979 UCUUGUGC CUGAUGAGGCCGUUAGGCCGAA
ICUCGGCC 5483 1020 CGAGCAGC A CAAGAUUG 4980 CAAUCUUG
CUGAUGAGGCCGUUAGGCCGAA ICUGCUCG 5484 1022 AGCAGCAC A AGAUUGUG 4981
CACAAUCU CUGAUGAGGCCGUUAGGCCGAA IUGCUGCU 5485 1039 AUGGAGAC C
GUUCCGGU 4982 ACCGGAAC CUGAUGAGGCCGUUAGGCCGAA IUCUCCAU 5486 1044
GACCGUUC C GGUGCUGA 4983 UCAGCACC CUGAUGAGGCCGUUAGGCCGAA IAACGGUC
5487 1050 UCCGGUGC U GAAGGCCC 4984 GGGCCUUC CUGAUGAGGCCGUUAGGCCGAA
ICACCGGA 5488 1057 CUGAAGGC C CAGGCGGA 4985 UCCGCCUG
CUGAUGAGGCCGUUAGGCCGAA ICCUUCAG 5489 1058 UGAAGGCC C AGGCGGAU 4986
AUCCGCCU CUGAUGAGGCCGUUAGGCCGAA IGCCUUCA 5490 1059 GAAGGCCC A
GGCGGAUA 4987 UAUCCGCC CUGAUGAGGCCGUUAGGCCGAA IGGCCUUC 5491 1070
CGGAUAUC U ACAAGGCG 4988 CGCCUUGU CUGAUGAGGCCGUUAGGCCGAA IAUAUCCG
5492 1073 AUAUCUAC A AGGCGGAC 4989 GUCCGCCU CUGAUGAGGCCGUUAGGCCGAA
IUAGAUAU 5493 1082 AGGCGGAC U UCCAGGCU 4990 AGCCUGGA
CUGAUGAGGCCGUUAGGCCGAA IUCCGCCU 5494 1085 CGGACUUC C AGGCUGAG 4991
CUCAGCCU CUGAUGAGGCCGUUAGGCCGAA IAAGUCCG 5495 1086 GGACUUCC A
GGCUGAGA 4992 UCUCAGCC CUGAUGAGGCCGUUAGGCCGAA IGAAGUCC 5496 1090
UUCCAGGC U GAGAGGCA 4993 UGCCUCUC CUGAUGAGGCCGUUAGGCCGAA ICCUGGAA
5497 1098 UGAGAGGC A GGCCCGGG 4994 CCCGGGCC CUGAUGAGGCCGUUAGGCCGAA
ICCUCUCA 5498 1102 AGGCAGGC C CGGGAGAA 4995 UUCUCCCG
CUGAUGAGGCCGUUAGGCCGAA ICCUGCCU 5499 1103 GGCAGGCC C GGGAGAAG 4996
CUUCUCCC CUGAUGAGGCCGUUAGGCCGAA IGCCUGCC 5500 1113 GGAGAAGC U
GGCCGAGA 4997 UCUCGGCC CUGAUGAGGCCGUUAGGCCGAA ICUUCUCC 5501 1117
AAGCUGGC C GAGAAGAA 4998 UUCUUCUC CUGAUGAGGCCGUUAGGCCGAA ICCAGCUU
5502 1131 GAAGGAGC U CCUGCAGG 4999 CCUGCAGG CUGAUGAGGCCGUUAGGCCGAA
ICUCCUUC 5503 1133 AGGAGCUC C UGCAGGAG 5000 CUCCUGCA
CUGAUGAGGCCGUUAGGCCGAA IAGCUCCU 5504 1134 GGAGCUCC U GCAGGAGC 5001
GCUCCUGC CUGAUGAGGCCGUUAGGCCGAA IGAGCUCC 5505 1137 GCUCCUGC A
GGAGCAGC 5002 GCUGCUCC CUGAUGAGGCCGUUAGGCCGAA ICAGGAGC 5506 1143
GCAGGAGC A GCUGGAGC 5003 GCUCCAGC CUGAUGAGGCCGUUAGGCCGAA ICUCCUGC
5507 1146 GGAGCAGC U GGAGCAGC 5004 GCUGCUCC CUGAUGAGGCCGUUAGGCCGAA
ICUGCUCC 5508 1152 GCUGGAGC A GCUGCAGA 5005 UCUGCAGC
CUGAUGAGGCCGUUAGGCCGAA ICUCCAGC 5509 1155 GGAGCAGC U GCAGAGGG 5006
CCCUCUGC CUGAUGAGGCCGUUAGGCCGAA ICUGCUCC 5510
1158 GCAGCUGC A GAGGGAGU 5007 ACUCCCUC CUGAUGAGGCCGUUAGGCCGAA
ICAGCUGC 5511 1169 GGGAGUAC A GCAAACUG 5008 CAGUUUGC
CUGAUGAGGCCGUUAGGCCGAA IUACUCCC 5512 1172 AGUACAGC A AACUGAAG 5009
CUUCAGUU CUGAUGAGGCCGUUAGGCCGAA ICUGUACU 5513 1176 CAGCAAAC U
GAAGGCCA 5010 UGGCCUUC CUGAUGAGGCCGUUAGGCCGAA IUUUGCUG 5514 1183
CUGAAGGC C AGCUGUCA 5011 UGACAGCU CUGAUGAGGCCGUUAGGCCGAA ICCUUCAG
5515 1184 UGAAGGCC A GCUGUCAG 5012 CUGACAGC CUGAUGAGGCCGUUAGGCCGAA
IGCCUUCA 5516 1187 AGGCCAGC U GUCAGGAG 5013 CUCCUGAC
CUGAUGAGGCCGUUAGGCCGAA ICUGGCCU 5517 1191 CAGCUGUC A GGAGUCGG 5014
CCGACUCC CUGAUGAGGCCGUUAGGCCGAA TACACCUG 5518 1201 GAGUCGGC C
AGGAUCGA 5015 UCGAUCCU CUGAUGAGGCCGUUAGGCCGAA ICCGACUC 5519 1202
AGUCGGCC A GGAUCGAG 5016 CUCGAUCC CUGAUGAGGCCGUUAGGCCGAA IGCCGACU
5520 1214 UCGAGGAC A UGAGGAAG 5017 CUUCCUCA CUGAUGAGGCCGUUAGGCCGAA
IUCCUCGA 5521 1227 GAAGCGGC A UGUCGAGG 5018 CCUCGACA
CUGAUGAGGCCGUUAGGCCGAA ICCGCUUC 5522 1238 UCGAGGUC U CCCAGGCC 5019
GGCCUGGG CUGAUGAGGCCGUUAGGCCGAA IACCUCGA 5523 1240 GAGGUCUC C
CAGGCCCC 5020 GGGGCCUG CUGAUGAGGCCGUUAGGCCGAA IAGACCUC 5524 1241
AGGUCUCC C AGGCCCCC 5021 GGGGGCCU CUGAUGAGGCCGUUAGGCCGAA IGAGACCU
5525 1242 GGUCUCCC A GGCCCCCU 5022 AGGGGGCC CUGAUGAGGCCGUUAGGCCGAA
IGGAGACC 5526 1246 UCCCAGGC C CCCUUGCC 5023 GGCAAGGG
CUGAUGAGGCCGUUAGGCCGAA ICCUGGGA 5527 1247 CCCAGGCC C CCUUGCCC 5024
GGGCAAGG CUGAUGAGGCCGUUAGGCCGAA IGCCUGGG 5528 1248 CCAGGCCC C
CUUGCCCC 5025 GGGGCAAG CUGAUGAGGCCGUUAGGCCGAA IGGCCUGG 5529 1249
CAGGCCCC C UUGCCCCC 5026 GGGGGCAA CUGAUGAGGCCGUUAGGCCGAA IGGGCCUG
5530 1250 AGGCCCCC U UGCCCCCC 5027 GGGGGGCA CUGAUGAGGCCGUUAGGCCGAA
IGGGGCCU 5531 1254 CCCCUUGC C CCCCGCCC 5028 GGGCGGGG
CUGAUGAGGCCGUUAGGCCGAA ICAAGGGG 5532 1255 CCCUUGCC C CCCGCCCC 5029
GGGGCGGG CUGAUGAGGCCGUUAGGCCGAA IGCAAGGG 5533 1256 CCUUGCCC C
CCGCCCCU 5030 AGGGGCGG CUGAUGAGGCCGUUAGGCCGAA IGGCAAGG 5534 1257
CUUGCCCC C CGCCCCUG 5031 CAGGGGCG CUGAUGAGGCCGUUAGGCCGAA IGGGCAAG
5535 1258 UUGCCCCC C GCCCCUGC 5032 GCAGGGGC CUGAUGAGGCCGUUAGGCCGAA
IGGGGCAA 5536 1261 CCCCCCGC C CCUGCCUA 5033 UAGGCAGG
CUGAUGAGGCCGUUAGGCCGAA ICGGGGGG 5537 1262 CCCCCGCC C CUGCCUAC 5034
GUAGGCAG CUGAUGAGGCCGUUAGGCCGAA IGCGGGGG 5538 1263 CCCCGCCC C
UGCCUACC 5035 GGUAGGCA CUGAUGAGGCCGUUAGGCCGAA IGGCGGGG 5539 1264
CCCGCCCC U GCCUACCU 5036 AGGUAGGC CUGAUGAGGCCGUUAGGCCGAA IGGGCGGG
5540 1267 GCCCCUGC C UACCUCUC 5037 GAGAGGUA CUGAUGAGGCCGUUAGGCCGAA
ICAGGGGC 5541 1268 CCCCUGCC U ACCUCUCC 5038 GGAGAGGU
CUGAUGAGGCCGUUAGGCCGAA IGCAGGGG 5542 1271 CUGCCUAC C UCUCCUCU 5039
AGAGGAGA CUGAUGAGGCCGUUAGGCCGAA IUAGGCAG 5543 1272 UGCCUACC U
CUCCUCUC 5040 GAGAGGAG CUGAUGAGGCCGUUAGGCCGAA IGUAGGCA 5544 1274
CCUACCUC U CCUCUCCC 5041 GGGAGAGG CUGAUGAGGCCGUUAGGCCGAA IAGGUAGG
5545 1276 UACCUCUC C UCUCCCCU 5042 AGGGGAGA CUGAUGAGGCCGUUAGGCCGAA
IAGAGGUA 5546 1277 ACCUCUCC U CUCCCCUG 5043 CAGGGGAG
CUGAUGAGGCCGUUAGGCCGAA IGAGAGGU 5547 1279 CUCUCCUC U CCCCUGGC 5044
GCCAGGGG CUGAUGAGGCCGUUAGGCCGAA IAGGAGAG 5548 1281 CUCCUCUC C
CCUGGCCC 5045 GGGCCAGG CUGAUGAGGCCGUUAGGCCGAA IAGAGGAG 5549 1282
UCCUCUCC C CUGGCCCU 5046 AGGGCCAG CUGAUGAGGCCGUUAGGCCGAA IGAGAGGA
5550 1283 CCUCUCCC C UGGCCCUG 5047 CAGGGCCA CUGAUGAGGCCGUUAGGCCGAA
IGGAGAGG 5551 1284 CUCUCCCC U GGCCCUGC 5048 GCAGGGCC
CUGAUGAGGCCGUUAGGCCGAA IGGGAGAG 5552 1288 CCCCUGGC C CUGCCCAG 5049
CUGGGCAG CUGAUGAGGCCGUUAGGCCGAA ICCAGGGG 5553 1289 CCCUGGCC C
UGCCCAGC 5050 GCUGGGCA CUGAUGAGGCCGUUAGGCCGAA IGCCAGGG 5554 1290
CCUGGCCC U GCCCAGCC 5051 GGCUGGGC CUGAUGAGGCCGUUAGGCCGAA IGGCCAGG
5555 1293 GGCCCUGC C CAGCCAGA 5052 UCUGGCUG CUGAUGAGGCCGUUAGGCCGAA
ICAGGGCC 5556 1294 GCCCUGCC C AGCCAGAG 5053 CUCUGGCU
CUGAUGAGGCCGUUAGGCCGAA IGCAGGGC 5557 1295 CCCUGCCC A GCCAGAGG 5054
CCUCUGGC CUGAUGAGGCCGUUAGGCCGAA IGGCAGGG 5558 1298 UGCCCAGC C
AGAGGAGG 5055 CCUCCUCU CUGAUGAGGCCGUUAGGCCGAA ICUGGGCA 5559 1299
GCCCAGCC A GAGGAGGA 5056 UCCUCCUC CUGAUGAGGCCGUUAGGCCGAA IGCUGGGC
5560 1310 GGAGGAGC C CCCCCGAG 5057 CUCGGGGG CUGAUGAGGCCGUUAGGCCGAA
ICUCCUCC 5561 1311 GAGGAGCC C CCCCGAGG 5058 CCUCGGGG
CUGAUGAGGCCGUUAGGCCGAA IGGUCCUC 5562 1312 AGGAGCCC C CCCGAGGA 5059
UCCUCGGG CUGAUGAGGCCGUUAGGCCGAA IGGCUCCU 5563 1313 GGAGCCCC C
CCGAGGAG 5060 CUCCUCGG CUGAUGAGGCCGUUAGGCCGAA IGGGCUCC 5564 1314
GAGCCCCC C CGAGGAGC 5061 GCUCCUCG CUGAUGAGGCCGUUAGGCCGAA IGGGGCUC
5565 1315 AGCCCCCC C GAGGAGCC 5062 GGCUCCUC CUGAUGAGGCCGUUAGGCCGAA
IGGGGGCU 5566 1323 CGAGGAGC C ACCUGACU 5063 AGUCAGGU
CUGAUGAGGCCGUUAGGCCGAA ICUCCUCG 5567 1324 GAGGAGCC A CCUGACUU 5064
AAGUCAGG CUGAUGAGGCCGUUAGGCCGAA IGCUCCUC 5568 1326 GGAGCCAC C
UGACUUCU 5065 AGAAGUCA CUGAUGAGGCCGUUAGGCCGAA IUGGCUCC 5569 1327
GAGCCACC U GACUUCUG 5066 CAGAAGUC CUGAUGAGGCCGUUAGGCCGAA IGUGGCUC
5570 1331 CACCUGAC U UCUGCUGU 5067 ACAGCAGA CUGAUGAGGCCGUUAGGCCGAA
IUCAGGUG 5571 1334 CUGACUUC U GCUGUCCC 5068 GGGACAGC
CUGAUGAGGCCGUUAGGCCGAA IAAGUCAG 5572 1337 ACUUCUGC U GUCCCAAG 5069
CUUGGGAC CUGAUGAGGCCGUUAGGCCGAA ICAGAAGU 5573 1341 CUGCUGUC C
CAAGUGCC 5070 GGCACUUG CUGAUGAGGCCGUUAGGCCGAA IACAGCAG 5574 1342
UGCUGUCC C AAGUGCCA 5071 UGGCACUU CUGAUGAGGCCGUUAGGCCGAA IGACAGCA
5575 1343 GCUGUCCC A AGUGCCAG 5072 CUGGCACU CUGAUGAGGCCGUUAGGCCGAA
IGGACAGC 5576 1349 CCAAGUGC C AGUAUCAG 5073 CUGAUACU
CUGAUGAGGCCGUUAGGCCGAA ICACUUGG 5577 1350 CAAGUGCC A GUAUCAGG 5074
CCUGAUAC CUGAUGAGGCCGUUAGGCCGAA IGCACUUG 5578 1356 CCAGUAUC A
GGCCCCUG 5075 CAGGGGCC CUGAUGAGGCCGUUAGGCCGAA IAUACUGG 5579 1360
UAUCAGGC C CCUGAUAU 5076 AUAUCAGG CUGAUGAGGCCGUUAGGCCGAA ICCUGAUA
5580 1361 AUCAGGCC C CUGAUAUG 5077 CAUAUCAG CUGAUGAGGCCGUUAGGCCGAA
IGCCUGAU 5581 1362 UCAGGCCC C UGAUAUGG 5078 CCAUAUCA
CUGAUGAGGCCGUUAGGCCGAA IGGCCUGA 5582 1363 CAGGCCCC U GAUAUGGA 5079
UCCAUAUC CUGAUGAGGCCGUUAGGCCGAA IGGGCCUG 5583 1373 AUAUGGAC A
CCCUGCAG 5080 CUGCAGGG CUGAUGAGGCCGUUAGGCCGAA IUCCAUAU 5584 1375
AUGGACAC C CUGCAGAU 5081 AUCUGCAG CUGAUGAGGCCGUUAGGCCGAA IUGUCCAU
5585 1376 UGGACACC C UGCAGAUA 5082 UAUCUGCA CUGAUGAGGCCGUUAGGCCGAA
IGUGUCCA 5586 1377 GGACACCC U GCAGAUAC 5083 GUAUCUGC
CUGAUGAGGCCGUUAGGCCGAA IGGUGUCC 5587 1380 CACCCUGC A GAUACAUG 5084
CAUGUAUC CUGAUGAGGCCGUUAGGCCGAA ICAGGGUG 5588 1386 GCAGAUAC A
UGUCAUGG 5085 CCAUGACA CUGAUGAGGCCGUUAGGCCGAA IUAUCUGC 5589 1391
UACAUGUC A UGGAGUGC 5086 GCACUCCA CUGAUGAGGCCGUUAGGCCGAA IACAUGUA
5590 1400 UGGAGUGC A UUGAGUAG 5087 CUACUCAA CUGAUGAGGCCGUUAGGCCGAA
ICACUCCA 5591 1412 AGUAGGGC C GGCCAGUG 5088 CACUGGCC
CUGAUGAGGCCGUUAGGCCGAA ICCCUACU 5592 1416 GGGCCGGC C AGUGCAAG 5089
CUUGCACU CUGAUGAGGCCGUUAGGCCGAA ICCGGCCC 5593 1417 GGCCGGCC A
GUGCAAGG 5090 CCUUGCAC CUGAUGAGGCCGUUAGGCCGAA IGCCGGCC 5594
1422 GCCAGUGC A AGGCCACU 5091 AGUGGCCU CUGAUGAGGCCGUUAGGCCGAA
ICACUGGC 5595 1427 UGCAAGGC C ACUGCCUG 5092 CAGGCAGU
CUGAUGAGGCCGUUAGGCCGAA ICCUUGCA 5596 1428 GCAAGGCC A CUGCCUGC 5093
GCAGGCAG CUGAUGAGGCCGUUAGGCCGAA IGCCUUGC 5597 1430 AAGGCCAC U
GCCUGCCC 5094 GGGCAGGC CUGAUGAGGCCGUUAGGCCGAA IUGGCCUU 5598 1433
GCCACUGC C UGCCCGAG 5095 CUCGGGCA CUGAUGAGGCCGUUAGGCCGAA ICAGUGGC
5599 1434 CCACUGCC U GCCCGAGG 5096 CCUCGGGC CUGAUGAGGCCGUUAGGCCGAA
IGCAGUGG 5600 1437 CUGCCUGC C CGAGGACG 5097 CGUCCUCG
CUGAUGAGGCCGUUAGGCCGAA ICAGGCAG 5601 1438 UGCCUGCC C GAGGACGU 5098
ACGUCCUC CUGAUGAGGCCGUUAGGCCGAA IGCAGGCA 5602 1449 GGACGUGC C
CGGGACCG 5099 CGGUCCCG CUGAUGAGGCCGUUAGGCCGAA ICACGUCC 5603 1450
GACGUGCC C GGGACCGU 5100 ACGGUCCC CUGAUGAGGCCGUUAGGCCGAA IGCACGUC
5604 1456 CCCGGGAC C GUGCAGUC 5101 GACUGCAC CUGAUGAGGCCGUUAGGCCGAA
IUCCCGGG 5605 1461 GACCGUGC A GUCUGCGC 5102 GCGCAGAC
CUGAUGAGGCCGUUAGGCCGAA ICACGGUC 5606 1465 GUGCAGUC U GCGCUUUC 5103
GAAAGCGC CUGAUGAGGCCGUUAGGCCGAA IACUGCAC 5607 1470 GUCUGCGC U
UUCCUCUC 5104 GAGAGGAA CUGAUGAGGCCGUUAGGCCGAA ICGCAGAC 5608 1474
GCGCUUUC C UCUCCCGC 5105 GCGGGAGA CUGAUGAGGCCGUUAGGCCGAA IAAAGCGC
5609 1475 CGCUUUCC U CUCCCGCC 5106 GGCGGGAG CUGAUGAGGCCGUUAGGCCGAA
IGAAAGCG 5610 1477 CUUUCCUC U CCCGCCUG 5107 CAGGCGGG
CUGAUGAGGCCGUUAGGCCGAA IAGGAAAG 5611 1479 UUCCUCUC C CGCCUGCC 5108
GGCAGGCG CUGAUGAGGCCGUUAGGCCGAA IAGAGGAA 5612 1480 UCCUCUCC C
GCCUGCCU 5109 AGGCAGGC CUGAUGAGGCCGUUAGGCCGAA IGAGAGGA 5613 1483
UCUCCCGC C UGCCUAGC 5110 GCUAGGCA CUGAUGAGGCCGUUAGGCCGAA ICGGGAGA
5614 1484 CUCCCGCC U GCCUAGCC 5111 GGCUAGGC CUGAUGAGGCCGUUAGGCCGAA
IGCGGGAG 5615 1487 CCGCCUGC C UAGCCCAG 5112 CUGGGCUA
CUGAUGAGGCCGUUAGGCCGAA ICAGGCGG 5616 1488 CGCCUGCC U AGCCCAGG 5113
CCUGGGCU CUGAUGAGGCCGUUAGGCCGAA IGCAGGCG 5617 1492 UGCCUAGC C
CAGGAUGA 5114 UCAUCCUG CUGAUGAGGCCGUUAGGCCGAA ICUAGGCA 5618 1493
GCCUAGCC C AGGAUGAA 5115 UUCAUCCU CUGAUGAGGCCGUUAGGCCGAA IGCUAGGC
5619 1494 CCUAGCCC A GGAUGAAG 5116 CUUCAUCC CUGAUGAGGCCGUUAGGCCGAA
IGGCUAGG 5620 1506 UGAAGGGC U GGGUGGCC 5117 GGCCACCC
CUGAUGAGGCCGUUAGGCCGAA ICCCUUCA 5621 1514 UGGGUGGC C ACAACUGG 5118
CCAGUUGU CUGAUGAGGCCGUUAGGCCGAA ICCACCCA 5622 1515 GGGUGGCC A
CAACUGGG 5119 CCCAGUUG CUGAUGAGGCCGUUAGGCCGAA IGCCACCC 5623 1517
GUGGCCAC A ACUGGGAU 5120 AUCCCAGU CUGAUGAGGCCGUUAGGCCGAA IUGGCCAC
5624 1520 GCCACAAC U GGGAUGCC 5121 GGCAUCCC CUGAUGAGGCCGUUAGGCCGAA
IUUGUGGC 5625 1528 UGGGAUGC C ACCUGGAG 5122 CUCCAGGU
CUGAUGAGGCCGUUAGGCCGAA ICAUCCCA 5626 1529 GGGAUGCC A CCUGGAGC 5123
GCUCCAGG CUGAUGAGGCCGUUAGGCCGAA IGCAUCCC 5627 1531 GAUGCCAC C
UGGAGCCC 5124 GGGCUCCA CUGAUGAGGCCGUUAGGCCGAA IUGGCAUC 5628 1532
AUGCCACC U GGAGCCCC 5125 GGGGCUCC CUGAUGAGGCCGUUAGGCCGAA IGUGGCAU
5629 1538 CCUGGAGC C CCACCCAG 5126 CUGGGUGG CUGAUGAGGCCGUUAGGCCGAA
ICUCCAGG 5630 1539 CUGGAGCC C CACCCAGG 5127 CCUGGGUG
CUGAUGAGGCCGUUAGGCCGAA IGCUCCAG 5631 1540 UGGAGCCC C ACCCAGGA 5128
UCCUGGGU CUGAUGAGGCCGUUAGGCCGAA IGGCUCCA 5632 1541 GGAGCCCC A
CCCAGGAG 5129 CUCCUGGG CUGAUGAGGCCGUUAGGCCGAA IGGGCUCC 5633 1543
AGCCCCAC C CAGGAGCU 5130 AGCUCCUG CUGAUGAGGCCGUUAGGCCGAA IUGGGGCU
5634 1544 GCCCCACC C AGGAGCUG 5131 CAGCUCCU CUGAUGAGGCCGUUAGGCCGAA
IGUGGGGC 5635 1545 CCCCACCC A GGAGCUGG 5132 CCAGCUCC
CUGAUGAGGCCGUUAGGCCGAA IGGUGGGG 5636 1551 CCAGGAGC U GGCCGCGG 5133
CCGCGGCC CUGAUGAGGCCGUUAGGCCGAA ICUCCUGG 5637 1555 GAGCUGGC C
GCGGCACC 5134 GGUGCCGC CUGAUGAGGCCGUUAGGCCGAA ICCAGCUC 5638 1561
GCCGCGGC A CCUUACGC 5135 GCGUAAGG CUGAUGAGGCCGUUAGGCCGAA ICCGCGGC
5639 1563 CGCGGCAC C UUACGCUU 5136 AAGCGUAA CUGAUGAGGCCGUUAGGCCGAA
IUGCCGCG 5640 1564 GCGGCACC U UACGCUUC 5137 GAAGCGUA
CUGAUGAGGCCGUUAGGCCGAA IGUGCCGC 5641 1570 CCUUACGC U UCAGCUGU 5138
ACAGCUGA CUGAUGAGGCCGUUAGGCCGAA ICGUAAGG 5642 1573 UACGCUUC A
GCUGUUGA 5139 UCAACAGC CUGAUGAGGCCGUUAGGCCGAA IAAGCGUA 5643 1576
GCUUCAGC U GUUGAUCC 5140 GGAUCAAC CUGAUGAGGCCGUUAGGCCGAA ICUGAAGC
5644 1584 UGUUGAUC C GCUGGUCC 5141 GGACCAGC CUGAUGAGGCCGUUAGGCCGAA
IAUCAACA 5645 1587 UGAUCCGC U GGUCCCCU 5142 AGGGGACC
CUGAUGAGGCCGUUAGGCCGAA ICGGAUCA 5646 1592 CGCUGGUC C CCUCUUUU 5143
AAAAGAGG CUGAUGAGGCCGUUAGGCCGAA IACCAGCG 5647 1593 GCUGGUCC C
CUCUUUUG 5144 CAAAAGAG CUGAUGAGGCCGUUAGGCCGAA IGACCAGC 5648 1594
CUGGUCCC C UCUUUUGG 5145 CCAAAAGA CUGAUGAGGCCGUUAGGCCGAA IGGACCAG
5649 1595 UGGUCCCC U CUUUUGGG 5146 CCCAAAAG CUGAUGAGGCCGUUAGGCCGAA
IGGGACCA 5650 1597 GUCCCCUC U UUUGGGGU 5147 ACCCCAAA
CUGAUGAGGCCGUUAGGCCGAA IAGGGGAC 5651 1615 GAUGCGGC C CCGAUCAG 5148
CUGAUCGG CUGAUGAGGCCGUUAGGCCGAA ICCGCAUC 5652 1616 AUGCGGCC C
CGAUCAGG 5149 CCUGAUCG CUGAUGAGGCCGUUAGGCCGAA IGCCGCAU 5653 1617
UGCGGCCC C GAUCAGGC 5150 GCCUGAUC CUGAUGAGGCCGUUAGGCCGAA IGGCCGCA
5654 1622 CCCCGAUC A GGCCUGAC 5151 GUCAGGCC CUGAUGAGGCCGUUAGGCCGAA
IAUCGGGG 5655 1626 GAUCAGGC C UGACUCGC 5152 GCGAGUCA
CUGAUGAGGCCGUUAGGCCGAA ICCUGAUC 5656 1627 AUCAGGCC U GACUCGCU 5153
AGCGAGUC CUGAUGAGGCCGUUAGGCCGAA IGCCUGAU 5657 1631 GGCCUGAC U
CGCUGCUC 5154 GAGCAGCG CUGAUGAGGCCGUUAGGCCGAA IUCAGGCC 5658 1635
UGACUCGC U GCUCUUUU 5155 AAAAGAGC CUGAUGAGGCCGUUAGGCCGAA ICGAGUCA
5659 1638 CUCGCUGC U CUUUUUGU 5156 ACAAAAAG CUGAUGAGGCCGUUAGGCCGAA
ICAGCGAG 5660 1640 CGCUGCUC U UUUUGUUC 5157 GAACAAAA
CUGAUGAGGCCGUUAGGCCGAA IAGCAGCG 5661 1649 UUUUGUUC C CUUCUGUC 5158
GACAGAAG CUGAUGAGGCCGUUAGGCCGAA IAACAAAA 5662 1650 UUUGUUCC C
UUCUGUCU 5159 AGACAGAA CUGAUGAGGCCGUUAGGCCGAA IGAACAAA 5663 1651
UUGUUCCC U UCUGUCUG 5160 CAGACAGA CUGAUGAGGCCGUUAGGCCGAA IGGAACAA
5664 1654 UUCCCUUC U GUCUGCUC 5161 GAGCAGAC CUGAUGAGGCCGUUAGGCCGAA
IAAGGGAA 5665 1658 CUUCUGUC U GCUCGAAC 5162 GUUCGAGC
CUGAUGAGGCCGUUAGGCCGAA IACAGAAG 5666 1661 CUGUCUGC U CGAACCAC 5163
GUGGUUCG CUGAUGAGGCCGUUAGGCCGAA ICAGACAG 5667 1667 GCUCGAAC C
ACUUGCCU 5164 AGGCAAGU CUGAUGAGGCCGUUAGGCCGAA IUUCGAGC 5668 1668
CUCGAACC A CUUGCCUC 5165 GAGGCAAG CUGAUGAGGCCGUUAGGCCGAA IGUUCGAG
5669 1670 CGAACCAC U UGCCUCGG 5166 CCGAGGCA CUGAUGAGGCCGUUAGGCCGAA
IUGGUUCG 5670 1674 CCACUUGC C UCGGGCUA 5167 UAGCCCGA
CUGAUGAGGCCGUUAGGCCGAA ICAAGUGG 5671 1675 CACUUGCC U CGGGCUAA 5168
UUAGCCCG CUGAUGAGGCCGUUAGGCCGAA IGCAAGUG 5672 1681 CCUCGGGC U
AAUCCCUC 5169 GAGGGAUU CUGAUGAGGCCGUUAGGCCGAA ICCCGAGG 5673 1686
GGCUAAUC C CUCCCUCU 5170 AGAGGGAG CUGAUGAGGCCGUUAGGCCGAA IAUUAGCC
5674 1687 GCUAAUCC C UCCCUCUU 5171 AAGAGGGA CUGAUGAGGCCGUUAGGCCGAA
IGAUUAGC 5675 1688 CUAAUCCC U CCCUCUUC 5172 GAAGAGGG
CUGAUGAGGCCGUUAGGCCGAA IGGAUUAG 5676 1690 AAUCCCUC C CUCUUCCU 5173
AGGAAGAG CUGAUGAGGCCGUUAGGCCGAA IAGGGAUU 5677 1691 AUCCCUCC C
UCUUCCUC 5174 GAGGAAGA CUGAUGAGGCCGUUAGGCCGAA IGAGGGAU
5678 1692 UCCCUCCC U CUUCCUCC 5175 GGAGGAAG CUGAUGAGGCCGUUAGGCCGAA
IGGAGGGA 5679 1694 CCUCCCUC U UCCUCCAC 5176 GUGGAGGA
CUGAUGAGGCCGUUAGGCCGAA IAGGGAGG 5680 1697 CCCUCUUC C UCCACCCG 5177
CGGGUGGA CUGAUGAGGCCGUUAGGCCGAA IAAGAGGG 5681 1698 CCUCUUCC U
CCACCCGG 5178 CCGGGUGG CUGAUGAGGCCGUUAGGCCGAA IGAAGAGG 5682 1700
UCUUCCUC C ACCCGGCA 5179 UGCCGGGU CUGAUGAGGCCGUUAGGCCGAA IAGGAAGA
5683 1701 CUUCCUCC A CCCGGCAC 5180 GUGCCGGG CUGAUGAGGCCGUUAGGCCGAA
IGAGGAAG 5684 1703 UCCUCCAC C CGGCACUG 5181 CAGUGCCG
CUGAUGAGGCCGUUAGGCCGAA IUGGAGGA 5685 1704 CCUCCACC C GGCACUGG 5182
CCAGUGCC CUGAUGAGGCCGUUAGGCCGAA IGUGGAGG 5686 1708 CACCCGGC A
CUGGGGAA 5183 UUCCCCAG CUGAUGAGGCCGUUAGGCCGAA ICCGGGUG 5687 1710
CCCGGCAC U GGGGAAGU 5184 ACUUCCCC CUGAUGAGGCCGUUAGGCCGAA IUGCCGGG
5688 1720 GGGAAGUC A AGAAUGGG 5185 CCCAUUCU CUGAUGAGGCCGUUAGGCCGAA
IACUUCCC 5689 1731 AAUGGGGC C UGGGGCUC 5186 GAGCCCCA
CUGAUGAGGCCGUUAGGCCGAA ICCCCAUU 5690 1732 AUGGGGCC U GGGGCUCU 5187
AGAGCCCC CUGAUGAGGCCGUUAGGCCGAA IGCCCCAU 5691 1738 CCUGGGGC U
CUCAGGGA 5188 UCCCUGAG CUGAUGAGGCCGUUAGGCCGAA ICCCCAGG 5692 1740
UGGGGCUC U CAGGGAGA 5189 UCUCCCUG CUGAUGAGGCCGUUAGGCCGAA IAGCCCCA
5693 1742 GGGCUCUC A GGGAGAAC 5190 GUUCUCCC CUGAUGAGGCCGUUAGGCCGAA
IAGAGCCC 5694 1751 GGGAGAAC U GCUUCCCC 5191 GGGGAAGC
CUGAUGAGGCCGUUAGGCCGAA IUUCUCCC 5695 1754 AGAACUGC U UCCCCUGG 5192
CCAGGGGA CUGAUGAGGCCGUUAGGCCGAA ICAGUUCU 5696 1757 ACUGCUUC C
CCUGGCAG 5193 CUGCCAGG CUGAUGAGGCCGUUAGGCCGAA IAAGCAGU 5697 1758
CUGCUUCC C CUGGCAGA 5194 UCUGCCAG CUGAUGAGGCCGUUAGGCCGAA IGAAGCAG
5698 1759 UGCUUCCC C UGGCAGAG 5195 CUCUGCCA CUGAUGAGGCCGUUAGGCCGAA
IGGAAGCA 5699 1760 GCUUCCCC U GGCAGAGC 5196 GCUCUGCC
CUGAUGAGGCCGUUAGGCCGAA IGGGAAGC 5700 1764 CCCCUGGC A GAGCUGGG 5197
CCCAGCUC CUGAUGAGGCCGUUAGGCCGAA ICCAGGGG 5701 1769 GGCAGAGC U
GGGUGGCA 5198 UGCCACCC CUGAUGAGGCCGUUAGGCCGAA ICUCUGCC 5702 1777
UGGGUGGC A GCUCUUCC 5199 GGAAGAGC CUGAUGAGGCCGUUAGGCCGAA ICCACCCA
5703 1780 GUGGCAGC U CUUCCUCC 5200 GGAGGAAG CUGAUGAGGCCGUUAGGCCGAA
ICUGCCAC 5704 1782 GGCAGCUC U UCCUCCCA 5201 UGGGAGGA
CUGAUGAGGCCGUUAGGCCGAA IAGCUGCC 5705 1785 AGCUCUUC C UCCCACCG 5202
CGGUGGGA CUGAUGAGGCCGUUAGGCCGAA IAAGAGCU 5706 1786 GCUCUUCC U
CCCACCGG 5203 CCGGUGGG CUGAUGAGGCCGUUAGGCCGAA IGAAGAGC 5707 1788
UCUUCCUC C CACCGGAC 5204 GUCCGGUG CUGAUGAGGCCGUUAGGCCGAA IAGGAAGA
5708 1789 CUUCCUCC C ACCGGACA 5205 UGUCCGGU CUGAUGAGGCCGUUAGGCCGAA
IGAGGAAG 5709 1790 UUCCUCCC A CCGGACAC 5206 GUGUCCGG
CUGAUGAGGCCGUUAGGCCGAA IGGAGGAA 5710 1792 CCUCCCAC C GGACACCG 5207
CGGUGUCC CUGAUGAGGCCGUUAGGCCGAA IUGGGAGG 5711 1797 CACCGGAC A
CCGACCCG 5208 CGGGUCGG CUGAUGAGGCCGUUAGGCCGAA IUCCGGUG 5712 1799
CCGGACAC C GACCCGCC 5209 GGCGGGUC CUGAUGAGGCCGUUAGGCCGAA IUGUCCGG
5713 1803 ACACCGAC C CGCCCGCC 5210 GGCGGGCG CUGAUGAGGCCGUUAGGCCGAA
IUCGGUGU 5714 1804 CACCGACC C GCCCGCCG 5211 CGGCGGGC
CUGAUGAGGCCGUUAGGCCGAA IGUCGGUG 5715 1807 CGACCCGC C CGCCGCUG 5212
CAGCGGCG CUGAUGAGGCCGUUAGGCCGAA ICGGGUCG 5716 1808 GACCCGCC C
GCCGCUGU 5213 ACAGCGGC CUGAUGAGGCCGUUAGGCCGAA IGCGGGUC 5717 1811
CCGCCCGC C GCUGUGCC 5214 GGCACAGC CUGAUGAGGCCGUUAGGCCGAA ICGGGCGG
5718 1814 CCCGCCGC U GUGCCCUG 5215 CAGGGCAC CUGAUGAGGCCGUUAGGCCGAA
ICGGCGGG 5719 1819 CGCUGUGC C CUGGGAGU 5216 ACUCCCAG
CUGAUGAGGCCGUUAGGCCGAA ICACAGCG 5720 1820 GCUGUGCC C UGGGAGUG 5217
CACUCCCA CUGAUGAGGCCGUUAGGCCGAA IGCACAGC 5721 1821 CUGUGCCC U
GGGAGUGC 5218 GCACUCCC CUGAUGAGGCCGUUAGGCCGAA IGGCACAG 5722 1830
GGGAGUGC U GCCCUCUU 5219 AAGAGGGC CUGAUGAGGCCGUUAGGCCGAA ICACUCCC
5723 1833 AGUGCUGC C CUCUUACC 5220 GGUAAGAG CUGAUGAGGCCGUUAGGCCGAA
ICAGCACU 5724 1834 GUGCUGCC C UCUUACCA 5221 UGGUAAGA
CUGAUGAGGCCGUUAGGCCGAA IGCAGCAC 5725 1835 UGCUGCCC U CUUACCAU 5222
AUGGUAAG CUGAUGAGGCCGUUAGGCCGAA IGGCAGCA 5726 1837 CUGCCCUC U
UACCAUGC 5223 GCAUGGUA CUGAUGAGGCCGUUAGGCCGAA IAGGGCAG 5727 1841
CCUCUUAC C AUGCACAC 5224 GUGUGCAU CUGAUGAGGCCGUUAGGCCGAA IUAAGAGG
5728 1842 CUCUUACC A UGCACACG 5225 CGUGUGCA CUGAUGAGGCCGUUAGGCCGAA
IGUAAGAG 5729 1846 UACCAUGC A CACGGGUG 5226 CACCCGUG
CUGAUGAGGCCGUUAGGCCGAA ICAUGGUA 5730 1848 CCAUGCAC A CGGGUGCU 5227
AGCACCCG CUGAUGAGGCCGUUAGGCCGAA IUGCAUGG 5731 1856 ACGGGUGC U
CUCCUUUU 5228 AAAAGGAG CUGAUGAGGCCGUUAGGCCGAA ICACCCGU 5732 1858
GGGUGCUC U CCUUUUGG 5229 CCAAAAGG CUGAUGAGGCCGUUAGGCCGAA IAGCACCC
5733 1860 GUGCUCUC C UUUUGGGC 5230 GCCCAAAA CUGAUGAGGCCGUUAGGCCGAA
IAGAGCAC 5734 1861 UGCUCUCC U UUUGGGCU 5231 AGCCCAAA
CUGAUGAGGCCGUUAGGCCGAA IGAGAGCA 5735 1869 UUUUGGGC U GCAUGCUA 5232
UAGCAUGC CUGAUGAGGCCGUUAGGCCGAA ICCCAAAA 5736 1872 UGGGCUGC A
UGCUAUUC 5233 GAAUAGCA CUGAUGAGGCCGUUAGGCCGAA ICAGCCCA 5737 1876
CUGCAUGC U AUUCCAUU 5234 AAUGGAAU CUGAUGAGGCCGUUAGGCCGAA ICAUGCAG
5738 1881 UGCUAUUC C AUUUUGCA 5235 UGCAAAAU CUGAUGAGGCCGUUAGGCCGAA
IAAUAGCA 5739 1882 GCUAUUCC A UUUUGCAG 5236 CUGCAAAA
CUGAUGAGGCCGUUAGGCCGAA IGAAUAGC 5740 1889 CAUUUUGC A GCCAGACC 5237
GGUCUGGC CUGAUGAGGCCGUUAGGCCGAA ICAAAAUG 5741 1892 UUUGCAGC C
AGACCGAU 5238 AUCGGUCU CUGAUGAGGCCGUUAGGCCGAA ICUGCAAA 5742 1893
UUGCAGCC A GACCGAUG 5239 CAUCGGUC CUGAUGAGGCCGUUAGGCCGAA IGCUGCAA
5743 1897 AGCCAGAC C GAUGUGUA 5240 UACACAUC CUGAUGAGGCCGUUAGGCCGAA
IUCUGGCU 5744 1912 UAUUUAAC C AGUCACUA 5241 UAGUGACU
CUGAUGAGGCCGUUAGGCCGAA IUUAAAUA 5745 1913 AUUUAACC A GUCACUAU 5242
AUAGUGAC CUGAUGAGGCCGUUAGGCCGAA IGUUAAAU 5746 1917 AACCAGUC A
CUAUUGAU 5243 AUCAAUAG CUGAUGAGGCCGUUAGGCCGAA IACUGGUU 5747 1919
CCAGUCAC U AUUGAUGG 5244 CCAUCAAU CUGAUGAGGCCGUUAGGCCGAA IUGACUGG
5748 1930 UGAUGGAC A UUUGGGUU 5245 AACCCAAA CUGAUGAGGCCGUUAGGCCGAA
IUCCAUCA 5749 1944 GUUGUUUC C CAUCUUUU 5246 AAAAGAUG
CUGAUGAGGCCGUUAGGCCGAA IAAACAAC 5750 1945 UUGUUUCC C AUCUUUUU 5247
AAAAAGAU CUGAUGAGGCCGUUAGGCCGAA IGAAACAA 5751 1946 UGUUUCCC A
UCUUUUUG 5248 CAAAAAGA CUGAUGAGGCCGUUAGGCCGAA IGGAAACA 5752 1949
UUCCCAUC U UUUUGUUA 5249 UAACAAAA CUGAUGAGGCCGUUAGGCCGAA IAUGGGAA
5753 1959 UUUGUUAC C AUAAAUAA 5250 UUAUUUAU CUGAUGAGGCCGUUAGGCCGAA
IUAACAAA 5754 1960 UUGUUACC A UAAAUAAU 5251 AUUAUUUA
CUGAUGAGGCCGUUAGGCCGAA IGUAACAA 5755 1972 AUAAUGGC A UAGUAAAA 5252
UUUUACUA CUGAUGAGGCCGUUAGGCCGAA ICCAUUAU 5756 Input Sequence =
NM_003639. Cut Site = CH/. Arm Length = 8. Core Sequence = CUGAUGAG
GCCGUUAGGC CGAA NM_003639 (Homo sapiens inhibitor of kappa light
polypeptide gene enhancer in B-cells, kinase gamma (IKBKG), mRNA.;
1994 bp) Underlined region can be any X sequence or linker, as
described herein. "I" stands for Inosine.
[0267] TABLE-US-00005 TABLE V Human IKK-gamma Zinzyme and Substrate
Sequence Seq Seq Pos Substrate ID Zinzyme ID 13 CGAGCAUG G CCCUUGUG
5757 CACAAGGG GCCGAAAGGCGAGUGAGGUCU CAUGCUCG 6034 19 UGGCCCUU G
UGAUCCAG 5758 CUGGAUCA GCCGAAAGGCGAGUGAGGUCU AAGGGCCA 6035 28
UGAUCCAG G UGGGGAAA 5759 UUUCCCCA GCCGAAAGGCGAGUGAGGUCU CUGGAUCA
6036 42 AAACUAAG G CCCAGAGA 5760 UCUCUGGG GCCGAAAGGCGAGUGAGGUCU
CUUAGUUU 6037 52 CCAGAGAA G UGAGGACC 5761 GGUCCUCA
GCCGAAAGGCGAGUGAGGUCU UUCUCUGG 6038 63 AGGACCCC G CAGACUAU 5762
AUAGUCUG GCCGAAAGGCGAGUGAGGUCU GGGGUCCU 6039 80 CAAUCCCA G UCUCUUCC
5763 GGAAGAGA GCCGAAAGGCGAGUGAGGUCU UGGGAUUG 6040 100 CACUCCCU G
UGAAGCUC 5764 GAGCUUCA GCCGAAAGGCGAGUGAGGUCU AGGGAGUG 6041 105
CCUGUGAA G CUCUCCAG 5765 CUGGAGAG GCCGAAAGGCGAGUGAGGUCU UUCACAGG
6042 113 GCUCUCCA G CAUCAUCG 5766 CGAUGAUG GCCGAAAGGCGAGUGAGGUCU
UGGAGAGC 6043 124 UCAUCGAG G UCCCAUCA 5767 UGAUGGGA
GCCGAAAGGCGAGUGAGGUCU CUCGAUGA 6044 133 UCCCAUCA G CCCUUGCC 5768
GGCAAGGG GCCGAAAGGCGAGUGAGGUCU UGAUGGGA 6045 139 CAGCCCUU G
CCCUGUUG 5769 CAACAGGG GCCGAAAGGCGAGUGAGGUCU AAGGGCUG 6046 144
CUUGCCCU G UUGGAUGA 5770 UCAUCCAA GCCGAAAGGCGAGUGAGGUCU AGGGCAAG
6047 157 AUGAAUAG G CACCUCUG 5771 CAGAGGUG GCCGAAAGGCGAGUGAGGUCU
CUAUUCAU 6046 171 CUGGAAGA G CCAACUGU 5772 ACAGUUGG
GCCGAAAGGCGAGUGAGGUCU UCUUCCAG 6049 178 AGCCAACU G UGUGAGAU 5773
AUCUCACA GCCGAAAGGCGAGUGAGGUCU AGUUGGCU 6050 180 CCAACUGU G
UGAGAUGG 5774 CCAUCUCA GCCGAAAGGCGAGUGAGGUCU ACAGUUGG 6051 188
GUGAGAUG G UGCAGCCC 5775 GGGCUGCA GCCGAAAGGCGAGUGAGGUCU CAUCUCAC
6052 190 GAGAUGGU G CAGCCCAG 5776 CUGGGCUG GCCGAAAGGCGAGUGAGGUCU
ACCAUCUC 6053 193 AUGGUGCA G CCCAGUGG 5777 CCACUGGG
GCCGAAAGGCGAGUGAGGUCU UGCACCAU 6054 198 GCAGCCCA G UGGUGGCC 5778
GGCCACCA GCCGAAAGGCGAGUGAGGUCU UGGGCUGC 6055 201 GCCCAGUG G
UGGCCCGG 5779 CCGGGCCA GCCGAAAGGCGAGUGAGGUCU CACUGGGC 6056 204
CAGUGGUG G CCCGGCAG 5780 CUGCCGGG GCCGAAAGGCGAGUGAGGUCU CACCACUG
6057 209 GUGGCCCG G CAGCAGAU 5781 AUCUGCUG GCCGAAAGGCGAGUGAGGUCU
CGGGCCAC 6058 212 GCCCGGCA G CAGAUCAG 5782 CUGAUCUG
GCCGAAAGGCGAGUGAGGUCU UGCCGGGC 6059 224 AUCAGGAC G UACUGGGC 5783
GCCCAGUA GCCGAAAGGCGAGUGAGGUCU GUCCUGAU 6060 231 CGUACUGG G
CGAAGAGU 5784 ACUCUUCG GCCGAAAGGCGAGUGAGGUCU CCAGUACG 6061 238
GGCGAAGA G UCUCCUCU 5785 AGAGGAGA GCCGAAAGGCGAGUGAGGUCU UCUUCGCC
6062 253 CUGGGGAA G CCAGCCAU 5786 AUGGCUGG GCCGAAAGGCGAGUGAGGUCU
UUCCCCAG 6063 257 GGAAGCCA G CCAUGCUG 5787 CAGCAUGG
GCCGAAAGGCGAGUGAGGUCU UGGCUUCC 6064 262 CCAGCCAU G CUGCACCU 5788
AGGUGCAG GCCGAAAGGCGAGUGAGGUCU AUGGCUGG 6065 265 GCCAUGCU G
CACCUGCC 5789 GGCAGGUG GCCGAAAGGCGAGUGAGGUCU AGCAUGGC 6066 271
CUGCACCU G CCUUCAGA 5790 UCUGAAGG GCCGAAAGGCGAGUGAGGUCU AGGUGCAG
6067 285 AGAACAGG G CGCUCCUG 5791 CAGGAGCG GCCGAAAGGCGAGUGAGGUCU
CCUGUUCU 6068 287 AACAGGGC G CUCCUGAG 5792 CUCAGGAG
GCCGAAAGGCGAGUGAGGUCU GCCCUGUU 6069 304 ACCCUCCA G CGCUGCCU 5793
AGGCAGCG GCCGAAAGGCGAGUGAGGUCU UGGAGGGU 6070 306 CCUCCAGC G
CUGCCUGG 5794 CCAGGCAG GCCGAAAGGCGAGUGAGGUCU GCUGGAGG 6071 309
CCAGCGCU G CCUGGAGG 5795 CCUCCAGG GCCGAAAGGCGAGUGAGGUCU AGCGCUGG
6072 328 AAUCAAGA G CUCCGAGA 5796 UCUCGGAG GCCGAAAGGCGAGUGAGGUCU
UCUUGAUU 6073 338 UCCGAGAU G CCAUCCGG 5797 CCGGAUGG
GCCGAAAGGCGAGUGAGGUCU AUCUCGGA 6074 346 GCCAUCCG G CAGAGCAA 5798
UUGCUCUG GCCGAAAGGCGAGUGAGGUCU CGGAUGGC 6075 351 CCGGCAGA G
CAACCAGA 5799 UCUGGUUG GCCGAAAGGCGAGUGAGGUCU UCUGCCGG 6076 364
CAGAUUCU G CGGGAGCG 5800 CGCUCCCG GCCGAAAGGCGAGUGAGGUCU AGAAUCUG
6077 370 CUGCGGGA G CGCUGCGA 5801 UCGCAGCG GCCGAAAGGCGAGUGAGGUCU
UCCCGCAG 6078 372 GCGGGAGC G CUGCGAGG 5802 CCUCGCAG
GCCGAAAGGCGAGUGAGGUCU GCUCCCGC 6079 375 GGAGCGCU G CGAGGAGC 5803
GCUCCUCG GCCGAAAGGCGAGUGAGGUCU AGCGCUCC 6080 382 UGCGAGGA G
CUUCUGCA 5804 UGCAGAAG GCCGAAAGGCGAGUGAGGUCU UCCUCGCA 6081 388
GAGCUUCU G CAUUUCCA 5805 UGGAAAUG GCCGAAAGGCGAGUGAGGUCU AGAAGCUC
6082 398 AUUUCCAA G CCAGCCAG 5806 CUGGCUGG GCCGAAAGGCGAGUGAGGUCU
UUGGAAAU 6083 402 CCAAGCCA G CCAGAGGG 5807 CCCUCUGG
GCCGAAAGGCGAGUGAGGUCU UGGCUUGG 6084 421 GAGAAGGA G UUCCUCAU 5808
AUGAGGAA GCCGAAAGGCGAGUGAGGUCU UCCUUCUC 6085 430 UUCCUCAU G
UGCAAGUU 5809 AACUUGCA GCCGAAAGGCGAGUGAGGUCU AUGAGGAA 6086 432
CCUCAUGU G CAAGUUCC 5810 GGAACUUG GCCGAAAGGCGAGUGAGGUCU ACAUGAGG
6087 436 AUGUGCAA G UUCCAGGA 5811 UCCUGGAA GCCGAAAGGCGAGUGAGGUCU
UUGCACAU 6088 446 UCCAGGAG G CCAGGAAA 5812 UUUCCUGG
GCCGAAAGGCGAGUGAGGUCU CUCCUGGA 6089 458 GGAAACUG G UGGAGAGA 5813
UCUCUCCA GCCGAAAGGCGAGUGAGGUCU CAGUUUCC 6090 471 GAGACUCG G
CCUGGAGA 5814 UCUCCAGG GCCGAAAGGCGAGUGAGGUCU CGAGUCUC 6091 481
CUGGAGAA G CUCGAUCU 5815 AGAUCGAG GCCGAAAGGCGAGUGAGGUCU UUCUCCAG
6092 496 CUGAAGAG G CAGAAGGA 5816 UCCUUCUG GCCGAAAGGCGAGUGAGGUCU
CUCUUCAG 6093 505 CAGAAGGA G CAGGCUCU 5817 AGAGCCUG
GCCGAAAGGCGAGUGAGGUCU UCCUUCUG 6094 509 AGGAGCAG G CUCUGCGG 5818
CCGCAGAG GCCGAAAGGCGAGUGAGGUCU CUGCUCCU 6095 514 CAGGCUCU G
CGGGAGGU 5819 ACCUCCCG GCCGAAAGGCGAGUGAGGUCU AGAGCCUG 6096 521
UGCGGGAG G UGGAGCAC 5820 GUGCUCCA GCCGAAAGGCGAGUGAGGUCU CUCCCGCA
6097 526 GAGGUGGA G CACCUGAA 5821 UUCAGGUG GCCGAAAGGCGAGUGAGGUCU
UCCACCUC 6098 540 GAAGAGAU G CCAGCAGC 5822 GCUGCUGG
GCCGAAAGGCGAGUGAGGUCU AUCUCUUC 6099 544 AGAUGCCA G CAGCAGAU 5823
AUCUGCUG GCCGAAAGGCGAGUGAGGUCU UGGCAUCU 6100 547 UGCCAGCA G
CAGAUGGC 5824 GCCAUCUG GCCGAAAGGCGAGUGAGGUCU UGCUGGCA 6101 554
AGCAGAUG G CUGAGGAC 5825 GUCCUCAG GCCGAAAGGCGAGUGAGGUCU CAUCUGCU
6102 566 AGGACAAG G CCUCUGUG 5826 CACAGAGG GCCGAAAGGCGAGUGAGGUCU
CUUGUCCU 6103 572 AGGCCUCU G UGAAAGCC 5827 GGCUUUCA
GCCGAAAGGCGAGUGAGGUCU AGAGGCCU 6104 578 CUGUGAAA G CCCAGGUG 5828
CACCUGGG GCCGAAAGGCGAGUGAGGUCU UUUCACAG 6105 584 AAGCCCAG G
UGACGUCC 5829 GGACGUCA GCCGAAAGGCGAGUGAGGUCU CUGGGCUU 6106 589
CAGGUGAC G UCCUUGCU 5830 AGCAAGGA GCCGAAAGGCGAGUGAGGUCU GUCACCUG
6107 595 ACGUCCUU G CUCGGGGA 5831 UCCCCGAG GCCGAAAGGCGAGUGAGGUCU
AAGGACGU 6108 604 CUCGGGGA G CUGCAGGA 5832 UCCUGCAG
GCCGAAAGGCGAGUGAGGUCU UCCCCGAG 6109 607 GGGGAGCU G CAGGAGAG 5833
CUCUCCUG GCCGAAAGGCGAGUGAGGUCU AGCUCCCC 6110 615 GCAGGAGA G
CCAGAGUC 5834 GACUCUGG GCCGAAAGGCGAGUGAGGUCU UCUCCUGC 6111 621
GAGCCAGA G UCGCUUGG 5835 CCAAGCGA GCCGAAAGGCGAGUGAGGUCU UCUGGCUC
6112 624 CCAGAGUC G CUUGGAGG 5836 CCUCCAAG GCCGAAAGGCGAGUGAGGUCU
GACUCUGG 6113 632 GCUUGGAG G CUGCCACU 5837 AGUGGCAG
GCCGAAAGGCGAGUGAGGUCU CUCCAAGC 6114 635 UGGAGGCU G CCACUAAG 5838
CUUAGUGG GCCGAAAGGCGAGUGAGGUCU AGCCUCCA 6115 648 UAAGGAAU G
CCAGGCUC 5839 GAGCCUGG GCCGAAAGGCGAGUGAGGUCU AUUCCUUA 6116 653
AAUGCCAG G CUCUGGAG 5840 CUCCAGAG GCCGAAAGGCGAGUGAGGUCU CUGGCAUU
6117 663 UCUGGAGG G UCGGGCCC 5841 GGGCCCGA GCCGAAAGGCGAGUGAGGUCU
CCUCCAGA 6118 668 AGGGUCGG G CCCGGGCG 5842 CGCCCGGG
GCCGAAAGGCGAGUGAGGUCU CCGACCCU 6119 674 GGGCCCGG G CGGCCAGC 5843
GCUGGCCG GCCGAAAGGCGAGUGAGGUCU CCGGGCCC 6120 677 CCCGGGCG G
CCAGCGAG 5844 CUCGCUGG GCCGAAAGGCGAGUGAGGUCU CGCCCGGG 6121 681
GGCGGCCA G CGAGCAGG 5845 CCUGCUCG GCCGAAAGGCGAGUGAGGUCU UGGCCGCC
6122 685 GCCAGCGA G CAGGCGCG 5846 CGCGCCUG GCCGAAAGGCGAGUGAGGUCU
UCGCUGGC 6123 689 GCGAGCAG G CGCGGCAG 5847 CUGCCGCG
GCCGAAAGGCGAGUGAGGUCU CUGCUCGC 6124 691 GAGCAGGC G CGGCAGCU 5848
AGCUGCCG GCCGAAAGGCGAGUGAGGUCU GCCUGCUC 6125 694 CAGGCGCG G
CAGCUGGA 5849 UCCAGCUG GCCGAAAGGCGAGUGAGGUCU CGCGCCUG 6126 697
GCGCGGCA G CUGGAGAG 5850 CUCUCCAG GCCGAAAGGCGAGUGAGGUCU UGCCGCGC
6127 705 GCUGGAGA G UGAGCGCG 5851 CGCGCUCA GCCGAAAGGCGAGUGAGGUCU
UCUCCAGC 6128 709 GAGAGUGA G CGCGAGGC 5852 GCCUCGCG
GCCGAAAGGCGAGUGAGGUCU UCACUCUC 6129 711 GAGUGAGC G CGAGGCGC 5853
GCGCCUCG GCCGAAAGGCGAGUGAGGUCU GCUCACUC 6130 716 AGCGCGAG G
CGCUGCAG 5854 CUGCAGCG GCCGAAAGGCGAGUGAGGUCU CUCGCGCU 6131 718
CGCGAGGC G CUGCAGCA 5855 UGCUGCAG GCCGAAAGGCGAGUGAGGUCU GCCUCGCG
6132 721 GAGGCGCU G CAGCAGCA 5856 UGCUGCUG GCCGAAAGGCGAGUGAGGUCU
AGCGCCUC 6133 724 GCGCUGCA G CAGCAGCA 5857 UGCUGCUG
GCCGAAAGGCGAGUGAGGUCU UGCAGCGC 6134 727 CUGCAGCA G CAGCACAG 5858
CUGUGCUG GCCGAAAGGCGAGUGAGGUCU UGCUGCAG 6135 730 CAGCAGCA G
CACAGCGU 5859 ACGCUGUG GCCGAAAGGCGAGUGAGGUCU UGCUGCUG 6136 735
GCAGCACA G CGUGCAGG 5860 CCUGCACG GCCGAAAGGCGAGUGAGGUCU UGUGCUGC
6137 737 AGCACAGC G UGCAGGUG 5861 CACCUGCA GCCGAAAGGCGAGUGAGGUCU
GCUGUGCU 6138 739 CACAGCGU G CAGGUGGA 5862 UCCACCUG
GCCGAAAGGCGAGUGAGGUCU ACGCUGUG 6139 743 GCGUGCAG G UGGACCAG 5863
CUGGUCCA GCCGAAAGGCGAGUGAGGUCU CUGCACGC 6140 751 GUGGACCA G
CUGCGCAU 5864 AUGCGCAG GCCGAAAGGCGAGUGAGGUCU UGGUCCAC 6141 754
GACCAGCU G CGCAUGCA 5865 UGCAUGCG GCCGAAAGGCGAGUGAGGUCU AGCUGGUC
6142 756 CCAGCUGC G CAUGCAGG 5866 CCUGCAUG GCCGAAAGGCGAGUGAGGUCU
GCAGCUGG 6143 760 CUGCGCAU G CAGGGCCA 5867 UGGCCCUG
GCCGAAAGGCGAGUGAGGUCU AUGCGCAG 6144 765 CAUGCAGG G CCAGAGCG 5868
CGCUCUGG GCCGAAAGGCGAGUGAGGUCU CCUGCAUG 6145 771 GGGCCAGA G
CGUGGAGG 5869 CCUCCACG GCCGAAAGGCGAGUGAGGUCU UCUGGCCC 6146 773
GCCAGAGC G UGGAGGCC 5870 GGCCUCCA GCCGAAAGGCGAGUGAGGUCU GCUCUGGC
6147 779 GCGUGGAG G CCGCGCUC 5871 GAGCGCGG GCCGAAAGGCGAGUGAGGUCU
CUCCACGC 6148 782 UGGAGGCC G CGCUCCGC 5872 GCGGAGCG
GCCGAAAGGCGAGUGAGGUCU GGCCUCCA 6149 784 GAGGCCGC G CUCCGCAU 5873
AUGCGGAG GCCGAAAGGCGAGUGAGGUCU GCGGCCUC 6150 789 CGCGCUCC G
CAUGGAGC 5874 GCUCCAUG GCCGAAAGGCGAGUGAGGUCU GGAGCGCG 6151 796
CGCAUGGA G CGCCAGGC 5875 GCCUGGCG GCCGAAAGGCGAGUGAGGUCU UCCAUGCG
6152 798 CAUGGAGC G CCAGGCCG 5876 CGGCCUGG GCCGAAAGGCGAGUGAGGUCU
GCUCCAUG 6153 803 AGCGCCAG G CCGCCUCG 5877 CGAGGCGG
GCCGAAAGGCGAGUGAGGUCU CUGGCGCU 6154 806 GCCAGGCC G CCUCGGAG 5878
CUCCGAGG GCCGAAAGGCGAGUGAGGUCU GGCCUGGC 6155
826 AAGAGGAA G CUGGCCCA 5879 UGGGCCAG GCCGAAAGGCGAGUGAGGUCU
UUCCUCUU 6156 830 GGAAGCUG G CCCAGUUG 5880 CAACUGGG
GCCGAAAGGCGAGUGAGGUCU CAGCUUCC 6157 835 CUGGCCCA G UUGCAGGU 5881
ACCUGCAA GCCGAAAGGCGAGUGAGGUCU UGGGCCAG 6158 838 GCCCAGUU G
CAGGUGGC 5882 GCCACCUG GCCGAAAGGCGAGUGAGGUCU AACUGGGC 6159 842
AGUUGCAG G UGGCCUAU 5883 AUAGGCCA GCCGAAAGGCGAGUGAGGUCU CUGCAACU
6160 845 UGCAGGUG G CCUAUCAC 5884 GUGAUAGG GCCGAAAGGCGAGUGAGGUCU
CACCUGCA 6161 856 UAUCACCA G CUCUUCCA 5885 UGGAAGAG
GCCGAAAGGCGAGUGAGGUCU UGGUGAUA 6162 888 CAUCAAGA G CAGCGUGG 5886
CCACGCUG GCCGAAAGGCGAGUGAGGUCU UCUUGAUG 6163 891 CAAGAGCA G
CGUGGUGG 5887 CCACCACG GCCGAAAGGCGAGUGAGGUCU UGCUCUUG 6164 893
AGAGCAGC G UGGUGGGC 5888 GCCCACCA GCCGAAAGGCGAGUGAGGUCU GCUGCUCU
6165 896 GCAGCGUG G UGGGCAGU 5889 ACUGCCCA GCCGAAAGGCGAGUGAGGUCU
CACGCUGC 6166 900 CGUGGUGG G CAGUGAGC 5890 GCUCACUG
GCCGAAAGGCGAGUGAGGUCU CCACCACG 6167 903 GGUGGGCA G UGAGCGGA 5891
UCCGCUCA GCCGAAAGGCGAGUGAGGUCU UGCCCACC 6168 907 GGCAGUGA G
CGGAAGCG 5892 CGCUUCCG GCCGAAAGGCGAGUGAGGUCU UCACUGCC 6169 913
GAGCGGAA G CGAGGAAU 5893 AUUCCUCG GCCGAAAGGCGAGUGAGGUCU UUCCGCUC
6170 922 CGAGGAAU G CAGCUGGA 5894 UCCAGCUG GCCGAAAGGCGAGUGAGGUCU
AUUCCUCG 6171 925 GGAAUGCA G CUGGAAGA 5895 UCUUCCAG
GCCGAAAGGCGAGUGAGGUCU UGCAUUCC 6172 943 CUCAAACA G CAGCUCCA 5896
UGGAGCUG GCCGAAAGGCGAGUGAGGUCU UGUUUGAG 6173 946 AAACAGCA G
CUCCAGCA 5897 UGCUGGAG GCCGAAAGGCGAGUGAGGUCU UGCUGUUU 6174 952
CAGCUCCA G CAGGCCGA 5898 UCGGCCUG GCCGAAAGGCGAGUGAGGUCU UGGAGCUG
6175 956 UCCAGCAG G CCGAGGAG 5899 CUCCUCGG GCCGAAAGGCGAGUGAGGUCU
CUGCUGGA 6176 965 CCGAGGAG G CCCUGGUG 5900 CACCAGGG
GCCGAAAGGCGAGUGAGGUCU CUCCUCGG 6177 971 AGGCCCUG G UGGCCAAA 5901
UUUGGCCA GCCGAAAGGCGAGUGAGGUCU CAGGGCCU 6178 974 CCCUGGUG G
CCAAACAG 5902 CUGUUUGG GCCGAAAGGCGAGUGAGGUCU CACCAGGG 6179 986
AACAGGAG G UGAUCGAU 5903 AUCGAUCA GCCGAAAGGCGAGUGAGGUCU CUCCUGUU
6180 997 AUCGAUAA G CUGAAGGA 5904 UCCUUCAG GCCGAAAGGCGAGUGAGGUCU
UUAUCGAU 6181 1010 AGGAGGAG G CCGAGCAG 5905 CUGCUCGG
GCCGAAAGGCGAGUGAGGUCU CUCCUCCU 6182 1015 GAGGCCGA G CAGCACAA 5906
UUGUGCUG GCCGAAAGGCGAGUGAGGUCU UCGGCCUC 6183 1018 GCCGAGCA G
CACAAGAU 5907 AUCUUGUG GCCGAAAGGCGAGUGAGGUCU UGCUCGGC 6184 1028
ACAAGAUU G UGAUGGAG 5908 CUCCAUCA GCCGAAAGGCGAGUGAGGUCU AAUCUUGU
6185 1040 UGGAGACC G UUCCGGUG 5909 CACCGGAA GCCGAAAGGCGAGUGAGGUCU
GGUCUCCA 6186 1046 CCGUUCCG G UGCUGAAG 5910 CUUCAGCA
GCCGAAAGGCGAGUGAGGUCU CGGAACGG 6187 1048 GUUCCGGU G CUGAAGGC 5911
GCCUUCAG GCCGAAAGGCGAGUGAGGUCU ACCGGAAC 6188 1055 UGCUGAAG G
CCCAGGCG 5912 CGCCUGGG GCCGAAAGGCGAGUGAGGUCU CUUCAGCA 6189 1061
AGGCCCAG G CGGAUAUC 5913 GAUAUCCG GCCGAAAGGCGAGUGAGGUCU CUGGGCCU
6190 1076 UCUACAAG G CGGACUUC 5914 GAAGUCCG GCCGAAAGGCGAGUGAGGUCU
CUUGUAGA 6191 1088 ACUUCCAG G CUGAGAGG 5915 CCUCUCAG
GCCGAAAGGCGAGUGAGGUCU CUGGAAGU 6192 1096 GCUGAGAG G CAGGCCCG 5916
CGGGCCUG GCCGAAAGGCGAGUGAGGUCU CUCUCAGC 6193 1100 AGAGGCAG G
CCCGGGAG 5917 CUCCCGGG GCCGAAAGGCGAGUGAGGUCU CUGCCUCU 6194 1111
CGGGAGAA G CUGGCCGA 5918 UCGGCCAG GCCGAAAGGCGAGUGAGGUCU UUCUCCCG
6195 1115 AGAAGCUG G CCGAGAAG 5919 CUUCUCGG GCCGAAAGGCGAGUGAGGUCU
CAGCUUCU 6196 1129 AAGAAGGA G CUCCUGCA 5920 UGCAGGAG
GCCGAAAGGCGAGUGAGGUCU UCCUUCUU 6197 1135 GAGCUCCU G CAGGAGCA 5921
UGCUCCUG GCCGAAAGGCGAGUGAGGUCU AGGAGCUC 6198 1141 CUGCAGGA G
CAGCUGGA 5922 UCCAGCUG GCCGAAAGGCGAGUGAGGUCU UCCUGCAG 6199 1144
CAGGAGCA G CUGGAGCA 5923 UGCUCCAG GCCGAAAGGCGAGUGAGGUCU UGCUCCUG
6200 1150 CAGCUGGA G CAGCUGCA 5924 UGCAGCUG GCCGAAAGGCGAGUGAGGUCU
UCCAGCUG 6201 1153 CUGGAGCA G CUGCAGAG 5925 CUCUGCAG
GCCGAAAGGCGAGUGAGGUCU UGCUCCAG 6202 1156 GAGCAGCU G CAGAGGGA 5926
UCCCUCUG GCCGAAAGGCGAGUGAGGUCU AGCUGCUC 6203 1165 CAGAGGGA G
UACAGCAA 5927 UUGCUGUA GCCGAAAGGCGAGUGAGGUCU UCCCUCUG 6204 1170
GGAGUACA G CAAACUGA 5928 UCAGUUUG GCCGAAAGGCGAGUGAGGUCU UGUACUCC
6205 1181 AACUGAAG G CCAGCUGU 5929 ACAGCUGG GCCGAAAGGCGAGUGAGGUCU
CUUCAGUU 6206 1185 GAAGGCCA G CUGUCAGG 5930 CCUGACAG
GCCGAAAGGCGAGUGAGGUCU UGGCCUUC 6207 1188 GGCCAGCU G UCAGGAGU 5931
ACUCCUGA GCCGAAAGGCGAGUGAGGUCU AGCUGGCC 6208 1195 UGUCAGGA G
UCGGCCAG 5932 CUGGCCGA GCCGAAAGGCGAGUGAGGUCU UCCUGACA 6209 1199
AGGAGUCG G CCAGGAUC 5933 GAUCCUGG GCCGAAAGGCGAGUGAGGUCU CGACUCCU
6210 1222 AUGAGGAA G CGGCAUGU 5934 ACAUGCCG GCCGAAAGGCGAGUGAGGUCU
UUCCUCAU 6211 1225 AGGAAGCG G CAUGUCGA 5935 UCGACAUG
GCCGAAAGGCGAGUGAGGUCU CGCUUCCU 6212 1229 AGCGGCAU G UCGAGGUC 5936
GACCUCGA GCCGAAAGGCGAGUGAGGUCU AUGCCGCU 6213 1235 AUGUCGAG G
UCUCCCAG 5937 CUGGGAGA GCCGAAAGGCGAGUGAGGUCU CUCGACAU 6214 1244
UCUCCCAG G CCCCCUUG 5938 CAAGGGGG GCCGAAAGGCGAGUGAGGUCU CUGGGAGA
6215 1252 GCCCCCUU G CCCCCCGC 5939 GCGGGGGG GCCGAAAGGCGAGUGAGGUCU
AAGGGGGC 6216 1259 UGCCCCCC G CCCCUGCC 5940 GGCAGGGG
GCCGAAAGGCGAGUGAGGUCU GGGGGGCA 6217 1265 CCGCCCCU G CCUACCUC 5941
GAGGUAGG GCCGAAAGGCGAGUGAGGUCU AGGGGCGG 6218 1286 CUCCCCUG G
CCCUGCCC 5942 GGGCAGGG GCCGAAAGGCGAGUGAGGUCU CAGGGGAG 6219 1291
CUGGCCCU G CCCAGCCA 5943 UGGCUGGG GCCGAAAGGCGAGUGAGGUCU AGGGCCAG
6220 1296 CCUGCCCA G CCAGAGGA 5944 UCCUCUGG GCCGAAAGGCGAGUGAGGUCU
UGGGCAGG 6221 1308 GAGGAGGA G CCCCCCCG 5945 CGGGGGGG
GCCGAAAGGCGAGUGAGGUCU UCCUCCUC 6222 1321 CCCGAGGA G CCACCUGA 5946
UCAGGUGG GCCGAAAGGCGAGUGAGGUCU UCCUCGGG 6223 1335 UGACUUCU G
CUGUCCCA 5947 UGGGACAG GCCGAAAGGCGAGUGAGGUCU AGAAGUCA 6224 1338
CUUCUGCU G UCCCAAGU 5948 ACUUGGGA GCCGAAAGGCGAGUGAGGUCU AGCAGAAG
6225 1345 UGUCCCAA G UGCCAGUA 5949 UACUGGCA GCCGAAAGGCGAGUGAGGUCU
UUGGGACA 6226 1347 UCCCAAGU G CCAGUAUC 5950 GAUACUGG
GCCGAAAGGCGAGUGAGGUCU ACUUGGGA 6227 1351 AAGUGCCA G UAUCAGGC 5951
GCCUGAUA GCCGAAAGGCGAGUGAGGUCU UGGCACUU 6228 1358 AGUAUCAG G
CCCCUGAU 5952 AUCAGGGG GCCGAAAGGCGAGUGAGGUCU CUGAUACU 6229 1378
GACACCCU G CAGAUACA 5953 UGUAUCUG GCCGAAAGGCGAGUGAGGUCU AGGGUGUC
6230 1388 AGAUACAU G UCAUGGAG 5954 CUCCAUGA GCCGAAAGGCGAGUGAGGUCU
AUGUAUCU 6231 1396 GUCAUGGA G UGCAUUGA 5955 UCAAUGCA
GCCGAAAGGCGAGUGAGGUCU UCCAUGAC 6232 1398 CAUGGAGU G CAUUGAGU 5956
ACUCAAUG GCCGAAAGGCGAGUGAGGUCU ACUCCAUG 6233 1405 UGCAUUGA G
UAGGGCCG 5957 CGGCCCUA GCCGAAAGGCGAGUGAGGUCU UCAAUGCA 6234 1410
UGAGUAGG G CCGGCCAG 5958 CUGGCCGG GCCGAAAGGCGAGUGAGGUCU CCUACUCA
6235 1414 UAGGGCCG G CCAGUGCA 5959 UGCACUGG GCCGAAAGGCGAGUGAGGUCU
CGGCCCUA 6236 1418 GCCGGCCA G UGCAAGGC 5960 GCCUUGCA
GCCGAAAGGCGAGUGAGGUCU UGGCCGGC 6237 1420 CGGCCAGU G CAAGGCCA 5961
UGGCCUUG GCCGAAAGGCGAGUGAGGUCU ACUGGCCG 6238 1425 AGUGCAAG G
CCACUGCC 5962 GGCAGUGG GCCGAAAGGCGAGUGAGGUCU CUUGCACU 6239 1431
AGGCCACU G CCUGCCCG 5963 CGGGCAGG GCCGAAAGGCGAGUGAGGUCU AGUGGCCU
6240 1435 CACUGCCU G CCCGAGGA 5964 UCCUCGGG GCCGAAAGGCGAGUGAGGUCU
AGGCAGUG 6241 1445 CCGAGGAC G UGCCCGGG 5965 CCCGGGCA
GCCGAAAGGCGAGUGAGGUCU GUCCUCGG 6242 1447 GAGGACGU G CCCGGGAC 5966
GUCCCGGG GCCGAAAGGCGAGUGAGGUCU ACGUCCUC 6243 1457 CCGGGACC G
UGCAGUCU 5967 AGACUGCA GCCGAAAGGCGAGUGAGGUCU GGUCCCGG 6244 1459
GGGACCGU G CAGUCUGC 5968 GCAGACUG GCCGAAAGGCGAGUGAGGUCU ACGGUCCC
6245 1462 ACCGUGCA G UCUGCGCU 5969 AGCGCAGA GCCGAAAGGCGAGUGAGGUCU
UGCACGGU 6246 1466 UGCAGUCU G CGCUUUCC 5970 GGAAAGCG
GCCGAAAGGCGAGUGAGGUCU AGACUGCA 6247
1468 CAGUCUGC G CUUUCCUC 5971 GAGGAAAG GCCGAAAGGCGAGUGAGGUCU
GCAGACUG 6248 1481 CCUCUCCC G CCUGCCUA 5972 UAGGCAGG
GCCGAAAGGCGAGUGAGGUCU GGGAGAGG 6249 1485 UCCCGCCU G CCUAGCCC 5973
GGGCUAGG GCCGAAAGGCGAGUGAGGUCU AGGCGGGA 6250 1490 CCUGCCUA G
CCCAGGAU 5974 AUCCUGGG GCCGAAAGGCGAGUGAGGUCU UAGGCAGG 6251 1504
GAUGAAGG G CUGGGUGG 5975 CCACCCAG GCCGAAAGGCGAGUGAGGUCU CCUUCAUC
6252 1509 AGGGCUGG G UGGCCACA 5976 UGUGGCCA GCCGAAAGGCGAGUGAGGUCU
CCAGCCCU 6253 1512 GCUGGGUG G CCACAACU 5977 AGUUGUGG
GCCGAAAGGCGAGUGAGGUCU CACCCAGC 6254 1526 ACUGGGAU G CCACCUGG 5978
CCAGGUGG GCCGAAAGGCGAGUGAGGUCU AUCCCAGU 6255 1536 CACCUGGA G
CCCCACCC 5979 GGGUGGGG GCCGAAAGGCGAGUGAGGUCU UCCAGGUG 6256 1549
ACCCAGGA G CUGGCCGC 5980 GCGGCCAG GCCGAAAGGCGAGUGAGGUCU UCCUGGGU
6257 1553 AGGAGCUG G CCGCGGCA 5981 UGCCGCGG GCCGAAAGGCGAGUGAGGUCU
CAGCUCCU 6258 1556 AGCUGGCC G CGGCACCU 5982 AGGUGCCG
GCCGAAAGGCGAGUGAGGUCU GGCCAGCU 6259 1559 UGGCCGCG G CACCUUAC 5983
GUAAGGUG GCCGAAAGGCGAGUGAGGUCU CGCGGCCA 6260 1568 CACCUUAC G
CUUCAGCU 5984 AGCUGAAG GCCGAAAGGCGAGUGAGGUCU GUAAGGUG 6261 1574
ACGCUUCA G CUGUUGAU 5985 AUCAACAG GCCGAAAGGCGAGUGAGGUCU UGAAGCGU
6262 1577 CUUCAGCU G UUGAUCCG 5986 CGGAUCAA GCCGAAAGGCGAGUGAGGUCU
AGCUGAAG 6263 1585 GUUGAUCC G CUGGUCCC 5987 GGGACCAG
GCCGAAAGGCGAGUGAGGUCU GGAUCAAC 6264 1589 AUCCGCUG G UCCCCUCU 5988
AGAGGGGA GCCGAAAGGCGAGUGAGGUCU CAGCGGAU 6265 1604 CUUUUGGG G
UAGAUGCG 5989 CGCAUCUA GCCGAAAGGCGAGUGAGGUCU CCCAAAAG 6266 1610
GGGUAGAU G CGGCCCCG 5990 CGGGGCCG GCCGAAAGGCGAGUGAGGUCU AUCUACCC
6267 1613 UAGAUGCG G CCCCGAUC 5991 GAUCGGGG GCCGAAAGGCGAGUGAGGUCU
CGCAUCUA 6268 1624 CCGAUCAG G CCUGACUC 5992 GAGUCAGG
GCCGAAAGGCGAGUGAGGUCU CUGAUCGG 6269 1633 CCUGACUC G CUGCUCUU 5993
AAGAGCAG GCCGAAAGGCGAGUGAGGUCU GAGUCAGG 6270 1636 GACUCGCU G
CUCUUUUU 5994 AAAAAGAG GCCGAAAGGCGAGUGAGGUCU AGCGAGUC 6271 1645
CUCUUUUU G UUCCCUUC 5995 GAAGGGAA GCCGAAAGGCGAGUGAGGUCU AAAAAGAG
6272 1655 UCCCUUCU G UCUGCUCG 5996 CGAGCAGA GCCGAAAGGCGAGUGAGGUCU
AGAAGGGA 6273 1659 UUCUGUCU G CUCGAACC 5997 GGUUCGAG
GCCGAAAGGCGAGUGAGGUCU AGACAGAA 6274 1672 AACCACUU G CCUCGGGC 5998
GCCCGAGG GCCGAAAGGCGAGUGAGGUCU AAGUGGUU 6275 1679 UGCCUCGG G
CUAAUCCC 5999 GGGAUUAG GCCGAAAGGCGAGUGAGGUCU CCGAGGCA 6276 1706
UCCACCCG G CACUGGGG 6000 CCCCAGUG GCCGAAAGGCGAGUGAGGUCU CGGGUGGA
6277 1717 CUGGGGAA G UCAAGAAU 6001 AUUCUUGA GCCGAAAGGCGAGUGAGGUCU
UUCCCCAG 6278 1729 AGAAUGGG G CCUGGGGC 6002 GCCCCAGG
GCCGAAAGGCGAGUGAGGUCU CCCAUUCU 6279 1736 GGCCUGGG G CUCUCAGG 6003
CCUGAGAG GCCGAAAGGCGAGUGAGGUCU CCCAGGCC 6280 1752 GGAGAACU G
CUUCCCCU 6004 AGGGGAAG GCCGAAAGGCGAGUGAGGUCU AGUUCUCC 6281 1762
UUCCCCUG G CAGAGCUG 6005 CAGCUCUG GCCGAAAGGCGAGUGAGGUCU CAGGGGAA
6282 1767 CUGGCAGA G CUGGGUGG 6006 CCACCCAG GCCGAAAGGCGAGUGAGGUCU
UCUGCCAG 6283 1772 AGAGCUGG G UGGCAGCU 6007 AGCUGCCA
GCCGAAAGGCGAGUGAGGUCU CCAGCUCU 6284 1775 GCUGGGUG G CAGCUCUU 6008
AAGAGCUG GCCGAAAGGCGAGUGAGGUCU CACCCAGC 6285 1778 GGGUGGCA G
CUCUUCCU 6009 AGGAAGAG GCCGAAAGGCGAGUGAGGUCU UGCCACCC 6286 1805
ACCGACCC G CCCGCCGC 6010 GCGGCGGG GCCGAAAGGCGAGUGAGGUCU GGGUCGGU
6287 1809 ACCCGCCC G CCGCUGUG 6011 CACAGCGG GCCGAAAGGCGAGUGAGGUCU
GGGCGGGU 6288 1812 CGCCCGCC G CUGUGCCC 6012 GGGCACAG
GCCGAAAGGCGAGUGAGGUCU GGCGGGCG 6289 1815 CCGCCGCU G UGCCCUGG 6013
CCAGGGCA GCCGAAAGGCGAGUGAGGUCU AGCGGCGG 6290 1817 GCCGCUGU G
CCCUGGGA 6014 UCCCAGGG GCCGAAAGGCGAGUGAGGUCU ACAGCGGC 6291 1826
CCCUGGGA G UGCUGCCC 6015 GGGCAGCA GCCGAAAGGCGAGUGAGGUCU UCCCAGGG
6292 1828 CUGGGAGU G CUGCCCUC 6016 GAGGGCAG GCCGAAAGGCGAGUGAGGUCU
ACUCCCAG 6293 1831 GGAGUGCU G CCCUCUUA 6017 UAAGAGGG
GCCGAAAGGCGAGUGAGGUCU AGCACUCC 6294 1844 CUUACCAU G CACACGGG 6018
CCCGUGUG GCCGAAAGGCGAGUGAGGUCU AUGGUAAG 6295 1852 GCACACGG G
UGCUCUCC 6019 GGAGAGCA GCCGAAAGGCGAGUGAGGUCU CCGUGUGC 6296 1854
ACACGGGU G CUCUCCUU 6020 AAGGAGAG GCCGAAAGGCGAGUGAGGUCU ACCCGUGU
6297 1867 CCUUUUGG G CUGCAUGC 6021 GCAUGCAG GCCGAAAGGCGAGUGAGGUCU
CCAAAAGG 6298 1870 UUUGGGCU G CAUGCUAU 6022 AUAGCAUG
GCCGAAAGGCGAGUGAGGUCU AGCCCAAA 6299 1874 GGCUGCAU G CUAUUCCA 6023
UGGAAUAG GCCGAAAGGCGAGUGAGGUCU AUGCAGCC 6300 1887 UCCAUUUU G
CAGCCAGA 6024 UCUGGCUG GCCGAAAGGCGAGUGAGGUCU AAAAUGGA 6301 1890
AUUUUGCA G CCAGACCG 6025 CGGUCUGG GCCGAAAGGCGAGUGAGGUCU UGCAAAAU
6302 1901 AGACCGAU G UGUAUUUA 6026 UAAAUACA GCCGAAAGGCGAGUGAGGUCU
AUCGGUCU 6303 1903 ACCGAUGU G UAUUUAAC 6027 GUUAAAUA
GCCGAAAGGCGAGUGAGGUCU ACAUCGGU 6304 1914 UUUAACCA G UCACUAUU 6028
AAUAGUGA GCCGAAAGGCGAGUGAGGUCU UGGUUAAA 6305 1936 ACAUUUGG G
UUGUUUCC 6029 GGAAACAA GCCGAAAGGCGAGUGAGGUCU CCAAAUGU 6306 1939
UUUGGGUU G UUUCCCAU 6030 AUGGGAAA GCCGAAAGGCGAGUGAGGUCU AACCCAAA
6307 1954 AUCUUUUU G UUACCAUA 6031 UAUGGUAA GCCGAAAGGCGAGUGAGGUCU
AAAAAGAU 6308 1970 AAAUAAUG G CAUAGUAA 6032 UUACUAUG
GCCGAAAGGCGAGUGAGGUCU CAUUAUUU 6309 1975 AUGGCAUA G UAAAAAAA 6033
UUUUUUUA GCCGAAAGGCGAGUGAGGUCU UAUGCCAU 6310 Input Sequence =
NM_003639. Cut Site = G/Y Arm Length = 8. Core Sequence =
GCcgaaagGCGaGuCaaGGuCu NM_003639 (Homo sapiens inhibitor of kappa
light polypeptide gene enhancer in B-cells, kinase gamma (IKBKG),
mRNA.; 1994 bp)
[0268] TABLE-US-00006 TABLE VI Human IKK-gamma DNAzyme and
Substrate Sequence Seq Seq Pos Substrate ID DNAzyme ID 10 GCACGAGC
A UGGCCCUU 4749 AAGGGCCA GGCTAGCTACAACGA GCTCGTGC 6380 13 CGAGCAUG
G CCCUUGUG 5757 CACAAGGG GGCTAGCTACAACGA CATGCTCG 6381 19 UGGCCCUU
G UGAUCCAG 5758 CTGGATCA GGCTAGCTACAACGA AAGGGCCA 6382 22 CCCUUGUG
A UCCAGGUG 6311 CACCTGGA GGCTAGCTACAACGA CACAAGGG 6383 28 UGAUCCAG
G UGGGGAAA 5759 TTTCCCCA GGCTAGCTACAACGA CTGGATCA 6384 36 GUGGGGAA
A CUAAGGCC 6312 GGCCTTAG GGCTAGCTACAACGA TTCCCCAC 6385 42 AAACUAAG
G CCCAGAGA 5760 TCTCTGGG GGCTAGCTACAACGA CTTAGTTT 6386 52 CCAGAGAA
G UGAGGACC 5761 GGTCCTCA GGCTAGCTACAACGA TTCTCTGG 6387 58 AAGUGAGG
A CCCCGCAG 6313 CTGCGGGG GGCTAGCTACAACGA CCTCACTT 6388 63 AGGACCCC
G CAGACUAU 5762 ATAGTCTG GGCTAGCTACAACGA GGGGTCCT 6389 67 CCCCGCAG
A CUAUCAAU 6314 ATTGATAG GGCTAGCTACAACGA CTGCGGGG 6390 70 CGCAGACU
A UCAAUCCC 4364 GGGATTGA GGCTAGCTACAACGA AGTCTGCG 6391 74 GACUAUCA
A UCCCAGUC 6315 GACTGGGA GGCTAGCTACAACGA TGATAGTC 6392 80 CAAUCCCA
G UCUCUUCC 5763 GGAAGAGA GGCTAGCTACAACGA TGGGATTG 6393 93 UUCCCCUC
A CUCCCUGU 4774 ACAGGGAG GGCTAGCTACAACGA GAGGGGAA 6394 100 CACUCCCU
G UGAAGCUC 5764 GAGCTTCA GGCTAGCTACAACGA AGGGAGTG 6395 105 CCUGUGAA
G CUCUCCAG 5765 CTGGAGAG GGCTAGCTACAACGA TTCACAGG 6396 113 GCUCUCCA
G CAUCAUCG 5766 CGATGATG GGCTAGCTACAACGA TGGAGAGC 6397 115 UCUCCAGC
A UCAUCGAG 4783 CTCGATGA GGCTAGCTACAACGA GCTGGAGA 6398 118 CCAGCAUC
A UCGAGGUC 4784 GACCTCGA GGCTAGCTACAACGA GATGCTGG 6399 124 UCAUCGAG
G UCCCAUCA 5767 TGATGGGA GGCTAGCTACAACGA CTCGATGA 6400 129 GAGGUCCC
A UCAGCCCU 4787 AGGGCTGA GGCTAGCTACAACGA GGGACCTC 6401 133 UCCCAUCA
G CCCUUGCC 5768 GGCAAGGG GGCTAGCTACAACGA TGATGGGA 6402 139 CAGCCCUU
G CCCUGUUG 5769 CAACAGGG GGCTAGCTACAACGA AAGGGCTG 6403 144 CUUGCCCU
G DUGGAUGA 5770 TCATCCAA GGCTAGCTACAACGA AGGGCAAG 6404 149 CCUGUUGG
A UGAAUAGG 6316 CCTATTCA GGCTAGCTACAACGA CCAACAGG 6405 153 UUGGAUGA
A UAGGCACC 6317 GGTGCCTA GGCTAGCTACAACGA TCATCCAA 6406 157 AUGAAUAG
G CACCUCUG 5771 CAGAGGTG GGCTAGCTACAACGA CTATTCAT 6407 159 GAAUAGGC
A CCUCUGGA 4795 TCCAGAGG GGCTAGCTACAACGA GCCTATTC 6408 171 CUGGAAGA
G CCAACUGU 5772 ACAGTTGG GGCTAGCTACAACGA TCTTCCAG 6409 175 AAGAGCCA
A CUGUGUGA 6318 TCACACAG GGCTAGCTACAACGA TGGCTCTT 6410 178 AGCCAACU
G UGUGAGAU 5773 ATCTCACA GGCTAGCTACAACGA AGTTGGCT 6411 180 CCAACUGU
G UGAGAUGG 5774 CCATCTCA GGCTAGCTACAACGA ACAGTTGG 6412 185 UGUGUGAG
A UGGUGCAG 6319 CTGCACCA GGCTAGCTACAACGA CTCACACA 6413 188 GUGAGAUG
G UGCAGCCC 5775 GGGCTGCA GGCTAGCTACAACGA CATCTCAC 6414 190 GAGAUGGU
G CAGCCCAG 5776 CTGGGCTG GGCTAGCTACAACGA ACCATCTC 6415 193 AUGGUGCA
G CCCAGUGG 5777 CCACTGGG GGCTAGCTACAACGA TGCACCAT 6416 198 GCAGCCCA
G UGGUGGCC 5778 GGCCACCA GGCTAGCTACAACGA TGGGCTGC 6417 201 GCCCAGUG
G UGGCCCGG 5779 CCGGGCCA GGCTAGCTACAACGA CACTGGGC 6418 204 CAGUGGUG
G CCCGGCAG 5780 CTGCCGGG GGCTAGCTACAACGA CACCACTG 6419 209 GUGGCCCG
G CAGCAGAU 5781 ATCTGCTG GGCTAGCTACAACGA CGGGCCAC 6420 212 GCCCGGCA
G CAGAUCAG 5782 CTGATCTG GGCTAGCTACAACGA TGCCGGGC 6421 216 GGCAGCAG
A UCAGGACG 6320 CGTCCTGA GGCTAGCTACAACGA CTGCTGCC 6422 222 AGAUCAGG
A CGUACUGG 6321 CCAGTACG GGCTAGCTACAACGA CCTGATCT 6423 224 AUCAGGAC
G UACUGGGC 5783 GCCCAGTA GGCTAGCTACAACGA GTCCTGAT 6424 226 CAGGACGU
A CUGGGCGA 4384 TCGCCCAG GGCTAGCTACAACGA ACGTCCTG 6425 231 CGUACUGG
G CGAAGAGU 5784 ACTCTTCG GGCTAGCTACAACGA CCAGTACG 6426 238 GGCGAAGA
G UCUCCUCU 5785 AGAGGAGA GGCTAGCTACAACGA TCTTCGCC 6427 253 CUGGGGAA
G CCAGCCAU 5786 ATGGCTGG GGCTAGCTACAACGA TTCCCCAG 6428 257 GGAAGCCA
G CCAUGCUG 5787 CAGCATGG GGCTAGCTACAACGA TGGCTTCC 6429 260 AGCCAGCC
A UGCUGCAC 4819 GTGCAGCA GGCTAGCTACAACGA GGCTGGCT 6430 262 CCAGCCAU
G CUGCACCU 5788 AGGTGCAG GGCTAGCTACAACGA ATGGCTGG 6431 265 GCCAUGCU
G CACCUGCC 5789 GGCAGGTG GGCTAGCTACAACGA AGCATGGC 6432 267 CAUGCUGC
A CCUGCCUU 4821 AAGGCAGG GGCTAGCTACAACGA GCAGCATG 6433 271 CUGCACCU
G CCUUCAGA 5790 TCTGAAGG GGCTAGCTACAACGA AGGTGCAG 6434 280 CCUUCAGA
A CAGGGCGC 6322 GCGCCCTG GGCTAGCTACAACGA TCTGAAGG 6435 285 AGAACAGG
G CGCUCCUG 5791 CAGGAGCG GGCTAGCTACAACGA CCTGTTCT 6436 287 AACAGGGC
G CUCCUGAG 5792 CTCAGGAG GGCTAGCTACAACGA GCCCTGTT 6437 296 CUCCUGAG
A CCCUCCAG 6323 CTGGAGGG GGCTAGCTACAACGA CTCAGGAG 6438 304 ACCCUCCA
G CGCUGCCU 5793 AGGCAGCG GGCTAGCTACAACGA TGGAGGGT 6439 306 CCUCCAGC
G CUGCCUGG 5794 CCAGGCAG GGCTAGCTACAACGA GCTGGAGG 6440 309 CCAGCGCU
G CCUGGAGG 5795 CCTCCAGG GGCTAGCTACAACGA AGCGCTGG 6441 321 GGAGGAGA
A UCAAGAGC 6324 GCTCTTGA GGCTAGCTACAACGA TCTCCTCC 6442 328 AAUCAAGA
G CUCCGAGA 5796 TCTCGGAG GGCTAGCTACAACGA TCTTGATT 6443 336 GCUCCGAG
A UGCCAUCC 6325 GGATGGCA GGCTAGCTACAACGA CTCGGAGC 6444 338 UCCGAGAU
G CCAUCCGG 5797 CCGGATGG GGCTAGCTACAACGA ATCTCGGA 6445 341 GAGAUGCC
A UCCGGCAG 4843 CTGCCGGA GGCTAGCTACAACGA GGCATCTC 6446 346 GCCAUCCG
G CAGAGCAA 5798 TTGCTCTG GGCTAGCTACAACGA CGGATGGC 6447 351 CCGGCAGA
G CAACCAGA 5799 TCTGGTTG GGCTAGCTACAACGA TCTGCCGG 6448 354 GCAGAGCA
A CCAGAUUC 6326 GAATCTGG GGCTAGCTACAACGA TGCTCTGC 6449 359 GCAACCAG
A UUCUGCGG 6327 CCGCAGAA GGCTAGCTACAACGA CTGGTTGC 6450 364 CAGAUUCU
G CGGGAGCG 5800 CGCTCCCG GGCTAGCTACAACGA AGAATCTG 6451 370 CUGCGGGA
G CGCUGCGA 5801 TCGCAGCG GGCTAGCTACAACGA TCCCGCAG 6452 372 GCGGGAGC
G CUGCGAGG 5802 CCTCGCAG GGCTAGCTACAACGA GCTCCCGC 6453 375 GGAGCGCU
G CGAGGAGC 5803 GCTCCTCG GGCTAGCTACAACGA AGCGCTCC 6454 382 UGCGAGGA
G CUUCUGCA 5804 TGCAGAAG GGCTAGCTACAACGA TCCTCGCA 6455 388 GAGCUUCU
G CAUUUCCA 5805 TGGAAATG GGCTAGCTACAACGA AGAAGCTC 6456 390 GCUUCUGC
A UUUCCAAG 4853 CTTGGAAA GGCTAGCTACAACGA GCAGAAGC 6457 398 AUUUCCAA
G CCAGCCAG 5806 CTGGCTGG GGCTAGCTACAACGA TTGGAAAT 6458 402 CCAAGCCA
G CCAGAGGG 5807 CCCTCTGG GGCTAGCTACAACGA TGGCTTGG 6459 421 GAGAAGGA
G UUCCUCAU 5808 ATGAGGAA GGCTAGCTACAACGA TCCTTCTC 6460 428 AGUUCCUC
A UGUGCAAG 4862 CTTGCACA GGCTAGCTACAACGA GAGGAACT 6461 430 UUCCUCAU
G UGCAAGUU 5809 AACTTGCA GGCTAGCTACAACGA ATGAGGAA 6462 432 CCUCAUGU
G CAAGUUCC 5810 GGAACTTG GGCTAGCTACAACGA ACATGAGG 6463 436 AUGUGCAA
G UUCCAGGA 5811 TCCTGGAA GGCTAGCTACAACGA TTGCACAT 6464 446 UCCAGGAG
G CCAGGAAA 5812 TTTCCTGG GGCTAGCTACAACGA CTCCTGGA 6465 454 GCCAGGAA
A CUGGUGGA 6328 TCCACCAG GGCTAGCTACAACGA TTCCTGGC 6466 458 GGAAACUG
G UGGAGAGA 5813 TCTCTCCA GGCTAGCTACAACGA CAGTTTCC 6467 466 GUGGAGAG
A CUCGGCCU 6329 AGGCCGAG GGCTAGCTACAACGA CTCTCCAC 6468 471 GAGACUCG
G CCUGGAGA 5814 TCTCCAGG GGCTAGCTACAACGA CGAGTCTC 6469 481 CUGGAGAA
G CUCGAUCU 5815 AGATCGAG GGCTAGCTACAACGA TTCTCCAG 6470 486 GAAGCUCG
A UCUGAAGA 6330 TCTTCAGA GGCTAGCTACAACGA CGAGCTTC 6471 496 CUGAAGAG
G CAGAAGGA 5816 TCCTTCTG GGCTAGCTACAACGA CTCTTCAG 6472 505 CAGAAGGA
G CAGGCUCU 5817 AGAGCCTG GGCTAGCTACAACGA TCCTTCTG 6473 509 AGGAGCAG
G CUCUGCGG 5818 CCGCAGAG GGCTAGCTACAACGA CTGCTCCT 6474 514 CAGGCUCU
G CGGGAGGU 5819 ACCTCCCG GGCTAGCTACAACGA AGAGCCTG 6475 521 UGCGGGAG
G UGGAGCAC 5820 GTGCTCCA GGCTAGCTACAACGA CTCCCGCA 6476 526 GAGGUGGA
G CACCUGAA 5821 TTCAGGTG GGCTAGCTACAACGA TCCACCTC 6477 528 GGUGGAGC
A CCUGAAGA 4878 TCTTCAGG GGCTAGCTACAACGA GCTCCACC 6478 538 CUGAAGAG
A UGCCAGCA 6331 TGCTGGCA GGCTAGCTACAACGA CTCTTCAG 6479 540 GAAGAGAU
G CCAGCAGC 5822 GCTGCTGG GGCTAGCTACAACGA ATCTCTTC 6480 544 AGAUGCCA
G CAGCAGAU 5823 ATCTGCTG GGCTAGCTACAACGA TGGCATCT 6481 547 UGCCAGCA
G CAGAUGGC 5824 GCCATCTG GGCTAGCTACAACGA TGCTGGCA 6482 551 AGCAGCAG
A UGGCUGAG 6332 CTCAGCCA GGCTAGCTACAACGA CTGCTGCT 6483 554 AGCAGAUG
G CUGAGGAC 5825 GTCCTCAG GGCTAGCTACAACGA CATCTGCT 6484 561 GGCUGAGG
A CAAGGCCU 6333 AGGCCTTG GGCTAGCTACAACGA CCTCAGCC 6485 566 AGGACAAG
G CCUCUGUG 5826 CACAGAGG GGCTAGCTACAACGA CTTGTCCT 6486 572 AGGCCUCU
G UGAAAGCC 5827 GGCTTTCA GGCTAGCTACAACGA AGAGGCCT 6487 578 CUGUGAAA
G CCCAGGUG 5828 CACCTGGG GGCTAGCTACAACGA TTTCACAG 6488 584 AAGCCCAG
G UGACGUCC 5829 GGACGTCA GGCTAGCTACAACGA CTGGGCTT 6489 587 GCCAGGUG
A CGUCCUUG 6334 CAAGGACG GGCTAGCTACAACGA CACCTGGG 6490 589 CAGGUGAC
G UCCUUGCU 5830 AGCAAGGA GGCTAGCTACAACGA GTCACCTG 6491 595 ACGUCCUU
G CUCGGGGA 5831 TCCCCGAG GGCTAGCTACAACGA AAGGACGT 6492 604 CUCGGGGA
G CUGCAGGA 5832 TCCTGCAG GGCTAGCTACAACGA TCCCCGAG 6493 607 GGGGAGCU
G CAGGAGAG 5833 CTCTCCTG GGCTAGCTACAACGA AGCTCCCC 6494 615 GCAGGAGA
G CCAGAGUC 5834 GACTCTGG GGCTAGCTACAACGA TCTCCTGC 6495 621 GAGCCAGA
G UCGCUUGG 5835 CCAAGCGA GGCTAGCTACAACGA TCTGGCTC 6496 624 CCAGAGUC
G CUUGGAGG 5836 CCTCCAAG GGCTAGCTACAACGA GACTCTGG 6497 632 GCUUGGAG
G CUGCCACU 5837 AGTGGCAG GGCTAGCTACAACGA CTCCAAGC 6498 635 UGGAGGCU
G CCACUAAG 5838 CTTAGTGG GGCTAGCTACAACGA AGCCTCCA 6499 638 AGGCUGCC
A CUAAGGAA 4903 TTCCTTAG GGCTAGCTACAACGA GGCAGCCT 6500 646 ACUAAGGA
A UGCCAGGC 6335 GCCTGGCA GGCTAGCTACAACGA TCCTTAGT 6501
648 UAAGGAAU G CCAGGCUC 5839 GAGCCTGG GGCTAGCTACAACGA ATTCCTTA 6502
653 AAUGCCAG G CUCUGGAG 5840 CTCCAGAG GGCTAGCTACAACGA CTGGCATT 6503
663 UCUGGAGG G UCGGGCCC 5841 GGGCCCGA GGCTAGCTACAACGA CCTCCAGA 6504
668 AGGGUCGG G CCCGGGCG 5842 CGCCCGGG GGCTAGCTACAACGA CCGACCCT 6505
674 GGGCCCGG G CGGCCAGC 5843 GCTGGCCG GGCTAGCTACAACGA CCGGGCCC 6506
677 CCCGGGCG G CCAGCGAG 5844 CTCGCTGG GGCTAGCTACAACGA CGCCCGGG 6507
681 GGCGGCCA G CGAGCAGG 5845 CCTGCTCG GGCTAGCTACAACGA TGGCCGCC 6508
685 GCCAGCGA G CAGGCGCG 5846 CGCGCCTG GGCTAGCTACAACGA TCGCTGGC 6509
689 GCGAGCAG G CGCGGCAG 5847 CTGCCGCG GGCTAGCTACAACGA CTGCTCGC 6510
691 GAGCAGGC G CGGCAGCU 5848 AGCTGCCG GGCTAGCTACAACGA GCCTGCTC 6511
694 CAGGCGCG G CAGCUGGA 5849 TCCAGCTG GGCTAGCTACAACGA CGCGCCTG 6512
697 GCGCGGCA G CUGGAGAG 5850 CTCTCCAG GGCTAGCTACAACGA TGCCGCGC 6513
705 GCUGGAGA G UGAGCGCG 5851 CGCGCTCA GGCTAGCTACAACGA TCTCCAGC 6514
709 GAGAGUGA G CGCGAGGC 5852 GCCTCGCG GGCTAGCTACAACGA TCACTCTC 6515
711 GAGUGAGC G CGAGGCGC 5853 GCGCCTCG GGCTAGCTACAACGA GCTCACTC 6516
716 AGCGCGAG G CGCUGCAG 5854 CTGCAGCG GGCTAGCTACAACGA CTCGCGCT 6517
718 CGCGAGGC G CUGCAGCA 5855 TGCTGCAG GGCTAGCTACAACGA GCCTCGCG 6518
721 GAGGCGCU G CAGCAGCA 5856 TGCTGCTG GGCTAGCTACAACGA AGCGCCTC 6519
724 GCGCUGCA G CAGCAGCA 5857 TGCTGCTG GGCTAGCTACAACGA TGCAGCGC 6520
727 CUGCAGCA G CAGCACAG 5858 CTGTGCTG GGCTAGCTACAACGA TGCTGCAG 6521
730 CAGCAGCA G CACAGCGU 5859 ACGCTGTG GGCTAGCTACAACGA TGCTGCTG 6522
732 GCAGCAGC A CAGCGUGC 4920 GCACGCTG GGCTAGCTACAACGA GCTGCTGC 6523
735 GCAGCACA G CGUGCAGG 5860 CCTGCACG GGCTAGCTACAACGA TGTGCTGC 6524
737 AGCACAGC G UGCAGGUG 5861 CACCTGCA GGCTAGCTACAACGA GCTGTGCT 6525
739 CACAGCGU G CAGGUGGA 5862 TCCACCTG GGCTAGCTACAACGA ACGCTGTG 6526
743 GCGUGCAG G UGGACCAG 5863 CTGGTCCA GGCTAGCTACAACGA CTGCACGC 6527
747 GCAGGUGG A CCAGCUGC 6336 GCAGCTGG GGCTAGCTACAACGA CCACCTGC 6528
751 GUGGACCA G CUGCGCAU 5864 ATGCGCAG GGCTAGCTACAACGA TGGTCCAC 6529
754 GACCAGCU G CGCAUGCA 5865 TGCATGCG GGCTAGCTACAACGA AGCTGGTC 6530
756 CCAGCUGC G CAUGCAGG 5866 CCTGCATG GGCTAGCTACAACGA GCAGCTGG 6531
758 AGCUGCGC A UGCAGGGC 4926 GCCCTGCA GGCTAGCTACAACGA GCGCAGCT 6532
760 CUGCGCAU G CAGGGCCA 5867 TGGCCCTG GGCTAGCTACAACGA ATGCGCAG 6533
765 CAUGCAGG G CCAGAGCG 5868 CGCTCTGG GGCTAGCTACAACGA CCTGCATG 6534
771 GGGCCAGA G CGUGGAGG 5869 CCTCCACG GGCTAGCTACAACGA TCTGGCCC 6535
773 GCCAGAGC G UGGAGGCC 5870 GGCCTCCA GGCTAGCTACAACGA GCTCTGGC 6536
779 GCGUGGAG G CCGCGCUC 5871 GAGCGCGG GGCTAGCTACAACGA CTCCACGC 6537
782 UGGAGGCC G CGCUCCGC 5872 GCGGAGCG GGCTAGCTACAACGA GGCCTCCA 6538
784 GAGGCCGC G CUCCGCAU 5873 ATGCGGAG GGCTAGCTACAACGA GCGGCCTC 6539
789 CGCGCUCC G CAUGGAGC 5874 GCTCCATG GGCTAGCTACAACGA GGAGCGCG 6540
791 CGCUCCGC A UGGAGCGC 4933 GCGCTCCA GGCTAGCTACAACGA GCGGAGCG 6541
796 CGCAUGGA G CGCCAGGC 5875 GCCTGGCG GGCTAGCTACAACGA TCCATGCG 6542
798 CAUGGAGC G CCAGGCCG 5876 CGGCCTGG GGCTAGCTACAACGA GCTCCATG 6543
803 AGCGCCAG G CCGCCUCG 5877 CGAGGCGG GGCTAGCTACAACGA CTGGCGCT 6544
806 GCCAGGCC G CCUCGGAG 5878 CTCCGAGG GGCTAGCTACAACGA GGCCTGGC 6545
826 AAGAGGAA G CUGGCCCA 5879 TGGGCCAG GGCTAGCTACAACGA TTCCTCTT 6546
830 GGAAGCUG G CCCAGUUG 5880 CAACTGGG GGCTAGCTACAACGA CAGCTTCC 6547
835 CUGGCCCA G UUGCAGGU 5881 ACCTGCAA GGCTAGCTACAACGA TGGGCCAG 6548
838 GCCCAGUU G CAGGUGGC 5882 GCCACCTG GGCTAGCTACAACGA AACTGGGC 6549
842 AGUUGCAG G UGGCCUAU 5883 ATAGGCCA GGCTAGCTACAACGA CTGCAACT 6550
845 UGCAGGUG G CCUAUCAC 5884 GTGATAGG GGCTAGCTACAACGA CACCTGCA 6551
849 GGUGGCCU A UCACCAGC 4423 GCTGGTGA GGCTAGCTACAACGA AGGCCACC 6552
852 GGCCUAUC A CCAGCUCU 4946 AGAGCTGG GGCTAGCTACAACGA GATAGGCC 6553
856 UAUCACCA G CUCUUCCA 5885 TGGAAGAG GGCTAGCTACAACGA TGGTGATA 6554
868 UUCCAAGA A UACGACAA 6337 TTGTCGTA GGCTAGCTACAACGA TCTTGGAA 6555
870 CCAAGAAU A CGACAACC 4428 GGTTGTCG GGCTAGCTACAACGA ATTCTTGG 6556
873 AGAAUACG A CAACCACA 6338 TGTGGTTG GGCTAGCTACAACGA CGTATTCT 6557
876 AUACGACA A CCACAUCA 6339 TGATGTGG GGCTAGCTACAACGA TGTCGTAT 6558
879 CGACAACC A CAUCAAGA 4955 TCTTGATG GGCTAGCTACAACGA GGTTGTCG 6559
881 ACAACCAC A UCAAGAGC 4956 GCTCTTGA GGCTAGCTACAACGA GTGGTTGT 6560
888 CAUCAAGA G CAGCGUGG 5886 CCACGCTG GGCTAGCTACAACGA TCTTGATG 6561
891 CAAGAGCA G CGUGGUGG 5887 CCACCACG GGCTAGCTACAACGA TGCTCTTG 6562
893 AGAGCAGC G UGGUGGGC 5888 GCCCACCA GGCTAGCTACAACGA GCTGCTCT 6563
896 GCAGCGUG 0 UGGGCAGU 5889 ACTGCCCA GGCTAGCTACAACGA CACGCTGC 6564
900 CGUGGUGG G CAGUGAGC 5890 GCTCACTG GGCTAGCTACAACGA CCACCACG 6565
903 GGUGGGCA G UGAGCGGA 5891 TCCGCTCA GGCTAGCTACAACGA TGCCCACC 6566
907 GGCAGUGA G CGGAAGCG 5892 CGCTTCCG GGCTAGCTACAACGA TCACTGCC 6567
913 GAGCGGAA G CGAGGAAU 5893 ATTCCTCG GGCTAGCTACAACGA TTCCGCTC 6568
920 AGCGAGGA A UGCAGCUG 6340 CAGCTGCA GGCTAGCTACAACGA TCCTCGCT 6569
922 CGAGGAAU G CAGCUGGA 5894 TCCAGCTG GGCTAGCTACAACGA ATTCCTCG 6570
925 GGAAUGCA G CUGGAAGA 5895 TCTTCCAG GGCTAGCTACAACGA TGCATTCC 6571
933 GCUGGAAG A UCUCAAAC 6341 GTTTGAGA GGCTAGCTACAACGA CTTCCAGC 6572
940 GAUCUCAA A CAGCAGCU 6342 AGCTGCTG GGCTAGCTACAACGA TTGAGATC 6573
943 CUCAAACA G CAGCUCCA 5896 TGGAGCTG GGCTAGCTACAACGA TGTTTGAG 6574
946 AAACAGCA G CUCCAGCA 5897 TGCTGGAG GGCTAGCTACAACGA TGCTGTTT 6575
952 CAGCUCCA G CAGGCCGA 5898 TCGGCCTG GGCTAGCTACAACGA TGGAGCTG 6576
956 UCCAGCAG G CCGAGGAG 5899 CTCCTCGG GGCTAGCTACAACGA CTGCTGGA 6577
965 CCGAGGAG G CCCUGGUG 5900 CACCAGGG GGCTAGCTACAACGA CTCCTCGG 6578
971 AGGCCCUG G UGGCCAAA 5901 TTTGGCCA GGCTAGCTACAACGA CAGGGCCT 6579
974 CCCUGGUG G CCAAACAG 5902 CTGTTTGG GGCTAGCTACAACGA CACCAGGG 6580
979 GUGGCCAA A CAGGAGGU 6343 ACCTCCTG GGCTAGCTACAACGA TTGGCCAC 6581
986 AACAGGAG G UGAUCGAU 5903 ATCGATCA GGCTAGCTACAACGA CTCCTGTT 6582
989 AGGAGGUG A UCGAUAAG 6344 CTTATCGA GGCTAGCTACAACGA CACCTCCT 6583
993 GGUGAUCG A UAAGCUGA 6345 TCAGCTTA GGCTAGCTACAACGA CGATCACC 6584
997 AUCGAUAA G CUGAAGGA 5904 TCCTTCAG GGCTAGCTACAACGA TTATCGAT 6585
1010 AGGAGGAG G CCGAGCAG 5905 CTGCTCGG GGCTAGCTACAACGA CTCCTCCT
6586 1015 GAGGCCGA G CAGCACAA 5906 TTGTGCTG GGCTAGCTACAACGA
TCGGCCTC 6587 1018 GCCGAGCA G CACAAGAU 5907 ATCTTGTG
GGCTAGCTACAACGA TGCTCGGC 6588 1020 CGAGCAGC A CAAGAUUG 4980
CAATCTTG GGCTAGCTACAACGA GCTGCTCG 6589 1025 AGCACAAG A UUGUGAUG
6346 CATCACAA GGCTAGCTACAACGA CTTGTGCT 6590 1028 ACAAGAUU G
UGAUGGAG 5908 CTCCATCA GGCTAGCTACAACGA AATCTTGT 6591 1031 AGAUUGUG
A UGGAGACC 6347 GGTCTCCA GGCTAGCTACAACGA CACAATCT 6592 1037
UGAUGGAG A CCGUUCCG 6348 CGGAACGG GGCTAGCTACAACGA CTCCATCA 6593
1040 UGGAGACC G UUCCGGUG 5909 CACCGGAA GGCTAGCTACAACGA GGTCTCCA
6594 1046 CCGUUCCG G UGCUGAAG 5910 CTTCAGCA GGCTAGCTACAACGA
CGGAACGG 6595 1048 GUUCCGGU G CUGAAGGC 5911 GCCTTCAG
GGCTAGCTACAACGA ACCGGAAC 6596 1055 UGCUGAAG G CCCAGGCG 5912
CGCCTGGG GGCTAGCTACAACGA CTTCAGCA 6597 1061 AGGCCCAG G CGGAUAUC
5913 GATATCCG GGCTAGCTACAACGA CTGGGCCT 6598 1065 CCAGGCGG A
UAUCUACA 6349 TGTAGATA GGCTAGCTACAACGA CCGCCTGG 6599 1067 AGGCGGAU
A UCUACAAG 4438 CTTGTAGA GGCTAGCTACAACGA ATCCGCCT 6600 1071
GGAUAUCU A CAAGGCGG 4440 CCGCCTTG GGCTAGCTACAACGA AGATATCC 6601
1076 UCUACAAG G CGGACUUC 5914 GAAGTCCG GGCTAGCTACAACGA CTTGTAGA
6602 1080 CAAGGCGG A CUUCCAGG 6350 CCTGGAAG GGCTAGCTACAACGA
CCGCCTTG 6603 1088 ACUUCCAG G CUGAGAGG 5915 CCTCTCAG
GGCTAGCTACAACGA CTGGAAGT 6604 1096 GCUGAGAG G CAGGCCCG 5916
CGGGCCTG GGCTAGCTACAACGA CTCTCAGC 6605 1100 AGAGGCAG G CCCGGGAG
5917 CTCCCGGG GGCTAGCTACAACGA CTGCCTCT 6606 1111 CGGGAGAA G
CUGGCCGA 5918 TCGGCCAG GGCTAGCTACAACGA TTCTCCCG 6607 1115 AGAAGCUG
G CCGAGAAG 5919 CTTCTCGG GGCTAGCTACAACGA CAGCTTCT 6608 1129
AAGAAGGA G CUCCUGCA 5920 TGCAGGAG GGCTAGCTACAACGA TCCTTCTT 6609
1135 GAGCUCCU G CAGGAGCA 5921 TGCTCCTG GGCTAGCTACAACGA AGGAGCTC
6610 1141 CUGCAGGA G CAGCUGGA 5922 TCCAGCTG GGCTAGCTACAACGA
TCCTGCAG 6611 1144 CAGGAGCA G CUGGAGCA 5923 TGCTCCAG
GGCTAGCTACAACGA TGCTCCTG 6612 1150 CAGCUGGA G CAGCUGCA 5924
TGCAGCTG GGCTAGCTACAACGA TCCAGCTG 6613 1153 CUGGAGCA G CUGCAGAG
5925 CTCTGCAG GGCTAGCTACAACGA TGCTCCAG 6614 1156 GAGCAGCU G
CAGAGGGA 5926 TCCCTCTG GGCTAGCTACAACGA AGCTGCTC 6615 1165 CAGAGGGA
G UACAGCAA 5927 TTGCTGTA GGCTAGCTACAACGA TCCCTCTG 6616 1167
GAGGGAGU A CAGCAAAC 4444 GTTTGCTG GGCTAGCTACAACGA ACTCCCTC 6617
1170 GGAGUACA G CAAACUGA 5928 TCAGTTTG GGCTAGCTACAACGA TGTACTCC
6618 1174 UACAGCAA A CUGAAGGC 6351 GCCTTCAG GGCTAGCTACAACGA
TTGCTGTA 6619 1181 AACUGAAG G CCAGCUGU 5929 ACAGCTGG
GGCTAGCTACAACGA CTTCAGTT 6620 1185 GAAGGCCA G CUGUCAGG 5930
CCTGACAG GGCTAGCTACAACGA TGGCCTTC 6621 1188 GGCCAGCU G UCAGGAGU
5931 ACTCCTGA GGCTAGCTACAACGA AGCTGGCC 6622 1195 UGUCAGGA G
UCGGCCAG 5932 CTGGCCGA GGCTAGCTACAACGA TCCTGACA 6623 1199 AGGAGUCG
G CCAGGAUC 5933 GATCCTGG GGCTAGCTACAACGA CGACTCCT 6624 1205
CGGCCAGG A UCGAGGAC 6352 GTCCTCGA GGCTAGCTACAACGA CCTGGCCG 6625
1212 GAUCGAGG A CAUGAGGA 6353 TCCTCATG GGCTAGCTACAACGA CCTCGATC
6626
1214 UCGAGGAC A UGAGGAAG 5017 CTTCCTCA GGCTAGCTACAACGA GTCCTCGA
6627 1222 AUGAGGAA G CGGCAUGU 5934 ACATGCCG GGCTAGCTACAACGA
TTCCTCAT 6628 1225 AGGAAGCG G CAUGUCGA 5935 TCGACATG
GGCTAGCTACAACGA CGCTTCCT 6629 1227 GAAGCGGC A UGUCGAGG 5018
CCTCGACA GGCTAGCTACAACGA GCCGCTTC 6630 1229 AGCGGCAU G UCGAGGUC
5936 GACCTCGA GGCTAGCTACAACGA ATGCCGCT 6631 1235 AUGUCGAG G
UCUCCCAG 5937 CTGGGAGA GGCTAGCTACAACGA CTCGACAT 6632 1244 UCUCCCAG
G CCCCCUUG 5938 CAAGGGGG GGCTAGCTACAACGA CTGGGAGA 6633 1252
GCCCCCUU G CCCCCCGC 5939 GCGGGGGG GGCTAGCTACAACGA AAGGGGGC 6634
1259 UGCCCCCC G CCCCUGCC 5940 GGCAGGGG GGCTAGCTACAACGA GGGGGGCA
6635 1265 CCGCCCCU G CCUACCUC 5941 GAGGTAGG GGCTAGCTACAACGA
AGGGGCGG 6636 1269 CCCUGCCU A CCUCUCCU 4452 AGGAGAGG
GGCTAGCTACAACGA AGGCAGGG 6637 1286 CUCCCCUG G CCCUGCCC 5942
GGGCAGGG GGCTAGCTACAACGA CAGGGGAG 6638 1291 CUGGCCCU G CCCAGCCA
5943 TGGCTGGG GGCTAGCTACAACGA AGGGCCAG 6639 1296 CCUGCCCA G
CCAGAGGA 5944 TCCTCTGG GGCTAGCTACAACGA TGGGCAGG 6640 1308 GAGGAGGA
G CCCCCCCG 5945 CGGGGGGG GGCTAGCTACAACGA TCCTCCTC 6641 1321
CCCGAGGA G CCACCUGA 5946 TCAGGTGG GGCTAGCTACAACGA TCCTCGGG 6642
1324 GAGGAGCC A CCUGACUU 5064 AAGTCAGG GGCTAGCTACAACGA GGCTCCTC
6643 1329 GCCACCUG A CUUCUGCU 6354 AGCAGAAG GGCTAGCTACAACGA
CAGGTGGC 6644 1335 UGACUUCU G CUGUCCCA 5947 TGGGACAG
GGCTAGCTACAACGA AGAAGTCA 6645 1338 CUUCUGCU G UCCCAAGU 5948
ACTTGGGA GGCTAGCTACAACGA AGCAGAAG 6646 1345 UGUCCCAA G UGCCAGUA
5949 TACTGGCA GGCTAGCTACAACGA TTGGGACA 6647 1347 UCCCAAGU G
CCAGUAUC 5950 GATACTGG GGCTAGCTACAACGA ACTTGGGA 6648 1351 AAGUGCCA
G UAUCAGGC 5951 GCCTGATA GGCTAGCTACAACGA TGGCACTT 6649 1353
GUGCCAGU A UCAGGCCC 4460 GGGCCTGA GGCTAGCTACAACGA ACTGGCAC 6650
1358 AGUAUCAG G CCCCUGAU 5952 ATCAGGGG GGCTAGCTACAACGA CTGATACT
6651 1365 GGCCCCUG A UAUGGACA 6355 TGTCCATA GGCTAGCTACAACGA
CAGGGGCC 6652 1367 CCCCUGAU A UGGACACC 4462 GGTGTCCA
GGCTAGCTACAACGA ATCAGGGG 6653 1371 UGAUAUGG A CACCCUGC 6356
GCAGGGTG GGCTAGCTACAACGA CCATATCA 6654 1373 AUAUGGAC A CCCUGCAG
5080 CTGCAGGG GGCTAGCTACAACGA GTCCATAT 6655 1378 GACACCCU G
CAGAUACA 5953 TGTATCTG GGCTAGCTACAACGA AGGGTGTC 6656 1382 CCCUGCAG
A UACAUGUC 6357 GACATGTA GGCTAGCTACAACGA CTGCAGGG 6657 1384
CUGCAGAU A CAUGUCAU 4463 ATGACATG GGCTAGCTACAACGA ATCTGCAG 6658
1386 GCAGAUAC A UGUCAUGG 5085 CCATGACA GGCTAGCTACAACGA GTATCTGC
6659 1388 AGAUACAU G UCAUGGAG 5954 CTCCATGA GGCTAGCTACAACGA
ATGTATCT 6660 1391 UACAUGUC A UGGAGUGC 5086 GCACTCCA
GGCTAGCTACAACGA GACATGTA 6661 1396 GUCAUGGA G UGCAUUGA 5955
TCAATGCA GGCTAGCTACAACGA TCCATGAC 6662 1398 CAUGGAGU G CAUUGAGU
5956 ACTCAATG GGCTAGCTACAACGA ACTCCATG 6663 1400 UGGAGUGC A
UUGAGUAG 5087 CTACTCAA GGCTAGCTACAACGA GCACTCCA 6664 1405 UGCAUUGA
G UAGGGCCG 5957 CGGCCCTA GGCTAGCTACAACGA TCAATGCA 6665 1410
UGAGUAGG G CCGGCCAG 5958 CTGGCCGG GGCTAGCTACAACGA CCTACTCA 6666
1414 UAGGGCCG G CCAGUGCA 5959 TGCACTGG GGCTAGCTACAACGA CGGCCCTA
6667 1418 GCCGGCCA G UGCAAGGC 5960 GCCTTGCA GGCTAGCTACAACGA
TGGCCGGC 6668 1420 CGGCCAGU G CAAGGCCA 5961 TGGCCTTG
GGCTAGCTACAACGA ACTGGCCG 6669 1425 AGUGCAAG G CCACUGCC 5962
GGCAGTGG GGCTAGCTACAACGA CTTGCACT 6670 1428 GCAAGGCC A CUGCCUGC
5093 GCAGGCAG GGCTAGCTACAACGA GGCCTTGC 6671 1431 AGGCCACU G
CCUGCCCG 5963 CGGGCAGG GGCTAGCTACAACGA AGTGGCCT 6672 1435 CACUGCCU
G CCCGAGGA 5964 TCCTCGGG GGCTAGCTACAACGA AGGCAGTG 6673 1443
GCCCGAGG A CGUGCCCG 6358 CGGGCACG GGCTAGCTACAACGA CCTCGGGC 6674
1445 CCGAGGAC G UGCCCGGG 5965 CCCGGGCA GGCTAGCTACAACGA GTCCTCGG
6675 1447 GAGGACGU G CCCGGGAC 5966 GTCCCGGG GGCTAGCTACAACGA
ACGTCCTC 6676 1454 UGCCCGGG A CCGUGCAG 6359 CTGCACGG
GGCTAGCTACAACGA CCCGGGCA 6677 1457 CCGGGACC G UGCAGUCU 5967
AGACTGCA GGCTAGCTACAACGA GGTCCCGG 6678 1459 GGGACCGU G CAGUCUGC
5968 GCAGACTG GGCTAGCTACAACGA ACGGTCCC 6679 1462 ACCGUGCA G
UCUGCGCU 5969 AGCGCAGA GGCTAGCTACAACGA TGCACGGT 6680 1466 UGCAGUCU
G CGCUUUCC 5970 GGAAAGCG GGCTAGCTACAACGA AGACTGCA 6681 1468
CAGUCUGC G CUUUCCUC 5971 GAGGAAAG GGCTAGCTACAACGA GCAGACTG 6682
1481 CCUCUCCC G CCUGCCUA 5972 TAGGCAGG GGCTAGCTACAACGA GGGAGAGG
6683 1485 UCCCGCCU G CCUAGCCC 5973 GGGCTAGG GGCTAGCTACAACGA
AGGCGGGA 6684 1490 CCUGCCUA G CCCAGGAU 5974 ATCCTGGG
GGCTAGCTACAACGA TAGGCAGG 6685 1497 AGCCCAGG A UGAAGGGC 6360
GCCCTTCA GGCTAGCTACAACGA CCTGGGCT 6686 1504 GAUGAAGG G CUGGGUGG
5975 CCACCCAG GGCTAGCTACAACGA CCTTCATC 6687 1509 AGGGCUGG G
UGGCCACA 5976 TGTGGCCA GGCTAGCTACAACGA CCAGCCCT 6688 1512 GCUGGGUG
G CCACAACU 5977 AGTTGTGG GGCTAGCTACAACGA CACCCAGC 6689 1515
GGGUGGCC A CAACUGGG 5119 CCCAGTTG GGCTAGCTACAACGA GGCCACCC 6690
1518 UGGCCACA A CUGGGAUG 6361 CATCCCAG GGCTAGCTACAACGA TGTGGCCA
6691 1524 CAACUGGG A UGCCACCU 6362 AGGTGGCA GGCTAGCTACAACGA
CCCAGTTG 6692 1526 ACUGGGAU G CCACCUGG 5978 CCAGGTGG
GGCTAGCTACAACGA ATCCCAGT 6693 1529 GGGAUGCC A CCUGGAGC 5123
GCTCCAGG GGCTAGCTACAACGA GGCATCCC 6694 1536 CACCUGGA G CCCCACCC
5979 GGGTGGGG GGCTAGCTACAACGA TCCAGGTG 6695 1541 GGAGCCCC A
CCCAGGAG 5129 CTCCTGGG GGCTAGCTACAACGA GGGGCTCC 6696 1549 ACCCAGGA
G CUGGCCGC 5980 GCGGCCAG GGCTAGCTACAACGA TCCTGGGT 6697 1553
AGGAGCUG G CCGCGGCA 5981 TGCCGCGG GGCTAGCTACAACGA CAGCTCCT 6698
1556 AGCUGGCC G CGGCACCU 5982 AGGTGCCG GGCTAGCTACAACGA GGCCAGCT
6699 1559 UGGCCGCG G CACCUUAC 5983 GTAAGGTG GGCTAGCTACAACGA
CGCGGCCA 6700 1561 GCCGCGGC A CCUUACGC 5135 GCGTAAGG
GGCTAGCTACAACGA GCCGCGGC 6701 1566 GGCACCUU A CGCUUCAG 4475
CTGAAGCG GGCTAGCTACAACGA AAGGTGCC 6702 1568 CACCUUAC G CUUCAGCU
5984 AGCTGAAG GGCTAGCTACAACGA GTAAGGTG 6703 1574 ACGCUUCA G
CUGUUGAU 5985 ATCAACAG GGCTAGCTACAACGA TGAAGCGT 6704 1577 CUUCAGCU
G UUGAUCCG 5986 CGGATCAA GGCTAGCTACAACGA AGCTGAAG 6705 1581
AGCUGUUG A UCCGCUGG 6363 CCAGCGGA GGCTAGCTACAACGA CAACAGCT 6706
1585 GUUGAUCC G CUGGUCCC 5987 GGGACCAG GGCTAGCTACAACGA GGATCAAC
6707 1589 AUCCGCUG G UCCCCUCU 5988 AGAGGGGA GGCTAGCTACAACGA
CAGCGGAT 6708 1604 CUUUUGGG G UAGAUGCG 5989 CGCATCTA
GGCTAGCTACAACGA CCCAAAAG 6709 1608 UGGGGUAG A UGCGGCCC 6364
GGGCCGCA GGCTAGCTACAACGA CTACCCCA 6710 1610 GGGUAGAU G CGGCCCCG
5990 CGGGGCCG GGCTAGCTACAACGA ATCTACCC 6711 1613 UAGAUGCG G
CCCCGAUC 5991 GATCGGGG GGCTAGCTACAACGA CGCATCTA 6712 1619 CGGCCCCG
A UCAGGCCU 6365 AGGCCTGA GGCTAGCTACAACGA CGGGGCCG 6713 1624
CCGAUCAG G CCUGACUC 5992 GAGTCAGG GGCTAGCTACAACGA CTGATCGG 6714
1629 CAGGCCUG A CUCGCUGC 6366 GCAGCGAG GGCTAGCTACAACGA CAGGCCTG
6715 1633 CCUGACUC G CUGCUCUU 5993 AAGAGCAG GGCTAGCTACAACGA
GAGTCAGG 6716 1636 GACUCGCU G CUCUUUUU 5994 AAAAAGAG
GGCTAGCTACAACGA AGCGAGTC 6717 1645 CUCUUUUU G UUCCCUUC 5995
GAAGGGAA GGCTAGCTACAACGA AAAAAGAG 6718 1655 UCCCUUCU G UCUGCUCG
5996 CGAGCAGA GGCTAGCTACAACGA AGAAGGGA 6719 1659 UUCUGUCU G
CUCGAACC 5997 GGTTCGAG GGCTAGCTACAACGA AGACAGAA 6720 1665 CUGCUCGA
A CCACUUGC 6367 GCAAGTGG GGCTAGCTACAACGA TCGAGCAG 6721 1668
CUCGAACC A CUUGCCUC 5165 GAGGCAAG GGCTAGCTACAACGA GGTTCGAG 6722
1672 AACCACUU G CCUCGGGC 5998 GCCCGAGG GGCTAGCTACAACGA AAGTGGTT
6723 1679 UGCCUCGG G CUAAUCCC 5999 GGGATTAG GGCTAGCTACAACGA
CCGAGGCA 6724 1683 UCGGGCUA A UCCCUCCC 6368 GGGAGGGA
GGCTAGCTACAACGA TAGCCCGA 6725 1701 CUUCCUCC A CCCGGCAC 5180
GTGCCGGG GGCTAGCTACAACGA GGAGGAAG 6726 1706 UCCACCCG G CACUGGGG
6000 CCCCAGTG GGCTAGCTACAACGA CGGGTGGA 6727 1708 CACCCGGC A
CUGGGGAA 5183 TTCCCCAG GGCTAGCTACAACGA GCCGGGTG 6728 1717 CUGGGGAA
G UCAAGAAU 6001 ATTCTTGA GGCTAGCTACAACGA TTCCCCAG 6729 1724
AGUCAAGA A UGGGGCCU 6369 AGGCCCCA GGCTAGCTACAACGA TCTTGACT 6730
1729 AGAAUGGG G CCUGGGGC 6002 GCCCCAGG GGCTAGCTACAACGA CCCATTCT
6731 1736 GGCCUGGG G CUCUCAGG 6003 CCTGAGAG GGCTAGCTACAACGA
CCCAGGCC 6732 1749 CAGGGAGA A CUGCUUCC 6370 GGAAGCAG
GGCTAGCTACAACGA TCTCCCTG 6733 1752 GGAGAACU G CUUCCCCU 6004
AGGGGAAG GGCTAGCTACAACGA AGTTCTCC 6734 1762 UUCCCCUG G CAGAGCUG
6005 CAGCTCTG GGCTAGCTACAACGA CAGGGGAA 6735 1767 CUGGCAGA G
CUGGGUGG 6006 CCACCCAG GGCTAGCTACAACGA TCTGCCAG 6736 1772 AGAGCUGG
G UGGCAGCU 6007 AGCTGCCA GGCTAGCTACAACGA CCAGCTCT 6737 1775
GCUGGGUG G CAGCUCUU 6008 AAGAGCTG GGCTAGCTACAACGA CACCCAGC 6738
1778 GGGUGGCA G CUCUUCCU 6009 AGGAAGAG GGCTAGCTACAACGA TGCCACCC
6739 1790 UUCCUCCC A CCGGACAC 5206 GTGTCCGG GGCTAGCTACAACGA
GGGAGGAA 6740 1795 CCCACCGG A CACCGACC 6371 GGTCGGTG
GGCTAGCTACAACGA CCGGTGGG 6741 1797 CACCGGAC A CCGACCCG 5208
CGGGTCGG GGCTAGCTACAACGA GTCCGGTG 6742 1801 GGACACCG A CCCGCCCG
6372 CGGGCGGG GGCTAGCTACAACGA CGGTGTCC 6743 1805 ACCGACCC G
CCCGCCGC 6010 GCGGCGGG GGCTAGCTACAACGA GGGTCGGT 6744 1809 ACCCGCCC
G CCGCUGUG 6011 CACAGCGG GGCTAGCTACAACGA GGGCGGGT 6745 1812
CGCCCGCC G CUGUGCCC 6012 GGGCACAG GGCTAGCTACAACGA GGCGGGCG 6746
1815 CCGCCGCU G UGCCCUGG 6013 CCAGGGCA GGCTAGCTACAACGA AGCGGCGG
6747 1817 GCCGCUGU G CCCUGGGA 6014 TCCCAGGG GGCTAGCTACAACGA
ACAGCGGC 6748 1826 CCCUGGGA G UGCUGCCC 6015 GGGCAGCA
GGCTAGCTACAACGA TCCCAGGG 6749 1828 CUGGGAGU G CUGCCCUC 6016
GAGGGCAG GGCTAGCTACAACGA ACTCCCAG 6750 1831 GGAGUGCU G CCCUCUUA
6017 TAAGAGGG GGCTAGCTACAACGA AGCACTCC 6751 1839 GCCCUCUU A
CCAUGCAC 4519 GTGCATGG GGCTAGCTACAACGA AAGAGGGC 6752
1842 CUCUUACC A UGCACACG 5225 CGTGTGCA GGCTAGCTACAACGA GGTAAGAG
6753 1844 CUUACCAU G CACACGGG 6018 CCCGTGTG GGCTAGCTACAACGA
ATGGTAAG 6754 1846 UACCAUGC A CACGGGUG 5226 CACCCGTG
GGCTAGCTACAACGA GCATGGTA 6755 1848 CCAUGCAC A CGGGUGCU 5227
AGCACCCG GGCTAGCTACAACGA GTGCATGG 6756 1852 GCACACGG G UGCUCUCC
6019 GGAGAGCA GGCTAGCTACAACGA CCGTGTGC 6757 1854 ACACGGGU G
CUCUCCUU 6020 AAGGAGAG GGCTAGCTACAACGA ACCCGTGT 6758 1867 CCUUUUGG
G CUGCAUGC 6021 GCATGCAG GGCTAGCTACAACGA CCAAAAGG 6759 1870
UUUGGGCU G CAUGCUAU 6022 ATAGCATG GGCTAGCTACAACGA AGCCCAAA 6760
1872 UGGGCUGC A UGCUAUUC 5233 GAATAGCA GGCTAGCTACAACGA GCAGCCCA
6761 1874 GGCUGCAU G CUAUUCCA 6023 TGGAATAG GGCTAGCTACAACGA
ATGCAGCC 6762 1877 UGCAUGCU A UUCCAUUU 4525 AAATGGAA
GGCTAGCTACAACGA AGCATGCA 6763 1882 GCUAUUCC A UUUUGCAG 5236
CTGCAAAA GGCTAGCTACAACGA GGAATAGC 6764 1887 UCCAUUUU G CAGCCAGA
6024 TCTGGCTG GGCTAGCTACAACGA AAAATGGA 6765 1890 AUUUUGCA G
CCAGACCG 6025 CGGTCTGG GGCTAGCTACAACGA TGCAAAAT 6766 1895 GCAGCCAG
A CCGAUGUG 6373 CACATCGG GGCTAGCTACAACGA CTGGCTGC 6767 1899
CCAGACCG A UGUGUAUU 6374 AATACACA GGCTAGCTACAACGA CGGTCTGG 6768
1901 AGACCGAU G UGUAUUUA 6026 TAAATACA GGCTAGCTACAACGA ATCGGTCT
6769 1903 ACCGAUGU G UAUUUAAC 6027 GTTAAATA GGCTAGCTACAACGA
ACATCGGT 6770 1905 CGAUGUGU A UUUAACCA 4531 TGGTTAAA
GGCTAGCTACAACGA ACACATCG 6771 1910 UGUAUUUA A CCAGUCAC 6375
GTGACTGG GGCTAGCTACAACGA TAAATACA 6772 1914 UUUAACCA G UCACUAUU
6028 AATAGTGA GGCTAGCTACAACGA TGGTTAAA 6773 1917 AACCAGUC A
CUAUUGAU 5243 ATCAATAG GGCTAGCTACAACGA GACTGGTT 6774 1920 CAGUCACU
A UUGAUGGA 4536 TCCATCAA GGCTAGCTACAACGA AGTGACTG 6775 1924
CACUAUUG A UGGACAUU 6376 AATGTCCA GGCTAGCTACAACGA CAATAGTG 6776
1928 AUUGAUGG A CAUUUGGG 6377 CCCAAATG GGCTAGCTACAACGA CCATCAAT
6777 1930 UGAUGGAC A UUUGGGUU 5245 AACCCAAA GGCTAGCTACAACGA
GTCCATCA 6778 1936 ACAUUUGG G UUGUUUCC 6029 GGAAACAA
GGCTAGCTACAACGA CCAAATGT 6779 1939 UUUGGGUU G UUUCCCAU 6030
ATGGGAAA GGCTAGCTACAACGA AACCCAAA 6780 1946 UGUUUCCC A UCUUUUUG
5248 CAAAAAGA GGCTAGCTACAACGA GGGAAACA 6781 1954 AUCUUUUU G
UUACCAUA 6031 TATGGTAA GGCTAGCTACAACGA AAAAAGAT 6782 1957 UUUUUGUU
A CCAUAAAU 4550 ATTTATGG GGCTAGCTACAACGA AACAAAAA 6783 1960
UUGUUACC A UAAAUAAU 5251 ATTATTTA GGCTAGCTACAACGA GGTAACAA 6784
1964 UACCAUAA A UAAUGGCA 6378 TGCCATTA GGCTAGCTACAACGA TTATGGTA
6785 1967 CAUAAAUA A UGGCAUAG 6379 CTATGCCA GGCTAGCTACAACGA
TATTTATG 6786 1970 AAAUAAUG G CAUAGUAA 6032 TTACTATG
GGCTAGCTACAACGA CATTATTT 6787 1972 AUAAUGGC A UAGUAAAA 5252
TTTTACTA GGCTAGCTACAACGA GCCATTAT 6788 1975 AUGGCAUA G UAAAAAAA
6033 TTTTTTTA GGCTAGCTACAACGA TATGCCAT 6789 Input Sequence =
NM_003639. Cut Site = R/Y Arm Length = 8. Core Sequence =
GGCTAGCTACAACGA NM_003639 (Homo sapiens inhibitor of kappa light
polypeptide gene enhancer in B-cells, kinase gamma (IKBKG), mRNA.;
1994 bp)
[0269] TABLE-US-00007 TABLE VII Human IKK-gamma Amberzyme and
Substrate Sequence Seq Seq Pos Substrate ID Amberzyme ID 12
ACGAGCAU G GCCCUUGU 6790 ACAAGGGC GGAGGAAACUCC CU
UCAAGGACAUCGUCCGGG AUGCUCGU 7142 13 CGAGCAUG G CCCUUGUG 5757
CACAAGGG GGAGGAAACUCC CU UCAAGGACAUCGUCCGGG CAUGCUCG 7143 19
UGGCCCUU G UGAUCCAG 5758 CUGGAUCA GGAGGAAACUCC CU
UCAAGGACAUCGUCCGGG AAGGGCCA 7144 21 GCCCUUGU G AUCCAGGU 6791
ACCUGGAU GGAGGAAACUCC CU UCAAGGACAUCGUCCGGG ACAAGGGC 7145 27
GUGAUCCA G GUGGGGAA 6792 UUCCCCAC GGAGGAAACUCC CU
UCAAGGACAUCGUCCGGG UGGAUCAC 7146 28 UGAUCCAG G UGGGGAAA 5759
UUUCCCCA GGAGGAAACUCC CU UCAAGGACAUCGUCCGGG CUGGAUCA 7147 30
AUCCAGGU G GGGAAACU 6793 AGUUUCCC GGAGGAAACUCC CU
UCAAGGACAUCGUCCGGG ACCUGGAU 7148 31 UCCAGGUG G GGAAACUA 6794
UAGUUUCC GGAGGAAACUCC CU UCAAGGACAUCGUCCGGG CACCUGGA 7149 32
CCAGGUGG G GAAACUAA 6795 UUAGUUUC GGAGGAAACUCC CU
UCAAGGACAUCGUCCGGG CCACCUGG 7150 33 CAGGUGGG G AAACUAAG 6796
CUUAGUUU GGAGGAAACUCC CU UCAAGGACAUCGUCCGGG CCCACCUG 7151 41
GAAACUAA G GCCCAGAG 6797 CUCUGGGC GGAGGAAACUCC CU
UCAAGGACAUCGUCCGGG UUAGUUUC 7152 42 AAACUAAG G CCCAGAGA 5760
UCUCUGGG GGAGGAAACUCC CU UCAAGGACAUCGUCCGGG CUUAGUUU 7153 47
AAGGCCCA G AGAAGUGA 6798 UCACUUCU GGAGGAAACUCC CU
UCAAGGACAUCGUCCGGG UGGGCCUU 7154 49 GGCCCAGA G AAGUGAGG 6799
CCUCACUU GGAGGAAACUCC CU UCAAGGACAUCGUCCGGG UCUGGGCC 7155 52
CCAGAGAA G UGAGGACC 5761 GGUCCUCA GGAGGAAACUCC CU
UCAAGGACAUCGUCCGGG UUCUCUGG 7156 54 AGAGAAGU G AGGACCCC 6800
GGGGUCCU GGAGGAAACUCC CU UCAAGGACAUCGUCCGGG ACUUCUCU 7157 56
AGAAGUGA G GACCCCGC 6801 GCGGGGUC GGAGGAAACUCC CU
UCAAGGACAUCGUCCGGG UCACUUCU 7158 57 GAAGUGAG G ACCCCGCA 6802
UGCGGGGU GGAGGAAACUCC CU UCAAGGACAUCGUCCGGG CUCACUUC 7159 63
AGGACCCC G CAGACUAU 5762 AUAGUCUG GGAGGAAACUCC CU
UCAAGGACAUCGUCCGGG GGGGUCCU 7160 66 ACCCCGCA G ACUAUCAA 6803
UUGAUAGU GGAGGAAACUCC CU UCAAGGACAUCGUCCGGG UGCGGGGU 7161 80
CAAUCCCA G UCUCUUCC 5763 GGAAGAGA GGAGGAAACUCC CU
UCAAGGACAUCGUCCGGG UGGGAUUG 7162 100 CACUCCCU G UGAAGCUC 5764
GAGCUUCA GGAGGAAACUCC CU UCAAGGACAUCGUCCGGG AGGGAGUG 7163 102
CUCCCUGU G AAGCUCUC 6804 GAGAGCUU GGAGGAAACUCC CU
UCAAGGACAUCGUCCGGG ACAGGGAG 7164 105 CCUGUGAA G CUCUCCAG 5765
CUGGAGAG GGAGGAAACUCC CU UCAAGGACAUCGUCCGGG UUCACAGG 7165 113
GCUCUCCA G CAUCAUCG 5766 CGAUGAUG GGAGGAAACUCC CU
UCAAGGACAUCGUCCGGG UGGAGAGC 7166 121 GCAUCAUC G AGGUCCCA 6805
UGGGACCU GGAGGAAACUCC CU UCAAGGACAUCGUCCGGG GAUGAUGC 7167 123
AUCAUCGA G GUCCCAUC 6806 GAUGGGAC GGAGGAAACUCC CU
UCAAGGACAUCGUCCGGG UCGAUGAU 7168 124 UCAUCGAG G UCCCAUCA 5767
UGAUGGGA GGAGGAAACUCC CU UCAAGGACAUCGUCCGGG CUCGAUGA 7169 133
UCCCAUCA G CCCUUGCC 5768 GGCAAGGG GGAGGAAACUCC CU
UCAAGGACAUCGUCCGGG UGAUGGGA 7170 139 CAGCCCUU G CCCUGUUG 5769
CAACAGGG GGAGGAAACUCC CU UCAAGGACAUCGUCCGGG AAGGGCUG 7171 144
CUUGCCCU G UUGGAUGA 5770 UCAUCCAA GGAGGAAACUCC CU
UCAAGGACAUCGUCCGGG AGGGCAAG 7172 147 GCCCUGUU G GAUGAAUA 6807
UAUUCAUC GGAGGAAACUCC CU UCAAGGACAUCGUCCGGG AACAGGGC 7173 148
CCCUGUUG G AUGAAUAG 6808 CUAUUCAU GGAGGAAACUCC CU
UCAAGGACAUCGUCCGGG CAACAGGG 7174 151 UGUUGGAU G AAUAGGCA 6809
UGCCUAUU GGAGGAAACUCC CU UCAAGGACAUCGUCCGGG AUCCAACA 7175 156
GAUGAAUA G GCACCUCU 6810 AGAGGUGC GGAGGAAACUCC CU
UCAAGGACAUCGUCCGGG UAUUCAUC 7176 157 AUGAAUAG G CACCUCUG 5771
CAGAGGUG GGAGGAAACUCC CU UCAAGGACAUCGUCCGGG CUAUUCAU 7177 165
GCACCUCU G GAAGAGCC 6811 GGCUCUUC GGAGGAAACUCC CU
UCAAGGACAUCGUCCGGG AGAGGUGC 7178 166 CACCUCUG G AAGAGCCA 6812
UGGCUCUU GGAGGAAACUCC CU UCAAGGACAUCGUCCGGG CAGAGGUG 7179 169
CUCUGGAA G AGCCAACU 6813 AGUUGGCU GGAGGAAACUCC CU
UCAAGGACAUCGUCCGGG UUCCAGAG 7180 171 CUGGAAGA G CCAACUGU 5772
ACAGUUGG GGAGGAAACUCC CU UCAAGGACAUCGUCCGGG UCUUCCAG 7181 178
AGCCAACU G UGUGAGAU 5773 AUCUCACA GGAGGAAACUCC CU
UCAAGGACAUCGUCCGGG AGUUGGCU 7182 180 CCAACUGU G UGAGAUGG 5774
CCAUCUCA GGAGGAAACUCC CU UCAAGGACAUCGUCCGGG ACAGUUGG 7183 182
AACUGUGU G AGAUGGUG 6814 CACCAUCU GGAGGAAACUCC CU
UCAAGGACAUCGUCCGGG ACACAGUU 7184 184 CUGUGUGA G AUGGUGCA 6815
UGCACCAU GGAGGAAACUCC CU UCAAGGACAUCGUCCGGG UCACACAG 7185 187
UGUGAGAU G GUGCAGCC 6816 GGCUGCAC GGAGGAAACUCC CU
UCAAGGACAUCGUCCGGG AUCUCACA 7186 188 GUGAGAUG G UGCAGCCC 5775
GGGCUGCA GGAGGAAACUCC CU UCAAGGACAUCGUCCGGG CAUCUCAC 7187 190
GAGAUGGU G CAGCCCAG 5776 CUGGGCUG GGAGGAAACUCC CU
UCAAGGACAUCGUCCGGG ACCAUCUC 7188 193 AUGGUGCA G CCCAGUGG 5777
CCACUGGG GGAGGAAACUCC CU UCAAGGACAUCGUCCGGG UGCACCAU 7189 198
GCAGCCCA G UGGUGGCC 5778 GGCCACCA GGAGGAAACUCC CU
UCAAGGACAUCGUCCGGG UGGGCUGC 7190 200 AGCCCAGU G GUGGCCCG 6817
CGGGCCAC GGAGGAAACUCC CU UCAAGGACAUCGUCCGGG ACUGGGCU 7191 201
GCCCAGUG G UGGCCCGG 5779 CCGGGCCA GGAGGAAACUCC CU
UCAAGGACAUCGUCCGGG CACUGGGC 7192 203 CCAGUGGU G GCCCGGCA 6818
UGCCGGGC GGAGGAAACUCC CU UCAAGGACAUCGUCCGGG ACCACUGG 7193 204
CAGUGGUG G CCCGGCAG 5780 CUGCCGGG GGAGGAAACUCC CU
UCAAGGACAUCGUCCGGG CACCACUG 7194 208 GGUGGCCC G GCAGCAGA 6819
UCUGCUGC GGAGGAAACUCC CU UCAAGGACAUCGUCCGGG GGGCCACC 7195 209
GUGGCCCG G CAGCAGAU 5781 AUCUGCUG GGAGGAAACUCC CU
UCAAGGACAUCGUCCGGG CGGGCCAC 7196 212 GCCCGGCA G CAGAUCAG 5782
CUGAUCUG GGAGGAAACUCC CU UCAAGGACAUCGUCCGGG UGCCGGGC 7197 215
CGGCAGCA G AUCAGGAC 6820 GUCCUGAU GGAGGAAACUCC CU
UCAAGGACAUCGUCCGGG UGCUGCCG 7198 220 GCAGAUCA G GACGUACU 6821
AGUACGUC GGAGGAAACUCC CU UCAAGGACAUCGUCCGGG UGAUCUGC 7199 221
CAGAUCAG G ACGUACUG 6822 CAGUACGU GGAGGAAACUCC CU
UCAAGGACAUCGUCCGGG CUGAUCUG 7200 224 AUCAGGAC G UACUGGGC 5783
GCCCAGUA GGAGGAAACUCC CU UCAAGGACAUCGUCCGGG GUCCUGAU 7201 229
GACGUACU G GGCGAAGA 6823 UCUUCGCC GGAGGAAACUCC CU
UCAAGGACAUCGUCCGGG AGUACGUC 7202 230 ACGUACUG G GCGAAGAG 6824
CUCUUCGC GGAGGAAACUCC CU UCAAGGACAUCGUCCGGG CAGUACGU 7203 231
CGUACUGG G CGAAGAGU 5784 ACUCUUCG GGAGGAAACUCC CU
UCAAGGACAUCGUCCGGG CCAGUACG 7204 233 UACUGGGC G AAGAGUCU 6825
AGACUCUU GGAGGAAACUCC CU UCAAGGACAUCGUCCGGG GCCCAGUA 7205 236
UGGGCGAA G AGUCUCCU 6826 AGGAGACU GGAGGAAACUCC CU
UCAAGGACAUCGUCCGGG UUCGCCCA 7206 238 GGCGAAGA G UCUCCUCU 5785
AGAGGAGA GGAGGAAACUCC CU UCAAGGACAUCGUCCGGG UCUUCGCC 7207 247
UCUCCUCU G GGGAAGCC 6827 GGCUUCCC GGAGGAAACUCC CU
UCAAGGACAUCGUCCGGG AGAGGAGA 7208 248 CUCCUCUG G GGAAGCCA 6828
UGGCUUCC GGAGGAAACUCC CU UCAAGGACAUCGUCCGGG CAGAGGAG 7209 249
UCCUCUGG G GAAGCCAG 6829 CUGGCUUC GGAGGAAACUCC CU
UCAAGGACAUCGUCCGGG CCAGAGGA 7210 250 CCUCUGGG G AAGCCAGC 6830
GCUGGCUU GGAGGAAACUCC CU UCAAGGACAUCGUCCGGG CCCAGAGG 7211 253
CUGGGGAA G CCAGCCAU 5786 AUGGCUGG GGAGGAAACUCC CU
UCAAGGACAUCGUCCGGG UUCCCCAG 7212 257 GGAAGCCA G CCAUGCUG 5787
CAGCAUGG GGAGGAAACUCC CU UCAAGGACAUCGUCCGGG UGGCUUCC 7213 262
CCAGCCAU G CUGCACCU 5788 AGGUGCAG GGAGGAAACUCC CU
UCAAGGACAUCGUCCGGG AUGGCUGG 7214 265 GCCAUGCU G CACCUGCC 5789
GGCAGGUG GGAGGAAACUCC CU UCAAGGACAUCGUCCGGG AGCAUGGC 7215 271
CUGCACCU G CCUUCAGA 5790 UCUGAAGG GGAGGAAACUCC CU
UCAAGGACAUCGUCCGGG AGGUGCAG 7216 278 UGCCUUCA G AACAGGGC 6831
GCCCUGUU GGAGGAAACUCC CU UCAAGGACAUCGUCCGGG UGAAGGCA 7217 283
UCAGAACA G GGCGCUCC 6832 GGAGCGCC GGAGGAAACUCC CU
UCAAGGACAUCGUCCGGG UGUUCUGA 7218 284 CAGAACAG G GCGCUCCU 6833
AGGAGCGC GGAGGAAACUCC CU UCAAGGACAUCGUCCGGG CUGUUCUG 7219 285
AGAACAGG G CGCUCCUG 5791 CAGGAGCG GGAGGAAACUCC CU
UCAAGGACAUCGUCCGGG CCUGUUCU 7220 287 AACAGGGC G CUCCUGAG 5792
CUCAGGAG GGAGGAAACUCC CU UCAAGGACAUCGUCCGGG GCCCUGUU 7221 293
GCGCUCCU G AGACCCUC 6834 GAGGGUCU GGAGGAAACUCC CU
UCAAGGACAUCGUCCGGG AGGAGCGC 7222
295 GCUCCUGA G ACCCUCCA 6835 UGGAGGGU GGAGGAAACUCC CU
UCAAGGACAUCGUCCGGG UCAGGAGC 7223 304 ACCCUCCA G CGCUGCCU 5793
AGGCAGCG GGAGGAAACUCC CU UCAAGGACAUCGUCCGGG UGGAGGGU 7224 306
CCUCCAGC G CUGCCUGG 5794 CCAGGCAG GGAGGAAACUCC CU
UCAAGGACAUCGUCCGGG GCUGGAGG 7225 309 CCAGCGCU G CCUGGAGG 5795
CCUCCAGG GGAGGAAACUCC CU UCAAGGACAUCGUCCGGG AGCGCUGG 7226 313
CGCUGCCU G GAGGAGAA 6836 UUCUCCUC GGAGGAAACUCC CU
UCAAGGACAUCGUCCGGG AGGCAGCG 7227 314 GCUGCCUG G AGGAGAAU 6837
AUUCUCCU GGAGGAAACUCC CU UCAAGGACAUCGUCCGGG CAGGCAGC 7228 316
UGCCUGGA G GAGAAUCA 6838 UGAUUCUC GGAGGAAACUCC CU
UCAAGGACAUCGUCCGGG UCCAGGCA 7229 317 GCCUGGAG G AGAAUCAA 6839
UUGAUUCU GGAGGAAACUCC CU UCAAGGACAUCGUCCGGG CUCCAGGC 7230 319
CUGGAGGA G AAUCAAGA 6840 UCUUGAUU GGAGGAAACUCC CU
UCAAGGACAUCGUCCGGG UCCUCCAG 7231 326 AGAAUCAA G AGCUCCGA 6841
UCGGAGCU GGAGGAAACUCC CU UCAAGGACAUCGUCCGGG UUGAUUCU 7232 328
AAUCAAGA G CUCCGAGA 5796 UCUCGGAG GGAGGAAACUCC CU
UCAAGGACAUCGUCCGGG UCUUGAUU 7233 333 AGAGCUCC G AGAUGCCA 6842
UGGCAUCU GGAGGAAACUCC CU UCAAGGACAUCGUCCGGG GGAGCUCU 7234 335
AGCUCCGA G AUGCCAUC 6843 GAUGGCAU GGAGGAAACUCC CU
UCAAGGACAUCGUCCGGG UCGGAGCU 7235 338 UCCGAGAU G CCAUCCGG 5797
CCGGAUGG GGAGGAAACUCC CU UCAAGGACAUCGUCCGGG AUCUCGGA 7236 345
UGCCAUCC G GCAGAGCA 6844 UGCUCUGC GGAGGAAACUCC CU
UCAAGGACAUCGUCCGGG GGAUGGCA 7237 346 GCCAUCCG G CAGAGCAA 5798
UUGCUCUG GGAGGAAACUCC CU UCAAGGACAUCGUCCGGG CGGAUGGC 7238 349
AUCCGGCA G AGCAACCA 6845 UGGUUGCU GGAGGAAACUCC CU
UCAAGGACAUCGUCCGGG UGCCGGAU 7239 351 CCGGCAGA G CAACCAGA 5799
UCUGGUUG GGAGGAAACUCC CU UCAAGGACAUCGUCCGGG UCUGCCGG 7240 358
AGCAACCA G AUUCUGCG 6846 CGCAGAAU GGAGGAAACUCC CU
UCAAGGACAUCGUCCGGG UGGUUGCU 7241 364 CAGAUUCU G CGGGAGCG 5800
CGCUCCCG GGAGGAAACUCC CU UCAAGGACAUCGUCCGGG AGAAUCUG 7242 366
GAUUCUGC G GGAGCGCU 6847 AGCGCUCC GGAGGAAACUCC CU
UCAAGGACAUCGUCCGGG GCAGAAUC 7243 367 AUUCUGCG G GAGCGCUG 6848
CAGCGCUC GGAGGAAACUCC CU UCAAGGACAUCGUCCGGG CGCAGAAU 7244 368
UUCUGCGG G AGCGCUGC 6849 GCAGCGCU GGAGGAAACUCC CU
UCAAGGACAUCGUCCGGG CCGCAGAA 7245 370 CUGCGGGA G CGCUGCGA 5801
UCGCAGCG GGAGGAAACUCC CU UCAAGGACAUCGUCCGGG UCCCGCAG 7246 372
GCGGGAGC G CUGCGAGG 5802 CCUCGCAG GGAGGAAACUCC CU
UCAAGGACAUCGUCCGGG GCUCCCGC 7247 375 GGAGCGCU G CGAGGAGC 5803
GCUCCUCG GGAGGAAACUCC CU UCAAGGACAUCGUCCGGG AGCGCUCC 7248 377
AGCGCUGC G AGGAGCUU 6850 AAGCUCCU GGAGGAAACUCC CU
UCAAGGACAUCGUCCGGG GCAGCGCU 7249 379 CGCUGCGA G GAGCUUCU 6851
AGAAGCUC GGAGGAAACUCC CU UCAAGGACAUCGUCCGGG UCGCACCG 7250 380
GCUGCGAG G AGCUUCUG 6852 CAGAAGCU GGAGGAAACUCC CU
UCAAGGACAUCGUCCGGG CUCGCAGC 7251 382 UGCGAGGA G CUUCUGCA 5804
UGCAGAAG GGAGGAAACUCC CU UCAAGGACAUCGUCCGGG UCCUCGCA 7252 388
GAGCUUCU G CAUUUCCA 5805 UGGAAAUG GGAGGAAACUCC CU
UCAAGGACAUCGUCCGGG AGAAGCUC 7253 398 AUUUCCAA G CCAGCCAG 5806
CUGGCUGG GGAGGAAACUCC CU UCAAGGACAUCGUCCGGG UUGCAAAU 7254 402
CCAAGCCA G CCACAGGG 5807 CCCUCUGG GGAGGAAACUCC CU
UCAAGGACAUCGUCCGGG UGGCUUCG 7255 406 GCCAGCCA G AGGGACCA 6853
UCCUCCCU GGAGGAAACUCC CU UCAAGGACAUCGUCCGGG UCCCUGCC 7256 408
CAGCCAGA G CCACGAGA 6854 UCUCCUCC GGAGGAAACUCC CU
UCAAGGACAUCGUCCGGG UCUCCCUC 7257 409 ACCCAGAC G GAGCAGAA 6855
UUCUCCUC GGAGGAAACUCC CU UCAAGGACAUCGUCCGGG CUCUCGCU 7258 410
CCCACACC G AGCAGAAC 6856 CUUCUCCU GGAGGAAACUCC CU
UCAAGGACAUCGUCCGGG CCUCUGCC 7259 412 CAGAGGCA G GAGAACGA 6657
UCCUUCUC GGAGGAAACUCC CU UCAAGGACAUCGUCCGGG UCCCUCUC 7260 413
AGAGGGAG G ACAACCAC 6858 CUCCUUCU GGAGGAAACUCC CU
UCAAGGACAUCGUCCGGG CUCCCUCU 7261 415 AGGGAGGA G AAGGACUU 6859
AACUCCUU GGAGGAAACUCC CU UCAAGGACAUCGUCCGGG UCCUCCCU 7262 418
CACGAGAA G GACUUCCU 6860 AGGAACUC GGAGGAAACUCC CU
UCAAGGACAUCGUCCGGG UUCUCCUC 7263 419 AGCAGAAG G ACUUCCUC 6861
GAGCAACU GGAGGAAACUCC CU UCAAGGACAUCGUCCGGG CUUCUCCU 7264 421
GACAACGA G UUCCUCAU 5808 AUCAGCAA GGAGGAAACUCC CU
UCAAGGACAUCGUCCGGG UCCUUCUC 7265 430 UUCCUCAU G UCCAACUU 5809
AACUUCCA GGAGGAAACUCC CU UCAAGGACAUCGUCCGGG AUCAGCAA 7266 432
CCUCAUCU G CAAGUUCC 5810 CGAACUUG GGAGGAAACUCC CU
UCAAGGACAUCGUCCGGG ACAUGAGC 7267 436 AUCUCCAA G UUCCACCA 5811
UCCUCCAA GGAGGAAACUCC CU UCAAGGACAUCGUCCGGG UUCCACAU 7268 442
AACUUCCA G CACCCCAC 6862 CUCCCCUC GGAGGAAACUCC CU
UCAAGGACAUCGUCCGGG UCCAACUU 7269 443 ACUUCCAC G ACCCCACC 6863
CCUCCCCU GGAGGAAACUCC CU UCAAGGACAUCGUCCGGG CUCCAACU 7270 445
UUCCACCA G CCCACCAA 6864 UUCCUCCC GGAGGAAACUCC CU
UCAAGGACAUCGUCCGGG UCCUCCAA 7271 446 UCCACCAC G CCACCAAA 5812
UUUCCUCC GGAGGAAACUCC CU UCAAGGACAUCGUCCGGG CUCCUCCA 7272 450
CCACCCCA G CAAACUCC 6865 CCACUUUC GGAGGAAACUCC CU
UCAAGGACAUCGUCCGGG UCCCCUCC 7273 451 CACCCCAC G AAACUCCU 6866
ACCACUUU GGAGGAAACUCC CU UCAAGGACAUCGUCCGGG CUCCCCUC 7274 457
ACCAAACU G CUCCACAC 6867 CUCUCCAC GGAGGAAACUCC CU
UCAAGGACAUCGUCCGGG ACUUUCCU 7275 458 CCAAACUC G UCCACACA 5813
UCUCUCCA GGAGGAAACUCC CU UCAAGGACAUCGUCCGGG CACUUUCC 7276 460
AAACUCCU G CACACACU 6868 ACUCUCUC GGAGGAAACUCC CU
UCAAGGACAUCGUCCGGG ACCACUUU 7277 461 AACUCCUC G ACACACUC 6869
CACUCUCU GGAGGAAACUCC CU UCAAGGACAUCGUCCGGG CACCACUU 7278 463
CUGGUCCA G ACACUCCC 6870 CCCACUCU GGAGGAAACUCC CU
UCAAGGACAUCGUCCGGG UCCACCAC 7279 465 CCUCCACA G ACUCCCCC 6871
CCCCCACU GGAGGAAACUCC CU UCAAGGACAUCGUCCGGG UCUCCACC 7280 470
ACACACUC G CCCUCCAC 6872 CUCCACCC GGAGGAAACUCC CU
UCAAGGACAUCGUCCGGG CACUCUCU 7281 471 CACACUCC G CCUCCACA 5814
UCUCCACC GGAGGAAACUCC CU UCAAGGACAUCGUCCGGG CCACUCUC 7282 475
CUCCCCCU G CACAACCU 6873 ACCUUCUC GGAGGAAACUCC CU
UCAAGGACAUCGUCCGGG ACCCCCAC 7283 476 UCGGCCUG G AGAACCUC 6874
CACCUUCU GGAGGAAACUCC CU UCAAGGACAUCGUCCGGG CACCCCCA 7284 478
GGCCUGGA G AACCUCCA 6875 UCCACCUU GGAGGAAACUCC CU
UCAAGGACAUCGUCCGGG UCCACCCC 7285 481 CUGGACAA G CUCCAUCU 5815
AGAUCCAC GGAGGAAACUCC CU UCAAGGACAUCGUCCGGG UUCUCCAC 7286 485
AGAAGCUC G AUCUGAAG 6876 CUUCAGAU GGAGGAAACUCC CU
UCAAGGACAUCGUCCGGG GAGCUUCU 7287 490 CUCGAUCU G AAGAGGCA 6877
UGCCUCUU GGAGGAAACUCC CU UCAAGGACAUCGUCCGGG AGAUCGAG 7288 493
GAUCUGAA G AGGCAGAA 6878 UUCUGCCU GGAGGAAACUCC CU
UCAAGGACAUCGUCCGGG UUCAGAUC 7289 495 UCUGAAGA G GCAGAAGG 6879
CCUUCUGC GGAGGAAACUCC CU UCAAGGACAUCGUCCGGG UCUUCAGA 7290 496
CUGAAGAG G CAGAAGGA 5816 UCCUUCUG GGAGGAAACUCC CU
UCAAGGACAUCGUCCGGG CUCUUCAG 7291 499 AAGAGGCA G AAGGAGCA 6880
UGCUCCUU GGAGGAAACUCC CU UCAAGGACAUCGUCCGGG UGCCUCUU 7292 502
AGGCAGAA G GAGCAGGC 6881 GCCUGCUC GGAGGAAACUCC CU
UCAAGGACAUCGUCCGGG UUCUGCCU 7293 503 GGCAGAAG G AGCAGGCU 6882
AGCCUGCU GGAGGAAACUCC CU UCAAGGACAUCGUCCGGG CUUCUGCC 7294 505
CAGAAGGA G CAGGCUCU 5817 AGAGCCUG GGAGGAAACUCC CU
UCAAGGACAUCGUCCGGG UCCUUCUG 7295 508 AAGGAGCA G GCUCUGCG 6883
CGCAGAGC GGAGGAAACUCC CU UCAAGGACAUCGUCCGGG UGCUCCUU 7296 509
AGGAGCAG G CUCUGCGG 5818 CCGCAGAG GGAGGAAACUCC CU
UCAAGGACAUCGUCCGGG CUGCUCCU 7297 514 CAGGCUCU G CGGGAGGU 5819
ACCUCCCG GGAGGAAACUCC CU UCAAGGACAUCGUCCGGG AGAGCCUG 7298 516
GGCUCUGC G GGAGGUGG 6884 CCACCUCC GGAGGAAACUCC CU
UCAAGGACAUCGUCCGGG GCAGAGCC 7299 517 GCUCUGCG G GAGGUGGA 6885
UCCACCUC GGAGGAAACUCC CU UCAAGGACAUCGUCCGGG CGCAGAGC 7300 518
CUCUGCGG G AGGUGGAG 6886 CUCCACCU GGAGGAAACUCC CU
UCAAGGACAUCGUCCGGG CCGCAGAG 7301 520 CUGCGGGA G GUGGAGCA 6887
UGCUCCAC GGAGGAAACUCC CU UCAAGGACAUCGUCCGGG UCCCGCAG 7302 521
UGCGGGAG G UGGAGCAC 5820 GUGCUCCA GGAGGAAACUCC CU
UCAAGGACAUCGUCCGGG CUCCCGCA 7303 523 CGGGAGGU G GAGCACCU 6888
AGGUGCUC GGAGGAAACUCC CU UCAAGGACAUCGUCCGGG ACCUCCCG 7304 524
GGGAGGUG G AGCACCUG 6889 CAGGUGCU GGAGGAAACUCC CU
UCAAGGACAUCGUCCGGG CACCUCCC 7305 526 GAGGUGGA G CACCUGAA 5821
UUCAGGUG GGAGGAAACUCC CU UCAAGGACAUCGUCCGGG UCCACCUC 7306
532 GAGCACCU G AAGAGAUG 6890 CAUCUCUU GGAGGAAACUCC CU
UCAAGGACAUCGUCCGGG AGGUGCUC 7307 535 CACCUGAA G AGAUGCCA 6891
UGGCAUCU GGAGGAAACUCC CU UCAAGGACAUCGUCCGGG UUCAGGUG 7308 537
CCUGAAGA G AUGCCAGC 6892 GCUGGCAU GGAGGAAACUCC CU
UCAAGGACAUCGUCCGGG UCUUCAGG 7309 540 GAAGAGAU G CCAGCAGC 5822
GCUGCUGG GGAGGAAACUCC CU UCAAGGACAUCGUCCGGG AUCUCUUC 7310 544
AGAUGCCA G CAGCAGAU 5823 AUCUGCUG GGAGGAAACUCC CU
UCAAGGACAUCGUCCGGG UGGCAUCU 7311 547 UGCCAGCA G CAGAUGGC 5824
GCCAUCUG GGAGGAAACUCC CU UCAAGGACAUCGUCCGGG UGCUGGCA 7312 550
CAGCAGCA G AUGGCUGA 6893 UCAGCCAU GGAGGAAACUCC CU
UCAAGGACAUCGUCCGGG UGCUGCUG 7313 553 CAGCAGAU G GCUGAGGA 6894
UCCUCAGC GGAGGAAACUCC CU UCAAGGACAUCGUCCGGG AUCUGCUG 7314 554
AGCAGAUG G CUGAGGAC 5825 GUCCUCAG GGAGGAAACUCC CU
UCAAGGACAUCGUCCGGG CAUCUGCU 7315 557 AGAUGGCU G AGGACAAG 6895
CUUGUCCU GGAGGAAACUCC CU UCAAGGACAUCGUCCGGG AGCCAUCU 7316 559
AUGGCUGA G GACAAGGC 6896 GCCUUGUC GGAGGAAACUCC CU
UCAAGGACAUCGUCCGGG UCAGCCAU 7317 560 UGGCUGAG G ACAAGGCC 6897
GGCCUUGU GGAGGAAACUCC CU UCAAGGACAUCGUCCGGG CUCAGCCA 7318 565
GAGGACAA G GCCUCUGU 6898 ACAGAGGC GGAGGAAACUCC CU
UCAAGGACAUCGUCCGGG UUGUCCUC 7319 566 AGGACAAG G CCUCUGUG 5826
CACAGAGG GGAGGAAACUCC CU UCAAGGACAUCGUCCGGG CUUGUCCU 7320 572
AGGCCUCU G UGAAAGCC 5827 GGCUUUCA GGAGGAAACUCC CU
UCAAGGACAUCGUCCGGG AGAGGCCU 7321 574 GCCUCUGU G AAAGCCCA 6899
UGGGCUUU GGAGGAAACUCC CU UCAAGGACAUCGUCCGGG ACAGAGGC 7322 578
CUGUGAAA G CCCAGGUG 5828 CACCUGGG GGAGGAAACUCC CU
UCAAGGACAUCGUCCGGG UUUCACAG 7323 583 AAAGCCCA G GUGACGUC 6900
GACGUCAC GGAGGAAACUCC CU UCAAGGACAUCGUCCGGG UGGGCUUU 7324 584
AAGCCCAG G UGACGUCC 5829 GGACGUCA GGAGGAAACUCC CU
UCAAGGACAUCGUCCGGG CUGGGCUU 7325 586 GCCCAGGU G ACGUCCUU 6901
AAGGACGU GGAGGAAACUCC CU UCAAGGACAUCGUCCGGG ACCUGGGC 7326 589
CAGGUGAC G UCCUUGCU 5830 AGCAAGGA GGAGGAAACUCC CU
UCAAGGACAUCGUCCGGG GUCACCUG 7327 595 ACGUCCUU G CUCGGGGA 5831
UCCCCGAG GGAGGAAACUCC CU UCAAGGACAUCGUCCGGG AAGGACGU 7328 599
CCUUGCUC G GGGAGCUG 6902 CAGCUCCC GGAGGAAACUCC CU
UCAAGGACAUCGUCCGGG GAGCAAGG 7329 600 CUUGCUCG G GGAGCUGC 6903
GCAGCUCC GGAGGAAACUCC CU UCAAGGACAUCGUCCGGG CGAGCAAG 7330 601
UUGCUCGG G GAGCUGCA 6904 UGCAGCUC GGAGGAAACUCC CU
UCAAGGACAUCGUCCGGG CCGAGCAA 7331 602 UGCUCGGG G AGCUGCAG 6905
CUGCAGCU GGAGGAAACUCC CU UCAAGGACAUCGUCCGGG CCCGAGCA 7332 604
CUCGGGGA G CUGCAGGA 5832 UCCUGCAG GGAGGAAACUCC CU
UCAAGGACAUCGUCCGGG UCCCCGAG 7333 607 GGGGAGCU G CAGGAGAG 5833
CUCUCCUG GGAGGAAACUCC CU UCAAGGACAUCGUCCGGG AGCUCCCC 7334 610
GAGCUGCA G GAGAGCCA 6906 UGGCUCUC GGAGGAAACUCC CU
UCAAGGACAUCGUCCGGG UGCAGCUC 7335 611 AGCUGCAG G AGAGCCAG 6907
CUGGCUCU GGAGGAAACUCC CU UCAAGGACAUCGUCCGGG CUGCAGCU 7336 613
CUGCAGGA G AGCCAGAG 6908 CUCUGGCU GGAGGAAACUCC CU
UCAAGGACAUCGUCCGGG UCCUGCAG 7337 615 GCAGGAGA G CCAGAGUC 5834
GACUCUGG GGAGGAAACUCC CU UCAAGGACAUCGUCCGGG UCUCCUGC 7338 619
GAGAGCCA G AGUCGCUU 6909 AAGCGACU GGAGGAAACUCC CU
UCAAGGACAUCGUCCGGG UGGCUCUC 7339 621 GAGCCAGA G UCGCUUGG 5835
CCAAGCGA GGAGGAAACUCC CU UCAAGGACAUCGUCCGGG UCUGGCUC 7340 624
CCAGAGUC G CUUGGAGG 5836 CCUCCAAG GGAGGAAACUCC CU
UCAAGGACAUCGUCCGGG GACUCUGG 7341 628 AGUCGCUU G GAGGCUGC 6910
GCAGCCUC GGAGGAAACUCC CU UCAAGGACAUCGUCCGGG AAGCGACU 7342 629
GUCGCUUG G AGGCUGCC 6911 GGCAGCCU GGAGGAAACUCC CU
UCAAGGACAUCGUCCGGG CAAGCGAC 7343 631 CGCUUGGA G GCUGCCAC 6912
GUGGCAGC GGAGGAAACUCC CU UCAAGGACAUCGUCCGGG UCCAAGCG 7344 632
GCUUGGAG G CUGCCACU 5837 AGUGGCAG GGAGGAAACUCC CU
UCAAGGACAUCGUCCGGG CUCCAAGC 7345 635 UGGAGGCU G CCACUAAG 5838
CUUAGUGG GGAGGAAACUCC CU UCAAGGACAUCGUCCGGG AGCCUCCA 7346 643
GCCACUAA G GAAUGCCA 6913 UGGCAUUC GGAGGAAACUCC CU
UCAAGGACAUCGUCCGGG UUAGUGGC 7347 644 CCACUAAG G AAUGCCAG 6914
CUGGCAUU GGAGGAAACUCC CU UCAAGGACAUCGUCCGGG CUUAGUGG 7348 648
UAAGGAAU G CCAGGCUC 5839 GAGCCUGG GGAGGAAACUCC CU
UCAAGGACAUCGUCCGGG AUUCCUUA 7349 652 GAAUGCCA G GCUCUGGA 6915
UCCAGAGC GGAGGAAACUCC CU UCAAGGACAUCGUCCGGG UGGCAUUC 7350 653
AAUGCCAG G CUCUGGAG 5840 CUCCAGAG GGAGGAAACUCC CU
UCAAGGACAUCGUCCGGG CUGGCAUU 7351 658 CAGGCUCU G GAGGGUCG 6916
CGACCCUC GGAGGAAACUCC CU UCAAGGACAUCGUCCGGG AGAGCCUG 7352 659
AGGCUCUG G AGGGUCGG 6917 CCGACCCU GGAGGAAACUCC CU
UCAAGGACAUCGUCCGGG CAGAGCCU 7353 661 GCUCUGGA G GGUCGGGC 6918
GCCCGACC GGAGGAAACUCC CU UCAAGGACAUCGUCCGGG UCCAGAGC 7354 662
CUCUGGAG G GUCGGGCC 6919 GGCCCGAC GGAGGAAACUCC CU
UCAAGGACAUCGUCCGGG CUCCAGAG 7355 663 UCUGGAGG G UCGGGCCC 5841
GGGCCCGA GGAGGAAACUCC CU UCAAGGACAUCGUCCGGG CCUCCAGA 7356 666
GGAGGGUC G GGCCCGGG 6920 CCCGGGCC GGAGGAAACUCC CU
UCAAGGACAUCGUCCGGG GACCCUCC 7357 667 GAGGGUCG G GCCCGGGC 6921
GCCCGGGC GGAGGAAACUCC CU UCAAGGACAUCGUCCGGG CGACCCUC 7358 668
AGGGUCGG G CCCGGGCG 5842 CGCCCGGG GGAGGAAACUCC CU
UCAAGGACAUCGUCCGGG CCGACCCU 7359 672 UCGGGCCC G GGCGGCCA 6922
UGGCCGCC GGAGGAAACUCC CU UCAAGGACAUCGUCCGGG GGGCCCGA 7360 673
CGGGCCCG G GCGGCCAG 6923 CUGGCCGC GGAGGAAACUCC CU
UCAAGGACAUCGUCCGGG CGGGCCCG 7361 674 GGGCCCGG G CGGCCAGC 5843
GCUGGCCG GGAGGAAACUCC CU UCAAGGACAUCGUCCGGG CCGGGCCC 7362 676
GCCCGGGC G GCCAGCGA 6924 UCGCUGGC GGAGGAAACUCC CU
UCAAGGACAUCGUCCGGG GCCCGGGC 7363 677 CCCGGGCG G CCAGCGAG 5844
CUCGCUGG GGAGGAAACUCC CU UCAAGGACAUCGUCCGGG CGCCCGGG 7364 681
GGCGGCCA G CGAGCAGG 5845 CCUGCUCG GGAGGAAACUCC CU
UCAAGGACAUCGUCCGGG UGGCCGCC 7365 683 CGGCCAGC G AGCAGGCG 6925
CGCCUGCU GGAGGAAACUCC CU UCAAGGACAUCGUCCGGG GCUGGCCG 7366 685
GCCAGCGA G CAGGCGCG 5846 CGCGCCUG GGAGGAAACUCC CU
UCAAGGACAUCGUCCGGG UCGCUGGC 7367 688 AGCGAGCA G GCGCGGCA 6926
UGCCGCGC GGAGGAAACUCC CU UCAAGGACAUCGUCCGGG UGCUCGCU 7368 689
GCGAGCAG G CGCGGCAG 5847 CUGCCGCG GGAGGAAACUCC CU
UCAAGGACAUCGUCCGGG CUGCUCGC 7369 691 GAGCAGGC G CGGCAGCU 5848
AGCUGCCG GGAGGAAACUCC CU UCAAGGACAUCGUCCGGG GCCUGCUC 7370 693
GCAGGCGC G GCAGCUGG 6927 CCAGCUGC GGAGGAAACUCC CU
UCAAGGACAUCGUCCGGG GCGCCUGC 7371 694 CAGGCGCG G CAGCUGGA 5849
UCCAGCUG GGAGGAAACUCC CU UCAAGGACAUCGUCCGGG CGCGCCUG 7372 697
GCGCGGCA G CUGGAGAG 5850 CUCUCCAG GGAGGAAACUCC CU
UCAAGGACAUCGUCCGGG UGCCGCGC 7373 700 CGGCAGCU G GAGAGUGA 6928
UCACUCUC GGAGGAAACUCC CU UCAAGGACAUCGUCCGGG AGCUGCCG 7374 701
GGCAGCUG G AGAGUGAG 6929 CUCACUCU GGAGGAAACUCC CU
UCAAGGACAUCGUCCGGG CAGCUGCC 7375 703 CAGCUGGA G AGUGAGCG 6930
CGCUCACU GGAGGAAACUCC CU UCAAGGACAUCGUCCGGG UCCAGCUG 7376 705
GCUGGAGA G UGAGCGCG 5851 CGCGCUCA GGAGGAAACUCC CU
UCAAGGACAUCGUCCGGG UCUCCAGC 7377 707 UGGAGAGU G AGCGCGAG 6931
CUCGCGCU GGAGGAAACUCC CU UCAAGGACAUCGUCCGGG ACUCUCCA 7378 709
GAGAGUGA G CGCGAGGC 5852 GCCUCGCG GGAGGAAACUCC CU
UCAAGGACAUCGUCCGGG UCACUCUC 7379 711 GAGUGAGC G CGAGGCGC 5853
GCGCCUCG GGAGGAAACUCC CU UCAAGGACAUCGUCCGGG GCUCACUC 7380 713
GUGAGCGC G AGGCGCUG 6932 CAGCGCCU GGAGGAAACUCC CU
UCAAGGACAUCGUCCGGG GCGCUCAC 7381 715 GAGCGCGA G GCGCUGCA 6933
UGCAGCGC GGAGGAAACUCC CU UCAAGGACAUCGUCCGGG UCGCGCUC 7382 716
AGCGCGAG G CGCUGCAG 5854 CUGCAGCG GGAGGAAACUCC CU
UCAAGGACAUCGUCCGGG CUCGCGCU 7383 718 CGCGAGGC G CUGCAGCA 5855
UGCUGCAG GGAGGAAACUCC CU UCAAGGACAUCGUCCGGG GCCUCGCG 7384 721
GAGGCGCU G CAGCAGCA 5856 UGCUGCUG GGAGGAAACUCC CU
UCAAGGACAUCGUCCGGG AGCGCCUC 7385 724 GCGCUGCA G CAGCAGCA 5857
UGCUGCUG GGAGGAAACUCC CU UCAAGGACAUCGUCCGGG UGCAGCGC 7386 727
CUGCAGCA G CAGCACAG 5858 CUGUGCUG GGAGGAAACUCC CU
UCAAGGACAUCGUCCGGG UGCUGCAG 7387 730 CAGCAGCA G CACAGCGU 5859
ACGCUGUG GGAGGAAACUCC CU UCAAGGACAUCGUCCGGG UGCUGCUG 7388 735
GCAGCACA G CGUGCAGG 5860 CCUGCACG GGAGGAAACUCC CU
UCAAGGACAUCGUCCGGG UGUGCUGC 7389 737 AGCACAGC G UGCAGGUG 5861
CACCUGCA GGAGGAAACUCC CU UCAAGGACAUCGUCCGGG
GCUGUGCU 7390 739 CACAGCGU G CAGGUGGA 5862 UCCACCUG GGAGGAAACUCC CU
UCAAGGACAUCGUCCGGG ACGCUGUG 7391 742 AGCGUGCA G GUGGACCA 6934
UGGUCCAC GGAGGAAACUCC CU UCAAGGACAUCGUCCGGG UGCACGCU 7392 743
GCGUGCAG G UGGACCAG 5863 CUGGUCCA GGAGGAAACUCC CU
UCAAGGACAUCGUCCGGG CUGCACGC 7393 745 GUGCAGGU G GACCAGCU 6935
AGCUGGUC GGAGGAAACUCC CU UCAAGGACAUCGUCCGGG ACCUGCAC 7394 746
UGCAGGUG G ACCAGCUG 6936 CAGCUGGU GGAGGAAACUCC CU
UCAAGGACAUCGUCCGGG CACCUGCA 7395 751 GUGGACCA G CUGCGCAU 5864
AUGCGCAG GGAGGAAACUCC CU UCAAGGACAUCGUCCGGG UGGUCCAC 7396 754
GACCAGCU G CGCAUGCA 5865 UGCAUGCG GGAGGAAACUCC CU
UCAAGGACAUCGUCCGGG AGCUGGUC 7397 756 CCAGCUGC G CAUGCAGG 5866
CCUGCAUG GGAGGAAACUCC CU UCAAGGACAUCGUCCGGG GCAGCUGG 7398 760
CUGCGCAU G CAGGGCCA 5867 UGGCCCUG GGAGGAAACUCC CU
UCAAGGACAUCGUCCGGG AUGCGCAG 7399 763 CGCAUGCA G GGCCAGAG 6937
CUCUGGCC GGAGGAAACUCC CU UCAAGGACAUCGUCCGGG UGCAUGCG 7400 764
GCAUGCAG G GCCAGAGC 6938 GCUCUGGC GGAGGAAACUCC CU
UCAAGGACAUCGUCCGGG CUGCAUGC 7401 765 CAUGCAGG G CCAGAGCG 5868
CGCUCUGG GGAGGAAACUCC CU UCAAGGACAUCGUCCGGG CCUGCAUG 7402 769
CAGGGCCA G AGCGUGGA 6939 UCCACGCU GGAGGAAACUCC CU
UCAAGGACAUCGUCCGGG UGGCCCUG 7403 771 GGGCCAGA G CGUGGAGG 5869
CCUCCACG GGAGGAAACUCC CU UCAAGGACAUCGUCCGGG UCUGGCCC 7404 773
GCCAGAGC G UGGAGGCC 5870 GGCCUCCA GGAGGAAACUCC CU
UCAAGGACAUCGUCCGGG GCUCUGGC 7405 775 CAGAGCGU G GAGGCCGC 6940
GCGGCCUC GGAGGAAACUCC CU UCAAGGACAUCGUCCGGG ACGCUCUG 7406 776
AGAGCGUG G AGGCCGCG 6941 CGCGGCCU GGAGGAAACUCC CU
UCAAGGACAUCGUCCGGG CACGCUCU 7407 778 AGCGUGGA G GCCGCGCU 6942
AGCGCGGC GGAGGAAACUCC CU UCAAGGACAUCGUCCGGG UCCACGCU 7408 779
GCGUGGAG G CCGCGCUC 5871 GAGCGCGG GGAGGAAACUCC CU
UCAAGGACAUCGUCCGGG CUCCACGC 7409 782 UGGAGGCC G CGCUCCGC 5872
GCGGAGCG GGAGGAAACUCC CU UCAAGGACAUCGUCCGGG GGCCUCCA 7410 784
GAGGCCGC G CUCCGCAU 5873 AUGCGGAG GGAGGAAACUCC CU
UCAAGGACAUCGUCCGGG GCGGCCUC 7411 789 CGCGCUCC G CAUGGAGC 5874
GCUCCAUG GGAGGAAACUCC CU UCAAGGACAUCGUCCGGG GGAGCGCG 7412 793
CUCCGCAU G GAGCGCCA 6943 UGGCGCUC GGAGGAAACUCC CU
UCAAGGACAUCGUCCGGG AUGCGGAG 7413 794 UCCGCAUG G AGCGCCAG 6944
CUGGCGCU GGAGGAAACUCC CU UCAAGGACAUCGUCCGGG CAUGCGGA 7414 796
CGCAUGGA G CGCCAGGC 5875 GCCUGGCG GGAGGAAACUCC CU
UCAAGGACAUCGUCCGGG UCCAUGCG 7415 798 CAUGGAGC G CCAGGCCG 5876
CGGCCUGG GGAGGAAACUCC CU UCAAGGACAUCGUCCGGG GCUCCAUG 7416 802
GAGCGCCA G GCCGCCUC 6945 GAGGCGGC GGAGGAAACUCC CU
UCAAGGACAUCGUCCGGG UGGCGCUC 7417 803 AGCGCCAG G CCGCCUCG 5877
CGAGGCGG GGAGGAAACUCC CU UCAAGGACAUCGUCCGGG CUGGCGCU 7418 806
GCCAGGCC G CCUCGGAG 5878 CUCCGAGG GGAGGAAACUCC CU
UCAAGGACAUCGUCCGGG GGCCUGGC 7419 811 GCCGCCUC G GAGGAGAA 6946
UUCUCCUC GGAGGAAACUCC CU UCAAGGACAUCGUCCGGG GAGGCGGC 7420 812
CCGCCUCG G AGGAGAAG 6947 CUUCUCCU GGAGGAAACUCC CU
UCAAGGACAUCGUCCGGG CGAGGCGG 7421 814 GCCUCGGA G GAGAAGAG 6948
CUCUUCUC GGAGGAAACUCC CU UCAAGGACAUCGUCCGGG UCCGAGGC 7422 815
CCUCGGAG G AGAAGAGG 6949 CCUCUUCU GGAGGAAACUCC CU
UCAAGGACAUCGUCCGGG CUCCGAGG 7423 817 UCGGAGGA G AAGAGGAA 6950
UUCCUCUU GGAGGAAACUCC CU UCAAGGACAUCGUCCGGG UCCUCCGA 7424 820
GAGGAGAA G AGGAAGCU 6951 AGCUUCCU GGAGGAAACUCC CU
UCAAGGACAUCGUCCGGG UUCUCCUC 7425 822 GGAGAAGA G GAAGCUGG 6952
CCAGCUUC GGAGGAAACUCC CU UCAAGGACAUCGUCCGGG UCUUCUCC 7426 823
GAGAAGAG G AAGCUGGC 6953 GCCAGCUU GGAGGAAACUCC CU
UCAAGGACAUCGUCCGGG CUCUUCUC 7427 826 AAGAGGAA G CUGGCCCA 5879
UGGGCCAG GGAGGAAACUCC CU UCAAGGACAUCGUCCGGG UUCCUCUU 7428 829
AGGAAGCU G GCCCAGUU 6954 AACUGGGC GGAGGAAACUCC CU
UCAAGGACAUCGUCCGGG AGCUUCCU 7429 830 GGAAGCUG G CCCAGUUG 5880
CAACUGGG GGAGGAAACUCC CU UCAAGGACAUCGUCCGGG CAGCUUCC 7430 835
CUGGCCCA G UUGCAGGU 5881 ACCUGCAA GGAGGAAACUCC CU
UCAAGGACAUCGUCCGGG UGGGCCAG 7431 838 GCCCAGUU G CAGGUGGC 5882
GCCACCUG GGAGGAAACUCC CU UCAAGGACAUCGUCCGGG AACUGGGC 7432 841
CAGUUGCA G GUGGCCUA 6955 UAGGCCAC GGAGGAAACUCC CU
UCAAGGACAUCGUCCGGG UGCAACUG 7433 842 AGUUGCAG G UGGCCUAU 5883
AUAGGCCA GGAGGAAACUCC CU UCAAGGACAUCGUCCGGG CUGCAACU 7434 844
UUGCAGGU G GCCUAUCA 6956 UGAUAGGC GGAGGAAACUCC CU
UCAAGGACAUCGUCCGGG ACCUGCAA 7435 845 UGCAGGUG G CCUAUCAC 5884
GUGAUAGG GGAGGAAACUCC CU UCAAGGACAUCGUCCGGG CACCUGCA 7436 856
UAUCACCA G CUCUUCCA 5885 UGGAAGAG GGAGGAAACUCC CU
UCAAGGACAUCGUCCGGG UGGUGAUA 7437 866 UCUUCCAA G AAUACGAC 6957
GUCGUAUU GGAGGAAACUCC CU UCAAGGACAUCGUCCGGG UUGGAAGA 7438 872
AAGAAUAC G ACAACCAC 6958 GUGGUUGU GGAGGAAACUCC CU
UCAAGGACAUCGUCCGGG GUAUUCUU 7439 886 CACAUCAA G AGCAGCGU 6959
ACGCUGCU GGAGGAAACUCC CU UCAAGGACAUCGUCCGGG UUGAUGUG 7440 888
CAUCAAGA G CAGCGUGG 5886 CCACGCUG GGAGGAAACUCC CU
UCAAGGACAUCGUCCGGG UCUUGAUG 7441 891 CAAGAGCA G CGUGGUGG 5887
CCACCACG GGAGGAAACUCC CU UCAAGGACAUCGUCCGGG UGCUCUUG 7442 893
AGAGCAGC G UGGUGGGC 5888 GCCCACCA GGAGGAAACUCC CU
UCAAGGACAUCGUCCGGG GCUGCUCU 7443 895 AGCAGCGU G GUGGGCAG 6960
CUGCCCAC GGAGGAAACUCC CU UCAAGGACAUCGUCCGGG ACGCUGCU 7444 896
GCAGCGUG G UGGGCAGU 5889 ACUGCCCA GGAGGAAACUCC CU
UCAAGGACAUCGUCCGGG CACGCUGC 7445 898 AGCGUGGU G GGCAGUGA 6961
UCACUGCC GGAGGAAACUCC CU UCAAGGACAUCGUCCGGG ACCACGCU 7446 899
GCGUGGUG G GCAGUGAG 6962 CUCACUGC GGAGGAAACUCC CU
UCAAGGACAUCGUCCGGG CACCACGC 7447 900 CGUGGUGG G CAGUGAGC 5890
GCUCACUG GGAGGAAACUCC CU UCAAGGACAUCGUCCGGG CCACCACG 7448 903
GGUGGGCA G UGAGCGGA 5891 UCCGCUCA GGAGGAAACUCC CU
UCAAGGACAUCGUCCGGG UGCCCACC 7449 905 UGGGCAGU G AGCGGAAG 6963
CUUCCGCU GGAGGAAACUCC CU UCAAGGACAUCGUCCGGG ACUGCCCA 7450 907
GGCAGUGA G CGGAAGCG 5892 CGCUUCCG GGAGGAAACUCC CU
UCAAGGACAUCGUCCGGG UCACUGCC 7451 909 CAGUGAGC G GAAGCGAG 6964
CUCGCUUC GGAGGAAACUCC CU UCAAGGACAUCGUCCGGG GCUCACUG 7452 910
AGUGAGCG G AAGCGAGG 6965 CCUCGCUU GGAGGAAACUCC CU
UCAAGGACAUCGUCCGGG CGCUCACU 7453 913 GAGCGGAA G CGAGGAAU 5893
AUUCCUCG GGAGGAAACUCC CU UCAAGGACAUCGUCCGGG UUCCGCUC 7454 915
GCGGAAGC G AGGAAUGC 6966 GCAUUCCU GGAGGAAACUCC CU
UCAAGGACAUCGUCCGGG GCUUCCGC 7455 917 GGAAGCGA G GAAUGCAG 6967
CUGCAUUC GGAGGAAACUCC CU UCAAGGACAUCGUCCGGG UCGCUUCC 7456 918
GAAGCGAG G AAUGCAGC 6968 GCUGCAUU GGAGGAAACUCC CU
UCAAGGACAUCGUCCGGG CUCGCUUC 7457 922 CGAGGAAU G CAGCUGGA 5894
UCCAGCUG GGAGGAAACUCC CU UCAAGGACAUCGUCCGGG AUUCCUCG 7458 925
GGAAUGCA G CUGGAAGA 5895 UCUUCCAG GGAGGAAACUCC CU
UCAAGGACAUCGUCCGGG UGCAUUCC 7459 928 AUGCAGCU G GAAGAUCU 6969
AGAUCUUC GGAGGAAACUCC CU UCAAGGACAUCGUCCGGG AGCUGCAU 7460 929
UGCAGCUG G AAGAUCUC 6970 GAGAUCUU GGAGGAAACUCC CU
UCAAGGACAUCGUCCGGG CAGCUGCA 7461 932 AGCUGGAA G AUCUCAAA 6971
UUUGAGAU GGAGGAAACUCC CU UCAAGGACAUCGUCCGGG UUCCAGCU 7462 943
CUCAAACA G CAGCUCCA 5896 UGGAGCUG GGAGGAAACUCC CU
UCAAGGACAUCGUCCGGG UGUUUGAG 7463 946 AAACAGCA G CUCCAGCA 5897
UGCUGGAG GGAGGAAACUCC CU UCAAGGACAUCGUCCGGG UGCUGUUU 7464 952
CAGCUCCA G CAGGCCGA 5898 UCGGCCUG GGAGGAAACUCC CU
UCAAGGACAUCGUCCGGG UGGAGCUG 7465 955 CUCCAGCA G GCCGAGGA 6972
UCCUCGGC GGAGGAAACUCC CU UCAAGGACAUCGUCCGGG UGCUGGAG 7466 956
UCCAGCAG G CCGAGGAG 5899 CUCCUCGG GGAGGAAACUCC CU
UCAAGGACAUCGUCCGGG CUGCUGGA 7467 959 AGCAGGCC G AGGAGGCC 6973
GGCCUCCU GGAGGAAACUCC CU UCAAGGACAUCGUCCGGG GGCCUGCU 7468 961
CAGGCCGA G GAGGCCCU 6974 AGGGCCUC GGAGGAAACUCC CU
UCAAGGACAUCGUCCGGG UCGGCCUG 7469 962 AGGCCGAG G AGGCCCUG 6975
CAGGGCCU GGAGGAAACUCC CU UCAAGGACAUCGUCCGGG CUCGGCCU 7470 964
GCCGAGGA a GCCCUGGU 6976 ACCAGGGC GGAGGAAACUCC CU
UCAAGGACAUCGUCCGGG UCCUCGGC 7471 965 CCGAGGAG G CCCUGGUG 5900
CACCAGGG GGAGGAAACUCC CU UCAAGGACAUCGUCCGGG CUCCUCGG 7472 970
GAGGCCCU G GUGGCCAA 6977 UUGGCCAC GGAGGAAACUCC CU
UCAAGGACAUCGUCCGGG AGGGCCUC 7473
971 AGGCCCUG G UGGCCAAA 5901 UUUGGCCA GGAGGAAACUCC CU
UCAAGGACAUCGUCCGGG CAGGGCCU 7474 973 GCCCUGGU G GCCAAACA 6978
UGUUUGGC GGAGGAAACUCC CU UCAAGGACAUCGUCCGGG ACCAGGGC 7475 974
CCCUGGUG G CCAAACAG 5902 CUGUUUGG GGAGGAAACUCC CU
UCAAGGACAUCGUCCGGG CACCAGGG 7476 982 GCCAAACA G GAGGUGAU 6979
AUCACCUC GGAGGAAACUCC CU UCAAGGACAUCGUCCGGG UGUUUGGC 7477 983
CCAAACAG G AGGUGAUC 6980 GAUCACCU GGAGGAAACUCC CU
UCAAGGACAUCGUCCGGG CUGUUUGG 7478 985 AAACAGGA G GUGAUCGA 6981
UCGAUCAC GGAGGAAACUCC CU UCAAGGACAUCGUCCGGG UCCUGUUU 7479 986
AACAGGAG G UGAUCGAU 5903 AUCGAUCA GGAGGAAACUCC CU
UCAAGGACAUCGUCCGGG CUCCUGUU 7480 988 CAGGAGGU G AUCGAUAA 6982
UUAUCGAU GGAGGAAACUCC CU UCAAGGACAUCGUCCGGG ACCUCCUG 7481 992
AGGUGAUC G AUAAGCUG 6983 CAGCUUAU GGAGGAAACUCC CU
UCAAGGACAUCGUCCGGG GAUCACCU 7482 997 AUCGAUAA G CUGAAGGA 5904
UCCUUCAG GGAGGAAACUCC CU UCAAGGACAUCGUCCGGG UUAUCGAU 7483 1000
GAUAAGCU G AAGGAGGA 6984 UCCUCCUU GGAGGAAACUCC CU
UCAAGGACAUCGUCCGGG AGCUUAUC 7484 1003 AAGCUGAA G GAGGAGGC 6985
GCCUCCUC GGAGGAAACUCC CU UCAAGGACAUCGUCCGGG UUCAGCUU 7485 1004
AGCUGAAG G AGGAGGCC 6986 GGCCUCCU GGAGGAAACUCC CU
UCAAGGACAUCGUCCGGG CUUCAGCU 7486 1006 CUGAAGGA G GAGGCCGA 6987
UCGGCCUC GGAGGAAACUCC CU UCAAGGACAUCGUCCGGG UCCUUCAG 7487 1007
UGAAGGAG G AGGCCGAG 6988 CUCGGCCU GGAGGAAACUCC CU
UCAAGGACAUCGUCCGGG CUCCUUCA 7488 1009 AAGGAGGA G GCCGAGCA 6989
UGCUCGGC GGAGGAAACUCC CU UCAAGGACAUCGUCCGGG UCCUCCUU 7489 1010
AGGAGGAG G CCGAGCAG 5905 CUGCUCGG GGAGGAAACUCC CU
UCAAGGACAUCGUCCGGG CUCCUCCU 7490 1013 AGGAGGCC G AGCAGCAC 6990
GUGCUGCU GGAGGAAACUCC CU UCAAGGACAUCGUCCGGG GGCCUCCU 7491 1015
GAGGCCGA G CAGCACAA 5906 UUGUGCUG GGAGGAAACUCC CU
UCAAGGACAUCGUCCGGG UCGGCCUC 7492 1018 GCCGAGCA G CACAAGAU 5907
AUCUUGUG GGAGGAAACUCC CU UCAAGGACAUCGUCCGGG UGCUCGGC 7493 1024
CAGCACAA G AUUGUGAU 6991 AUCACAAU GGAGGAAACUCC CU
UCAAGGACAUCGUCCGGG UUGUGCUG 7494 1028 ACAAGAUU G UGAUGGAG 5908
CUCCAUCA GGAGGAAACUCC CU UCAAGGACAUCGUCCGGG AAUCUUGU 7495 1030
AAGAUUGU G AUGGAGAC 6992 GUCUCCAU GGAGGAAACUCC CU
UCAAGGACAUCGUCCGGG ACAAUCUU 7496 1033 AUUGUGAU G GAGACCGU 6993
ACGGUCUC GGAGGAAACUCC CU UCAAGGACAUCGUCCGGG AUCACAAU 7497 1034
UUGUGAUG G AGACCGUU 6994 AACGGUCU GGAGGAAACUCC CU
UCAAGGACAUCGUCCGGG CAUCACAA 7498 1036 GUGAUGGA G ACCGUUCC 6995
GGAACGGU GGAGGAAACUCC CU UCAAGGACAUCGUCCGGG UCCAUCAC 7499 1040
UGGAGACC G UUCCGGUG 5909 CACCGGAA GGAGGAAACUCC CU
UCAAGGACAUCGUCCGGG GGUCUCCA 7500 1045 ACCGUUCC G GUGCUGAA 6996
UUCAGCAC GGAGGAAACUCC CU UCAAGGACAUCGUCCGGG GGAACGGU 7501 1046
CCGUUCCG G UGCUGAAG 5910 CUUCAGCA GGAGGAAACUCC CU
UCAAGGACAUCGUCCGGG CGGAACGG 7502 1048 GUUCCGGU G CUGAAGGC 5911
GCCUUCAG GGAGGAAACUCC CU UCAAGGACAUCGUCCGGG ACCGGAAC 7503 1051
CCGGUGCU G AAGGCCCA 6997 UGGGCCUU GGAGGAAACUCC CU
UCAAGGACAUCGUCCGGG AGCACCGG 7504 1054 GUGCUGAA G GCCCAGGC 6998
GCCUGGGC GGAGGAAACUCC CU UCAAGGACAUCGUCCGGG UUCAGCAC 7505 1055
UGCUGAAG G CCCAGGCG 5912 CGCCUGGG GGAGGAAACUCC CU
UCAAGGACAUCGUCCGGG CUUCAGCA 7506 1060 AAGGCCCA G GCGGAUAU 6999
AUAUCCGC GGAGGAAACUCC CU UCAAGGACAUCGUCCGGG UGGGCCUU 7507 1061
AGGCCCAG G CGGAUAUC 5913 GAUAUCCG GGAGGAAACUCC CU
UCAAGGACAUCGUCCGGG CUGGGCCU 7508 1063 GCCCAGGC G GAUAUCUA 7000
UAGAUAUC GGAGGAAACUCC CU UCAAGGACAUCGUCCGGG GCCUGGGC 7509 1064
CCCAGGCG G AUAUCUAC 7001 GUAGAUAU GGAGGAAACUCC CU
UCAAGGACAUCGUCCGGG CGCCUGGG 7510 1075 AUCUACAA G GCGGACUU 7002
AAGUCCGC GGAGGAAACUCC CU UCAAGGACAUCGUCCGGG UUGUAGAU 7511 1076
UCUACAAG G CGGACUUC 5914 GAAGUCCG GGAGGAAACUCC CU
UCAAGGACAUCGUCCGGG CUUGUAGA 7512 1078 UACAAGGC G GACUUCCA 7003
UGGAAGUC GGAGGAAACUCC CU UCAAGGACAUCGUCCGGG GCCUUGUA 7513 1079
ACAAGGCG G ACUUCCAG 7004 CUGGAAGU GGAGGAAACUCC CU
UCAAGGACAUCGUCCGGG CGCCUUGU 7514 1087 GACUUCCA G GCUGAGAG 7005
CUCUCAGC GGAGGAAACUCC CU UCAAGGACAUCGUCCGGG UGGAAGUC 7515 1088
ACUUCCAG G CUGAGAGG 5915 CCUCUCAG GGAGGAAACUCC CU
UCAAGGACAUCGUCCGGG CUGGAAGU 7516 1091 UCCAGGCU G AGAGGCAG 7006
CUGCCUCU GGAGGAAACUCC CU UCAAGGACAUCGUCCGGG AGCCUGGA 7517 1093
CAGGCUGA G AGGCAGGC 7007 GCCUGCCU GGAGGAAACUCC CU
UCAAGGACAUCGUCCGGG UCAGCCUG 7518 1095 GGCUGAGA G GCAGGCCC 7008
GGGCCUGC GGAGGAAACUCC CU UCAAGGACAUCGUCCGGG UCUCAGCC 7519 1096
GCUGAGAG G CAGGCCCG 5916 CGGGCCUG GGAGGAAACUCC CU
UCAAGGACAUCGUCCGGG CUCUCAGC 7520 1099 GAGAGGCA G GCCCGGGA 7009
UCCCGGGC GGAGGAAACUCC CU UCAAGGACAUCGUCCGGG UGCCUCUC 7521 1100
AGAGGCAG G CCCGGGAG 5917 CUCCCGGG GGAGGAAACUCC CU
UCAAGGACAUCGUCCGGG CUGCCUCU 7522 1104 GCAGGCCC G GGAGAAGC 7010
GCUUCUCC GGAGGAAACUCC CU UCAAGGACAUCGUCCGGG GGGCCUGC 7523 1105
CAGGCCCG G GAGAAGCU 7011 AGCUUCUC GGAGGAAACUCC CU
UCAAGGACAUCGUCCGGG CGGGCCUG 7524 1106 AGGCCCGG G AGAAGCUG 7012
CAGCUUCU GGAGGAAACUCC CU UCAAGGACAUCGUCCGGG CCGGGCCU 7525 1108
GCCCGGGA G AAGCUGGC 7013 GCCAGCUU GGAGGAAACUCC CU
UCAAGGACAUCGUCCGGG UCCCGGGC 7526 1111 CGGGAGAA G CUGGCCGA 5918
UCGGCCAG GGAGGAAACUCC CU UCAAGGACAUCGUCCGGG UUCUCCCG 7527 1114
GAGAAGCU G GCCGAGAA 7014 UUCUCGGC GGAGGAAACUCC CU
UCAAGGACAUCGUCCGGG AGCUUCUC 7528 1115 AGAAGCUG G CCGAGAAG 5919
CUUCUCGG GGAGGAAACUCC CU UCAAGGACAUCGUCCGGG CAGCUUCU 7529 1118
AGCUGGCC G AGAAGAAG 7015 CUUCUUCU GGAGGAAACUCC CU
UCAAGGACAUCGUCCGGG GGCCAGCU 7530 1120 CUGGCCGA G AAGAAGGA 7016
UCCUUCUU GGAGGAAACUCC CU UCAAGGACAUCGUCCGGG UCGGCCAG 7531 1123
GCCGAGAA G AAGGAGCU 7017 AGCUCCUU GGAGGAAACUCC CU
UCAAGGACAUCGUCCGGG UUCUCGGC 7532 1126 GAGAAGAA G GAGCUCCU 7018
AGGAGCUC GGAGGAAACUCC CU UCAAGGACAUCGUCCGGG UUCUUCUC 7533 1127
AGAAGAAG G AGCUCCUG 7019 CAGGAGCU GGAGGAAACUCC CU
UCAAGGACAUCGUCCGGG CUUCUUCU 7534 1129 AAGAAGGA G CUCCUGCA 5920
UGCAGGAG GGAGGAAACUCC CU UCAAGGACAUCGUCCGGG UCCUUCUU 7535 1135
GAGCUCCU G CAGGAGCA 5921 UGCUCCUG GGAGGAAACUCC CU
UCAAGGACAUCGUCCGGG AGGAGCUC 7536 1138 CUCCUGCA G GAGCAGCU 7020
AGCUGCUC GGAGGAAACUCC CU UCAAGGACAUCGUCCGGG UGCAGGAG 7537 1139
UCCUGCAG G AGCAGCUG 7021 CAGCUGCU GGAGGAAACUCC CU
UCAAGGACAUCGUCCGGG CUGCAGGA 7538 1141 CUGCAGGA G CAGCUGGA 5922
UCCAGCUG GGAGGAAACUCC CU UCAAGGACAUCGUCCGGG UCCUGCAG 7539 1144
CAGGAGCA G CUGGAGCA 5923 UGCUCCAG GGAGGAAACUCC CU
UCAAGGACAUCGUCCGGG UGCUCCUG 7540 1147 GAGCAGCU G GAGCAGCU 7022
AGCUGCUC GGAGGAAACUCC CU UCAAGGACAUCGUCCGGG AGCUGCUC 7541 1148
AGCAGCUG G AGCAGCUG 7023 CAGCUGCU GGAGGAAACUCC CU
UCAAGGACAUCGUCCGGG CAGCUGCU 7542 1150 CAGCUGGA G CAGCUGCA 5924
UGCAGCUG GGAGGAAACUCC CU UCAAGGACAUCGUCCGGG UCCAGCUG 7543 1153
CUGGAGCA G CUGCAGAG 5925 CUCUGCAG GGAGGAAACUCC CU
UCAAGGACAUCGUCCGGG UGCUCCAG 7544 1156 GAGCAGCU G CAGAGGGA 5926
UCCCUCUG GGAGGAAACUCC CU UCAAGGACAUCGUCCGGG AGCUGCUC 7545 1159
CAGCUGCA G AGGGAGUA 7024 UACUCCCU GGAGGAAACUCC CU
UCAAGGACAUCGUCCGGG UGCAGCUG 7546 1161 GCUGCAGA G GGAGUACA 7025
UGUACUCC GGAGGAAACUCC CU UCAAGGACAUCGUCCGGG UCUGCAGC 7547 1162
CUGCAGAG G GAGUACAG 7026 CUGUACUC GGAGGAAACUCC CU
UCAAGGACAUCGUCCGGG CUCUGCAG 7548 1163 UGCAGAGG G AGUACAGC 7027
GCUGUACU GGAGGAAACUCC CU UCAAGGACAUCGUCCGGG CCUCUGCA 7549 1165
CAGAGGGA G UACAGCAA 5927 UUGCUGUA GGAGGAAACUCC CU
UCAAGGACAUCGUCCGGG UCCCUCUG 7550 1170 GGAGUACA G CAAACUGA 5928
UCAGUUUG GGAGGAAACUCC CU UCAAGGACAUCGUCCGGG UGUACUCC 7551 1177
AGCAAACU G AAGGCCAG 7028 CUGGCCUU GGAGGAAACUCC CU
UCAAGGACAUCGUCCGGG AGUUUGCU 7552 1180 AAACUGAA G GCCAGCUG 7029
CAGCUGGC GGAGGAAACUCC CU UCAAGGACAUCGUCCGGG UUCAGUUU 7553 1181
AACUGAAG G CCAGCUGU 5929 ACAGCUGG GGAGGAAACUCC CU
UCAAGGACAUCGUCCGGG CUUCAGUU 7554 1185 GAAGGCCA G CUGUCAGG 5930
CCUGACAG GGAGGAAACUCC CU UCAAGGACAUCGUCCGGG UGGCCUUC 7555 1188
GGCCAGCU G UCAGGAGU 5931 ACUCCUGA GGAGGAAACUCC CU
UCAAGGACAUCGUCCGGG AGCUGGCC 7556 1192 AGCUGUCA G GAGUCGGC 7030
GCCGACUC GGAGGAAACUCC CU UCAAGGACAUCGUCCGGG UGACAGCU 7557
1193 GCUGUCAG G AGUCGGCC 7031 GGCCGACU GGAGGAAACUCC CU
UCAAGGACAUCGUCCGGG CUGACAGC 7558 1195 UGUCAGGA G UCGGCCAG 5932
CUGGCCGA GGAGGAAACUCC CU UCAAGGACAUCGUCCGGG UCCUGACA 7559 1198
CAGGAGUC G GCCAGGAU 7032 AUCCUGGC GGAGGAAACUCC CU
UCAAGGACAUCGUCCGGG GACUCCUG 7560 1199 AGGAGUCG G CCAGGAUC 5933
GAUCCUGG GGAGGAAACUCC CU UCAAGGACAUCGUCCGGG CGACUCCU 7561 1203
GUCGGCCA G GAUCGAGG 7033 CCUCGAUC GGAGGAAACUCC CU
UCAAGGACAUCGUCCGGG UGGCCGAC 7562 1204 UCGGCCAG G AUCGAGGA 7034
UCCUCGAU GGAGGAAACUCC CU UCAAGGACAUCGUCCGGG CUGGCCGA 7563 1208
CCAGGAUC G AGGACAUG 7035 CAUGUCCU GGAGGAAACUCC CU
UCAAGGACAUCGUCCGGG GAUCCUGG 7564 1210 AGGAUCGA G GACAUGAG 7036
CUCAUGUC GGAGGAAACUCC CU UCAAGGACAUCGUCCGGG UCGAUCCU 7565 1211
GGAUCGAG G ACAUGAGG 7037 CCUCAUGU GGAGGAAACUCC CU
UCAAGGACAUCGUCCGGG CUCGAUCC 7566 1216 GAGGACAU G AGGAAGCG 7038
CGCUUCCU GGAGGAAACUCC CU UCAAGGACAUCGUCCGGG AUGUCCUC 7567 1218
GGACAUGA G GAAGCGGC 7039 GCCGCUUC GGAGGAAACUCC CU
UCAAGGACAUCGUCCGGG UCAUGUCC 7568 1219 GACAUGAG G AAGCGGCA 7040
UGCCGCUU GGAGGAAACUCC CU UCAAGGACAUCGUCCGGG CUCAUGUC 7569 1222
AUGAGGAA G CGGCAUGU 5934 ACAUGCCG GGAGGAAACUCC CU
UCAAGGACAUCGUCCGGG UUCCUCAU 7570 1224 GAGGAAGC G GCAUGUCG 7041
CGACAUGC GGAGGAAACUCC CU UCAAGGACAUCGUCCGGG GCUUCCUC 7571 1225
AGGAAGCG G CAUGUCGA 5935 UCGACAUG GGAGGAAACUCC CU
UCAAGGACAUCGUCCGGG CGCUUCCU 7572 1229 AGCGGCAU G UCGAGGUC 5936
GACCUCGA GGAGGAAACUCC CU UCAAGGACAUCGUCCGGG AUGCCGCU 7573 1232
GGCAUGUC G AGGUCUCC 7042 GGAGACCU GGAGGAAACUCC CU
UCAAGGACAUCGUCCGGG GACAUGCC 7574 1234 CAUGUCGA G GUCUCCCA 7043
UGGGAGAC GGAGGAAACUCC CU UCAAGGACAUCGUCCGGG UCGACAUG 7575 1235
AUGUCGAG G UCUCCCAG 5937 CUGGGAGA GGAGGAAACUCC CU
UCAAGGACAUCGUCCGGG CUCGACAU 7576 1243 GUCUCCCA G GCCCCCUU 7044
AAGGGGGC GGAGGAAACUCC CU UCAAGGACAUCGUCCGGG UGGGAGAC 7577 1244
UCUCCCAG G CCCCCUUG 5938 CAAGGGGG GGAGGAAACUCC CU
UCAAGGACAUCGUCCGGG CUGGGAGA 7578 1252 GCCCCCUU G CCCCCCGC 5939
GCGGGGGG GGAGGAAACUCC CU UCAAGGACAUCGUCCGGG AAGGGGGC 7579 1259
UGCCCCCC G CCCCUGCC 5940 GGCAGGGG GGAGGAAACUCC CU
UCAAGGACAUCGUCCGGG GGGGGGCA 7580 1265 CCGCCCCU G CCUACCUC 5941
GAGGUAGG GGAGGAAACUCC CU UCAAGGACAUCGUCCGGG AGGGGCGG 7581 1285
UCUCCCCU G GCCCUGCC 7045 GGCAGGGC GGAGGAAACUCC CU
UCAAGGACAUCGUCCGGG AGGGGAGA 7582 1286 CUCCCCUG G CCCUGCCC 5942
GGGCAGGG GGAGGAAACUCC CU UCAAGGACAUCGUCCGGG CAGGGGAG 7583 1291
CUGGCCCU G CCCAGCCA 5943 UGGCUGGG GGAGGAAACUCC CU
UCAAGGACAUCGUCCGGG AGGGCCAG 7584 1296 CCUGCCCA G CCAGAGGA 5944
UCCUCUGG GGAGGAAACUCC CU UCAAGGACAUCGUCCGGG UGGGCAGG 7585 1300
CCCAGCCA G AGGAGGAG 7046 CUCCUCCU GGAGGAAACUCC CU
UCAAGGACAUCGUCCGGG UGGCUGGG 7586 1302 CAGCCAGA G GAGGAGCC 7047
GGCUCCUC GGAGGAAACUCC CU UCAAGGACAUCGUCCGGG UCUGGCUG 7587 1303
AGCCAGAG G AGGAGCCC 7048 GGGCUCCU GGAGGAAACUCC CU
UCAAGGACAUCGUCCGGG CUCUGGCU 7588 1305 CCAGAGGA G GAGCCCCC 7049
GGGGGCUC GGAGGAAACUCC CU UCAAGGACAUCGUCCGGG UCCUCUGG 7589 1306
CAGAGGAG G AGCCCCCC 7050 GGGGGGCU GGAGGAAACUCC CU
UCAAGGACAUCGUCCGGG CUCCUCUG 7590 1308 GAGGAGGA G CCCCCCCG 5945
CGGGGGGG GGAGGAAACUCC CU UCAAGGACAUCGUCCGGG UCCUCCUC 7591 1316
GCCCCCCC G AGGAGCCA 7051 UGGCUCCU GGAGGAAACUCC CU
UCAAGGACAUCGUCCGGG GGGGGGGC 7592 1318 CCCCCCGA G GAGCCACC 7052
GGUGGCUC GGAGGAAACUCC CU UCAAGGACAUCGUCCGGG UCGGGGGG 7593 1319
CCCCCGAG G AGCCACCU 7053 AGGUGGCU GGAGGAAACUCC CU
UCAAGGACAUCGUCCGGG CUCGGGGG 7594 1321 CCCGAGGA G CCACCUGA 5946
UCAGGUGG GGAGGAAACUCC CU UCAAGGACAUCGUCCGGG UCCUCGGG 7595 1328
AGCCACCU G ACUUCUGC 7054 GCAGAAGU GGAGGAAACUCC CU
UCAAGGACAUCGUCCGGG AGGUGGCU 7596 1335 UGACUUCU G CUGUCCCA 5947
UGGGACAG GGAGGAAACUCC CU UCAAGGACAUCGUCCGGG AGAAGUCA 7597 1338
CUUCUGCU G UCCCAAGU 5948 ACUUGGGA GGAGGAAACUCC CU
UCAAGGACAUCGUCCGGG AGCAGAAG 7598 1345 UGUCCCAA G UGCCAGUA 5949
UACUGGCA GGAGGAAACUCC CU UCAAGGACAUCGUCCGGG UUGGGACA 7599 1347
UCCCAAGU G CCAGUAUC 5950 GAUACUGG GGAGGAAACUCC CU
UCAAGGACAUCGUCCGGG ACUUGGGA 7600 1351 AAGUGCCA G UAUCAGGC 5951
GCCUGAUA GGAGGAAACUCC CU UCAAGGACAUCGUCCGGG UGGCACUU 7601 1357
CAGUAUCA G GCCCCUGA 7055 UCAGGGGC GGAGGAAACUCC CU
UCAAGGACAUCGUCCGGG UGAUACUG 7602 1358 AGUAUCAG G CCCCUGAU 5952
AUCAGGGG GGAGGAAACUCC CU UCAAGGACAUCGUCCGGG CUGAUACU 7603 1364
AGGCCCCU G AUAUGGAC 7056 GUCCAUAU GGAGGAAACUCC CU
UCAAGGACAUCGUCCGGG AGGGGCCU 7604 1369 CCUGAUAU G GACACCCU 7057
AGGGUGUC GGAGGAAACUCC CU UCAAGGACAUCGUCCGGG AUAUCAGG 7605 1370
CUGAUAUG G ACACCCUG 7058 CAGGGUGU GGAGGAAACUCC CU
UCAAGGACAUCGUCCGGG CAUAUCAG 7606 1378 GACACCCU G CAGAUACA 5953
UGUAUCUG GGAGGAAACUCC CU UCAAGGACAUCGUCCGGG AGGGUGUC 7607 1381
ACCCUGCA G AUACAUGU 7059 ACAUGUAU GGAGGAAACUCC CU
UCAAGGACAUCGUCCGGG UGCAGGGU 7608 1388 AGAUACAU G UCAUGGAG 5954
CUCCAUGA GGAGGAAACUCC CU UCAAGGACAUCGUCCGGG AUGUAUCU 7609 1393
CAUGUCAU G GAGUGCAU 7060 AUGCACUC GGAGGAAACUCC CU
UCAAGGACAUCGUCCGGG AUGACAUG 7610 1394 AUGUCAUG G AGUGCAUU 7061
AAUGCACU GGAGGAAACUCC CU UCAAGGACAUCGUCCGGG CAUGACAU 7611 1396
GUCAUGGA G UGCAUUGA 5955 UCAAUGCA GGAGGAAACUCC CU
UCAAGGACAUCGUCCGGG UCCAUGAC 7612 1398 CAUGGAGU G CAUUGAGU 5956
ACUCAAUG GGAGGAAACUCC CU UCAAGGACAUCGUCCGGG ACUCCAUG 7613 1403
AGUGCAUU G AGUAGGGC 7062 GCCCUACU GGAGGAAACUCC CU
UCAAGGACAUCGUCCGGG AAUGCACU 7614 1405 UGCAUUGA G UAGGGCCG 5957
CGGCCCUA GGAGGAAACUCC CU UCAAGGACAUCGUCCGGG UCAAUGCA 7615 1408
AUUGAGUA G GGCCGGCC 7063 GGCCGGCC GGAGGAAACUCC CU
UCAAGGACAUCGUCCGGG UACUCAAU 7616 1409 UUGAGUAG G GCCGGCCA 7064
UGGCCGGC GGAGGAAACUCC CU UCAAGGACAUCGUCCGGG CUACUCAA 7617 1410
UGAGUAGG G CCGGCCAG 5958 CUGGCCGG GGAGGAAACUCC CU
UCAAGGACAUCGUCCGGG CCUACUCA 7618 1413 GUAGGGCC G GCCAGUGC 7065
GCACUGGC GGAGGAAACUCC CU UCAAGGACAUCGUCCGGG GGCCCUAC 7619 1414
UAGGGCCG G CCAGUGCA 5959 UGCACUGG GGAGGAAACUCC CU
UCAAGGACAUCGUCCGGG CGGCCCUA 7620 1418 GCCGGCCA G UGCAAGGC 5960
GCCUUGCA GGAGGAAACUCC CU UCAAGGACAUCGUCCGGG UGGCCGGC 7621 1420
CGGCCAGU G CAAGGCCA 5961 UGGCCUUG GGAGGAAACUCC CU
UCAAGGACAUCGUCCGGG ACUGGCCG 7622 1424 CAGUGCAA G GCCACUGC 7066
GCAGUGGC GGAGGAAACUCC CU UCAAGGACAUCGUCCGGG UUGCACUG 7623 1425
AGUGCAAG G CCACUGCC 5962 GGCAGUGG GGAGGAAACUCC CU
UCAAGGACAUCGUCCGGG CUUGCACU 7624 1431 AGGCCACU G CCUGCCCG 5963
CGGGCAGG GGAGGAAACUCC CU UCAAGGACAUCGUCCGGG AGUGGCCU 7625 1435
CACUGCCU G CCCGAGGA 5964 UCCUCGGG GGAGGAAACUCC CU
UCAAGGACAUCGUCCGGG AGGCAGUG 7626 1439 GCCUGCCC G AGGACGUG 7067
CACGUCCU GGAGGAAACUCC CU UCAAGGACAUCGUCCGGG GGGCAGGC 7627 1441
CUGCCCGA G GACGUGCC 7068 GGCACGUC GGAGGAAACUCC CU
UCAAGGACAUCGUCCGGG UCGGGCAG 7628 1442 UGCCCGAG G ACGUGCCC 7069
GGGCACGU GGAGGAAACUCC CU UCAAGGACAUCGUCCGGG CUCGGGCA 7629 1445
CCGAGGAC G UGCCCGGG 5965 CCCGGGCA GGAGGAAACUCC CU
UCAAGGACAUCGUCCGGG GUCCUCGG 7630 1447 GAGGACGU G CCCGGGAC 5966
GUCCCGGG GGAGGAAACUCC CU UCAAGGACAUCGUCCGGG ACGUCCUC 7631 1451
ACGUGCCC G GGACCGUG 7070 CACGGUCC GGAGGAAACUCC CU
UCAAGGACAUCGUCCGGG GGGCACGU 7632 1452 CGUGCCCG G GACCGUGC 7071
GCACGGUC GGAGGAAACUCC CU UCAAGGACAUCGUCCGGG CGGGCACG 7633 1453
GUGCCCGG G ACCGUGCA 7072 UGCACGGU GGAGGAAACUCC CU
UCAAGGACAUCGUCCGGG CCGGGCAC 7634 1457 CCGGGACC G UGCAGUCU 5967
AGACUGCA GGAGGAAACUCC CU UCAAGGACAUCGUCCGGG GGUCCCGG 7635 1459
GGGACCGU G CAGUCUGC 5968 GCAGACUG GGAGGAAACUCC CU
UCAAGGACAUCGUCCGGG ACGGUCCC 7636 1462 ACCGUGCA G UCUGCGCU 5969
AGCGCAGA GGAGGAAACUCC CU UCAAGGACAUCGUCCGGG UGCACGGU 7637 1466
UGCAGUCU G CGCUUUCC 5970 GGAAAGCG GGAGGAAACUCC CU
UCAAGGACAUCGUCCGGG AGACUGCA 7638 1468 CAGUCUGC G CUUUCCUC 5971
GAGGAAAG GGAGGAAACUCC CU UCAAGGACAUCGUCCGGG GCAGACUG 7639 1481
CCUCUCCC G CCUGCCUA 5972 UAGGCAGG GGAGGAAACUCC CU
UCAAGGACAUCGUCCGGG GGGAGAGG 7640 1485 UCCCGCCU G CCUAGCCC 5973
GGGCUAGG GGAGGAAACUCC CU UCAAGGACAUCGUCCGGG
AGGCGGGA 7641 1490 CCUGCCUA G CCCAGGAU 5974 AUCCUGGG GGAGGAAACUCC
CU UCAAGGACAUCGUCCGGG UAGGCAGG 7642 1495 CUAGCCCA G GAUGAAGG 7073
CCUUCAUC GGAGGAAACUCC CU UCAAGGACAUCGUCCGGG UGGGCUAG 7643 1496
UAGCCCAG G AUGAAGGG 7074 CCCUUCAU GGAGGAAACUCC CU
UCAAGGACAUCGUCCGGG CUGGGCUA 7644 1499 CCCAGGAU G AAGGGCUG 7075
CAGCCCUU GGAGGAAACUCC CU UCAAGGACAUCGUCCGGG AUCCUGGG 7645 1502
AGGAUGAA G GGCUGGGU 7076 ACCCAGCC GGAGGAAACUCC CU
UCAAGGACAUCGUCCGGG UUCAUCCU 7646 1503 GGAUGAAG G GCUGGGUG 7077
CACCCAGC GGAGGAAACUCC CU UCAAGGACAUCGUCCGGG CUUCAUCC 7647 1504
GAUGAAGG G CUGGGUGG 5975 CCACCCAG GGAGGAAACUCC CU
UCAAGGACAUCGUCCGGG CCUUCAUC 7648 1507 GAAGGGCU G GGUGGCCA 7078
UGGCCACC GGAGGAAACUCC CU UCAAGGACAUCGUCCGGG AGCCCUUC 7649 1508
AAGGGCUG G GUGGCCAC 7079 GUGGCCAC GGAGGAAACUCC CU
UCAAGGACAUCGUCCGGG CAGCCCUU 7650 1509 AGGGCUGG G UGGCCACA 5976
UGUGGCCA GGAGGAAACUCC CU UCAAGGACAUCGUCCGGG CCAGCCCU 7651 1511
GGCUGGGU G GCCACAAC 7080 GUUGUGGC GGAGGAAACUCC CU
UCAAGGACAUCGUCCGGG ACCCAGCC 7652 1512 GCUGGGUG G CCACAACU 5977
AGUUGUGG GGAGGAAACUCC CU UCAAGGACAUCGUCCGGG CACCCAGC 7653 1521
CCACAACU G GGAUGCCA 7081 UGGCAUCC GGAGGAAACUCC CU
UCAAGGACAUCGUCCGGG AGUUGUGG 7654 1522 CACAACUG G GAUGCCAC 7082
GUGGCAUC GGAGGAAACUCC CU UCAAGGACAUCGUCCGGG CAGUUGUG 7655 1523
ACAACUGG G AUGCCACC 7083 GGUGGCAU GGAGGAAACUCC CU
UCAAGGACAUCGUCCGGG CCAGUUGU 7656 1526 ACUGGGAU G CCACCUGG 5978
CCAGGUGG GGAGGAAACUCC CU UCAAGGACAUCGUCCGGG AUCCCAGU 7657 1533
UGCCACCU G GAGCCCCA 7084 UGGGGCUC GGAGGAAACUCC CU
UCAAGGACAUCGUCCGGG AGGUGGCA 7658 1534 GCCACCUG G AGCCCCAC 7085
GUGGGGCU GGAGGAAACUCC CU UCAAGGACAUCGUCCGGG CAGGUGGC 7659 1536
CACCUGGA G CCCCACCC 5979 GGGUGGGG GGAGGAAACUCC CU
UCAAGGACAUCGUCCGGG UCCAGGUG 7660 1546 CCCACCCA G GAGCUGGC 7086
GCCAGCUC GGAGGAAACUCC CU UCAAGGACAUCGUCCGGG UGGGUGGG 7661 1547
CCACCCAG G AGCUGGCC 7087 GGCCAGCU GGAGGAAACUCC CU
UCAAGGACAUCGUCCGGG CUGGGUGG 7662 1549 ACCCAGGA G CUGGCCGC 5980
GCGGCCAG GGAGGAAACUCC CU UCAAGGACAUCGUCCGGG UCCUGGGU 7663 1552
CAGGAGCU 0 GCCGCGGC 7088 GCCGCGGC GGAGGAAACUCC CU
UCAAGGACAUCGUCCGGG AGCUCCUG 7664 1553 AGGAGCUG G CCGCGGCA 5981
UGCCGCGG GGAGGAAACUCC CU UCAAGGACAUCGUCCGGG CAGCUCCU 7665 1556
AGCUGGCC G CGGCACCU 5982 AGGUGCCG GGAGGAAACUCC CU
UCAAGGACAUCGUCCGGG GGCCAGCU 7666 1558 CUGGCCGC G GCACCUUA 7089
UAAGGUGC GGAGGAAACUCC CU UCAAGGACAUCGUCCGGG GCGGCCAG 7667 1559
UGGCCGCG G CACCUUAC 5983 GUAAGGUG GGAGGAAACUCC CU
UCAAGGACAUCGUCCGGG CGCGGCCA 7668 1568 CACCUUAC G CUUCAGCU 5984
AGCUGAAG GGAGGAAACUCC CU UCAAGGACAUCGUCCGGG GUAAGGUG 7669 1574
ACGCUUCA G CUGUUGAU 5985 AUCAACAG GGAGGAAACUCC CU
UCAAGGACAUCGUCCGGG UGAAGCGU 7670 1577 CUUCAGCU G UUGAUCCG 5986
CGGAUCAA GGAGGAAACUCC CU UCAAGGACAUCGUCCGGG AGCUGAAG 7671 1580
CAGCUGUU G AUCCGCUG 7090 CAGCGGAU GGAGGAAACUCC CU
UCAAGGACAUCGUCCGGG AACAGCUG 7672 1585 GUUGAUCC G CUGGUCCC 5987
GGGACCAG GGAGGAAACUCC CU UCAAGGACAUCGUCCGGG GGAUCAAC 7673 1588
GAUCCGCU G GUCCCCUC 7091 GAGGGGAC GGAGGAAACUCC CU
UCAAGGACAUCGUCCGGG AGCGGAUC 7674 1589 AUCCGCUG G UCCCCUCU 5988
AGAGGGGA GGAGGAAACUCC CU UCAAGGACAUCGUCCGGG CAGCGGAU 7675 1601
CCUCUUUU G GGGUAGAU 7092 AUCUACCC GGAGGAAACUCC CU
UCAAGGACAUCGUCCGGG AAAAGAGG 7676 1602 CUCUUUUG G GGUAGAUG 7093
CAUCUACC GGAGGAAACUCC CU UCAAGGACAUCGUCCGGG CAAAAGAG 7677 1603
UCUUUUGG G GUAGAUGC 7094 GCAUCUAC GGAGGAAACUCC CU
UCAAGGACAUCGUCCGGG CCAAAAGA 7678 1604 CUUUUGGG G UAGAUGCG 5989
CGCAUCUA GGAGGAAACUCC CU UCAAGGACAUCGUCCGGG CCCAAAAG 7679 1607
UUGGGGUA G AUGCGGCC 7095 GGCCGCAU GGAGGAAACUCC CU
UCAAGGACAUCGUCCGGG UACCCCAA 7680 1610 GGGUAGAU G CGGCCCCG 5990
CGGGGCCG GGAGGAAACUCC CU UCAAGGACAUCGUCCGGG AUCUACCC 7681 1612
GUAGAUGC G GCCCCGAU 7096 AUCGGGGC GGAGGAAACUCC CU
UCAAGGACAUCGUCCGGG GCAUCUAC 7682 1613 UAGAUGCG G CCCCGAUC 5991
GAUCGGGG GGAGGAAACUCC CU UCAAGGACAUCGUCCGGG CGCAUCUA 7683 1618
GCGGCCCC G AUCAGGCC 7097 GGCCUGAU GGAGGAAACUCC CU
UCAAGGACAUCGUCCGGG GGGGCCGC 7684 1623 CCCGAUCA G GCCUGACU 7098
AGUCAGCC GGAGGAAACUCC CU UCAAGGACAUCGUCCGGG UGAUCGGG 7685 1624
CCGAUCAG G CCUGACUC 5992 GAGUCAGG GGAGGAAACUCC CU
UCAAGGACAUCGUCCGGG CUGAUCGG 7686 1628 UCAGGCCU G ACUCGCUG 7099
CAGCGAGU GGAGGAAACUCC CU UCAAGGACAUCGUCCGGG AGGCCUGA 7687 1633
CCUGACUC G CUGCUCUU 5993 AAGAGCAG GGAGGAAACUCC CU
UCAAGGACAUCGUCCGGG GAGUCAGG 7688 1636 GACUCGCU G CUCUUUUU 5994
AAAAAGAG GGAGGAAACUCC CU UCAAGGACAUCGUCCGGG AGCGAGUC 7689 1645
CUCUUUUU G UUCCCUUC 5995 GAAGGGAA GGAGGAAACUCC CU
UCAAGGACAUCGUCCGGG AAAAAGAG 7690 1655 UCCCUUCU G UCUGCUCG 5996
CGAGCAGA GGAGGAAACUCC CU UCAAGGACAUCGUCCGGG AGAAGGGA 7691 1659
UUCUGUCU G CUCGAACC 5997 GGUUCGAG GGAGGAAACUCC CU
UCAAGGACAUCGUCCGGG AGACAGAA 7692 1663 GUCUGCUC G AACCACUU 7100
AAGUGGUU GGAGGAAACUCC CU UCAAGGACAUCGUCCGGG GAGCAGAC 7693 1672
AACCACUU G CCUCGGGC 5998 GCCCGAGG GGAGGAAACUCC CU
UCAAGGACAUCGUCCGGG AAGUGGUU 7694 1677 CUUGCCUC G GGCUAAUC 7101
GAUUAGCC GGAGGAAACUCC CU UCAAGGACAUCGUCCGGG GAGGCAAG 7695 1678
UUGCCUCG G GCUAAUCC 7102 GGAUUAGC GGAGGAAACUCC CU
UCAAGGACAUCGUCCGGG CGAGGCAA 7696 1679 UGCCUCGG G CUAAUCCC 5999
GGGAUUAG GGAGGAAACUCC CU UCAAGGACAUCGUCCGGG CCGAGGCA 7697 1705
CUCCACCC G GCACUGGG 7103 CCCAGUGC GGAGGAAACUCC CU
UCAAGGACAUCGUCCGGG GGGUGGAG 7698 1706 UCCACCCG G CACUGGGG 6000
CCCCAGUG GGAGGAAACUCC CU UCAAGGACAUCGUCCGGG CGGGUGGA 7699 1711
CCGGCACU G GGGAAGUC 7104 GACUUCCC GGAGGAAACUCC CU
UCAAGGACAUCGUCCGGG AGUGCCGG 7700 1712 CGGCACUG G GGAAGUCA 7105
UGACUUCC GGAGGAAACUCC CU UCAAGGACAUCGUCCGGG CAGUGCCG 7701 1713
GGCACUGG G GAAGUCAA 7106 UUGACUUC GGAGGAAACUCC CU
UCAAGGACAUCGUCCGGG CCAGUGCC 7702 1714 GCACUGGG G AAGUCAAG 7107
CUUGACUU GGAGGAAACUCC CU UCAAGGACAUCGUCCGGG CCCAGUGC 7703 1717
CUGGGGAA G UCAAGAAU 6001 AUUCUUGA GGAGGAAACUCC CU
UCAAGGACAUCGUCCGGG UUCCCCAG 7704 1722 GAAGUCAA G AAUGGGGC 7108
GCCCCAUU GGAGGAAACUCC CU UCAAGGACAUCGUCCGGG UUGACUUC 7705 1726
UCAAGAAU G GGGCCUGG 7109 CCAGGCCC GGAGGAAACUCC CU
UCAAGGACAUCGUCCGGG AUUCUUGA 7706 1727 CAAGAAUG G GGCCUGGG 7110
CCCAGGCC GGAGGAAACUCC CU UCAAGGACAUCGUCCGGG CAUUCUUG 7707 1728
AAGAAUGG G GCCUGGGG 7111 CCCCAGGC GGAGGAAACUCC CU
UCAAGGACAUCGUCCGGG CCAUUCUU 7708 1729 AGAAUGGG G CCUGGGGC 6002
GCCCCAGG GGAGGAAACUCC CU UCAAGGACAUCGUCCGGG CCCAUUCU 7709 1733
UGGGGCCU G GGGCUCUC 7112 GAGAGCCC GGAGGAAACUCC CU
UCAAGGACAUCGUCCGGG AGGCCCCA 7710 1734 GGGGCCUG G GGCUCUCA 7113
UGAGAGCC GGAGGAAACUCC CU UCAAGGACAUCGUCCGGG CAGGCCCC 7711 1735
GGGCCUGG G GCUCUCAG 7114 CUGAGAGC GGAGGAAACUCC CU
UCAAGGACAUCGUCCGGG CCAGGCCC 7712 1736 GGCCUGGG G CUCUCAGG 6003
CCUGAGAG GGAGGAAACUCC CU UCAAGGACAUCGUCCGGG CCCAGGCC 7713 1743
GGCUCUCA G GGAGAACU 7115 AGUUCUCC GGAGGAAACUCC CU
UCAAGGACAUCGUCCGGG UGAGAGCC 7714 1744 GCUCUCAG G GAGAACUG 7116
CAGUUCUC GGAGGAAACUCC CU UCAAGGACAUCGUCCGGG CUGAGAGC 7715 1745
CUCUCAGG G AGAACUGC 7117 GCAGUUCU GGAGGAAACUCC CU
UCAAGGACAUCGUCCGGG CCUGAGAG 7716 1747 CUCAGGGA G AACUGCUU 7118
AAGCAGUU GGAGGAAACUCC CU UCAAGGACAUCGUCCGGG UCCCUGAG 7717 1752
GGAGAACU G CUUCCCCU 6004 AGGGGAAG GGAGGAAACUCC CU
UCAAGGACAUCGUCCGGG AGUUCUCC 7718 1761 CUUCCCCU G GCAGAGCU 7119
AGCUCUGC GGAGGAAACUCC CU UCAAGGACAUCGUCCGGG AGGGGAAG 7719 1762
UUCCCCUG G CAGAGCUG 6005 CAGCUCUG GGAGGAAACUCC CU
UCAAGGACAUCGUCCGGG CAGGGGAA 7720 1765 CCCUGGCA G AGCUGGGU 7120
ACCCAGCU GGAGGAAACUCC CU UCAAGGACAUCGUCCGGG UGCCAGGG 7721 1767
CUGGCAGA G CUGGGUGG 6006 CCACCCAG GGAGGAAACUCC CU
UCAAGGACAUCGUCCGGG UCUGCCAG 7722 1770 GCAGAGCU G GGUGGCAG 7121
CUGCCACC GGAGGAAACUCC CU UCAAGGACAUCGUCCGGG AGCUCUGC 7723 1771
CAGAGCUG G GUGGCAGC 7122 GCUGCCAC GGAGGAAACUCC CU
UCAAGGACAUCGUCCGGG CACCUCUG 7724
1772 AGAGCUGG G UGGCAGCU 6007 AGCUGCCA GGAGGAAACUCC CU
UCAAGGACAUCGUCCGGG CCAGCUCU 7725 1774 AGCUGGGU G GCAGCUCU 7123
AGAGCUGC GGAGGAAACUCC CU UCAAGGACAUCGUCCGGG ACCCAGCU 7726 1775
GCUGGGUG G CAGCUCUU 6008 AAGAGCUG GGAGGAAACUCC CU
UCAAGGACAUCGUCCGGG CACCCAGC 7727 1778 GGGUGGCA G CUCUUCCU 6009
AGGAAGAG GGAGGAAACUCC CU UCAAGGACAUCGUCCGGG UGCCACCC 7728 1793
CUCCCACC G GACACCGA 7124 UCGGUGUC GGAGGAAACUCC CU
UCAAGGACAUCGUCCGGG GGUGGGAG 7729 1794 UCCCACCG G ACACCGAC 7125
GUCGGUGU GGAGGAAACUCC CU UCAAGGACAUCGUCCGGG CGGUGGGA 7730 1800
CGGACACC G ACCCGCCC 7126 GGGCGGGU GGAGGAAACUCC CU
UCAAGGACAUCGUCCGGG GGUGUCCG 7731 1805 ACCGACCC G CCCGCCGC 6010
GCGGCGGG GGAGGAAACUCC CU UCAAGGACAUCGUCCGGG GGGUCGGU 7732 1809
ACCCGCCC G CCGCUGUG 6011 CACAGCGG GGAGGAAACUCC CU
UCAAGGACAUCGUCCGGG GGGCGGGU 7733 1812 CGCCCGCC G CUGUGCCC 6012
GGGCACAG GGAGGAAACUCC CU UCAAGGACAUCGUCCGGG GGCGGGCG 7734 1815
CCGCCGCU G UGCCCUGG 6013 CCAGGGCA GGAGGAAACUCC CU
UCAAGGACAUCGUCCGGG AGCGGCGG 7735 1817 GCCGCUGU G CCCUGGGA 6014
UCCCAGGG GGAGGAAACUCC CU UCAAGGACAUCGUCCGGG ACAGCGGC 7736 1822
UGUGCCCU G GGAGUGCU 7127 AGCACUCC GGAGGAAACUCC CU
UCAAGGACAUCGUCCGGG AGGGCACA 7737 1823 GUGCCCUG G GAGUGCUG 7128
CAGCACUC GGAGGAAACUCC CU UCAAGGACAUCGUCCGGG CAGGGCAC 7738 1824
UGCCCUGG G AGUGCUGC 7129 GCAGCACU GGAGGAAACUCC CU
UCAAGGACAUCGUCCGGG CCAGGGCA 7739 1826 CCCUGGGA G UGCUGCCC 6015
GGGCAGCA GGAGGAAACUCC CU UCAAGGACAUCGUCCGGG UCCCAGGG 7740 1828
CUGGGAGU G CUGCCCUC 6016 GAGGGCAG GGAGGAAACUCC CU
UCAAGGACAUCGUCCGGG ACUCCCAG 7741 1831 GGAGUGCU G CCCUCUUA 6017
UAAGAGGG GGAGGAAACUCC CU UCAAGGACAUCGUCCGGG AGCACUCC 7742 1844
CUUACCAU G CACACGGG 6018 CCCGUGUG GGAGGAAACUCC CU
UCAAGGACAUCGUCCGGG AUGGUAAG 7743 1850 AUGCACAC G GGUGCUCU 7130
AGAGCACC GGAGGAAACUCC CU UCAAGGACAUCGUCCGGG GUGUGCAU 7744 1851
UGCACACG G GUGCUCUC 7131 GAGAGCAC GGAGGAAACUCC CU
UCAAGGACAUCGUCCGGG CGUGUGCA 7745 1852 GCACACGG G UGCUCUCC 6019
GGAGAGCA GGAGGAAACUCC CU UCAAGGACAUCGUCCGGG CCGUGUGC 7746 1854
ACACGGGU G CUCUCCUU 6020 AAGGAGAG GGAGGAAACUCC CU
UCAAGGACAUCGUCCGGG ACCCGUGU 7747 1865 CUCCUUUU G GGCUGCAU 7132
AUGCAGCC GGAGGAAACUCC CU UCAAGGACAUCGUCCGGG AAAAGGAG 7748 1866
UCCUUUUG G GCUGCAUG 7133 CAUGCAGC GGAGGAAACUCC CU
UCAAGGACAUCGUCCGCG CAAAAGGA 7749 1867 CCUUUUGG G CUGCAUGC 6021
GCAUGCAG GGAGGAAACUCC CU UCAAGGACAUCGUCCGGG CCAAAAGG 7750 1870
UUUGGGCU G CAUGCUAU 6022 AUAGCAUG GGAGGAAACUCC CU
UCAAGGACAUCGUCCGGG AGCCCAAA 7751 1874 GGCUGCAU G CUAUUCCA 6023
UGGAAUAG GGAGGAAACUCC CU UCAAGGACAUCGUCCGGG AUGCAGCC 7752 1887
UCCAUUUU G CAGCCAGA 6024 UCUGGCUG GGAGGAAACUCC CU
UCAAGGACAUCGUCCGGG AAAAUGGA 7753 1890 AUUUUGCA G CCAGACCG 6025
CGGUCUGG GGAGGAAACUCC CU UCAAGGACAUCGUCCGGG UGCAAAAU 7754 1894
UGCAGCCA G ACCGAUGU 7134 ACAUCGGU GGAGGAAACUCC CU
UCAAGGACAUCGUCCGGG UGGCUGCA 7755 1898 GCCAGACC G AUGUGUAU 7135
AUACACAU GGAGGAAACUCC CU UCAAGGACAUCGUCCGGG GGUCUGGC 7756 1901
AGACCGAU G UGUAUUUA 6026 UAAAUACA GGAGGAAACUCC CU
UCAAGGACAUCGUCCGGG AUCGGUCU 7757 1903 ACCGAUGU G UAUUUAAC 6027
GUUAAAUA GGAGGAAACUCC CU UCAAGGACAUCGUCCGGG ACAUCGGU 7758 1914
UUUAACCA G UCACUAUU 6028 AAUAGUGA GGAGGAAACUCC CU
UCAAGGACAUCGUCCGGG UGGUUAAA 7759 1923 UCACUAUU G AUGGACAU 7136
AUGUCCAU GGAGGAAACUCC CU UCAAGGACAUCGUCCGGG AAUAGUGA 7760 1926
CUAUUGAU G GACAUUUG 7137 CAAAUGUC GGAGGAAACUCC CU
UCAAGGACAUCGUCCGGG AUCAAUAG 7761 1927 UAUUGAUG G ACAUUUGG 7138
CCAAAUGU GGAGGAAACUCC CU UCAAGGACAUCGUCCGGG CAUCAAUA 7762 1934
GGACAUUU G GGUUGUUU 7139 AAACAACC GGAGGAAACUCC CU
UCAAGGACAUCGUCCGGG AAAUGUCC 7763 1935 GACAUUUG G GUUGUUUC 7140
GAAACAAC GGAGGAAACUCC CU UCAAGGACAUCGUCCGGG CAAAUGUC 7764 1936
ACAUUUGG G UUGUUUCC 6029 GGAAACAA GGAGGAAACUCC CU
UCAAGGACAUCGUCCGGG CCAAAUGU 7765 1939 UUUGGGUU G UUUCCCAU 6030
AUGGGAAA GGAGGAAACUCC CU UCAAGGACAUCGUCCGGG AACCCAAA 7766 1954
AUCUUUUU G UUACCAUA 6031 UAUGGUAA GGAGGAAACUCC CU
UCAAGGACAUCGUCCGGG AAAAAGAU 7767 1969 UAAAUAAU G GCAUAGUA 7141
UACUAUGC GGAGGAAACUCC CU UCAAGGACAUCGUCCGGG AUUAUUUA 7768 1970
AAAUAAUG G CAUAGUAA 6032 UUACUAUG GGAGGAAACUCC CU
UCAAGGACAUCGUCCGGG CAUUAUUU 7769 1975 AUGGCAUA G UAAAAAAA 6033
UUUUUUUA GGAGGAAACUCC CU UCAAGGACAUCGUCCGGG UAUGCCAU 7770 Input
Sequence = NM_003639. Cut Site = G/. Arm Length = 8. Core Sequence
GGAGGAAACUCC CU UCAAGGACAUCGUCCGGG NM_003639 (Homo sapiens
inhibitor of kappa light polypeptide gene enhancer in B-cells,
kinase (IKBKG), mRNA.; 1994 bp)
[0270] TABLE-US-00008 TABLE VIII Human PKR Hammerhead and Substrate
Sequence Seq Seq Pos Substrate ID Hammerhead ID 20 GGCGCAGU U
UGCUCAUA 1 UAUGAGCA CUGAUGAGGCCGUUAGGCCGAA ACUGCGCC 632 21 GCGCAGUU
U GCUCAUAC 2 GUAUGAGC CUGAUGAGGCCGUUAGGCCGAA AACUGCGC 633 25
AGUUUGCU C AUACUUUG 3 CAAAGUAU CUGAUGAGGCCGUUAGGCCGAA AGCAAACU 634
28 UUGCUCAU A CUUUGUGA 4 UCACAAAG CUGAUGAGGCCGUUAGGCCGAA AUGAGCAA
635 31 CUCAUACU U UGUGACUU 5 AAGUCACA CUGAUGAGGCCGUUAGGCCGAA
AGUAUGAG 636 32 UCAUACUU U GUGACUUG 6 CAAGUCAC
CUGAUGAGGCCGUUAGGCCGAA AAGUAUGA 637 39 UUGUGACU U GCGGUCAC 7
GUGACCGC CUGAUGAGGCCGUUAGGCCGAA AGUCACAA 638 45 CUUGCGGU C ACAGUGGC
8 GCCACUGU CUGAUGAGGCCGUUAGGCCGAA ACCGCAAG 639 56 AGUGGCAU U
CAGCUCCA 9 UGGAGCUG CUGAUGAGGCCGUUAGGCCGAA AUGCCACU 640 57 GUGGCAUU
C AGCUCCAC 10 GUGGAGCU CUGAUGAGGCCGUUAGGCCGAA AAUGCCAC 641 62
AUUCAGCU C CACACUUG 11 CAAGUGUG CUGAUGAGGCCGUUAGGCCGAA AGCUGAAU 642
69 UCCACACU U GGUAGAAC 12 GUUCUACC CUGAUGAGGCCGUUAGGCCGAA AGUGUGGA
643 73 CACUUGGU A GAACCACA 13 UGUGGUUC CUGAUGAGGCCGUUAGGCCGAA
ACCAAGUG 644 96 ACAAGCAU A GAAACAUC 14 GAUGUUUC
CUGAUGAGGCCGUUAGGCCGAA AUGCUUGU 645 104 AGAAACAU C CUAAACAA 15
UUGUUUAG CUGAUGAGGCCGUUAGGCCGAA AUGUUUCU 646 107 AACAUCCU A
AACAAUCU 16 AGAUUGUU CUGAUGAGGCCGUUAGGCCGAA AGGAUGUU 647 114
UAAACAAU C UUCAUCGA 17 UCGAUGAA CUGAUGAGGCCGUUAGGCCGAA AUUGUUUA 648
116 AACAAUCU U CAUCGAGG 18 CCUCGAUG CUGAUGAGGCCGUUAGGCCGAA AGAUUGUU
649 117 ACAAUCUU C AUCGAGGC 19 GCCUCGAU CUGAUGAGGCCGUUAGGCCGAA
AAGAUUGU 650 120 AUCUUCAU C GAGGCAUC 20 GAUGCCUC
CUGAUGAGGCCGUUAGGCCGAA AUGAAGAU 651 128 CGAGGCAU C GAGGUCCA 21
UGGACCUC CUGAUGAGGCCGUUAGGCCGAA AUGCCUCG 652 134 AUCGAGGU C
CAUCCCAA 22 UUGGGAUG CUGAUGAGGCCGUUAGGCCGAA ACCUCGAU 653 138
AGGUCCAU C CCAAUAAA 23 UUUAUUGG CUGAUGAGGCCGUUAGGCCGAA AUGGACCU 654
144 AUCCCAAU A AAAAUCAG 24 CUGAUUUU CUGAUGAGGCCGUUAGGCCGAA AUUGGGAU
655 150 AUAAAAAU C AGGAGACC 25 GGUCUCCU CUGAUGAGGCCGUUAGGCCGAA
AUUUUUAU 656 165 CCCUGGCU A UCAUAGAC 26 GUCUAUGA
CUGAUGAGGCCGUUAGGCCGAA AGCCAGGG 657 167 CUGGCUAU C AUAGACCU 27
AGGUCUAU CUGAUGAGGCCGUUAGGCCGAA AUAGCCAG 658 170 GCUAUCAU A
GACCUUAG 28 CUAAGGUC CUGAUGAGGCCGUUAGGCCGAA AUGAUAGC 659 176
AUAGACCU U AGUCUUCG 29 CGAAGACU CUGAUGAGGCCGUUAGGCCGAA AGGUCUAU 660
177 UAGACCUU A GUCUUCGC 30 GCGAAGAC CUGAUGAGGCCGUUAGGCCGAA AAGGUCUA
661 180 ACCUUAGU C UUCGCUGG 31 CCAGCGAA CUGAUGAGGCCGUUAGGCCGAA
ACUAAGGU 662 182 CUUAGUCU U CGCUGGUA 32 UACCAGCG
CUGAUGAGGCCGUUAGGCCGAA AGACUAAG 663 183 UUAGUCUU C GCUGGUAU 33
AUACCAGC CUGAUGAGGCCGUUAGGCCGAA AAGACUAA 664 190 UCGCUGGU A
UACUCGCU 34 AGCGAGUA CUGAUGAGGCCGUUAGGCCGAA ACCAGCGA 665 192
GCUGGUAU A CUCGCUGU 35 ACAGCGAG CUGAUGAGGCCGUUAGGCCGAA AUACCAGC 666
195 GGUAUACU C GCUGUCUG 36 CAGACAGC CUGAUGAGGCCGUUAGGCCGAA AGUAUACC
667 201 CUCGCUGU C UGUCAACC 37 GGUUGACA CUGAUGAGGCCGUUAGGCCGAA
ACAGCGAG 668 205 CUGUCUGU C AACCAGCG 38 CGCUGGUU
CUGAUGAGGCCGUUAGGCCGAA ACAGACAG 669 216 CCAGCGGU U GACUUUUU 39
AAAAAGUC CUGAUGAGGCCGUUAGGCCGAA ACCGCUGG 670 221 GGUUGACU U
UUUUUAAG 40 CUUAAAAA CUGAUGAGGCCGUUAGGCCGAA AGUCAACC 671 222
GUUGACUU U UUUUAAGC 41 GCUUAAAA CUGAUGAGGCCGUUAGGCCGAA AAGUCAAC 672
223 UUGACUUU U UUUAAGCC 42 GGCUUAAA CUGAUGAGGCCGUUAGGCCGAA AAAGUCAA
673 224 UGACUUUU U UUAAGCCU 43 AGGCUUAA CUGAUGAGGCCGUUAGGCCGAA
AAAAGUCA 674 225 GACUUUUU U UAAGCCUU 44 AAGGCUUA
CUGAUGAGGCCGUUAGGCCGAA AAAAAGUC 675 226 ACUUUUUU U AAGCCUUC 45
GAAGGCUU CUGAUGAGGCCGUUAGGCCGAA AAAAAAGU 676 227 CUUUUUUU A
AGCCUUCU 46 AGAAGGCU CUGAUGAGGCCGUUAGGCCGAA AAAAAAAG 677 233
UUAAGCCU U CUUUUUUC 47 GAAAAAAG CUGAUGAGGCCGUUAGGCCGAA AGGCUUAA 678
234 UAAGCCUU C UUUUUUCU 48 AGAAAAAA CUGAUGAGGCCGUUAGGCCGAA AAGGCUUA
679 236 AGCCUUCU U UUUUCUCU 49 AGAGAAAA CUGAUGAGGCCGUUAGGCCGAA
AGAAGGCU 680 237 GCCUUCUU U UUUCUCUU 50 AAGAGAAA
CUGAUGAGGCCGUUAGGCCGAA AAGAAGGC 681 238 CCUUCUUU U UUCUCUUU 51
AAAGAGAA CUGAUGAGGCCGUUAGGCCGAA AAAGAAGG 682 239 CUUCUUUU U
UCUCUUUU 52 AAAAGAGA CUGAUGAGGCCGUUAGGCCGAA AAAAGAAG 683 240
UUCUUUUU U CUCUUUUA 53 UAAAAGAG CUGAUGAGGCCGUUAGGCCGAA AAAAAGAA 684
241 UCUUUUUU C UCUUUUAC 54 GUAAAAGA CUGAUGAGGCCGUUAGGCCGAA AAAAAAGA
685 243 UUUUUUCU C UUUUACCA 55 UGGUAAAA CUGAUGAGGCCGUUAGGCCGAA
AGAAAAAA 686 245 UUUUCUCU U UUACCAGU 56 ACUGGUAA
CUGAUGAGGCCGUUAGGCCGAA AGAGAAAA 687 246 UUUCUCUU U UACCAGUU 57
AACUGGUA CUGAUGAGGCCGUUAGGCCGAA AAGAGAAA 688 247 UUCUCUUU U
ACCAGUUU 58 AAACUGGU CUGAUGAGGCCGUUAGGCCGAA AAAGAGAA 689 248
UCUCUUUU A CCAGUUUC 59 GAAACUGG CUGAUGAGGCCGUUAGGCCGAA AAAAGAGA 690
254 UUACCAGU U UCUGGAGC 60 GCUCCAGA CUGAUGAGGCCGUUAGGCCGAA ACUGGUAA
691 255 UACCAGUU U CUGGAGCA 61 UGCUCCAG CUGAUGAGGCCGUUAGGCCGAA
AACUGGUA 692 256 ACCAGUUU C UGGAGCAA 62 UUGCUCCA
CUGAUGAGGCCGUUAGGCCGAA AAACUGGU 693 267 GAGCAAAU U CAGUUUGC 63
GCAAACUG CUGAUGAGGCCGUUAGGCCGAA AUUUGCUC 694 268 AGCAAAUU C
AGUUUGCC 64 GGCAAACU CUGAUGAGGCCGUUAGGCCGAA AAUUUGCU 695 272
AAUUCAGU U UGCCUUCC 65 GGAAGGCA CUGAUGAGGCCGUUAGGCCGAA ACUGAAUU 696
273 AUUCAGUU U GCCUUCCU 66 AGGAAGGC CUGAUGAGGCCGUUAGGCCGAA AACUGAAU
697 278 GUUUGCCU U CCUGGAUU 67 AAUCCAGG CUGAUGAGGCCGUUAGGCCGAA
AGGCAAAC 698 279 UUUGCCUU C CUGGAUUU 68 AAAUCCAG
CUGAUGAGGCCGUUAGGCCGAA AAGGCAAA 699 286 UCCUGGAU U UGUAAAUU 69
AAUUUACA CUGAUGAGGCCGUUAGGCCGAA AUCCAGGA 700 287 CCUGGAUU U
GUAAAUUG 70 CAAUUUAC CUGAUGAGGCCGUUAGGCCGAA AAUCCAGG 701 290
GGAUUUGU A AAUUGUAA 71 UUACAAUU CUGAUGAGGCCGUUAGGCCGAA ACAAAUCC 702
294 UUGUAAAU U GUAAUGAC 72 GUCAUUAC CUGAUGAGGCCGUUAGGCCGAA AUUUACAA
703 297 UAAAUUGU A AUGACCUC 73 GAGGUCAU CUGAUGAGGCCGUUAGGCCGAA
ACAAUUUA 704 305 AAUGACCU C AAAACUUU 74 AAAGUUUU
CUGAUGAGGCCGUUAGGCCGAA AGGUCAUU 705 312 UCAAAACU U UAGCAGUU 75
AACUGCUA CUGAUGAGGCCGUUAGGCCGAA AGUUUUGA 706 313 CAAAACUU U
AGCAGUUC 76 GAACUGCU CUGAUGAGGCCGUUAGGCCGAA AAGUUUUG 707 314
AAAACUUU A GCAGUUCU 77 AGAACUGC CUGAUGAGGCCGUUAGGCCGAA AAAGUUUU 708
320 UUAGCAGU U CUUCCAUC 78 GAUGGAAG CUGAUGAGGCCGUUAGGCCGAA ACUGCUAA
709 321 UAGCAGUU C UUCCAUCU 79 AGAUGGAA CUGAUGAGGCCGUUAGGCCGAA
AACUGCUA 710 323 GCAGUUCU U CCAUCUGA 80 UCAGAUGG
CUGAUGAGGCCGUUAGGCCGAA AGAACUGC 711 324 CAGUUCUU C CAUCUGAC 81
GUCAGAUG CUGAUGAGGCCGUUAGGCCGAA AAGAACUG 712 328 UCUUCCAU C
UGACUCAG 82 CUGAGUCA CUGAUGAGGCCGUUAGGCCGAA AUGGAAGA 713 334
AUCUGACU C AGGUUUGC 83 GCAAACCU CUGAUGAGGCCGUUAGGCCGAA AGUCAGAU 714
339 ACUCAGGU U UGCUUCUC 84 GAGAAGCA CUGAUGAGGCCGUUAGGCCGAA ACCUGAGU
715 340 CUCAGGUU U GCUUCUCU 85 AGAGAAGC CUGAUGAGGCCGUUAGGCCGAA
AACCUGAG 716 344 GGUUUGCU U CUCUGGCG 86 CGCCAGAG
CUGAUGAGGCCGUUAGGCCGAA AGCAAACC 717 345 GUUUGCUU C UCUGGCGG 87
CCGCCAGA CUGAUGAGGCCGUUAGGCCGAA AAGCAAAC 718 347 UUGCUUCU C
UGGCGGUC 88 GACCGCCA CUGAUGAGGCCGUUAGGCCGAA AGAAGCAA 719 355
CUGGCGGU C UUCAGAAU 89 AUUCUGAA CUGAUGAGGCCGUUAGGCCGAA ACCGCCAG 720
357 GGCGGUCU U CAGAAUCA 90 UGAUUCUG CUGAUGAGGCCGUUAGGCCGAA AGACCGCC
721 358 GCGGUCUU C AGAAUCAA 91 UUGAUUCU CUGAUGAGGCCGUUAGGCCGAA
AAGACCGC 722 364 UUCAGAAU C AACAUCCA 92 UGGAUGUU
CUGAUGAGGCCGUUAGGCCGAA AUUCUGAA 723 370 AUCAACAU C CACACUUC 93
GAAGUGUG CUGAUGAGGCCGUUAGGCCGAA AUGUUGAU 724 377 UCCACACU U
CCGUGAUU 94 AAUCACGG CUGAUGAGGCCGUUAGGCCGAA AGUGUGGA 725 378
CCACACUU C CGUGAUUA 95 UAAUCACG CUGAUGAGGCCGUUAGGCCGAA AAGUGUGG 726
385 UCCGUGAU U AUCUGCGU 96 ACGCAGAU CUGAUGAGGCCGUUAGGCCGAA AUCACGGA
727 386 CCGUGAUU A UCUGCGUG 97 CACGCAGA CUGAUGAGGCCGUUAGGCCGAA
AAUCACGG 728 388 GUGAUUAU C UGCGUGCA 98 UGCACGCA
CUGAUGAGGCCGUUAGGCCGAA AUAAUCAC 729 398 GCGUGCAU U UUGGACAA 99
UUGUCCAA CUGAUGAGGCCGUUAGGCCGAA AUGCACGC 730 399 CGUGCAUU U
UGGACAAA 100 UUUGUCCA CUGAUGAGGCCGUUAGGCCGAA AAUGCACG 731 400
GUGCAUUU U GGACAAAG 101 CUUUGUCC CUGAUGAGGCCGUUAGGCCGAA AAAUGCAC
732 411 ACAAAGCU U CCAACCAG 102 CUGGUUGG CUGAUGAGGCCGUUAGGCCGAA
AGCUUUGU 733 412 CAAAGCUU C CAACCAGG 103 CCUGGUUG
CUGAUGAGGCCGUUAGGCCGAA AAGCUUUG 734 423 ACCAGGAU A CGGGAAGA 104
UCUUCCCG CUGAUGAGGCCGUUAGGCCGAA AUCCUGGU 735 448 CUGGUGAU C
UUUCAGCA 105 UGCUGAAA CUGAUGAGGCCGUUAGGCCGAA AUCACCAG 736 450
GGUGAUCU U UCAGCAGG 106 CCUGCUGA CUGAUGAGGCCGUUAGGCCGAA AGAUCACC
737 451 GUGAUCUU U CAGCAGGU 107 ACCUGCUG CUGAUGAGGCCGUUAGGCCGAA
AAGAUCAC 738 452 UGAUCUUU C AGCAGGUU 108 AACCUGCU
CUGAUGAGGCCGUUAGGCCGAA AAAGAUCA 739 460 CAGCAGGU U UCUUCAUG 109
CAUGAAGA CUGAUGAGGCCGUUAGGCCGAA ACCUGCUG 740 461 AGCAGGUU U
CUUCAUGG 110 CCAUGAAG CUGAUGAGGCCGUUAGGCCGAA AACCUGCU 741 462
GCAGGUUU C UUCAUGGA 111 UCCAUGAA CUGAUGAGGCCGUUAGGCCGAA AAACCUGC
742 464 AGGUUUCU U CAUGGAGG 112 CCUCCAUG CUGAUGAGGCCGUUAGGCCGAA
AGAAACCU 743 465 GGUUUCUU C AUGGAGGA 113 UCCUCCAU
CUGAUGAGGCCGUUAGGCCGAA AAGAAACC 744 477 GAGGAACU U AAUACAUA 114
UAUGUAUU CUGAUGAGGCCGUUAGGCCGAA AGUUCCUC 745 478 AGGAACUU A
AUACAUAC 115 GUAUGUAU CUGAUGAGGCCGUUAGGCCGAA AAGUUCCU 746 481
AACUUAAU A CAUACCGU 116 ACGGUAUG CUGAUGAGGCCGUUAGGCCGAA AUUAAGUU
747 485 UAAUACAU A CCGUCAGA 117 UCUGACGG CUGAUGAGGCCGUUAGGCCGAA
AUGUAUUA 748 490 CAUACCGU C AGAAGCAG 118 CUGCUUCU
CUGAUGAGGCCGUUAGGCCGAA ACGGUAUG 749 504 CAGGGAGU A GUACUUAA 119
UUAAGUAC CUGAUGAGGCCGUUAGGCCGAA ACUCCCUG 750 507 GGAGUAGU A
CUUAAAUA 120 UAUUUAAG CUGAUGAGGCCGUUAGGCCGAA ACUACUCC 751 510
GUAGUACU U AAAUAUCA 121 UGAUAUUU CUGAUGAGGCCGUUAGGCCGAA AGUACUAC
752 511 UAGUACUU A AAUAUCAA 122 UUGAUAUU CUGAUGAGGCCGUUAGGCCGAA
AAGUACUA 753
515 ACUUAAAU A UCAAGAAC 123 GUUCUUGA CUGAUGAGGCCGUUAGGCCGAA
AUUUAAGU 754 517 UUAAAUAU C AAGAACUG 124 CAGUUCUU
CUGAUGAGGCCGUUAGGCCGAA AUAUUUAA 755 529 AACUGCCU A AUUCAGGA 125
UCCUGAAU CUGAUGAGGCCGUUAGGCCGAA AGGCAGUU 756 532 UGCCUAAU U
CAGGACCU 126 AGGUCCUG CUGAUGAGGCCGUUAGGCCGAA AUUAGGCA 757 533
GCCUAAUU C AGGACCUC 127 GAGGUCCU CUGAUGAGGCCGUUAGGCCGAA AAUUAGGC
758 541 CAGGACCU C CACAUGAU 128 AUCAUGUG CUGAUGAGGCCGUUAGGCCGAA
AGGUCCUG 759 550 CACAUGAU A GGAGGUUU 129 AAACCUCC
CUGAUGAGGCCGUUAGGCCGAA AUCAUGUG 760 557 UAGGAGGU U UACAUUUC 130
GAAAUGUA CUGAUGAGGCCGUUAGGCCGAA ACCUCCUA 761 558 AGGAGGUU U
ACAUUUCA 131 UGAAAUGU CUGAUGAGGCCGUUAGGCCGAA AACCUCCU 762 559
GGAGGUUU A CAUUUCAA 132 UUGAAAUG CUGAUGAGGCCGUUAGGCCGAA AAACCUCC
763 563 GUUUACAU U UCAAGUUA 133 UAACUUGA CUGAUGAGGCCGUUAGGCCGAA
AUGUAAAC 764 564 UUUACAUU U CAAGUUAU 134 AUAACUUG
CUGAUGAGGCCGUUAGGCCGAA AAUGUAAA 765 565 UUACAUUU C AAGUUAUA 135
UAUAACUU CUGAUGAGGCCGUUAGGCCGAA AAAUGUAA 766 570 UUUCAAGU U
AUAAUAGA 136 UCUAUUAU CUGAUGAGGCCGUUAGGCCGAA ACUUGAAA 767 571
UUCAAGUU A UAAUAGAU 137 AUCUAUUA CUGAUGAGGCCGUUAGGCCGAA AACUUGAA
768 573 CAAGUUAU A AUAGAUGG 138 CCAUCUAU CUGAUGAGGCCGUUAGGCCGAA
AUAACUUG 769 576 GUUAUAAU A GAUGGAAG 139 CUUCCAUC
CUGAUGAGGCCGUUAGGCCGAA AUUAUAAC 770 590 AAGAGAAU U UCCAGAAG 140
CUUCUGGA CUGAUGAGGCCGUUAGGCCGAA AUUCUCUU 771 591 AGAGAAUU U
CCAGAAGG 141 CCUUCUGG CUGAUGAGGCCGUUAGGCCGAA AAUUCUCU 772 592
GAGAAUUU C CAGAAGGU 142 ACCUUCUG CUGAUGAGGCCGUUAGGCCGAA AAAUUCUC
773 607 GUGAAGGU A GAUCAAAG 143 CUUUGAUC CUGAUGAGGCCGUUAGGCCGAA
ACCUUCAC 774 611 AGGUAGAU C AAAGAAGG 144 CCUUCUUU
CUGAUGAGGCCGUUAGGCCGAA AUCUACCU 775 644 AGCCAAAU U AGCUGUUG 145
CAACAGCU CUGAUGAGGCCGUUAGGCCGAA AUUUGGCU 776 645 GCCAAAUU A
GCUGUUGA 146 UCAACAGC CUGAUGAGGCCGUUAGGCCGAA AAUUUGGC 777 651
UUAGCUGU U GAGAUACU 147 AGUAUCUC CUGAUGAGGCCGUUAGGCCGAA ACAGCUAA
778 657 GUUGAGAU A CUUAAUAA 148 UUAUUAAG CUGAUGAGGCCGUUAGGCCGAA
AUCUCAAC 779 660 GAGAUACU U AAUAAGGA 149 UCCUUAUU
CUGAUGAGGCCGUUAGGCCGAA AGUAUCUC 780 661 AGAUACUU A AUAAGGAA 150
UUCCUUAU CUGAUGAGGCCGUUAGGCCGAA AAGUAUCU 781 664 UACUUAAU A
AGGAAAAG 151 CUUUUCCU CUGAUGAGGCCGUUAGGCCGAA AUUAAGUA 782 681
AAGGCAGU U AGUCCUUU 152 AAAGGACU CUGAUGAGGCCGUUAGGCCGAA ACUGCCUU
783 682 AGGCAGUU A GUCCUUUA 153 UAAAGGAC CUGAUGAGGCCGUUAGGCCGAA
AACUGCCU 784 685 CAGUUAGU C CUUUAUUA 154 UAAUAAAG
CUGAUGAGGCCGUUAGGCCGAA ACUAACUG 785 688 UUAGUCCU U UAUUAUUG 155
CAAUAAUA CUGAUGAGGCCGUUAGGCCGAA AGGACUAA 786 689 UAGUCCUU U
AUUAUUGA 156 UCAAUAAU CUGAUGAGGCCGUUAGGCCGAA AAGGACUA 787 690
AGUCCUUU A UUAUUGAC 157 GUCAAUAA CUGAUGAGGCCGUUAGGCCGAA AAAGGACU
788 692 UCCUUUAU U AUUGACAA 158 UUGUCAAU CUGAUGAGGCCGUUAGGCCGAA
AUAAAGGA 789 693 CCUUUAUU A UUGACAAC 159 GUUGUCAA
CUGAUGAGGCCGUUAGGCCGAA AAUAAAGG 790 695 UUUAUUAU U GACAACAA 160
UUGUUGUC CUGAUGAGGCCGUUAGGCCGAA AUAAUAAA 791 709 CAACGAAU U
CUUCAGAA 161 UUCUGAAG CUGAUGAGGCCGUUAGGCCGAA AUUCGUUG 792 710
AACGAAUU C UUCAGAAG 162 CUUCUGAA CUGAUGAGGCCGUUAGGCCGAA AAUUCGUU
793 712 CGAAUUCU U CAGAAGGA 163 UCCUUCUG CUGAUGAGGCCGUUAGGCCGAA
AGAAUUCG 794 713 GAAUUCUU C AGAAGGAU 164 AUCCUUCU
CUGAUGAGGCCGUUAGGCCGAA AAGAAUUC 795 722 AGAAGGAU U AUCCAUGG 165
CCAUGGAU CUGAUGAGGCCGUUAGGCCGAA AUCCUUCU 796 723 GAAGGAUU A
UCCAUGGG 166 CCCAUGGA CUGAUGAGGCCGUUAGGCCGAA AAUCCUUC 797 725
AGGAUUAU C CAUGGGGA 167 UCCCCAUG CUGAUGAGGCCGUUAGGCCGAA AUAAUCCU
798 736 UGGGGAAU U ACAUAGGC 168 GCCUAUGU CUGAUGAGGCCGUUAGGCCGAA
AUUCCCCA 799 737 GGGGAAUU A CAUAGGCC 169 GGCCUAUG
CUGAUGAGGCCGUUAGGCCGAA AAUUCCCC 800 741 AAUUACAU A GGCCUUAU 170
AUAAGGCC CUGAUGAGGCCGUUAGGCCGAA AUGUAAUU 801 747 AUAGGCCU U
AUCAAUAG 171 CUAUUGAU CUGAUGAGGCCGUUAGGCCGAA AGGCCUAU 802 748
UAGGCCUU A UCAAUAGA 172 UCUAUUGA CUGAUGAGGCCGUUAGGCCGAA AAGGCCUA
803 750 GGCCUUAU C AAUAGAAU 173 AUUCUAUU CUGAUGAGGCCGUUAGGCCGAA
AUAAGGCC 804 754 UUAUCAAU A GAAUUGCC 174 GGCAAUUC
CUGAUGAGGCCGUUAGGCCGAA AUUGAUAA 805 759 AAUAGAAU U GCCCAGAA 175
UUCUGGGC CUGAUGAGGCCGUUAGGCCGAA AUUCUAUU 806 777 AAAAGACU A
ACUGUAAA 176 UUUACAGU CUGAUGAGGCCGUUAGGCCGAA AGUCUUUU 807 783
CUAACUGU A AAUUAUGA 177 UCAUAAUU CUGAUGAGGCCGUUAGGCCGAA ACAGUUAG
808 787 CUGUAAAU U AUGAACAG 178 CUGUUCAU CUGAUGAGGCCGUUAGGCCGAA
AUUUACAG 809 788 UGUAAAUU A UGAACAGU 179 ACUGUUCA
CUGAUGAGGCCGUUAGGCCGAA AAUUUACA 810 803 GUGUGCAU C GGGGGUGC 180
GCACCCCC CUGAUGAGGCCGUUAGGCCGAA AUGCACAC 811 827 AGAAGGAU U
UCAUUAUA 181 UAUAAUGA CUGAUGAGGCCGUUAGGCCGAA AUCCUUCU 812 828
GAAGGAUU U CAUUAUAA 182 UUAUAAUG CUGAUGAGGCCGUUAGGCCGAA AAUCCUUC
813 829 AAGGAUUU C AUUAUAAA 183 UUUAUAAU CUGAUGAGGCCGUUAGGCCGAA
AAAUCCUU 814 832 GAUUUCAU U AUAAAUGC 184 GCAUUUAU
CUGAUGAGGCCGUUAGGCCGAA AUGAAAUC 815 833 AUUUCAUU A UAAAUGCA 185
UGCAUUUA CUGAUGAGGCCGUUAGGCCGAA AAUGAAAU 816 835 UUCAUUAU A
AAUGCAAA 186 UUUGCAUU CUGAUGAGGCCGUUAGGCCGAA AUAAUGAA 817 860
GAAAGAAU A UAGUAUUG 187 CAAUACUA CUGAUGAGGCCGUUAGGCCGAA AUUCUUUC
818 862 AAGAAUAU A GUAUUGGU 188 ACCAAUAC CUGAUGAGGCCGUUAGGCCGAA
AUAUUCUU 819 865 AAUAUAGU A UUGGUACA 189 UGUACCAA
CUGAUGAGGCCGUUAGGCCGAA ACUAUAUU 820 867 UAUAGUAU U GGUACAGG 190
CCUGUACC CUGAUGAGGCCGUUAGGCCGAA AUACUAUA 821 871 GUAUUGGU A
CAGGUUCU 191 AGAACCUG CUGAUGAGGCCGUUAGGCCGAA ACCAAUAC 822 877
GUACAGGU U CUACUAAA 192 UUUAGUAG CUGAUGAGGCCGUUAGGCCGAA ACCUGUAC
823 878 UACAGGUU C UACUAAAC 193 GUUUAGUA CUGAUGAGGCCGUUAGGCCGAA
AACCUGUA 824 880 CAGGUUCU A CUAAACAG 194 CUGUUUAG
CUGAUGAGGCCGUUAGGCCGAA AGAACCUG 825 883 GUUCUACU A AACAGGAA 195
UUCCUGUU CUGAUGAGGCCGUUAGGCCGAA AGUAGAAC 826 902 AAAACAAU U
GGCCGCUA 196 UAGCGGCC CUGAUGAGGCCGUUAGGCCGAA AUUGUUUU 827 910
UGGCCGCU A AACUUGCA 197 UGCAAGUU CUGAUGAGGCCGUUAGGCCGAA AGCGGCCA
828 915 GCUAAACU U GCAUAUCU 198 AGAUAUGC CUGAUGAGGCCGUUAGGCCGAA
AGUUUAGC 829 920 ACUUGCAU A UCUUCAGA 199 UCUGAAGA
CUGAUGAGGCCGUUAGGCCGAA AUGCAAGU 830 922 UUGCAUAU C UUCAGAUA 200
UAUCUGAA CUGAUGAGGCCGUUAGGCCGAA AUAUGCAA 831 924 GCAUAUCU U
CAGAUAUU 201 AAUAUCUG CUGAUGAGGCCGUUAGGCCGAA AGAUAUGC 832 925
CAUAUCUU C AGAUAUUA 202 UAAUAUCU CUGAUGAGGCCGUUAGGCCGAA AAGAUAUG
833 930 CUUCAGAU A UUAUCAGA 203 UCUGAUAA CUGAUGAGGCCGUUAGGCCGAA
AUCUGAAG 834 932 UCAGAUAU U AUCAGAAG 204 CUUCUGAU
CUGAUGAGGCCGUUAGGCCGAA AUAUCUGA 835 933 CAGAUAUU A UCAGAAGA 205
UCUUCUGA CUGAUGAGGCCGUUAGGCCGAA AAUAUCUG 836 935 GAUAUUAU C
AGAAGAAA 206 UUUCUUCU CUGAUGAGGCCGUUAGGCCGAA AUAAUAUC 837 947
AGAAACCU C AGUGAAAU 207 AUUUCACU CUGAUGAGGCCGUUAGGCCGAA AGGUUUCU
838 956 AGUGAAAU C UGACUACC 208 GGUAGUCA CUGAUGAGGCCGUUAGGCCGAA
AUUUCACU 839 962 AUCUGACU A CCUGUCCU 209 AGGACAGG
CUGAUGAGGCCGUUAGGCCGAA AGUCAGAU 840 968 CUACCUGU C CUCUGGUU 210
AACCAGAG CUGAUGAGGCCGUUAGGCCGAA ACAGGUAG 841 971 CCUGUCCU C
UGGUUCUU 211 AAGAACCA CUGAUGAGGCCGUUAGGCCGAA AGGACAGG 842 976
CCUCUGGU U CUUUUGCU 212 AGCAAAAG CUGAUGAGGCCGUUAGGCCGAA ACCAGAGG
843 977 CUCUGGUU C UUUUGCUA 213 UAGCAAAA CUGAUGAGGCCGUUAGGCCGAA
AACCAGAG 844 979 CUGGUUCU U UUGCUACU 214 AGUAGCAA
CUGAUGAGGCCGUUAGGCCGAA AGAACCAG 845 980 UGGUUCUU U UGCUACUA 215
UAGUAGCA CUGAUGAGGCCGUUAGGCCGAA AAGAACCA 846 981 GGUUCUUU U
GCUACUAC 216 GUAGUAGC CUGAUGAGGCCGUUAGGCCGAA AAAGAACC 847 985
CUUUUGCU A CUACGUGU 217 ACACGUAG CUGAUGAGGCCGUUAGGCCGAA AGCAAAAG
848 988 UUGCUACU A CGUGUGAG 218 CUCACACG CUGAUGAGGCCGUUAGGCCGAA
AGUAGCAA 849 998 GUGUGAGU C CCAAAGCA 219 UGCUUUGG
CUGAUGAGGCCGUUAGGCCGAA ACUCACAC 850 1010 AAGCAACU C UUUAGUGA 220
UCACUAAA CUGAUGAGGCCGUUAGGCCGAA AGUUGCUU 851 1012 GCAACUCU U
UAGUGACC 221 GGUCACUA CUGAUGAGGCCGUUAGGCCGAA AGAGUUGC 852 1013
CAACUCUU U AGUGACCA 222 UGGUCACU CUGAUGAGGCCGUUAGGCCGAA AAGAGUUG
853 1014 AACUCUUU A GUGACCAG 223 CUGGUCAC CUGAUGAGGCCGUUAGGCCGAA
AAAGAGUU 854 1029 AGCACACU C GCUUCUGA 224 UCAGAAGC
CUGAUGAGGCCGUUAGGCCGAA AGUGUGCU 855 1033 CACUCGCU U CUGAAUCA 225
UGAUUCAG CUGAUGAGGCCGUUAGGCCGAA AGCGAGUG 856 1034 ACUCGCUU C
UGAAUCAU 226 AUGAUUCA CUGAUGAGGCCGUUAGGCCGAA AAGCGAGU 857 1040
UUCUGAAU C AUCAUCUG 227 CAGAUGAU CUGAUGAGGCCGUUAGGCCGAA AUUCAGAA
858 1043 UGAAUCAU C AUCUGAAG 228 CUUCAGAU CUGAUGAGGCCGUUAGGCCGAA
AUGAUUCA 859 1046 AUCAUCAU C UGAAGGUG 229 CACCUUCA
CUGAUGAGGCCGUUAGGCCGAA AUGAUGAU 860 1058 AGGUGACU U CUCAGCAG 230
CUGCUGAG CUGAUGAGGCCGUUAGGCCGAA AGUCACCU 861 1059 GGUGACUU C
UCAGCAGA 231 UCUGCUGA CUGAUGAGGCCGUUAGGCCGAA AAGUCACC 862 1061
UGACUUCU C AGCAGAUA 232 UAUCUGCU CUGAUGAGGCCGUUAGGCCGAA AGAAGUCA
863 1069 CAGCAGAU A CAUCAGAG 233 CUCUGAUG CUGAUGAGGCCGUUAGGCCGAA
AUCUGCUG 864 1073 AGAUACAU C AGAGAUAA 234 UUAUCUCU
CUGAUGAGGCCGUUAGGCCGAA AUGUAUCU 865 1080 UCAGAGAU A AAUUCUAA 235
UUAGAAUU CUGAUGAGGCCGUUAGGCCGAA AUCUCUGA 866 1084 AGAUAAAU U
CUAACAGU 236 ACUGUUAG CUGAUGAGGCCGUUAGGCCGAA AUUUAUCU 867 1085
GAUAAAUU C UAACAGUG 237 CACUGUUA CUGAUGAGGCCGUUAGGCCGAA AAUUUAUC
868 1087 UAAAUUCU A ACAGUGAC 238 GUCACUGU CUGAUGAGGCCGUUAGGCCGAA
AGAAUUUA 869 1099 GUGACAGU U UAAACAGU 239 ACUGUUUA
CUGAUGAGGCCGUUAGGCCGAA ACUGUCAC 870 1100 UGACAGUU U AAACAGUU 240
AACUGUUU CUGAUGAGGCCGUUAGGCCGAA AACUGUCA 871 1101 GACAGUUU A
AACAGUUC 241 GAACUGUU CUGAUGAGGCCGUUAGGCCGAA AAACUGUC 872 1108
UAAACAGU U CUUCGUUG 242 CAACGAAG CUGAUGAGGCCGUUAGGCCGAA ACUGUUUA
873 1109 AAACAGUU C UUCGUUGC 243 GCAACGAA CUGAUGAGGCCGUUAGGCCGAA
AACUGUUU 874 1111 ACAGUUCU U CGUUGCUU 244 AAGCAACG
CUGAUGAGGCCGUUAGGCCGAA AGAACUGU 875 1112 CAGUUCUU C GUUGCUUA 245
UAAGCAAC CUGAUGAGGCCGUUAGGCCGAA AAGAACUG 876 1115 UUCUUCGU U
GCUUAUGA 246 UCAUAAGC CUGAUGAGGCCGUUAGGCCGAA ACGAAGAA 877 1119
UCGUUGCU U AUGAAUGG 247 CCAUUCAU CUGAUGAGGCCGUUAGGCCGAA AGCAACGA
878
1120 CGUUGCUU A UGAAUGGU 248 ACCAUUCA CUGAUGAGGCCGUUAGGCCGAA
AAGCAACG 879 1129 UGAAUGGU C UCAGAAAU 249 AUUUCUGA
CUGAUGAGGCCGUUAGGCCGAA ACCAUUCA 880 1131 AAUGGUCU C AGAAAUAA 250
UUAUUUCU CUGAUGAGGCCGUUAGGCCGAA AGACCAUU 881 1138 UCAGAAAU A
AUCAAAGG 251 CCUUUGAU CUGAUGAGGCCGUUAGGCCGAA AUUUCUGA 882 1141
GAAAUAAU C AAAGGAAG 252 CUUCCUUU CUGAUGAGGCCGUUAGGCCGAA AUUAUUUC
883 1160 AAAAAGAU C UUUGGCAC 253 GUGCCAAA CUGAUGAGGCCGUUAGGCCGAA
AUCUUUUU 884 1162 AAAGAUCU U UGGCACCC 254 GGGUGCCA
CUGAUGAGGCCGUUAGGCCGAA AGAUCUUU 885 1163 AAGAUCUU U GGCACCCA 255
UGGGUGCC CUGAUGAGGCCGUUAGGCCGAA AAGAUCUU 886 1175 ACCCAGAU U
UGACCUUC 256 GAAGGUCA CUGAUGAGGCCGUUAGGCCGAA AUCUGGGU 887 1176
CCCAGAUU U GACCUUCC 257 GGAAGGUC CUGAUGAGGCCGUUAGGCCGAA AAUCUGGG
888 1182 UUUGACCU U CCUGACAU 258 AUGUCAGG CUGAUGAGGCCGUUAGGCCGAA
AGGUCAAA 889 1183 UUGACCUU C CUGACAUG 259 CAUGUCAG
CUGAUGAGGCCGUUAGGCCGAA AAGGUCAA 890 1205 AACAAAGU A UACUGUGG 260
CCACAGUA CUGAUGAGGCCGUUAGGCCGAA ACUUUGUU 891 1207 CAAAGUAU A
CUGUGGAC 261 GUCCACAG CUGAUGAGGCCGUUAGGCCGAA AUACUUUG 892 1223
CAAGAGGU U UGGCAUGG 262 CCAUGCCA CUGAUGAGGCCGUUAGGCCGAA ACCUCUUG
893 1224 AAGAGGUU U GGCAUGGA 263 UCCAUGCC CUGAUGAGGCCGUUAGGCCGAA
AACCUCUU 894 1234 GCAUGGAU U UUAAAGAA 264 UUCUUUAA
CUGAUGAGGCCGUUAGGCCGAA AUCCAUGC 895 1235 CAUGGAUU U UAAAGAAA 265
UUUCUUUA CUGAUGAGGCCGUUAGGCCGAA AAUCCAUG 896 1236 AUGGAUUU U
AAAGAAAU 266 AUUUCUUU CUGAUGAGGCCGUUAGGCCGAA AAAUCCAU 897 1237
UGGAUUUU A AAGAAAUA 267 UAUUUCUU CUGAUGAGGCCGUUAGGCCGAA AAAAUCCA
898 1245 AAAGAAAU A GAAUUAAU 268 AUUAAUUC CUGAUGAGGCCGUUAGGCCGAA
AUUUCUUU 899 1250 AAUAGAAU U AAUUGGCU 269 AGCCAAUU
CUGAUGAGGCCGUUAGGCCGAA AUUCUAUU 900 1251 AUAGAAUU A AUUGGCUC 270
GAGCCAAU CUGAUGAGGCCGUUAGGCCGAA AAUUCUAU 901 1254 GAAUUAAU U
GGCUCAGG 271 CCUGAGCC CUGAUGAGGCCGUUAGGCCGAA AUUAAUUC 902 1259
AAUUGGCU C AGGUGGAU 272 AUCCACCU CUGAUGAGGCCGUUAGGCCGAA AGCCAAUU
903 1268 AGGUGGAU U UGGCCAAG 273 CUUGGCCA CUGAUGAGGCCGUUAGGCCGAA
AUCCACCU 904 1269 GGUGGAUU U GGCCAAGU 274 ACUUGGCC
CUGAUGAGGCCGUUAGGCCGAA AAUCCACC 905 1278 GGCCAAGU U UUCAAAGC 275
GCUUUGAA CUGAUGAGGCCGUUAGGCCGAA ACUUGGCC 906 1279 GCCAAGUU U
UCAAAGCA 276 UGCUUUGA CUGAUGAGGCCGUUAGGCCGAA AACUUGGC 907 1280
CCAAGUUU U CAAAGCAA 277 UUGCUUUG CUGAUGAGGCCGUUAGGCCGAA AAACUUGG
908 1281 CAAGUUUU C AAAGCAAA 278 UUUGCUUU CUGAUGAGGCCGUUAGGCCGAA
AAAACUUG 909 1299 CACAGAAU U GACGGAAA 279 UUUCCGUC
CUGAUGAGGCCGUUAGGCCGAA AUUCUGUG 910 1312 GAAAGACU U ACGUUAUU 280
AAUAACGU CUGAUGAGGCCGUUAGGCCGAA AGUCUUUC 911 1313 AAAGACUU A
CGUUAUUA 281 UAAUAACG CUGAUGAGGCCGUUAGGCCGAA AAGUCUUU 912 1317
ACUUACGU U AUUAAACG 282 CGUUUAAU CUGAUGAGGCCGUUAGGCCGAA ACGUAAGU
913 1318 CUUACGUU A UUAAACGU 283 ACGUUUAA CUGAUGAGGCCGUUAGGCCGAA
AACGUAAG 914 1320 UACGUUAU U AAACGUGU 284 ACACGUUU
CUGAUGAGGCCGUUAGGCCGAA AUAACGUA 915 1321 ACGUUAUU A AACGUGUU 285
AACACGUU CUGAUGAGGCCGUUAGGCCGAA AAUAACGU 916 1329 AAACGUGU U
AAAUAUAA 286 UUAUAUUU CUGAUGAGGCCGUUAGGCCGAA ACACGUUU 917 1330
AACGUGUU A AAUAUAAU 287 AUUAUAUU CUGAUGAGGCCGUUAGGCCGAA AACACGUU
918 1334 UGUUAAAU A UAAUAACG 288 CGUUAUUA CUGAUGAGGCCGUUAGGCCGAA
AUUUAACA 919 1336 UUAAAUAU A AUAACGAG 289 CUCGUUAU
CUGAUGAGGCCGUUAGGCCGAA AUAUUUAA 920 1339 AAUAUAAU A ACGAGAAG 290
CUUCUCGU CUGAUGAGGCCGUUAGGCCGAA AUUAUAUU 921 1362 CGUGAAGU A
AAAGCAUU 291 AAUGCUUU CUGAUGAGGCCGUUAGGCCGAA ACUUCACG 922 1370
AAAAGCAU U GGCAAAAC 292 GUUUUGCC CUGAUGAGGCCGUUAGGCCGAA AUGCUUUU
923 1380 GCAAAACU U GAUCAUGU 293 ACAUGAUC CUGAUGAGGCCGUUAGGCCGAA
AGUUUUGC 924 1384 AACUUGAU C AUGUAAAU 294 AUUUACAU
CUGAUGAGGCCGUUAGGCCGAA AUCAAGUU 925 1389 GAUCAUGU A AAUAUUGU 295
ACAAUAUU CUGAUGAGGCCGUUAGGCCGAA ACAUGAUC 926 1393 AUGUAAAU A
UUGUUCAC 296 GUGAACAA CUGAUGAGGCCGUUAGGCCGAA AUUUACAU 927 1395
GUAAAUAU U GUUCACUA 297 UAGUGAAC CUGAUGAGGCCGUUAGGCCGAA AUAUUUAC
928 1398 AAUAUUGU U CACUACAA 298 UUGUAGUG CUGAUGAGGCCGUUAGGCCGAA
ACAAUAUU 929 1399 AUAUUGUU C ACUACAAU 299 AUUGUAGU
CUGAUGAGGCCGUUAGGCCGAA AACAAUAU 930 1403 UGUUCACU A CAAUGGCU 300
AGCCAUUG CUGAUGAGGCCGUUAGGCCGAA AGUGAACA 931 1414 AUGGCUGU U
GGGAUGGA 301 UCCAUCCC CUGAUGAGGCCGUUAGGCCGAA ACAGCCAU 932 1424
GGAUGGAU U UGAUUAUG 302 CAUAAUCA CUGAUGAGGCCGUUAGGCCGAA AUCCAUCC
933 1425 GAUGGAUU U GAUUAUGA 303 UCAUAAUC CUGAUGAGGCCGUUAGGCCGAA
AAUCCAUC 934 1429 GAUUUGAU U AUGAUCCU 304 AGGAUCAU
CUGAUGAGGCCGUUAGGCCGAA AUCAAAUC 935 1430 AUUUGAUU A UGAUCCUG 305
CAGGAUCA CUGAUGAGGCCGUUAGGCCGAA AAUCAAAU 936 1435 AUUAUGAU C
CUGAGACC 306 GGUCUCAG CUGAUGAGGCCGUUAGGCCGAA AUCAUAAU 937 1453
GUGAUGAU U CUCUUGAG 307 CUCAAGAG CUGAUGAGGCCGUUAGGCCGAA AUCAUCAC
938 1454 UGAUGAUU C UCUUGAGA 308 UCUCAAGA CUGAUGAGGCCGUUAGGCCGAA
AAUCAUCA 939 1456 AUGAUUCU C UUGAGAGC 309 GCUCUCAA
CUGAUGAGGCCGUUAGGCCGAA AGAAUCAU 940 1458 GAUUCUCU U GAGAGCAG 310
CUGCUCUC CUGAUGAGGCCGUUAGGCCGAA AGAGAAUC 941 1471 GCAGUGAU U
AUGAUCCU 311 AGGAUCAU CUGAUGAGGCCGUUAGGCCGAA AUCACUGC 942 1472
CAGUGAUU A UGAUCCUG 312 CAGGAUCA CUGAUGAGGCCGUUAGGCCGAA AAUCACUG
943 1477 AUUAUGAU C CUGAGAAC 313 GUUCUCAG CUGAUGAGGCCGUUAGGCCGAA
AUCAUAAU 944 1495 GCAAAAAU A GUUCAAGG 314 CCUUGAAC
CUGAUGAGGCCGUUAGGCCGAA AUUUUUGC 945 1498 AAAAUAGU U CAAGGUCA 315
UGACCUUG CUGAUGAGGCCGUUAGGCCGAA ACUAUUUU 946 1499 AAAUAGUU C
AAGGUCAA 316 UUGACCUU CUGAUGAGGCCGUUAGGCCGAA AACUAUUU 947 1505
UUCAAGGU C AAAGACUA 317 UAGUCUUU CUGAUGAGGCCGUUAGGCCGAA ACCUUGAA
948 1513 CAAAGACU A AGUGCCUU 318 AAGGCACU CUGAUGAGGCCGUUAGGCCGAA
AGUCUUUG 949 1521 AAGUGCCU U UUCAUCCA 319 UGGAUGAA
CUGAUGAGGCCGUUAGGCCGAA AGGCACUU 950 1522 AGUGCCUU U UCAUCCAA 320
UUGGAUGA CUGAUGAGGCCGUUAGGCCGAA AAGGCACU 951 1523 GUGCCUUU U
CAUCCAAA 321 UUUGGAUG CUGAUGAGGCCGUUAGGCCGAA AAAGGCAC 952 1524
UGCCUUUU C AUCCAAAU 322 AUUUGGAU CUGAUGAGGCCGUUAGGCCGAA AAAAGGCA
953 1527 CUUUUCAU C CAAAUGGA 323 UCCAUUUG CUGAUGAGGCCGUUAGGCCGAA
AUGAAAAG 954 1538 AAUGGAAU U CUGUGAUA 324 UAUCACAG
CUGAUGAGGCCGUUAGGCCGAA AUUCCAUU 955 1539 AUGGAAUU C UGUGAUAA 325
UUAUCACA CUGAUGAGGCCGUUAGGCCGAA AAUUCCAU 956 1546 UCUGUGAU A
AAGGGACC 326 GGUCCCUU CUGAUGAGGCCGUUAGGCCGAA AUCACAGA 957 1556
AGGGACCU U GGAACAAU 327 AUUGUUCC CUGAUGAGGCCGUUAGGCCGAA AGGUCCCU
958 1569 CAAUGGAU U GAAAAAAG 328 CUUUUUUC CUGAUGAGGCCGUUAGGCCGAA
AUCCAUUG 959 1593 GAGAAACU A GACAAAGU 329 ACUUUGUC
CUGAUGAGGCCGUUAGGCCGAA AGUUUCUC 960 1602 GACAAAGU U UUGGCUUU 330
AAAGCCAA CUGAUGAGGCCGUUAGGCCGAA ACUUUGUC 961 1603 ACAAAGUU U
UGGCUUUG 331 CAAAGCCA CUGAUGAGGCCGUUAGGCCGAA AACUUUGU 962 1604
CAAAGUUU U GGCUUUGG 332 CCAAAGCC CUGAUGAGGCCGUUAGGCCGAA AAACUUUG
963 1609 UUUUGGCU U UGGAACUC 333 GAGUUCCA CUGAUGAGGCCGUUAGGCCGAA
AGCCAAAA 964 1610 UUUGGCUU U GGAACUCU 334 AGAGUUCC
CUGAUGAGGCCGUUAGGCCGAA AAGCCAAA 965 1617 UUGGAACU C UUUGAACA 335
UGUUCAAA CUGAUGAGGCCGUUAGGCCGAA AGUUCCAA 966 1619 GGAACUCU U
UGAACAAA 336 UUUGUUCA CUGAUGAGGCCGUUAGGCCGAA AGAGUUCC 967 1620
GAACUCUU U GAACAAAU 337 AUUUGUUC CUGAUGAGGCCGUUAGGCCGAA AAGAGUUC
968 1629 GAACAAAU A ACAAAAGG 338 CCUUUUGU CUGAUGAGGCCGUUAGGCCGAA
AUUUGUUC 969 1645 GGGUGGAU U AUAUACAU 339 AUGUAUAU
CUGAUGAGGCCGUUAGGCCGAA AUCCACCC 970 1646 GGUGGAUU A UAUACAUU 340
AAUGUAUA CUGAUGAGGCCGUUAGGCCGAA AAUCCACC 971 1648 UGGAUUAU A
UACAUUCA 341 UGAAUGUA CUGAUGAGGCCGUUAGGCCGAA AUAAUCCA 972 1650
GAUUAUAU A CAUUCAAA 342 UUUGAAUG CUGAUGAGGCCGUUAGGCCGAA AUAUAAUC
973 1654 AUAUACAU U CAAAAAAA 343 UUUUUUUG CUGAUGAGGCCGUUAGGCCGAA
AUGUAUAU 974 1655 UAUACAUU C AAAAAAAU 344 AUUUUUUU
CUGAUGAGGCCGUUAGGCCGAA AAUGUAUA 975 1664 AAAAAAAU U AAUUCAUA 345
UAUGAAUU CUGAUGAGGCCGUUAGGCCGAA AUUUUUUU 976 1665 AAAAAAUU A
AUUCAUAG 346 CUAUGAAU CUGAUGAGGCCGUUAGGCCGAA AAUUUUUU 977 1668
AAAUUAAU U CAUAGAGA 347 UCUCUAUG CUGAUGAGGCCGUUAGGCCGAA AUUAAUUU
978 1669 AAUUAAUU C AUAGAGAU 348 AUCUCUAU CUGAUGAGGCCGUUAGGCCGAA
AAUUAAUU 979 1672 UAAUUCAU A GAGAUCUU 349 AAGAUCUC
CUGAUGAGGCCGUUAGGCCGAA AUGAAUUA 980 1678 AUAGAGAU C UUAAGCCA 350
UGGCUUAA CUGAUGAGGCCGUUAGGCCGAA AUCUCUAU 981 1680 AGAGAUCU U
AAGCCAAG 351 CUUGGCUU CUGAUGAGGCCGUUAGGCCGAA AGAUCUCU 982 1681
GAGAUCUU A AGCCAAGU 352 ACUUGGCU CUGAUGAGGCCGUUAGGCCGAA AAGAUCUC
983 1690 AGCCAAGU A AUAUAUUC 353 GAAUAUAU CUGAUGAGGCCGUUAGGCCGAA
ACUUGGCU 984 1693 CAAGUAAU A UAUUCUUA 354 UAAGAAUA
CUGAUGAGGCCGUUAGGCCGAA AUUACUUG 985 1695 AGUAAUAU A UUCUUAGU 355
ACUAAGAA CUGAUGAGGCCGUUAGGCCGAA AUAUUACU 986 1697 UAAUAUAU U
CUUAGUAG 356 CUACUAAG CUGAUGAGGCCGUUAGGCCGAA AUAUAUUA 987 1698
AAUAUAUU C UUAGUAGA 357 UCUACUAA CUGAUGAGGCCGUUAGGCCGAA AAUAUAUU
988 1700 UAUAUUCU U AGUAGAUA 358 UAUCUACU CUGAUGAGGCCGUUAGGCCGAA
AGAAUAUA 989 1701 AUAUUCUU A GUAGAUAC 359 GUAUCUAC
CUGAUGAGGCCGUUAGGCCGAA AAGAAUAU 990 1704 UUCUUAGU A GAUACAAA 360
UUUGUAUC CUGAUGAGGCCGUUAGGCCGAA ACUAAGAA 991 1708 UAGUAGAU A
CAAAACAA 361 UUGUUUUG CUGAUGAGGCCGUUAGGCCGAA AUCUACUA 992 1719
AAACAAGU A AAGAUUGG 362 CCAAUCUU CUGAUGAGGCCGUUAGGCCGAA ACUUGUUU
993 1725 GUAAAGAU U GGAGACUU 363 AAGUCUCC CUGAUGAGGCCGUUAGGCCGAA
AUCUUUAC 994 1733 UGGAGACU U UGGACUUG 364 CAAGUCCA
CUGAUGAGGCCGUUAGGCCGAA AGUCUCCA 995 1734 GGAGACUU U GGACUUGU 365
ACAAGUCC CUGAUGAGGCCGUUAGGCCGAA AAGUCUCC 996 1740 UUUGGACU U
GUAACAUC 366 GAUGUUAC CUGAUGAGGCCGUUAGGCCGAA AGUCCAAA 997 1743
GGACUUGU A ACAUCUCU 367 AGAGAUGU CUGAUGAGGCCGUUAGGCCGAA ACAAGUCC
998 1748 UGUAACAU C UCUGAAAA 368 UUUUCAGA CUGAUGAGGCCGUUAGGCCGAA
AUGUUACA 999 1750 UAACAUCU C UGAAAAAU 369 AUUUUUCA
CUGAUGAGGCCGUUAGGCCGAA AGAUGUUA 1000 1780 CAAGGAGU A AGGGAACU 370
AGUUCCCU CUGAUGAGGCCGUUAGGCCGAA ACUCCUUG 1001 1789 AGGGAACU U
UGCGAUAC 371 GUAUCGCA CUGAUGAGGCCGUUAGGCCGAA AGUUCCCU 1002
1790 GGGAACUU U GCGAUACA 372 UGUAUCGC CUGAUGAGGCCGUUAGGCCGAA
AAGUUCCC 1003 1796 UUUGCGAU A CAUGAGCC 373 GGCUCAUG
CUGAUGAGGCCGUUAGGCCGAA AUCGCAAA 1004 1815 GAACAGAU U UCUUCGCA 374
UGCGAAGA CUGAUGAGGCCGUUAGGCCGAA AUCUGUUC 1005 1816 AACAGAUU U
CUUCGCAA 375 UUGCGAAG CUGAUGAGGCCGUUAGGCCGAA AAUCUGUU 1006 1817
ACAGAUUU C UUCGCAAG 376 CUUGCGAA CUGAUGAGGCCGUUAGGCCGAA AAAUCUGU
1007 1819 AGAUUUCU U CGCAAGAC 377 GUCUUGCG CUGAUGAGGCCGUUAGGCCGAA
AGAAAUCU 1008 1820 GAUUUCUU C GCAAGACU 378 AGUCUUGC
CUGAUGAGGCCGUUAGGCCGAA AAGAAAUC 1009 1829 GCAAGACU A UGGAAAGG 379
CCUUUCCA CUGAUGAGGCCGUUAGGCCGAA AGUCUUGC 1010 1848 GUGGACCU C
UACGCUUU 380 AAAGCGUA CUGAUGAGGCCGUUAGGCCGAA AGGUCCAC 1011 1850
GGACCUCU A CGCUUUGG 381 CCAAAGCG CUGAUGAGGCCGUUAGGCCGAA AGAGGUCC
1012 1855 UCUACGCU U UGGGGCUA 382 UAGCCCCA CUGAUGAGGCCGUUAGGCCGAA
AGCGUAGA 1013 1856 CUACGCUU U GGGGCUAA 383 UUAGCCCC
CUGAUGAGGCCGUUAGGCCGAA AAGCGUAG 1014 1863 UUGGGGCU A AUUCUUGC 384
GCAAGAAU CUGAUGAGGCCGUUAGGCCGAA AGCCCCAA 1015 1866 GGGCUAAU U
CUUGCUGA 385 UCAGCAAG CUGAUGAGGCCGUUAGGCCGAA AUUAGCCC 1016 1867
GGCUAAUU C UUGCUGAA 386 UUCAGCAA CUGAUGAGGCCGUUAGGCCGAA AAUUAGCC
1017 1869 CUAAUUCU U GCUGAACU 387 AGUUCAGC CUGAUGAGGCCGUUAGGCCGAA
AGAAUUAG 1018 1878 GCUGAACU U CUUCAUGU 388 ACAUGAAG
CUGAUGAGGCCGUUAGGCCGAA AGUUCAGC 1019 1879 CUGAACUU C UUCAUGUA 389
UACAUGAA CUGAUGAGGCCGUUAGGCCGAA AAGUUCAG 1020 1881 GAACUUCU U
CAUGUAUG 390 CAUACAUG CUGAUGAGGCCGUUAGGCCGAA AGAAGUUC 1021 1882
AACUUCUU C AUGUAUGU 391 ACAUACAU CUGAUGAGGCCGUUAGGCCGAA AAGAAGUU
1022 1887 CUUCAUGU A UGUGACAC 392 GUGUCACA CUGAUGAGGCCGUUAGGCCGAA
ACAUGAAG 1023 1900 ACACUGCU U UUGAAACA 393 UGUUUCAA
CUGAUGAGGCCGUUAGGCCGAA AGCAGUGU 1024 1901 CACUGCUU U UGAAACAU 394
AUGUUUCA CUGAUGAGGCCGUUAGGCCGAA AAGCAGUG 1025 1902 ACUGCUUU U
GAAACAUC 395 GAUGUUUC CUGAUGAGGCCGUUAGGCCGAA AAAGCAGU 1026 1910
UGAAACAU C AAAGUUUU 396 AAAACUUU CUGAUGAGGCCGUUAGGCCGAA AUGUUUCA
1027 1916 AUCAAAGU U UUUCACAG 397 CUGUGAAA CUGAUGAGGCCGUUAGGCCGAA
ACUUUGAU 1028 1917 UCAAAGUU U UUCACAGA 398 UCUGUGAA
CUGAUGAGGCCGUUAGGCCGAA AACUUUGA 1029 1918 CAAAGUUU U UCACAGAC 399
GUCUGUGA CUGAUGAGGCCGUUAGGCCGAA AAACUUUG 1030 1919 AAAGUUUU U
CACAGACC 400 GGUCUGUG CUGAUGAGGCCGUUAGGCCGAA AAAACUUU 1031 1920
AAGUUUUU C ACAGACCU 401 AGGUCUGU CUGAUGAGGCCGUUAGGCCGAA AAAAACUU
1032 1929 ACAGACCU A CGGGAUGG 402 CCAUCCCG CUGAUGAGGCCGUUAGGCCGAA
AGGUCUGU 1033 1941 GAUGGCAU C AUCUCAGA 403 UCUGAGAU
CUGAUGAGGCCGUUAGGCCGAA AUGCCAUC 1034 1944 GGCAUCAU C UCAGAUAU 404
AUAUCUGA CUGAUGAGGCCGUUAGGCCGAA AUGAUGCC 1035 1946 CAUCAUCU C
AGAUAUAU 405 AUAUAUCU CUGAUGAGGCCGUUAGGCCGAA AGAUGAUG 1036 1951
UCUCAGAU A UAUUUGAU 406 AUCAAAUA CUGAUGAGGCCGUUAGGCCGAA AUCUGAGA
1037 1953 UCAGAUAU A UUUGAUAA 407 UUAUCAAA CUGAUGAGGCCGUUAGGCCGAA
AUAUCUGA 1038 1955 AGAUAUAU U UGAUAAAA 408 UUUUAUCA
CUGAUGAGGCCGUUAGGCCGAA AUAUAUCU 1039 1956 GAUAUAUU U GAUAAAAA 409
UUUUUAUC CUGAUGAGGCCGUUAGGCCGAA AAUAUAUC 1040 1960 UAUUUGAU A
AAAAAGAA 410 UUCUUUUU CUGAUGAGGCCGUUAGGCCGAA AUCAAAUA 1041 1975
AAAAAACU C UUCUACAG 411 CUGUAGAA CUGAUGAGGCCGUUAGGCCGAA AGUUUUUU
1042 1977 AAAACUCU U CUACAGAA 412 UUCUGUAG CUGAUGAGGCCGUUAGGCCGAA
AGAGUUUU 1043 1978 AAACUCUU C UACAGAAA 413 UUUCUGUA
CUGAUGAGGCCGUUAGGCCGAA AAGAGUUU 1044 1980 ACUCUUCU A CAGAAAUU 414
AAUUUCUG CUGAUGAGGCCGUUAGGCCGAA AGAAGAGU 1045 1988 ACAGAAAU U
ACUCUCAA 415 UUGAGAGU CUGAUGAGGCCGUUAGGCCGAA AUUUCUGU 1046 1989
CAGAAAUU A CUCUCAAA 416 UUUGAGAG CUGAUGAGGCCGUUAGGCCGAA AAUUUCUG
1047 1992 AAAUUACU C UCAAAGAA 417 UUCUUUGA CUGAUGAGGCCGUUAGGCCGAA
AGUAAUUU 1048 1994 AUUACUCU C AAAGAAAC 418 GUUUCUUU
CUGAUGAGGCCGUUAGGCCGAA AGAGUAAU 1049 2011 CUGAGGAU C GACCUAAC 419
GUUAGGUC CUGAUGAGGCCGUUAGGCCGAA AUCCUCAG 1050 2017 AUCGACCU A
ACACAUCU 420 AGAUGUGU CUGAUGAGGCCGUUAGGCCGAA AGGUCGAU 1051 2024
UAACACAU C UGAAAUAC 421 GUAUUUCA CUGAUGAGGCCGUUAGGCCGAA AUGUGUUA
1052 2031 UCUGAAAU A CUAAGGAC 422 GUCCUUAG CUGAUGAGGCCGUUAGGCCGAA
AUUUCAGA 1053 2034 GAAAUACU A AGGACCUU 423 AAGGUCCU
CUGAUGAGGCCGUUAGGCCGAA AGUAUUUC 1054 2042 AAGGACCU U GACUGUGU 424
ACACAGUC CUGAUGAGGCCGUUAGGCCGAA AGGUCCUU 1055 2089 ACACAUGU U
AGAGCCCU 425 AGGGCUCU CUGAUGAGGCCGUUAGGCCGAA ACAUGUGU 1056 2090
CACAUGUU A GAGCCCUU 426 AAGGGCUC CUGAUGAGGCCGUUAGGCCGAA AACAUGUG
1057 2098 AGAGCCCU U CUGAAAAA 427 UUUUUCAG CUGAUGAGGCCGUUAGGCCGAA
AGGGCUCU 1058 2099 GAGCCCUU C UGAAAAAG 428 CUUUUUCA
CUGAUGAGGCCGUUAGGCCGAA AAGGGCUC 1059 2109 GAAAAAGU A UCCUGCUU 429
AAGCAGGA CUGAUGAGGCCGUUAGGCCGAA ACUUUUUC 1060 2111 AAAAGUAU C
CUGCUUCU 430 AGAAGCAG CUGAUGAGGCCGUUAGGCCGAA AUACUUUU 1061 2117
AUCCUGCU U CUGAUAUG 431 CAUAUCAG CUGAUGAGGCCGUUAGGCCGAA AGCAGGAU
1062 2118 UCCUGCUU C UGAUAUGC 432 GCAUAUCA CUGAUGAGGCCGUUAGGCCGAA
AAGCAGGA 1063 2123 CUUCUGAU A UGCAGUUU 433 AAACUGCA
CUGAUGAGGCCGUUAGGCCGAA AUCAGAAG 1064 2130 UAUGCAGU U UUCCUUAA 434
UUAAGGAA CUGAUGAGGCCGUUAGGCCGAA ACUGCAUA 1065 2131 AUGCAGUU U
UCCUUAAA 435 UUUAAGGA CUGAUGAGGCCGUUAGGCCGAA AACUGCAU 1066 2132
UGCAGUUU U CCUUAAAU 436 AUUUAAGG CUGAUGAGGCCGUUAGGCCGAA AAACUGCA
1067 2133 GCAGUUUU C CUUAAAUU 437 AAUUUAAG CUGAUGAGGCCGUUAGGCCGAA
AAAACUGC 1068 2136 GUUUUCCU U AAAUUAUC 438 GAUAAUUU
CUGAUGAGGCCGUUAGGCCGAA AGGAAAAC 1069 2137 UUUUCCUU A AAUUAUCU 439
AGAUAAUU CUGAUGAGGCCGUUAGGCCGAA AAGGAAAA 1070 2141 CCUUAAAU U
AUCUAAAA 440 UUUUAGAU CUGAUGAGGCCGUUAGGCCGAA AUUUAAGG 1071 2142
CUUAAAUU A UCUAAAAU 441 AUUUUAGA CUGAUGAGGCCGUUAGGCCGAA AAUUUAAG
1072 2144 UAAAUUAU C UAAAAUCU 442 AGAUUUUA CUGAUGAGGCCGUUAGGCCGAA
AUAAUUUA 1073 2146 AAUUAUCU A AAAUCUGC 443 GCAGAUUU
CUGAUGAGGCCGUUAGGCCGAA AGAUAAUU 1074 2151 UCUAAAAU C UGCUAGGG 444
CCCUAGCA CUGAUGAGGCCGUUAGGCCGAA AUUUUAGA 1075 2156 AAUCUGCU A
GGGAAUAU 445 AUAUUCCC CUGAUGAGGCCGUUAGGCCGAA AGCAGAUU 1076 2163
UAGGGAAU A UCAAUAGA 446 UCUAUUGA CUGAUGAGGCCGUUAGGCCGAA AUUCCCUA
1077 2165 GGGAAUAU C AAUAGAUA 447 UAUCUAUU CUGAUGAGGCCGUUAGGCCGAA
AUAUUCCC 1078 2169 AUAUCAAU A GAUAUUUA 448 UAAAUAUC
CUGAUGAGGCCGUUAGGCCGAA AUUGAUAU 1079 2173 CAAUAGAU A UUUACCUU 449
AAGGUAAA CUGAUGAGGCCGUUAGGCCGAA AUCUAUUG 1080 2175 AUAGAUAU U
UACCUUUU 450 AAAAGGUA CUGAUGAGGCCGUUAGGCCGAA AUAUCUAU 1081 2176
UAGAUAUU U ACCUUUUA 451 UAAAAGGU CUGAUGAGGCCGUUAGGCCGAA AAUAUCUA
1082 2177 AGAUAUUU A CCUUUUAU 452 AUAAAAGG CUGAUGAGGCCGUUAGGCCGAA
AAAUAUCU 1083 2181 AUUUACCU U UUAUUUUA 453 UAAAAUAA
CUGAUGAGGCCGUUAGGCCGAA AGGUAAAU 1084 2182 UUUACCUU U UAUUUUAA 454
UUAAAAUA CUGAUGAGGCCGUUAGGCCGAA AAGGUAAA 1085 2183 UUACCUUU U
AUUUUAAU 455 AUUAAAAU CUGAUGAGGCCGUUAGGCCGAA AAAGGUAA 1086
2184 UACCUUUU A UUUUAAUG 456 CAUUAAAA CUGAUGAGGCCGUUAGGCCGAA
AAAAGGUA 1087 2186 CCUUUUAU U UUAAUGUU 457 AACAUUAA
CUGAUGAGGCCGUUAGGCCGAA AUAAAAGG 1088 2187 CUUUUAUU U UAAUGUUU 458
AAACAUUA CUGAUGAGGCCGUUAGGCCGAA AAUAAAAG 1089 2188 UUUUAUUU U
AAUGUUUC 459 GAAACAUU CUGAUGAGGCCGUUAGGCCGAA AAAUAAAA 1090 2189
UUUAUUUU A AUGUUUCC 460 GGAAACAU CUGAUGAGGCCGUUAGGCCGAA AAAAUAAA
1091 2194 UUUAAUGU U UCCUUUAA 461 UUAAAGGA CUGAUGAGGCCGUUAGGCCGAA
ACAUUAAA 1092 2195 UUAAUGUU U CCUUUAAU 462 AUUAAAGG
CUGAUGAGGCCGUUAGGCCGAA AACAUUAA 1093 2196 UAAUGUUU C CUUUAAUU 463
AAUUAAAG CUGAUGAGGCCGUUAGGCCGAA AAACAUUA 1094 2199 UGUUUCCU U
UAAUUUUU 464 AAAAAUUA CUGAUGAGGCCGUUAGGCCGAA AGGAAACA 1095 2200
GUUUCCUU U AAUUUUUU 465 AAAAAAUU CUGAUGAGGCCGUUAGGCCGAA AAGGAAAC
1096 2201 UUUCCUUU A AUUUUUUA 466 UAAAAAAU CUGAUGAGGCCGUUAGGCCGAA
AAAGGAAA 1097 2204 CCUUUAAU U UUUUACUA 467 UAGUAAAA
CUGAUGAGGCCGUUAGGCCGAA AUUAAAGG 1098 2205 CUUUAAUU U UUUACUAU 468
AUAGUAAA CUGAUGAGGCCGUUAGGCCGAA AAUUAAAG 1099 2206 UUUAAUUU U
UUACUAUU 469 AAUAGUAA CUGAUGAGGCCGUUAGGCCGAA AAAUUAAA 1100 2207
UUAAUUUU U UACUAUUU 470 AAAUAGUA CUGAUGAGGCCGUUAGGCCGAA AAAAUUAA
1101 2208 UAAUUUUU U ACUAUUUU 471 AAAAUAGU CUGAUGAGGCCGUUAGGCCGAA
AAAAAUUA 1102 2209 AAUUUUUU A CUAUUUUU 472 AAAAAUAG
CUGAUGAGGCCGUUAGGCCGAA AAAAAAUU 1103 2212 UUUUUACU A UUUUUACU 473
AGUAAAAA CUGAUGAGGCCGUUAGGCCGAA AGUAAAAA 1104 2214 UUUACUAU U
UUUACUAA 474 UUAGUAAA CUGAUGAGGCCGUUAGGCCGAA AUAGUAAA 1105 2215
UUACUAUU U UUACUAAU 475 AUUAGUAA CUGAUGAGGCCGUUAGGCCGAA AAUAGUAA
1106 2216 UACUAUUU U UACUAAUC 476 GAUUAGUA CUGAUGAGGCCGUUAGGCCGAA
AAAUAGUA 1107 2217 ACUAUUUU U ACUAAUCU 477 AGAUUAGU
CUGAUGAGGCCGUUAGGCCGAA AAAAUAGU 1108 2218 CUAUUUUU A CUAAUCUU 478
AAGAUUAG CUGAUGAGGCCGUUAGGCCGAA AAAAAUAG 1109 2221 UUUUUACU A
AUCUUUCU 479 AGAAAGAU CUGAUGAGGCCGUUAGGCCGAA AGUAAAAA 1110 2224
UUACUAAU C UUUCUGCA 480 UGCAGAAA CUGAUGAGGCCGUUAGGCCGAA AUUAGUAA
1111 2226 ACUAAUCU U UCUGCAGA 481 UCUGCAGA CUGAUGAGGCCGUUAGGCCGAA
AGAUUAGU 1112 2227 CUAAUCUU U CUGCAGAA 482 UUCUGCAG
CUGAUGAGGCCGUUAGGCCGAA AAGAUUAG 1113 2228 UAAUCUUU C UGCAGAAA 483
UUUCUGCA CUGAUGAGGCCGUUAGGCCGAA AAAGAUUA 1114 2246 AGAAAGGU U
UUCUUCUU 484 AAGAAGAA CUGAUGAGGCCGUUAGGCCGAA ACCUUUCU 1115 2247
GAAAGGUU U UCUUCUUU 485 AAAGAAGA CUGAUGAGGCCGUUAGGCCGAA AACCUUUC
1116 2248 AAAGGUUU U CUUCUUUU 486 AAAAGAAG CUGAUGAGGCCGUUAGGCCGAA
AAACCUUU 1117 2249 AAGGUUUU C UUCUUUUU 487 AAAAAGAA
CUGAUGAGGCCGUUAGGCCGAA AAAACCUU 1118 2251 GGUUUUCU U CUUUUUGC 488
GCAAAAAG CUGAUGAGGCCGUUAGGCCGAA AGAAAACC 1119 2252 GUUUUCUU C
UUUUUGCU 489 AGCAAAAA CUGAUGAGGCCGUUAGGCCGAA AAGAAAAC 1120 2254
UUUCUUCU U UUUGCUUC 490 GAAGCAAA CUGAUGAGGCCGUUAGGCCGAA AGAAGAAA
1121 2255 UUCUUCUU U UUGCUUCA 491 UGAAGCAA CUGAUGAGGCCGUUAGGCCGAA
AAGAAGAA 1122 2256 UCUUCUUU U UGCUUCAA 492 UUGAAGCA
CUGAUGAGGCCGUUAGGCCGAA AAAGAAGA 1123 2257 CUUCUUUU U GCUUCAAA 493
UUUGAAGC CUGAUGAGGCCGUUAGGCCGAA AAAAGAAG 1124 2261 UUUUUGCU U
CAAAAACA 494 UGUUUUUG CUGAUGAGGCCGUUAGGCCGAA AGCAAAAA 1125 2262
UUUUGCUU C AAAAACAU 495 AUGUUUUU CUGAUGAGGCCGUUAGGCCGAA AAGCAAAA
1126 2271 AAAAACAU U CUUACAUU 496 AAUGUAAG CUGAUGAGGCCGUUAGGCCGAA
AUGUUUUU 1127 2272 AAAACAUU C UUACAUUU 497 AAAUGUAA
CUGAUGAGGCCGUUAGGCCGAA AAUGUUUU 1128 2274 AACAUUCU U ACAUUUUA 498
UAAAAUGU CUGAUGAGGCCGUUAGGCCGAA AGAAUGUU 1129 2275 ACAUUCUU A
CAUUUUAC 499 GUAAAAUG CUGAUGAGGCCGUUAGGCCGAA AAGAAUGU 1130 2279
UCUUACAU U UUACUUUU 500 AAAAGUAA CUGAUGAGGCCGUUAGGCCGAA AUGUAAGA
1131 2280 CUUACAUU U UACUUUUU 501 AAAAAGUA CUGAUGAGGCCGUUAGGCCGAA
AAUGUAAG 1132 2281 UUACAUUU U ACUUUUUC 502 GAAAAAGU
CUGAUGAGGCCGUUAGGCCGAA AAAUGUAA 1133 2282 UACAUUUU A CUUUUUCC 503
GGAAAAAG CUGAUGAGGCCGUUAGGCCGAA AAAAUGUA 1134 2285 AUUUUACU U
UUUCCUGG 504 CCAGGAAA CUGAUGAGGCCGUUAGGCCGAA AGUAAAAU 1135 2286
UUUUACUU U UUCCUGGC 505 GCCAGGAA CUGAUGAGGCCGUUAGGCCGAA AAGUAAAA
1136 2287 UUUACUUU U UCCUGGCU 506 AGCCAGGA CUGAUGAGGCCGUUAGGCCGAA
AAAGUAAA 1137 2288 UUACUUUU U CCUGGCUC 507 GAGCCAGG
CUGAUGAGGCCGUUAGGCCGAA AAAAGUAA 1138 2289 UACUUUUU C CUGGCUCA 508
UGAGCCAG CUGAUGAGGCCGUUAGGCCGAA AAAAAGUA 1139 2296 UCCUGGCU C
AUCUCUUU 509 AAAGAGAU CUGAUGAGGCCGUUAGGCCGAA AGCCAGGA 1140 2299
UGGCUCAU C UCUUUAUU 510 AAUAAAGA CUGAUGAGGCCGUUAGGCCGAA AUGAGCCA
1141 2301 GCUCAUCU C UUUAUUCU 511 AGAAUAAA CUGAUGAGGCCGUUAGGCCGAA
AGAUGAGC 1142 2303 UCAUCUCU U UAUUCUUU 512 AAAGAAUA
CUGAUGAGGCCGUUAGGCCGAA AGAGAUGA 1143 2304 CAUCUCUU U AUUCUUUU 513
AAAAGAAU CUGAUGAGGCCGUUAGGCCGAA AAGAGAUG 1144 2305 AUCUCUUU A
UUCUUUUU 514 AAAAAGAA CUGAUGAGGCCGUUAGGCCGAA AAAGAGAU 1145 2307
CUCUUUAU U CUUUUUUU 515 AAAAAAAG CUGAUGAGGCCGUUAGGCCGAA AUAAAGAG
1146 2308 UCUUUAUU C UUUUUUUU 516 AAAAAAAA CUGAUGAGGCCGUUAGGCCGAA
AAUAAAGA 1147 2310 UUUAUUCU U UUUUUUUU 517 AAAAAAAA
CUGAUGAGGCCGUUAGGCCGAA AGAAUAAA 1148 2311 UUAUUCUU U UUUUUUUU 518
AAAAAAAA CUGAUGAGGCCGUUAGGCCGAA AAGAAUAA 1149 2312 UAUUCUUU U
UUUUUUUU 519 AAAAAAAA CUGAUGAGGCCGUUAGGCCGAA AAAGAAUA 1150 2313
AUUCUUUU U UUUUUUUU 520 AAAAAAAA CUGAUGAGGCCGUUAGGCCGAA AAAAGAAU
1151 2314 UUCUUUUU U UUUUUUUU 521 AAAAAAAA CUGAUGAGGCCGUUAGGCCGAA
AAAAAGAA 1152 2315 UCUUUUUU U UUUUUUUA 522 UAAAAAAA
CUGAUGAGGCCGUUAGGCCGAA AAAAAAGA 1153 2316 CUUUUUUU U UUUUUUAA 523
UUAAAAAA CUGAUGAGGCCGUUAGGCCGAA AAAAAAAG 1154 2317 UUUUUUUU U
UUUUUAAA 524 UUUAAAAA CUGAUGAGGCCGUUAGGCCGAA AAAAAAAA 1155 2318
UUUUUUUU U UUUUAAAG 525 CUUUAAAA CUGAUGAGGCCGUUAGGCCGAA AAAAAAAA
1156 2319 UUUUUUUU U UUUAAAGA 526 UCUUUAAA CUGAUGAGGCCGUUAGGCCGAA
AAAAAAAA 1157 2320 UUUUUUUU U UUAAAGAC 527 GUCUUUAA
CUGAUGAGGCCGUUAGGCCGAA AAAAAAAA 1158 2321 UUUUUUUU U UAAAGACA 528
UGUCUUUA CUGAUGAGGCCGUUAGGCCGAA AAAAAAAA 1159 2322 UUUUUUUU U
AAAGACAG 529 CUGUCUUU CUGAUGAGGCCGUUAGGCCGAA AAAAAAAA 1160 2323
UUUUUUUU A AAGACAGA 530 UCUGUCUU CUGAUGAGGCCGUUAGGCCGAA AAAAAAAA
1161 2334 GACAGAGU C UCGCUCUG 531 CAGAGCGA CUGAUGAGGCCGUUAGGCCGAA
ACUCUGUC 1162 2336 CAGAGUCU C GCUCUGUU 532 AACAGAGC
CUGAUGAGGCCGUUAGGCCGAA AGACUCUG 1163 2340 GUCUCGCU C UGUUGCCC 533
GGGCAACA CUGAUGAGGCCGUUAGGCCGAA AGCGAGAC 1164 2344 CGCUCUGU U
GCCCAGGC 534 GCCUGGGC CUGAUGAGGCCGUUAGGCCGAA ACAGAGCG 1165 2372
GACACAGU C UUGGCUCA 535 UGAGCCAA CUGAUGAGGCCGUUAGGCCGAA ACUGUGUC
1166 2374 CACAGUCU U GGCUCACU 536 AGUGAGCC CUGAUGAGGCCGUUAGGCCGAA
AGACUGUG 1167 2379 UCUUGGCU C ACUGCAAC 537 GUUGCAGU
CUGAUGAGGCCGUUAGGCCGAA AGCCAAGA 1168 2389 CUGCAACU U CUGCCUCU 538
AGAGGCAG CUGAUGAGGCCGUUAGGCCGAA AGUUGCAG 1169 2390 UGCAACUU C
UGCCUCUU 539 AAGAGGCA CUGAUGAGGCCGUUAGGCCGAA AAGUUGCA 1170
2396 UUCUGCCU C UUGGGUUC 540 GAACCCAA CUGAUGAGGCCGUUAGGCCGAA
AGGCAGAA 1171 2398 CUGCCUCU U GGGUUCAA 541 UUGAACCC
CUGAUGAGGCCGUUAGGCCGAA AGAGGCAG 1172 2403 UCUUGGGU U CAAGUGAU 542
AUCACUUG CUGAUGAGGCCGUUAGGCCGAA ACCCAAGA 1173 2404 CUUGGGUU C
AAGUGAUU 543 AAUCACUU CUGAUGAGGCCGUUAGGCCGAA AACCCAAG 1174 2412
CAAGUGAU U CUCCUGCC 544 GGCAGGAG CUGAUGAGGCCGUUAGGCCGAA AUCACUUG
1175 2413 AAGUGAUU C UCCUGCCU 545 AGGCAGGA CUGAUGAGGCCGUUAGGCCGAA
AAUCACUU 1176 2415 GUGAUUCU C CUGCCUCA 546 UGAGGCAG
CUGAUGAGGCCGUUAGGCCGAA AGAAUCAC 1177 2422 UCCUGCCU C AGCCUCCU 547
AGGAGGCU CUGAUGAGGCCGUUAGGCCGAA AGGCAGGA 1178 2428 CUCAGCCU C
CUGAGUAG 548 CUACUCAG CUGAUGAGGCCGUUAGGCCGAA AGGCUGAG 1179 2435
UCCUGAGU A GCUGGAUU 549 AAUCCAGC CUGAUGAGGCCGUUAGGCCGAA ACUCAGGA
1180 2443 AGCUGGAU U ACAGGCAU 550 AUGCCUGU CUGAUGAGGCCGUUAGGCCGAA
AUCCAGCU 1181 2444 GCUGGAUU A CAGGCAUG 551 CAUGCCUG
CUGAUGAGGCCGUUAGGCCGAA AAUCCAGC 1182 2469 ACCCAACU A AUUUUUGU 552
ACAAAAAU CUGAUGAGGCCGUUAGGCCGAA AGUUGGGU 1183 2472 CAACUAAU U
UUUGUGUU 553 AACACAAA CUGAUGAGGCCGUUAGGCCGAA AUUAGUUG 1184 2473
AACUAAUU U UUGUGUUU 554 AAACACAA CUGAUGAGGCCGUUAGGCCGAA AAUUAGUU
1185 2474 ACUAAUUU U UGUGUUUU 555 AAAACACA CUGAUGAGGCCGUUAGGCCGAA
AAAUUAGU 1186 2475 CUAAUUUU U GUGUUUUU 556 AAAAACAC
CUGAUGAGGCCGUUAGGCCGAA AAAAUUAG 1187 2480 UUUUGUGU U UUUAAUAA 557
UUAUUAAA CUGAUGAGGCCGUUAGGCCGAA ACACAAAA 1188 2481 UUUGUGUU U
UUAAUAAA 558 UUUAUUAA CUGAUGAGGCCGUUAGGCCGAA AACACAAA 1189 2482
UUGUGUUU U UAAUAAAG 559 CUUUAUUA CUGAUGAGGCCGUUAGGCCGAA AAACACAA
1190 2483 UGUGUUUU U AAUAAAGA 560 UCUUUAUU CUGAUGAGGCCGUUAGGCCGAA
AAAACACA 1191 2484 GUGUUUUU A AUAAAGAC 561 GUCUUUAU
CUGAUGAGGCCGUUAGGCCGAA AAAAACAC 1192 2487 UUUUUAAU A AAGACAGG 562
CCUGUCUU CUGAUGAGGCCGUUAGGCCGAA AUUAAAAA 1193 2498 GACAGGGU U
UCACCAUG 563 CAUGGUGA CUGAUGAGGCCGUUAGGCCGAA ACCCUGUC 1194 2499
ACAGGGUU U CACCAUGU 564 ACAUGGUG CUGAUGAGGCCGUUAGGCCGAA AACCCUGU
1195 2500 CAGGGUUU C ACCAUGUU 565 AACAUGGU CUGAUGAGGCCGUUAGGCCGAA
AAACCCUG 1196 2508 CACCAUGU U GGCCAGGC 566 GCCUGGCC
CUGAUGAGGCCGUUAGGCCGAA ACAUGGUG 1197 2521 AGGCUGGU C UCAAACUC 567
GAGUUUGA CUGAUGAGGCCGUUAGGCCGAA ACCAGCCU 1198 2523 GCUGGUCU C
AAACUCCU 568 AGGAGUUU CUGAUGAGGCCGUUAGGCCGAA AGACCAGC 1199 2529
CUCAAACU C CUGACCUC 569 GAGGUCAG CUGAUGAGGCCGUUAGGCCGAA AGUUUGAG
1200 2537 CCUGACCU C AAGUAAUC 570 GAUUACUU CUGAUGAGGCCGUUAGGCCGAA
AGGUCAGG 1201 2542 CCUCAAGU A AUCCACCU 571 AGGUGGAU
CUGAUGAGGCCGUUAGGCCGAA ACUUGAGG 1202 2545 CAAGUAAU C CACCUGCC 572
GGCAGGUG CUGAUGAGGCCGUUAGGCCGAA AUUACUUG 1203 2555 ACCUGCCU C
GGCCUCCC 573 GGGAGGCC CUGAUGAGGCCGUUAGGCCGAA AGGCAGGU 1204 2561
CUCGGCCU C CCAAAGUG 574 CACUUUGG CUGAUGAGGCCGUUAGGCCGAA AGGCCGAG
1205 2577 GCUGGGAU U ACAGGGAU 575 AUCCCUGU CUGAUGAGGCCGUUAGGCCGAA
AUCCCAGC 1206 2578 CUGGGAUU A CAGGGAUG 576 CAUCCCUG
CUGAUGAGGCCGUUAGGCCGAA AAUCCCAG 1207 2605 CCCAGCCU C AUCUCUUU 577
AAAGAGAU CUGAUGAGGCCGUUAGGCCGAA AGGCUGGG 1208 2608 AGCCUCAU C
UCUUUGUU 578 AACAAAGA CUGAUGAGGCCGUUAGGCCGAA AUGAGGCU 1209 2610
CCUCAUCU C UUUGUUCU 579 AGAACAAA CUGAUGAGGCCGUUAGGCCGAA AGAUGAGG
1210 2612 UCAUCUCU U UGUUCUAA 580 UUAGAACA CUGAUGAGGCCGUUAGGCCGAA
AGAGAUGA 1211 2613 CAUCUCUU U GUUCUAAA 581 UUUAGAAC
CUGAUGAGGCCGUUAGGCCGAA AAGAGAUG 1212 2616 CUCUUUGU U CUAAAGAU 582
AUCUUUAG CUGAUGAGGCCGUUAGGCCGAA ACAAAGAG 1213 2617 UCUUUGUU C
UAAAGAUG 583 CAUCUUUA CUGAUGAGGCCGUUAGGCCGAA AACAAAGA 1214 2619
UUUGUUCU A AAGAUGGA 584 UCCAUCUU CUGAUGAGGCCGUUAGGCCGAA AGAACAAA
1215 2644 CCCCAAAU U UUCUUUUU 585 AAAAAGAA CUGAUGAGGCCGUUAGGCCGAA
AUUUGGGG 1216 2645 CCCAAAUU U UCUUUUUA 586 UAAAAAGA
CUGAUGAGGCCGUUAGGCCGAA AAUUUGGG 1217 2646 CCAAAUUU U CUUUUUAU 587
AUAAAAAG CUGAUGAGGCCGUUAGGCCGAA AAAUUUGG 1218 2647 CAAAUUUU C
UUUUUAUA 588 UAUAAAAA CUGAUGAGGCCGUUAGGCCGAA AAAAUUUG 1219 2649
AAUUUUCU U UUUAUACU 589 AGUAUAAA CUGAUGAGGCCGUUAGGCCGAA AGAAAAUU
1220 2650 AUUUUCUU U UUAUACUA 590 UAGUAUAA CUGAUGAGGCCGUUAGGCCGAA
AAGAAAAU 1221 2651 UUUUCUUU U UAUACUAU 591 AUAGUAUA
CUGAUGAGGCCGUUAGGCCGAA AAAGAAAA 1222 2652 UUUCUUUU U AUACUAUU 592
AAUAGUAU CUGAUGAGGCCGUUAGGCCGAA AAAAGAAA 1223 2653 UUCUUUUU A
UACUAUUA 593 UAAUAGUA CUGAUGAGGCCGUUAGGCCGAA AAAAAGAA 1224 2655
CUUUUUAU A CUAUUAAU 594 AUUAAUAG CUGAUGAGGCCGUUAGGCCGAA AUAAAAAG
1225 2658 UUUAUACU A UUAAUGAA 595 UUCAUUAA CUGAUGAGGCCGUUAGGCCGAA
AGUAUAAA 1226 2660 UAUACUAU U AAUGAAUC 596 GAUUCAUU
CUGAUGAGGCCGUUAGGCCGAA AUAGUAUA 1227 2661 AUACUAUU A AUGAAUCA 597
UGAUUCAU CUGAUGAGGCCGUUAGGCCGAA AAUAGUAU 1228 2668 UAAUGAAU C
AAUCAAUU 598 AAUUGAUU CUGAUGAGGCCGUUAGGCCGAA AUUCAUUA 1229 2672
GAAUCAAU C AAUUCAUA 599 UAUGAAUU CUGAUGAGGCCGUUAGGCCGAA AUUGAUUC
1230 2676 CAAUCAAU U CAUAUCUA 600 UAGAUAUG CUGAUGAGGCCGUUAGGCCGAA
AUUGAUUG 1231 2677 AAUCAAUU C AUAUCUAU 601 AUAGAUAU
CUGAUGAGGCCGUUAGGCCGAA AAUUGAUU 1232 2680 CAAUUCAU A UCUAUUUA 602
UAAAUAGA CUGAUGAGGCCGUUAGGCCGAA AUGAAUUG 1233 2682 AUUCAUAU C
UAUUUAUU 603 AAUAAAUA CUGAUGAGGCCGUUAGGCCGAA AUAUGAAU 1234 2684
UCAUAUCU A UUUAUUAA 604 UUAAUAAA CUGAUGAGGCCGUUAGGCCGAA AGAUAUGA
1235 2686 AUAUCUAU U UAUUAAAU 605 AUUUAAUA CUGAUGAGGCCGUUAGGCCGAA
AUAGAUAU 1236 2687 UAUCUAUU U AUUAAAUU 606 AAUUUAAU
CUGAUGAGGCCGUUAGGCCGAA AAUAGAUA 1237 2688 AUCUAUUU A UUAAAUUU 607
AAAUUUAA CUGAUGAGGCCGUUAGGCCGAA AAAUAGAU 1238 2690 CUAUUUAU U
AAAUUUCU 608 AGAAAUUU CUGAUGAGGCCGUUAGGCCGAA AUAAAUAG 1239 2691
UAUUUAUU A AAUUUCUA 609 UAGAAAUU CUGAUGAGGCCGUUAGGCCGAA AAUAAAUA
1240 2695 UAUUAAAU U UCUACCGC 610 GCGGUAGA CUGAUGAGGCCGUUAGGCCGAA
AUUUAAUA 1241 2696 AUUAAAUU U CUACCGCU 611 AGCGGUAG
CUGAUGAGGCCGUUAGGCCGAA AAUUUAAU 1242 2697 UUAAAUUU C UACCGCUU 612
AAGCGGUA CUGAUGAGGCCGUUAGGCCGAA AAAUUUAA 1243 2699 AAAUUUCU A
CCGCUUUU 613 AAAAGCGG CUGAUGAGGCCGUUAGGCCGAA AGAAAUUU 1244 2705
CUACCGCU U UUAGGCCA 614 UGGCCUAA CUGAUGAGGCCGUUAGGCCGAA AGCGGUAG
1245 2706 UACCGCUU U UAGGCCAA 615 UUGGCCUA CUGAUGAGGCCGUUAGGCCGAA
AAGCGGUA 1246 2707 ACCGCUUU U AGGCCAAA 616 UUUGGCCU
CUGAUGAGGCCGUUAGGCCGAA AAAGCGGU 1247 2708 CCGCUUUU A GGCCAAAA 617
UUUUGGCC CUGAUGAGGCCGUUAGGCCGAA AAAAGCGG 1248 2723 AAAAAUGU A
AGAUCGUU 618 AACGAUCU CUGAUGAGGCCGUUAGGCCGAA ACAUUUUU 1249 2728
UGUAAGAU C GUUCUCUG 619 CAGAGAAC CUGAUGAGGCCGUUAGGCCGAA AUCUUACA
1250 2731 AAGAUCGU U CUCUGCCU 620 AGGCAGAG CUGAUGAGGCCGUUAGGCCGAA
ACGAUCUU 1251 2732 AGAUCGUU C UCUGCCUC 621 GAGGCAGA
CUGAUGAGGCCGUUAGGCCGAA AACGAUCU 1252 2734 AUCGUUCU C UGCCUCAC 622
GUGAGGCA CUGAUGAGGCCGUUAGGCCGAA AGAACGAU 1253
2740 CUCUGCCU C ACAUAGCU 623 AGCUAUGU CUGAUGAGGCCGUUAGGCCGAA
AGGCAGAG 1254 2745 CCUCACAU A GCUUACAA 624 UUGUAAGC
CUGAUGAGGCCGUUAGGCCGAA AUGUGAGG 1255 2749 ACAUAGCU U ACAAGCCA 625
UGGCUUGU CUGAUGAGGCCGUUAGGCCGAA AGCUAUGU 1256 2750 CAUAGCUU A
CAAGCCAG 626 CUGGCUUG CUGAUGAGGCCGUUAGGCCGAA AAGCUAUG 1257 2769
GGAGAAAU A UGGUACUC 627 GAGUACCA CUGAUGAGGCCGUUAGGCCGAA AUUUCUCC
1258 2774 AAUAUGGU A CUCAUUAA 628 UUAAUGAG CUGAUGAGGCCGUUAGGCCGAA
ACCAUAUU 1259 2777 AUGGUACU C AUUAAAAA 629 UUUUUAAU
CUGAUGAGGCCGUUAGGCCGAA AGUACCAU 1260 2780 GUACUCAU U AAAAAAAA 630
UUUUUUUU CUGAUGAGGCCGUUAGGCCGAA AUGAGUAC 1261 2781 UACUCAUU A
AAAAAAAA 631 UUUUUUUU CUGAUGAGGCCGUUAGGCCGAA AAUGAGUA 1262 Input
Sequence = NM_002759. Cut Site = UH/. Arm Length = 8. Core Sequence
= CUGAUGAG GCCGUUAGGC CGAA NM_002759 (Homo sapiens protein kinase,
interferon-inducible double stranded RNA dependent (PRKR), mRNA.;
2808 bp) Underlined region can be any X sequence or linker, as
described herein.
[0271] TABLE-US-00009 TABLE IX Human PKR Inozyme and Substrate
Sequence Seq Seq Pos Substrate ID Inozyme ID 17 GGCGGCGC A GUUUGCUC
1263 GAGCAAAC CUGAUGAGGCCGUUAGGCCGAA ICGCCGCC 1762 24 CAGUUUGC U
CAUACUUU 1264 AAAGUAUG CUGAUGAGGCCGUUAGGCCGAA ICAAACUG 1763 26
GUUUGCUC A UACUUUGU 1265 ACAAAGUA CUGAUGAGGCCGUUAGGCCGAA IAGCAAAC
1764 30 GCUCAUAC U UUGUGACU 1266 AGUCACAA CUGAUGAGGCCGUUAGGCCGAA
IUAUGAGC 1765 38 UUUGUGAC U UGCGGUCA 1267 UGACCGCA
CUGAUGAGGCCGUUAGGCCGAA IUCACAAA 1766 46 UUGCGGUC A CAGUGGCA 1268
UGCCACUG CUGAUGAGGCCGUUAGGCCGAA IACCGCAA 1767 48 GCGGUCAC A
GUGGCAUU 1269 AAUGCCAC CUGAUGAGGCCGUUAGGCCGAA IUGACCGC 1768 54
ACAGUGGC A UUCAGCUC 1270 GAGCUGAA CUGAUGAGGCCGUUAGGCCGAA ICCACUGU
1769 58 UGGCAUUC A GCUCCACA 1271 UGUGGAGC CUGAUGAGGCCGUUAGGCCGAA
IAAUGCCA 1770 61 CAUUCAGC U CCACACUU 1272 AAGUGUGG
CUGAUGAGGCCGUUAGGCCGAA ICUGAAUG 1771 63 UUCAGCUC C ACACUUGG 1273
CCAAGUGU CUGAUGAGGCCGUUAGGCCGAA IAGCUGAA 1772 64 UCAGCUCC A
CACUUGGU 1274 ACCAAGUG CUGAUGAGGCCGUUAGGCCGAA IGAGCUGA 1773 66
AGCUCCAC A CUUGGUAG 1275 CUACCAAG CUGAUGAGGCCGUUAGGCCGAA IUGGAGCU
1774 68 CUCCACAC U UGGUAGAA 1276 UUCUACCA CUGAUGAGGCCGUUAGGCCGAA
IUGUGGAG 1775 78 GGUAGAAC C ACAGGCAC 1277 GUGCCUGU
CUGAUGAGGCCGUUAGGCCGAA IUUCUACC 1776 79 GUAGAACC A CAGGCACG 1278
CGUGCCUG CUGAUGAGGCCGUUAGGCCGAA IGUUCUAC 1777 81 AGAACCAC A
GGCACGAC 1279 GUCGUGCC CUGAUGAGGCCGUUAGGCCGAA IUGGUUCU 1778 85
CCACAGGC A CGACAAGC 1280 GCUUGUCG CUGAUGAGGCCGUUAGGCCGAA ICCUGUGG
1779 90 GGCACGAC A AGCAUAGA 1281 UCUAUGCU CUGAUGAGGCCGUUAGGCCGAA
IUCGUGCC 1780 94 CGACAAGC A UAGAAACA 1282 UGUUUCUA
CUGAUGAGGCCGUUAGGCCGAA ICUUGUCG 1781 102 AUAGAAAC A UCCUAAAC 1283
GUUUAGGA CUGAUGAGGCCGUUAGGCCGAA IUUUCUAU 1782 105 GAAACAUC C
UAAACAAU 1284 AUUGUUUA CUGAUGAGGCCGUUAGGCCGAA IAUGUUUC 1783 106
AAACAUCC U AAACAAUC 1285 GAUUGUUU CUGAUGAGGCCGUUAGGCCGAA IGAUGUUU
1784 111 UCCUAAAC A AUCUUCAU 1286 AUGAAGAU CUGAUGAGGCCGUUAGGCCGAA
IUUUAGGA 1785 115 AAACAAUC U UCAUCGAG 1287 CUCGAUGA
CUGAUGAGGCCGUUAGGCCGAA IAUUGUUU 1786 118 CAAUCUUC A UCGAGGCA 1288
UGCCUCGA CUGAUGAGGCCGUUAGGCCGAA IAAGAUUG 1787 126 AUCGAGGC A
UCGAGGUC 1289 GACCUCGA CUGAUGAGGCCGUUAGGCCGAA ICCUCGAU 1788 135
UCGAGGUC C AUCCCAAU 1290 AUUGGGAU CUGAUGAGGCCGUUAGGCCGAA IACCUCGA
1789 136 CGAGGUCC A UCCCAAUA 1291 UAUUGGGA CUGAUGAGGCCGUUAGGCCGAA
IGACCUCG 1790 139 GGUCCAUC C CAAUAAAA 1292 UUUUAUUG
CUGAUGAGGCCGUUAGGCCGAA IAUGGACC 1791 140 GUCCAUCC C AAUAAAAA 1293
UUUUUAUU CUGAUGAGGCCGUUAGGCCGAA IGAUGGAC 1792 141 UCCAUCCC A
AUAAAAAU 1294 AUUUUUAU CUGAUGAGGCCGUUAGGCCGAA IGGAUGGA 1793 151
UAAAAAUC A GGAGACCC 1295 GGGUCUCC CUGAUGAGGCCGUUAGGCCGAA IAUUUUUA
1794 158 CAGGAGAC C CUGGCUAU 1296 AUAGCCAG CUGAUGAGGCCGUUAGGCCGAA
IUCUCCUG 1795 159 AGGAGACC C UGGCUAUC 1297 GAUAGCCA
CUGAUGAGGCCGUUAGGCCGAA IGUCUCCU 1796 160 GGAGACCC U GGCUAUCA 1298
UGAUAGCC CUGAUGAGGCCGUUAGGCCGAA IGGUCUCC 1797 164 ACCCUGGC U
AUCAUAGA 1299 UCUAUGAU CUGAUGAGGCCGUUAGGCCGAA ICCAGGGU 1798 168
UGGCUAUC A UAGACCUU 1300 AAGGUCUA CUGAUGAGGCCGUUAGGCCGAA IAUAGCCA
1799 174 UCAUAGAC C UUAGUCUU 1301 AAGACUAA CUGAUGAGGCCGUUAGGCCGAA
IUCUAUGA 1800 175 CAUAGACC U UAGUCUUC 1302 GAAGACUA
CUGAUGAGGCCGUUAGGCCGAA IGUCUAUG 1801 181 CCUUAGUC U UCGCUGGU 1303
ACCAGCGA CUGAUGAGGCCGUUAGGCCGAA IACUAAGG 1802 186 GUCUUCGC U
GGUAUACU 1304 AGUAUACC CUGAUGAGGCCGUUAGGCCGAA ICGAAGAC 1803 194
UGGUAUAC U CGCUGUCU 1305 AGACAGCG CUGAUGAGGCCGUUAGGCCGAA IUAUACCA
1804 198 AUACUCGC U GUCUGUCA 1306 UGACAGAC CUGAUGAGGCCGUUAGGCCGAA
ICGAGUAU 1805 202 UCGCUGUC U GUCAACCA 1307 UGGUUGAC
CUGAUGAGGCCGUUAGGCCGAA IACAGCGA 1806 206 UGUCUGUC A ACCAGCGG 1308
CCGCUGGU CUGAUGAGGCCGUUAGGCCGAA IACAGACA 1807 209 CUGUCAAC C
AGCGGUUG 1309 CAACCGCU CUGAUGAGGCCGUUAGGCCGAA IUUGACAG 1808 210
UGUCAACC A GCGGUUGA 1310 UCAACCGC CUGAUGAGGCCGUUAGGCCGAA IGUUGACA
1809 220 CGGUUGAC U UUUUUUAA 1311 UUAAAAAA CUGAUGAGGCCGUUAGGCCGAA
IUCAACCG 1810 231 UUUUAAGC C UUCUUUUU 1312 AAAAAGAA
CUGAUGAGGCCGUUAGGCCGAA ICUUAAAA 1811 232 UUUAAGCC U UCUUUUUU 1313
AAAAAAGA CUGAUGAGGCCGUUAGGCCGAA IGCUUAAA 1812 235 AAGCCUUC U
UUUUUCUC 1314 GAGAAAAA CUGAUGAGGCCGUUAGGCCGAA IAAGGCUU 1813 242
CUUUUUUC U CUUUUACC 1315 GGUAAAAG CUGAUGAGGCCGUUAGGCCGAA IAAAAAAG
1814 244 UUUUUCUC U UUUACCAG 1316 CUGGUAAA CUGAUGAGGCCGUUAGGCCGAA
IAGAAAAA 1815 250 UCUUUUAC C AGUUUCUG 1317 CAGAAACU
CUGAUGAGGCCGUUAGGCCGAA IUAAAAGA 1816 251 CUUUUACC A GUUUCUGG 1318
CCAGAAAC CUGAUGAGGCCGUUAGGCCGAA IGUAAAAG 1817 257 CCAGUUUC U
GGAGCAAA 1319 UUUGCUCC CUGAUGAGGCCGUUAGGCCGAA IAAACUGG 1818 263
UCUGGAGC A AAUUCAGU 1320 ACUGAAUU CUGAUGAGGCCGUUAGGCCGAA ICUCCAGA
1819 269 GCAAAUUC A GUUUGCCU 1321 AGGCAAAC CUGAUGAGGCCGUUAGGCCGAA
IAAUUUGC 1820 276 CAGUUUGC C UUCCUGGA 1322 UCCAGGAA
CUGAUGAGGCCGUUAGGCCGAA ICAAACUG 1821 277 AGUUUGCC U UCCUGGAU 1323
AUCCAGGA CUGAUGAGGCCGUUAGGCCGAA IGCAAACU 1822 280 UUGCCUUC C
UGGAUUUG 1324 CAAAUCCA CUGAUGAGGCCGUUAGGCCGAA IAAGGCAA 1823 281
UGCCUUCC U GGAUUUGU 1325 ACAAAUCC CUGAUGAGGCCGUUAGGCCGAA IGAAGGCA
1824 303 GUAAUGAC C UCAAAACU 1326 AGUUUUGA CUGAUGAGGCCGUUAGGCCGAA
IUCAUUAC 1825 304 UAAUGACC U CAAAACUU 1327 AAGUUUUG
CUGAUGAGGCCGUUAGGCCGAA IGUCAUUA 1826 306 AUGACCUC A AAACUUUA 1328
UAAAGUUU CUGAUGAGGCCGUUAGGCCGAA IAGGUCAU 1827 311 CUCAAAAC U
UUAGCAGU 1329 ACUGCUAA CUGAUGAGGCCGUUAGGCCGAA IUUUUGAG 1828 317
ACUUUAGC A GUUCUUCC 1330 GGAAGAAC CUGAUGAGGCCGUUAGGCCGAA ICUAAAGU
1829 322 AGCAGUUC U UCCAUCUG 1331 CAGAUGGA CUGAUGAGGCCGUUAGGCCGAA
IAACUGCU 1830 325 AGUUCUUC C AUCUGACU 1332 AGUCAGAU
CUGAUGAGGCCGUUAGGCCGAA IAAGAACU 1831 326 GUUCUUCC A UCUGACUC 1333
GAGUCAGA CUGAUGAGGCCGUUAGGCCGAA IGAAGAAC 1832 329 CUUCCAUC U
GACUCAGG 1334 CCUGAGUC CUGAUGAGGCCGUUAGGCCGAA IAUGGAAG 1833 333
CAUCUGAC U CAGGUUUG 1335 CAAACCUG CUGAUGAGGCCGUUAGGCCGAA IUCAGAUG
1834 335 UCUGACUC A GGUUUGCU 1336 AGCAAACC CUGAUGAGGCCGUUAGGCCGAA
IAGUCAGA 1835 343 AGGUUUGC U UCUCUGGC 1337 GCCAGAGA
CUGAUGAGGCCGUUAGGCCGAA ICAAACCU 1836 346 UUUGCUUC U CUGGCGGU 1338
ACCGCCAG CUGAUGAGGCCGUUAGGCCGAA IAAGCAAA 1837 348 UGCUUCUC U
GGCGGUCU 1339 AGACCGCC CUGAUGAGGCCGUUAGGCCGAA IAGAAGCA 1838 356
UGGCGGUC U UCAGAAUC 1340 GAUUCUGA CUGAUGAGGCCGUUAGGCCGAA IACCGCCA
1839 359 CGGUCUUC A GAAUCAAC 1341 GUUGAUUC CUGAUGAGGCCGUUAGGCCGAA
IAAGACCG 1840 365 UCAGAAUC A ACAUCCAC 1342 GUGGAUGU
CUGAUGAGGCCGUUAGGCCGAA IAUUCUGA 1841 368 GAAUCAAC A UCCACACU 1343
AGUGUGGA CUGAUGAGGCCGUUAGGCCGAA IUUGAUUC 1842 371 UCAACAUC C
ACACUUCC 1344 GGAAGUGU CUGAUGAGGCCGUUAGGCCGAA IAUGUUGA 1843 372
CAACAUCC A CACUUCCG 1345 CGGAAGUG CUGAUGAGGCCGUUAGGCCGAA IGAUGUUG
1844 374 ACAUCCAC A CUUCCGUG 1346 CACGGAAG CUGAUGAGGCCGUUAGGCCGAA
IUGGAUGU 1845 376 AUCCACAC U UCCGUGAU 1347 AUCACGGA
CUGAUGAGGCCGUUAGGCCGAA IUGUGGAU 1846 379 CACACUUC C GUGAUUAU 1348
AUAAUCAC CUGAUGAGGCCGUUAGGCCGAA IAAGUGUG 1847 389 UGAUUAUC U
GCGUGCAU 1349 AUGCACGC CUGAUGAGGCCGUUAGGCCGAA IAUAAUCA 1848 396
CUGCGUGC A UUUUGGAC 1350 GUCCAAAA CUGAUGAGGCCGUUAGGCCGAA ICACGCAG
1849
405 UUUUGGAC A AAGCUUCC 1351 GGAAGCUU CUGAUGAGGCCGUUAGGCCGAA
IUCCAAAA 1850 410 GACAAAGC U UCCAACCA 1352 UGGUUGGA
CUGAUGAGGCCGUUAGGCCGAA ICUUUGUC 1851 413 AAAGCUUC C AACCAGGA 1353
UCCUGGUU CUGAUGAGGCCGUUAGGCCGAA IAAGCUUU 1852 414 AAGCUUCC A
ACCAGGAU 1354 AUCCUGGU CUGAUGAGGCCGUUAGGCCGAA IGAAGCUU 1853 417
CUUCCAAC C AGGAUACG 1355 CGUAUCCU CUGAUGAGGCCGUUAGGCCGAA IUUGGAAG
1854 418 UUCCAACC A GGAUACGG 1356 CCGUAUCC CUGAUGAGGCCGUUAGGCCGAA
IGUUGGAA 1855 441 GAAAUGGC U GGUGAUCU 1357 AGAUCACC
CUGAUGAGGCCGUUAGGCCGAA ICCAUUUC 1856 449 UGGUGAUC U UUCAGCAG 1358
CUGCUGAA CUGAUGAGGCCGUUAGGCCGAA IAUCACCA 1857 453 GAUCUUUC A
GCAGGUUU 1359 AAACCUGC CUGAUGAGGCCGUUAGGCCGAA IAAAGAUC 1858 456
CUUUCAGC A GGUUUCUU 1360 AAGAAACC CUGAUGAGGCCGUUAGGCCGAA ICUGAAAG
1859 463 CAGGUUUC U UCAUGGAG 1361 CUCCAUGA CUGAUGAGGCCGUUAGGCCGAA
IAAACCUG 1860 466 GUUUCUUC A UGGAGGAA 1362 UUCCUCCA
CUGAUGAGGCCGUUAGGCCGAA IAAGAAAC 1861 476 GGAGGAAC U UAAUACAU 1363
AUGUAUUA CUGAUGAGGCCGUUAGGCCGAA IUUCCUCC 1862 483 CUUAAUAC A
UACCGUCA 1364 UGACGGUA CUGAUGAGGCCGUUAGGCCGAA IUAUUAAG 1863 487
AUACAUAC C GUCAGAAG 1365 CUUCUGAC CUGAUGAGGCCGUUAGGCCGAA IUAUGUAU
1864 491 AUACCGUC A GAAGCAGG 1366 CCUGCUUC CUGAUGAGGCCGUUAGGCCGAA
IACGGUAU 1865 497 UCAGAAGC A GGGAGUAG 1367 CUACUCCC
CUGAUGAGGCCGUUAGGCCGAA ICUUCUGA 1866 509 AGUAGUAC U UAAAUAUC 1368
GAUAUUUA CUGAUGAGGCCGUUAGGCCGAA IUACUACU 1867 518 UAAAUAUC A
AGAACUGC 1369 GCAGUUCU CUGAUGAGGCCGUUAGGCCGAA IAUAUUUA 1868 524
UCAAGAAC U GCCUAAUU 1370 AAUUAGGC CUGAUGAGGCCGUUAGGCCGAA IUUCUUGA
1869 527 AGAACUGC C UAAUUCAG 1371 CUGAAUUA CUGAUGAGGCCGUUAGGCCGAA
ICAGUUCU 1870 528 GAACUGCC U AAUUCAGG 1372 CCUGAAUU
CUGAUGAGGCCGUUAGGCCGAA IGCAGUUC 1871 534 CCUAAUUC A GGACCUCC 1373
GGAGGUCC CUGAUGAGGCCGUUAGGCCGAA IAAUUAGG 1872 539 UUCAGGAC C
UCCACAUG 1374 CAUGUGGA CUGAUGAGGCCGUUAGGCCGAA IUCCUGAA 1873 540
UCAGGACC U CCACAUGA 1375 UCAUGUGG CUGAUGAGGCCGUUAGGCCGAA IGUCCUGA
1874 542 AGGACCUC C ACAUGAUA 1376 UAUCAUGU CUGAUGAGGCCGUUAGGCCGAA
IAGGUCCU 1875 543 GGACCUCC A CAUGAUAG 1377 CUAUCAUG
CUGAUGAGGCCGUUAGGCCGAA IGAGGUCC 1876 545 ACCUCCAC A UGAUAGGA 1378
UCCUAUCA CUGAUGAGGCCGUUAGGCCGAA IUGGAGGU 1877 561 AGGUUUAC A
UUUCAAGU 1379 ACUUGAAA CUGAUGAGGCCGUUAGGCCGAA IUAAACCU 1878 566
UACAUUUC A AGUUAUAA 1380 UUAUAACU CUGAUGAGGCCGUUAGGCCGAA IAAAUGUA
1879 593 AGAAUUUC C AGAAGGUG 1381 CACCUUCU CUGAUGAGGCCGUUAGGCCGAA
IAAAUUCU 1880 594 GAAUUUCC A GAAGGUGA 1382 UCACCUUC
CUGAUGAGGCCGUUAGGCCGAA IGAAAUUC 1881 612 GGUAGAUC A AAGAAGGA 1383
UCCUUCUU CUGAUGAGGCCGUUAGGCCGAA IAUCUACC 1882 624 AAGGAAGC A
AAAAAUGC 1384 GCAUUUUU CUGAUGAGGCCGUUAGGCCGAA ICUUCCUU 1883 633
AAAAAUGC C GCAGCCAA 1385 UUGGCUGC CUGAUGAGGCCGUUAGGCCGAA ICAUUUUU
1884 636 AAUGCCGC A GCCAAAUU 1386 AAUUUGGC CUGAUGAGGCCGUUAGGCCGAA
ICGGCAUU 1885 639 GCCGCAGC C AAAUUAGC 1387 GCUAAUUU
CUGAUGAGGCCGUUAGGCCGAA ICUGCGGC 1886 640 CCGCAGCC A AAUUAGCU 1388
AGCUAAUU CUGAUGAGGCCGUUAGGCCGAA IGCUGCGG 1887 648 AAAUUAGC U
GUUGAGAU 1389 AUCUCAAC CUGAUGAGGCCGUUAGGCCGAA ICUAAUUU 1888 659
UGAGAUAC U UAAUAAGG 1390 CCUUAUUA CUGAUGAGGCCGUUAGGCCGAA IUAUCUCA
1889 678 AAGAAGGC A GUUAGUCC 1391 GGACUAAC CUGAUGAGGCCGUUAGGCCGAA
ICCUUCUU 1890 686 AGUUAGUC C UUUAUUAU 1392 AUAAUAAA
CUGAUGAGGCCGUUAGGCCGAA IACUAACU 1891 687 GUUAGUCC U UUAUUAUU 1393
AAUAAUAA CUGAUGAGGCCGUUAGGCCGAA IGACUAAC 1892 699 UUAUUGAC A
ACAACGAA 1394 UUCGUUGU CUGAUGAGGCCGUUAGGCCGAA IUCAAUAA 1893 702
UUGACAAC A ACGAAUUC 1395 GAAUUCGU CUGAUGAGGCCGUUAGGCCGAA IUUGUCAA
1894 711 ACGAAUUC U UCAGAAGG 1396 CCUUCUGA CUGAUGAGGCCGUUAGGCCGAA
IAAUUCGU 1895 714 AAUUCUUC A GAAGGAUU 1397 AAUCCUUC
CUGAUGAGGCCGUUAGGCCGAA IAAGAAUU 1896 726 GGAUUAUC C AUGGGGAA 1398
UUCCCCAU CUGAUGAGGCCGUUAGGCCGAA IAUAAUCC 1897 727 GAUUAUCC A
UGGGGAAU 1399 AUUCCCCA CUGAUGAGGCCGUUAGGCCGAA IGAUAAUC 1898 739
GGAAUUAC A UAGGCCUU 1400 AAGGCCUA CUGAUGAGGCCGUUAGGCCGAA IUAAUUCC
1899 745 ACAUAGGC C UUAUCAAU 1401 AUUGAUAA CUGAUGAGGCCGUUAGGCCGAA
ICCUAUGU 1900 746 CAUAGGCC U UAUCAAUA 1402 UAUUGAUA
CUGAUGAGGCCGUUAGGCCGAA IGCCUAUG 1901 751 GCCUUAUC A AUAGAAUU 1403
AAUUCUAU CUGAUGAGGCCGUUAGGCCGAA IAUAAGGC 1902 762 AGAAUUGC C
CAGAAGAA 1404 UUCUUCUG CUGAUGAGGCCGUUAGGCCGAA ICAAUUCU 1903 763
GAAUUGCC C AGAAGAAA 1405 UUUCUUCU CUGAUGAGGCCGUUAGGCCGAA IGCAAUUC
1904 764 AAUUGCCC A GAAGAAAA 1406 UUUUCUUC CUGAUGAGGCCGUUAGGCCGAA
IGGCAAUU 1905 776 GAAAAGAC U AACUGUAA 1407 UUACAGUU
CUGAUGAGGCCGUUAGGCCGAA IUCUUUUC 1906 780 AGACUAAC U GUAAAUUA 1408
UAAUUUAC CUGAUGAGGCCGUUAGGCCGAA IUUAGUCU 1907 794 UUAUGAAC A
GUGUGCAU 1409 AUGCACAC CUGAUGAGGCCGUUAGGCCGAA IUUCAUAA 1908 801
CAGUGUGC A UCGGGGGU 1410 ACCCCCGA CUGAUGAGGCCGUUAGGCCGAA ICACACUG
1909 812 GGGGGUGC A UGGGCCAG 1411 CUGGCCCA CUGAUGAGGCCGUUAGGCCGAA
ICACCCCC 1910 818 GCAUGGGC C AGAAGGAU 1412 AUCCUUCU
CUGAUGAGGCCGUUAGGCCGAA ICCCAUGC 1911 819 CAUGGGCC A GAAGGAUU 1413
AAUCCUUC CUGAUGAGGCCGUUAGGCCGAA IGCCCAUG 1912 830 AGGAUUUC A
UUAUAAAU 1414 AUUUAUAA CUGAUGAGGCCGUUAGGCCGAA IAAAUCCU 1913 841
AUAAAUGC A AAAUGGGA 1415 UCCCAUUU CUGAUGAGGCCGUUAGGCCGAA ICAUUUAU
1914 851 AAUGGGAC A GAAAGAAU 1416 AUUCUUUC CUGAUGAGGCCGUUAGGCCGAA
IUCCCAUU 1915 873 AUUGGUAC A GGUUCUAC 1417 GUAGAACC
CUGAUGAGGCCGUUAGGCCGAA IUACCAAU 1916 879 ACAGGUUC U ACUAAACA 1418
UGUUUAGU CUGAUGAGGCCGUUAGGCCGAA IAACCUGU 1917 882 GGUUCUAC U
AAACAGGA 1419 UCCUGUUU CUGAUGAGGCCGUUAGGCCGAA IUAGAACC 1918 887
UACUAAAC A GGAAGCAA 1420 UUGCUUCC CUGAUGAGGCCGUUAGGCCGAA IUUUAGUA
1919 894 CAGGAAGC A AAACAAUU 1421 AAUUGUUU CUGAUGAGGCCGUUAGGCCGAA
ICUUCCUG 1920 899 AGCAAAAC A AUUGGCCG 1422 CGGCCAAU
CUGAUGAGGCCGUUAGGCCGAA IUUUUGCU 1921 906 CAAUUGGC C GCUAAACU 1423
AGUUUAGC CUGAUGAGGCCGUUAGGCCGAA ICCAAUUG 1922 909 UUGGCCGC U
AAACUUGC 1424 GCAAGUUU CUGAUGAGGCCGUUAGGCCGAA ICGGCCAA 1923 914
CGCUAAAC U UGCAUAUC 1425 GAUAUGCA CUGAUGAGGCCGUUAGGCCGAA IUUUAGCG
1924 918 AAACUUGC A UAUCUUCA 1426 UGAAGAUA CUGAUGAGGCCGUUAGGCCGAA
ICAAGUUU 1925 923 UGCAUAUC U UCAGAUAU 1427 AUAUCUGA
CUGAUGAGGCCGUUAGGCCGAA IAUAUGCA 1926 926 AUAUCUUC A GAUAUUAU 1428
AUAAUAUC CUGAUGAGGCCGUUAGGCCGAA IAAGAUAU 1927 936 AUAUUAUC A
GAAGAAAC 1429 GUUUCUUC CUGAUGAGGCCGUUAGGCCGAA IAUAAUAU 1928 945
GAAGAAAC C UCAGUGAA 1430 UUCACUGA CUGAUGAGGCCGUUAGGCCGAA IUUUCUUC
1929 946 AAGAAACC U CAGUGAAA 1431 UUUCACUG CUGAUGAGGCCGUUAGGCCGAA
IGUUUCUU 1930 948 GAAACCUC A GUGAAAUC 1432 GAUUUCAC
CUGAUGAGGCCGUUAGGCCGAA IAGGUUUC 1931 957 GUGAAAUC U GACUACCU 1433
AGGUAGUC CUGAUGAGGCCGUUAGGCCGAA IAUUUCAC 1932
961 AAUCUGAC U ACCUGUCC 1434 GGACAGGU CUGAUGAGGCCGUUAGGCCGAA
IUCAGAUU 1933 964 CUGACUAC C UGUCCUCU 1435 AGAGGACA
CUGAUGAGGCCGUUAGGCCGAA IUAGUCAG 1934 965 UGACUACC U GUCCUCUG 1436
CAGAGGAC CUGAUGAGGCCGUUAGGCCGAA IGUAGUCA 1935 969 UACCUGUC C
UCUGGUUC 1437 GAACCAGA CUGAUGAGGCCGUUAGGCCGAA IACAGGUA 1936 970
ACCUGUCC U CUGGUUCU 1438 AGAACCAG CUGAUGAGGCCGUUAGGCCGAA IGACAGGU
1937 972 CUGUCCUC U GGUUCUUU 1439 AAAGAACC CUGAUGAGGCCGUUAGGCCGAA
IAGGACAG 1938 978 UCUGGUUC U UUUGCUAC 1440 GUAGCAAA
CUGAUGAGGCCGUUAGGCCGAA IAACCAGA 1939 984 UCUUUUGC U ACUACGUG 1441
CACGUAGU CUGAUGAGGCCGUUAGGCCGAA ICAAAAGA 1940 987 UUUGCUAC U
ACGUGUGA 1442 UCACACGU CUGAUGAGGCCGUUAGGCCGAA IUAGCAAA 1941 999
UGUGAGUC C CAAAGCAA 1443 UUGCUUUG CUGAUGAGGCCGUUAGGCCGAA IACUCACA
1942 1000 GUGAGUCC C AAAGCAAC 1444 GUUGCUUU CUGAUGAGGCCGUUAGGCCGAA
IGACUCAC 1943 1001 UGAGUCCC A AAGCAACU 1445 AGUUGCUU
CUGAUGAGGCCGUUAGGCCGAA IGGACUCA 1944 1006 CCCAAAGC A ACUCUUUA 1446
UAAAGAGU CUGAUGAGGCCGUUAGGCCGAA ICUUUGGG 1945 1009 AAAGCAAC U
CUUUAGUG 1447 CACUAAAG CUGAUGAGGCCGUUAGGCCGAA IUUGCUUU 1946 1011
AGCAACUC U UUAGUGAC 1448 GUCACUAA CUGAUGAGGCCGUUAGGCCGAA IAGUUGCU
1947 1020 UUAGUGAC C AGCACACU 1449 AGUGUGCU CUGAUGAGGCCGUUAGGCCGAA
IUCACUAA 1948 1021 UAGUGACC A GCACACUC 1450 GAGUGUGC
CUGAUGAGGCCGUUAGGCCGAA IGUCACUA 1949 1024 UGACCAGC A CACUCGCU 1451
AGCGAGUG CUGAUGAGGCCGUUAGGCCGAA ICUGGUCA 1950 1026 ACCAGCAC A
CUCGCUUC 1452 GAAGCGAG CUGAUGAGGCCGUUAGGCCGAA IUGCUGGU 1951 1028
CAGCACAC U CGCUUCUG 1453 CAGAAGCG CUGAUGAGGCCGUUAGGCCGAA IUGUGCUG
1952 1032 ACACUCGC U UCUGAAUC 1454 GAUUCAGA CUGAUGAGGCCGUUAGGCCGAA
ICGAGUGU 1953 1035 CUCGCUUC U GAAUCAUC 1455 GAUGAUUC
CUGAUGAGGCCGUUAGGCCGAA IAAGCGAG 1954 1041 UCUGAAUC A UCAUCUGA 1456
UCAGAUGA CUGAUGAGGCCGUUAGGCCGAA IAUUCAGA 1955 1044 GAAUCAUC A
UCUGAAGG 1457 CCUUCAGA CUGAUGAGGCCGUUAGGCCGAA IAUGAUUC 1956 1047
UCAUCAUC U GAAGGUGA 1458 UCACCUUC CUGAUGAGGCCGUUAGGCCGAA IAUGAUGA
1957 1057 AAGGUGAC U UCUCAGCA 1459 UGCUGAGA CUGAUGAGGCCGUUAGGCCGAA
IUCACCUU 1958 1060 GUGACUUC U CAGCAGAU 1460 AUCUGCUG
CUGAUGAGGCCGUUAGGCCGAA IAAGUCAC 1959 1062 GACUUCUC A GCAGAUAC 1461
GUAUCUGC CUGAUGAGGCCGUUAGGCCGAA IAGAAGUC 1960 1065 UUCUCAGC A
GAUACAUC 1462 GAUGUAUC CUGAUGAGGCCGUUAGGCCGAA ICUGAGAA 1961 1071
GCAGAUAC A UCAGAGAU 1463 AUCUCUGA CUGAUGAGGCCGUUAGGCCGAA IUAUCUGC
1962 1074 GAUACAUC A GAGAUAAA 1464 UUUAUCUC CUGAUGAGGCCGUUAGGCCGAA
IAUGUAUC 1963 1086 AUAAAUUC U AACAGUGA 1465 UCACUGUU
CUGAUGAGGCCGUUAGGCCGAA IAAUUUAU 1964 1090 AUUCUAAC A GUGACAGU 1466
ACUGUCAC CUGAUGAGGCCGUUAGGCCGAA IUUAGAAU 1965 1096 ACAGUGAC A
GUUUAAAC 1467 GUUUAAAC CUGAUGAGGCCGUUAGGCCGAA IUCACUGU 1966 1105
GUUUAAAC A GUUCUUCG 1468 CGAAGAAC CUGAUGAGGCCGUUAGGCCGAA IUUUAAAC
1967 1110 AACAGUUC U UCGUUGCU 1469 AGCAACGA CUGAUGAGGCCGUUAGGCCGAA
IAACUGUU 1968 1118 UUCGUUGC U UAUGAAUG 1470 CAUUCAUA
CUGAUGAGGCCGUUAGGCCGAA ICAACGAA 1969 1130 GAAUGGUC U CAGAAAUA 1471
UAUUUCUG CUGAUGAGGCCGUUAGGCCGAA IACCAUUC 1970 1132 AUGGUCUC A
GAAAUAAU 1472 AUUAUUUC CUGAUGAGGCCGUUAGGCCGAA IAGACCAU 1971 1142
AAAUAAUC A AAGGAAGG 1473 CCUUCCUU CUGAUGAGGCCGUUAGGCCGAA IAUUAUUU
1972 1152 AGGAAGGC A AAAAGAUC 1474 GAUCUUUU CUGAUGAGGCCGUUAGGCCGAA
ICCUUCCU 1973 1161 AAAAGAUC U UUGGCACC 1475 GGUGCCAA
CUGAUGAGGCCGUUAGGCCGAA IAUCUUUU 1974 1167 UCUUUGGC A CCCAGAUU 1476
AAUCUGGG CUGAUGAGGCCGUUAGGCCGAA ICCAAAGA 1975 1169 UUUGGCAC C
CAGAUUUG 1477 CAAAUCUG CUGAUGAGGCCGUUAGGCCGAA IUGCCAAA 1976 1170
UUGGCACC C AGAUUUGA 1478 UCAAAUCU CUGAUGAGGCCGUUAGGCCGAA IGUGCCAA
1977 1171 UGGCACCC A GAUUUGAC 1479 GUCAAAUC CUGAUGAGGCCGUUAGGCCGAA
IGGUGCCA 1978 1180 GAUUUGAC C UUCCUGAC 1480 GUCAGGAA
CUGAUGAGGCCGUUAGGCCGAA IUCAAAUC 1979 1181 AUUUGACC U UCCUGACA 1481
UGUCAGGA CUGAUGAGGCCGUUAGGCCGAA IGUCAAAU 1980 1184 UGACCUUC C
UGACAUGA 1482 UCAUGUCA CUGAUGAGGCCGUUAGGCCGAA IAAGGUCA 1981 1185
GACCUUCC U GACAUGAA 1483 UUCAUGUC CUGAUGAGGCCGUUAGGCCGAA IGAAGGUC
1982 1189 UUCCUGAC A UGAAAGAA 1484 UUCUUUCA CUGAUGAGGCCGUUAGGCCGAA
IUCAGGAA 1983 1200 AAAGAAAC A AAGUAUAC 1485 GUAUACUU
CUGAUGAGGCCGUUAGGCCGAA IUUUCUUU 1984 1209 AAGUAUAC U GUGGACAA 1486
UUGUCCAC CUGAUGAGGCCGUUAGGCCGAA IUAUACUU 1985 1216 CUGUGGAC A
AGAGGUUU 1487 AAACCUCU CUGAUGAGGCCGUUAGGCCGAA IUCCACAG 1986 1228
GGUUUGGC A UGGAUUUU 1488 AAAAUCCA CUGAUGAGGCCGUUAGGCCGAA ICCAAACC
1987 1258 UAAUUGGC U CAGGUGGA 1489 UCCACCUG CUGAUGAGGCCGUUAGGCCGAA
ICCAAUUA 1988 1260 AUUGGCUC A GGUGGAUU 1490 AAUCCACC
CUGAUGAGGCCGUUAGGCCGAA IAGCCAAU 1989 1273 GAUUUGGC C AAGUUUUC 1491
GAAAACUU CUGAUGAGGCCGUUAGGCCGAA ICCAAAUC 1990 1274 AUUUGGCC A
AGUUUUCA 1492 UGAAAACU CUGAUGAGGCCGUUAGGCCGAA IGCCAAAU 1991 1282
AAGUUUUC A AAGCAAAA 1493 UUUUGCUU CUGAUGAGGCCGUUAGGCCGAA IAAAACUU
1992 1287 UUCAAAGC A AAACACAG 1494 CUGUGUUU CUGAUGAGGCCGUUAGGCCGAA
ICUUUGAA 1993 1292 AGCAAAAC A CAGAAUUG 1495 CAAUUCUG
CUGAUGAGGCCGUUAGGCCGAA IUUUUGCU 1994 1294 CAAAACAC A GAAUUGAC 1496
GUCAAUUC CUGAUGAGGCCGUUAGGCCGAA IUGUUUUG 1995 1311 GGAAAGAC U
UACGUUAU 1497 AUAACGUA CUGAUGAGGCCGUUAGGCCGAA IUCUUUCC 1996 1368
GUAAAAGC A UUGGCAAA 1498 UUUGCCAA CUGAUGAGGCCGUUAGGCCGAA ICUUUUAC
1997 1374 GCAUUGGC A AAACUUGA 1499 UCAAGUUU CUGAUGAGGCCGUUAGGCCGAA
ICCAAUGC 1998 1379 GGCAAAAC U UGAUCAUG 1500 CAUGAUCA
CUGAUGAGGCCGUUAGGCCGAA IUUUUGCC 1999 1385 ACUUGAUC A UGUAAAUA 1501
UAUUUACA CUGAUGAGGCCGUUAGGCCGAA IAUCAAGU 2000 1400 UAUUGUUC A
CUACAAUG 1502 CAUUGUAG CUGAUGAGGCCGUUAGGCCGAA IAACAAUA 2001 1402
UUGUUCAC U ACAAUGGC 1503 GCCAUUGU CUGAUGAGGCCGUUAGGCCGAA IUGAACAA
2002 1405 UUCACUAC A AUGGCUGU 1504 ACAGCCAU CUGAUGAGGCCGUUAGGCCGAA
IUAGUGAA 2003 1411 ACAAUGGC U GUUGGGAU 1505 AUCCCAAC
CUGAUGAGGCCGUUAGGCCGAA ICCAUUGU 2004 1436 UUAUGAUC C UGAGACCA 1506
UGGUCUCA CUGAUGAGGCCGUUAGGCCGAA IAUCAUAA 2005 1437 UAUGAUCC U
GAGACCAG 1507 CUGGUCUC CUGAUGAGGCCGUUAGGCCGAA IGAUCAUA 2006 1443
CCUGAGAC C AGUGAUGA 1508 UCAUCACU CUGAUGAGGCCGUUAGGCCGAA IUCUCAGG
2007 1444 CUGAGACC A GUGAUGAU 1509 AUCAUCAC CUGAUGAGGCCGUUAGGCCGAA
IGUCUCAG 2008 1455 GAUGAUUC U CUUGAGAG 1510 CUCUCAAG
CUGAUGAGGCCGUUAGGCCGAA IAAUCAUC 2009 1457 UGAUUCUC U UGAGAGCA 1511
UGCUCUCA CUGAUGAGGCCGUUAGGCCGAA IAGAAUCA 2010 1465 UUGAGAGC A
GUGAUUAU 1512 AUAAUCAC CUGAUGAGGCCGUUAGGCCGAA ICUCUCAA 2011 1478
UUAUGAUC C UGAGAACA 1513 UGUUCUCA CUGAUGAGGCCGUUAGGCCGAA IAUCAUAA
2012 1479 UAUGAUCC U GAGAACAG 1514 CUGUUCUC CUGAUGAGGCCGUUAGGCCGAA
IGAUCAUA 2013 1486 CUGAGAAC A GCAAAAAU 1515 AUUUUUGC
CUGAUGAGGCCGUUAGGCCGAA IUUCUCAG 2014 1489 AGAACAGC A AAAAUAGU 1516
ACUAUUUU CUGAUGAGGCCGUUAGGCCGAA ICUGUUCU 2015 1500 AAUAGUUC A
AGGUCAAA 1517 UUUGACCU CUGAUGAGGCCGUUAGGCCGAA IAACUAUU 2016
1506 UCAAGGUC A AAGACUAA 1518 UUAGUCUU CUGAUGAGGCCGUUAGGCCGAA
IACCUUGA 2017 1512 UCAAAGAC U AAGUGCCU 1519 AGGCACUU
CUGAUGAGGCCGUUAGGCCGAA IUCUUUGA 2018 1519 CUAAGUGC C UUUUCAUC 1520
GAUGAAAA CUGAUGAGGCCGUUAGGCCGAA ICACUUAG 2019 1520 UAAGUGCC U
UUUCAUCC 1521 GGAUGAAA CUGAUGAGGCCGUUAGGCCGAA IGCACUUA 2020 1525
GCCUUUUC A UCCAAAUG 1522 CAUUUGGA CUGAUGAGGCCGUUAGGCCGAA IAAAAGGC
2021 1528 UUUUCAUC C AAAUGGAA 1523 UUCCAUUU CUGAUGAGGCCGUUAGGCCGAA
IAUGAAAA 2022 1529 UUUCAUCC A AAUGGAAU 1524 AUUCCAUU
CUGAUGAGGCCGUUAGGCCGAA IGAUGAAA 2023 1540 UGGAAUUC U GUGAUAAA 1525
UUUAUCAC CUGAUGAGGCCGUUAGGCCGAA IAAUUCCA 2024 1554 AAAGGGAC C
UUGGAACA 1526 UGUUCCAA CUGAUGAGGCCGUUAGGCCGAA IUCCCUUU 2025 1555
AAGGGACC U UGGAACAA 1527 UUGUUCCA CUGAUGAGGCCGUUAGGCCGAA IGUCCCUU
2026 1562 CUUGGAAC A AUGGAUUG 1528 CAAUCCAU CUGAUGAGGCCGUUAGGCCGAA
IUUCCAAG 2027 1592 CGAGAAAC U AGACAAAG 1529 CUUUGUCU
CUGAUGAGGCCGUUAGGCCGAA IUUUCUCG 2028 1597 AACUAGAC A AAGUUUUG 1530
CAAAACUU CUGAUGAGGCCGUUAGGCCGAA IUCUAGUU 2029 1608 GUUUUGGC U
UUGGAACU 1531 AGUUCCAA CUGAUGAGGCCGUUAGGCCGAA ICCAAAAC 2030 1616
UUUGGAAC U CUUUGAAC 1532 GUUCAAAG CUGAUGAGGCCGUUAGGCCGAA IUUCCAAA
2031 1618 UGGAACUC U UUGAACAA 1533 UUGUUCAA CUGAUGAGGCCGUUAGGCCGAA
IAGUUCCA 2032 1625 CUUUGAAC A AAUAACAA 1534 UUGUUAUU
CUGAUGAGGCCGUUAGGCCGAA IUUCAAAG 2033 1632 CAAAUAAC A AAAGGGGU 1535
ACCCCUUU CUGAUGAGGCCGUUAGGCCGAA IUUAUUUG 2034 1652 UUAUAUAC A
UUCAAAAA 1536 UUUUUGAA CUGAUGAGGCCGUUAGGCCGAA IUAUAUAA 2035 1656
AUACAUUC A AAAAAAUU 1537 AAUUUUUU CUGAUGAGGCCGUUAGGCCGAA IAAUGUAU
2036 1670 AUUAAUUC A UAGAGAUC 1538 GAUCUCUA CUGAUGAGGCCGUUAGGCCGAA
IAAUUAAU 2037 1679 UAGAGAUC U UAAGCCAA 1539 UUGGCUUA
CUGAUGAGGCCGUUAGGCCGAA IAUCUCUA 2038 1685 UCUUAAGC C AAGUAAUA 1540
UAUUACUU CUGAUGAGGCCGUUAGGCCGAA ICUUAAGA 2039 1686 CUUAAGCC A
AGUAAUAU 1541 AUAUUACU CUGAUGAGGCCGUUAGGCCGAA IGCUUAAG 2040 1699
AUAUAUUC U UAGUAGAU 1542 AUCUACUA CUGAUGAGGCCGUUAGGCCGAA IAAUAUAU
2041 1710 GUAGAUAC A AAACAAGU 1543 ACUUGUUU CUGAUGAGGCCGUUAGGCCGAA
IUAUCUAC 2042 1715 UACAAAAC A AGUAAAGA 1544 UCUUUACU
CUGAUGAGGCCGUUAGGCCGAA IUUUUGUA 2043 1732 UUGGAGAC U UUGGACUU 1545
AAGUCCAA CUGAUGAGGCCGUUAGGCCGAA IUCUCCAA 2044 1739 CUUUGGAC U
UGUAACAU 1546 AUGUUACA CUGAUGAGGCCGUUAGGCCGAA IUCCAAAG 2045 1746
CUUGUAAC A UCUCUGAA 1547 UUCAGAGA CUGAUGAGGCCGUUAGGCCGAA IUUACAAG
2046 1749 GUAACAUC U CUGAAAAA 1548 UUUUUCAG CUGAUGAGGCCGUUAGGCCGAA
IAUGUUAC 2047 1751 AACAUCUC U GAAAAAUG 1549 CAUUUUUC
CUGAUGAGGCCGUUAGGCCGAA IAGAUGUU 2048 1773 AAGCGAAC A AGGAGUAA 1550
UUACUCCU CUGAUGAGGCCGUUAGGCCGAA IUUCGCUU 2049 1788 AAGGGAAC U
UUGCGAUA 1551 UAUCGCAA CUGAUGAGGCCGUUAGGCCGAA IUUCCCUU 2050 1798
UGCGAUAC A UGAGCCCA 1552 UGGGCUCA CUGAUGAGGCCGUUAGGCCGAA IUAUCGCA
2051 1804 ACAUGAGC C CAGAACAG 1553 CUGUUCUG CUGAUGAGGCCGUUAGGCCGAA
ICUCAUGU 2052 1805 CAUGAGCC C AGAACAGA 1554 UCUGUUCU
CUGAUGAGGCCGUUAGGCCGAA IGCUCAUG 2053 1806 AUGAGCCC A GAACAGAU 1555
AUCUGUUC CUGAUGAGGCCGUUAGGCCGAA IGGCUCAU 2054 1811 CCCAGAAC A
GAUUUCUU 1556 AAGAAAUC CUGAUGAGGCCGUUAGGCCGAA IUUCUGGG 2055 1818
CAGAUUUC U UCGCAAGA 1557 UCUUGCGA CUGAUGAGGCCGUUAGGCCGAA IAAAUCUG
2056 1823 UUCUUCGC A AGACUAUG 1558 CAUAGUCU CUGAUGAGGCCGUUAGGCCGAA
ICGAAGAA 2057 1828 CGCAAGAC U AUGGAAAG 1559 CUUUCCAU
CUGAUGAGGCCGUUAGGCCGAA IUCUUGCG 2058 1846 AAGUGGAC C UCUACGCU 1560
AGCGUAGA CUGAUGAGGCCGUUAGGCCGAA IUCCACUU 2059 1847 AGUGGACC U
CUACGCUU 1561 AAGCGUAG CUGAUGAGGCCGUUAGGCCGAA IGUCCACU 2060 1849
UGGACCUC U ACGCUUUG 1562 CAAAGCGU CUGAUGAGGCCGUUAGGCCGAA IAGGUCCA
2061 1854 CUCUACGC U UUGGGGCU 1563 AGCCCCAA CUGAUGAGGCCGUUAGGCCGAA
ICGUAGAG 2062 1862 UUUGGGGC U AAUUCUUG 1564 CAAGAAUU
CUGAUGAGGCCGUUAGGCCGAA ICCCCAAA 2063 1868 GCUAAUUC U UGCUGAAC 1565
GUUCAGCA CUGAUGAGGCCGUUAGGCCGAA IAAUUAGC 2064 1872 AUUCUUGC U
GAACUUCU 1566 AGAAGUUC CUGAUGAGGCCGUUAGGCCGAA ICAAGAAU 2065 1877
UGCUGAAC U UCUUCAUG 1567 CAUGAAGA CUGAUGAGGCCGUUAGGCCGAA IUUCAGCA
2066 1880 UGAACUUC U UCAUGUAU 1568 AUACAUGA CUGAUGAGGCCGUUAGGCCGAA
IAAGUUCA 2067 1883 ACUUCUUC A UGUAUGUG 1569 CACAUACA
CUGAUGAGGCCGUUAGGCCGAA IAAGAAGU 2068 1894 UAUGUGAC A CUGCUUUU 1570
AAAAGCAG CUGAUGAGGCCGUUAGGCCGAA IUCACAUA 2069 1896 UGUGACAC U
GCUUUUGA 1571 UCAAAAGC CUGAUGAGGCCGUUAGGCCGAA IUGUCACA 2070 1899
GACACUGC U UUUGAAAC 1572 GUUUCAAA CUGAUGAGGCCGUUAGGCCGAA ICAGUGUC
2071 1908 UUUGAAAC A UCAAAGUU 1573 AACUUUGA CUGAUGAGGCCGUUAGGCCGAA
IUUUCAAA 2072 1911 GAAACAUC A AAGUUUUU 1574 AAAAACUU
CUGAUGAGGCCGUUAGGCCGAA IAUGUUUC 2073 1921 AGUUUUUC A CAGACCUA 1575
UAGGUCUG CUGAUGAGGCCGUUAGGCCGAA IAAAAACU 2074 1923 UUUUUCAC A
GACCUACG 1576 CGUAGGUC CUGAUGAGGCCGUUAGGCCGAA IUGAAAAA 2075 1927
UCACAGAC C UACGGGAU 1577 AUCCCGUA CUGAUGAGGCCGUUAGGCCGAA IUCUGUGA
2076 1928 CACAGACC U ACGGGAUG 1578 CAUCCCGU CUGAUGAGGCCGUUAGGCCGAA
IGUCUGUG 2077 1939 GGGAUGGC A UCAUCUCA 1579 UGAGAUGA
CUGAUGAGGCCGUUAGGCCGAA ICCAUCCC 2078 1942 AUGGCAUC A UCUCAGAU 1580
AUCUGAGA CUGAUGAGGCCGUUAGGCCGAA IAUGCCAU 2079 1945 GCAUCAUC U
CAGAUAUA 1581 UAUAUCUG CUGAUGAGGCCGUUAGGCCGAA IAUGAUGC 2080 1947
AUCAUCUC A GAUAUAUU 1582 AAUAUAUC CUGAUGAGGCCGUUAGGCCGAA IAGAUGAU
2081 1974 GAAAAAAC U CUUCUACA 1583 UGUAGAAG CUGAUGAGGCCGUUAGGCCGAA
IUUUUUUC 2082 1976 AAAAACUC U UCUACAGA 1584 UCUGUAGA
CUGAUGAGGCCGUUAGGCCGAA IAGUUUUU 2083 1979 AACUCUUC U ACAGAAAU 1585
AUUUCUGU CUGAUGAGGCCGUUAGGCCGAA IAAGAGUU 2084 1982 UCUUCUAC A
GAAAUUAC 1586 GUAAUUUC CUGAUGAGGCCGUUAGGCCGAA IUAGAAGA 2085 1991
GAAAUUAC U CUCAAAGA 1587 UCUUUGAG CUGAUGAGGCCGUUAGGCCGAA IUAAUUUC
2086 1993 AAUUACUC U CAAAGAAA 1588 UUUCUUUG CUGAUGAGGCCGUUAGGCCGAA
IAGUAAUU 2087 1995 UUACUCUC A AAGAAACC 1589 GGUUUCUU
CUGAUGAGGCCGUUAGGCCGAA IAGAGUAA 2088 2003 AAAGAAAC C UGAGGAUC 1590
GAUCCUCA CUGAUGAGGCCGUUAGGCCGAA IUUUCUUU 2089 2004 AAGAAACC U
GAGGAUCG 1591 CGAUCCUC CUGAUGAGGCCGUUAGGCCGAA IGUUUCUU 2090 2015
GGAUCGAC C UAACACAU 1592 AUGUGUUA CUGAUGAGGCCGUUAGGCCGAA IUCGAUCC
2091 2016 GAUCGACC U AACACAUC 1593 GAUGUGUU CUGAUGAGGCCGUUAGGCCGAA
IGUCGAUC 2092 2020 GACCUAAC A CAUCUGAA 1594 UUCAGAUG
CUGAUGAGGCCGUUAGGCCGAA IUUAGGUC 2093 2022 CCUAACAC A UCUGAAAU 1595
AUUUCAGA CUGAUGAGGCCGUUAGGCCGAA IUGUUAGG 2094 2025 AACACAUC U
GAAAUACU 1596 AGUAUUUC CUGAUGAGGCCGUUAGGCCGAA IAUGUGUU 2095 2033
UGAAAUAC U AAGGACCU 1597 AGGUCCUU CUGAUGAGGCCGUUAGGCCGAA IUAUUUCA
2096 2040 CUAAGGAC C UUGACUGU 1598 ACAGUCAA CUGAUGAGGCCGUUAGGCCGAA
IUCCUUAG 2097 2041 UAAGGACC U UGACUGUG 1599 CACAGUCA
CUGAUGAGGCCGUUAGGCCGAA IGUCCUUA 2098 2046 ACCUUGAC U GUGUGGAA 1600
UUCCACAC CUGAUGAGGCCGUUAGGCCGAA IUCAAGGU 2099 2062 AGAAAAGC C
CAGAGAAA 1601 UUUCUCUG CUGAUGAGGCCGUUAGGCCGAA ICUUUUCU
2100 2063 GAAAAGCC C AGAGAAAA 1602 UUUUCUCU CUGAUGAGGCCGUUAGGCCGAA
IGCUUUUC 2101 2064 AAAAGCCC A GAGAAAAA 1603 UUUUUCUC
CUGAUGAGGCCGUUAGGCCGAA IGGCUUUU 2102 2081 UGAACGAC A CACAUGUU 1604
AACAUGUG CUGAUGAGGCCGUUAGGCCGAA IUCGUUCA 2103 2083 AACGACAC A
CAUGUUAG 1605 CUAACAUG CUGAUGAGGCCGUUAGGCCGAA IUGUCGUU 2104 2085
CGACACAC A UGUUAGAG 1606 CUCUAACA CUGAUGAGGCCGUUAGGCCGAA IUGUGUCG
2105 2095 GUUAGAGC C CUUCUGAA 1607 UUCAGAAG CUGAUGAGGCCGUUAGGCCGAA
ICUCUAAC 2106 2096 UUAGAGCC C UUCUGAAA 1608 UUUCAGAA
CUGAUGAGGCCGUUAGGCCGAA IGCUCUAA 2107 2097 UAGAGCCC U UCUGAAAA 1609
UUUUCAGA CUGAUGAGGCCGUUAGGCCGAA IGGCUCUA 2108 2100 AGCCCUUC U
GAAAAAGU 1610 ACUUUUUC CUGAUGAGGCCGUUAGGCCGAA IAAGGGCU 2109 2112
AAAGUAUC C UGCUUCUG 1611 CAGAAGCA CUGAUGAGGCCGUUAGGCCGAA IAUACUUU
2110 2113 AAGUAUCC U GCUUCUGA 1612 UCAGAAGC CUGAUGAGGCCGUUAGGCCGAA
IGAUACUU 2111 2116 UAUCCUGC U UCUGAUAU 1613 AUAUCAGA
CUGAUGAGGCCGUUAGGCCGAA ICAGGAUA 2112 2119 CCUGCUUC U GAUAUGCA 1614
UGCAUAUC CUGAUGAGGCCGUUAGGCCGAA IAAGCAGG 2113 2127 UGAUAUGC A
GUUUUCCU 1615 AGGAAAAC CUGAUGAGGCCGUUAGGCCGAA ICAUAUCA 2114 2134
CAGUUUUC C UUAAAUUA 1616 UAAUUUAA CUGAUGAGGCCGUUAGGCCGAA IAAAACUG
2115 2135 AGUUUUCC U UAAAUUAU 1617 AUAAUUUA CUGAUGAGGCCGUUAGGCCGAA
IGAAAACU 2116 2145 AAAUUAUC U AAAAUCUG 1618 CAGAUUUU
CUGAUGAGGCCGUUAGGCCGAA IAUAAUUU 2117 2152 CUAAAAUC U GCUAGGGA 1619
UCCCUAGC CUGAUGAGGCCGUUAGGCCGAA IAUUUUAG 2118 2155 AAAUCUGC U
AGGGAAUA 1620 UAUUCCCU CUGAUGAGGCCGUUAGGCCGAA ICAGAUUU 2119 2166
GGAAUAUC A AUAGAUAU 1621 AUAUCUAU CUGAUGAGGCCGUUAGGCCGAA IAUAUUCC
2120 2179 AUAUUUAC C UUUUAUUU 1622 AAAUAAAA CUGAUGAGGCCGUUAGGCCGAA
IUAAAUAU 2121 2180 UAUUUACC U UUUAUUUU 1623 AAAAUAAA
CUGAUGAGGCCGUUAGGCCGAA IGUAAAUA 2122 2197 AAUGUUUC C UUUAAUUU 1624
AAAUUAAA CUGAUGAGGCCGUUAGGCCGAA IAAACAUU 2123 2198 AUGUUUCC U
UUAAUUUU 1625 AAAAUUAA CUGAUGAGGCCGUUAGGCCGAA IGAAACAU 2124 2211
UUUUUUAC U AUUUUUAC 1626 GUAAAAAU CUGAUGAGGCCGUUAGGCCGAA IUAAAAAA
2125 2220 AUUUUUAC U AAUCUUUC 1627 GAAAGAUU CUGAUGAGGCCGUUAGGCCGAA
IUAAAAAU 2126 2225 UACUAAUC U UUCUGCAG 1628 CUGCAGAA
CUGAUGAGGCCGUUAGGCCGAA IAUUAGUA 2127 2229 AAUCUUUC U GCAGAAAC 1629
GUUUCUGC CUGAUGAGGCCGUUAGGCCGAA IAAAGAUU 2128 2232 CUUUCUGC A
GAAACAGA 1630 UCUGUUUC CUGAUGAGGCCGUUAGGCCGAA ICAGAAAG 2129 2238
GCAGAAAC A GAAAGGUU 1631 AACCUUUC CUGAUGAGGCCGUUAGGCCGAA IUUUCUGC
2130 2250 AGGUUUUC U UCUUUUUG 1632 CAAAAAGA CUGAUGAGGCCGUUAGGCCGAA
IAAAACCU 2131 2253 UUUUCUUC U UUUUGCUU 1633 AAGCAAAA
CUGAUGAGGCCGUUAGGCCGAA IAAGAAAA 2132 2260 CUUUUUGC U UCAAAAAC 1634
GUUUUUGA CUGAUGAGGCCGUUAGGCCGAA ICAAAAAG 2133 2263 UUUGCUUC A
AAAACAUU 1635 AAUGUUUU CUGAUGAGGCCGUUAGGCCGAA IAAGCAAA 2134 2269
UCAAAAAC A UUCUUACA 1636 UGUAAGAA CUGAUGAGGCCGUUAGGCCGAA IUUUUUGA
2135 2273 AAACAUUC U UACAUUUU 1637 AAAAUGUA CUGAUGAGGCCGUUAGGCCGAA
IAAUGUUU 2136 2277 AUUCUUAC A UUUUACUU 1638 AAGUAAAA
CUGAUGAGGCCGUUAGGCCGAA IUAAGAAU 2137 2284 CAUUUUAC U UUUUCCUG 1639
CAGGAAAA CUGAUGAGGCCGUUAGGCCGAA IUAAAAUG 2138 2290 ACUUUUUC C
UGGCUCAU 1640 AUGAGCCA CUGAUGAGGCCGUUAGGCCGAA IAAAAAGU 2139 2291
CUUUUUCC U GGCUCAUC 1641 GAUGAGCC CUGAUGAGGCCGUUAGGCCGAA IGAAAAAG
2140 2295 UUCCUGGC U CAUCUCUU 1642 AAGAGAUG CUGAUGAGGCCGUUAGGCCGAA
ICCAGGAA 2141 2297 CCUGGCUC A UCUCUUUA 1643 UAAAGAGA
CUGAUGAGGCCGUUAGGCCGAA IAGCCAGG 2142 2300 GGCUCAUC U CUUUAUUC 1644
GAAUAAAG CUGAUGAGGCCGUUAGGCCGAA IAUGAGCC 2143 2302 CUCAUCUC U
UUAUUCUU 1645 AAGAAUAA CUGAUGAGGCCGUUAGGCCGAA IAGAUGAG 2144 2309
CUUUAUUC U UUUUUUUU 1646 AAAAAAAA CUGAUGAGGCCGUUAGGCCGAA IAAUAAAG
2145 2329 UUAAAGAC A GAGUCUCG 1647 CGAGACUC CUGAUGAGGCCGUUAGGCCGAA
IUCUUUAA 2146 2335 ACAGAGUC U CGCUCUGU 1648 ACAGAGCG
CUGAUGAGGCCGUUAGGCCGAA IACUCUGU 2147 2339 AGUCUCGC U CUGUUGCC 1649
GGCAACAG CUGAUGAGGCCGUUAGGCCGAA ICGAGACU 2148 2341 UCUCGCUC U
GUUGCCCA 1650 UGGGCAAC CUGAUGAGGCCGUUAGGCCGAA IAGCGAGA 2149 2347
UCUGUUGC C CAGGCUGG 1651 CCAGCCUG CUGAUGAGGCCGUUAGGCCGAA ICAACAGA
2150 2348 CUGUUGCC C AGGCUGGA 1652 UCCAGCCU CUGAUGAGGCCGUUAGGCCGAA
IGCAACAG 2151 2349 UGUUGCCC A GGCUGGAG 1653 CUCCAGCC
CUGAUGAGGCCGUUAGGCCGAA IGGCAACA 2152 2353 GCCCAGGC U GGAGUGCA 1654
UGCACUCC CUGAUGAGGCCGUUAGGCCGAA ICCUGGGC 2153 2361 UGGAGUGC A
AUGACACA 1655 UGUGUCAU CUGAUGAGGCCGUUAGGCCGAA ICACUCCA 2154 2367
GCAAUGAC A CAGUCUUG 1656 CAAGACUG CUGAUGAGGCCGUUAGGCCGAA IUCAUUGC
2155 2369 AAUGACAC A GUCUUGGC 1657 GCCAAGAC CUGAUGAGGCCGUUAGGCCGAA
IUGUCAUU 2156 2373 ACACAGUC U UGGCUCAC 1658 GUGAGCCA
CUGAUGAGGCCGUUAGGCCGAA IACUGUGU 2157 2378 GUCUUGGC U CACUGCAA 1659
UUGCAGUG CUGAUGAGGCCGUUAGGCCGAA ICCAAGAC 2158 2380 CUUGGCUC A
CUGCAACU 1660 AGUUGCAG CUGAUGAGGCCGUUAGGCCGAA IAGCCAAG 2159 2382
UGGCUCAC U GCAACUUC 1661 GAAGUUGC CUGAUGAGGCCGUUAGGCCGAA IUGAGCCA
2160 2385 CUCACUGC A ACUUCUGC 1662 GCAGAAGU CUGAUGAGGCCGUUAGGCCGAA
ICAGUGAG 2161 2388 ACUGCAAC U UCUGCCUC 1663 GAGGCAGA
CUGAUGAGGCCGUUAGGCCGAA IUUGCAGU 2162 2391 GCAACUUC U GCCUCUUG 1664
CAAGAGGC CUGAUGAGGCCGUUAGGCCGAA IAAGUUGC 2163 2394 ACUUCUGC C
UCUUGGGU 1665 ACCCAAGA CUGAUGAGGCCGUUAGGCCGAA ICAGAAGU 2164 2395
CUUCUGCC U CUUGGGUU 1666 AACCCAAG CUGAUGAGGCCGUUAGGCCGAA IGCAGAAG
2165 2397 UCUGCCUC U UGGGUUCA 1667 UGAACCCA CUGAUGAGGCCGUUAGGCCGAA
IAGGCAGA 2166 2405 UUGGGUUC A AGUGAUUC 1668 GAAUCACU
CUGAUGAGGCCGUUAGGCCGAA IAACCCAA 2167 2414 AGUGAUUC U CCUGCCUC 1669
GAGGCAGG CUGAUGAGGCCGUUAGGCCGAA IAAUCACU 2168 2416 UGAUUCUC C
UGCCUCAG 1670 CUGAGGCA CUGAUGAGGCCGUUAGGCCGAA IAGAAUCA 2169 2417
GAUUCUCC U GCCUCAGC 1671 GCUGAGGC CUGAUGAGGCCGUUAGGCCGAA IGAGAAUC
2170 2420 UCUCCUGC C UCAGCCUC 1672 GAGGCUGA CUGAUGAGGCCGUUAGGCCGAA
ICAGGAGA 2171 2421 CUCCUGCC U CAGCCUCC 1673 GGAGGCUG
CUGAUGAGGCCGUUAGGCCGAA IGCAGGAG 2172 2423 CCUGCCUC A GCCUCCUG 1674
CAGGAGGC CUGAUGAGGCCGUUAGGCCGAA IAGGCAGG 2173 2426 GCCUCAGC C
UCCUGAGU 1675 ACUCAGGA CUGAUGAGGCCGUUAGGCCGAA ICUGAGGC 2174 2427
CCUCAGCC U CCUGAGUA 1676 UACUCAGG CUGAUGAGGCCGUUAGGCCGAA IGCUGAGG
2175 2429 UCAGCCUC C UGAGUAGC 1677 GCUACUCA CUGAUGAGGCCGUUAGGCCGAA
IAGGCUGA 2176 2430 CAGCCUCC U GAGUAGCU 1678 AGCUACUC
CUGAUGAGGCCGUUAGGCCGAA IGAGGCUG 2177 2438 UGAGUAGC U GGAUUACA 1679
UGUAAUCC CUGAUGAGGCCGUUAGGCCGAA ICUACUCA 2178 2446 UGGAUUAC A
GGCAUGUG 1680 CACAUGCC CUGAUGAGGCCGUUAGGCCGAA IUAAUCCA 2179 2450
UUACAGGC A UGUGCCAC 1681 GUGGCACA CUGAUGAGGCCGUUAGGCCGAA ICCUGUAA
2180 2456 GCAUGUGC C ACCCACCC 1682 GGGUGGGU CUGAUGAGGCCGUUAGGCCGAA
ICACAUGC 2181 2457 CAUGUGCC A CCCACCCA 1683 UGGGUGGG
CUGAUGAGGCCGUUAGGCCGAA IGCACAUG 2182 2459 UGUGCCAC C CACCCAAC 1684
GUUGGGUG CUGAUGAGGCCGUUAGGCCGAA IUGGCACA 2183
2460 GUGCCACC C ACCCAACU 1685 AGUUGGGU CUGAUGAGGCCGUUAGGCCGAA
IGUGGCAC 2184 2461 UGCCACCC A CCCAACUA 1686 UAGUUGGG
CUGAUGAGGCCGUUAGGCCGAA IGGUGGCA 2185 2463 CCACCCAC C CAACUAAU 1687
AUUAGUUG CUGAUGAGGCCGUUAGGCCGAA IUGGGUGG 2186 2464 CACCCACC C
AACUAAUU 1688 AAUUAGUU CUGAUGAGGCCGUUAGGCCGAA IGUGGGUG 2187 2465
ACCCACCC A ACUAAUUU 1689 AAAUUAGU CUGAUGAGGCCGUUAGGCCGAA IGGUGGGU
2188 2468 CACCCAAC U AAUUUUUG 1690 CAAAAAUU CUGAUGAGGCCGUUAGGCCGAA
IUUGGGUG 2189 2493 AUAAAGAC A GGGUUUCA 1691 UGAAACCC
CUGAUGAGGCCGUUAGGCCGAA IUCUUUAU 2190 2501 AGGGUUUC A CCAUGUUG 1692
CAACAUGG CUGAUGAGGCCGUUAGGCCGAA IAAACCCU 2191 2503 GGUUUCAC C
AUGUUGGC 1693 GCCAACAU CUGAUGAGGCCGUUAGGCCGAA IUGAAACC 2192 2504
GUUUCACC A UGUUGGCC 1694 GGCCAACA CUGAUGAGGCCGUUAGGCCGAA IGUGAAAC
2193 2512 AUGUUGGC C AGGCUGGU 1695 ACCAGCCU CUGAUGAGGCCGUUAGGCCGAA
ICCAACAU 2194 2513 UGUUGGCC A GGCUGGUC 1696 GACCAGCC
CUGAUGAGGCCGUUAGGCCGAA IGCCAACA 2195 2517 GGCCAGGC U GGUCUCAA 1697
UUGAGACC CUGAUGAGGCCGUUAGGCCGAA ICCUGGCC 2196 2522 GGCUGGUC U
CAAACUCC 1698 GGAGUUUG CUGAUGAGGCCGUUAGGCCGAA IACCAGCC 2197 2524
CUGGUCUC A AACUCCUG 1699 CAGGAGUU CUGAUGAGGCCGUUAGGCCGAA IAGACCAG
2198 2528 UCUCAAAC U CCUGACCU 1700 AGGUCAGG CUGAUGAGGCCGUUAGGCCGAA
IUUUGAGA 2199 2530 UCAAACUC C UGACCUCA 1701 UGAGGUCA
CUGAUGAGGCCGUUAGGCCGAA IAGUUUGA 2200 2531 CAAACUCC U GACCUCAA 1702
UUGAGGUC CUGAUGAGGCCGUUAGGCCGAA IGAGUUUG 2201 2535 CUCCUGAC C
UCAAGUAA 1703 UUACUUGA CUGAUGAGGCCGUUAGGCCGAA IUCAGGAG 2202 2536
UCCUGACC U CAAGUAAU 1704 AUUACUUG CUGAUGAGGCCGUUAGGCCGAA IGUCAGGA
2203 2538 CUGACCUC A AGUAAUCC 1705 GGAUUACU CUGAUGAGGCCGUUAGGCCGAA
IAGGUCAG 2204 2546 AAGUAAUC C ACCUGCCU 1706 AGGCAGGU
CUGAUGAGGCCGUUAGGCCGAA IAUUACUU 2205 2547 AGUAAUCC A CCUGCCUC 1707
GAGGCAGG CUGAUGAGGCCGUUAGGCCGAA IGAUUACU 2206 2549 UAAUCCAC C
UGCCUCGG 1708 CCGAGGCA CUGAUGAGGCCGUUAGGCCGAA IUGGAUUA 2207 2550
AAUCCACC U GCCUCGGC 1709 GCCGAGGC CUGAUGAGGCCGUUAGGCCGAA IGUGGAUU
2208 2553 CCACCUGC C UCGGCCUC 1710 GAGGCCGA CUGAUGAGGCCGUUAGGCCGAA
ICAGGUGG 2209 2554 CACCUGCC U CGGCCUCC 1711 GGAGGCCG
CUGAUGAGGCCGUUAGGCCGAA IGCAGGUG 2210 2559 GCCUCGGC C UCCCAAAG 1712
CUUUGGGA CUGAUGAGGCCGUUAGGCCGAA ICCGAGGC 2211 2560 CCUCGGCC U
CCCAAAGU 1713 ACUUUGGG CUGAUGAGGCCGUUAGGCCGAA IGCCGAGG 2212 2562
UCGGCCUC C CAAAGUGC 1714 GCACUUUG CUGAUGAGGCCGUUAGGCCGAA IAGGCCGA
2213 2563 CGGCCUCC C AAAGUGCU 1715 AGCACUUU CUGAUGAGGCCGUUAGGCCGAA
IGAGGCCG 2214 2564 GGCCUCCC A AAGUGCUG 1716 CAGCACUU
CUGAUGAGGCCGUUAGGCCGAA IGGAGGCC 2215 2571 CAAAGUGC U GGGAUUAC 1717
GUAAUCCC CUGAUGAGGCCGUUAGGCCGAA ICACUUUG 2216 2580 GGGAUUAC A
GGGAUGAG 1718 CUCAUCCC CUGAUGAGGCCGUUAGGCCGAA IUAAUCCC 2217 2590
GGAUGAGC C ACCGCGCC 1719 GGCGCGGU CUGAUGAGGCCGUUAGGCCGAA ICUCAUCC
2218 2591 GAUGAGCC A CCGCGCCC 1720 GGGCGCGG CUGAUGAGGCCGUUAGGCCGAA
IGCUCAUC 2219 2593 UGAGCCAC C GCGCCCAG 1721 CUGGGCGC
CUGAUGAGGCCGUUAGGCCGAA IUGGCUCA 2220 2598 CACCGCGC C CAGCCUCA 1722
UGAGGCUG CUGAUGAGGCCGUUAGGCCGAA ICGCGGUG 2221 2599 ACCGCGCC C
AGCCUCAU 1723 AUGAGGCU CUGAUGAGGCCGUUAGGCCGAA IGCGCGGU 2222 2600
CCGCGCCC A GCCUCAUC 1724 GAUGAGGC CUGAUGAGGCCGUUAGGCCGAA IGGCGCGG
2223 2603 CGCCCAGC C UCAUCUCU 1725 AGAGAUGA CUGAUGAGGCCGUUAGGCCGAA
ICUGGGCG 2224 2604 GCCCAGCC U CAUCUCUU 1726 AAGAGAUG
CUGAUGAGGCCGUUAGGCCGAA IGCUGGGC 2225 2606 CCAGCCUC A UCUCUUUG 1727
CAAAGAGA CUGAUGAGGCCGUUAGGCCGAA IAGGCUGG 2226 2609 GCCUCAUC U
CUUUGUUC 1728 GAACAAAG CUGAUGAGGCCGUUAGGCCGAA IAUGAGGC 2227 2611
CUCAUCUC U UUGUUCUA 1729 UAGAACAA CUGAUGAGGCCGUUAGGCCGAA IAGAUGAG
2228 2618 CUUUGUUC U AAAGAUGG 1730 CCAUCUUU CUGAUGAGGCCGUUAGGCCGAA
IAACAAAG 2229 2633 GGAAAAAC C ACCCCCAA 1731 UUGGGGGU
CUGAUGAGGCCGUUAGGCCGAA IUUUUUCC 2230 2634 GAAAAACC A CCCCCAAA 1732
UUUGGGGG CUGAUGAGGCCGUUAGGCCGAA IGUUUUUC 2231 2636 AAAACCAC C
CCCAAAUU 1733 AAUUUGGG CUGAUGAGGCCGUUAGGCCGAA IUGGUUUU 2232 2637
AAACCACC C CCAAAUUU 1734 AAAUUUGG CUGAUGAGGCCGUUAGGCCGAA IGUGGUUU
2233 2638 AACCACCC C CAAAUUUU 1735 AAAAUUUG CUGAUGAGGCCGUUAGGCCGAA
IGGUGGUU 2234 2639 ACCACCCC C AAAUUUUC 1736 GAAAAUUU
CUGAUGAGGCCGUUAGGCCGAA IGGGUGGU 2235 2640 CCACCCCC A AAUUUUCU 1737
AGAAAAUU CUGAUGAGGCCGUUAGGCCGAA IGGGGUGG 2236 2648 AAAUUUUC U
UUUUAUAC 1738 GUAUAAAA CUGAUGAGGCCGUUAGGCCGAA IAAAAUUU 2237 2657
UUUUAUAC U AUUAAUGA 1739 UCAUUAAU CUGAUGAGGCCGUUAGGCCGAA IUAUAAAA
2238 2669 AAUGAAUC A AUCAAUUC 1740 GAAUUGAU CUGAUGAGGCCGUUAGGCCGAA
IAUUCAUU 2239 2673 AAUCAAUC A AUUCAUAU 1741 AUAUGAAU
CUGAUGAGGCCGUUAGGCCGAA IAUUGAUU 2240 2678 AUCAAUUC A UAUCUAUU 1742
AAUAGAUA CUGAUGAGGCCGUUAGGCCGAA IAAUUGAU 2241 2683 UUCAUAUC U
AUUUAUUA 1743 UAAUAAAU CUGAUGAGGCCGUUAGGCCGAA IAUAUGAA 2242 2698
UAAAUUUC U ACCGCUUU 1744 AAAGCGGU CUGAUGAGGCCGUUAGGCCGAA IAAAUUUA
2243 2701 AUUUCUAC C GCUUUUAG 1745 CUAAAAGC CUGAUGAGGCCGUUAGGCCGAA
IUAGAAAU 2244 2704 UCUACCGC U UUUAGGCC 1746 GGCCUAAA
CUGAUGAGGCCGUUAGGCCGAA ICGGUAGA 2245 2712 UUUUAGGC C AAAAAAAU 1747
AUUUUUUU CUGAUGAGGCCGUUAGGCCGAA ICCUAAAA 2246 2713 UUUAGGCC A
AAAAAAUG 1748 CAUUUUUU CUGAUGAGGCCGUUAGGCCGAA IGCCUAAA 2247 2733
GAUCGUUC U CUGCCUCA 1749 UGAGGCAG CUGAUGAGGCCGUUAGGCCGAA IAACGAUC
2248 2735 UCGUUCUC U GCCUCACA 1750 UGUGAGGC CUGAUGAGGCCGUUAGGCCGAA
IAGAACGA 2249 2738 UUCUCUGC C UCACAUAG 1751 CUAUGUGA
CUGAUGAGGCCGUUAGGCCGAA ICAGAGAA 2250 2739 UCUCUGCC U CACAUAGC 1752
GCUAUGUG CUGAUGAGGCCGUUAGGCCGAA IGCAGAGA 2251 2741 UCUGCCUC A
CAUAGCUU 1753 AAGCUAUG CUGAUGAGGCCGUUAGGCCGAA IAGGCAGA 2252 2743
UGCCUCAC A UAGCUUAC 1754 GUAAGCUA CUGAUGAGGCCGUUAGGCCGAA IUGAGGCA
2253 2748 CACAUAGC U UACAAGCC 1755 GGCUUGUA CUGAUGAGGCCGUUAGGCCGAA
ICUAUGUG 2254 2752 UAGCUUAC A AGCCAGCU 1756 AGCUGGCU
CUGAUGAGGCCGUUAGGCCGAA IUAAGCUA 2255 2756 UUACAAGC C AGCUGGAG 1757
CUCCAGCU CUGAUGAGGCCGUUAGGCCGAA ICUUGUAA 2256 2757 UACAAGCC A
GCUGGAGA 1758 UCUCCAGC CUGAUGAGGCCGUUAGGCCGAA IGCUUGUA 2257 2760
AAGCCAGC U GGAGAAAU 1759 AUUUCUCC CUGAUGAGGCCGUUAGGCCGAA ICUGGCUU
2258 2776 UAUGGUAC U CAUUAAAA 1760 UUUUAAUG CUGAUGAGGCCGUUAGGCCGAA
IUACCAUA 2259 2778 UGGUACUC A UUAAAAAA 1761 UUUUUUAA
CUGAUGAGGCCGUUAGGCCGAA IAGUACCA 2260 Input Sequence = NM_002759.
Cut Site = CH/. Arm Length = 8. Core Sequence = CUGAUGAG X CGAA (X
= GCCGUUAGGC or other stem II) NM_002759 (Homo sapiens protein
kinase, interferon-inducible double stranded RNA dependent (PRKR),
mRNA.; 2808 bp) Underlined region can be any X sequence or linker,
as described herein. "I" stands for Inosine.
[0272] TABLE-US-00010 TABLE X Human PKR Zinzyme and Substrate
Sequence Seq Pos Substrate Seq ID Zinzyme ID 10 CGGCGGCG G CGGCGCAG
2261 CUGCGCCG GCCGAAAGGCGAGUGAGGUCU CGCCGCCG 2480 13 CGGCGGCG G
CGCAGUUU 2433 AAACUGCG GCCGAAAGGCGAGUGAGGUCU CGCCGCCG 2652 15
GCGGCGGC G CAGUUUGC 2434 GCAAACUG GCCGAAAGGCGAGUGAGGUCU GCCGCCGC
2653 18 GCGGCGCA G UUUGCUCA 2435 UGAGCAAA GCCGAAAGGCGAGUGAGGUCU
UGCGCCGC 2654 22 CGCAGUUU G CUCAUACU 2436 AGUAUGAG
GCCGAAAGGCGAGUGAGGUCU AAACUGCG 2655 33 CAUACUUU G UGACUUGC 2437
GCAAGUCA GCCGAAAGGCGAGUGAGGUCU AAAGUAUG 2656 40 UGUGACUU G CGGUCACA
2438 UGUGACCG GCCGAAAGGCGAGUGAGGUCU AAGUCACA 2657 43 GACUUGCG G
UCACAGUG 2439 CACUGUGA GCCGAAAGGCGAGUGAGGUCU CGCAAGUC 2658 49
CGGUCACA G UGGCAUUC 2440 GAAUGCCA GCCGAAAGGCGAGUGAGGUCU UGUGACCG
2659 52 UCACAGUG G CAUUCAGC 2441 GCUGAAUG GCCGAAAGGCGAGUGAGGUCU
CACUGUGA 2660 59 GGCAUUCA G CUCCACAC 2442 GUGUGGAG
GCCGAAAGGCGAGUGAGGUCU UGAAUGCC 2661 71 CACACUUG G UAGAACCA 2443
UGGUUCUA GCCGAAAGGCGAGUGAGGUCU CAAGUGUG 2662 83 AACCACAG G CACGACAA
2444 UUGUCGUG GCCGAAAGGCGAGUGAGGUCU CUGUGGUU 2663 92 CACGACAA G
CAUAGAAA 2445 UUUCUAUG GCCGAAAGGCGAGUGAGGUCU UUGUCGUG 2664 124
UCAUCGAG G CAUCGAGG 2446 CCUCGAUG GCCGAAAGGCGAGUGAGGUCU CUCGAUGA
2665 132 GCAUCGAG G UCCAUCCC 2447 GGGAUGGA GCCGAAAGGCGAGUGAGGUCU
CUCGAUGC 2666 162 AGACCCUG G CUAUCAUA 2448 UAUGAUAG
GCCGAAAGGCGAGUGAGGUCU CAGGGUCU 2667 178 AGACCUUA G UCUUCGCU 2449
AGCGAAGA GCCGAAAGGCGAGUGAGGUCU UAAGGUCU 2668 184 UAGUCUUC G
CUGGUAUA 2450 UAUACCAG GCCGAAAGGCGAGUGAGGUCU GAAGACUA 2669 188
CUUCGCUG G UAUACUCG 2451 CGAGUAUA GCCGAAAGGCGAGUGAGGUCU CAGCGAAG
2670 196 GUAUACUC G CUGUCUGU 2452 ACAGACAG GCCGAAAGGCGAGUGAGGUCU
GAGUAUAC 2671 199 UACUCGCU G UCUGUCAA 2453 UUGACAGA
GCCGAAAGGCGAGUGAGGUCU AGCGAGUA 2672 203 CGCUGUCU G UCAACCAG 2454
CUGGUUGA GCCGAAAGGCGAGUGAGGUCU AGACAGCG 2673 211 GUCAACCA G
CGGUUGAC 2455 GUCAACCG GCCGAAAGGCGAGUGAGGUCU UGGUUGAC 2674 214
AACCAGCG G UUGACUUU 2456 AAAGUCAA GCCGAAAGGCGAGUGAGGUCU CGCUGGUU
2675 229 UUUUUUAA G CCUUCUUU 2457 AAAGAAGG GCCGAAAGGCGAGUGAGGUCU
UUAAAAAA 2676 252 UUUUACCA G UUUCUGGA 2458 UCCAGAAA
GCCGAAAGGCGAGUGAGGUCU UGGUAAAA 2677 261 UUUCUGGA G CAAAUUCA 2459
UGAAUUUG GCCGAAAGGCGAGUGAGGUCU UCCAGAAA 2678 270 CAAAUUCA G
UUUGCCUU 2460 AAGGCAAA GCCGAAAGGCGAGUGAGGUCU UGAAUUUG 2679 274
UUCAGUUU G CCUUCCUG 2461 CAGGAAGG GCCGAAAGGCGAGUGAGGUCU AAACUGAA
2680 288 CUGGAUUU G UAAAUUGU 2462 ACAAUUUA GCCGAAAGGCGAGUGAGGUCU
AAAUCCAG 2681 295 UGUAAAUU G UAAUGACC 2463 GGUCAUUA
GCCGAAAGGCGAGUGAGGUCU AAUUUACA 2682 315 AAACUUUA G CAGUUCUU 2464
AAGAACUG GCCGAAAGGCGAGUGAGGUCU UAAAGUUU 2683 318 CUUUAGCA G
UUCUUCCA 2465 UGGAAGAA GCCGAAAGGCGAGUGAGGUCU UGCUAAAG 2684 337
UGACUCAG G UUUGCUUC 2466 GAAGCAAA GCCGAAAGGCGAGUGAGGUCU CUGAGUCA
2685 341 UCAGGUUU G CUUCUCUG 2467 CAGAGAAG GCCGAAAGGCGAGUGAGGUCU
AAACCUGA 2686 350 CUUCUCUG G CGGUCUUC 2468 GAAGACCG
GCCGAAAGGCGAGUGAGGUCU CAGAGAAG 2687 353 CUCUGGCG G UCUUCAGA 2469
UCUGAAGA GCCGAAAGGCGAGUGAGGUCU CGCCAGAG 2688 380 ACACUUCC G
UGAUUAUC 2470 GAUAAUCA GCCGAAAGGCGAGUGAGGUCU GGAAGUGU 2689 390
GAUUAUCU G CGUGCAUU 2471 AAUGCACG GCCGAAAGGCGAGUGAGGUCU AGAUAAUC
2690 392 UUAUCUGC G UGCAUUUU 2472 AAAAUGCA GCCGAAAGGCGAGUGAGGUCU
GCAGAUAA 2691 394 AUCUGCGU G CAUUUUGG 2473 CCAAAAUG
GCCGAAAGGCGAGUGAGGUCU ACGCAGAU 2692 408 UGGACAAA G CUUCCAAC 2474
GUUGGAAG GCCGAAAGGCGAGUGAGGUCU UUUGUCCA 2693 439 AAGAAAUG G
CUGGUGAU 2475 AUCACCAG GCCGAAAGGCGAGUGAGGUCU CAUUUCUU 2694 443
AAUGGCUG G UGAUCUUU 2476 AAAGAUCA GCCGAAAGGCGAGUGAGGUCU CAGCCAUU
2695 454 AUCUUUCA G CAGGUUUC 2477 GAAACCUG GCCGAAAGGCGAGUGAGGUCU
UGAAAGAU 2696 458 UUCAGCAG G UUUCUUCA 2478 UGAAGAAA
GCCGAAAGGCGAGUGAGGUCU CUGCUGAA 2697 488 UACAUACC G UCAGAAGC 2479
GCUUCUGA GCCGAAAGGCGAGUGAGGUCU GGUAUGUA 2698 495 CGUCAGAA G
CAGGGAGU 2262 ACUCCCUG GCCGAAAGGCGAGUGAGGUCU UUCUGACG 2481 502
AGCAGGGA G UAGUACUU 2263 AAGUACUA GCCGAAAGGCGAGUGAGGUCU UCCCUGCU
2482 505 AGGGAGUA G UACUUAAA 2264 UUUAAGUA GCCGAAAGGCGAGUGAGGUCU
UACUCCCU 2483 525 CAAGAACU G CCUAAUUC 2265 GAAUUAGG
GCCGAAAGGCGAGUGAGGUCU AGUUCUUG 2484 555 GAUAGGAG G UUUACAUU 2266
AAUGUAAA GCCGAAAGGCGAGUGAGGUCU CUCCUAUC 2485 568 CAUUUCAA G
UUAUAAUA 2267 UAUUAUAA GCCGAAAGGCGAGUGAGGUCU UUGAAAUG 2486 599
UCCAGAAG G UGAAGGUA 2268 UACCUUCA GCCGAAAGGCGAGUGAGGUCU CUUCUGGA
2487 605 AGGUGAAG G UAGAUCAA 2269 UUGAUCUA GCCGAAAGGCGAGUGAGGUCU
CUUCACCU 2488 622 AGAAGGAA G CAAAAAAU 2270 AUUUUUUG
GCCGAAAGGCGAGUGAGGUCU UUCCUUCU 2489 631 CAAAAAAU G CCGCAGCC 2271
GGCUGCGG GCCGAAAGGCGAGUGAGGUCU AUUUUUUG 2490 634 AAAAUGCC G
CAGCCAAA 2272 UUUGGCUG GCCGAAAGGCGAGUGAGGUCU GGCAUUUU 2491 637
AUGCCGCA G CCAAAUUA 2273 UAAUUUGG GCCGAAAGGCGAGUGAGGUCU UGCGGCAU
2492 646 CCAAAUUA G CUGUUGAG 2274 CUCAACAG GCCGAAAGGCGAGUGAGGUCU
UAAUUUGG 2493 649 AAUUAGCU G UUGAGAUA 2275 UAUCUCAA
GCCGAAAGGCGAGUGAGGUCU AGCUAAUU 2494 676 AAAAGAAG G CAGUUAGU 2276
ACUAACUG GCCGAAAGGCGAGUGAGGUCU CUUCUUUU 2495 679 AGAAGGCA G
UUAGUCCU 2277 AGGACUAA GCCGAAAGGCGAGUGAGGUCU UGCCUUCU 2496 683
GGCAGUUA G UCCUUUAU 2278 AUAAAGGA GCCGAAAGGCGAGUGAGGUCU UAACUGCC
2497 743 UUACAUAG G CCUUAUCA 2279 UGAUAAGG GCCGAAAGGCGAGUGAGGUCU
CUAUGUAA 2498 760 AUAGAAUU G CCCAGAAG 2280 CUUCUGGG
GCCGAAAGGCGAGUGAGGUCU AAUUCUAU 2499 781 GACUAACU G UAAAUUAU 2281
AUAAUUUA GCCGAAAGGCGAGUGAGGUCU AGUUAGUC 2500 795 UAUCAACA G
UGUGCAUC 2282 GAUGCACA GCCGAAAGGCGAGUGAGGUCU UGUUCAUA 2501 797
UGAACAGU G UGCAUCGG 2283 CCGAUGCA GCCGAAAGGCGAGUGAGGUCU ACUGUUCA
2502 799 AACAGUGU G CAUCGGGG 2284 CCCCGAUG GCCGAAAGGCGAGUGAGGUCU
ACACUGUU 2503 808 CAUCGGGG G UGCAUGGG 2285 CCCAUGCA
GCCGAAAGGCGAGUGAGGUCU CCCCGAUG 2504 810 UCGGGGGU G CAUGGGCC 2286
GGCCCAUG GCCGAAAGGCGAGUGAGGUCU ACCCCCGA 2505 816 GUGCAUGG G
CCAGAAGG 2287 CCUUCUGG GCCGAAAGGCGAGUGAGGUCU CCAUGCAC 2506 839
UUAUAAAU G CAAAAUGG 2288 CCAUUUUG GCCGAAAGGCGAGUGAGGUCU AUUUAUAA
2507 863 AGAAUAUA G UAUUGGUA 2289 UACCAAUA GCCGAAAGGCGAGUGAGGUCU
UAUAUUCU 2508 869 UAGUAUUG G UACAGGUU 2290 AACCUGUA
GCCGAAAGGCGAGUGAGGUCU CAAUACUA 2509 875 UGGUACAG G UUCUACUA 2291
UAGUAGAA GCCGAAAGGCGAGUGAGGUCU CUGUACCA 2510 892 AACAGGAA G
CAAAACAA 2292 UUGUUUUG GCCGAAAGGCGAGUGAGGUCU UUCCUGUU 2511 904
AACAAUUG G CCGCUAAA 2293 UUUAGCGG GCCGAAAGGCGAGUGAGGUCU CAAUUGUU
2512 907 AAUUGGCC G CUAAACUU 2294 AAGUUUAG GCCGAAAGGCGAGUGAGGUCU
GGCCAAUU 2513 916 CUAAACUU G CAUAUCUU 2295 AAGAUAUG
GCCGAAAGGCGAGUGAGGUCU AAGUUUAG 2514 949 AAACCUCA G UGAAAUCU 2296
AGAUUUCA GCCGAAAGGCGAGUGAGGUCU UGAGGUUU 2515 966 GACUACCU G
UCCUCUGG 2297 CCACAGGA GCCGAAAGGCGAGUGAGGUCU AGGUAGUC 2516 974
GUCCUCUG G UUCUUUUG 2298 CAAAAGAA GCCGAAAGGCGAGUGAGGUCU CAGAGGAC
2517 982 GUUCUUUU G CUACUACG 2299 CGUAGUAG GCCGAAAGGCGAGUGAGGUCU
AAAAGAAC 2518 990 GCUACUAC G UGUGAGUC 2300 GACUCACA
GCCGAAAGGCGAGUGAGGUCU GUAGUAGC 2519 992 UACUACCU G UGAGUCCC 2301
GGGACUCA GCCGAAAGGCGAGUGAGGUCU ACGUAGUA 2520 996 ACGUCUGA G
UCCCAAAG 2302 CUUUGGGA GCCGAAAGGCGAGUGAGGUCU UCACACGU 2521 1004
GUCCCAAA G CAACUCUU 2303 AAGAGUUG GCCGAAAGGCGAGUGAGGUCU UUUGGGAC
2522 1015 ACUCUUUA G UGACCAGC 2304 GCUGGUCA GCCGAAAGGCGAGUGAGGUCU
UAAAGAGU 2523 1022 AGUGACCA G CACACUCG 2305 CGAGUGUG
GCCGAAAGGCGAGUGAGGUCU UGGUCACU 2524 1030 GCACACUC G CUUCUGAA 2306
UUCAGAAG GCCGAAAGGCGAGUGAGGUCU GAGUGUGC 2525 1052 AUCUGAAG G
UGACUUCU 2307 AGAAGUCA GCCGAAAGGCGAGUGAGGUCU CUUCAGAU 2526 1063
ACUUCUGA G CAGAUACA 2308 UGUAUCUG GCCGAAAGGCGAGUGAGGUCU UGAGAAGU
2527 1091 UUCUAACA G UGACAGUU 2309 AACUGUCA GCCGAAAGGCGAGUGAGGUCU
UGUUAGAA 2528 1097 CAGUGACA G UUUAAACA 2310 UGUUUAAA
GCCGAAAGGCGAGUGAGGUCU UGUCACUG 2529 1106 UUUAAACA G UUCUUCGU 2311
ACGAAGAA GCCGAAAGGCGAGUGAGGUCU UGUUUAAA 2530 1113 AGUUCUUC G
UUGCUUAU 2312 AUAAGCAA GCCGAAAGGCGAGUGAGGUCU GAAGAACU 2531 1116
UCUUCGUU G CUUAUGAA 2313 UUCAUAAG GCCGAAAGGCGAGUGAGGUCU AACGAAGA
2532 1127 UAUGAAUG G UCUCAGAA 2314 UUCUGAGA GCCGAAAGGCGAGUGAGGUCU
CAUUCAUA 2533 1150 AAAGGAAG G CAAAAAGA 2315 UCUUUUUG
GCCGAAAGGCGAGUGAGGUCU CUUCCUUU 2534 1165 GAUCUUUG G CACCCAGA 2316
UCUGGGUG GCCGAAAGGCGAGUGAGGUCU CAAAGAUC 2535 1203 GAAACAAA G
UAUACUGU 2317 ACAGUAUA GCCGAAAGGCGAGUGAGGUCU UUUGUUUC 2536 1210
AGUAUACU G UGGACAAG 2318 CUUGUCCA GCCGAAAGGCGAGUGAGGUCU AGUAUACU
2537 1221 GACAAGAG G UUUGGCAU 2319 AUGCCAAA GCCGAAAGGCGAGUGAGGUCU
CUCUUGUC 2538 1226 GAGGUUUG G CAUGGAUU 2320 AAUCCAUG
GCCGAAAGGCGAGUGAGGUCU CAAACCUC 2539 1256 AUUAAUUG G CUCAGGUG 2321
CACCUGAG GCCGAAAGGCGAGUGAGGUCU CAAUUAAU 2540 1262 UGGCUCAG G
UGGAUUUG 2322 CAAAUCCA GCCGAAAGGCGAGUGAGGUCU CUGAGCCA 2541 1271
UGGAUUUG G CCAAGUUU 2323 AAACUUGG GCCGAAAGGCGAGUGAGGUCU CAAAUCCA
2542 1276 UUGGCCAA G UUUUCAAA 2324 UUUGAAAA GCCGAAAGGCGAGUGAGGUCU
UUGGCCAA 2543
1285 UUUUCAAA G CAAAACAC 2325 GUGUUUUG GCCGAAAGGCGAGUGAGGUCU
UUUGAAAA 2544 1315 AGACUUAC G UUAUUAAA 2326 UUUAAUAA
GCCGAAAGGCGAGUGAGGUCU GUAAGUCU 2545 1325 UAUUAAAC G UGUUAAAU 2327
AUUUAACA GCCGAAAGGCGAGUGAGGUCU GUUUAAUA 2546 1327 UUAAACGU G
UUAAAUAU 2328 AUAUUUAA GCCGAAAGGCGAGUGAGGUCU ACGUUUAA 2547 1348
ACGAGAAG G CGGAGCGU 2329 ACGCUCCG GCCGAAAGGCGAGUGAGGUCU CUUCUCGU
2548 1353 AAGGCGGA G CGUGAAGU 2330 ACUUCACG GCCGAAAGGCGAGUGAGGUCU
UCCGCCUU 2549 1355 GGCGGAGC G UGAAGUAA 2331 UUACUUCA
GCCGAAAGGCGAGUGAGGUCU GCUCCGCC 2550 1360 AGCGUGAA G UAAAAGCA 2332
UGCUUUUA GCCGAAAGGCGAGUGAGGUCU UUCACGCU 2551 1366 AAGUAAAA G
CAUUGGCA 2333 UGCCAAUG GCCGAAAGGCGAGUGAGGUCU UUUUACUU 2552 1372
AAGCAUUG G CAAAACUU 2334 AAGUUUUG GCCGAAAGGCGAGUGAGGUCU CAAUGCUU
2553 1387 UUGAUCAU G UAAAUAUU 2335 AAUAUUUA GCCGAAAGGCGAGUGAGGUCU
AUGAUCAA 2554 1396 UAAAUAUU G UUCACUAC 2336 GUAGUGAA
GCCGAAAGGCGAGUGAGGUCU AAUAUUUA 2555 1409 CUACAAUG G CUGUUGGG 2337
CCCAACAG GCCGAAAGGCGAGUGAGGUCU CAUUGUAG 2556 1412 CAAUGGCU G
UUGGGAUG 2338 CAUCCCAA GCCGAAAGGCGAGUGAGGUCU AGCCAUUG 2557 1445
UGAGACCA G UGAUGAUU 2339 AAUCAUCA GCCGAAAGGCGAGUGAGGUCU UGGUCUCA
2558 1463 UCUUGAGA G CAGUGAUU 2340 AAUCACUG GCCGAAAGGCGAGUGAGGUCU
UCUCAAGA 2559 1466 UGAGAGCA G UGAUUAUG 2341 CAUAAUCA
GCCGAAAGGCGAGUGAGGUCU UGCUCUCA 2560 1487 UGAGAACA G CAAAAAUA 2342
UAUUUUUG GCCGAAAGGCGAGUGAGGUCU UGUUCUCA 2561 1496 CAAAAAUA G
UUCAAGGU 2343 ACCUUGAA GCCGAAAGGCGAGUGAGGUCU UAUUUUUG 2562 1503
AGUUCAAG G UCAAAGAC 2344 GUCUUUGA GCCGAAAGGCGAGUGAGGUCU CUUGAACU
2563 1515 AAGACUAA G UGCCUUUU 2345 AAAAGGCA GCCGAAAGGCGAGUGAGGUCU
UUAGUCUU 2564 1517 GACUAAGU G CCUUUUCA 2346 UGAAAAGG
GCCGAAAGGCGAGUGAGGUCU ACUUAGUC 2565 1541 GGAAUUCU G UGAUAAAG 2347
CUUUAUCA GCCGAAAGGCGAGUGAGGUCU AGAAUUCC 2566 1583 AAGAAGAG G
CGAGAAAC 2348 GUUUCUCG GCCGAAAGGCGAGUGAGGUCU CUCUUCUU 2567 1600
UAGACAAA G UUUUGGCU 2349 AGCCAAAA GCCGAAAGGCGAGUGAGGUCU UUUGUCUA
2568 1606 AAGUUUUG G CUUUGGAA 2350 UUCCAAAG GCCGAAAGGCGAGUGAGGUCU
CAAAACUU 2569 1639 CAAAAGGG G UGGAUUAU 2351 AUAAUCCA
GCCGAAAGGCGAGUGAGGUCU CCCUUUUG 2570 1683 GAUCUUAA G CCAAGUAA 2352
UUACUUGG GCCGAAAGGCGAGUGAGGUCU UUAAGAUC 2571 1688 UAAGCCAA G
UAAUAUAU 2353 AUAUAUUA GCCGAAAGGCGAGUGAGGUCU UUGGCUUA 2572 1702
UAUUCUUA G UAGAUACA 2354 UGUAUCUA GCCGAAAGGCGAGUGAGGUCU UAAGAAUA
2573 1717 CAAAACAA G UAAAGAUU 2355 AAUCUUUA GCCGAAAGGCGAGUGAGGUCU
UUGUUUUG 2574 1741 UUGGACUU G UAACAUCU 2356 AGAUGUUA
GCCGAAAGGCGAGUGAGGUCU AAGUCCAA 2575 1767 GAUGGAAA G CGAACAAG 2357
CUUGUUCG GCCGAAAGGCGAGUGAGGUCU UUUCCAUC 2576 1778 AACAAGGA G
UAAGGGAA 2358 UUCCCUUA GCCGAAAGGCGAGUGAGGUCU UCCUUGUU 2577 1791
GGAACUUU G CGAUACAU 2359 AUGUAUCG GCCGAAAGGCGAGUGAGGUCU AAAGUUCC
2578 1802 AUACAUGA G CCCAGAAC 2360 GUUCUGGG GCCGAAAGGCGAGUGAGGUCU
UCAUGUAU 2579 1821 AUUUCUUC G CAAGACUA 2361 UAGUCUUG
GCCGAAAGGCGAGUGAGGUCU GAAGAAAU 2580 1840 GAAAGGAA G UGGACCUC 2362
GAGGUCCA GCCGAAAGGCGAGUGAGGUCU UUCCUUUC 2581 1852 ACCUCUAC G
CUUUGGGG 2363 CCCCAAAG GCCGAAAGGCGAGUGAGGUCU GUAGAGGU 2582 1860
GCUUUGGG G CUAAUUCU 2364 AGAAUUAG GCCGAAAGGCGAGUGAGGUCU CCCAAAGC
2583 1870 UAAUUCUU G CUGAACUU 2365 AAGUUCAG GCCGAAAGGCGAGUGAGGUCU
AAGAAUUA 2584 1885 UUCUUCAU G UAUGUGAC 2366 GUCACAUA
GCCGAAAGGCGAGUGAGGUCU AUGAAGAA 2585 1889 UCAUGUAU G UGACACUG 2367
CAGUGUCA GCCGAAAGGCGAGUGAGGUCU AUACAUGA 2586 1897 GUGACACU G
CUUUUGAA 2368 UUCAAAAG GCCGAAAGGCGAGUGAGGUCU AGUGUCAC 2587 1914
ACAUCAAA G UUUUUCAC 2369 GUGAAAAA GCCGAAAGGCGAGUGAGGUCU UUUGAUGU
2588 1937 ACGGGAUG G CAUCAUCU 2370 AGAUGAUG GCCGAAAGGCGAGUGAGGUCU
CAUCCCGU 2589 2047 CCUUGACU G UGUGGAAG 2371 CUUCCACA
GCCGAAAGGCGAGUGAGGUCU AGUCAAGG 2590 2049 UUGACUGU G UGGAAGAA 2372
UUCUUCCA GCCGAAAGGCGAGUGAGGUCU ACAGUCAA 2591 2060 GAAGAAAA G
CCCAGAGA 2373 UCUCUGGG GCCGAAAGGCGAGUGAGGUCU UUUUCUUC 2592 2087
ACACACAU G UUAGAGCC 2374 GGCUCUAA GCCGAAAGGCGAGUGAGGUCU AUGUGUGU
2593 2093 AUGUUAGA G CCCUUCUG 2375 CAGAAGGG GCCGAAAGGCGAGUGAGGUCU
UCUAACAU 2594 2107 CUGAAAAA G UAUCCUGC 2376 GCAGGAUA
GCCGAAAGGCGAGUGAGGUCU UUUUUCAG 2595 2114 AGUAUCCU G CUUCUGAU 2377
AUCAGAAG GCCGAAAGGCGAGUGAGGUCU AGGAUACU 2596 2125 UCUGAUAU G
CAGUUUUC 2378 GAAAACUG GCCGAAAGGCGAGUGAGGUCU AUAUCAGA 2597 2128
GAUAUGCA G UUUUCCUU 2379 AAGGAAAA GCCGAAAGGCGAGUGAGGUCU UGCAUAUC
2598 2153 UAAAAUCU G CUAGGGAA 2380 UUCCCUAG GCCGAAAGGCGAGUGAGGUCU
AGAUUUUA 2599 2192 AUUUUAAU G UUUCCUUU 2381 AAAGGAAA
GCCGAAAGGCGAGUGAGGUCU AUUAAAAU 2600 2230 AUCUUUCU G CAGAAACA 2382
UGUUUCUG GCCGAAAGGCGAGUGAGGUCU AGAAAGAU 2601 2244 ACAGAAAG G
UUUUCUUC 2383 GAAGAAAA GCCGAAAGGCGAGUGAGGUCU CUUUCUGU 2602 2258
UUCUUUUU G CUUCAAAA 2384 UUUUGAAG GCCGAAAGGCGAGUGAGGUCU AAAAAGAA
2603 2293 UUUUCCUG G CUCAUCUC 2385 GAGAUGAG GCCGAAAGGCGAGUGAGGUCU
CAGGAAAA 2604 2332 AAGACAGA G UCUCGCUC 2386 GAGCGAGA
GCCGAAAGGCGAGUGAGGUCU UCUGUCUU 2605 2337 AGAGUCUC G CUCUGUUG 2387
CAACAGAG GCCGAAAGGCGAGUGAGGUCU GAGACUCU 2606 2342 CUCGCUCU G
UUGCCCAG 2388 CUGGGCAA GCCGAAAGGCGAGUGAGGUCU AGAGCGAG 2607 2345
GCUCUGUU G CCCAGGCU 2389 AGCCUGGG GCCGAAAGGCGAGUGAGGUCU AACAGAGC
2608 2351 UUGCCCAG G CUGGAGUG 2390 CACUCCAG GCCGAAAGGCGAGUGAGGUCU
CUGGGCAA 2609 2357 AGGCUGGA G UGCAAUGA 2391 UCAUUGCA
GCCGAAAGGCGAGUGAGGUCU UCCAGCCU 2610 2359 GCUGGAGU G CAAUGACA 2392
UGUCAUUG GCCGAAAGGCGAGUGAGGUCU ACUCCAGC 2611 2370 AUGACACA G
UCUUGGCU 2393 AGCCAAGA GCCGAAAGGCGAGUGAGGUCU UGUGUCAU 2612 2376
CAGUCUUG G CUCACUGC 2394 GCAGUGAG GCCGAAAGGCGAGUGAGGUCU CAAGACUG
2613 2383 GGCUCACU G CAACUUCU 2395 AGAAGUUG GCCGAAAGGCGAGUGAGGUCU
AGUGAGCC 2614 2392 CAACUUCU G CCUCUUGG 2396 CCAAGAGG
GCCGAAAGGCGAGUGAGGUCU AGAAGUUG 2615 2401 CCUCUUGG G UUCAAGUG 2397
CACUUGAA GCCGAAAGGCGAGUGAGGUCU CCAAGAGG 2616 2407 GGGUUCAA G
UGAUUCUC 2398 GAGAAUCA GCCGAAAGGCGAGUGAGGUCU UUGAACCC 2617 2418
AUUCUCCU G CCUCAGCC 2399 GGCUGAGG GCCGAAAGGCGAGUGAGGUCU AGGAGAAU
2618 2424 CUGCCUCA G CCUCCUGA 2400 UCAGGAGG GCCGAAAGGCGAGUGAGGUCU
UGAGGCAG 2619 2433 CCUCCUGA G UAGCUGGA 2401 UCCAGCUA
GCCGAAAGGCGAGUGAGGUCU UCAGGAGG 2620 2436 CCUGAGUA G CUGGAUUA 2402
UAAUCCAG GCCGAAAGGCGAGUGAGGUCU UACUCAGG 2621 2448 GAUUACAG G
CAUGUGCC 2403 GGCACAUG GCCGAAAGGCGAGUGAGGUCU CUGUAAUC 2622 2452
ACAGGCAU G UGCCACCC 2404 GGGUGGCA GCCGAAAGGCGAGUGAGGUCU AUGCCUGU
2623 2454 AGGCAUGU G CCACCCAC 2405 GUGGGUGG GCCGAAAGGCGAGUGAGGUCU
ACAUGCCU 2624 2476 UAAUUUUU G UGUUUUUA 2406 UAAAAACA
GCCGAAAGGCGAGUGAGGUCU AAAAAUUA 2625 2478 AUUUUUGU G UUUUUAAU 2407
AUUAAAAA GCCGAAAGGCGAGUGAGGUCU ACAAAAAU 2626 2496 AAGACAGG G
UUUCACCA 2408 UGGUGAAA GCCGAAAGGCGAGUGAGGUCU CCUGUCUU 2627
2506 UUCACCAU G UUGGCCAG 2409 CUGGCCAA GCCGAAAGGCGAGUGAGGUCU
AUGGUGAA 2628 2510 CCAUGUUG G CCAGGCUG 2410 CAGCCUGG
GCCGAAAGGCGAGUGAGGUCU CAACAUGG 2629 2515 UUGGCCAG G CUGGUCUC 2411
GAGACCAG GCCGAAAGGCGAGUGAGGUCU CUGGCCAA 2630 2519 CCAGGCUG G
UCUCAAAC 2412 GUUUGAGA GCCGAAAGGCGAGUGAGGUCU CAGCCUGG 2631 2540
GACCUCAA G UAAUCCAC 2413 GUGGAUUA GCCGAAAGGCGAGUGAGGUCU UUGAGGUC
2632 2551 AUCCACCU G CCUCGGCC 2414 GGCCGAGG GCCGAAAGGCGAGUGAGGUCU
AGGUGGAU 2633 2557 CUGCCUCG G CCUCCCAA 2415 UUGGGAGG
GCCGAAAGGCGAGUGAGGUCU CGAGGCAG 2634 2567 CUCCCAAA G UGCUGGGA 2416
UCCCAGCA GCCGAAAGGCGAGUGAGGUCU UUUGGGAG 2635 2569 CCCAAAGU G
CUGGGAUU 2417 AAUCCCAG GCCGAAAGGCGAGUGAGGUCU ACUUUGGG 2636 2588
AGGGAUGA G CCACCGCG 2418 CGCGGUGG GCCGAAAGGCGAGUGAGGUCU UCAUCCCU
2637 2594 GAGCCACC G CGCCCAGC 2419 GCUGGGCG GCCGAAAGGCGAGUGAGGUCU
GGUGGCUC 2638 2596 GCCACCGC G CCCAGCCU 2420 AGGCUGGG
GCCGAAAGGCGAGUGAGGUCU GCGGUGGC 2639 2601 CGCGCCCA G CCUCAUCU 2421
AGAUGAGG GCCGAAAGGCGAGUGAGGUCU UGGGCGCG 2640 2614 AUCUCUUU G
UUCUAAAG 2422 CUUUAGAA GCCGAAAGGCGAGUGAGGUCU AAAGAGAU 2641 2702
UUUCUACC G CUUUUAGG 2423 CCUAAAAG GCCGAAAGGCGAGUGAGGUCU GGUAGAAA
2642 2710 GCUUUUAG G CCAAAAAA 2424 UUUUUUGG GCCGAAAGGCGAGUGAGGUCU
CUAAAAGC 2643 2721 AAAAAAAU G UAAGAUCG 2425 CGAUCUUA
GCCGAAAGGCGAGUGAGGUCU AUUUUUUU 2644 2729 GUAAGAUC G UUCUCUGC 2426
GCAGAGAA GCCGAAAGGCGAGUGAGGUCU GAUCUUAC 2645 2736 CGUUCUCU G
CCUCACAU 2427 AUGUGAGG GCCGAAAGGCGAGUGAGGUCU AGAGAACG 2646 2746
CUCACAUA G CUUACAAG 2428 CUUGUAAG GCCGAAAGGCGAGUGAGGUCU UAUGUGAG
2647 2754 GCUUACAA G CCAGCUGG 2429 CCAGCUGG GCCGAAAGCCCAGUGAGGUCU
UUGUAAGC 2648 2758 ACAAGCCA G CUGGAGAA 2430 UUCUCCAG
GCCGAAACGCGAGUGAGCUCU UCGCUUGU 2649 2772 GAAAUAUG G UACUCAUU 2431
AAUGAGUA GCCGAAAGGCGAGUGAGGUCU CAUAUUUC 2650 2796 AAAAAAAA G
UGAUGUAC 2432 GUACAUCA GCCGAAAGGCGAGUGAGGUCU UUUUUUUU 2651 Input
Sequence = NM_002759. Cut Site = G/Y Arm Length = 8. Core Sequence
= GCcgaaagGCGaGuCaaGGuCu NM_002759 (Homo sapiens protein kinase,
interferon-inducible double stranded RNA dependent (PRKR), mRNA.;
2808 bp)
[0273] TABLE-US-00011 TABLE XI Human PKR DNAzyme and Substrate
Sequence Seq Pos Substrate Seq ID DNAzyme ID 10 CGGCGGCG G CGGCGCAG
2261 CTGCGCCG GGCTAGCTACAACGA CGCCGCCG 2904 13 CGGCGGCG G CGCAGUUU
2433 AAACTGCG GGCTAGCTACAACGA CGCCGCCG 2905 15 GCGGCGGC G CAGUUUGC
2434 GCAAACTG GGCTAGCTACAACGA GCCGCCGC 2906 18 GCGGCGCA G UUUGCUCA
2435 TGAGCAAA GGCTAGCTACAACGA TGCGCCGC 2907 22 CGCAGUUU G CUCAUACU
2436 AGTATGAG GGCTAGCTACAACGA AAACTGCG 2908 26 GUUUGCUC A UACUUUGU
1265 ACAAAGTA GGCTAGCTACAACGA GAGCAAAC 2909 28 UUGCUCAU A CUUUGUGA
4 TCACAAAG GGCTAGCTACAACGA ATGAGCAA 2910 33 CAUACUUU G UGACUUGC
2437 GCAAGTCA GGCTAGCTACAACGA AAAGTATG 2911 36 ACUUUGUG A CUUGCGGU
2699 ACCGCAAG GGCTAGCTACAACGA CACAAAGT 2912 40 UGUGACUU G CGGUCACA
2438 TGTGACCG GGCTAGCTACAACGA AAGTCACA 2913 43 GACUUGCG G UCACAGUG
2439 CACTGTGA GGCTAGCTACAACGA CGCAAGTC 2914 46 UUGCGGUC A CAGUGGCA
1268 TGCCACTG GGCTAGCTACAACGA GACCGCAA 2915 49 CGGUCACA G UGGCAUUC
2440 GAATGCCA GGCTAGCTACAACGA TGTGACCG 2916 52 UCACAGUG G CAUUCAGC
2441 GCTGAATG GGCTAGCTACAACGA CACTGTGA 2917 54 ACAGUGGC A UUCAGCUC
1270 GAGCTGAA GGCTAGCTACAACGA GCCACTGT 2918 59 GGCAUUCA G CUCCACAC
2442 GTGTGGAG GGCTAGCTACAACGA TGAATGCC 2919 64 UCAGCUCC A CACUUGGU
1274 ACCAAGTG GGCTAGCTACAACGA GGAGCTGA 2920 66 AGCUCCAC A CUUGGUAG
1275 CTACCAAG GGCTAGCTACAACGA GTGGAGCT 2921 71 CACACUUG G UAGAACCA
2443 TGGTTCTA GGCTAGCTACAACGA CAAGTGTG 2922 76 UUGGUAGA A CCACAGGC
2700 GCCTGTGG GGCTAGCTACAACGA TCTACCAA 2923 79 GUAGAACC A CAGGCACG
1278 CGTGCCTG GGCTAGCTACAACGA GGTTCTAC 2924 83 AACCACAG G CACGACAA
2444 TTGTCGTG GGCTAGCTACAACGA CTGTGGTT 2925 85 CCACAGGC A CGACAAGC
1280 GCTTGTCG GGCTAGCTACAACGA GCCTGTGG 2926 88 CAGGCACG A CAAGCAUA
2701 TATGCTTG GGCTAGCTACAACGA CGTGCCTG 2927 92 CACGACAA G CAUAGAAA
2445 TTTCTATG GGCTAGCTACAACGA TTGTCGTG 2928 94 CGACAAGC A UAGAAACA
1282 TGTTTCTA GGCTAGCTACAACGA GCTTGTCG 2929 100 GCAUAGAA A CAUCCUAA
2702 TTAGGATG GGCTAGCTACAACGA TTCTATGC 2930 102 AUAGAAAC A UCCUAAAC
1283 GTTTAGGA GGCTAGCTACAACGA GTTTCTAT 2931 109 CAUCCUAA A CAAUCUUC
2703 GAAGATTG GGCTAGCTACAACGA TTAGGATG 2932 112 CCUAAACA A UCUUCAUC
2704 GATGAAGA GGCTAGCTACAACGA TGTTTAGG 2933 118 CAAUCUUC A UCGAGGCA
1288 TGCCTCGA GGCTAGCTACAACGA GAAGATTG 2934 124 UCAUCGAG C CAUCGAGG
2446 CCTCGATG GGCTAGCTACAACGA CTCGATGA 2935 126 AUCGAGGC A UCCAGGUC
1289 GACCTCGA GGCTAGCTACAACGA GCCTCGAT 2936 132 GCAUCGAG G UCCAUCCC
2447 GGGATGGA GGCTAGCTACAACGA CTCGATGC 2937 136 CGAGGUCC A UCCCAAUA
1291 TATTGGGA GGCTAGCTACAACGA GGACCTCG 2938 142 CCAUCCCA A UAAAAAUC
2705 GATTTTTA GGCTAGCTACAACGA TGGGATGG 2939 148 CAAUAAAA A UCAGGAGA
2706 TCTCCTGA GGCTAGCTACAACGA TTTTATTG 2940 156 AUCAGGAG A CCCUGGCU
2707 AGCCAGGG GGCTAGCTACAACGA CTCCTGAT 2941 162 AGACCCUG G CUAUCAUA
2448 TATGATAG GGCTAGCTACAACGA CAGGGTCT 2942 165 CCCUGGCU A UCAUAGAC
26 GTCTATGA GGCTAGCTACAACGA AGCCAGGG 2943 168 UGGCUAUC A UAGACCUU
1300 AAGGTCTA GGCTAGCTACAACGA GATAGCCA 2944 172 UAUCAUAG A CCUUAGUC
2708 GACTAAGG GGCTAGCTACAACGA CTATGATA 2945 178 AGACCUUA G UCUUCGCU
2449 AGCGAAGA GGCTAGCTACAACGA TAAGGTCT 2946 184 UAGUCUUC G CUGGUAUA
2450 TATACCAG GGCTAGCTACAACGA GAAGACTA 2947 188 CUUCGCUG G UAUACUCG
2451 CGAGTATA GGCTAGCTACAACGA CAGCGAAG 2948 190 UCGCUGGU A UACUCGCU
34 AGCGAGTA GGCTAGCTACAACGA ACCAGCGA 2949 192 GCUGGUAU A CUCGCUGU
35 ACAGCGAG GGCTAGCTACAACGA ATACCAGC 2950 196 GUAUACUC G CUGUCUGU
2452 ACAGACAG GGCTAGCTACAACGA GAGTATAC 2951 199 UACUCGCU G UCUGUCAA
2453 TTGACAGA GGCTAGCTACAACGA AGCGAGTA 2952 203 CGCUGUCU G UCAACCAG
2454 CTGGTTGA GGCTAGCTACAACGA AGACAGCG 2953 207 GUCUGUCA A CCAGCGGU
2709 ACCGCTGG GGCTAGCTACAACGA TGACAGAC 2954 211 GUCAACCA G CGGUUGAC
2455 GTCAACCG GGCTAGCTACAACGA TGGTTGAC 2955 214 AACCAGCG G UUGACUUU
2456 AAAGTCAA GGCTAGCTACAACGA CGCTGGTT 2956 218 AGCGGUUG A CUUUUUUU
2710 AAAAAAAG GGCTAGCTACAACGA CAACCGCT 2957 229 UUUUUUAA G CCUUCUUU
2457 AAAGAAGG GGCTAGCTACAACGA TTAAAAAA 2958 248 UCUCUUUU A CCAGUUUC
59 GAAACTGG GGCTAGCTACAACGA AAAAGAGA 2959 252 UUUUACCA G UUUCUGGA
2458 TCCAGAAA GGCTAGCTACAACGA TGGTAAAA 2960 261 UUUCUGGA G CAAAUUCA
2459 TGAATTTG GGCTAGCTACAACGA TCCAGAAA 2961 265 UGGAGCAA A UUCAGUUU
2711 AAACTGAA GGCTAGCTACAACGA TTGCTCCA 2962 270 CAAAUUCA G UUUGCCUU
2460 AAGGCAAA GGCTAGCTACAACGA TGAATTTG 2963 274 UUCAGUUU G CCUUCCUG
2461 CAGGAAGG GGCTAGCTACAACGA AAACTGAA 2964 284 CUUCCUGG A UUUGUAAA
2712 TTTACAAA GGCTAGCTACAACGA CCAGGAAG 2965 288 CUGGAUUU G UAAAUUGU
2462 ACAATTTA GGCTAGCTACAACGA AAATCCAG 2966 292 AUUUGUAA A UUGUAAUG
2713 CATTACAA GGCTAGCTACAACGA TTACAAAT 2967 295 UGUAAAUU G UAAUGACC
2463 GGTCATTA GGCTAGCTACAACGA AATTTACA 2968 298 AAAUUGUA A UGACCUCA
2714 TGAGGTCA GGCTAGCTACAACGA TACAATTT 2969 301 UUGUAAUG A CCUCAAAA
2715 TTTTGAGG GGCTAGCTACAACGA CATTACAA 2970 309 ACCUCAAA A CUUUAGCA
2716 TGCTAAAG GGCTAGCTACAACGA TTTGAGGT 2971 315 AAACUUUA G CAGUUCUU
2464 AAGAACTG GGCTAGCTACAACGA TAAAGTTT 2972 318 CUUUAGCA G UUCUUCCA
2465 TGGAAGAA GGCTAGCTACAACGA TGCTAAAG 2973 326 GUUCUUCC A UCUGACUC
1333 GAGTCAGA GGCTAGCTACAACGA GGAAGAAC 2974 331 UCCAUCUG A CUCAGGUU
2717 AACCTGAG GGCTAGCTACAACGA CAGATGGA 2975 337 UGACUCAG G UUUGCUUC
2466 GAAGCAAA GGCTAGCTACAACGA CTGAGTCA 2976 341 UCAGGUUU G CUUCUCUG
2467 CAGAGAAG GGCTAGCTACAACGA AAACCTGA 2977 350 CUUCUCUG G CGGUCUUC
2468 GAAGACCG GGCTAGCTACAACGA CAGAGAAG 2978 353 CUCUGGCG G UCUUCAGA
2469 TCTGAAGA GGCTAGCTACAACGA CGCCAGAG 2979 362 UCUUCAGA A UCAACAUC
2718 GATGTTGA GGCTAGCTACAACGA TCTGAAGA 2980 366 CAGAAUCA A CAUCCACA
2719 TGTGGATG GGCTAGCTACAACGA TGATTCTG 2981 368 GAAUCAAC A UCCACACU
1343 AGTGTGGA GGCTAGCTACAACGA GTTGATTC 2982 372 CAACAUCC A CACUUCCG
1345 CGGAAGTG GGCTAGCTACAACGA GGATGTTG 2983 374 ACAUCCAC A CUUCCGUG
1346 CACGGAAG GGCTAGCTACAACGA GTGGATGT 2984 380 ACACUUCC G UGAUUAUC
2470 GATAATCA GGCTAGCTACAACGA GGAAGTGT 2985 383 CUUCCGUG A UUAUCUGC
2720 GCAGATAA GGCTAGCTACAACGA CACGGAAG 2986 386 CCGUGAUU A UCUGCGUG
97 CACGCAGA GGCTAGCTACAACGA AATCACGG 2987 390 GAUUAUCU G CGUGCAUU
2471 AATGCACG GGCTAGCTACAACGA AGATAATC 2988 392 UUAUCUGC G UGCAUUUU
2472 AAAATGCA GGCTAGCTACAACGA GCAGATAA 2989 394 AUCUGCGU G CAUUUUGG
2473 CCAAAATG GGCTAGCTACAACGA ACGCAGAT 2990 396 CUGCGUGC A UUUUGGAC
1350 GTCCAAAA GGCTAGCTACAACGA GCACGCAG 2991 403 CAUUUUGG A CAAAGCUU
2721 AAGCTTTG GGCTAGCTACAACGA CCAAAATG 2992 408 UGGACAAA G CUUCCAAC
2474 GTTGGAAG GGCTAGCTACAACGA TTTGTCCA 2993 415 AGCUUCCA A CCAGGAUA
2722 TATCCTGG GGCTAGCTACAACGA TGGAAGCT 2994 421 CAACCAGG A UACGGGAA
2723 TTCCCGTA GGCTAGCTACAACGA CCTGGTTG 2995 423 ACCAGGAU A CGGGAAGA
104 TCTTCCCG GGCTAGCTACAACGA ATCCTGGT 2996 436 AAGAAGAA A UGGCUGGU
2724 ACCAGCCA GGCTAGCTACAACGA TTCTTCTT 2997 439 AAGAAAUG G CUGGUGAU
2475 ATCACCAG GGCTAGCTACAACGA CATTTCTT 2998 443 AAUGGCUG G UGAUCUUU
2476 AAAGATCA GGCTAGCTACAACGA CAGCCATT 2999 446 GGCUGGUG A UCUUUCAG
2725 CTGAAAGA GGCTAGCTACAACGA CACCAGCC 3000 454 AUCUUUCA G CAGGUUUC
2477 GAAACCTG GGCTAGCTACAACGA TGAAAGAT 3001 458 UUCAGCAG G UUUCUUCA
2478 TGAAGAAA GGCTAGCTACAACGA CTGCTGAA 3002 466 GUUUCUUC A UGGAGGAA
1362 TTCCTCCA GGCTAGCTACAACGA GAAGAAAC 3003 474 AUGGAGGA A CUUAAUAC
2726 GTATTAAG GGCTAGCTACAACGA TCCTCCAT 3004 479 GGAACUUA A UACAUACC
2727 GGTATGTA GGCTAGCTACAACGA TAAGTTCC 3005 481 AACUUAAU A CAUACCGU
116 ACGGTATG GGCTAGCTACAACGA ATTAAGTT 3006 483 CUUAAUAC A UACCGUCA
1364 TGACGGTA GGCTAGCTACAACGA GTATTAAG 3007 485 UAAUACAU A CCGUCAGA
117 TCTGACGG GGCTAGCTACAACGA ATGTATTA 3008 488 UACAUACC G UCAGAAGC
2479 GCTTCTGA GGCTAGCTACAACGA GGTATGTA 3009 495 CGUCAGAA G CAGGGAGU
2262 ACTCCCTG GGCTAGCTACAACGA TTCTGACG 3010 502 AGCAGGGA G UAGUACUU
2263 AAGTACTA GGCTAGCTACAACGA TCCCTGCT 3011 505 AGGGAGUA G UACUUAAA
2264 TTTAAGTA GGCTAGCTACAACGA TACTCCCT 3012 507 GGAGUAGU A CUUAAAUA
120 TATTTAAG GGCTAGCTACAACGA ACTACTCC 3013 513 GUACUUAA A UAUCAAGA
2728 TCTTGATA GGCTAGCTACAACGA TTAAGTAC 3014 515 ACUUAAAU A UCAAGAAC
123 GTTCTTGA GGCTAGCTACAACGA ATTTAAGT 3015 522 UAUCAAGA A CUGCCUAA
2729 TTAGGCAG GGCTAGCTACAACGA TCTTGATA 3016 525 CAAGAACU G CCUAAUUC
2265 GAATTAGG GGCTAGCTACAACGA AGTTCTTG 3017 530 ACUGCCUA A UUCAGGAC
2730 GTCCTGAA GGCTAGCTACAACGA TAGGCAGT 3018 537 AAUUCAGG A CCUCCACA
2731 TGTGGAGG GGCTAGCTACAACGA CCTGAATT 3019 543 GGACCUCC A CAUGAUAG
1377 CTATCATG GGCTAGCTACAACGA GGAGGTCC 3020 545 ACCUCCAC A UGAUAGGA
1378 TCCTATCA GGCTAGCTACAACGA GTGGAGGT 3021 548 UCCACAUG A UAGGAGGU
2732 ACCTCCTA GGCTAGCTACAACGA CATGTGGA 3022 555 GAUAGGAG G UUUACAUU
2266 AATGTAAA GGCTAGCTACAACGA CTCCTATC 3023 559 GGAGGUUU A CAUUUCAA
132 TTGAAATG GGCTAGCTACAACGA AAACCTCC 3024 561 AGGUUUAC A UUUCAAGU
1379 ACTTGAAA GGCTAGCTACAACGA GTAAACCT 3025
568 CAUUUCAA G UUAUAAUA 2267 TATTATAA GGCTAGCTACAACGA TTGAAATG 3026
571 UUCAAGUU A UAAUAGAU 137 ATCTATTA GGCTAGCTACAACGA AACTTGAA 3027
574 AAGUUAUA A UAGAUGGA 2733 TCCATCTA GGCTAGCTACAACGA TATAACTT 3028
578 UAUAAUAG A UGGAAGAG 2734 CTCTTCCA GGCTAGCTACAACGA CTATTATA 3029
588 GGAAGAGA A UUUCCAGA 2735 TCTGGAAA GGCTAGCTACAACGA TCTCTTCC 3030
599 UCCAGAAG G UGAAGGUA 2268 TACCTTCA GGCTAGCTACAACGA CTTCTGGA 3031
605 AGGUGAAG G UAGAUCAA 2269 TTGATCTA GGCTAGCTACAACGA CTTCACCT 3032
609 GAAGGUAG A UCAAAGAA 2736 TTCTTTGA GGCTAGCTACAACGA CTACCTTC 3033
622 AGAAGGAA G CAAAAAAU 2270 ATTTTTTG GGCTAGCTACAACGA TTCCTTCT 3034
629 AGCAAAAA A UGCCGCAG 2737 CTGCGGCA GGCTAGCTACAACGA TTTTTGCT 3035
631 CAAAAAAU G CCGCAGCC 2271 GGCTGCGG GGCTAGCTACAACGA ATTTTTTG 3036
634 AAAAUGCC G CAGCCAAA 2272 TTTGGCTG GGCTAGCTACAACGA GGCATTTT 3037
637 AUGCCGCA G CCAAAUUA 2273 TAATTTGG GGCTAGCTACAACGA TGCGGCAT 3038
642 GCAGCCAA A UUAGCUGU 2738 ACAGCTAA GGCTAGCTACAACGA TTGGCTGC 3039
646 CCAAAUUA G CUGUUGAG 2274 CTCAACAG GGCTAGCTACAACGA TAATTTGG 3040
649 AAUUAGCU G UUGAGAUA 2275 TATCTCAA GGCTAGCTACAACGA AGCTAATT 3041
655 CUGUUGAG A UACUUAAU 2739 ATTAAGTA GGCTAGCTACAACGA CTCAACAG 3042
657 GUUGAGAU A CUUAAUAA 148 TTATTAAG GGCTAGCTACAACGA ATCTCAAC 3043
662 GAUACUUA A UAAGGAAA 2740 TTTCCTTA GGCTAGCTACAACGA TAAGTATC 3044
676 AAAAGAAG G CAGUUAGU 2276 ACTAACTG GGCTAGCTACAACGA CTTCTTTT 3045
679 AGAAGGCA G UUAGUCCU 2277 AGGACTAA GGCTAGCTACAACGA TGCCTTCT 3046
683 GGCAGUUA G UCCUUUAU 2278 ATAAAGGA GGCTAGCTACAACGA TAACTGCC 3047
690 AGUCCUUU A UUAUUGAC 157 GTCAATAA GGCTAGCTACAACGA AAAGGACT 3048
693 CCUUUAUU A UUGACAAC 159 GTTGTCAA GGCTAGCTACAACGA AATAAAGG 3049
697 UAUUAUUG A CAACAACG 2741 CGTTGTTG GGCTAGCTACAACGA CAATAATA 3050
700 UAUUGACA A CAACGAAU 2742 ATTCGTTG GGCTAGCTACAACGA TGTCAATA 3051
703 UGACAACA A CGAAUUCU 2743 AGAATTCG GGCTAGCTACAACGA TGTTGTCA 3052
707 AACAACGA A UUCUUCAG 2744 CTGAAGAA GGCTAGCTACAACGA TCGTTGTT 3053
720 UCAGAAGG A UUAUCCAU 2745 ATGGATAA GGCTAGCTACAACGA CCTTCTGA 3054
723 GAAGGAUU A UCCAUGGG 166 CCCATGGA GGCTAGCTACAACGA AATCCTTC 3055
727 GAUUAUCC A UGGGGAAU 1399 ATTCCCCA GGCTAGCTACAACGA GGATAATC 3056
734 CAUGGGGA A UUACAUAG 2746 CTATGTAA GGCTAGCTACAACGA TCCCCATG 3057
737 GGGGAAUU A CAUAGGCC 169 GGCCTATG GGCTAGCTACAACGA AATTCCCC 3058
739 GGAAUUAC A UAGGCCUU 1400 AAGGCCTA GGCTAGCTACAACGA GTAATTCC 3059
743 UUACAUAG G CCUUAUCA 2279 TGATAAGG GGCTAGCTACAACGA CTATGTAA 3060
748 UAGGCCUU A UCAAUAGA 172 TCTATTGA GGCTAGCTACAACGA AAGGCCTA 3061
752 CCUUAUCA A UAGAAUUG 2747 CAATTCTA GGCTAGCTACAACGA TGATAAGG 3062
757 UCAAUAGA A UUGCCCAG 2748 CTGGGCAA GGCTAGCTACAACGA TCTATTGA 3063
760 AUAGAAUU G CCCAGAAG 2280 CTTCTGGG GGCTAGCTACAACGA AATTCTAT 3064
774 AAGAAAAG A CUAACUGU 2749 ACAGTTAG GGCTAGCTACAACGA CTTTTCTT 3065
778 AAAGACUA A CUGUAAAU 2750 ATTTACAG GGCTAGCTACAACGA TAGTCTTT 3066
781 GACUAACU G UAAAUUAU 2281 ATAATTTA GGCTAGCTACAACGA AGTTAGTC 3067
785 AACUGUAA A UUAUGAAC 2751 GTTCATAA GGCTAGCTACAACGA TTACAGTT 3068
788 UGUAAAUU A UGAACAGU 179 ACTGTTCA GGCTAGCTACAACGA AATTTACA 3069
792 AAUUAUGA A CAGUGUGC 2752 GCACACTG GGCTAGCTACAACGA TCATAATT 3070
795 UAUGAACA G UGUGCAUC 2282 GATGCACA GGCTAGCTACAACGA TGTTCATA 3071
797 UGAACAGU G UGCAUCGG 2283 CCGATGCA GGCTAGCTACAACGA ACTGTTCA 3072
799 AACAGUGU G CAUCGGGG 2284 CCCCGATG GGCTAGCTACAACGA ACACTGTT 3073
801 CAGUGUGC A UCGGGGGU 1410 ACCCCCGA GGCTAGCTACAACGA GCACACTG 3074
808 CAUCGGGG G UGCAUGGG 2285 CCCATGCA GGCTAGCTACAACGA CCCCGATG 3075
810 UCGGGGGU G CAUGGGCC 2286 GGCCCATG GGCTAGCTACAACGA ACCCCCGA 3076
812 GGGGGUGC A UGGGCCAG 1411 CTGGCCCA GGCTAGCTACAACGA GCACCCCC 3077
816 GUGCAUGG G CCAGAAGG 2287 CCTTCTGG GGCTAGCTACAACGA CCATGCAC 3078
825 CCAGAAGG A UUUCAUUA 2753 TAATGAAA GGCTAGCTACAACGA CCTTCTGG 3079
830 AGGAUUUC A UUAUAAAU 1414 ATTTATAA GGCTAGCTACAACGA GAAATCCT 3080
833 AUUUCAUU A UAAAUGCA 185 TGCATTTA GGCTAGCTACAACGA AATGAAAT 3081
837 CAUUAUAA A UGCAAAAU 2754 ATTTTGCA GGCTAGCTACAACGA TTATAATG 3082
839 UUAUAAAU G CAAAAUGG 2288 CCATTTTG GGCTAGCTACAACGA ATTTATAA 3083
844 AAUGCAAA A UGGGACAG 2755 CTGTCCCA GGCTAGCTACAACGA TTTGCATT 3084
849 AAAAUGGG A CAGAAAGA 2756 TCTTTCTG GGCTAGCTACAACGA CCCATTTT 3085
858 CAGAAAGA A UAUAGUAU 2757 ATACTATA GGCTAGCTACAACGA TCTTTCTG 3086
860 GAAAGAAU A UAGUAUUG 187 CAATACTA GGCTAGCTACAACGA ATTCTTTC 3087
863 AGAAUAUA G UAUUGGUA 2289 TACCAATA GGCTAGCTACAACGA TATATTCT 3088
865 AAUAUAGU A UUGGUACA 189 TGTACCAA GGCTAGCTACAACGA ACTATATT 3089
869 UAGUAUUG G UACAGGUU 2290 AACCTGTA GGCTAGCTACAACGA CAATACTA 3090
871 GUAUUGGU A CAGGUUCU 191 AGAACCTG GGCTAGCTACAACGA ACCAATAC 3091
875 UGGUACAG G UUCUACUA 2291 TAGTAGAA GGCTAGCTACAACGA CTGTACCA 3092
880 CAGGUUCU A CUAAACAG 194 CTGTTTAG GGCTAGCTACAACGA AGAACCTG 3093
885 UCUACUAA A CAGGAAGC 2758 GCTTCCTG GGCTAGCTACAACGA TTAGTAGA 3094
892 AACAGGAA G CAAAACAA 2292 TTGTTTTG GGCTAGCTACAACGA TTCCTGTT 3095
897 GAAGCAAA A CAAUUGGC 2759 GCCAATTG GGCTAGCTACAACGA TTTGCTTC 3096
900 GCAAAACA A UUGGCCGC 2760 GCGGCCAA GGCTAGCTACAACGA TGTTTTGC 3097
904 AACAAUUG G CCGCUAAA 2293 TTTAGCGG GGCTAGCTACAACGA CAATTGTT 3098
907 AAUUGGCC G CUAAACUU 2294 AAGTTTAG GGCTAGCTACAACGA GGCCAATT 3099
912 GCCGCUAA A CUUGCAUA 2761 TATGCAAG GGCTAGCTACAACGA TTAGCGGC 3100
916 CUAAACUU G CAUAUCUU 2295 AAGATATG GGCTAGCTACAACGA AAGTTTAG 3101
918 AAACUUGC A UAUCUUCA 1426 TGAAGATA GGCTAGCTACAACGA GCAAGTTT 3102
920 ACUUGCAU A UCUUCAGA 199 TCTGAAGA GGCTAGCTACAACGA ATGCAAGT 3103
928 AUCUUCAG A UAUUAUCA 2762 TGATAATA GGCTAGCTACAACGA CTGAAGAT 3104
930 CUUCAGAU A UUAUCAGA 203 TCTGATAA GGCTAGCTACAACGA ATCTGAAG 3105
933 CAGAUAUU A UCAGAAGA 205 TCTTCTGA GGCTAGCTACAACGA AATATCTG 3106
943 CAGAAGAA A CCUCAGUG 2763 CACTGAGG GGCTAGCTACAACGA TTCTTCTG 3107
949 AAACCUCA G UGAAAUCU 2296 AGATTTCA GGCTAGCTACAACGA TGAGGTTT 3108
954 UCAGUGAA A UCUGACUA 2764 TAGTCAGA GGCTAGCTACAACGA TTCACTGA 3109
959 GAAAUCUG A CUACCUGU 2765 ACAGGTAG GGCTAGCTACAACGA CAGATTTC 3110
962 AUCUGACU A CCUGUCCU 209 AGGACAGG GGCTAGCTACAACGA AGTCAGAT 3111
966 GACUACCU G UCCUCUGG 2297 CCAGAGGA GGCTAGCTACAACGA AGGTAGTC 3112
974 GUCCUCUG G UUCUUUUG 2298 CAAAAGAA GGCTAGCTACAACGA CAGAGGAC 3113
982 GUUCUUUU G CUACUACG 2299 CGTAGTAG GGCTAGCTACAACGA AAAAGAAC 3114
985 CUUUUGCU A CUACGUGU 217 ACACGTAG GGCTAGCTACAACGA AGCAAAAG 3115
988 UUGCUACU A CGUGUGAG 218 CTCACACG GGCTAGCTACAACGA AGTAGCAA 3116
990 GCUACUAC G UGUGAGUC 2300 GACTCACA GGCTAGCTACAACGA GTAGTAGC 3117
992 UACUACGU G UGAGUCCC 2301 GGGACTCA GGCTAGCTACAACGA ACGTAGTA 3118
996 ACGUGUGA G UCCCAAAG 2302 CTTTGGGA GGCTAGCTACAACGA TCACACGT 3119
1004 GUCCCAAA G CAACUCUU 2303 AAGAGTTG GGCTAGCTACAACGA TTTGGGAC
3120 1007 CCAAAGCA A CUCUUUAG 2766 CTAAAGAG GGCTAGCTACAACGA
TGCTTTGG 3121 1015 ACUCUUUA G UGACCAGC 2304 GCTGGTCA
GGCTAGCTACAACGA TAAAGAGT 3122 1018 CUUUAGUG A CCAGCACA 2767
TGTGCTGG GGCTAGCTACAACGA CACTAAAG 3123 1022 AGUGACCA G CACACUCG
2305 CGAGTGTG GGCTAGCTACAACGA TGGTCACT 3124 1024 UGACCAGC A
CACUCGCU 1451 AGCGAGTG GGCTAGCTACAACGA GCTGGTCA 3125 1026 ACCAGCAC
A CUCGCUUC 1452 GAAGCGAG GGCTAGCTACAACGA GTGCTGGT 3126 1030
GCACACUC G CUUCUGAA 2306 TTCAGAAG GGCTAGCTACAACGA GAGTGTGC 3127
1038 GCUUCUGA A UCAUCAUC 2768 GATGATGA GGCTAGCTACAACGA TCAGAAGC
3128 1041 UCUGAAUC A UCAUCUGA 1456 TCAGATGA GGCTAGCTACAACGA
GATTCAGA 3129 1044 GAAUCAUC A UCUGAAGG 1457 CCTTCAGA
GGCTAGCTACAACGA GATGATTC 3130 1052 AUCUGAAG G UGACUUCU 2307
AGAAGTCA GGCTAGCTACAACGA CTTCAGAT 3131 1055 UGAAGGUG A CUUCUCAG
2769 CTGAGAAG GGCTAGCTACAACGA CACCTTCA 3132 1063 ACUUCUCA G
CAGAUACA 2308 TGTATCTG GGCTAGCTACAACGA TGAGAAGT 3133 1067 CUCAGCAG
A UACAUCAG 2770 CTGATGTA GGCTAGCTACAACGA CTGCTGAG 3134 1069
CAGCAGAU A CAUCAGAG 233 CTCTGATG GGCTAGCTACAACGA ATCTGCTG 3135 1071
GCAGAUAC A UCAGAGAU 1463 ATCTCTGA GGCTAGCTACAACGA GTATCTGC 3136
1078 CAUCAGAG A UAAAUUCU 2771 AGAATTTA GGCTAGCTACAACGA CTCTGATG
3137 1082 AGAGAUAA A UUCUAACA 2772 TGTTAGAA GGCTAGCTACAACGA
TTATCTCT 3138 1088 AAAUUCUA A CAGUGACA 2773 TGTCACTG
GGCTAGCTACAACGA TAGAATTT 3139 1091 UUCUAACA G UGACAGUU 2309
AACTGTCA GGCTAGCTACAACGA TGTTAGAA 3140 1094 UAACAGUG A CAGUUUAA
2774 TTAAACTG GGCTAGCTACAACGA CACTGTTA 3141 1097 CAGUGACA G
UUUAAACA 2310 TGTTTAAA GGCTAGCTACAACGA TGTCACTG 3142 1103 CAGUUUAA
A CAGUUCUU 2775 AAGAACTG GGCTAGCTACAACGA TTAAACTG 3143 1106
UUUAAACA G UUCUUCGU 2311 ACGAAGAA GGCTAGCTACAACGA TGTTTAAA 3144
1113 AGUUCUUC G UUGCUUAU 2312 ATAAGCAA GGCTAGCTACAACGA GAAGAACT
3145 1116 UCUUCGUU G CUUAUGAA 2313 TTCATAAG GGCTAGCTACAACGA
AACGAAGA 3146 1120 CGUUGCUU A UGAAUGGU 248 ACCATTCA GGCTAGCTACAACGA
AAGCAACG 3147 1124 GCUUAUGA A UGGUCUCA 2776 TGAGACCA
GGCTAGCTACAACGA TCATAAGC 3148 1127 UAUGAAUG G UCUCAGAA 2314
TTCTGAGA GGCTAGCTACAACGA CATTCATA 3149 1136 UCUCAGAA A UAAUCAAA
2777 TTTGATTA GGCTAGCTACAACGA TTCTGAGA 3150
1139 CAGAAAUA A UCAAAGGA 2778 TCCTTTGA GGCTAGCTACAACGA TATTTCTG
3151 1150 AAAGGAAG G CAAAAAGA 2315 TCTTTTTG GGCTAGCTACAACGA
CTTCCTTT 3152 1158 GCAAAAAG A UCUUUGGC 2779 GCCAAAGA
GGCTAGCTACAACGA CTTTTTGC 3153 1165 GAUCUUUG G CACCCAGA 2316
TCTGGGTG GGCTAGCTACAACGA CAAAGATC 3154 1167 UCUUUGGC A CCCAGAUU
1476 AATCTGGG GGCTAGCTACAACGA GCCAAAGA 3155 1173 GCACCCAG A
UUUGACCU 2780 AGGTCAAA GGCTAGCTACAACGA CTGGGTGC 3156 1178 CAGAUUUG
A CCUUCCUG 2781 CAGGAAGG GGCTAGCTACAACGA CAAATCTG 3157 1187
CCUUCCUG A CAUGAAAG 2782 CTTTCATG GGCTAGCTACAACGA CAGGAAGG 3158
1189 UUCCUGAC A UGAAAGAA 1484 TTCTTTCA GGCTAGCTACAACGA GTCAGGAA
3159 1198 UGAAAGAA A CAAAGUAU 2783 ATACTTTG GGCTAGCTACAACGA
TTCTTTCA 3160 1203 GAAACAAA G UAUACUGU 2317 ACAGTATA
GGCTAGCTACAACGA TTTGTTTC 3161 1205 AACAAAGU A UACUGUGG 260 CCACAGTA
GGCTAGCTACAACGA ACTTTGTT 3162 1207 CAAAGUAU A CUGUGGAC 261 GTCCACAG
GGCTAGCTACAACGA ATACTTTG 3163 1210 AGUAUACU G UGGACAAG 2318
CTTGTCCA GGCTAGCTACAACGA AGTATACT 3164 1214 UACUGUGG A CAAGAGGU
2784 ACCTCTTG GGCTAGCTACAACGA CCACAGTA 3165 1221 GACAAGAG G
UUUGGCAU 2319 ATGCCAAA GGCTAGCTACAACGA CTCTTGTC 3166 1226 GAGGUUUG
G CAUGGAUU 2320 AATCCATG GGCTAGCTACAACGA CAAACCTC 3167 1228
GGUUUGGC A UGGAUUUU 1488 AAAATCCA GGCTAGCTACAACGA GCCAAACC 3168
1232 UGGCAUGG A UUUUAAAG 2785 CTTTAAAA GGCTAGCTACAACGA CCATGCCA
3169 1243 UUAAAGAA A UAGAAUUA 2786 TAATTCTA GGCTAGCTACAACGA
TTCTTTAA 3170 1248 GAAAUAGA A UUAAUUGG 2787 CCAATTAA
GGCTAGCTACAACGA TCTATTTC 3171 1252 UAGAAUUA A UUGGCUCA 2788
TGAGCCAA GGCTAGCTACAACGA TAATTCTA 3172 1256 AUUAAUUG G CUCAGGUG
2321 CACCTGAG GGCTAGCTACAACGA CAATTAAT 3173 1262 UGGCUCAG G
UGGAUUUG 2322 CAAATCCA GGCTAGCTACAACGA CTGAGCCA 3174 1266 UCAGGUGG
A UUUGGCCA 2789 TGGCCAAA GGCTAGCTACAACGA CCACCTGA 3175 1271
UGGAUUUG G CCAAGUUU 2323 AAACTTGG GGCTAGCTACAACGA CAAATCCA 3176
1276 UUGGCCAA G UUUUCAAA 2324 TTTGAAAA GGCTAGCTACAACGA TTGGCCAA
3177 1285 UUUUCAAA G CAAAACAC 2325 GTGTTTTG GGCTAGCTACAACGA
TTTGAAAA 3178 1290 AAAGCAAA A CACAGAAU 2790 ATTCTGTG
GGCTAGCTACAACGA TTTGCTTT 3179 1292 AGCAAAAC A CAGAAUUG 1495
CAATTCTG GGCTAGCTACAACGA GTTTTGCT 3180 1297 AACACAGA A UUGACGGA
2791 TCCGTCAA GGCTAGCTACAACGA TCTGTGTT 3181 1301 CAGAAUUG A
CGGAAAGA 2792 TCTTTCCG GGCTAGCTACAACGA CAATTCTG 3182 1309 ACGGAAAG
A CUUACGUU 2793 AACGTAAG GGCTAGCTACAACGA CTTTCCGT 3183 1313
AAAGACUU A CGUUAUUA 281 TAATAACG GGCTAGCTACAACGA AAGTCTTT 3184 1315
AGACUUAC G UUAUUAAA 2326 TTTAATAA GGCTAGCTACAACGA GTAAGTCT 3185
1318 CUUACGUU A UUAAACGU 283 ACGTTTAA GGCTAGCTACAACGA AACGTAAG 3186
1323 GUUAUUAA A CGUGUUAA 2794 TTAACACG GGCTAGCTACAACGA TTAATAAC
3187 1325 UAUUAAAC G UGUUAAAU 2327 ATTTAACA GGCTAGCTACAACGA
GTTTAATA 3188 1327 UUAAACGU G UUAAAUAU 2328 ATATTTAA
GGCTAGCTACAACGA ACGTTTAA 3189 1332 CGUGUUAA A UAUAAUAA 2795
TTATTATA GGCTAGCTACAACGA TTAACACG 3190 1334 UGUUAAAU A UAAUAACG 288
CGTTATTA GGCTAGCTACAACGA ATTTAACA 3191 1337 UAAAUAUA A UAACGAGA
2796 TCTCGTTA GGCTAGCTACAACGA TATATTTA 3192 1340 AUAUAAUA A
CGAGAAGG 2797 CCTTCTCG GGCTAGCTACAACGA TATTATAT 3193 1348 ACGAGAAG
G CGGAGCGU 2329 ACGCTCCG GGCTAGCTACAACGA CTTCTCGT 3194 1353
AAGGCGGA G CGUGAAGU 2330 ACTTCACG GGCTAGCTACAACGA TCCGCCTT 3195
1355 GGCGGAGC G UGAAGUAA 2331 TTACTTCA GGCTAGCTACAACGA GCTCCGCC
3196 1360 AGCGUGAA G UAAAAGCA 2332 TGCTTTTA GGCTAGCTACAACGA
TTCACGCT 3197 1366 AAGUAAAA G CAUUGGCA 2333 TGCCAATG
GGCTAGCTACAACGA TTTTACTT 3198 1368 GUAAAAGC A UUGGCAAA 1498
TTTGCCAA GGCTAGCTACAACGA GCTTTTAC 3199 1372 AAGCAUUG G CAAAACUU
2334 AAGTTTTG GGCTAGCTACAACGA CAATGCTT 3200 1377 UUGGCAAA A
CUUGAUCA 2798 TGATCAAG GGCTAGCTACAACGA TTTGCCAA 3201 1382 AAAACUUG
A UCAUGUAA 2799 TTACATGA GGCTAGCTACAACGA CAAGTTTT 3202 1385
ACUUGAUC A UGUAAAUA 1501 TATTTACA GGCTAGCTACAACGA GATCAAGT 3203
1387 UUGAUCAU G UAAAUAUU 2335 AATATTTA GGCTAGCTACAACGA ATGATCAA
3204 1391 UCAUGUAA A UAUUGUUC 2800 GAACAATA GGCTAGCTACAACGA
TTACATGA 3205 1393 AUGUAAAU A UUGUUCAC 296 GTGAACAA GGCTAGCTACAACGA
ATTTACAT 3206 1396 UAAAUAUU G UUCACUAC 2336 GTAGTGAA
GGCTAGCTACAACGA AATATTTA 3207 1400 UAUUGUUC A CUACAAUG 1502
CATTGTAG GGCTAGCTACAACGA GAACAATA 3208 1403 UGUUCACU A CAAUGGCU 300
AGCCATTG GGCTAGCTACAACGA AGTGAACA 3209 1406 UCACUACA A UGGCUGUU
2801 AACAGCCA GGCTAGCTACAACGA TGTAGTGA 3210 1409 CUACAAUG G
CUGUUGGG 2337 CCCAACAG GGCTAGCTACAACGA CATTGTAG 3211 1412 CAAUGGCU
G UUGGGAUG 2338 CATCCCAA GGCTAGCTACAACGA AGCCATTG 3212 1418
CUGUUGGG A UGGAUUUG 2802 CAAATCCA GGCTAGCTACAACGA CCCAACAG 3213
1422 UGGGAUGG A UUUGAUUA 2803 TAATCAAA GGCTAGCTACAACGA CCATCCCA
3214 1427 UGGAUUUG A UUAUGAUC 2804 GATCATAA GGCTAGCTACAACGA
CAAATCCA 3215 1430 AUUUGAUU A UGAUCCUG 305 CAGGATCA GGCTAGCTACAACGA
AATCAAAT 3216 1433 UGAUUAUG A UCCUGAGA 2805 TCTCAGGA
GGCTAGCTACAACGA CATAATCA 3217 1441 AUCCUGAG A CCAGUGAU 2806
ATCACTGG GGCTAGCTACAACGA CTCAGGAT 3218 1445 UGAGACCA G UGAUGAUU
2339 AATCATCA GGCTAGCTACAACGA TGGTCTCA 3219 1448 GACCAGUG A
UGAUUCUC 2807 GAGAATCA GGCTAGCTACAACGA CACTGGTC 3220 1451 CAGUGAUG
A UUCUCUUG 2808 CAAGAGAA GGCTAGCTACAACGA CATCACTG 3221 1463
UCUUGAGA G CAGUGAUU 2340 AATCACTG GGCTAGCTACAACGA TCTCAAGA 3222
1466 UGAGAGCA G UGAUUAUG 2341 CATAATCA GGCTAGCTACAACGA TGCTCTCA
3223 1469 GAGCAGUG A UUAUGAUC 2809 GATCATAA GGCTAGCTACAACGA
CACTGCTC 3224 1472 CAGUGAUU A UGAUCCUG 312 CAGGATCA GGCTAGCTACAACGA
AATCACTG 3225 1475 UGAUUAUG A UCCUGAGA 2805 TCTCAGGA
GGCTAGCTACAACGA CATAATCA 3217 1484 UCCUGAGA A CAGCAAAA 2810
TTTTGCTG GGCTAGCTACAACGA TCTCAGGA 3226 1487 UGAGAACA G CAAAAAUA
2342 TATTTTTG GGCTAGCTACAACGA TGTTCTCA 3227 1493 CAGCAAAA A
UAGUUCAA 2811 TTGAACTA GGCTAGCTACAACGA TTTTGCTG 3228 1496 CAAAAAUA
G UUCAAGGU 2343 ACCTTGAA GGCTAGCTACAACGA TATTTTTG 3229 1503
AGUUCAAG G UCAAAGAC 2344 GTCTTTGA GGCTAGCTACAACGA CTTGAACT 3230
1510 GGUCAAAG A CUAAGUGC 2812 GCACTTAG GGCTAGCTACAACGA CTTTGACC
3231 1515 AAGACUAA G UGCCUUUU 2345 AAAAGGCA GGCTAGCTACAACGA
TTAGTCTT 3232 1517 GACUAAGU G CCUUUUCA 2346 TGAAAAGG
GGCTAGCTACAACGA ACTTAGTC 3233 1525 GCCUUUUC A UCCAAAUG 1522
CATTTGGA GGCTAGCTACAACGA GAAAAGGC 3234 1531 UCAUCCAA A UGGAAUUC
2813 GAATTCCA GGCTAGCTACAACGA TTGGATGA 3235 1536 CAAAUGGA A
UUCUGUGA 2814 TCACAGAA GGCTAGCTACAACGA TCCATTTG 3236 1541 GGAAUUCU
G UGAUAAAG 2347 CTTTATCA GGCTAGCTACAACGA AGAATTCC 3237 1544
AUUCUGUG A UAAAGGGA 2815 TCCCTTTA GGCTAGCTACAACGA CACAGAAT 3238
1552 AUAAAGGG A CCUUGGAA 2816 TTCCAAGG GGCTAGCTACAACGA CCCTTTAT
3239 1560 ACCUUGGA A CAAUGGAU 2817 ATCCATTG GGCTAGCTACAACGA
TCCAAGGT 3240 1563 UUGGAACA A UGGAUUGA 2818 TCAATCCA
GGCTAGCTACAACGA TGTTCCAA 3241 1567 AACAAUGG A UUGAAAAA 2819
TTTTTCAA GGCTAGCTACAACGA CCATTGTT 3242 1583 AAGAAGAG G CGAGAAAC
2348 GTTTCTCG GGCTAGCTACAACGA CTCTTCTT 3243 1590 GGCGAGAA A
CUAGACAA 2820 TTGTCTAG GGCTAGCTACAACGA TTCTCGCC 3244 1595 GAAACUAG
A CAAAGUUU 2821 AAACTTTG GGCTAGCTACAACGA CTAGTTTC 3245 1600
UAGACAAA G UUUUGGCU 2349 AGCCAAAA GGCTAGCTACAACGA TTTGTCTA 3246
1606 AAGUUUUG G CUUUGGAA 2350 TTCCAAAG GGCTAGCTACAACGA CAAAACTT
3247 1614 GCUUUGGA A CUCUUUGA 2822 TCAAAGAG GGCTAGCTACAACGA
TCCAAAGC 3248 1623 CUCUUUGA A CAAAUAAC 2823 GTTATTTG
GGCTAGCTACAACGA TCAAAGAG 3249 1627 UUGAACAA A UAACAAAA 2824
TTTTGTTA GGCTAGCTACAACGA TTGTTCAA 3250 1630 AACAAAUA A CAAAAGGG
2825 CCCTTTTG GGCTAGCTACAACGA TATTTGTT 3251 1639 CAAAAGGG G
UGGAUUAU 2351 ATAATCCA GGCTAGCTACAACGA CCCTTTTG 3252 1643 AGGGGUGG
A UUAUAUAC 2826 GTATATAA GGCTAGCTACAACGA CCACCCCT 3253 1646
GGUGGAUU A UAUACAUU 340 AATGTATA GGCTAGCTACAACGA AATCCACC 3254 1648
UGGAUUAU A UACAUUCA 341 TGAATGTA GGCTAGCTACAACGA ATAATCCA 3255 1650
GAUUAUAU A CAUUCAAA 342 TTTGAATG GGCTAGCTACAACGA ATATAATC 3256 1652
UUAUAUAC A UUCAAAAA 1536 TTTTTGAA GGCTAGCTACAACGA GTATATAA 3257
1662 UCAAAAAA A UUAAUUCA 2827 TGAATTAA GGCTAGCTACAACGA TTTTTTGA
3258 1666 AAAAAUUA A UUCAUAGA 2828 TCTATGAA GGCTAGCTACAACGA
TAATTTTT 3259 1670 AUUAAUUC A UAGAGAUC 1538 GATCTCTA
GGCTAGCTACAACGA GAATTAAT 3260 1676 UCAUAGAG A UCUUAAGC 2829
GCTTAAGA GGCTAGCTACAACGA CTCTATGA 3261 1683 GAUCUUAA G CCAAGUAA
2352 TTACTTGG GGCTAGCTACAACGA TTAAGATC 3262 1688 UAAGCCAA G
UAAUAUAU 2353 ATATATTA GGCTAGCTACAACGA TTGGCTTA 3263 1691 GCCAAGUA
A UAUAUUCU 2830 AGAATATA GGCTAGCTACAACGA TACTTGGC 3264 1693
CAAGUAAU A UAUUCUUA 354 TAAGAATA GGCTAGCTACAACGA ATTACTTG 3265 1695
AGUAAUAU A UUCUUAGU 355 ACTAAGAA GGCTAGCTACAACGA ATATTACT 3266 1702
UAUUCUUA G UAGAUACA 2354 TGTATCTA GGCTAGCTACAACGA TAAGAATA 3267
1706 CUUAGUAG A UACAAAAC 2831 GTTTTGTA GGCTAGCTACAACGA CTACTAAG
3268 1708 UAGUAGAU A CAAAACAA 361 TTGTTTTG GGCTAGCTACAACGA ATCTACTA
3269 1713 GAUACAAA A CAAGUAAA 2832 TTTACTTG GGCTAGCTACAACGA
TTTGTATC 3270 1717 CAAAACAA G UAAAGAUU 2355 AATCTTTA
GGCTAGCTACAACGA TTGTTTTG 3271 1723 AAGUAAAG A UUGGAGAC 2833
GTCTCCAA GGCTAGCTACAACGA CTTTACTT 3272 1730 GAUUGGAG A CUUUGGAC
2834 GTCCAAAG GGCTAGCTACAACGA CTCCAATC 3273 1737 GACUUUGG A
CUUGUAAC 2835 GTTACAAG GGCTAGCTACAACGA CCAAAGTC 3274 1741 UUGGACUU
G UAACAUCU 2356 AGATGTTA GGCTAGCTACAACGA AAGTCCAA 3275
1744 GACUUGUA A CAUCUCUG 2836 CAGAGATG GGCTAGCTACAACGA TACAAGTC
3276 1746 CUUGUAAC A UCUCUGAA 1547 TTCAGAGA GGCTAGCTACAACGA
GTTACAAG 3277 1757 UCUGAAAA A UGAUGGAA 2837 TTCCATCA
GGCTAGCTACAACGA TTTTCAGA 3278 1760 GAAAAAUG A UGGAAAGC 2838
GCTTTCCA GGCTAGCTACAACGA CATTTTTC 3279 1767 GAUGGAAA G CGAACAAG
2357 CTTGTTCG GGCTAGCTACAACGA TTTCCATC 3280 1771 GAAAGCGA A
CAAGGAGU 2839 ACTCCTTG GGCTAGCTACAACGA TCGCTTTC 3281 1778 AACAAGGA
G UAAGGGAA 2358 TTCCCTTA GGCTAGCTACAACGA TCCTTGTT 3282 1786
GUAAGGGA A CUUUGCGA 2840 TCGCAAAG GGCTAGCTACAACGA TCCCTTAC 3283
1791 GGAACUUU G CGAUACAU 2359 ATGTATCG GGCTAGCTACAACGA AAAGTTCC
3284 1794 ACUUUGCG A UACAUGAG 2841 CTCATGTA GGCTAGCTACAACGA
CGCAAAGT 3285 1796 UUUGCGAU A CAUGAGCC 373 GGCTCATG GGCTAGCTACAACGA
ATCGCAAA 3286 1798 UGCGAUAC A UGAGCCCA 1552 TGGGCTCA
GGCTAGCTACAACGA GTATCGCA 3287 1802 AUACAUGA G CCCAGAAC 2360
GTTCTGGG GGCTAGCTACAACGA TCATGTAT 3288 1809 AGCCCAGA A CAGAUUUC
2842 GAAATCTG GGCTAGCTACAACGA TCTGGGCT 3289 1813 CAGAACAG A
UUUCUUCG 2843 CGAAGAAA GGCTAGCTACAACGA CTGTTCTG 3290 1821 AUUUCUUC
G CAAGACUA 2361 TAGTCTTG GGCTAGCTACAACGA GAAGAAAT 3291 1826
UUCGCAAG A CUAUGGAA 2844 TTCCATAG GGCTAGCTACAACGA CTTGCGAA 3292
1829 GCAAGACU A UGGAAAGG 379 CCTTTCCA GGCTAGCTACAACGA AGTCTTGC 3293
1840 GAAAGGAA G UGGACCUC 2362 GAGGTCCA GGCTAGCTACAACGA TTCCTTTC
3294 1844 GGAAGUGG A CCUCUACG 2845 CGTAGAGG GGCTAGCTACAACGA
CCACTTCC 3295 1850 GGACCUCU A CGCUUUGG 381 CCAAAGCG GGCTAGCTACAACGA
AGAGGTCC 3296 1852 ACCUCUAC G CUUUGGGG 2363 CCCCAAAG
GGCTAGCTACAACGA GTAGAGGT 3297 1860 GCUUUGGG G CUAAUUCU 2364
AGAATTAG GGCTAGCTACAACGA CCCAAAGC 3298 1864 UGGGGCUA A UUCUUGCU
2846 AGCAAGAA GGCTAGCTACAACGA TAGCCCCA 3299 1870 UAAUUCUU G
CUGAACUU 2365 AAGTTCAG GGCTAGCTACAACGA AAGAATTA 3300 1875 CUUGCUGA
A CUUCUUCA 2847 TGAAGAAG GGCTAGCTACAACGA TCAGCAAG 3301 1883
ACUUCUUC A UGUAUGUG 1569 CACATACA GGCTAGCTACAACGA GAAGAAGT 3302
1885 UUCUUCAU G UAUGUGAC 2366 GTCACATA GGCTAGCTACAACGA ATGAAGAA
3303 1887 CUUCAUGU A UGUGACAC 392 GTGTCACA GGCTAGCTACAACGA ACATGAAG
3304 1889 UCAUGUAU G UGACACUG 2367 CAGTGTCA GGCTAGCTACAACGA
ATACATGA 3305 1892 UGUAUGUG A CACUGCUU 2848 AAGCAGTG
GGCTAGCTACAACGA CACATACA 3306 1894 UAUGUGAC A CUGCUUUU 1570
AAAAGCAG GGCTAGCTACAACGA GTCACATA 3307 1897 GUGACACU G CUUUUGAA
2368 TTCAAAAG GGCTAGCTACAACGA AGTGTCAC 3308 1906 CUUUUGAA A
CAUCAAAG 2849 CTTTGATG GGCTAGCTACAACGA TTCAAAAG 3309 1908 UUUGAAAC
A UCAAAGUU 1573 AACTTTGA GGCTAGCTACAACGA GTTTCAAA 3310 1914
ACAUCAAA G UUUUUCAC 2369 GTGAAAAA GGCTAGCTACAACGA TTTGATGT 3311
1921 AGUUUUUC A CAGACCUA 1575 TAGGTCTG GGCTAGCTACAACGA GAAAAACT
3312 1925 UUUCACAG A CCUACGGG 2850 CCCGTAGG GGCTAGCTACAACGA
CTGTGAAA 3313 1929 ACAGACCU A CGGGAUGG 402 CCATCCCG GGCTAGCTACAACGA
AGGTCTGT 3314 1934 CCUACGGG A UGGCAUCA 2851 TGATGCCA
GGCTAGCTACAACGA CCCGTAGG 3315 1937 ACGGGAUG G CAUCAUCU 2370
AGATGATG GGCTAGCTACAACGA CATCCCGT 3316 1939 GGGAUGGC A UCAUCUCA
1579 TGAGATGA GGCTAGCTACAACGA GCCATCCC 3317 1942 AUGGCAUC A
UCUCAGAU 1580 ATCTGAGA GGCTAGCTACAACGA GATGCCAT 3318 1949 CAUCUCAG
A UAUAUUUG 2852 CAAATATA GGCTAGCTACAACGA CTGAGATG 3319 1951
UCUCAGAU A UAUUUGAU 406 ATCAAATA GGCTAGCTACAACGA ATCTGAGA 3320 1953
UCAGAUAU A UUUGAUAA 407 TTATCAAA GGCTAGCTACAACGA ATATCTGA 3321 1958
UAUAUUUG A UAAAAAAG 2853 CTTTTTTA GGCTAGCTACAACGA CAAATATA 3322
1972 AAGAAAAA A CUCUUCUA 2854 TAGAAGAG GGCTAGCTACAACGA TTTTTCTT
3323 1980 ACUCUUCU A CAGAAAUU 414 AATTTCTG GGCTAGCTACAACGA AGAAGAGT
3324 1986 CUACAGAA A UUACUCUC 2855 GAGAGTAA GGCTAGCTACAACGA
TTCTGTAG 3325 1989 CAGAAAUU A CUCUCAAA 416 TTTGAGAG GGCTAGCTACAACGA
AATTTCTG 3326 2001 UCAAAGAA A CCUGAGGA 2856 TCCTCAGG
GGCTAGCTACAACGA TTCTTTGA 3327 2009 ACCUGAGG A UCGACCUA 2857
TAGGTCGA GGCTAGCTACAACGA CCTCAGGT 3328 2013 GAGGAUCG A CCUAACAC
2858 GTGTTAGG GGCTAGCTACAACGA CGATCCTC 3329 2018 UCGACCUA A
CACAUCUG 2859 CAGATGTG GGCTAGCTACAACGA TAGGTCGA 3330 2020 GACCUAAC
A CAUCUGAA 1594 TTCAGATG GGCTAGCTACAACGA GTTAGGTC 3331 2022
CCUAACAC A UCUGAAAU 1595 ATTTCAGA GGCTAGCTACAACGA GTGTTAGG 3332
2029 CAUCUGAA A UACUAAGG 2860 CCTTAGTA GGCTAGCTACAACGA TTCAGATG
3333 2031 UCUGAAAU A CUAAGGAC 422 GTCCTTAG GGCTAGCTACAACGA ATTTCAGA
3334 2038 UACUAAGG A CCUUGACU 2861 AGTCAAGG GGCTAGCTACAACGA
CCTTAGTA 3335 2044 GGACCUUG A CUGUGUGG 2862 CCACACAG
GGCTAGCTACAACGA CAAGGTCC 3336 2047 CCUUGACU G UGUGGAAG 2371
CTTCCACA GGCTAGCTACAACGA AGTCAAGG 3337 2049 UUGACUGU G UGGAAGAA
2372 TTCTTCCA GGCTAGCTACAACGA ACAGTCAA 3338 2060 GAAGAAAA G
CCCAGAGA 2373 TCTCTGGG GGCTAGCTACAACGA TTTTCTTC 3339 2072 AGAGAAAA
A UGAACGAC 2863 GTCGTTCA GGCTAGCTACAACGA TTTTCTCT 3340 2076
AAAAAUGA A CGACACAC 2864 GTGTGTCG GGCTAGCTACAACGA TCATTTTT 3341
2079 AAUGAACG A CACACAUG 2865 CATGTGTG GGCTAGCTACAACGA CGTTCATT
3342 2081 UGAACGAC A CACAUGUU 1604 AACATGTG GGCTAGCTACAACGA
GTCGTTCA 3343 2083 AACGACAC A CAUGUUAG 1605 CTAACATG
GGCTAGCTACAACGA GTGTCGTT 3344 2085 CGACACAC A UGUUAGAG 1606
CTCTAACA GGCTAGCTACAACGA GTGTGTCG 3345 2087 ACACACAU G UUAGAGCC
2374 GGCTCTAA GGCTAGCTACAACGA ATGTGTGT 3346 2093 AUGUUAGA G
CCCUUCUG 2375 CAGAAGGG GGCTAGCTACAACGA TCTAACAT 3347 2107 CUGAAAAA
G UAUCCUGC 2376 GCAGGATA GGCTAGCTACAACGA TTTTTCAG 3348 2109
GAAAAAGU A UCCUGCUU 429 AAGCAGGA GGCTAGCTACAACGA ACTTTTTC 3349 2114
AGUAUCCU G CUUCUGAU 2377 ATCAGAAG GGCTAGCTACAACGA AGGATACT 3350
2121 UGCUUCUG A UAUGCAGU 2866 ACTGCATA GGCTAGCTACAACGA CAGAAGCA
3351 2123 CUUCUGAU A UGCAGUUU 433 AAACTGCA GGCTAGCTACAACGA ATCAGAAG
3352 2125 UCUGAUAU G CAGUUUUC 2378 GAAAACTG GGCTAGCTACAACGA
ATATCAGA 3353 2128 GAUAUGCA G UUUUCCUU 2379 AAGGAAAA
GGCTAGCTACAACGA TGCATATC 3354 2139 UUCCUUAA A UUAUCUAA 2867
TTAGATAA GGCTAGCTACAACGA TTAAGGAA 3355 2142 CUUAAAUU A UCUAAAAU 441
ATTTTAGA GGCTAGCTACAACGA AATTTAAG 3356 2149 UAUCUAAA A UCUGCUAG
2868 CTAGCAGA GGCTAGCTACAACGA TTTAGATA 3357 2153 UAAAAUCU G
CUAGGGAA 2380 TTCCCTAG GGCTAGCTACAACGA AGATTTTA 3358 2161 GCUAGGGA
A UAUCAAUA 2869 TATTGATA GGCTAGCTACAACGA TCCCTAGC 3359 2163
UAGGGAAU A UCAAUAGA 446 TCTATTGA GGCTAGCTACAACGA ATTCCCTA 3360 2167
GAAUAUCA A UAGAUAUU 2870 AATATCTA GGCTAGCTACAACGA TGATATTC 3361
2171 AUCAAUAG A UAUUUACC 2871 GGTAAATA GGCTAGCTACAACGA CTATTGAT
3362 2173 CAAUAGAU A UUUACCUU 449 AAGGTAAA GGCTAGCTACAACGA ATCTATTG
3363 2177 AGAUAUUU A CCUUUUAU 452 ATAAAAGG GGCTAGCTACAACGA AAATATCT
3364 2184 UACCUUUU A UUUUAAUG 456 CATTAAAA GGCTAGCTACAACGA AAAAGGTA
3365 2190 UUAUUUUA A UGUUUCCU 2872 AGGAAACA GGCTAGCTACAACGA
TAAAATAA 3366 2192 AUUUUAAU G UUUCCUUU 2381 AAAGGAAA
GGCTAGCTACAACGA ATTAAAAT 3367 2202 UUCCUUUA A UUUUUUAC 2873
GTAAAAAA GGCTAGCTACAACGA TAAAGGAA 3368 2209 AAUUUUUU A CUAUUUUU 472
AAAAATAG GGCTAGCTACAACGA AAAAAATT 3369 2212 UUUUUACU A UUUUUACU 473
AGTAAAAA GGCTAGCTACAACGA AGTAAAAA 3370 2218 CUAUUUUU A CUAAUCUU 478
AAGATTAG GGCTAGCTACAACGA AAAAATAG 3371 2222 UUUUACUA A UCUUUCUG
2874 CAGAAAGA GGCTAGCTACAACGA TAGTAAAA 3372 2230 AUCUUUCU G
CAGAAACA 2382 TGTTTCTG GGCTAGCTACAACGA AGAAAGAT 3373 2236 CUGCAGAA
A CAGAAAGG 2875 CCTTTCTG GGCTAGCTACAACGA TTCTGCAG 3374 2244
ACAGAAAG G UUUUCUUC 2383 GAAGAAAA GGCTAGCTACAACGA CTTTCTGT 3375
2258 UUCUUUUU G CUUCAAAA 2384 TTTTGAAG GGCTAGCTACAACGA AAAAAGAA
3376 2267 CUUCAAAA A CAUUCUUA 2876 TAAGAATG GGCTAGCTACAACGA
TTTTGAAG 3377 2269 UCAAAAAC A UUCUUACA 1636 TGTAAGAA
GGCTAGCTACAACGA GTTTTTGA 3378 2275 ACAUUCUU A CAUUUUAC 499 GTAAAATG
GGCTAGCTACAACGA AAGAATGT 3379 2277 AUUCUUAC A UUUUACUU 1638
AAGTAAAA GGCTAGCTACAACGA GTAAGAAT 3380 2282 UACAUUUU A CUUUUUCC 503
GGAAAAAG GGCTAGCTACAACGA AAAATGTA 3381 2293 UUUUCCUG G CUCAUCUC
2385 GAGATGAG GGCTAGCTACAACGA CAGGAAAA 3382 2297 CCUGGCUC A
UCUCUUUA 1643 TAAAGAGA GGCTAGCTACAACGA GAGCCAGG 3383 2305 AUCUCUUU
A UUCUUUUU 514 AAAAAGAA GGCTAGCTACAACGA AAAGAGAT 3384 2327 UUUUAAAG
A CAGAGUCU 2877 AGACTCTG GGCTAGCTACAACGA CTTTAAAA 3385 2332
AAGACAGA G UCUCGCUC 2386 GAGCGAGA GGCTAGCTACAACGA TCTGTCTT 3386
2337 AGAGUCUC G CUCUGUUG 2387 CAACAGAG GGCTAGCTACAACGA GAGACTCT
3387 2342 CUCGCUCU G UUGCCCAG 2388 CTGGGCAA GGCTAGCTACAACGA
AGAGCGAG 3388 2345 GCUCUGUU G CCCAGGCU 2389 AGCCTGGG
GGCTAGCTACAACGA AACAGAGC 3389 2351 UUGCCCAG G CUGGAGUG 2390
CACTCCAG GGCTAGCTACAACGA CTGGGCAA 3390 2357 AGGCUGGA G UGCAAUGA
2391 TCATTGCA GGCTAGCTACAACGA TCCAGCCT 3391 2359 GCUGGAGU G
CAAUGACA 2392 TGTCATTG GGCTAGCTACAACGA ACTCCAGC 3392 2362 GGAGUGCA
A UGACACAG 2878 CTGTGTCA GGCTAGCTACAACGA TGCACTCC 3393 2365
GUGCAAUG A CACAGUCU 2879 AGACTGTG GGCTAGCTACAACGA CATTGCAC 3394
2367 GCAAUGAC A CAGUCUUG 1656 CAAGACTG GGCTAGCTACAACGA GTCATTGC
3395 2370 AUGACACA G UCUUGGCU 2393 AGCCAAGA GGCTAGCTACAACGA
TGTGTCAT 3396 2376 CAGUCUUG G CUCACUGC 2394 GCAGTGAG
GGCTAGCTACAACGA CAAGACTG 3397 2380 CUUGGCUC A CUGCAACU 1660
AGTTGCAG GGCTAGCTACAACGA GAGCCAAG 3398 2383 GGCUCACU G CAACUUCU
2395 AGAAGTTG GGCTAGCTACAACGA AGTGAGCC 3399 2386 UCACUGCA A
CUUCUGCC 2880 GGCAGAAG GGCTAGCTACAACGA TGCAGTGA 3400
2392 CAACUUCU G CCUCUUGG 2396 CCAAGAGG GGCTAGCTACAACGA AGAAGTTG
3401 2401 CCUCUUGG G UUCAAGUG 2397 CACTTGAA GGCTAGCTACAACGA
CCAAGAGG 3402 2407 GGGUUCAA G UGAUUCUC 2398 GAGAATCA
GGCTAGCTACAACGA TTGAACCC 3403 2410 UUCAAGUG A UUCUCCUG 2881
CAGGAGAA GGCTAGCTACAACGA CACTTGAA 3404 2418 AUUCUCCU G CCUCAGCC
2399 GGCTGAGG GGCTAGCTACAACGA AGGAGAAT 3405 2424 CUGCCUCA G
CCUCCUGA 2400 TCAGGAGG GGCTAGCTACAACGA TGAGGCAG 3406 2433 CCUCCUGA
G UAGCUGGA 2401 TCCAGCTA GGCTAGCTACAACGA TCAGGAGG 3407 2436
CCUGAGUA G CUGGAUUA 2402 TAATCCAG GGCTAGCTACAACGA TACTCAGG 3408
2441 GUAGCUGG A UUACAGGC 2882 GCCTGTAA GGCTAGCTACAACGA CCAGCTAC
3409 2444 GCUGGAUU A CAGGCAUG 551 CATGCCTG GGCTAGCTACAACGA AATCCAGC
3410 2448 GAUUACAG G CAUGUGCC 2403 GGCACATG GGCTAGCTACAACGA
CTGTAATC 3411 2450 UUACAGGC A UGUGCCAC 1681 GTGGCACA
GGCTAGCTACAACGA GCCTGTAA 3412 2452 ACAGGCAU G UGCCACCC 2404
GGGTGGCA GGCTAGCTACAACGA ATGCCTGT 3413 2454 AGGCAUGU G CCACCCAC
2405 GTGGGTGG GGCTAGCTACAACGA ACATGCCT 3414 2457 CAUGUGCC A
CCCACCCA 1683 TGGGTGGG GGCTAGCTACAACGA GGCACATG 3415 2461 UGCCACCC
A CCCAACUA 1686 TAGTTGGG GGCTAGCTACAACGA GGGTGGCA 3416 2466
CCCACCCA A CUAAUUUU 2883 AAAATTAG GGCTAGCTACAACGA TGGGTGGG 3417
2470 CCCAACUA A UUUUUGUG 2884 CACAAAAA GGCTAGCTACAACGA TAGTTGGG
3418 2476 UAAUUUUU G UGUUUUUA 2406 TAAAAACA GGCTAGCTACAACGA
AAAAATTA 3419 2478 AUUUUUGU G UUUUUAAU 2407 ATTAAAAA
GGCTAGCTACAACGA ACAAAAAT 3420 2485 UGUUUUUA A UAAAGACA 2885
TGTCTTTA GGCTAGCTACAACGA TAAAAACA 3421 2491 UAAUAAAG A CAGGGUUU
2886 AAACCCTG GGCTAGCTACAACGA CTTTATTA 3422 2496 AAGACAGG G
UUUCACCA 2408 TGGTGAAA GGCTAGCTACAACGA CCTGTCTT 3423 2501 AGGGUUUC
A CCAUGUUG 1692 CAACATGG GGCTAGCTACAACGA GAAACCCT 3424 2504
GUUUCACC A UGUUGGCC 1694 GGCCAACA GGCTAGCTACAACGA GGTGAAAC 3425
2506 UUCACCAU G UUGGCCAG 2409 CTGGCCAA GGCTAGCTACAACGA ATGGTGAA
3426 2510 CCAUGUUG G CCAGGCUG 2410 CAGCCTGG GGCTAGCTACAACGA
CAACATGG 3427 2515 UUGGCCAG G CUGGUCUC 2411 GAGACCAG
GGCTAGCTACAACGA CTGGCCAA 3428 2519 CCAGGCUG G UCUCAAAC 2412
GTTTGAGA GGCTAGCTACAACGA CAGCCTGG 3429 2526 GGUCUCAA A CUCCUGAC
2887 GTCAGGAG GGCTAGCTACAACGA TTGAGACC 3430 2533 AACUCCUG A
CCUCAAGU 2888 ACTTGAGG GGCTAGCTACAACGA CAGGAGTT 3431 2540 GACCUCAA
G UAAUCCAC 2413 GTGGATTA GGCTAGCTACAACGA TTGAGGTC 3432 2543
CUCAAGUA A UCCACCUG 2889 CAGGTGGA GGCTAGCTACAACGA TACTTGAG 3433
2547 AGUAAUCC A CCUGCCUC 1707 GAGGCAGG GGCTAGCTACAACGA GGATTACT
3434 2551 AUCCACCU G CCUCGGCC 2414 GGCCGAGG GGCTAGCTACAACGA
AGGTGGAT 3435 2557 CUGCCUCG G CCUCCCAA 2415 TTGGGAGG
GGCTAGCTACAACGA CGAGGCAG 3436 2567 CUCCCAAA G UGCUGGGA 2416
TCCCAGCA GGCTAGCTACAACGA TTTGGGAG 3437 2569 CCCAAAGU G CUGGGAUU
2417 AATCCCAG GGCTAGCTACAACGA ACTTTGGG 3438 2575 GUGCUGGG A
UUACAGGG 2890 CCCTGTAA GGCTAGCTACAACGA CCCAGCAC 3439 2578 CUGGGAUU
A CAGGGAUG 576 CATCCCTG GGCTAGCTACAACGA AATCCCAG 3440 2584 UUACAGGG
A UGAGCCAC 2891 GTGGCTCA GGCTAGCTACAACGA CCCTGTAA 3441 2588
AGGGAUGA G CCACCGCG 2418 CGCGGTGG GGCTAGCTACAACGA TCATCCCT 3442
2591 GAUGAGCC A CCGCGCCC 1720 GGGCGCGG GGCTAGCTACAACGA GGCTCATC
3443 2594 GAGCCACC G CGCCCAGC 2419 GCTGGGCG GGCTAGCTACAACGA
GGTGGCTC 3444 2596 GCCACCGC G CCCAGCCU 2420 AGGCTGGG
GGCTAGCTACAACGA GCGGTGGC 3445 2601 CGCGCCCA G CCUCAUCU 2421
AGATGAGG GGCTAGCTACAACGA TGGGCGCG 3446 2606 CCAGCCUC A UCUCUUUG
1727 CAAAGAGA GGCTAGCTACAACGA GAGGCTGG 3447 2614 AUCUCUUU G
UUCUAAAG 2422 CTTTAGAA GGCTAGCTACAACGA AAAGAGAT 3448 2623 UUCUAAAG
A UGGAAAAA 2892 TTTTTCCA GGCTAGCTACAACGA CTTTAGAA 3449 2631
AUGGAAAA A CCACCCCC 2893 GGGGGTGG GGCTAGCTACAACGA TTTTCCAT 3450
2634 GAAAAACC A CCCCCAAA 1732 TTTGGGGG GGCTAGCTACAACGA GGTTTTTC
3451 2642 ACCCCCAA A UUUUCUUU 2894 AAAGAAAA GGCTAGCTACAACGA
TTGGGGGT 3452 2653 UUCUUUUU A UACUAUUA 593 TAATAGTA GGCTAGCTACAACGA
AAAAAGAA 3453 2655 CUUUUUAU A CUAUUAAU 594 ATTAATAG GGCTAGCTACAACGA
ATAAAAAG 3454 2658 UUUAUACU A UUAAUGAA 595 TTCATTAA GGCTAGCTACAACGA
AGTATAAA 3455 2662 UACUAUUA A UGAAUCAA 2895 TTGATTCA
GGCTAGCTACAACGA TAATAGTA 3456 2666 AUUAAUGA A UCAAUCAA 2896
TTGATTGA GGCTAGCTACAACGA TCATTAAT 3457 2670 AUGAAUCA A UCAAUUCA
2897 TGAATTGA GGCTAGCTACAACGA TGATTCAT 3458 2674 AUCAAUCA A
UUCAUAUC 2898 GATATGAA GGCTAGCTACAACGA TGATTGAT 3459 2678 AUCAAUUC
A UAUCUAUU 1742 AATAGATA GGCTAGCTACAACGA GAATTGAT 3460 2680
CAAUUCAU A UCUAUUUA 602 TAAATAGA GGCTAGCTACAACGA ATGAATTG 3461 2684
UCAUAUCU A UUUAUUAA 604 TTAATAAA GGCTAGCTACAACGA AGATATGA 3462 2688
AUCUAUUU A UUAAAUUU 607 AAATTTAA GGCTAGCTACAACGA AAATAGAT 3463 2693
UUUAUUAA A UUUCUACC 2899 GGTAGAAA GGCTAGCTACAACGA TTAATAAA 3464
2699 AAAUUUCU A CCGCUUUU 613 AAAAGCGG GGCTAGCTACAACGA AGAAATTT 3465
2702 UUUCUACC G CUUUUAGG 2423 CCTAAAAG GGCTAGCTACAACGA GGTAGAAA
3466 2710 GCUUUUAG G CCAAAAAA 2424 TTTTTTGG GGCTAGCTACAACGA
CTAAAAGC 3467 2719 CCAAAAAA A UGUAAGAU 2900 ATCTTACA
GGCTAGCTACAACGA TTTTTTGG 3468 2721 AAAAAAAU G UAAGAUCG 2425
CGATCTTA GGCTAGCTACAACGA ATTTTTTT 3469 2726 AAUGUAAG A UCGUUCUC
2901 GAGAACGA GGCTAGCTACAACGA CTTACATT 3470 2729 GUAAGAUC G
UUCUCUGC 2426 GCAGAGAA GGCTAGCTACAACGA GATCTTAC 3471 2736 CGUUCUCU
G CCUCACAU 2427 ATGTGAGG GGCTAGCTACAACGA AGAGAACG 3472 2741
UCUGCCUC A CAUAGCUU 1753 AAGCTATG GGCTAGCTACAACGA GAGGCAGA 3473
2743 UGCCUCAC A UAGCUUAC 1754 GTAAGCTA GGCTAGCTACAACGA GTGAGGCA
3474 2746 CUCACAUA G CUUACAAG 2428 CTTGTAAG GGCTAGCTACAACGA
TATGTGAG 3475 2750 CAUAGCUU A CAAGCCAG 626 CTGGCTTG GGCTAGCTACAACGA
AAGCTATG 3476 2754 GCUUACAA G CCAGCUGG 2429 CCAGCTGG
GGCTAGCTACAACGA TTGTAAGC 3477 2758 ACAAGCCA G CUGGAGAA 2430
TTCTCCAG GGCTAGCTACAACGA TGGCTTGT 3478 2767 CUGGAGAA A UAUGGUAC
2902 GTACCATA GGCTAGCTACAACGA TTCTCCAG 3479 2769 GGAGAAAU A
UGGUACUC 627 GAGTACCA GGCTAGCTACAACGA ATTTCTCC 3480 2772 GAAAUAUG G
UACUCAUU 2431 AATGAGTA GGCTAGCTACAACGA CATATTTC 3481 2774 AAUAUGGU
A CUCAUUAA 628 TTAATGAG GGCTAGCTACAACGA ACCATATT 3482 2778 UGGUACUC
A UUAAAAAA 1761 TTTTTTAA GGCTAGCTACAACGA GAGTACCA 3483 2796
AAAAAAAA G UGAUGUAC 2432 GTACATCA GGCTAGCTACAACGA TTTTTTTT 3484
2799 AAAAAGUG A UGUACAAC 2903 GTTGTACA GGCTAGCTACAACGA CACTTTTT
3485 Input Sequence = NM_002759. Cut Site = R/Y Arm Length = 8.
Core Sequence = GGCTAGCTACAACGA NM_002759 (Homo sapiens protein
kinase, interferon-inducible double stranded RNA dependent (PRKR),
mRNA.; 2808 bp)
[0274] TABLE-US-00012 TABLE XII Human PKR Amberzyme and Substrate
Sequence Seq Seq Pos Substrate ID Amberzyme ID 9 GCGGCGGC G
GCGGCGCA 3486 UGCGCCGC GGAGGAAACUCC CU UCAAGGACAUCGUCCGGG GCCGCCGC
3814 10 CGGCGGCG G CGGCGCAG 2261 CUGCGCCG GGAGGAAACUCC CU
UCAAGGACAUCGUCCGGG CGCCGCCG 3815 12 GCGGCGGC G GCGCAGUU 3487
AACUGCGC GGAGGAAACUCC CU UCAAGGACAUCGUCCGGG GCCGCCGC 3816 13
CGGCGGCG G CGCAGUUU 2433 AAACUGCG GGAGGAAACUCC CU
UCAAGGACAUCGUCCGGG CGCCGCCG 3817 15 GCGGCGGC G CAGUUUGC 2434
GCAAACUG GGAGGAAACUCC CU UCAAGGACAUCGUCCGGG GCCGCCGC 3818 18
GCGGCGCA G UUUGCUCA 2435 UGAGCAAA GGAGGAAACUCC CU
UCAAGGACAUCGUCCGGG UGCGCCGC 3819 22 CGCAGUUU G CUCAUACU 2436
AGUAUGAG GGAGGAAACUCC CU UCAAGGACAUCGUCCGGG AAACUGCG 3820 33
CAUACUUU G UGACUUGC 2437 GCAAGUCA GGAGGAAACUCC CU
UCAAGGACAUCGUCCGGG AAAGUAUG 3821 35 UACUUUGU G ACUUGCGG 3488
CCGCAAGU GGAGGAAACUCC CU UCAAGGACAUCGUCCGGG ACAAAGUA 3822 40
UGUGACUU G CGGUCACA 2438 UGUGACCG GGAGGAAACUCC CU
UCAAGGACAUCGUCCGGG AAGUCACA 3823 42 UGACUUGC G GUCACAGU 3489
ACUGUGAC GGAGGAAACUCC CU UCAAGGACAUCGUCCGGG GCAAGUCA 3824 43
GACUUGCG G UCACAGUG 2439 CACUGUGA GGAGGAAACUCC CU
UCAAGGACAUCGUCCGGG CGCAAGUC 3825 49 CGGUCACA G UGGCAUUC 2440
GAAUGCCA GGAGGAAACUCC CU UCAAGGACAUCGUCCGGG UGUGACOG 3826 51
GUCACAGU G GCAUUCAG 3490 CUGAAUGC GGAGGAAACUCC CU
UCAAGGACAUCGUCCGGG ACUGUGAC 3827 52 UCACAGUG G CAUUCAGC 2441
GCUGAAUG GGAGGAAACUCC CU UCAAGGACAUCGUCCGGG CACUGUGA 3828 59
GGCAUUCA G CUCCACAC 2442 GUGUGGAG GGAGGAAACUCC CU
UCAAGGACAUCGUCCGGG UGAAUGCC 3829 70 CCACACUU G GUAGAACC 3491
GGUUCUAC GGAGGAAACUCC CU UCAAGGACAUCGUCCGGG AAGUGUGG 3830 71
CACACUUG G UAGAACCA 2443 UGGUUCUA GGAGGAAACUCC CU
UCAAGGACAUCGUCCGGG CAAGUGUG 3831 74 ACUUGGUA G AACCACAG 3492
CUGUGGUU GGAGGAAACUCC CU UCAAGGACAUCGUCCGGG UACCAAGU 3832 82
GAACCACA G GCACGACA 3493 UGUCGUGC GGAGGAAACUCC CU
UCAAGGACAUCGUCCGGG UGUGGUUC 3833 83 AACCACAG G CACGACAA 2444
UUGUCGUG GGAGGAAACUCC CU UCAAGGACAUCGUCCGGG CUGUGGUU 3834 87
ACAGGCAC G ACAAGCAU 3494 AUGCUUGU GGAGGAAACUCC CU
UCAAGGACAUCGUCCGGG GUGCCUGU 3835 92 CACGACAA G CAUAGAAA 2445
UUUCUAUG GGAGGAAACUCC CU UCAAGGACAUCGUCCGGG UUGUCGUG 3836 97
CAAGCAUA G AAACAUCC 3495 GGAUGUUU GGAGGAAACUCC CU
UCAAGGACAUCGUCCGGG UAUGCUUG 3837 121 UCUUCAUC G AGGCAUCG 3496
CGAUGCCU GGAGGAAACUCC CU UCAAGGACAUCGUCCGGG GAUGAAGA 3838 123
UUCAUCGA G GCAUCGAG 3497 CUCGAUGC GGAGGAAACUCC CU
UCAAGGACAUCGUCCGGG UCGAUGAA 3839 124 UCAUCGAG G CAUCGAGG 2446
CCUCGAUG GGAGGAAACUCC CU UCAAGGACAUCGUCCGGG CUCGAUGA 3840 129
GAGGCAUC G AGGUCCAU 3498 AUGGACCU GGAGGAAACUCC CU
UCAAGGACAUCGUCCGGG GAUGCCUC 3841 131 GGCAUCGA G GUCCAUCC 3499
GGAUGGAC GGAGGAAACUCC CU UCAAGGACAUCGUCCGGG UCGAUGCC 3842 132
GCAUCGAG G UCCAUCCC 2447 OGGAUGGA GGAGGAAACUCC CU
UCAAGGACAUCGUCCGGG CUCGAUGC 3843 152 AAAAAUCA G GAGACCCU 3500
AGGGUCUC GGAGGAAACUCC CU UCAAGGACAUCGUCCGGG UGAUUUUU 3844 153
AAAAUCAG G AGACCCUG 3501 CAGGGUCU GGAGGAAACUCC CU
UCAAGGACAUCGUCCGGG CUGAUUUU 3845 155 AAUCAGGA G ACCCUGGC 3502
GCCAGGGU GGAGGAAACUCC CU UCAAGGACAUCGUCCGGG UCCUGAUU 3846 161
GAGACCCU G GCUAUCAU 3503 AUGAUAGC GGAGGAAACUCC CU
UCAAGGACAUCGUCCGGG AGGGUCUC 3847 162 AGACCCUG G CUAUCAUA 2448
UAUGAUAG GGAGGAAACUCC CU UCAAGGACAUCGUCCGGG CAGGGUCU 3848 171
CUAUCAUA G ACCUUAGU 3504 ACUAAGGU GGAGGAAACUCC CU
UCAAGGACAUCGUCCGGG UAUGAUAG 3849 178 AGACCUUA G UCUUCGCU 2449
AGCGAAGA GGAGGAAACUCC CU UCAAGGACAUCGUCCGGG UAAGGUCU 3850 184
UAGUCUUC G CUGGUAUA 2450 UAUACCAG GGAGGAAACUCC CU
UCAAGGACAUCGUCCGGG GAAGACUA 3851 187 UCUUCGCU G GUAUACUC 3505
GAGUAUAC GGAGGAAACUCC CU UCAAGGACAUCGUCCGGG AGCGAAGA 3852 188
CUUCGCUG G UAUACUCG 2451 CGAGUAUA GGAGGAAACUCC CU
UCAAGGACAUCGUCCGGG CAGCGAAG 3853 196 GUAUACUC G CUGUCUGU 2452
ACAGACAG GGAGGAAACUCC CU UCAAGGACAUCGUCCGGG GAGUAUAC 3854 199
UACUCGCU G UCUGUCAA 2453 UUGACAGA GGAGGAAACUCC CU
UCAAGGACAUCGUCCGGG AGCGAGUA 3855 203 CGCUGUCU G UCAACCAG 2454
CUGGUUGA GGAGGAAACUCC CU UCAAGGACAUCGUCCGGG AGACAGCG 3856 211
GUCAACCA G CGGUUGAC 2455 GUCAACCG GGAGGAAACUCC CU
UCAAGGACAUCGUCCGGG UGGUUGAC 3857 213 CAACCAGC G GUUGACUU 3506
AAGUCAAC GGAGGAAACUCC CU UCAAGGACAUCGUCCGGG GCUGGUUG 3858 214
AACCAGCG G UUGACUUU 2456 AAAGUCAA GGAGGAAACUCC CU
UCAAGGACAUCGUCCGGG CGCUGGUU 3859 217 CAGCGGUU G ACUUUUUU 3507
AAAAAAGU GGAGGAAACUCC CU UCAAGGACAUCGUCCGGG AACCGCUG 3860 229
UUUUUUAA G CCUUCUUU 2457 AAAGAAGG GGAGGAAACUCC CU
UCAAGGACAUCGUCCGGG UUAAAAAA 3861 252 UUUUACCA G UUUCUGGA 2458
UCCAGAAA GGAGGAAACUCC CU UCAAGGACAUCGUCCGGG UGGUAAAA 3862 258
CAGUUUCU G GAGCAAAU 3508 AUUUGCUC GGAGGAAACUCC CU
UCAAGGACAUCGUCCGGG AGAAACUG 3863 259 AGUUUCUG G AGCAAAUU 3509
AAUUUGCU GGAGGAAACUCC CU UCAAGGACAUCGUCCGGG CAGAAACU 3864 261
UUUCUGGA G CAAAUUCA 2459 UGAAUUUG GGAGGAAACUCC CU
UCAAGGACAUCGUCCGGG UCCAGAAA 3865 270 CAAAUUCA G UUUGCCUU 2460
AAGGCAAA GGAGGAAACUCC CU UCAAGGACAUCGUCCGGG UGAAUUUG 3866 274
UUCAGUUU G CCUUCCUG 2461 CAGGAAGG GGAGGAAACUCC CU
UCAAGGACAUCGUCCGGG AAACUGAA 3867 282 GCCUUCCU G GAUUUGUA 3510
UACAAAUC GGAGGAAACUCC CU UCAAGGACAUCGUCCGGG AGGAAGGC 3868 283
CCUUCCUG G AUUUGUAA 3511 UUACAAAU GGAGGAAACUCC CU
UCAAGGACAUCGUCCGGG CAGGAAGG 3869 288 CUGGAUUU G UAAAUUGU 2462
ACAAUUUA GGAGGAAACUCC CU UCAAGGACAUCGUCCGGG AAAUCCAG 3870 295
UGUAAAUU G UAAUGACC 2463 GGUCAUUA GGAGGAAACUCC CU
UCAAGGACAUCGUCCGGG AAUUUACA 3871 300 AUUGUAAU G ACCUCAAA 3512
UUUGAGGU GGAGGAAACUCC CU UCAAGGACAUCGUCCGGG AUUACAAU 3872 315
AAACUUUA G CAGUUCUU 2464 AAGAACUG GGAGGAAACUCC CU
UCAAGGACAUCGUCCGGG UAAAGUUU 3873 318 CUUUAGCA G UUCUUCCA 2465
UGGAAGAA GGAGGAAACUCC CU UCAAGGACAUCGUCCGGG UGCUAAAG 3874 330
UUCCAUCU G ACUCAGGU 3513 ACCUGAGU GGAGGAAACUCC CU
UCAAGGACAUCGUCCGGG AGAUGGAA 3875 336 CUGACUCA G GUUUGCUU 3514
AAGCAAAC GGAGGAAACUCC CU UCAAGGACAUCGUCCGGG UGAGUCAG 3876 337
UGACUCAG G UUUGCUUC 2466 GAAGCAAA GGAGGAAACUCC CU
UCAAGGACAUCGUCCGGG CUGAGUCA 3877 341 UCAGGUUU G CUUCUCUG 2467
CAGAGAAG GGAGGAAACUCC CU UCAAGGACAUCGUCCGGG AAACCUGA 3878 349
GCUUCUCU G GCGGUCUU 3515 AAGACCGC GGAGGAAACUCC CU
UCAAGGACAUCGUCCGGG AGAGAAGC 3879 350 CUUCUCUG G CGGUCUUC 2468
GAAGACCG GGAGGAAACUCC CU UCAAGGACAUCGUCCGGG CAGAGAAG 3880 352
UCUCUGGC G GUCUUCAG 3516 CUGAAGAC GGAGGAAACUCC CU
UCAAGGACAUCGUCCGGG GCCAGAGA 3881 353 CUCUGGCG G UCUUCAGA 2469
UCUGAAGA GGAGGAAACUCC CU UCAAGGACAUCGUCCGGG CGCCAGAG 3882 360
GGUCUUCA G AAUCAACA 3517 UGUUGAUU GGAGGAAACUCC CU
UCAAGGACAUCGUCCGGG UGAAGACC 3883 380 ACACUUCC G UGAUUAUC 2470
GAUAAUCA GGAGGAAACUCC CU UCAAGGACAUCGUCCGGG GGAAGUGU 3884 382
ACUUCCGU G AUUAUCUG 3518 CAGAUAAU GGAGGAAACUCC CU
UCAAGGACAUCGUCCGGG ACGGAAGU 3885 390 GAUUAUCU G CGUGCAUU 2471
AAUGCACG GGAGGAAACUCC CU UCAAGGACAUCGUCCGGG AGAUAAUC 3886 392
UUAUCUGC G UGCAUUUU 2472 AAAAUGCA GGAGGAAACUCC CU
UCAAGGACAUCGUCCGGG GCAGAUAA 3887 394 AUCUGCGU G CAUUUUGG 2473
CCAAAAUG GGAGGAAACUCC CU UCAAGGACAUCGUCCGGG ACGCAGAU 3888 401
UGCAUUUU G GACAAAGC 3519 GCUUUGUC GGAGGAAACUCC CU
UCAAGGACAUCGUCCGGG AAAAUGCA 3889 402 GCAUUUUG G ACAAAGCU 3520
AGCUUUGU GGAGGAAACUCC CU UCAAGGACAUCGUCCGGG CAAAAUGC 3890 408
UGGACAAA G CUUCCAAC 2474 GUUGGAAG GGAGGAAACUCC CU
UCAAGGACAUCGUCCGGG UUUGUCCA 3891 419 UCCAACCA G GAUACGGG 3521
CCCGUAUC GGAGGAAACUCC CU UCAAGGACAUCGUCCGGG UGGUUGGA 3892 420
CCAACCAG G AUACGGGA 3522 UCCCGUAU GGAGGAAACUCC CU
UCAAGGACAUCGUCCGGG CUGGUUGG 3893 425 CAGGAUAC G GGAAGAAG 3523
CUUCUUCC GGAGGAAACUCC CU UCAAGGACAUCGUCCGGG GUAUCCUG 3894
426 AGGAUACG G GAAGAAGA 3524 UCUUCUUC GGAGGAAACUCC CU
UCAAGGACAUCGUCCGGG CGUAUCCU 3895 427 GGAUACGG G AAGAAGAA 3525
UUCUUCUU GGAGGAAACUCC CU UCAAGGACAUCGUCCGGG CCGUAUCC 3896 430
UACGGGAA G AAGAAAUG 3526 CAUUUCUU GGAGGAAACUCC CU
UCAAGGACAUCGUCCGGG UUCCCGUA 3897 433 GGGAAGAA G AAAUGGCU 3527
AGCCAUUU GGAGGAAACUCC CU UCAAGGACAUCGUCCGGG UUCUUCCC 3898 438
GAAGAAAU G GCUGGUGA 3528 UCACCAGC GGAGGAAACUCC CU
UCAAGGACAUCGUCCGGG AUUUCUUC 3899 439 AAGAAAUG G CUGGUGAU 2475
AUCACCAG GGAGGAAACUCC CU UCAAGGACAUCGUCCGGG CAUUUCUU 3900 442
AAAUGGCU G GUGAUCUU 3529 AAGAUCAC GGAGGAAACUCC CU
UCAAGGACAUCGUCCGGG AGCCAUUU 3901 443 AAUGGCUG G UGAUCUUU 2476
AAAGAUCA GGAGGAAACUCC CU UCAAGGACAUCGUCCGGG CAGCCAUU 3902 445
UGGCUGGU G AUCUUUCA 3530 UGAAAGAU GGAGGAAACUCC CU
UCAAGGACAUCGUCCGGG ACCAGCCA 3903 454 AUCUUUCA G CAGGUUUC 2477
GAAACCUG GGAGGAAACUCC CU UCAAGGACAUCGUCCGGG UGAAAGAU 3904 457
UUUCAGCA G GUUUCUUC 3531 GAAGAAAC GGAGGAAACUCC CU
UCAAGGACAUCGUCCGGG UGCUGAAA 3905 458 UUCAGCAG G UUUCUUCA 2478
UGAAGAAA GGAGGAAACUCC CU UCAAGGACAUCGUCCGGG CUGCUGAA 3906 468
UUCUUCAU G GAGGAACU 3532 AGUUCCUC GGAGGAAACUCC CU
UCAAGGACAUCGUCCGGG AUGAAGAA 3907 469 UCUUCAUG G AGGAACUU 3533
AAGUUCCU GGAGGAAACUCC CU UCAAGGACAUCGUCCGGG CAUGAAGA 3908 471
UUCAUGGA G GAACUUAA 3534 UUAAGUUC GGAGGAAACUCC CU
UCAAGGACAUCGUCCGGG UCCAUGAA 3909 472 UCAUGGAG G AACUUAAU 3535
AUUAAGUU GGAGGAAACUCC CU UCAAGGACAUCGUCCGGG CUCCAUGA 3910 488
UACAUACC G UCAGAAGC 2479 GCUUCUGA GGAGGAAACUCC CU
UCAAGGACAUCGUCCGGG GGUAUGUA 3911 492 UACCGUCA G AAGCAGGG 3536
CCCUGCUU GGAGGAAACUCC CU UCAAGGACAUCGUCCGGG UGACGGUA 3912 495
CGUCAGAA G CAGGGAGU 2262 ACUCCCUG GGAGGAAACUCC CU
UCAAGGACAUCGUCCGGG UUCUGACG 3913 498 CAGAAGCA G GGAGUAGU 3537
ACUACUCC GGAGGAAACUCC CU UCAAGGACAUCGUCCGGG UGCUUCUG 3914 499
AGAAGCAG G GAGUAGUA 3538 UACUACUC GGAGGAAACUCC CU
UCAAGGACAUCGUCCGGG CUGCUUCU 3915 500 GAAGCAGG G AGUAGUAC 3539
GUACUACU GGAGGAAACUCC CU UCAAGGACAUCGUCCGGG CCUGCUUC 3916 502
AGCAGGGA G UAGUACUU 2263 AAGUACUA GGAGGAAACUCC CU
UCAAGGACAUCGUCCGGG UCCCUGCU 3917 505 AGGGAGUA G UACUUAAA 2264
UUUAAGUA GGAGGAAACUCC CU UCAAGGACAUCGUCCGGG UACUCCCU 3918 520
AAUAUCAA G AACUGCCU 3540 AGGCAGUU GGAGGAAACUCC CU
UCAAGGACAUCGUCCGGG UUGAUAUU 3919 525 CAAGAACU G CCUAAUUC 2265
GAAUUAGG GGAGGAAACUCC CU UCAAGGACAUCGUCCGGG AGUUCUUG 3920 535
CUAAUUCA G GACCUCCA 3541 UGGAGGUC GGAGGAAACUCC CU
UCAAGGACAUCGUCCGGG UGAAUUAG 3921 536 UAAUUCAG G ACCUCCAC 3542
GUGGAGGU GGAGGAAACUCC CU UCAAGGACAUCGUCCGGG CUGAAUUA 3922 547
CUCCACAU G AUAGGAGG 3543 CCUCCUAU GGAGGAAACUCC CU
UCAAGGACAUCGUCCGGG AUGUGGAG 3923 551 ACAUGAUA G GAGGUUUA 3544
UAAACCUC GGAGGAAACUCC CU UCAAGGACAUCGUCCGGG UAUCAUGU 3924 552
CAUGAUAG G AGGUUUAC 3545 GUAAACCU GGAGGAAACUCC CU
UCAAGGACAUCGUCCGGG CUAUCAUG 3925 554 UGAUAGGA G GUUUACAU 3546
AUGUAAAC GGAGGAAACUCC CU UCAAGGACAUCGUCCGGG UCCUAUCA 3926 555
GAUAGGAG G UUUACAUU 2266 AAUGUAAA GGAGGAAACUCC CU
UCAAGGACAUCGUCCGGG CUCCUAUC 3927 568 CAUUUCAA G UUAUAAUA 2267
UAUUAUAA GGAGGAAACUCC CU UCAAGGACAUCGUCCGGG UUGAAAUG 3928 577
UUAUAAUA G AUGGAAGA 3547 UCUUCCAU GGAGGAAACUCC CU
UCAAGGACAUCGUCCGGG UAUUAUAA 3929 580 UAAUAGAU G GAAGAGAA 3548
UUCUCUUC GGAGGAAACUCC CU UCAAGGACAUCGUCCGGG AUCUAUUA 3930 581
AAUAGAUG G AAGAGAAU 3549 AUUCUCUU GGAGGAAACUCC CU
UCAAGGACAUCGUCCGGG CAUCUAUU 3931 584 AGAUGGAA G AGAAUUUC 3550
GAAAUUCU GGAGGAAACUCC CU UCAAGGACAUCGUCCGGG UUCCAUCU 3932 586
AUGGAAGA G AAUUUCCA 3551 UGGAAAUU GGAGGAAACUCC CU
UCAAGGACAUCGUCCGGG UCUUCCAU 3933 595 AAUUUCCA G AAGGUGAA 3552
UUCACCUU GGAGGAAACUCC CU UCAAGGACAUCGUCCGGG UGGAAAUU 3934 598
UUCCAGAA G GUGAAGGU 3553 ACCUUCAC GGAGGAAACUCC CU
UCAAGGACAUCGUCCGGG UUCUGGAA 3935 599 UCCAGAAG G UGAAGGUA 2268
UACCUUCA GGAGGAAACUCC CU UCAAGGACAUCGUCCGGG CUUCUGGA 3936 601
CAGAAGGU G AAGGUAGA 3554 UCUACCUU GGAGGAAACUCC CU
UCAAGGACAUCGUCCGGG ACCUUCUG 3937 604 AAGGUGAA G GUAGAUCA 3555
UGAUCUAC GGAGGAAACUCC CU UCAAGGACAUCGUCCGGG UUCACCUU 3938 605
AGGUGAAG G UAGAUCAA 2269 UUGAUCUA GGAGGAAACUCC CU
UCAAGGACAUCGUCCGGG CUUCACCU 3939 608 UGAAGGUA G AUCAAAGA 3556
UCUUUGAU GGAGGAAACUCC CU UCAAGGACAUCGUCCGGG UACCUUCA 3940 615
AGAUCAAA G AAGGAAGC 3557 GCUUCCUU GGAGGAAACUCC CU
UCAAGGACAUCGUCCGGG UUUGAUCU 3941 618 UCAAAGAA G GAAGCAAA 3558
UUUGCUUC GGAGGAAACUCC CU UCAAGGACAUCGUCCGGG UUCUUUGA 3942 619
CAAAGAAG G AAGCAAAA 3559 UUUUGCUU GGAGGAAACUCC CU
UCAAGGACAUCGUCCGGG CUUCUUUG 3943 622 AGAAGGAA G CAAAAAAU 2270
AUUUUUUG GGAGGAAACUCC CU UCAAGGACAUCGUCCGGG UUCCUUCU 3944 631
CAAAAAAU G CCGCAGCC 2271 GGCUGCGG GGAGGAAACUCC CU
UCAAGGACAUCGUCCGGG AUUUUUUG 3945 634 AAAAUGCC G CAGCCAAA 2272
UUUGGCUG GGAGGAAACUCC CU UCAAGGACAUCGUCCGGG GGCAUUUU 3946 637
AUGCCGCA G CCAAAUUA 2273 UAAUUUGG GGAGGAAACUCC CU
UCAAGGACAUCGUCCGGG UGCGGCAU 3947 646 CCAAAUUA G CUGUUGAG 2274
CUCAACAG GGAGGAAACUCC CU UCAAGGACAUCGUCCGGG UAAUUUGG 3948 649
AAUUAGCU G UUGAGAUA 2275 UAUCUCAA GGAGGAAACUCC CU
UCAAGGACAUCGUCCGGG AGCUAAUU 3949 652 UAGCUGUU G AGAUACUU 3560
AAGUAUCU GGAGGAAACUCC CU UCAAGGACAUCGUCCGGG AACAGCUA 3950 654
GCUGUUGA G AUACUUAA 3561 UUAAGUAU GGAGGAAACUCC CU
UCAAGGACAUCGUCCGGG UCAACAGC 3951 666 CUUAAUAA G GAAAAGAA 3562
UUCUUUUC GGAGGAAACUCC CU UCAAGGACAUCGUCCGGG UUAUUAAG 3952 667
UUAAUAAG G AAAAGAAG 3563 CUUCUUUU GGAGGAAACUCC CU
UCAAGGACAUCGUCCGGG CUUAUUAA 3953 672 AAGGAAAA G AAGGCAGU 3564
ACUGCCUU GGAGGAAACUCC CU UCAAGGACAUCGUCCGGG UUUUCCUU 3954 675
GAAAAGAA G GCAGUUAG 3565 CUAACUGC GGAGGAAACUCC CU
UCAAGGACAUCGUCCGGG UUCUUUUC 3955 676 AAAAGAAG G CAGUUAGU 2276
ACUAACUG GGAGGAAACUCC CU UCAAGGACAUCGUCCGGG CUUCUUUU 3956 679
AGAAGGCA G UUAGUCCU 2277 AGGACUAA GGAGGAAACUCC CU
UCAAGGACAUCGUCCGGG UGCCUUCU 3957 683 GGCAGUUA G UCCUUUAU 2278
AUAAAGGA GGAGGAAACUCC CU UCAAGGACAUCGUCCGGG UAACUGCC 3958 696
UUAUUAUU G ACAACAAC 3566 GUUGUUGU GGAGGAAACUCC CU
UCAAGGACAUCGUCCGGG AAUAAUAA 3959 705 ACAACAAC G AAUUCUUC 3567
GAAGAAUU GGAGGAAACUCC CU UCAAGGACAUCGUCCGGG GUUGUUGU 3960 715
AUUCUUCA G AAGGAUUA 3568 UAAUCCUU GGAGGAAACUCC CU
UCAAGGACAUCGUCCGGG UGAAGAAU 3961 718 CUUCAGAA G GAUUAUCC 3569
GGAUAAUC GGAGGAAACUCC CU UCAAGGACAUCGUCCGGG UUCUGAAG 3962 719
UUCAGAAG G AUUAUCCA 3570 UGGAUAAU GGAGGAAACUCC CU
UCAAGGACAUCGUCCGGG CUUCUGAA 3963 729 UUAUCCAU G GGGAAUUA 3571
UAAUUCCC GGAGGAAACUCC CU UCAAGGACAUCGUCCGGG AUGGAUAA 3964 730
UAUCCAUG G GGAAUUAC 3572 GUAAUUCC GGAGGAAACUCC CU
UCAAGGACAUCGUCCGGG CAUGGAUA 3965 731 AUCCAUGG G GAAUUACA 3573
UGUAAUUC GGAGGAAACUCC CU UCAAGGACAUCGUCCGGG CCAUGGAU 3966 732
UCCAUGGG G AAUUACAU 3574 AUGUAAUU GGAGGAAACUCC CU
UCAAGGACAUCGUCCGGG CCCAUGGA 3967 742 AUUACAUA G GCCUUAUC 3575
GAUAAGGC GGAGGAAACUCC CU UCAAGGACAUCGUCCGGG UAUGUAAU 3968 743
UUACAUAG G CCUUAUCA 2279 UGAUAAGG GGAGGAAACUCC CU
UCAAGGACAUCGUCCGGG CUAUGUAA 3969 755 UAUCAAUA G AAUUGCCC 3576
GGGCAAUU GGAGGAAACUCC CU UCAAGGACAUCGUCCGGG UAUUGAUA 3970 760
AUAGAAUU G CCCAGAAG 2280 CUUCUGGG GGAGGAAACUCC CU
UCAAGGACAUCGUCCGGG AAUUCUAU 3971 765 AUUGCCCA G AAGAAAAG 3577
CUUUUCUU GGAGGAAACUCC CU UCAAGGACAUCGUCCGGG UGGGCAAU 3972 768
GCCCAGAA G AAAAGACU 3578 AGUCUUUU GGAGGAAACUCC CU
UCAAGGACAUCGUCCGGG UUCUGGGC 3973 773 GAAGAAAA G ACUAACUG 3579
CAGUUAGU GGAGGAAACUCC CU UCAAGGACAUCGUCCGGG UUUUCUUC 3974 781
GACUAACU G UAAAUUAU 2281 AUAAUUUA GGAGGAAACUCC CU
UCAAGGACAUCGUCCGGG AGUUAGUC 3975 790 UAAAUUAU G AACAGUGU 3580
ACACUGUU GGAGGAAACUCC CU UCAAGGACAUCGUCCGGG AUAAUUUA 3976 795
UAUGAACA G UGUGCAUC 2282 GAUGCACA GGAGGAAACUCC CU
UCAAGGACAUCGUCCGGG UGUUCAUA 3977 797 UGAACAGU G UGCAUCGG 2283
CCGAUGCA GGAGGAAACUCC CU UCAAGGACAUCGUCCGGG ACUGUUCA 3978
799 AACAGUGU G CAUCGGGG 2284 CCCCGAUG GGAGGAAACUCC CU
UCAAGGACAUCGUCCGGG ACACUGUU 3979 804 UGUGCAUC G GGGGUGCA 3581
UGCACCCC GGAGGAAACUCC CU UCAAGGACAUCGUCCGGG GAUGCACA 3980 805
GUGCAUCG G GGGUGCAU 3582 AUGCACCC GGAGGAAACUCC CU
UCAAGGACAUCGUCCGGG CGAUGCAC 3981 806 UGCAUCGG G GGUGCAUG 3583
CAUGCACC GGAGGAAACUCC CU UCAAGGACAUCGUCCGGG CCGAUGCA 3982 807
GCAUCGGG G GUGCAUGG 3584 CCAUGCAC GGAGGAAACUCC CU
UCAAGGACAUCGUCCGGG CCCGAUGC 3983 808 CAUCGGGG G UGCAUGGG 2285
CCCAUGCA GGAGGAAACUCC CU UCAAGGACAUCGUCCGGG CCCCGAUG 3984 810
UCGGGGGU G CAUGGGCC 2286 GGCCCAUG GGAGGAAACUCC CU
UCAAGGACAUCGUCCGGG ACCCCCGA 3985 814 GGGUGCAU G GGCCAGAA 3585
UUCUGGCC GGAGGAAACUCC CU UCAAGGACAUCGUCCGGG AUGCACCC 3986 815
GGUGCAUG G GCCAGAAG 3586 CUUCUGGC GGAGGAAACUCC CU
UCAAGGACAUCGUCCGGG CAUGCACC 3987 816 GUGCAUGG G CCAGAAGG 2287
CCUUCUGG GGAGGAAACUCC CU UCAAGGACAUCGUCCGGG CCAUGCAC 3988 820
AUGGGCCA G AAGGAUUU 3587 AAAUCCUU GGAGGAAACUCC CU
UCAAGGACAUCGUCCGGG UGGCCCAU 3989 823 GGCCAGAA G GAUUUCAU 3588
AUGAAAUC GGAGGAAACUCC CU UCAAGGACAUCGUCCGGG UUCUGGCC 3990 824
GCCAGAAG G AUUUCAUU 3589 AAUGAAAU GGAGGAAACUCC CU
UCAAGGACAUCGUCCGGG CUUCUGGC 3991 839 UUAUAAAU G CAAAAUGG 2288
CCAUUUUG GGAGGAAACUCC CU UCAAGGACAUCGUCCGGG AUUUAUAA 3992 846
UGCAAAAU G GGACAGAA 3590 UUCUGUCC GGAGGAAACUCC CU
UCAAGGACAUCGUCCGGG AUUUUGCA 3993 847 GCAAAAUG G GACAGAAA 3591
UUUCUGUC GGAGGAAACUCC CU UCAAGGACAUCGUCCGGG CAUUUUGC 3994 848
CAAAAUGG G ACAGAAAG 3592 CUUUCUGU GGAGGAAACUCC CU
UCAAGGACAUCGUCCGGG CCAUUUUG 3995 852 AUGGGACA G AAAGAAUA 3593
UAUUCUUU GGAGGAAACUCC CU UCAAGGACAUCGUCCGGG UGUCCCAU 3996 856
GACAGAAA G AAUAUAGU 3594 ACUAUAUU GGAGGAAACUCC CU
UCAAGGACAUCGUCCGGG UUUCUGUC 3997 863 AGAAUAUA G UAUUGGUA 2289
UACCAAUA GGAGGAAACUCC CU UCAAGGACAUCGUCCGGG UAUAUUCU 3998 868
AUAGUAUU G GUACAGGU 3595 ACCUGUAC GGAGGAAACUCC CU
UCAAGGACAUCGUCCGGG AAUACUAU 3999 869 UAGUAUUG G UACAGGUU 2290
AACCUGUA GGAGGAAACUCC CU UCAAGGACAUCGUCCGGG CAAUACUA 4000 874
UUGGUACA G GUUCUACU 3596 AGUAGAAC GGAGGAAACUCC CU
UCAAGGACAUCGUCCGGG UGUACCAA 4001 875 UGGUACAG G UUCUACUA 2291
UAGUAGAA GGAGGAAACUCC CU UCAAGGACAUCGUCCGGG CUGUACCA 4002 888
ACUAAACA G GAAGCAAA 3597 UUUGCUUC GGAGGAAACUCC CU
UCAAGGACAUCGUCCGGG UGUUUAGU 4003 889 CUAAACAG G AAGCAAAA 3598
UUUUGCUU GGAGGAAACUCC CU UCAAGGACAUCGUCCGGG CUGUUUAG 4004 892
AACAGGAA G CAAAACAA 2292 UUGUUUUG GGAGGAAACUCC CU
UCAAGGACAUCGUCCGGG UUCCUGUU 4005 903 AAACAAUU G GCCGCUAA 3599
UUAGCGGC GGAGGAAACUCC CU UCAAGGACAUCGUCCGGG AAUUGUUU 4006 904
AACAAUUG G CCGCUAAA 2293 UUUAGCGG GGAGGAAACUCC CU
UCAAGGACAUCGUCCGGG CAAUUGUU 4007 907 AAUUGGCC G CUAAACUU 2294
AAGUUUAG GGAGGAAACUCC CU UCAAGGACAUCGUCCGGG GGCCAAUU 4008 916
CUAAACUU G CAUAUCUU 2295 AAGAUAUG GGAGGAAACUCC CU
UCAAGGACAUCGUCCGGG AAGUUUAG 4009 927 UAUCUUCA G AUAUUAUC 3600
GAUAAUAU GGAGGAAACUCC CU UCAAGGACAUCGUCCGOG UGAAGAUA 4010 937
UAUUAUCA G AAGAAACC 3601 GGUUUCUU GGAGGAAACUCC CU
UCAAGGACAUCGUCCGGG UGAUAAUA 4011 940 UAUCAGAA G AAACCUCA 3602
UGAGGUUU GGAGGAAACUCC CU UCAAGGACAUCGUCCGGG UUCUGAUA 4012 949
AAACCUCA G UGAAAUCU 2296 AGAUUUCA GGAGGAAACUCC CU
UCAAGGACAUCGUCCGGG UGAGGUUU 4013 951 ACCUCAGU G AAAUCUGA 3603
UCAGAUUU GGAGGAAACUCC CU UCAAGGACAUCGUCCGGG ACUGAGGU 4014 958
UGAAAUCU G ACUACCUG 3604 CAGGUAGU GGAGGAAACUCC CU
UCAAGGACAUCGUCCGGG AGAUUUCA 4015 966 GACUACCU G UCCUCUGG 2297
CCAGAGGA GGAGGAAACUCC CU UCAAGGACAUCGUCCGGG AGGUAGUC 4016 973
UGUCCUCU G GUUCUUUU 3605 AAAAGAAC GGAGGAAACUCC CU
UCAAGGACAUCGUCCGGG AGAGGACA 4017 974 GUCCUCUG G UUCUUUUG 2298
CAAAAGAA GGAGGAAACUCC CU UCAAGGACAUCGUCCGGG CAGAGGAC 4018 982
GUUCUUUU G CUACUACG 2299 CGUAGUAG GGAGGAAACUCC CU
UCAAGGACAUCGUCCGGG AAAAGAAC 4019 990 GCUACUAC G UGUGAGUC 2300
GACUCACA GGAGGAAACUCC CU UCAAGGACAUCGUCCGGG GUAGUAGC 4020 992
UACUACGU G UGAGUCCC 2301 GGGACUCA GGAGGAAACUCC CU
UCAAGGACAUCGUCCGGG ACGUAGUA 4021 994 CUACGUGU G AGUCCCAA 3606
UUGGGACU GGAGGAAACUCC CU UCAAGGACAUCGUCCGGG ACACGUAG 4022 996
ACGUGUGA G UCCCAAAG 2302 CUUUGGGA GGAGGAAACUCC CU
UCAAGGACAUCGUCCGGG UCACACGU 4023 1004 GUCCCAAA G CAACUCUU 2303
AAGAGUUG GGAGGAAACUCC CU UCAAGGACAUCGUCCGGG UUUGGGAC 4024 1015
ACUCUUUA G UGACCAGC 2304 GCUGGUCA GGAGGAAACUCC CU
UCAAGGACAUCGUCCGGG UAAAGAGU 4025 1017 UCUUUAGU G ACCAGCAC 3607
GUGCUGGU GGAGGAAACUCC CU UCAAGGACAUCGUCCGGG ACUAAAGA 4026 1022
AGUGACCA G CACACUCG 2305 CGAGUGUG GGAGGAAACUCC CU
UCAAGGACAUCGUCCGGG UGGUCACU 4027 1030 GCACACUC G CUUCUGAA 2306
UUCAGAAG GGAGGAAACUCC CU UCAAGGACAUCGUCCGGG GAGUGUGC 4028 1036
UCGCUUCU G AAUCAUCA 3608 UGAUGAUU GGAGGAAACUCC CU
UCAAGGACAUCGUCCGGG AGAAGCGA 4029 1048 CAUCAUCU G AAGGUGAC 3609
GUCACCUU GGAGGAAACUCC CU UCAAGGACAUCGUCCGGG AGAUGAUG 4030 1051
CAUCUGAA G GUGACUUC 3610 GAAGUCAC GGAGGAAACUCC CU
UCAAGGACAUCGUCCGGG UUCAGAUG 4031 1052 AUCUGAAG G UGACUUCU 2307
AGAAGUCA GGAGGAAACUCC CU UCAAGGACAUCGUCCGGG CUUCAGAU 4032 1054
CUGAAGGU G ACUUCUCA 3611 UGAGAAGU GGAGGAAACUCC CU
UCAAGGACAUCGUCCGGG ACCUUCAG 4033 1063 ACUUCUCA G CAGAUACA 2308
UGUAUCUG GGAGGAAACUCC CU UCAAGGACAUCGUCCGGG UGAGAAGU 4034 1066
UCUCAGCA G AUACAUCA 3612 UGAUGUAU GGAGGAAACUCC CU
UCAAGGACAUCGUCCGGG UGCUGAGA 4035 1075 AUACAUCA G AGAUAAAU 3613
AUUUAUCU GGAGGAAACUCC CU UCAAGGACAUCGUCCGGG UGAUGUAU 4036 1077
ACAUCAGA G AUAAAUUC 3614 GAAUUUAU GGAGGAAACUCC CU
UCAAGGACAUCGUCCGGG UCUGAUGU 4037 1091 UUCUAACA G UGACAGUU 2309
AACUGUCA GGAGGAAACUCC CU UCAAGGACAUCGUCCGGG UGUUAGAA 4038 1093
CUAACAGU G ACAGUUUA 3615 UAAACUGU GGAGGAAACUCC CU
UCAAGGACAUCGUCCGGG ACUGUUAG 4039 1097 CAGUGACA G UUUAAACA 2310
UGUUUAAA GGAGGAAACUCC CU UCAAGGACAUCGUCCGGG UGUCACUG 4040 1106
UUUAAACA G UUCUUCGU 2311 ACGAAGAA GGAGGAAACUCC CU
UCAAGGACAUCGUCCGGG UGUUUAAA 4041 1113 AGUUCUUC G UUGCUUAU 2312
AUAAGCAA GGAGGAAACUCC CU UCAAGGACAUCGUCCGGG GAAGAACU 4042 1116
UCUUCGUU G CUUAUGAA 2313 UUCAUAAG GGAGGAAACUCC CU
UCAAGGACAUCGUCCGGG AACGAAGA 4043 1122 UUGCUUAU G AAUGGUCU 3616
AGACCAUU GGAGGAAACUCC CU UCAAGGACAUCGUCCGGG AUAAGCAA 4044 1126
UUAUGAAU G GUCUCAGA 3617 UCUGAGAC GGAGGAAACUCC CU
UCAAGGACAUCGUCCGGG AUUCAUAA 4045 1127 UAUGAAUG G UCUCAGAA 2314
UUCUGAGA GGAGGAAACUCC CU UCAAGGACAUCGUCCGGG CAUUCAUA 4046 1133
UGGUCUCA G AAAUAAUC 3618 GAUUAUUU GGAGGAAACUCC CU
UCAAGGACAUCGUCCGGG UGAGACCA 4047 1145 UAAUCAAA G GAAGGCAA 3619
UUGCCUUC GGAGGAAACUCC CU UCAAGGACAUCGUCCGGG UUUGAUUA 4048 1146
AAUCAAAG G AAGGCAAA 3620 UUUGCCUU GGAGGAAACUCC CU
UCAAGGACAUCGUCCGGG CUUUGAUU 4049 1149 CAAAGGAA G GCAAAAAG 3621
CUUUUUGC GGAGGAAACUCC CU UCAAGGACAUCGUCCGGG UUCCUUUG 4050 1150
AAAGGAAG G CAAAAAGA 2315 UCUUUUUG GGAGGAAACUCC CU
UCAAGGACAUCGUCCGGG CUUCCUUU 4051 1157 GGCAAAAA G AUCUUUGG 3622
CCAAAGAU GGAGGAAACUCC CU UCAAGGACAUCGUCCGGG UUUUUGCC 4052 1164
AGAUCUUU G GCACCCAG 3623 CUGGGUGC GGAGGAAACUCC CU
UCAAGGACAUCGUCCGGG AAAGAUCU 4053 1165 GAUCUUUG G CACCCAGA 2316
UCUGGGUG GGAGGAAACUCC CU UCAAGGACAUCGUCCGGG CAAAGAUC 4054 1172
GGCACCCA G AUUUGACC 3624 GGUCAAAU GGAGGAAACUCC CU
UCAAGGACAUCGUCCGGG UGGGUGCC 4055 1177 CCAGAUUU G ACCUUCCU 3625
AGGAAGGU GGAGGAAACUCC CU UCAAGGACAUCGUCCGGG AAAUCUGG 4056 1186
ACCUUCCU G ACAUGAAA 3626 UUUCAUGU GGAGGAAACUCC CU
UCAAGGACAUCGUCCGGG AGGAAGGU 4057 1191 CCUGACAU G AAAGAAAC 3627
GUUUCUUU GGAGGAAACUCC CU UCAAGGACAUCGUCCGGG AUGUCAGG 4058 1195
ACAUGAAA G AAACAAAG 3628 CUUUGUUU GGAGGAAACUCC CU
UCAAGGACAUCGUCCGGG UUUCAUGU 4059 1203 GAAACAAA G UAUACUGU 2317
ACAGUAUA GGAGGAAACUCC CU UCAAGGACAUCGUCCGGG UUUGUUUC 4060 1210
AGUAUACU G UGGACAAG 2318 CUUGUCCA GGAGGAAACUCC CU
UCAAGGACAUCGUCCGGG AGUAUACU 4061 1212 UAUACUGU G GACAAGAG 3629
CUCUUGUC GGAGGAAACUCC CU UCAAGGACAUCGUCCGGG
ACAGUAUA 4062 1213 AUACUGUG G ACAAGAGG 3630 CCUCUUGU GGAGGAAACUCC
CU UCAAGGACAUCGUCCGGG CACAGUAU 4063 1218 GUGGACAA G AGGUUUGG 3631
CCAAACCU GGAGGAAACUCC CU UCAAGGACAUCGUCCGGG UUGUCCAC 4064 1220
GGACAAGA G GUUUGGCA 3632 UGCCAAAC GGAGGAAACUCC CU
UCAAGGACAUCGUCCGGG UCUUGUCC 4065 1221 GACAAGAG G UUUGGCAU 2319
AUGCCAAA GGAGGAAACUCC CU UCAAGGACAUCGUCCGGG CUCUUGUC 4066 1225
AGAGGUUU G GCAUGGAU 3633 AUCCAUGC GGAGGAAACUCC CU
UCAAGGACAUCGUCCGGG AAACCUCU 4067 1226 GAGGUUUG G CAUGGAUU 2320
AAUCCAUG GGAGGAAACUCC CU UCAAGGACAUCGUCCGGG CAAACCUC 4068 1230
UUUGGCAU G GAUUUUAA 3634 UUAAAAUC GGAGGAAACUCC CU
UCAAGGACAUCGUCCGGG AUGCCAAA 4069 1231 UUGGCAUG G AUUUUAAA 3635
UUUAAAAU GGAGGAAACUCC CU UCAAGGACAUCGUCCGGG CAUGCCAA 4070 1240
AUUUUAAA G AAAUAGAA 3636 UUCUAUUU GGAGGAAACUCC CU
UCAAGGACAUCGUCCGGG UUUAAAAU 4071 1246 AAGAAAUA G AAUUAAUU 3637
AAUUAAUU GGAGGAAACUCC CU UCAAGGACAUCGUCCGGG UAUUUCUU 4072 1255
AAUUAAUU G GCUCAGGU 3638 ACCUGAGC GGAGGAAACUCC CU
UCAAGGACAUCGUCCGGG AAUUAAUU 4073 1256 AUUAAUUG G CUCAGGUG 2321
CACCUGAG GGAGGAAACUCC CU UCAAGGACAUCGUCCGGG CAAUUAAU 4074 1261
UUGGCUCA G GUGGAUUU 3639 AAAUCCAC GGAGGAAACUCC CU
UCAAGGACAUCGUCCGGG UGAGCCAA 4075 1262 UGGCUCAG G UGGAUUUG 2322
CAAAUCCA GGAGGAAACUCC CU UCAAGGACAUCGUCCGGG CUGAGCCA 4076 1264
GCUCAGGU G GAUUUGGC 3640 GCCAAAUC GGAGGAAACUCC CU
UCAAGGACAUCGUCCGGG ACCUGAGC 4077 1265 CUCAGGUG G AUUUGGCC 3641
GGCCAAAU GGAGGAAACUCC CU UCAAGGACAUCGUCCGGG CACCUGAG 4078 1270
GUGGAUUU G GCCAAGUU 3642 AACUUGGC GGAGGAAACUCC CU
UCAAGGACAUCGUCCGGG AAAUCCAC 4079 1271 UGGAUUUG G CCAAGUUU 2323
AAACUUGG GGAGGAAACUCC CU UCAAGGACAUCGUCCGGG CAAAUCCA 4080 1276
UUGGCCAA G UUUUCAAA 2324 UUUGAAAA GGAGGAAACUCC CU
UCAAGGACAUCGUCCGGG UUGGCCAA 4081 1285 UUUUCAAA G CAAAACAC 2325
GUGUUUUG GGAGGAAACUCC CU UCAAGGACAUCGUCCGGG UUUGAAAA 4082 1295
AAAACACA G AAUUGACG 3643 CGUCAAUU GGAGGAAACUCC CU
UCAAGGACAUCGUCCGGG UGUGUUUU 4083 1300 ACAGAAUU G ACGGAAAG 3644
CUUUCCGU GGAGGAAACUCC CU UCAAGGACAUCGUCCGGG AAUUCUGU 4084 1303
GAAUUGAC G GAAAGACU 3645 AGUCUUUC GGAGGAAACUCC CU
UCAAGGACAUCGUCCGGG GUCAAUUC 4085 1304 AAUUGACG G AAAGACUU 3646
AAGUCUUU GGAGGAAACUCC CU UCAAGGACAUCGUCCGGG CGUCAAUU 4086 1308
GACGGAAA G ACUUACGU 3647 ACGUAAGU GGAGGAAACUCC CU
UCAAGGACAUCGUCCGGG UUUCCGUC 4087 1315 AGACUUAC G UUAUUAAA 2326
UUUAAUAA GGAGGAAACUCC CU UCAAGGACAUCGUCCGGG GUAAGUCU 4088 1325
UAUUAAAC G UGUUAAAU 2327 AUUUAACA GGAGGAAACUCC CU
UCAAGGACAUCGUCCGGG GUUUAAUA 4089 1327 UUAAACGU G UUAAAUAU 2328
AUAUUUAA GGAGGAAACUCC CU UCAAGGACAUCGUCCGGG ACGUUUAA 4090 1342
AUAAUAAC G AGAAGGCG 3648 CGCCUUCU GGAGGAAACUCC CU
UCAAGGACAUCGUCCGGG GUUAUUAU 4091 1344 AAUAACGA G AAGGCGGA 3649
UCCGCCUU GGAGGAAACUCC CU UCAAGGACAUCGUCCGGG UCGUUAUU 4092 1347
AACGAGAA G GCGGAGCG 3650 CGCUCCGC GGAGGAAACUCC CU
UCAAGGACAUCGUCCGGG UUCUCGUU 4093 1348 ACGAGAAG G CGGAGCGU 2329
ACGCUCCG GGAGGAAACUCC CU UCAAGGACAUCGUCCGGG CUUCUCGU 4094 1350
GAGAAGGC G GAGCGUGA 3651 UCACGCUC GGAGGAAACUCC CU
UCAAGGACAUCGUCCGGG GCCUUCUC 4095 1351 AGAAGGCG G AGCGUGAA 3652
UUCACGCU GGAGGAAACUCC CU UCAAGGACAUCGUCCGGG CGCCUUCU 4096 1353
AAGGCGGA G CGUGAAGU 2330 ACUUCACG GGAGGAAACUCC CU
UCAAGGACAUCGUCCGGG UCCGCCUU 4097 1355 GGCGGAGC G UGAAGUAA 2331
UUACUUCA GGAGGAAACUCC CU UCAAGGACAUCGUCCGGG GCUCCGCC 4098 1357
CGGAGCGU G AAGUAAAA 3653 UUUUACUU GGAGGAAACUCC CU
UCAAGGACAUCGUCCGGG ACGCUCCG 4099 1360 AGCGUGAA G UAAAAGCA 2332
UGCUUUUA GGAGGAAACUCC CU UCAAGGACAUCGUCCGGG UUCACGCU 4100 1366
AAGUAAAA G CAUUGGCA 2333 UGCCAAUG GGAGGAAACUCC CU
UCAAGGACAUCGUCCGGG UUUUACUU 4101 1371 AAAGCAUU G GCAAAACU 3654
AGUUUUGC GGAGGAAACUCC CU UCAAGGACAUCGUCCGGG AAUGCUUU 4102 1372
AAGCAUUG G CAAAACUU 2334 AAGUUUUG GGAGGAAACUCC CU
UCAAGGACAUCGUCCGGG CAAUGCUU 4103 1381 CAAAACUU G AUCAUGUA 3655
UACAUGAU GGAGGAAACUCC CU UCAAGGACAUCGUCCGGG AAGUUUUG 4104 1387
UUGAUCAU G UAAAUAUU 2335 AAUAUUUA GGAGGAAACUCC CU
UCAAGGACAUCGUCCGGG AUGAUCAA 4105 1396 UAAAUAUU G UUCACUAC 2336
GUAGUGAA GGAGGAAACUCC CU UCAAGGACAUCGUCCGGG AAUAUUUA 4106 1408
ACUACAAU G GCUGUUGG 3656 CCAACAGC GGAGGAAACUCC CU
UCAAGGACAUCGUCCGGG AUUGUAGU 4107 1409 CUACAAUG G CUGUUGGG 2337
CCCAACAG GGAGGAAACUCC CU UCAAGGACAUCGUCCGGG CAUUGUAG 4108 1412
CAAUGGCU G UUGGGAUG 2338 CAUCCCAA GGAGGAAACUCC CU
UCAAGGACAUCGUCCGGG AGCCAUUG 4109 1415 UGGCUGUU G GGAUGGAU 3657
AUCCAUCC GGAGGAAACUCC CU UCAAGGACAUCGUCCGGG AACAGCCA 4110 1416
GGCUGUUG G GAUGGAUU 3658 AAUCCAUC GGAGGAAACUCC CU
UCAAGGACAUCGUCCGGG CAACAGCC 4111 1417 GCUGUUGG G AUGGAUUU 3659
AAAUCCAU GGAGGAAACUCC CU UCAAGGACAUCGUCCGGG CCAACAGC 4112 1420
GUUGGGAU G GAUUUGAU 3660 AUCAAAUC GGAGGAAACUCC CU
UCAAGGACAUCGUCCGGG AUCCCAAC 4113 1421 UUGGGAUG G AUUUGAUU 3661
AAUCAAAU GGAGGAAACUCC CU UCAAGGACAUCGUCCGGG CAUCCCAA 4114 1426
AUGGAUUU G AUUAUGAU 3662 AUCAUAAU GGAGGAAACUCC CU
UCAAGGACAUCGUCCGGG AAAUCCAU 4115 1432 UUGAUUAU G AUCCUGAG 3663
CUCAGGAU GGAGGAAACUCC CU UCAAGGACAUCGUCCGGG AUAAUCAA 4116 1438
AUGAUCCU G AGACCAGU 3664 ACUGGUCU GGAGGAAACUCC CU
UCAAGGACAUCGUCCGGG AGGAUCAU 4117 1440 GAUCCUGA G ACCAGUGA 3665
UCACUGGU GGAGGAAACUCC CU UCAAGGACAUCGUCCGGG UCAGGAUC 4118 1445
UGAGACCA G UGAUGAUU 2339 AAUCAUCA GGAGGAAACUCC CU
UCAAGGACAUCGUCCGGG UGGUCUCA 4119 1447 AGACCAGU G AUGAUUCU 3666
AGAAUCAU GGAGGAAACUCC CU UCAAGGACAUCGUCCGGG ACUGGUCU 4120 1450
CCAGUGAU G AUUCUCUU 3667 AAGAGAAU GGAGGAAACUCC CU
UCAAGGACAUCGUCCGGG AUCACUGG 4121 1459 AUUCUCUU G AGAGCAGU 3668
ACUGCUCU GGAGGAAACUCC CU UCAAGGACAUCGUCCGGG AAGAGAAU 4122 1461
UCUCUUGA G AGCAGUGA 3669 UCACUGCU GGAGGAAACUCC CU
UCAAGGACAUCGUCCGGG UCAAGAGA 4123 1463 UCUUGAGA G CAGUGAUU 2340
AAUCACUG GGAGGAAACUCC CU UCAAGGACAUCGUCCGGG UCUCAAGA 4124 1466
UGAGAGCA G UGAUUAUG 2341 CAUAAUCA GGAGGAAACUCC CU
UCAAGGACAUCGUCCGGG UGCUCUCA 4125 1468 AGAGCAGU G AUUAUGAU 3670
AUCAUAAU GGAGGAAACUCC CU UCAAGGACAUCGUCCGGG ACUGCUCU 4126 1474
GUGAUUAU G AUCCUGAG 3671 CUCAGGAU GGAGGAAACUCC CU
UCAAGGACAUCGUCCGGG AUAAUCAC 4127 1480 AUGAUCCU G AGAACAGC 3672
GCUGUUCU GGAGGAAACUCC CU UCAAGGACAUCGUCCGGG AGGAUCAU 4128 1482
GAUCCUGA G AACAGCAA 3673 UUGCUGUU GGAGGAAACUCC CU
UCAAGGACAUCGUCCGGG UCAGGAUC 4129 1487 UGAGAACA G CAAAAAUA 2342
UAUUUUUG GGAGGAAACUCC CU UCAAGGACAUCGUCCGGG UGUUCUCA 4130 1496
CAAAAAUA G UUCAAGGU 2343 ACCUUGAA GGAGGAAACUCC CU
UCAAGGACAUCGUCCGGG UAUUUUUG 4131 1502 UAGUUCAA G GUCAAAGA 3674
UCUUUGAC GGAGGAAACUCC CU UCAAGGACAUCGUCCGGG UUGAACUA 4132 1503
AGUUCAAG G UCAAAGAC 2344 GUCUUUGA GGAGGAAACUCC CU
UCAAGGACAUCGUCCGGG CUUGAACU 4133 1509 AGGUCAAA G ACUAAGUG 3675
CACUUAGU GGAGGAAACUCC CU UCAAGGACAUCGUCCGGG UUUGACCU 4134 1515
AAGACUAA G UGCCUUUU 2345 AAAAGGCA GGAGGAAACUCC CU
UCAAGGACAUCGUCCGGG UUAGUCUU 4135 1517 GACUAAGU G CCUUUUCA 2346
UGAAAAGG GGAGGAAACUCC CU UCAAGGACAUCGUCCGGG ACUUAGUC 4136 1533
AUCCAAAU G GAAUUCUG 3676 CAGAAUUC GGAGGAAACUCC CU
UCAAGGACAUCGUCCGGG AUUUGGAU 4137 1534 UCCAAAUG G AAUUCUGU 3677
ACAGAAUU GGAGGAAACUCC CU UCAAGGACAUCGUCCGGG CAUUUGGA 4138 1541
GGAAUUCU G UGAUAAAG 2347 CUUUAUCA GGAGGAAACUCC CU
UCAAGGACAUCGUCCGGG AGAAUUCC 4139 1543 AAUUCUGU G AUAAAGGG 3678
CCCUUUAU GGAGGAAACUCC CU UCAAGGACAUCGUCCGGG ACAGAAUU 4140 1549
GUGAUAAA G GGACCUUG 3679 CAAGGUCC GGAGGAAACUCC CU
UCAAGGACAUCGUCCGGG UUUAUCAC 4141 1550 UGAUAAAG G GACCUUGG 3680
CCAAGGUC GGAGGAAACUCC CU UCAAGGACAUCGUCCGGG CUUUAUCA 4142 1551
GAUAAAGG G ACCUUGGA 3681 UCCAAGGU GGAGGAAACUCC CU
UCAAGGACAUCGUCCGGG CCUUUAUC 4143 1557 GGGACCUU G GAACAAUG 3682
CAUUGUUC GGAGGAAACUCC CU UCAAGGACAUCGUCCGGG AAGGUCCC 4144 1558
GGACCUUG G AACAAUGG 3683 CCAUUGUU GGAGGAAACUCC CU
UCAAGGACAUCGUCCGGG CAAGGUCC 4145
1565 GGAACAAU G GAUUGAAA 3684 UUUCAAUC GGAGGAAACUCC CU
UCAAGGACAUCGUCCGGG AUUGUUCC 4146 1566 GAACAAUG G AUUGAAAA 3685
UUUUCAAU GGAGGAAACUCC CU UCAAGGACAUCGUCCGGG CAUUGUUC 4147 1570
AAUGGAUU G AAAAAAGA 3686 UCUUUUUU GGAGGAAACUCC CU
UCAAGGACAUCGUCCGGG AAUCCAUU 4148 1577 UGAAAAAA G AAGAGGCG 3687
CGCCUCUU GGAGGAAACUCC CU UCAAGGACAUCGUCCGGG UUUUUUCA 4149 1580
AAAAAGAA G AGGCGAGA 3688 UCUCGCCU GGAGGAAACUCC CU
UCAAGGACAUCGUCCGGG UUCUUUUU 4150 1582 AAAGAAGA G GCGAGAAA 3689
UUUCUCGC GGAGGAAACUCC CU UCAAGGACAUCGUCCGGG UCUUCUUU 4151 1583
AAGAAGAG G CGAGAAAC 2348 GUUUCUCG GGAGGAAACUCC CU
UCAAGGACAUCGUCCGGG CUCUUCUU 4152 1585 GAAGAGGC G AGAAACUA 3690
UAGUUUCU GGAGGAAACUCC CU UCAAGGACAUCGUCCGGG GCCUCUUC 4153 1587
AGAGGCGA G AAACUAGA 3691 UCUAGUUU GGAGGAAACUCC CU
UCAAGGACAUCGUCCGGG UCGCCUCU 4154 1594 AGAAACUA G ACAAAGUU 3692
AACUUUGU GGAGGAAACUCC CU UCAAGGACAUCGUCCGGG UAGUUUCU 4155 1600
UAGACAAA G UUUUGGCU 2349 AGCCAAAA GGAGGAAACUCC CU
UCAAGGACAUCGUCCGGG UUUGUCUA 4156 1605 AAAGUUUU G GCUUUGGA 3693
UCCAAAGC GGAGGAAACUCC CU UCAAGGACAUCGUCCGGG AAAACUUU 4157 1606
AAGUUUUG G CUUUGGAA 2350 UUCCAAAG GGAGGAAACUCC CU
UCAAGGACAUCGUCCGGG CAAAACUU 4158 1611 UUGGCUUU G GAACUCUU 3694
AAGAGUUC GGAGGAAACUCC CU UCAAGGACAUCGUCCGGG AAAGCCAA 4159 1612
UGGCUUUG G AACUCUUU 3695 AAAGAGUU GGAGGAAACUCC CU
UCAAGGACAUCGUCCGGG CAAAGCCA 4160 1621 AACUCUUU G AACAAAUA 3696
UAUUUGUU GGAGGAAACUCC CU UCAAGGACAUCGUCCGGG AAAGAGUU 4161 1636
UAACAAAA G GGGUGGAU 3697 AUCCACCC GGAGGAAACUCC CU
UCAAGGACAUCGUCCGGG UUUUGUUA 4162 1637 AACAAAAG G GGUGGAUU 3698
AAUCCACC GGAGGAAACUCC CU UCAAGGACAUCGUCCGGG CUUUUGUU 4163 1638
ACAAAAGG G GUGGAUUA 3699 UAAUCCAC GGAGGAAACUCC CU
UCAAGGACAUCGUCCGGG CCUUUUGU 4164 1639 CAAAAGGG G UGGAUUAU 2351
AUAAUCCA GGAGGAAACUCC CU UCAAGGACAUCGUCCGGG CCCUUUUG 4165 1641
AAAGGGGU G GAUUAUAU 3700 AUAUAAUC GGAGGAAACUCC CU
UCAAGGACAUCGUCCGGG ACCCCUUU 4166 1642 AAGGGGUG G AUUAUAUA 3701
UAUAUAAU GGAGGAAACUCC CU UCAAGGACAUCGUCCGGG CACCCCUU 4167 1673
AAUUCAUA G AGAUCUUA 3702 UAAGAUCU GGAGGAAACUCC CU
UCAAGGACAUCGUCCGGG UAUGAAUU 4168 1675 UUCAUAGA G AUCUUAAG 3703
CUUAAGAU GGAGGAAACUCC CU UCAAGGACAUCGUCCGGG UCUAUGAA 4169 1683
GAUCUUAA G CCAAGUAA 2352 UUACUUGG GGAGGAAACUCC CU
UCAAGGACAUCGUCCGGG UUAAGAUC 4170 1688 UAAGCCAA G UAAUAUAU 2353
AUAUAUUA GGAGGAAACUCC CU UCAAGGACAUCGUCCGGG UUGGCUUA 4171 1702
UAUUCUUA G UAGAUACA 2354 UGUAUCUA GGAGGAAACUCC CU
UCAAGGACAUCGUCCGGG UAAGAAUA 4172 1705 UCUUAGUA G AUACAAAA 3704
UUUUGUAU GGAGGAAACUCC CU UCAAGGACAUCGUCCGGG UACUAAGA 4173 1717
CAAAACAA G UAAAGAUU 2355 AAUCUUUA GGAGGAAACUCC CU
UCAAGGACAUCGUCCGGG UUGUUUUG 4174 1722 CAAGUAAA G AUUGGAGA 3705
UCUCCAAU GGAGGAAACUCC CU UCAAGGACAUCGUCCGGG UUUACUUG 4175 1726
UAAAGAUU G GAGACUUU 3706 AAAGUCUC GGAGGAAACUCC CU
UCAAGGACAUCGUCCGGG AAUCUUUA 4176 1727 AAAGAUUG G AGACUUUG 3707
CAAAGUCU GGAGGAAACUCC CU UCAAGGACAUCGUCCGGG CAAUCUUU 4177 1729
AGAUUGGA G ACUUUGGA 3708 UCCAAAGU GGAGGAAACUCC CU
UCAAGGACAUCGUCCGGG UCCAAUCU 4178 1735 GAGACUUU G GACUUGUA 3709
UACAAGUC GGAGGAAACUCC CU UCAAGGACAUCGUCCGGG AAAGUCUC 4179 1736
AGACUUUG G ACUUGUAA 3710 UUACAAGU GGAGGAAACUCC CU
UCAAGGACAUCGUCCGGG CAAAGUCU 4180 1741 UUGGACUU G UAACAUCU 2356
AGAUGUUA GGAGGAAACUCC CU UCAAGGACAUCGUCCGGG AAGUCCAA 4181 1752
ACAUCUCU G AAAAAUGA 3711 UCAUUUUU GGAGGAAACUCC CU
UCAAGGACAUCGUCCGGG AGAGAUGU 4182 1759 UGAAAAAU G AUGGAAAG 3712
CUUUCCAU GGAGGAAACUCC CU UCAAGGACAUCGUCCGGG AUUUUUCA 4183 1762
AAAAUGAU G GAAAGCGA 3713 UCGCUUUC GGAGGAAACUCC CU
UCAAGGACAUCGUCCGGG AUCAUUUU 4184 1763 AAAUGAUG G AAAGCGAA 3714
UUCGCUUU GGAGGAAACUCC CU UCAAGGACAUCGUCCGGG CAUCAUUU 4185 1767
GAUGGAAA G CGAACAAG 2357 CUUGUUCG GGAGGAAACUCC CU
UCAAGGACAUCGUCCGGG UUUCCAUC 4186 1769 UGGAAAGC G AACAAGGA 3715
UCCUUGUU GGAGGAAACUCC CU UCAAGGACAUCGUCCGGG GCUUUCCA 4187 1775
GCGAACAA G GAGUAAGG 3716 CCUUACUC GGAGGAAACUCC CU
UCAAGGACAUCGUCCGGG UUGUUCGC 4188 1776 CGAACAAG G AGUAAGGG 3717
CCCUUACU GGAGGAAACUCC CU UCAAGGACAUCGUCCGGG CUUGUUCG 4189 1778
AACAAGGA G UAAGGGAA 2358 UUCCCUUA GGAGGAAACUCC CU
UCAAGGACAUCGUCCGGG UCCUUGUU 4190 1782 AGGAGUAA G GGAACUUU 3718
AAAGUUCC GGAGGAAACUCC CU UCAAGGACAUCGUCCGGG UUACUCCU 4191 1783
GGAGUAAG G GAACUUUG 3719 CAAAGUUC GGAGGAAACUCC CU
UCAAGGACAUCGUCCGGG CUUACUCC 4192 1784 GAGUAAGG G AACUUUGC 3720
GCAAAGUU GGAGGAAACUCC CU UCAAGGACAUCGUCCGGG CCUUACUC 4193 1791
GGAACUUU G CGAUACAU 2359 AUGUAUCG GGAGGAAACUCC CU
UCAAGGACAUCGUCCGGG AAAGUUCC 4194 1793 AACUUUGC G AUACAUGA 3721
UCAUGUAU GGAGGAAACUCC CU UCAAGGACAUCGUCCGGG GCAAAGUU 4195 1800
CGAUACAU G AGCCCAGA 3722 UCUGGGCU GGAGGAAACUCC CU
UCAAGGACAUCGUCCGGG AUGUAUCG 4196 1802 AUACAUGA G CCCAGAAC 2360
GUUCUGGG GGAGGAAACUCC CU UCAAGGACAUCGUCCGGG UCAUGUAU 4197 1807
UGAGCCCA G AACAGAUU 3723 AAUCUGUU GGAGGAAACUCC CU
UCAAGGACAUCGUCCGGG UGGGCUCA 4198 1812 CCAGAACA G AUUUCUUC 3724
GAAGAAAU GGAGGAAACUCC CU UCAAGGACAUCGUCCGGG UGUUCUGG 4199 1821
AUUUCUUC G CAAGACUA 2361 UAGUCUUG GGAGGAAACUCC CU
UCAAGGACAUCGUCCGGG GAAGAAAU 4200 1825 CUUCGCAA G ACUAUGGA 3725
UCCAUAGU GGAGGAAACUCC CU UCAAGGACAUCGUCCGGG UUGCGAAG 4201 1831
AAGACUAU G GAAAGGAA 3726 UUCCUUUC GGAGGAAACUCC CU
UCAAGGACAUCGUCCGGG AUAGUCUU 4202 1832 AGACUAUG G AAAGGAAG 3727
CUUCCUUU GGAGGAAACUCC CU UCAAGGACAUCGUCCGGG CAUAGUCU 4203 1836
UAUGGAAA G GAAGUGGA 3728 UCCACUUC GGAGGAAACUCC CU
UCAAGGACAUCGUCCGGG UUUCCAUA 4204 1837 AUGGAAAG G AAGUGGAC 3729
GUCCACUU GGAGGAAACUCC CU UCAAGGACAUCGUCCGGG CUUUCCAU 4205 1840
GAAAGGAA G UGGACCUC 2362 GAGGUCCA GGAGGAAACUCC CU
UCAAGGACAUCGUCCGGG UUCCUUUC 4206 1842 AAGGAAGU G GACCUCUA 3730
UAGAGGUC GGAGGAAACUCC CU UCAAGGACAUCGUCCGGG ACUUCCUU 4207 1843
AGGAAGUG G ACCUCUAC 3731 GUAGAGGU GGAGGAAACUCC CU
UCAAGGACAUCGUCCGGG CACUUCCU 4208 1852 ACCUCUAC G CUUUGGGG 2363
CCCCAAAG GGAGGAAACUCC CU UCAAGGACAUCGUCCGGG GUAGAGGU 4209 1857
UACGCUUU G GGGCUAAU 3732 AUUAGCCC GGAGGAAACUCC CU
UCAAGGACAUCGUCCGGG AAAGCGUA 4210 1858 ACGCUUUG G GGCUAAUU 3733
AAUUAGCC GGAGGAAACUCC CU UCAAGGACAUCGUCCGGG CAAAGCGU 4211 1859
CGCUUUGG G GCUAAUUC 3734 GAAUUAGC GGAGGAAACUCC CU
UCAAGGACAUCGUCCGGG CCAAAGCG 4212 1860 GCUUUGGG G CUAAUUCU 2364
AGAAUUAG GGAGGAAACUCC CU UCAAGGACAUCGUCCGGG CCCAAAGC 4213 1870
UAAUUCUU G CUGAACUU 2365 AAGUUCAG GGAGGAAACUCC CU
UCAAGGACAUCGUCCGGG AAGAAUUA 4214 1873 UUCUUGCU G AACUUCUU 3735
AAGAAGUU GGAGGAAACUCC CU UCAAGGACAUCGUCCGGG AGCAAGAA 4215 1885
UUCUUCAU G UAUGUGAC 2366 GUCACAUA GGAGGAAACUCC CU
UCAAGGACAUCGUCCGGG AUGAAGAA 4216 1889 UCAUGUAU G UGACACUG 2367
CAGUGUCA GGAGGAAACUCC CU UCAAGGACAUCGUCCGGG AUACAUGA 4217 1891
AUGUAUGU G ACACUGCU 3736 AGCAGUGU GGAGGAAACUCC CU
UCAAGGACAUCGUCCGGG ACAUACAU 4218 1897 GUGACACU G CUUUUGAA 2368
UUCAAAAG GGAGGAAACUCC CU UCAAGGACAUCGUCCGGG AGUGUCAC 4219 1903
CUGCUUUU G AAACAUCA 3737 UGAUGUUU GGAGGAAACUCC CU
UCAAGGACAUCGUCCGGG AAAAGCAG 4220 1914 ACAUCAAA G UUUUUCAC 2369
GUGAAAAA GGAGGAAACUCC CU UCAAGGACAUCGUCCGGG UUUGAUGU 4221 1924
UUUUCACA G ACCUACGG 3738 CCGUAGGU GGAGGAAACUCC CU
UCAAGGACAUCGUCCGGG UGUGAAAA 4222 1931 AGACCUAC G GGAUGGCA 3739
UGCCAUCC GGAGGAAACUCC CU UCAAGGACAUCGUCCGGG GUAGGUCU 4223 1932
GACCUACG G GAUGGCAU 3740 AUGCCAUC GGAGGAAACUCC CU
UCAAGGACAUCGUCCGGG CGUAGGUC 4224 1933 ACCUACGG G AUGGCAUC 3741
GAUGCCAU GGAGGAAACUCC CU UCAAGGACAUCGUCCGGG CCGUAGGU 4225 1936
UACGGGAU G GCAUCAUC 3742 GAUGAUGC GGAGGAAACUCC CU
UCAAGGACAUCGUCCGGG AUCCCGUA 4226 1937 ACGGGAUG G CAUCAUCU 2370
AGAUGAUG GGAGGAAACUCC CU UCAAGGACAUCGUCCGGG CAUCCCGU 4227 1948
UCAUCUCA G AUAUAUUU 3743 AAAUAUAU GGAGGAAACUCC CU
UCAAGGACAUCGUCCGGG UGAGAUGA 4228 1957 AUAUAUUU G AUAAAAAA 3744
UUUUUUAU GGAGGAAACUCC CU UCAAGGACAUCGUCCGGG AAAUAUAU 4229
1966 AUAAAAAA G AAAAAACU 3745 AGUUUUUU GGAGGAAACUCC CU
UCAAGGACAUCGUCCGGG UUUUUUAU 4230 1983 CUUCUACA G AAAUUACU 3746
AGUAAUUU GGAGGAAACUCC CU UCAAGGACAUCGUCCGGG UGUAGAAG 4231 1998
CUCUCAAA G AAACCUGA 3747 UCAGGUUU GGAGGAAACUCC CU
UCAAGGACAUCGUCCGGG UUUGAGAG 4232 2005 AGAAACCU G AGGAUCGA 3748
UCGAUCCU GGAGGAAACUCC CU UCAAGGACAUCGUCCGGG AGGUUUCU 4233 2007
AAACCUGA G GAUCGACC 3749 GGUCGAUC GGAGGAAACUCC CU
UCAAGGACAUCGUCCGGG UCAGGUUU 4234 2008 AACCUGAG G AUCGACCU 3750
AGGUCGAU GGAGGAAACUCC CU UCAAGGACAUCGUCCGGG CUCAGGUU 4235 2012
UGAGGAUC G ACCUAACA 3751 UGUUAGGU GGAGGAAACUCC CU
UCAAGGACAUCGUCCGGG GAUCCUCA 4236 2026 ACACAUCU G AAAUACUA 3752
UAGUAUUU GGAGGAAACUCC CU UCAAGGACAUCGUCCGGG AGAUGUGU 4237 2036
AAUACUAA G GACCUUGA 3753 UCAAGGUC GGAGGAAACUCC CU
UCAAGGACAUCGUCCGGG UUAGUAUU 4238 2037 AUACUAAG G ACCUUGAC 3754
GUCAAGGU GGAGGAAACUCC CU UCAAGGACAUCGUCCGGG CUUAGUAU 4239 2043
AGGACCUU G ACUGUGUG 3755 CACACAGU GGAGGAAACUCC CU
UCAAGGACAUCGUCCGGG AAGGUCCU 4240 2047 CCUUGACU G UGUGGAAG 2371
CUUCCACA GGAGGAAACUCC CU UCAAGGACAUCGUCCGGG AGUCAAGG 4241 2049
UUGACUGU G UGGAAGAA 2372 UUCUUCCA GGAGGAAACUCC CU
UCAAGGACAUCGUCCGGG ACAGUCAA 4242 2051 GACUGUGU G GAAGAAAA 3756
UUUUCUUC GGAGGAAACUCC CU UCAAGGACAUCGUCCGGG ACACAGUC 4243 2052
ACUGUGUG G AAGAAAAG 3757 CUUUUCUU GGAGGAAACUCC CU
UCAAGGACAUCGUCCGGG CACACAGU 4244 2055 GUGUGGAA G AAAAGCCC 3758
GGGCUUUU GGAGGAAACUCC CU UCAAGGACAUCGUCCGGG UUCCACAC 4245 2060
GAAGAAAA G CCCAGAGA 2373 UCUCUGGG GGAGGAAACUCC CU
UCAAGGACAUCGUCCGGG UUUUCUUC 4246 2065 AAAGCCCA G AGAAAAAU 3759
AUUUUUCU GGAGGAAACUCC CU UCAAGGACAUCGUCCGGG UGGGCUUU 4247 2067
AGCCCAGA G AAAAAUGA 3760 UCAUUUUU GGAGGAAACUCC CU
UCAAGGACAUCGUCCGGG UCUGGGCU 4248 2074 AGAAAAAU G AACGACAC 3761
GUGUCGUU GGAGGAAACUCC CU UCAAGGACAUCGUCCGGG AUUUUUCU 4249 2078
AAAUGAAC G ACACACAU 3762 AUGUGUGU GGAGGAAACUCC CU
UCAAGGACAUCGUCCGGG GUUCAUUU 4250 2087 ACACACAU G UUAGAGCC 2374
GGCUCUAA GGAGGAAACUCC CU UCAAGGACAUCGUCCGGG AUGUGUGU 4251 2091
ACAUGUUA G AGCCCUUC 3763 GAAGGGCU GGAGGAAACUCC CU
UCAAGGACAUCGUCCGGG UAACAUGU 4252 2093 AUGUUAGA G CCCUUCUG 2375
CAGAAGGG GGAGGAAACUCC CU UCAAGGACAUCGUCCGGG UCUAACAU 4253 2101
GCCCUUCU G AAAAAGUA 3764 UACUUUUU GGAGGAAACUCC CU
UCAAGGACAUCGUCCGGG AGAAGGGC 4254 2107 CUGAAAAA G UAUCCUGC 2376
GCAGGAUA GGAGGAAACUCC CU UCAAGGACAUCGUCCGGG UUUUUCAG 4255 2114
AGUAUCCU G CUUCUGAU 2377 AUCAGAAG GGAGGAAACUCC CU
UCAAGGACAUCGUCCGGG AGGAUACU 4256 2120 CUGCUUCU G AUAUGCAG 3765
CUGCAUAU GGAGGAAACUCC CU UCAAGGACAUCGUCCGGG AGAAGCAG 4257 2125
UCUGAUAU G CAGUUUUC 2378 GAAAACUG GGAGGAAACUCC CU
UCAAGGACAUCGUCCGGG AUAUCAGA 4258 2128 GAUAUGCA G UUUUCCUU 2379
AAGGAAAA GGAGGAAACUCC CU UCAAGGACAUCGUCCGGG UGCAUAUC 4259 2153
UAAAAUCU G CUAGGGAA 2380 UUCCCUAG GGAGGAAACUCC CU
UCAAGGACAUCGUCCGGG AGAUUUUA 4260 2157 AUCUGCUA G GGAAUAUC 3766
GAUAUUCC GGAGGAAACUCC CU UCAAGGACAUCGUCCGGG UAGCAGAU 4261 2158
UCUGCUAG G GAAUAUCA 3767 UGAUAUUC GGAGGAAACUCC CU
UCAAGGACAUCGUCCGGG CUAGCAGA 4262 2159 CUGCUAGG G AAUAUCAA 3768
UUGAUAUU GGAGGAAACUCC CU UCAAGGACAUCGUCCGGG CCUAGCAG 4263 2170
UAUCAAUA G AUAUUUAC 3769 GUAAAUAU GGAGGAAACUCC CU
UCAAGGACAUCGUCCGGG UAUUGAUA 4264 2192 AUUUUAAU G UUUCCUUU 2381
AAAGGAAA GGAGGAAACUCC CU UCAAGGACAUCGUCCGGG AUUAAAAU 4265 2230
AUCUUUCU G CAGAAACA 2382 UGUUUCUG GGAGGAAACUCC CU
UCAAGGACAUCGUCCGGG AGAAAGAU 4266 2233 UUUCUGCA G AAACAGAA 3770
UUCUGUUU GGAGGAAACUCC CU UCAAGGACAUCGUCCGGG UGCAGAAA 4267 2239
CAGAAACA G AAAGGUUU 3771 AAACCUUU GGAGGAAACUCC CU
UCAAGGACAUCGUCCGGG UGUUUCUG 4268 2243 AACAGAAA G GUUUUCUU 3772
AAGAAAAC GGAGGAAACUCC CU UCAAGGACAUCGUCCGGG UUUCUGUU 4269 2244
ACAGAAAG G UUUUCUUC 2383 GAAGAAAA GGAGGAAACUCC CU
UCAAGGACAUCGUCCGGG CUUUCUGU 4270 2258 UUCUUUUU G CUUCAAAA 2384
UUUUGAAG GGAGGAAACUCC CU UCAAGGACAUCGUCCGGG AAAAAGAA 4271 2292
UUUUUCCU G GCUCAUCU 3773 AGAUGAGC GGAGGAAACUCC CU
UCAAGGACAUCGUCCGGG AGGAAAAA 4272 2293 UUUUCCUG G CUCAUCUC 2385
GAGAUGAG GGAGGAAACUCC CU UCAAGGACAUCGUCCGGG CAGGAAAA 4273 2326
UUUUUAAA G ACAGAGUC 3774 GACUCUGU GGAGGAAACUCC CU
UCAAGGACAUCGUCCGGG UUUAAAAA 4274 2330 UAAAGACA G AGUCUCGC 3775
GCGAGACU GGAGGAAACUCC CU UCAAGGACAUCGUCCGGG UGUCUUUA 4275 2332
AAGACAGA G UCUCGCUC 2386 GAGCGAGA GGAGGAAACUCC CU
UCAAGGACAUCGUCCGGG UCUGUCUU 4276 2337 AGAGUCUC G CUCUGUUG 2387
CAACAGAG GGAGGAAACUCC CU UCAAGGACAUCGUCCGGG GAGACUCU 4277 2342
CUCGCUCU G UUGCCCAG 2388 CUGGGCAA GGAGGAAACUCC CU
UCAAGGACAUCGUCCGGG AGAGCGAG 4278 2345 GCUCUGUU G CCCAGGCU 2389
AGCCUGGG GGAGGAAACUCC CU UCAAGGACAUCGUCCGGG AACAGAGC 4279 2350
GUUGCCCA G GCUGGAGU 3776 ACUCCAGC GGAGGAAACUCC CU
UCAAGGACAUCGUCCGGG UGGGCAAC 4280 2351 UUGCCCAG G CUGGAGUG 2390
CACUCCAG GGAGGAAACUCC CU UCAAGGACAUCGUCCGGG CUGGGCAA 4281 2354
CCCAGGCU G GAGUGCAA 3777 UUGCACUC GGAGGAAACUCC CU
UCAAGGACAUCGUCCGGG AGCCUGGG 4282 2355 CCAGGCUG G AGUGCAAU 3778
AUUGCACU GGAGGAAACUCC CU UCAAGGACAUCGUCCGGG CAGCCUGG 4283 2357
AGGCUGGA G UGCAAUGA 2391 UCAUUGCA GGAGGAAACUCC CU
UCAAGGACAUCGUCCGGG UCCAGCCU 4284 2359 GCUGGAGU G CAAUGACA 2392
UGUCAUUG GGAGGAAACUCC CU UCAAGGACAUCGUCCGGG ACUCCAGC 4285 2364
AGUGCAAU G ACACAGUC 3779 GACUGUGU GGAGGAAACUCC CU
UCAAGGACAUCGUCCGGG AUUGCACU 4286 2370 AUGACACA G UCUUGGCU 2393
AGCCAAGA GGAGGAAACUCC CU UCAAGGACAUCGUCCGGG UGUGUCAU 4287 2375
ACAGUCUU G GCUCACUG 3780 CAGUGAGC GGAGGAAACUCC CU
UCAAGGACAUCGUCCGGG AAGACUGU 4288 2376 CAGUCUUG G CUCACUGC 2394
GCAGUGAG GGAGGAAACUCC CU UCAAGGACAUCGUCCGGG CAAGACUG 4289 2383
GGCUCACU G CAACUUCU 2395 AGAAGUUG GGAGGAAACUCC CU
UCAAGGACAUCGUCCGGG AGUGAGCC 4290 2392 CAACUUCU G CCUCUUGG 2396
CCAAGAGG GGAGGAAACUCC CU UCAAGGACAUCGUCCGGG AGAAGUUG 4291 2399
UGCCUCUU G GGUUCAAG 3781 CUUGAACC GGAGGAAACUCC CU
UCAAGGACAUCGUCCGGG AAGAGGCA 4292 2400 GCCUCUUG G GUUCAAGU 3782
ACUUGAAC GGAGGAAACUCC CU UCAAGGACAUCGUCCGGG CAAGAGGC 4293 2401
CCUCUUGG G UUCAAGUG 2397 CACUUGAA GGAGGAAACUCC CU
UCAAGGACAUCGUCCGGG CCAAGAGG 4294 2407 GGGUUCAA G UGAUUCUC 2398
GAGAAUCA GGAGGAAACUCC CU UCAAGGACAUCGUCCGGG UUGAACCC 4295 2409
GUUCAAGU G AUUCUCCU 3783 AGGAGAAU GGAGGAAACUCC CU
UCAAGGACAUCGUCCGGG ACUUGAAC 4296 2418 AUUCUCCU G CCUCAGCC 2399
GGCUGAGG GGAGGAAACUCC CU UCAAGGACAUCGUCCGGG AGGAGAAU 4297 2424
CUGCCUCA G CCUCCUGA 2400 UCAGGAGG GGAGGAAACUCC CU
UCAAGGACAUCGUCCGGG UGAGGCAG 4298 2431 AGCCUCCU G AGUAGCUG 3784
CAGCUACU GGAGGAAACUCC CU UCAAGGACAUCGUCCGGG AGGAGGCU 4299 2433
CCUCCUGA G UAGCUGGA 2401 UCCAGCUA GGAGGAAACUCC CU
UCAAGGACAUCGUCCGGG UCAGGAGG 4300 2436 CCUGAGUA G CUGGAUUA 2402
UAAUCCAG GGAGGAAACUCC CU UCAAGGACAUCGUCCGGG UACUCAGG 4301 2439
GAGUAGCU G GAUUACAG 3785 CUGUAAUC GGAGGAAACUCC CU
UCAAGGACAUCGUCCGGG AGCUACUC 4302 2440 AGUAGCUG G AUUACAGG 3786
CCUGUAAU GGAGGAAACUCC CU UCAAGGACAUCGUCCGGG CAGCUACU 4303 2447
GGAUUACA G GCAUGUGC 3787 GCACAUGC GGAGGAAACUCC CU
UCAAGGACAUCGUCCGGG UGUAAUCC 4304 2448 GAUUACAG G CAUGUGCC 2403
GGCACAUG GGAGGAAACUCC CU UCAAGGACAUCGUCCGGG CUGUAAUC 4305 2452
ACAGGCAU G UGCCACCC 2404 GGGUGGCA GGAGGAAACUCC CU
UCAAGGACAUCGUCCGGG AUGCCUGU 4306 2454 AGGCAUGU G CCACCCAC 2405
GUGGGUGG GGAGGAAACUCC CU UCAAGGACAUCGUCCGGG ACAUGCCU 4307 2476
UAAUUUUU G UGUUUUUA 2406 UAAAAACA GGAGGAAACUCC CU
UCAAGGACAUCGUCCGGG AAAAAUUA 4308 2478 AUUUUUGU G UUUUUAAU 2407
AUUAAAAA GGAGGAAACUCC CU UCAAGGACAUCGUCCGGG ACAAAAAU 4309 2490
UUAAUAAA G ACAGGGUU 3788 AACCCUGU GGAGGAAACUCC CU
UCAAGGACAUCGUCCGGG UUUAUUAA 4310 2494 UAAAGACA G GGUUUCAC 3789
GUGAAACC GGAGGAAACUCC CU UCAAGGACAUCGUCCGGG UGUCUUUA 4311 2495
AAAGACAG G GUUUCACC 3790 GGUGAAAC GGAGGAAACUCC CU
UCAAGGACAUCGUCCGGG CUGUCUUU 4312 2496 AAGACAGG G UUUCACCA 2408
UGGUGAAA GGAGGAAACUCC CU UCAAGGACAUCGUCCGGG
CCUGUCUU 4313 2506 UUCACCAU G UUGGCCAG 2409 CUGGCCAA GGAGGAAACUCC
CU UCAAGGACAUCGUCCGGG AUGGUGAA 4314 2509 ACCAUGUU G GCCAGGCU 3791
AGCCUGGC GGAGGAAACUCC CU UCAAGGACAUCGUCCGGG AACAUGGU 4315 2510
CCAUGUUG G CCAGGCUG 2410 CAGCCUGG GGAGGAAACUCC CU
UCAAGGACAUCGUCCGGG CAACAUGG 4316 2514 GUUGGCCA G GCUGGUCU 3792
AGACCAGC GGAGGAAACUCC CU UCAAGGACAUCGUCCGGG UGGCCAAC 4317 2515
UUGGCCAG G CUGGUCUC 2411 GAGACCAG GGAGGAAACUCC CU
UCAAGGACAUCGUCCGGG CUGGCCAA 4318 2518 GCCAGGCU G GUCUCAAA 3793
UUUGAGAC GGAGGAAACUCC CU UCAAGGACAUCGUCCGGG AGCCUGGC 4319 2519
CCAGGCUG G UCUCAAAC 2412 GUUUGAGA GGAGGAAACUCC CU
UCAAGGACAUCGUCCGGG CAGCCUGG 4320 2532 AAACUCCU G ACCUCAAG 3794
CUUGAGGU GGAGGAAACUCC CU UCAAGGACAUCGUCCGGG AGGAGUUU 4321 2540
GACCUCAA G UAAUCCAC 2413 GUGGAUUA GGAGGAAACUCC CU
UCAAGGACAUCGUCCGGG UUGAGGUC 4322 2551 AUCCACCU G CCUCGGCC 2414
GGCCGAGG GGAGGAAACUCC CU UCAAGGACAUCGUCCGGG AGGUGGAU 4323 2556
CCUGCCUC G GCCUCCCA 3795 UGGGAGGC GGAGGAAACUCC CU
UCAAGGACAUCGUCCGGG GAGGCAGG 4324 2557 CUGCCUCG G CCUCCCAA 2415
UUGGGAGG GGAGGAAACUCC CU UCAAGGACAUCGUCCGGG CGAGGCAG 4325 2567
CUCCCAAA G UGCUGGGA 2416 UCCCAGCA GGAGGAAACUCC CU
UCAAGGACAUCGUCCGGG UUUGGGAG 4326 2569 CCCAAAGU G CUGGGAUU 2417
AAUCCCAG GGAGGAAACUCC CU UCAAGGACAUCGUCCGGG ACUUUGGG 4327 2572
AAAGUGCU G GGAUUACA 3796 UGUAAUCC GGAGGAAACUCC CU
UCAAGGACAUCGUCCGGG AGCACUUU 4328 2573 AAGUGCUG G GAUUACAG 3797
CUGUAAUC GGAGGAAACUCC CU UCAAGGACAUCGUCCGGG CAGCACUU 4329 2574
AGUGCUGG G AUUACAGG 3798 CCUGUAAU GGAGGAAACUCC CU
UCAAGGACAUCGUCCGGG CCAGCACU 4330 2581 GGAUUACA G GGAUGAGC 3799
GCUCAUCC GGAGGAAACUCC CU UCAAGGACAUCGUCCGGG UGUAAUCC 4331 2582
GAUUACAG G GAUGAGCC 3800 GGCUCAUC GGAGGAAACUCC CU
UCAAGGACAUCGUCCGGG CUGUAAUC 4332 2583 AUUACAGG G AUGAGCCA 3801
UGGCUCAU GGAGGAAACUCC CU UCAAGGACAUCGUCCGGG CCUGUAAU 4333 2586
ACAGGGAU G AGCCACCG 3802 CGGUGGCU GGAGGAAACUCC CU
UCAAGGACAUCGUCCGGG AUCCCUGU 4334 2588 AGGGAUGA G CCACCGCG 2418
CGCGGUGG GGAGGAAACUCC CU UCAAGGACAUCGUCCGGG UCAUCCCU 4335 2594
GAGCCACC G CGCCCAGC 2419 GCUGGGCG GGAGGAAACUCC CU
UCAAGGACAUCGUCCGGG GGUGGCUC 4336 2596 GCCACCGC G CCCAGCCU 2420
AGGCUGGG GGAGGAAACUCC CU UCAAGGACAUCGUCCGGG GCGGUGGC 4337 2601
CGCGCCCA G CCUCAUCU 2421 AGAUGAGG GGAGGAAACUCC CU
UCAAGGACAUCGUCCGGG UGGGCGCG 4338 2614 AUCUCUUU G UUCUAAAG 2422
CUUUAGAA GGAGGAAACUCC CU UCAAGGACAUCGUCCGGG AAAGAGAU 4339 2622
GUUCUAAA G AUGGAAAA 3803 UUUUCCAU GGAGGAAACUCC CU
UCAAGGACAUCGUCCGGG UUUAGAAC 4340 2625 CUAAAGAU G GAAAAACC 3804
GGUUUUUC GGAGGAAACUCC CU UCAAGGACAUCGUCCGGG AUCUUUAG 4341 2626
UAAAGAUG G AAAAACCA 3805 UGGUUUUU GGAGGAAACUCC CU
UCAAGGACAUCGUCCGGG CAUCUUUA 4342 2664 CUAUUAAU G AAUCAAUC 3806
GAUUGAUU GGAGGAAACUCC CU UCAAGGACAUCGUCCGGG AUUAAUAG 4343 2702
UUUCUACC G CUUUUAGG 2423 CCUAAAAG GGAGGAAACUCC CU
UCAAGGACAUCGUCCGGG GGUAGAAA 4344 2709 CGCUUUUA G GCCAAAAA 3807
UUUUUGGC GGAGGAAACUCC CU UCAAGGACAUCGUCCGGG UAAAAGCG 4345 2710
GCUUUUAG G CCAAAAAA 2424 UUUUUUGG GGAGGAAACUCC CU
UCAAGGACAUCGUCCGGG CUAAAAGC 4346 2721 AAAAAAAU G UAAGAUCG 2425
CGAUCUUA GGAGGAAACUCC CU UCAAGGACAUCGUCCGGG AUUUUUUU 4347 2725
AAAUGUAA G AUCGUUCU 3808 AGAACGAU GGAGGAAACUCC CU
UCAAGGACAUCGUCCGGG UUACAUUU 4348 2729 GUAAGAUC G UUCUCUGC 2426
GCAGAGAA GGAGGAAACUCC CU UCAAGGACAUCGUCCGGG GAUCUUAC 4349 2736
CGUUCUCU G CCUCACAU 2427 AUGUGAGG GGAGGAAACUCC CU
UCAAGGACAUCGUCCGGG AGAGAACG 4350 2746 CUCACAUA G CUUACAAG 2428
CUUGUAAG GGAGGAAACUCC CU UCAAGGACAUCGUCCGGG UAUGUGAG 4351 2754
GCUUACAA G CCAGCUGG 2429 CCAGCUGG GGAGGAAACUCC CU
UCAAGGACAUCGUCCGGG UUGUAAGC 4352 2758 ACAAGCCA G CUGGAGAA 2430
UUCUCCAG GGAGGAAACUCC CU UCAAGGACAUCGUCCGGG UGGCUUGU 4353 2761
AGCCAGCU G GAGAAAUA 3809 UAUUUCUC GGAGGAAACUCC CU
UCAAGGACAUCGUCCGGG AGCUGGCU 4354 2762 GCCAGCUG G AGAAAUAU 3810
AUAUUUCU GGAGGAAACUCC CU UCAAGGACAUCGUCCGGG CAGCUGGC 4355 2764
CAGCUGGA G AAAUAUGG 3811 CCAUAUUU GGAGGAAACUCC CU
UCAAGGACAUCGUCCGGG UCCAGCUG 4356 2771 AGAAAUAU G GUACUCAU 3812
AUGAGUAC GGAGGAAACUCC CU UCAAGGACAUCGUCCGGG AUAUUUCU 4357 2772
GAAAUAUG G UACUCAUU 2431 AAUGAGUA GGAGGAAACUCC CU
UCAAGGACAUCGUCCGGG CAUAUUUC 4358 2796 AAAAAAAA G UGAUGUAC 2432
GUACAUCA GGAGGAAACUCC CU UCAAGGACAUCGUCCGGG UUUUUUUU 4359 2798
AAAAAAGU G AUGUACAA 3813 UUGUACAU GGAGGAAACUCC CU
UCAAGGACAUCGUCCGGG ACUUUUUU 4360 Input Sequence = NM_002759. Cut
Site = G/. Arm Length = 8. Core Sequence = GGAGGAAACUCC CU
UCAAGGACAUCGUCCGGG NM_002759 (Homo sapiens protein kinase,
interferon-inducible double stranded RNA dependent (PRKR), mRNA.;
2808 bp)
[0275] TABLE-US-00013 TABLE XIII Human IKK-gamma and PKR Nucleic
Acid and Target molecules Seq Gene Pos Target Seq ID RPI# Enzymatic
Nucleic Acid ID PKR 563 UUUACAUUUCAAGUU 7771 24072
a.sub.Sa.sub.Sc.sub.Su.sub.SugacUGAuGaggccguuaggccGaaAuguaaaB 7884
PKR 571 UCAAGUUAUAAUAGA 7772 24073
u.sub.Sc.sub.Su.sub.Sa.sub.SuuacUGAuGaggccguuaggccGaaAacuugaB 7885
PKR 644 GCCAAAUUAGCUGUU 7773 24074
a.sub.Sa.sub.Sc.sub.Sa.sub.SgcucUGAuGaggccguuaggccGaaAuuuggcB 7886
PKR 645 CCAAAUUAGCUGUUG 7774 24075
c.sub.Sa.sub.Sa.sub.Sc.sub.SagccUGAuGaggccguuaggccGaaAauuuggB 7887
PKR 1259 UUGGCUCAGGUGG 7775 24076
c.sub.Sc.sub.Sa.sub.Sc.sub.ScucUGAuGaggccguuaggccGaaAgccaaB 7888
PKR 1259 AUUGGCUCAGGUGGA 7776 24077
u.sub.Sc.sub.Sc.sub.Sa.sub.SccucUGAuGaggccguuaggccGaaAgccaauB 7889
PKR 1538 UGGAAUUCUGUGA 7777 24078
u.sub.Sc.sub.Sa.sub.Sc.sub.SagcUGAuGaggccguuaggccGaaAuuccaB 7890
PKR 1538 AUGGAAUUCUGUGAU 7778 24079
a.sub.Su.sub.Sc.sub.Sa.sub.ScagcUGAuGaggccguuaggccGaaAuuccauB 7891
PKR 1678 AGAGAUCUUAAGC 7779 24080
g.sub.Sc.sub.Su.sub.Su.sub.SaacUGAuGaggccguuaggccGaaAucucuB 7892
PKR control GACGAUUGCAAUC 7780 24081
g.sub.Sa.sub.Su.sub.Su.sub.SgccUAGuGacgccguuaggcgGaaAucgucB 7893
PKR control ACACCGUUGGAUCGC 7781 24082
g.sub.Sc.sub.Sg.sub.Sa.sub.SucccUAGuGaggccguuaggccGaalcgguguB 7894
PKR 764 UUGCCCAGAAGAA 7782 24153
u.sub.Su.sub.Sc.sub.Su.sub.SuccUGAuGaggccguuaggccGaalggcaaB 7895
PKR 1540 GGAAUUCUGUGAUAA 7783 24154
u.sub.Su.sub.Sa.sub.Su.sub.ScaccUGAuGaggccguuaggccGaalaauuccB 7896
PKR 1679 GAGAUCUUAAGCC 7784 24155
g.sub.Sg.sub.Sc.sub.Su.sub.SuacUGAuGaggccguuaggccGaalaucucB 7897
PKR 1679 AGAGAUCUUAAGCCA 7785 24156
u.sub.Sg.sub.Sg.sub.Sc.sub.SuuacUGAuGaggccguuaggccGaalaucucuB 7898
PKR Control ACUGGCAUACAUG 7786 24157
c.sub.Sa.sub.Su.sub.Sg.sub.SuacUAGuGacgccguuaggcgGaaIccaguB 7899
PKR Control CAUUCGCUAAAUGAG 7787 24158
c.sub.Su.sub.Sc.sub.Sa.sub.SuuucUAGuGacgccguuaggcgGaalcgaaugB 7900
PKR 1348 GAGAAGGCGGAGC 7788 24210
g.sub.Sc.sub.Su.sub.Sc.sub.ScggccgaaaggCgagugaGguCucuucucB 7901 PKR
Control CCGUACGUUAAGA 7789 24211
u.sub.Sc.sub.Su.sub.Su.sub.SaagccgaaaggCuCugGagugagguacggB 7902 PKR
Control ACGAAGAGUUACCUU 7790 24212
a.sub.Sa.sub.Sg.sub.Sg.sub.SuaagccgaaaggCuCugGagugagucuucguB 7903
PKR 1224 AGAGGUUUGGCAUGG 7791 24416
ccaugccCUGAUGAggccguuaggccGAAAaccucuB 7904 PKR 1556 GGGACCUUGGAACAA
7792 24417 uuguuccCUGAUGAggccguuaggccGAAAggucccB 7905 PKR 1780
AAGGAGUAAGGGAAC 7793 24418 guucccuCUGAUGAggccguuaggccGAAAcuccuuB
7906 PKR 2296 CCUGGCUCAUCUCUU 7794 24419
aagagauCUGAUGAggccguuaggccGAAAgccaggB 7907 PKR 2732 GAUCGUUCUCUGCCU
7795 24420 aggcagaCUGAUGAggccguuaggccGAAAacgaucB 7908 PKR 198
UACUCGCUGUCUGUC 7796 24421 gacagacCUGAUGAggccguuaggccGAAlcgaguaB
7909 PKR 322 GCAGUUCUUCCAUCU 7797 24422
agauggaCUGAUGAggccguuaggccGAAlaacugcB 7910 PKR 1805 AUGAGCCCAGAACAG
7798 24423 cuguucuCUGAUGAggccguuaggccGAAlgcucauB 7911 PKR 2297
CUGGCUCAUCUCUUU 7799 24424 aaagagaCUGAUGAggccguuaggccGAAlagccagB
7912 PKR 2733 AUCGUUCUCUGCCUC 7800 24425
gaggcagCUGAUGAggccguuaggccGAAlaacgauB 7913 PKR 199 ACUCGCUGUCUGUCA
7801 24426 ugacagagccgaaaggCgagugaGGuCuagcgaguB 7914 PKR 810
CGGGGGUGCAUGGGC 7802 24427 gcccauggccgaaaggCgagugaGGuCuacccccgB
7915 PKR 904 ACAAUUGGCCGCUAA 7803 24428
uuagcgggccgaaaggCgagugaGGuCucaauuguB 7916 PKR 966 ACUACCUGUCCUCUG
7804 24429 cagaggagccgaaaggCgagugaGGuCuagguaguB 7917 PKR 992
ACUACGUGUGAGUCC 7805 24430 ggacucagccgaaaggCgagugaGGuCuacguaguB
7918 PKR 396 UGCGUGCAUUUUGGA 7806 24431
uccaaaaGGCTAGCTACAACGAgcacgcaB 7919 PKR 966 ACUACCUGUCCUCUG 7804
24432 cagaggaGGCTAGCTACAACGAagguaguB 7920 PKR 1563 UGGAACAAUGGAUUG
7807 24433 caauccaGGCTAGCTACAACGAuguuccaB 7921 PKR 2297
CUGGCUCAUCUCUUU 7799 24434 aaagagaGGCTAGCTACAACGAgagccagB 7922 PKR
2543 UCAAGUAAUCCACCU 7808 24435 agguggaGGCTAGCTACAACGAuacuugaB 7923
PKR 604 AGGUGAAGGUAGAUC 7809 24436
gaucuacGgaggaaacucCCUUCaaggacaucgucCGGGuucaccuB 7924 PKR 903
AACAAUUGGCCGCUA 7810 24437
uagcggcGgaggaaacucCCUUCaaggacaucgucCGGGaauuguuB 7925 PKR 966
ACUACCUGUCCUCUG 7804 24438
cagaggaGgaggaaacucCCUUCaaggacaucgucCGGGagguaguB 7926 PKR 1186
CCUUCCUGACAUGAA 7811 24439
uucauguGgaggaaacucCCUUCaaggacaucgucCGGGaggaaggB 7927 PKR 2292
UUUUCCUGGCUCAUC 7812 24440
gaugagcGgaggaaacucCCUUCaaggacaucgucCGGGaggaaaaB 7928 IKKg 427
AGUUCCUCAUGUGCA 7813 24083
u.sub.Sg.sub.Sc.sub.Sa.sub.ScaucUGAuGaggccguuaggccGaaAggaacuB 7929
IKKg 1067 GCGGAUAUCUACA 7814 24084
u.sub.Sg.sub.Su.sub.Sa.sub.SgacUGAuGaggccguuaggccGaaAuccgcB 7930
IKKg 1067 GGCGGAUAUCUACAA 7815 24085
u.sub.Su.sub.Sg.sub.Su.sub.SagacUGAuGaggccguuaggccGaaAuccgccB 7931
IKKg 1069 CGGAUAUCUACAAGG 7816 24086
c.sub.Sc.sub.Su.sub.Su.sub.SguacUGAuGaggccguuaggccGaaAuauccgB 7932
IKKg 1071 AUAUCUACAAGGC 7817 24087
g.sub.Sc.sub.Sc.sub.Su.sub.SugcUGAuGaggccguuaggccGaaAgauauB 7933
IKKg 1390 UACAUGUCAUGGAGU 7818 24088
a.sub.Sc.sub.Su.sub.Sc.sub.ScaucUGAuGaggccguuaggccGaaAcauguaB 7934
IKKg 1402 AGUGCAUUGAGUAGG 7819 24089
c.sub.Sc.sub.Su.sub.Sa.sub.ScuccUGAuGaggccguuaggccGaaAugcacuB 7935
IKKg control ACGACUCGGAGCU 7820 24090
a.sub.Sg.sub.Sc.sub.Su.sub.ScccUAGuGacgccguuaggcgGaaAgucguB 7936
IKKg control UCUGAGUCAGGCGAC 7821 24091
g.sub.Su.sub.Sc.sub.Sg.sub.SccucUAGuGacgccguuaggcgGaaAcucagaB 7937
IKKg 195 UGCAGCCCAGUGG 7822 24159
c.sub.Sc.sub.Sa.sub.Sc.sub.SugcUGAuGaggccguuaggccGaalcugcaB 7938
IKKg 196 GCAGCCCAGUGGU 7823 24160
a.sub.Sc.sub.Sc.sub.Sa.sub.ScucUGAuGaggccguuaggccGaalgcugcB 7939
IKKg 303 CCCUCCAGCGCUG 7824 24161
c.sub.Sa.sub.Sg.sub.Sc.sub.SgccUGAuGaggccguuaggccGaalgagggB 7940
IKKg 324 AGAAUCAAGAGCU 7825 24162
a.sub.Sg.sub.Sc.sub.Su.sub.ScucUGAuGaggccguuaggccGaalauucuB 7941
IKKg 324 GAGAAUCAAGAGCUC 7826 24163
g.sub.Sa.sub.Sg.sub.Sc.sub.SucucUGAuGaggccguuaggccGaalauucucB 7942
IKKg 556 GAUGGCUGAGGAC 7827 24164
g.sub.Su.sub.Sc.sub.Sc.sub.SuccUGAuGaggccguuaggccGaalccaucB 7943
IKKg 556 AGAUGGCUGAGGACA 7828 24165
u.sub.Sg.sub.Su.sub.Sc.sub.ScuccUGAuGaggccguuaggccGaalccaucuB 7944
IKKg 568 ACAAGGCCUCUGUGA 7829 24166
u.sub.Sc.sub.Sa.sub.Sc.sub.SagacUGAuGaggccguuaggccGaalccuuguB 7945
IKKg 571 GGCCUCUGUGAAA 7830 24167
u.sub.Su.sub.Su.sub.Sc.sub.SaccUGAuGaggccguuaggccoaalaggccB 7946
IKKg 580 UGAAAGCCCAGGUGA 7831 24168
u.sub.Sc.sub.Sa.sub.Sc.sub.ScugcUGAuGaggccguuaggccGaalcuuucaB 7947
IKKg 749 GUGGACCAGCUGC 7832 24169
g.sub.Sc.sub.Sa.sub.Sg.sub.ScucUGAuGaggccguuaggccGaaluccacB 7948
lKKg 927 UGCAGCUGGAAGA 7833 24170
u.sub.Sc.sub.Su.sub.Su.sub.ScccUGAuGaggccguuaggccGaalcugcaB 7949
lKKg 927 AUGCAGCUGGAAGAU 7834 24171
a.sub.Su.sub.Sc.sub.Su.sub.SucccUGAuGaggccguuaggccGaalcugcauB 7950
IKKg 1012 GGAGGCCGAGCAG 7835 24172
c.sub.Su.sub.Sg.sub.Sc.sub.SuccUGAuGaggccguuaggccGaalccuccB 7951
IKKg 1012 AGGAGGCCGAGCAGC 7836 24173
g.sub.Sc.sub.Su.sub.Sg.sub.ScuccUGAuGaggccguuaggccGaalccuccuB 7952
IKKg 1020 AGCAGCACAAGAU 7837 24174
a.sub.Su.sub.Sc.sub.Su.sub.SugcUGAuGaggccguuaggccGaalcugcuB 7953
IKKg 1020 GAGCAGCACAAGAUU 7838 24175
a.sub.Sa.sub.Su.sub.Sc.sub.SuugcUGAuGaggccguuaggccGaalcugcucB 7954
IKKg 1022 GCAGCACAAGAUUGU 7839 24176
a.sub.Sc.sub.Sa.sub.Sa.sub.SucucUGAuGaggccguuaggccGaalugcugcB 7955
IKKg 1070 GGAUAUCUACAAGGC 7840 24177
g.sub.Sc.sub.Sc.sub.Su.sub.SugucUGAuGaggccguuaggccGaalauauccB 7956
IKKg 1143 AGGAGCAGCUGGA 7841 24178
u.sub.Sc.sub.Sc.sub.Sa.sub.SgccUGAuGaggccguuaggccGaalcuccuB 7957
IKKg 1350 AAGUGCCAGUAUCAG 7842 24179
c.sub.Su.sub.Sg.sub.Sa.sub.SuaccUGAuGaggccguuaggccGaalgcacuuB 7958
IKKg 1391 CAUGUCAUGGAGU 7843 24180
a.sub.Sc.sub.Su.sub.Sc.sub.ScacUGAuGaggccguuaggccGaalacaugB 7959
IKKg 1391 ACAUGUCAUGGAGUG 7844 24181
c.sub.Sa.sub.Sc.sub.Su.sub.SccacUGAuGaggccguuaggccGaalacauguB 7960
IKKg Control CACGUCUGCGGAA 7845 24182
u.sub.Su.sub.Sc.sub.Sc.sub.SgccUAGuGacgccguuaggcgGaalacgugB 7961
IKKg Control UCGGAACCAGGUCUG 7846 24183
c.sub.Sa.sub.Sg.sub.Sa.sub.SccucUAGuGacgccguuaggcgGaaluuccgaB 7962
IKKg 304 CCCUCCAGCGCUGCC 7847 24213
g.sub.Sg.sub.Sc.sub.Sa.sub.SgcggccgaaaggCgagugaGguCuuggagggB 7963
IKKg 306 CUCCAGCGCUGCCUG 7848 24214
c.sub.Sa.sub.Sg.sub.Sg.sub.ScaggccgaaaggCgagugaGguCugcuggagB 7964
IKKg 309 AGCGCUGCCUGGA 7849 24215
u.sub.Sc.sub.Sc.sub.Sa.sub.SgggccgaaaggCgagugaGguCuagcgcuB 7965
IKKg 328 UCAAGAGCUCCGA 7850 24216
u.sub.Sc.sub.Sg.sub.Sg.sub.SaggccgaaaggCgagugaGguCuucuugaB 7966
IKKg 328 AUCAAGAGCUCCGAG 7851 24217
c.sub.Su.sub.Sc.sub.Sg.sub.SgaggccgaaaggCgagugaGguCuucuugauB 7967
IKKg 572 GCCUCUGUGAAAG 7852 24218
c.sub.Su.sub.Su.sub.Su.sub.ScagccgaaaggCgagugaGguCuagaggcB 7968
IKKg 572 GGCCUCUGUGAAAGC 7853 24219
g.sub.Sc.sub.Su.sub.Su.sub.SucagccgaaaggCgagugaGguCuagaggccB 7969
IKKg 705 UGGAGAGUGAGCG 7854 24220
c.sub.Sg.sub.Sc.sub.Su.sub.ScagccgaaaggCgagugaGguCuucuccaB 7970
IKKg 1028 CAAGAUUGUGAUGGA 7855 24221
u.sub.Sc.sub.Sc.sub.Sa.sub.SucagccgaaaggCgagugaGguCuaaucuugB 7971
IKKg 1222 GAGGAAGCGGCAU 7856 24222
a.sub.Su.sub.Sg.sub.Sc.sub.ScggccgaaaggCgagugaGguCuuuccucB 7972
IKKg 1222 UGAGGAAGCGGCAUG 7857 24223
c.sub.Sa.sub.Su.sub.Sg.sub.SccggccgaaaggCgagugaGguCuuuccucaB 7973
IKKg 1351 AGUGCCAGUAUCAGG 7858 24224
c.sub.Sc.sub.Su.sub.Sg.sub.SauagccgaaaggCgagugaGguCuuggcacuB 7974
IKKg Control ACUCCGGCGUAGA 7859 24225
u.sub.Sc.sub.Su.sub.Sa.sub.ScggccgaaaggCuCugGagugagcggaguB 7975
IKKg Control GUGACGCGUGUCACA 7860 24226
u.sub.Sg.sub.Su.sub.Sg.sub.SacagccgaaaggCuCugGagugaggcgucacB 7976
IKKg 438 UGCAAGUUCCAGGAG 7861 24463
cuccuggCUGAUGAggccguuaggccGAAAcuugcaB 7977 IKKg 1167
AGGGAGUACAGCAAA 7862 24464 uuugcugCUGAUGAggccguuaggccGAAAcucccuB
7978 IKKg 1273 CCUACCUCUCCUCUC 7863 24465
gagaggaCUGAUGAggccguuaggccGAAAgguaggB 7979 IKKg 1639
CGCUGCUCUUUUUGU 7864 24466 acaaaaaCUGAUGAggccguuaggccGAAAgcagcgB
7980 IKKg 1781 GGCAGCUCUUCCUCC 7865 24467
ggaggaaCUGAUGAggccguuaggccGAAAgcugccB 7981 IKKg 741 AGCGUGCAGGUGGAC
7866 24468 guccaccCUGAUGAggccguuaggccGAAlcacgcuB 7982 IKKg 1158
CAGCUGCAGAGGGAG 7867 24469 cucccucCUGAUGAggccguuaggccGAAlcagcugB
7983 IKKg 1272 GCCUACCUCUCCUCU 7868 24470
agaggagCUGAUGAggccguuaggccGAAlguaggcB 7984 IKKg 1650
UUGUUCCCUUCUGUC 7869 24471 gacagaaCUGAUGAggccguuaggccGAAlgaacaaB
7985 IKKg 1834 UGCUGCCCUCUUACC 7870 24472
gguaagaCUGAUGAggccguuaggccGAAlgcagcaB 7986 IKKg 52 CAGAGAAGUGAGGAC
7871 24473 guccucagccgaaaggCgagugaGGuCuuucucugB 7987 IKKg 124
CAUCGAGGUCCCAUC 7872 24474 gaugggagccgaaaggCgagugaGGuCucucgaugB
7988 IKKg 1338 UUCUGCUGUCCCAAG 7873 24475
cuugggagccgaaaggCgagugaGGuCuagcagaaB 7989 IKKg 1633 CUGACUCGCUGCUCU
7874 24476 agagcaggccgaaaggCgagugaGGuCugagucagB 7990 IKKg 1655
CCCUUCUGUCUGCUC 7875 24477 gagcagagccgaaaggCgagugaGGuCuagaagggB
7991 IKKg 52 CAGAGAAGUGAGGAC 7871 24478
guccucaGGCTAGCTACAACGAuucucugB 7992 IKKg 216 GCAGCAGAUCAGGAC 7876
24479 guccugaGGCTAGCTACAACGAcugcugcB 7993 IKKg 538 UGAAGAGAUGCCAGC
7877 24480 gcuggcaGGCTAGCTACAACGAcucuucaB 7994 IKKg 868
UCCAAGAAUACGACA 7878 24481 ugucguaGGCTAGCTACAACGAucuuggaB 7995 IKKg
940 AUCUCAAACAGCAGC 7879 24482 gcugcugGGCTAGCTACAACGAuugagauB 7996
IKKg 52 CAGAGAAGUGAGGAC 7871 24483
guccucaGgaggaaacucCCUUCaaggacaucgucCGGGuucucugB 7997 IKKg 215
GGCAGCAGAUCAGGA 7880 24484
uccugauGgaggaaacucCCUUCaaggacaucgucCGGGugcugccB 7998 IKKg 817
CGGAGGAGAAGAGGA 7881 24485
uccucuuGgaggaaacucCCUUCaaggacaucgucCGGGuccuccgB 7999 IKKg 986
ACAGGAGGUGAUCGA 7882 24486
ucgaucaGgaggaaacucCCUUCaaggacaucgucCGGGcuccuguB 8000 IKKg 1826
CCUGGGAGUGCUGCC 7883 24487
ggcagcaGgaggaaacucCCUUCaaggacaucgucCGGGucccaggB 8001 A, G, C, U =
Ribo A, G, C, T (italic) = deoxy lower case = 2'-O-methyl s =
phosphorothioate 3'-internucleotide linkage U = 2'-deoxy-2'-C-allyl
uridine U = 2'-deoxy-2'-Amino uridine C = 2'-deoxy-2'-Amino
cytidine I = Inosine B = inverted deoxyabasic derivative
[0276]
Sequence CWU 0 SQTB SEQUENCE LISTING The patent application
contains a lengthy "Sequence Listing" section. A copy of the
"Sequence Listing" is available in electronic form from the USPTO
web site
(http://seqdata.uspto.gov/?pageRequest=docDetail&DocID=US20060154271A1).
An electronic copy of the "Sequence Listing" will also be available
from the USPTO upon request and payment of the fee set forth in 37
CFR 1.19(b)(3).
0 SQTB SEQUENCE LISTING The patent application contains a lengthy
"Sequence Listing" section. A copy of the "Sequence Listing" is
available in electronic form from the USPTO web site
(http://seqdata.uspto.gov/?pageRequest=docDetail&DocID=US20060154271A1).
An electronic copy of the "Sequence Listing" will also be available
from the USPTO upon request and payment of the fee set forth in 37
CFR 1.19(b)(3).
* * * * *
References